% Exported from Psilocybin Research Publication Tracker
% Tracker site: https://psilocybin-research.com
% Publication tracker: https://psilocybin-research.com/
\documentclass[11pt]{article}
\usepackage[T1]{fontenc}
\usepackage[utf8]{inputenc}
\usepackage{enumitem}
\usepackage[hidelinks]{hyperref}
\usepackage[margin=1in]{geometry}
\title{Psilocybin and Psilocin Research Export}
\author{Psilocybin Research Publication Tracker}
\date{2026-07-05}
\begin{document}
\maketitle
\noindent Exported from \href{https://psilocybin-research.com}{psilocybin-research.com}. Records: 4054.

\begin{enumerate}[leftmargin=*]
\item Ibi Daisuke, Takaba Rika, Yoshida Keisuke, Kawase Ririna, Kitagawa Hiroko, Matsushita Momoko, Ito Kana, Uno Shoya, Nishimura Fumiya, Kitagaki Shinji, Hiramatsu Masayuki (2026). \textit{Contribution of the Serotonin 5-HT2A Receptor to the Therapeutic Effect of Psilocin on Social Behavior Deficits in Mice Repeatedly Exposed to Social Defeat Stress}. Neuropsychopharmacology Reports. [published; Crossref]. \href{https://doi.org/10.1002/npr2.70152}{doi:10.1002/npr2.70152}.
\item Unknown authors (2026). \textit{Phase 1 trial suggests benefit of psilocybin in OCD treatment}. The Brown University Psychopharmacology Update. [published; Crossref]. \href{https://doi.org/10.1002/pu.31474}{doi:10.1002/pu.31474}.
\item Enriquez-Geppert Stefanie, Bevers Lisa, Rosander Arvid, Fodran Peter, Polito Vince (2026). \textit{Naturally Derived Psilocybin for Therapeutic Use: A Six-Criterion Framework for Evidence, Safety, and Benefit-Risk Considerations in Policy and Clinical Development}. Biomolecules. [published; Crossref]. \href{https://doi.org/10.3390/biom16070983}{doi:10.3390/biom16070983}.
\item Whitfield Henry J., Schepers Jan, Mason Natasha L., Luca Maria, Kuypers Kim P. C. (2026). \textit{Trajectories of psychedelic-assisted change: An observational study of a psilocybin retreat program followed by psychotherapeutic interventions}. Journal of Psychedelic Studies. [published; Crossref]. \href{https://doi.org/10.1556/2054.2026.00530}{doi:10.1556/2054.2026.00530}.
\item Amiel Sharchaton, Shilat Parsha, Sara P. Azerrad, Yaron Dekel, Nisreen Rabah, Tomáš Páleníček, Eyal Kurzbaum (2026). \textit{Surprising Variability in Tryptamine Profiles of Psilocybe cubensis Fruiting Bodies: Inter- and Intra-Strain Differences Across 14 Strains Cultivated Under Controlled Conditions}. Journal of Fungi. [published; OpenAlex]. \href{https://doi.org/10.3390/jof12070486}{doi:10.3390/jof12070486}.
\item Koning E, Richard J, Keshen A. (2026). \textit{Psilocybin as a Transdiagnostic Treatment for Eating Disorders and Comorbid Psychopathology: Implications for Clinical Nosology and Research Directions.}. International Journal of Eating Disorders. [published; Europe PMC]. \href{https://doi.org/10.1002/eat.70164}{doi:10.1002/eat.70164}.
\item Seale M. (2026). \textit{Sexual identity as a moderator of associations between lifetime MDMA/ecstasy or psilocybin use and mental health outcomes: An exploratory analysis of a nationally representative sample using NSDUH 2015-2019}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-10208910/v1}{doi:10.21203/rs.3.rs-10208910/v1}.
\item University of Wisconsin, Madison (2026). \textit{Consciousness and Psilocybin Effects on Well-Being: The CoPEWell Study}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07360301}{source link}.
\item Busby Mattha (2026). \textit{Psilocybin helps woman with Alzheimer's}. New Scientist. [published; Crossref]. \href{https://doi.org/10.1016/s0262-4079(26)01034-1}{doi:10.1016/s0262-4079(26)01034-1}.
\item Askari M, Surapaneni V. (2026). \textit{Convergent biosynthesis of psilocybin in an ectomycorrhizal lineage: is the psychoactive end-product the selected trait?}. EcoEvoRxiv. [preprint; Europe PMC]. \href{https://doi.org/10.32942/x2fd49}{doi:10.32942/x2fd49}.
\item Hummel Haley M., Obrochta Alexia N., Kerr David C. R., Cservenka Anita (2026). \textit{Past-Year Psilocybin and Alcohol Co-Use: Associations With Mental Health Symptoms}. Journal of Drug Issues. [published; Crossref]. \href{https://doi.org/10.1177/00220426261466154}{doi:10.1177/00220426261466154}.
\item Smith SA, Mohammad H, Lee LHN, Dennett L, Smith S, Burback L, Winkler O, Greenshaw A, Jetly R, Kennedy SH, Bhat V, Swainson J, Vermetten E, Cao B, Li XM, Zhang Y. (2026). \textit{Investigating the impact of serotonergic psychedelic drugs, MDMA and ketamine on social cognition in psychiatric disorders: A scoping review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s00213-026-07110-y}{doi:10.1007/s00213-026-07110-y}.
\item Centre Hospitalier Universitaire de Nīmes (2026). \textit{Efficacy in Relapse Prevention: Psilocybin in Alcohol Use Disorder With Depressive Symptoms}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07638553}{source link}.
\item Sunstone Medical (2026). \textit{A Phase 2, Open-Label Study Investigating the Safety and Efficacy of Psilocybin-Assisted Therapy for Sexual Assault-Related Posttraumatic Stress Disorder (PTSD)}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06902974}{source link}.
\item Pasquini L, Vohryzek J, Escrichs A, Perl YS, Ponce-Alvarez A, Idesis S, Girn M, Roseman L, Mitchell JM, Gazzaley A, Kringelbach M, Nutt DJ, Lyons T, Carhart-Harris RL, Deco G. (2026). \textit{Modeled Long-Term Effects of Psilocybin on Dynamic Activity and Effective Connectivity of Fronto-Striatal-Thalamic Circuits.}. Human Brain Mapping. [published; Europe PMC]. \href{https://doi.org/10.1002/hbm.70596}{doi:10.1002/hbm.70596}.
\item Jalalian-Javadpour Marzieh, Yekta Batool Ghorbani, Reyhani Niloufar, Hajizamani Shadi, Azizi Ali, Azad Najma Khoshrooz, Mohammadi Hamidreza, Vaseghi Salar (2026). \textit{Revealing shortcomings in the assessment of psilocybin effects on OCD-related symptoms in preclinical and clinical studies: A systematic review}. Journal of Affective Disorders Reports. [published; Crossref]. \href{https://doi.org/10.1016/j.jadr.2026.101098}{doi:10.1016/j.jadr.2026.101098}.
\item Plourde L, Chang SL, Nguyen O, Garel N, Farzin H, Stephan JF, Fallu JS, Dorval M, P3A Research Group (2026). \textit{Implementing psilocybin-assisted therapy in palliative care settings: A survey of stakeholders.}. Palliative medicine. [published; PubMed]. \href{https://doi.org/10.1177/02692163261446141}{doi:10.1177/02692163261446141}.
\item Akbar RJ, Stringer AD, Wiah S, Dachepalli M, Daws SE, Inan S, Rawls SM. (2026). \textit{Psilocybin induces stereotyped movements and reduces defensive responding in planarians through 5-hydroxytryptamine mechanisms.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1097/fbp.0000000000000879}{doi:10.1097/fbp.0000000000000879}.
\item Junior WSC, Bezerra KS, Matias EGC, Oliveira JIN, Fulco UL. (2026). \textit{MFCC-DFT mapping of ligand recognition at the 5-HT2A receptor: energetic analysis of the interactions between serotonin, psychedelics, and antipsychotics.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1039/d6cp00943c}{doi:10.1039/d6cp00943c}.
\item Gumpper RH, Nichols DE (2026). \textit{Chemistry/structural biology of psychedelic drugs and their receptor(s).}. British journal of pharmacology. [published; PubMed]. \href{https://doi.org/10.1111/bph.17361}{doi:10.1111/bph.17361}.
\item Askey T, Lasrado R, Maiarú M, Stephens GJ (2026). \textit{Psilocybin as a novel treatment for chronic pain.}. British journal of pharmacology. [published; PubMed]. \href{https://doi.org/10.1111/bph.17420}{doi:10.1111/bph.17420}.
\item Nutt DJ, Hunt P, Schlag AK, Fitzgerald P (2026). \textit{The Australia story: Current status and future challenges for the clinical applications of psychedelics.}. British journal of pharmacology. [published; PubMed]. \href{https://doi.org/10.1111/bph.17398}{doi:10.1111/bph.17398}.
\item Sharp T, Ippolito A (2026). \textit{Neuropsychopharmacology of hallucinogenic and non-hallucinogenic 5-HT receptor agonists.}. British journal of pharmacology. [published; PubMed]. \href{https://doi.org/10.1111/bph.70050}{doi:10.1111/bph.70050}.
\item Hoyer D (2026). \textit{Psychedelics, entactogens and psychoplastogens for depression and related disorders.}. British journal of pharmacology. [published; PubMed]. \href{https://doi.org/10.1111/bph.70088}{doi:10.1111/bph.70088}.
\item Qureshi O, Cowley J, Pegg A, Cooper AJ, Gordon J, Brady CA, Belli A, Butterworth S, Upthegrove R, Andrews N, Barnes NM (2026). \textit{Are we hallucinating or can psychedelic drugs modulate the immune system to control inflammation?}. British journal of pharmacology. [published; PubMed]. \href{https://doi.org/10.1111/bph.70138}{doi:10.1111/bph.70138}.
\item Wittenkeller L, Gudelsky G, Winhusen TJ, Amato D (2026). \textit{Psychedelics as pharmacotherapeutics for substance use disorders: A scoping review on clinical trials and perspectives on underlying neurobiology.}. British journal of pharmacology. [published; PubMed]. \href{https://doi.org/10.1111/bph.70181}{doi:10.1111/bph.70181}.
\item Fleury S, Nautiyal KM. (2026). \textit{Correction: The serotonin 1B receptor is required for some of the behavioral effects of psilocybin in mice.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41380-026-03488-5}{doi:10.1038/s41380-026-03488-5}.
\item Ascone F, Buzzelli V, Mottarlini F, Di Trapano M, Miglioranza P, Rava A, Feo A, Spano F, Hausman M, Sugaya K, Caffino L, Fumagalli F, Trezza V (2026). \textit{Psilocybin improves novel object recognition in a rat model of Fragile X Syndrome through the modulation of the BDNF/TrkB signaling pathway.}. Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology. [published; PubMed]. \href{https://doi.org/10.1038/s41386-026-02361-x}{doi:10.1038/s41386-026-02361-x}.
\item Silvester A, Hampton S, May TW, Holmes GD, Leang YH (2026). \textit{Three cases of wood-lover paralysis: clinical insights from Victoria, Australia.}. Clinical toxicology (Philadelphia, Pa.). [published; PubMed]. \href{https://doi.org/10.1080/15563650.2026.2640196}{doi:10.1080/15563650.2026.2640196}.
\item Arikci D, Borgulya J, Straumann I, Vizeli P, Luethi D, Thomann J, Rudin D, Vukalovic I, Eckert A, Liechti ME, Holze F (2026). \textit{Acute dose-dependent effects of 4-bromo-2,5-dimethoxyphenethylamine (2C-B) compared with 3,4-methylenedioxymethamphetamine (MDMA) and psilocybin in a double-blind, placebo-controlled study in healthy participants.}. Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology. [published; PubMed]. \href{https://doi.org/10.1038/s41386-026-02428-9}{doi:10.1038/s41386-026-02428-9}.
\item University of Colorado, Denver (2026). \textit{A Multicenter Phase 1 Safety and Tolerability Trial of Psilocybin in Healthy Older Adults}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07516405}{source link}.
\item Escobar-Cornejo Guillermo, Corredor-Gamba Julián, Rodriguez-Rojas Yoly, Cárdenas F. P. (2026). \textit{The relevance of the 5HT2A-mGlu2 heterodimer in explaining the clinical ambivalence of psilocybin}. Revista de Neuro-Psiquiatría. [published; Crossref]. \href{https://doi.org/10.20453/rnp.v89i2.7539}{doi:10.20453/rnp.v89i2.7539}.
\item Sjöström D, Schau Rybäck O, Claesdotter Knutsson E, Kajonius P, Jensen Sondén O, Carlbring P, Björkstrand J, Movahed Rad P. (2026). \textit{Study Protocol for "Exploring the safety and therapeutic potential of psilocybin in the treatment of anorexia nervosa in adolescents and young adults".}. PLoS ONE. [published; Europe PMC]. \href{https://doi.org/10.1371/journal.pone.0352246}{doi:10.1371/journal.pone.0352246}.
\item Ladislavová L, Kútná V, Mazochová K, Šíchová K, Danda H, Lhotková E, Uttl L, Brejtr V, Syrová K, Mazoch V, Horsley R, Páleníček T. (2026). \textit{Chronic psilocin microdosing produces limited behavioral effects and does not enhance neurogenesis in rats.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.pbb.2026.174231}{doi:10.1016/j.pbb.2026.174231}.
\item Stefanie Enriquez Geppert, Lisa Bevers, Arvid Rosander, Peter Fodran, Vince Polito (2026). \textit{Naturally Derived Psilocybin for Therapeutic Use: A Six-Criterion Framework for Evidence, Safety, and Benefit-Risk Considerations in Policy and Clinical Development}. University of Groningen research database (University of Groningen / Centre for Information Technology). [published; OpenAlex]. \href{https://research.rug.nl/en/publications/370a82bd-d8db-4a02-b644-bf0c9131680b}{source link}.
\item Thileepan Naren, Suzanne Nielsen, Myfanwy Graham (2026). \textit{MDMA and psilocybin therapy rules have been relaxed. Here’s what might happen next}. Unknown journal. [published; OpenAlex]. \href{https://doi.org/10.64628/aa.ffmxwhc4v}{doi:10.64628/aa.ffmxwhc4v}.
\item Yale University (2026). \textit{The Efficacy of Psilocybin Therapy for Depression in Parkinson's Disease}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07610369}{source link}.
\item Johns Hopkins University (2026). \textit{5-HT2A Agonist Psilocybin in the Treatment of Tobacco Use Disorder}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05452772}{source link}.
\item Du Y, Zhao X, Yao Y, Li Y, Wang G, Zhang L. (2026). \textit{Psilocybin reduces fear memory and restores neuroplasticity in the hippocampus and medial prefrontal cortex.}. Journal of Psychopharmacology. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811261453819}{doi:10.1177/02698811261453819}.
\item Unity Health Toronto (2026). \textit{Psilocybin-Assisted Massed Cognitive Processing Therapy for Chronic Posttraumatic Stress Disorder: An Open-label Trial}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06386003}{source link}.
\item University of California, San Diego (2026). \textit{Psilocybin-Assisted Therapy for Physician Well-Being and Burnout: Feasibility, Safety, Clinical Effectiveness and Biomarkers of Response [PAT-B (Psilocybin-Assisted Therapy for Physician Well-Being and Burnout)]}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06814522}{source link}.
\item Dagnino, P. C.; Acero-Pousa, I.; Carhart-Harris, R.; Erritzoe, D.; Nutt, D. J.; Kringelbach, M. L.; Sanz Perl, Y.; Deco, G. (2026). \textit{Divergent changes in perturbation-induced brain reconfiguration following depression treatment with psilocybin and escitalopram}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.64898/2026.06.22.733731}{doi:10.64898/2026.06.22.733731}.
\item University Hospital, Basel, Switzerland (2026). \textit{Acute Effects of MDMA Co-administration on the Response to Psilocybin in Healthy Subjects}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06884514}{source link}.
\item Anthony P King (2026). \textit{A Pilot Mechanistic RCT of Psilocybin With Mindfulness-based Therapy vs Support for Posttraumatic Stress Disorder (PTSD)}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07104916}{source link}.
\item Johns Hopkins University (2026). \textit{Psilocybin Administration With 5-HT1a Blockade}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07565493}{source link}.
\item Brar PS, Price RB, Ross S, Tofighi B, Sarpal DK (2026). \textit{The intersection between psychedelics and schizophrenia spectrum disorders: Reevaluating risk and therapeutic potential.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811261456191}{doi:10.1177/02698811261456191}.
\item Guidetti C, Fava M, Papakostas GI. (2026). \textit{Novel approaches in depression treatment: from rapid-acting antidepressants to personalized interventions.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41380-026-03722-0}{doi:10.1038/s41380-026-03722-0}.
\item M.D. Anderson Cancer Center (2026). \textit{TRIP - TReatment to Improve Depression and/or Anxiety Using Psilocybin-Assisted Psychotherapy in Patients With Advanced Cancer on Maintenance Therapy}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06200155}{source link}.
\item M.D. Anderson Cancer Center (2026). \textit{TRIPS - Treatment to Improve Depression and/or Anxiety Using Psilocybin-assisted Psychotherapy in Cancer Survivors}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06801041}{source link}.
\item M.D. Anderson Cancer Center (2026). \textit{NeuroGuard: Psilocybin Trial for Preventing Chemo-induced Neuropathy}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07227909}{source link}.
\item Yale University (2026). \textit{Effects of Psilocybin Microdosing on Cognition, Mood and Quality of Life: A Pilot Study}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07449351}{source link}.
\item University Health Network, Toronto (2026). \textit{Psilocybin-assisted Existential, Attachment and Relational (PEARL) Therapy for Caregivers of Patients With Advanced Cancer: A Phase II Open-Label Trial}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07048743}{source link}.
\item University of Virginia (2026). \textit{Psilocybin-Assisted Therapy for Prolonged Grief}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06724289}{source link}.
\item Lenka Seillier, Alexandre Seillier, Morgan A. Zvolska, Romana Šlamberová (2026). \textit{Blocking 5-HT2B receptors abolishes psilocybin’s efficacy in the rat forced swim test}. Journal of Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1177/02698811261458349}{doi:10.1177/02698811261458349}.
\item van den Busken WJ, Dines AM, Eyer F, Heyerdahl F, Hovda KE, Liechti ME, Miró Ò, Vallersnes OM, Wood DM, Yates C, Dargan PI, (on behalf of the Euro-DEN Plus Research Group), Gresnigt FMJ, Euro-DEN Plus Research Group (2026). \textit{Cardiovascular effects associated with acute recreational drug toxicity presentations to the emergency department: a European drug emergencies network (Euro-DEN plus) study.}. Clinical toxicology (Philadelphia, Pa.). [published; PubMed]. \href{https://doi.org/10.1080/15563650.2026.2669671}{doi:10.1080/15563650.2026.2669671}.
\item Roswell Park Cancer Institute (2026). \textit{Low-Dose Psilocybin Therapy for Palliative Care Patients With Chronic Cancer Pain Requiring Opioids}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06827054}{source link}.
\item Johns Hopkins University (2026). \textit{Psilocybin for PTSD With or Without Psychotherapy: A Pilot Study of Safety and Efficacy}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06407635}{source link}.
\item University Health Network, Toronto (2026). \textit{Psilocybin-assisted Existential, Attachment and RelationaL (PEARL) Therapy for Patients With Advanced Cancer: A Phase II Open-Label Trial}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06416085}{source link}.
\item Frick A, Blest-Hopley G, Grin M, Erritzoe D, Nutt D, Carhart-Harris R. (2026). \textit{Sex-Specific Effects of Psilocybin Versus Escitalopram on Anxiety and Anhedonia: A Bayesian Reanalysis of Antidepressant Treatment Outcomes}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-9880403/v1}{doi:10.21203/rs.3.rs-9880403/v1}.
\item Astrit Sabani, Adnan Khatak (2026). \textit{Psilocybin-assisted therapy in treatment-resistant depression: rapid remission, uncertain durability, and the next phase of clinical evidence}. Annals of Medicine and Surgery. [published; OpenAlex]. \href{https://doi.org/10.1097/ms9.0000000000005244}{doi:10.1097/ms9.0000000000005244}.
\item Mengxuan Dong, Yi Zhang, Manzhu Cao, Tong Shi, Liqin Li, Xingxing Zong, Chen Wang (2026). \textit{DESI-MSI-Based Multi-Organ Distribution Mapping of Psilocin in Zebrafish}. Molecules. [published; OpenAlex]. \href{https://doi.org/10.3390/molecules31122143}{doi:10.3390/molecules31122143}.
\item Michał Wanke, Paweł Matuszewski, Piotr Siuda (2026). \textit{“I even saw four deer grazing”: online-offline entanglements in the psilocybin pluriverse}. Unknown journal. [published; OpenAlex]. \href{https://doi.org/10.31235/osf.io/tk4bv\_v1}{doi:10.31235/osf.io/tk4bv\_v1}.
\item Lawrence Leeman, Maya Armstrong, Dara Menashi, Hanifa Nayo-Washington, Elliot Marseille, Janus Herrera, Crystal Romero, Janet Page-Reeves (2026). \textit{Community engagement as a foundation for implementation research for group psilocybin assisted therapy in New Mexico}. Frontiers in Public Health. [published; OpenAlex]. \href{https://doi.org/10.3389/fpubh.2026.1845943}{doi:10.3389/fpubh.2026.1845943}.
\item Bhat A, Zolali E, Sakib MA, Rahimian M, McMahon LR, German N, Obeng S (2026). \textit{Short- and Long-Acting Psychedelics: Structure-Activity Relationships, Pharmacology, and Implications for Neuropsychiatric Therapeutics.}. ACS chemical neuroscience. [published; PubMed]. \href{https://doi.org/10.1021/acschemneuro.6c00202}{doi:10.1021/acschemneuro.6c00202}.
\item Dagnino PC, Acero-Pousa I, Zamora-López G, Escrichs A, Erritzoe D, Nutt DJ, Carhart-Harris RL, Sanz Perl Y, Kringelbach ML, Deco G. (2026). \textit{Distinct brain responses to psilocybin and escitalopram in depression captured by the Fluctuation-Dissipation Theorem}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.64898/2026.06.12.731811}{doi:10.64898/2026.06.12.731811}.
\item Manoj Doss (2026). \textit{The Acute Effects of Psilocybin on Cognition, Memory, and Brain Function}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07079852}{source link}.
\item Brigham and Women's Hospital (2026). \textit{Psilocybin-Assisted Psychotherapy for the Treatment of Severe Alcohol Use Disorder: A Double-Blind, Dose-Comparison Concurrent Control Randomized Trial}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07296094}{source link}.
\item SAIMSARA (2026). \textit{Psilocybin and Mental Health Outcomes: Scoping Review with ☸SAIMSARA}. SAIMSARA Journal. [published; OpenAlex]. \href{https://doi.org/10.62487/saimsara7a54f680}{doi:10.62487/saimsara7a54f680}.
\item Angel Labra-Lorenzana, Dania Nimbe Lima Sanchez, Christian Alejandro Delaflor-Wagner, Diana Martínez-Hernández, Christian Ramos-Jiménez, Christian Gabriel Toledo-Lozano (2026). \textit{Efficacy of Psilocybin-Assisted Therapy in Major Depressive Disorder: A Systematic Review and Meta-Analysis}. Psychiatry International. [published; OpenAlex]. \href{https://doi.org/10.3390/psychiatryint7030137}{doi:10.3390/psychiatryint7030137}.
\item Bhavaraju Kirshna Prasad, Mason Natasha L., Mallaroni Pablo, Heinke Dietmar, Toennes Stefan W., Ramaekers Johannes G., Amico Enrico (2026). \textit{Unmixing the Psychedelic Connectome: Brain Network Traits of Psilocybin}. Network Neuroscience. [published; Crossref]. \href{https://doi.org/10.1162/netn.a.594}{doi:10.1162/netn.a.594}.
\item Zachary N. Abrahms, Mohammad Majdi, Siena M. Madsen, Chloe J. Morton, Abhishek K. Sen, Niya B. Fried, Lily E. Sawyer, Evelyn R. Cegielski, Sean J. Spezzano, J. Andrew Jones (2026). \textit{Genome-based optimization of psilocybin and N,N-dimethyltryptamine biosynthetic pathways in E. coli using CRISPR-associated transposases}. Metabolic Engineering. [published; OpenAlex]. \href{https://doi.org/10.1016/j.ymben.2026.102490}{doi:10.1016/j.ymben.2026.102490}.
\item Katherine Cheung, Caleigh Propes, David B. Yaden (2026). \textit{Balancing safety and access in Oregon’s psilocybin services}. International Journal of Drug Policy. [published; OpenAlex]. \href{https://doi.org/10.1016/j.drugpo.2026.105384}{doi:10.1016/j.drugpo.2026.105384}.
\item Guimarães AL, Beserra FR, Cruz L, Bienemmann B, Freind JMK, Guinle V, Rodrigues RS, Regalado JA, Mograbi DC (2026). \textit{Barriers and Facilitators for Psychedelic Research and Regulation in Brazil: Insights From Diverse Stakeholders.}. Clinical therapeutics. [published; PubMed]. \href{https://doi.org/10.1016/j.clinthera.2026.05.012}{doi:10.1016/j.clinthera.2026.05.012}.
\item Unknown authors (2026). \textit{Altered States, Enhanced Potential: Psychedelics and Physical Performance}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/txgq2\_v2}{source link}.
\item Jajcay N, Vejmola Č, Korčák J, Tylš F, Viktorinová M, Viktorin V, Bravermanová A, Androvičová R, Balíková M, Horáček J, Brunovský M, Hlinka J, Páleníček T. (2026). \textit{EEG microstate dynamics during psilocybin intoxication relate to acute experience and persisting psychological changes}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.64898/2026.06.09.731183}{doi:10.64898/2026.06.09.731183}.
\item J. Mingardi, R. Molteni, F. Bifari (2026). \textit{Pharmacokinetic and pharmacodynamic rational for expanding the therapeutic landscape of psilocybin beyond depression}. Pharmacological Research. [published; OpenAlex]. \href{https://doi.org/10.1016/j.phrs.2026.108290}{doi:10.1016/j.phrs.2026.108290}.
\item Unknown authors (2026). \textit{Aquahenosis: A non-pharmacological altered state of consciousness induced by Floatation-REST in individuals with anxiety and depression}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/6mj8n\_v2}{source link}.
\item Yale University (2026). \textit{Psilocybin as a Treatment for Chronic Pain in Smokers}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07118332}{source link}.
\item Alexander Bryson, Chiranth Bhagavan, O. Carter, Glenn Nielsen, David Berlowitz, Sara Issak, Zachary Attard, Dina Eleftheriadis, Gina Oliver, Deanne Mayne, Greg Roebuck, James Rucker, Matthew Butler, Richard Kanaan (2026). \textit{Psilocybin-assisted Physiotherapy for Refractory Motor Functional Neurological Disorder: A Randomized Dose-comparison Pilot Study (P7-17.001)}. Neurology. [published; OpenAlex]. \href{https://doi.org/10.1212/wnl.0000000000212934}{doi:10.1212/wnl.0000000000212934}.
\item Johns Hopkins University (2026). \textit{PRISMatic: A Phase 1b Randomized, Double-Armed, Parallel-Group, Placebo-Controlled Trial of Psilocybin Efficacy With or Without Pimavanserin Pretreatment}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07610135}{source link}.
\item Jennifer Mitchell (2026). \textit{A Double Blind, Randomized Trial Investigating the Safety, Feasibility, and Mechanisms of Psychedelics in Healthy Older Adults With Low Well-being as Moderated by Biomarkers for Preclinical Alzheimer's Disease}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07386730}{source link}.
\item Robin Carhart-Harris, PhD, MA (2026). \textit{Multivariate Neural and Physiological Correlates of Psychedelic Sub-states: a Within-subjects, Healthy Volunteer Study With Experience-sampling}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05698511}{source link}.
\item VA Office of Research and Development (2026). \textit{A Multi-site Randomized Controlled Trial of Psilocybin for Treatment-Resistant Depression (TRD) in Veterans}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07226232}{source link}.
\item Matthew J. Reid, Hannes Kettner, Tessa F. Blanken, Brandon Weiss, Robin Carhart-Harris (2026). \textit{Correction to: Preliminary Evidence of Sleep Improvements Following Psilocybin Administration, and their Involvement in Antidepressant Therapeutic Action}. Current Psychiatry Reports. [published; OpenAlex]. \href{https://doi.org/10.1007/s11920-026-01685-1}{doi:10.1007/s11920-026-01685-1}.
\item Samaneh Ahmadian-Moghadam, Shiva Roshan-Milani, Ehsan Saboory (2026). \textit{Prenatal stress, excitatory-inhibitory imbalance, and ADHD risk: a hypothesis-driven perspective on psilocybin-induced neuroplasticity}. Translational Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1038/s41398-026-04151-x}{doi:10.1038/s41398-026-04151-x}.
\item Elise C. Tarbi, Ian Bhatia, Nabil Balach, Suzannah Buehler, Magdalena Demeo-Meres, Cailin Gramling, Tej Thambi, Julia Hart, Maija Reblin, Donna M. Rizzo, Robert Gramling, Manish Agrawal, Emily Manetta (2026). \textit{Developing Methods for Observing Awe Narration in Psilocybin-Assisted Therapy}. Healthcare. [published; OpenAlex]. \href{https://doi.org/10.3390/healthcare14111589}{doi:10.3390/healthcare14111589}.
\item Yale University (2026). \textit{Effects of Repeated Dosing of Psilocybin on Obsessive-Compulsive Disorder: A Randomized, Waitlist-Controlled Study}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05370911}{source link}.
\item Robin Carhart-Harris, PhD, MA (2026). \textit{2 x 2 Factorial, Double-blind, Randomized Trial of 'Set and Setting': a Translational Study in Healthy Volunteers}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06626139}{source link}.
\item Cecelia Kelly, Mathieu Fradet, Catherine M. Bostian, Anna Donnelly, Sara Ellis, Michael Ostacher, Scott Aaronson, Trisha Suppes (2026). \textit{Changes in anxiety, quality of life, and functioning following psilocybin-assisted therapy in veterans with treatment-resistant depression}. Journal of Affective Disorders. [published; OpenAlex]. \href{https://doi.org/10.1016/j.jad.2026.122063}{doi:10.1016/j.jad.2026.122063}.
\item Shuhan Lu, Zhixin Zhang, Xinmiao Xue, Yuke Jiang, Chi Zhang, Peng Liu (120506), Dongdong He, Shen Weidong, Shiming Yang, Fangyuan Wang (2026). \textit{Current status and future prospects of research on psilocybin's regulation of neurotransmitters and their receptors related to the pathogenesis of tinnitus}. Hearing Research. [published; OpenAlex]. \href{https://doi.org/10.1016/j.heares.2026.109701}{doi:10.1016/j.heares.2026.109701}.
\item Michel Dorval, Virginie Audet-Croteau, Sue-Ling Chang, Marianne Masse-Grenier, Annie Tremblay, Elodie Bénard, Alexandra Chapdelaine, Nicolas Garel, Jason Robert Guertin (2026). \textit{Bringing Psilocybin-Assisted Therapy to Palliative Oncology: Early Lessons from Real-World Implementation}. Healthcare. [published; OpenAlex]. \href{https://doi.org/10.3390/healthcare14111559}{doi:10.3390/healthcare14111559}.
\item University of Calgary (2026). \textit{The Role of the Subjective Experience in Supporting Positive Effects Following Psilocybin: a Randomized, Controlled Clinical Trial Using Risperidone in Healthy Adults}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06768944}{source link}.
\item Carter D, Reardon I, Swain J, Vando L. (2026). \textit{Prolonged Grief Symptom Outcomes During At-Home Ketamine-Assisted Therapy: A Real-World Retrospective Analysis of 503 Adults}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-9839240/v1}{doi:10.21203/rs.3.rs-9839240/v1}.
\item Genís Oña, Cristina Llagostera, Oscar Alvarez, Rosa M. Dueñas, Débora González, Óscar Soto-Angona (2026). \textit{Time to embrace the whole: considering the replacement of psilocybin with Psilocybe spp. in psychedelic research and therapy}. Natural Product Research. [published; OpenAlex]. \href{https://doi.org/10.1080/14786419.2026.2683121}{doi:10.1080/14786419.2026.2683121}.
\item Centre for Addiction and Mental Health (2026). \textit{Imaging the Effects of Serotonin 2A Receptor Modulation on Synaptic Density in Treatment-resistant Depression (SYNVEST)}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06512220}{source link}.
\item Usona Institute (2026). \textit{A Phase 3, Randomized, Double-Blind, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Psilocybin in Adults With Major Depressive Disorder (MDD)}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06308653}{source link}.
\item University of Pennsylvania (2026). \textit{Psilocybin: Capturing Brain Mechanisms of Motivation and Neurocognition in Individuals With Opioid Use Disorder}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06810310}{source link}.
\item Li EJ, Mosharraf B, Ali H, Noyes M, Doshi P, Wallace C, Petranker R, Adili A, Khan M, Busse JW, MacKillop J, Madden K. (2026). \textit{Patient perceptions towards psychedelics for musculoskeletal pain: A cross-sectional survey}. medRxiv. [preprint; medRxiv]. \href{https://doi.org/10.64898/2026.05.29.26354422}{doi:10.64898/2026.05.29.26354422}.
\item Unknown authors (2026). \textit{Corrigendum to “From Prohibited to Prescribed: The Rescheduling of MDMA and Psilocybin in Australia”}. Drug Science Policy and Law. [published; OpenAlex]. \href{https://doi.org/10.1177/20503245261459447}{doi:10.1177/20503245261459447}.
\item Matthew Sidovar, Shane J. O’Connor, Lucinda Orsini (2026). \textit{EE127 A REVIEW OF HEALTH ECONOMIC ANALYSES OF PSILOCYBIN, MIDOMAFETAMINE(MDMA), AND KETAMINE-BASED TREATMENTS FOR MENTAL HEALTH CARE}. Value in Health. [published; OpenAlex]. \href{https://doi.org/10.1016/j.jval.2026.03.422}{doi:10.1016/j.jval.2026.03.422}.
\item Yosr Ziadi, Taehwan Park (2026). \textit{EE341 COST-EFFECTIVENESS OF PSILOCYBIN-ASSISTED THERAPY (PAT) FOR PATIENTS WITH TREATMENT-RESISTANT DEPRESSION}. Value in Health. [published; OpenAlex]. \href{https://doi.org/10.1016/j.jval.2026.03.635}{doi:10.1016/j.jval.2026.03.635}.
\item Jenna Houff, Andrew Williams, Obie Allen, Barbara Gisabella, Harry Pantazopoulos, Alberto Del Arco (2026). \textit{Psilocybin Decreases Preference for Large Rewards Accompanied by Increased Activity of Parvalbumin Neurons With Perineuronal Nets in the Medial Prefrontal Cortex}. European Journal of Neuroscience. [published; OpenAlex]. \href{https://doi.org/10.1111/ejn.70574}{doi:10.1111/ejn.70574}.
\item Fotiadis P, Jang H, Dai R, Li D, Cofré R, Timmermann C, Mashour GA, Hudetz AG, Huang Z. (2026). \textit{Reorganization of Human Brain Waves Across Diverse States of Consciousness}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.64898/2026.05.27.728182}{doi:10.64898/2026.05.27.728182}.
\item Josh Allen, Bianca Jupp, Tamara L. Baker, Mohammad B. Haskali, Robert Brkljača, Zoe Plummer, Mujun Sun, Justin Brand, Brian R. Christie, Chantel T. Debert, Stuart J. McDonald, Terence J. O’Brien, Pablo M. Casillas-Espinosa, Sandy R. Shultz (2026). \textit{Psilocybin restores behavior and 5-HT2A signaling while reducing microglial density after chronic traumatic brain injury in rats}. Cell Reports Medicine. [published; OpenAlex]. \href{https://doi.org/10.1016/j.xcrm.2026.102867}{doi:10.1016/j.xcrm.2026.102867}.
\item University of Washington (2026). \textit{A Phase 2a Study of Group Retreat Psilocybin Therapy for Cancer-Related Anxiety and Depression}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07336238}{source link}.
\item Valerie A. Canady (2026). \textit{Psilocybin shows rapid relief for depression symptoms}. Mental Health Weekly. [published; OpenAlex]. \href{https://doi.org/10.1002/mhw.34890}{doi:10.1002/mhw.34890}.
\item Unknown authors (2026). \textit{Psilocybin shows mixed results for patients with treatment-resistant depression}. The Brown University Psychopharmacology Update. [published; OpenAlex]. \href{https://doi.org/10.1002/pu.31461}{doi:10.1002/pu.31461}.
\item Unknown authors (2026). \textit{Single-dose psilocybin with CBT more effective than nicotine patch for smoking cessation}. The Brown University Psychopharmacology Update. [published; OpenAlex]. \href{https://doi.org/10.1002/pu.31467}{doi:10.1002/pu.31467}.
\item Alex Hood, Gary ELKINS (2026). \textit{Effect of psilocybin-assisted psychotherapy on anxiety symptoms: A systematic review and meta-analysis}. Journal of Psychedelic Studies. [published; OpenAlex]. \href{https://doi.org/10.1556/2054.2026.00507}{doi:10.1556/2054.2026.00507}.
\item Kristoffer Brendstrup-Brix, Brice Ozenne, Patrick M. Fisher, Dea S. Stenbæk, Anja S. Petersen, Sophia Armand, Drummond E-Wen. McCulloch, Maja Rou Marstrand-Joergensen, Sara M. Ulv Larsen, Annette Johansen, R O B V Jensen, Gitte M. Knudsen, M.K. Madsen (2026). \textit{Effects of psilocybin on sleep quality and brain microstructure in chronic cluster headache}. Journal of Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1177/02698811261449380}{doi:10.1177/02698811261449380}.
\item Gang Pei (2026). \textit{A spatiotemporal gating hypothesis for psilocybin plasticity: reconciling the 5-HT₂A-TrkB mechanistic paradox}. Cell Discovery. [published; OpenAlex]. \href{https://doi.org/10.1038/s41421-026-00906-4}{doi:10.1038/s41421-026-00906-4}.
\item Eskinazi M, Nasserdine R, Cusin RM, Baniotoupoulos P, Saccaro LF, De Pieri M, Corino T, Seragnoli F, Briefer JF, Aboulafia Brakha T, Richard-Lepouriel H, Penzenstadler L, Böge K, Kirchner M, Zullino D, Højlund M, Sapienza J, Bosia M, Catalan A, Vieta E, Solmi M, Sabé M. (2026). \textit{Psychedelic-induced hypomania and mania: a systematic review and meta-analysis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41380-026-03657-6}{doi:10.1038/s41380-026-03657-6}.
\item L Belinger, N M Rieser, E J E Engeli, L Becciolini, M Clamote, M Pribis, F Saissi, G.A. Florineth, N L Hehl, M Herdener, K H Preller (2026). \textit{Blinding integrity in psychedelic research: Evidence from a comparative randomized controlled trial of psilocybin, MDMA, and methylphenidate in healthy volunteers.}. Open Access CRIS of the University of Bern. [published; OpenAlex]. \href{https://doi.org/10.48620/98266}{doi:10.48620/98266}.
\item Lin Wei, Hong Chen, Yuanyuan Li (2026). \textit{Rapid and Sensitive Detection of Psilocybin and Psilocin in Urine by Surface-Enhanced Raman Spectroscopy}. Journal of Raman Spectroscopy. [published; OpenAlex]. \href{https://doi.org/10.1002/jrs.70178}{doi:10.1002/jrs.70178}.
\item Mazen A. Atiq, Eli Weisman, Rodrigo B. Guerra, Luis Luna Martinez, David B. Yaden, Frederick S. Barrett, Sandeep Nayak, Ceyda Sayalı (2026). \textit{Psilocybin-induced neurocardiogenic syncope: a case report}. Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1007/s00213-026-07079-8}{doi:10.1007/s00213-026-07079-8}.
\item Marcos Lago, Mariana Cerveira, Joe Xavier Simonet (2026). \textit{Transient multidomain functional improvement in advanced Alzheimer’s disease following high-dose psilocybin-containing mushroom administration: a case report}. Frontiers in Neuroscience. [published; OpenAlex]. \href{https://doi.org/10.3389/fnins.2026.1813281}{doi:10.3389/fnins.2026.1813281}.
\item NYU Langone Health (2026). \textit{Targeting Reward Circuits: Psilocybin as a Novel Therapy for Residual Anhedonia}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07607938}{source link}.
\item Lea J. Mertens, Felix Betzler, Manuela Brand, Ricarda Evens, Andrea Jungaberle, Henrik Jungaberle, Laura Kärtner, Tomislav Majić, Christian N. Schmitz, Andreas Ströhle, Dennis Scharf, Moritz Spangemacher, Max Wolff, Zahra Assadi, Scharif Bahri, Lilith Becher, Luca V. Färber, Henry Harder, Niklas Kirchen, Eugenia Kulakova, Linda C. Kunz, Andy Meijer, Barbara Rohrmoser, Stefan Wellek, Moritz M. Berger, Michael Koslowski, Gerhard Gründer (2026). \textit{Long-Term Efficacy of Psilocybin with Adjunct Psychotherapy in Treatment-Resistant Major Depression (EPIsoDE): 6- and 12-Month Naturalistic Follow-Up of a Phase 2b Trial}. Psychotherapy and Psychosomatics. [published; OpenAlex]. \href{https://doi.org/10.1159/000552272}{doi:10.1159/000552272}.
\item Jasbir Singh, Pranathi Mruthyunjaya (2026). \textit{Catatonia Associated With First-Time Psilocybin Exposure: A Case Report}. Cureus. [published; OpenAlex]. \href{https://doi.org/10.7759/cureus.c439}{doi:10.7759/cureus.c439}.
\item David A Barajas, Heather C Noda Carter, Michael R Tomedi, Hiu Yu Lam, Tiffany N Deloatch, Gregory D Reynolds, Marisol S. Castaneto, Pucheng Ke (2026). \textit{Studies on enzymatic hydrolysis of psilocin- O -glucuronide for screening of psilocin in human urine by liquid chromatography-triple quadrupole tandem mass spectrometry}. Journal of Analytical Toxicology. [published; OpenAlex]. \href{https://doi.org/10.1093/jat/bkag030}{doi:10.1093/jat/bkag030}.
\item Emory University (2026). \textit{The Safety and Acceptability of Psilocybin With Support and With Massed Prolonged Exposure Therapy for PTSD}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07332143}{source link}.
\item Rahman T. (2026). \textit{Environmental and Internal Gating of Memory: ARCH Multiplicative Threshold Framework for Encoding and Retrieval}. Preprints.org. [preprint; Europe PMC]. \href{https://doi.org/10.20944/preprints202605.1558.v1}{doi:10.20944/preprints202605.1558.v1}.
\item Urban MM, Zillich L, Rieser NM, Herdener M, Spanagel R, Vollenweider FX, Preller KH, Meinhardt MW. (2026). \textit{Epigenome-wide association study of psilocybin-induced methylome changes in alcohol use disorder.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41398-026-03961-3}{doi:10.1038/s41398-026-03961-3}.
\item Berg CJ, LoParco CR, Rossheim ME, McCready DM, Langan L, Platt E, Romm KF, Johnson M, Speer MB, Burris S, Cavazos-Rehg PA. (2026). \textit{Mystery shopper assessments of cannabis retailer practices and regulatory compliance in five U.S. states, 2025.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.drugalcdep.2026.113218}{doi:10.1016/j.drugalcdep.2026.113218}.
\item Zhang T, Lin C, Wang X. (2026). \textit{Overcoming Pharmacokinetic and Peripheral Safety Challenges in Psychedelic Therapies: The Promise of Advanced Drug Delivery Systems.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/acsptsci.6c00146}{doi:10.1021/acsptsci.6c00146}.
\item Unknown authors (2026). \textit{Serotonergic Psychedelics as a Potential Therapeutic Strategy for Anxiety, A Systematic Review}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/gf7bq\_v1}{source link}.
\item Dallas T Mason (2026). \textit{Psilocybin for Treatment-Resistant Depression: A Comprehensive Review of Mechanisms and Therapeutic Potential}. Digital Showcase Research, Scholarship, \& Creative Works (University of Lynchburg). [published; OpenAlex]. \href{https://digitalshowcase.lynchburg.edu/dmscjournal/vol8/iss1/6}{source link}.
\item Rachel N Clark (2026). \textit{The Use of Psilocybin for Managing Refractory Behavioral Health Conditions: A New and Promising Approach}. Digital Showcase Research, Scholarship, \& Creative Works (University of Lynchburg). [published; OpenAlex]. \href{https://digitalshowcase.lynchburg.edu/cgi/viewcontent.cgi?article=3694\&context=dmscjournal}{source link}.
\item Caleb Lemus (2026). \textit{Psilocybin-Assisted Therapy in the Management of Anxiety and Depression Among Cancer Patients}. Digital Showcase Research, Scholarship, \& Creative Works (University of Lynchburg). [published; OpenAlex]. \href{https://digitalshowcase.lynchburg.edu/cgi/viewcontent.cgi?article=3713\&context=dmscjournal}{source link}.
\item Hampus Yngwe, J O Lundberg (2026). \textit{A single dose of psilocybin eased depression symptoms for months, our study found}. Unknown journal. [published; OpenAlex]. \href{https://doi.org/10.64628/ab.esysa7wnu}{doi:10.64628/ab.esysa7wnu}.
\item University of Colorado, Denver (2026). \textit{Effects of Psilocybin With Psychological Support on Anhedonia in Treatment-resistant Depression: a Randomized Controlled Pilot Trial}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06230757}{source link}.
\item University of New Mexico (2026). \textit{Group Psilocybin-Assisted Therapy for Post-Traumatic Stress Disorder}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07506395}{source link}.
\item Leonardo Novelli, Devon Stoliker, Tamrin Barta, Matthew D. Greaves, Sidhant Chopra, James Jackson, Jessica Kwee, James C. Pang, Martin L. Williams, Adeel Razi (2026). \textit{PsiConnect: Multimodal Neuroimaging of Context-Dependent Brain and Behaviour Dynamics under Psilocybin}. Scientific Data. [published; OpenAlex]. \href{https://doi.org/10.1038/s41597-026-07312-1}{doi:10.1038/s41597-026-07312-1}.
\item Washington University School of Medicine (2026). \textit{A Pilot Mechanistic Study of Psilocybin-Assisted Therapy as a Treatment for Depression}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07582120}{source link}.
\item Millay T, Kodali M, Cottler L. (2026). \textit{265 Self-reported rates of psilocybin use in North Florida, 2012 to present}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC13172864}{source link}.
\item Huels E, Smith S, Liu T, Pal D. (2026). \textit{361 Effect of intravenous psilocybin on mechanical hypersensitivity in a rat model of reserpine-induced chronic centralized pain}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC13172966}{source link}.
\item University of California, Los Angeles (2026). \textit{Psilocybin-assisted Cognitive Behavioral Therapy for Depression}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05227612}{source link}.
\item University of Alabama at Birmingham (2026). \textit{Psilocybin-facilitated Treatment for Cocaine Use}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT02037126}{source link}.
\item Centre for Addiction and Mental Health (2026). \textit{Evaluating the Feasibility, Clinical Effects, and Safety of Psilocybin-assisted Psychotherapy for Treatment-resistant Obsessive-compulsive Disorder: An Open-label Clinical Trial}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06299319}{source link}.
\item Conn K, Wong N, Sunnetci S, Al Siyabi A, McCoy K, Huang K, Greaves E, Milton LK, Kuhlmann L, Maguire S, Foldi CJ. (2026). \textit{Appetite for change: How psilocybin reshapes food reward learning through striatal dopamine function}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.64898/2026.05.14.725265}{doi:10.64898/2026.05.14.725265}.
\item Unknown authors (2026). \textit{Corrigendum to: “Psilocybin in the real world: Regulatory, ethical, and operational challenges in Australia’s clinical landscape”}. Australian \& New Zealand Journal of Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1177/00048674261450797}{doi:10.1177/00048674261450797}.
\item Hampus Yngwe, Pontus Plavén-Sigray, Carl Johan Ekman, Eva Henje, Anders Berglund, Mikael Tiger, Maria Beckman, J O Lundberg (2026). \textit{Short-Term and Late-Term Effects of Psilocybin on Symptoms in Major Depression}. JAMA Network Open. [published; OpenAlex]. \href{https://doi.org/10.1001/jamanetworkopen.2026.12589}{doi:10.1001/jamanetworkopen.2026.12589}.
\item Alan Davis (2026). \textit{Exploring the Safety, Acceptability, and Efficacy of Psilocybin Among Non-Small Cell Lung Cancer Patients With Major Depressive Disorder: A Proof-of-Concept Trial (DREAM LUNG STUDY)}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07216404}{source link}.
\item University of Calgary (2026). \textit{Psilocybin-assisted Therapy for Post-Traumatic Stress Disorder in Survivors of Intimate Partner Violence}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06885996}{source link}.
\item Unknown authors (2026). \textit{Low doses of psilocybin as adjunct pharmacological treatment to virtual reality exposure therapy for social anxiety disorder: A study protocol for a double-blind randomized controlled trial.}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/3b9fx\_v1}{source link}.
\item Jamarie Geller, Rachel Pacilio, Amanda E. Downey, Anya Ragnhildstveit, Marissa Raymond-Flesch, Stephanie Knatz-Peck, Natalie Gukasyan (2026). \textit{Psilocybin-Assisted Therapy for Adolescent Anorexia Nervosa: Clinical Considerations and Emerging Models of Care}. Current Psychiatry Reports. [published; OpenAlex]. \href{https://doi.org/10.1007/s11920-026-01679-z}{doi:10.1007/s11920-026-01679-z}.
\item Christina Chwyl, Alissa Bazinet, Adrianne R. Wilson-Poe, Kim Hoffman, Kellie Pertl, R. Cameron Wolf, P. Todd Korthuis, Jason B. Luoma (2026). \textit{Ethical Complexities and Best Practices in Informed Consent Processes for Psilocybin Services: A Qualitative Study}. Neuroethics. [published; OpenAlex]. \href{https://doi.org/10.1007/s12152-026-09645-5}{doi:10.1007/s12152-026-09645-5}.
\item Feliciano Yu, Joe Tafur, Francisco Moreno, Stephen Dahmer (2026). \textit{Inaugural year of regulated psilocybin services in Oregon: safety, motivations, and utilization}. Frontiers in Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.3389/fpsyt.2026.1777387}{doi:10.3389/fpsyt.2026.1777387}.
\item Francisco A Moreno (2026). \textit{A Randomized Double-masked Dose-controlled Trial to Assess the Tolerability, Safety, Subjective Experience, and Efficacy of Repeated Administration of Three Different Doses of Psilocybin Whole Mushroom for the Treatment of Obsessive-compulsive Disorder.}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07347405}{source link}.
\item University of Wisconsin, Madison (2026). \textit{Safety and Feasibility of Psilocybin in Methamphetamine Use Disorder in a Community-Based Sample}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05322954}{source link}.
\item COMPASS Pathways (2026). \textit{A Phase 2b/3, Multicentre, Randomised, Double-blind, Controlled Trial, With an Open Label Extension, to Investigate the Efficacy, Safety, and Tolerability of COMP360 in Participants With Post-traumatic Stress Disorder}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07570654}{source link}.
\item Bartłomiej Kosiarski, Anna Skrzypek, Patrycja Markowicz, Mikołaj Zbrożek, Krzysztof Biłyk, Maciej Hutkowski, Zuzanna Chwostek, Hanna Maruchniak, Wiktoria Marzec, Paulina Biedroń (2026). \textit{Rapid-acting interventions in treatment-resistant depression - a comparative review of esketamine and psilocybin}. Journal of Pre-Clinical and Clinical Research. [published; OpenAlex]. \href{https://doi.org/10.26444/jpccr/221219}{doi:10.26444/jpccr/221219}.
\item Austin Mallard, Jessica Harbour, Catherine Pappano, Mary Mancuso, Kristin Kilbourn, Stacy M. Fischer (2026). \textit{Demoralization in Psilocybin-Assisted Therapy for Advanced Cancer: An Exploratory Network Analysis}. Journal of Pain and Symptom Management. [published; OpenAlex]. \href{https://doi.org/10.1016/j.jpainsymman.2026.04.025}{doi:10.1016/j.jpainsymman.2026.04.025}.
\item Andrew van der Vaart, Jeffrey LaPratt, Kimberly Swartz, Audrey Shoultz, Margo Lauterbach, Trisha Suppes, Harold A. Sackeïm, Scott T. Aaronson (2026). \textit{Efficacy and Safety of a Single Dose of Psilocybin for Chronic Suicidal Ideation}. The Journal of Clinical Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.4088/jcp.26m16338}{doi:10.4088/jcp.26m16338}.
\item Walters CK, Chetty S, Rants’o TA, Gossayn S, Lerotholi LJ. (2026). \textit{Safety and Efficacy of Psilocybin in the Management of Treatment-Resistant Depression: A Systematic Review}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-9283280/v1}{doi:10.21203/rs.3.rs-9283280/v1}.
\item University Medical Center Groningen (2026). \textit{The Safety and Efficacy of Psilocybin Therapy Compared to Low-dose Control in Reducing Depressive Symptoms in Patients With COPD, ALS, MS, or APD.}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06782724}{source link}.
\item Tarailis P, Griskova-Bulanova I. (2026). \textit{Characterizing Resting-State Brain Dynamics with Frequency-Resolved EEG Microstates: Parallel Analyses of Psilocybin Microdosing and Acute Inhaled DMT}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.64898/2026.05.05.723034}{doi:10.64898/2026.05.05.723034}.
\item Lorenzo Pasquini, Manesh Girn, Hannes Kettner, Avery Ostrand, Kate Allison, Christian Valtierra, Will Lucas, Patrick McConnell, Catriona Miller, Sydney Griffith, Dawn Weinstein, B L Anderson, Andrea Rosati, Jennifer Mitchell, Robin Carhart-Harris (2026). \textit{Neural correlates of insight on psilocybin: a within-subjects, healthy volunteer study}. Unknown journal. [published; OpenAlex]. \href{https://doi.org/10.21428/8e6ba8ef.1db8272c}{doi:10.21428/8e6ba8ef.1db8272c}.
\item Centre for Addiction and Mental Health (2026). \textit{Does Psilocybin Require Psychedelic Effects to Treat Depression? A4-Week, Double-Blind, Proof-of-Concept Randomized Controlled Trial}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05710237}{source link}.
\item Kinga Zachar, Maksymilian Sito, Filip Jurkowski, Łukasz Wójcik, Natalia Gawron, Hubert Tomasz Bojanowski, Aleksandra Dobracka, Zuzanna Marczak, Monika Jarowicz, Jędrzej Czmyr (2026). \textit{Psilocybin-Assisted Therapy in Depressive Disorders: Efficacy, Safety, and Persistence of Clinical Effects - A Narrative Review}. Journal of Education Health and Sport. [published; OpenAlex]. \href{https://doi.org/10.12775/jehs.2026.91.70672}{doi:10.12775/jehs.2026.91.70672}.
\item Peter S. Hendricks, Sara Lappan, Richard C. Shelton, Adrienne C. Lahti, Karen L. Cropsey, Matthew W. Johnson, Melissa Bradley, Otto Simonsson, Lori L. Davis, Daniel H. Grossman, Cynthia E. Ortiz (2026). \textit{Psilocybin in the Treatment of Cocaine Use Disorder}. JAMA Network Open. [published; OpenAlex]. \href{https://doi.org/10.1001/jamanetworkopen.2026.11029}{doi:10.1001/jamanetworkopen.2026.11029}.
\item Erin E Bonar (2026). \textit{Pilot Results for Psilocybin-Assisted Psychotherapy for Cocaine Use Disorder-A Critical Appraisal}. JAMA Network Open. [published; OpenAlex]. \href{https://doi.org/10.1001/jamanetworkopen.2026.11042}{doi:10.1001/jamanetworkopen.2026.11042}.
\item Nuwer R (2026). \textit{Magic mushroom compound shows promise against cocaine addiction.}. Science (New York, N.Y.). [published; PubMed]. \href{https://doi.org/10.1126/science.aei6155}{doi:10.1126/science.aei6155}.
\item Dayna Forsyth, Nicoletta Faraone, Simon G. Lamarre, Suzanne Currie (2026). \textit{The magic of mushrooms: psilocybin influences behavior in the mangrove rivulus fish, Kryptolebias marmoratus}. Frontiers in Behavioral Neuroscience. [published; OpenAlex]. \href{https://doi.org/10.3389/fnbeh.2026.1767175}{doi:10.3389/fnbeh.2026.1767175}.
\item Sunstone Medical (2026). \textit{A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of up to Two Doses of Psilocybin for the Treatment of Major Depressive Disorder in Adults With Cancer}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05947383}{source link}.
\item University of North Carolina, Chapel Hill (2026). \textit{Induction Protocol for Psilocybin-Assisted Therapy in Treatment-Resistant Depression (TRD): A Pilot Study}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06303739}{source link}.
\item Stanford University (2026). \textit{A Phase 2 Randomized Study Examining the Safety, Feasibility, and Effectiveness of Masking Psilocybin Therapy With General Anesthesia in Major Depressive Disorder}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07479550}{source link}.
\item University of Nebraska (2026). \textit{An Exploratory Pilot Study of Palliadelic Treatment to Reduce Psychological Distress in People With Pancreatobiliary and Other Advanced Gastrointestinal Cancers}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05220046}{source link}.
\item Lyons T, Spriggs M, Kerkelä L, Rosas FE, Roseman L, Mediano PAM, Timmermann C, Oestreich L, Pagni BA, Zeifman RJ, Hampshire A, Trender W, Douglass HM, Girn M, Godfrey K, Kettner H, Sharif F, Espasiano L, Gazzaley A, Wall MB, Erritzoe D, Nutt DJ, Carhart-Harris RL. (2026). \textit{Human brain changes after first psilocybin use.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41467-026-71962-3}{doi:10.1038/s41467-026-71962-3}.
\item Usona Institute (2026). \textit{A One-Year Observational Follow-up Study of Participants With Major Depressive Disorder Following a Randomized, Double-Blind Single-Dose of Psilocybin or Niacin-Control}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT04353921}{source link}.
\item University of Washington (2026). \textit{A Phase 2 Sequential Dose-Finding Study of Preparation for Group Retreat Psilocybin Therapy for Healthcare Clinicians With Loss of Meaning in Their Work and Symptoms of Depression}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07565909}{source link}.
\item James J. Peters Veterans Affairs Medical Center (2026). \textit{Safety, Tolerability, Outcomes of Psilocybin for Depression (STOP Depression) in Veterans With Spinal Cord Injury}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07251491}{source link}.
\item University of California, Los Angeles (2026). \textit{Group Psilocybin-assisted Cognitive Behavioral Therapy for Major Depressive Disorder}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07566104}{source link}.
\item Kevin H. Yang, Nora Satybaldiyeva, Wayne Kepner, Joseph Friedman, Siyuan Ping, Eric C. Leas (2026). \textit{Prevalence and Reasons for Microdosing Cannabis, Psilocybin, LSD, and MDMA Among U.S. Adults}. American Journal of Preventive Medicine. [published; OpenAlex]. \href{https://doi.org/10.1016/j.amepre.2026.108381}{doi:10.1016/j.amepre.2026.108381}.
\item Ceyda Sayalı, Eli Weisman, Frederick Barrett (2026). \textit{Effects of Psilocybin Treatment on Cognitive Effort Avoidance in Major Depressive Disorder and Co-Occurring Alcohol Use Disorder}. Unknown journal. [published; OpenAlex]. \href{https://doi.org/10.21428/8e6ba8ef.31e358f9}{doi:10.21428/8e6ba8ef.31e358f9}.
\item Lakshmi N Yatham (2026). \textit{Psilocybin-Assisted Therapy for Treatment-Resistant Depression in Bipolar II Disorder: A Randomized Controlled Trial}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06943573}{source link}.
\item Yale University (2026). \textit{Computationally, Electrophysiologically, and Qualitatively Characterizing Serotonergic Psychedelics; Transdiagnostic Therapeutic and Pro-Psychotic Effects}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06624137}{source link}.
\item Erin Mauney, Juliana Zambrano, Jenna Clukey, Helen Burton-Murray, Michael Datko, Vitaly Napadow, Braden Kuo, Franklin King (2026). \textit{Sa1731 A PILOT STUDY OF OPEN-LABEL PSILOCYBIN-ASSISTED THERAPY IN TREATMENT-REFRACTORY IBS}. Gastrointestinal Endoscopy. [published; OpenAlex]. \href{https://doi.org/10.1016/s0016-5107(26)04363-4}{doi:10.1016/s0016-5107(26)04363-4}.
\item Herman Melissa (2026). \textit{Sex-Specific Effects of Psilocin on Paraventricular Nucleus of the Thalamus (PVT) Circuitry and Threat Responding Behavior in Male and Female Rats}. Biological Psychiatry. [published; Crossref]. \href{https://doi.org/10.1016/j.biopsych.2026.03.055}{doi:10.1016/j.biopsych.2026.03.055}.
\item Kayleigh LaMalfa, Diego A. Pizzagalli, Jack Bergman, Christopher W. Thomas, Brian Kangas (2026). \textit{Prohedonic Effects of Psilocybin (COMP360) in a Touchscreen-Based Rodent Probabilistic Reward Task (Abstract ID: 227883)}. Journal of Pharmacology and Experimental Therapeutics. [published; OpenAlex]. \href{https://doi.org/10.1016/j.jpet.2026.104267}{doi:10.1016/j.jpet.2026.104267}.
\item Matthew Reid, Abigail Yaffe, Ian Geithner, Alison Rebman, John Aucott, Albert Garcia-Romeu (2026). \textit{1020 Long-term Impact of Psilocybin Administration on Sleep-Continuity via Wearable Sensor Time-series: Preliminary-results in Post-Treatment Lyme Disease}. SLEEP. [published; OpenAlex]. \href{https://doi.org/10.1093/sleep/zsag091.1019}{doi:10.1093/sleep/zsag091.1019}.
\item Sean Hayduk, Amy Stringer, Satoria Zagorski, Sara Jane Ward (2026). \textit{PDE4B Inhibition and Psilocybin as Promising Approaches for Treating Methamphetamine Use Disorder: Preclinical Evidence From Rat Models (Abstract ID: 232554)}. Journal of Pharmacology and Experimental Therapeutics. [published; OpenAlex]. \href{https://doi.org/10.1016/j.jpet.2026.104282}{doi:10.1016/j.jpet.2026.104282}.
\item Unknown authors (2026). \textit{Pure psilocybin reduces reward-associated preference while mushroom extract shows transient exploratory effects in rats}. RevSALUS - Revista Científica da Rede Académica das Ciências da Saúde da Lusofonia. [published; OpenAlex]. \href{https://doi.org/10.51126/revsalus.v8isupii.46826}{doi:10.51126/revsalus.v8isupii.46826}.
\item L Hecker, J M Kleinhenz, C Coarfa, K Kato (2026). \textit{C29-12 Psilocybin Treatment Could Improve Outcomes for Age-associated Lung Diseases}. American Journal of Respiratory and Critical Care Medicine. [published; OpenAlex]. \href{https://doi.org/10.1093/ajrccm/aamag162.144}{doi:10.1093/ajrccm/aamag162.144}.
\item R Andrew Yockey, Amber Amis, Elise Devier, Aminul Apu, Rachel Hoopsick (2026). \textit{Prevalence and Correlates of Past-Year Psilocybin Use in the U.S., 2024, USA}. AJPM Focus. [published; OpenAlex]. \href{https://doi.org/10.1016/j.focus.2026.100518}{doi:10.1016/j.focus.2026.100518}.
\item Joseph Hennessey, John Mantsch, John McCorvy (2026). \textit{Effects of Psilocybin on Attentional Set-Shifting Following Chronic Unpredictable Stress in Rats (Abstract ID: 231339)}. Journal of Pharmacology and Experimental Therapeutics. [published; OpenAlex]. \href{https://doi.org/10.1016/j.jpet.2026.104291}{doi:10.1016/j.jpet.2026.104291}.
\item Unknown authors (2026). \textit{Preclinical evaluation of psilocybin and related compounds: Inhibition of cytochrome P450 isoforms}. RevSALUS - Revista Científica da Rede Académica das Ciências da Saúde da Lusofonia. [published; OpenAlex]. \href{https://doi.org/10.51126/revsalus.v8isupii.46635}{doi:10.51126/revsalus.v8isupii.46635}.
\item Matthew Reid, Eli Weisman, Luis Luna Martinez, William Coon, Frederick Barrett (2026). \textit{1080 Psilocybin Elicits Non-Linear Night to Night Changes in Sleep Spectral Power}. SLEEP. [published; OpenAlex]. \href{https://doi.org/10.1093/sleep/zsag091.1079}{doi:10.1093/sleep/zsag091.1079}.
\item Anna Signor, Martina Colognesi, Giovanna Finzi, Daniela Gabbia, Andrea Mattarei, Stefano Comai, Gianfranco Pasut, Franco Folli, Paolo Manfredi, Sara De Martin (2026). \textit{SAT-219 Hepatic 5-HT2B receptor antagonism mediates the anti-steatotic and antifibrotic effects of psilocybin in preclinical MASH models}. Journal of Hepatology. [published; OpenAlex]. \href{https://doi.org/10.1016/s0168-8278(26)01861-1}{doi:10.1016/s0168-8278(26)01861-1}.
\item Unknown authors (2026). \textit{Cytochrome P450 Inhibition by Psilocybin and Psilocin: A Combined Molecular Dynamics and Enzymatic Screening Study}. RevSALUS - Revista Científica da Rede Académica das Ciências da Saúde da Lusofonia. [published; OpenAlex]. \href{https://doi.org/10.51126/revsalus.v8isupii.46839}{doi:10.51126/revsalus.v8isupii.46839}.
\item Denise Vidot, Bria-Necole Diggs, Amrit Baral, Michelle Thompson, Girardin Jean-Louis (2026). \textit{0408 Insomnia Severity Differences by Psilocybin, LSD, and DMT Use Status Among Young Adult Daily Cannabis Consumers in the Herbal Heart Study}. SLEEP. [published; OpenAlex]. \href{https://doi.org/10.1093/sleep/zsag091.0408}{doi:10.1093/sleep/zsag091.0408}.
\item Gyandev Gupta, Ravina Yadav (2026). \textit{Role of Psychological support in sustaining Antidepressants effects in Psilocybin - Assisted Clinical}. JOURNAL OF ADVANCE AND FUTURE RESEARCH. [published; OpenAlex]. \href{https://doi.org/10.56975/jaafr.v4i5.509087}{doi:10.56975/jaafr.v4i5.509087}.
\item Viljoen G, Walter H, Bendau A, Koslowski M, Betzler F (2026). \textit{Predictors of therapeutic response to psychedelic-assisted therapy: A systematic review.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811251389581}{doi:10.1177/02698811251389581}.
\item O'Mahony B, Harrington C, Harkin A, Lally N (2026). \textit{Trip killers: Addressing a critical knowledge gap in psychedelic research.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811261431056}{doi:10.1177/02698811261431056}.
\item Simonsson O, Sun S, Wesseldijk LW, Ullén F, Osika W, Mosing MA (2026). \textit{Associations between psychedelic use and migraine history in Swedish twins.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811261449385}{doi:10.1177/02698811261449385}.
\item Zeina Beidas, Anya Ragnhildstveit, Adam Blackman, Thomas Anderson, Emily Fewster, Omer A. Syed, Valentyne Sobolenko, Ismail Kaan Kanca, Tatiana Son, Norman Farb, Rotem Petranker (2026). \textit{Microdosing psilocybin for major depressive disorder: study protocol for a phase II double-blind placebo-controlled randomised partial crossover trial - CORRIGENDUM}. BJPsych Open. [published; OpenAlex]. \href{https://doi.org/10.1192/bjo.2026.12000}{doi:10.1192/bjo.2026.12000}.
\item Kurt Stocker, Matthias Hartmann, Frederick S. Barrett, William A. Richards, Nathan D. Sepeda, Laura Ley, Anna M. Becker, Friederike Holze, Matthias E. Liechti (2026). \textit{Integrating the Mystical Experience Questionnaire Into a Broader Psychometric Framework: English Validation of the Psychedelic Experience Scale and Comparison of Psilocybin and LSD Sessions Across Two Controlled Settings}. Repository for Publications and Research Data (ETH Zurich). [published; OpenAlex]. \href{https://doi.org/10.3929/ethz-c-000799490}{doi:10.3929/ethz-c-000799490}.
\item Tyler Girard, Boris Heifets, Robert Sapolsky, X Chen, Stanford University (2026). \textit{Characterizing psilocybin’s effects on nociception and thermoregulation in preclinical pain models}. Stanford Digital Repository. [published; OpenAlex]. \href{https://doi.org/10.25740/yr748bv5776}{doi:10.25740/yr748bv5776}.
\item Dylan Briggs, Thomas B. Sease, Ruthie Menou, David R. Perkins (2026). \textit{Does Psychological Flexibility Correlate with Mystical Experiences: A Machine Learning Approach Including State of Surrender, Near-Death Experiences, and Psilocybin Consumption}. Behavioral Sciences. [published; OpenAlex]. \href{https://doi.org/10.3390/bs16050686}{doi:10.3390/bs16050686}.
\item University Hospital, Basel, Switzerland (2026). \textit{Lysergic Acid Diethylamide (LSD) in Palliative Care: a Randomised, Double-blind, Active-placebo Controlled Phase II Study (LPC-Study)}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05883540}{source link}.
\item Joshua Woolley, MD, PhD (2026). \textit{A Double-blind, Randomized Trial Examining the Preliminary Efficacy of Psilocybin Therapy for People With Chronic Low Back Pain}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05351541}{source link}.
\item Marini S, De Berardis D. (2026). \textit{The Ecstasy of Gold in Neurodiversity: Focus on the Use of Psychedelics in Autism Spectrum Disorder}. Preprints.org. [preprint; Europe PMC]. \href{https://doi.org/10.20944/preprints202604.1998.v1}{doi:10.20944/preprints202604.1998.v1}.
\item Zajaczkowski M, Koutsoftidis S, Sheeraz M, Barsakcioglu DY, Jia T, McGeady CA, Kundu A, Pizzi M, Tatti F, Bashford J, Bhavesh P, Farina D, Drakakis E. (2026). \textit{A128-Channel Wireless Wearable Myolink (W2 Myolink): Functional Characteristics and Multidisciplinary Experiments}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-9266175/v1}{doi:10.21203/rs.3.rs-9266175/v1}.
\item Wang H, Li X, Yu F, Wang X (2026). \textit{The Harmonious Dance: A Narrative Review on Psychedelics and Music in Therapeutic Settings.}. Current neuropharmacology. [published; PubMed]. \href{https://doi.org/10.2174/011570159x442471260422110855}{doi:10.2174/011570159x442471260422110855}.
\item Neil K. Savalia, Lingxiao Shao, Cory Knox, A. Gilbert, Quan Jiang, Alex Kwan (2026). \textit{157. Opposing 5-HT Receptors Modulate Psilocybin's Action on Dendritic Calcium Dynamics}. Biological Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.biopsych.2026.03.391}{doi:10.1016/j.biopsych.2026.03.391}.
\item Friederike Holze, Denis Arikci, Jan Thomann, Deborah Rudin, Dino Luethi, Matthias E. Liechti (2026). \textit{Acute Effects of 4-Bromo-2,5-Dimethoxyphenethylamine (2C-B) Compared With Psilocybin and MDMA in Healthy Participants}. Biological Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.biopsych.2026.03.056}{doi:10.1016/j.biopsych.2026.03.056}.
\item Heike Schuler, Delong Zhou, Chloé Savignac, Vedrana Cvetkovska, Yiu-Chung Tse, Juliet Meccia, Danilo Bzdok, Rosemary C. Bagot (2026). \textit{Profiling the Cell-Type Specific Effects of Psilocybin in Medial Prefrontal Cortexh}. Biological Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.biopsych.2026.03.054}{doi:10.1016/j.biopsych.2026.03.054}.
\item Ellen Bradley, D Parker Kelley, Martin Picard, Balazs Szigeti, Kimberly Sakai, Gisele Fernandes, Jill Ostrem, Caroline Tanner, Patrick Finley, Connie Ludwig, Katiah Llerena, Zach Busby, Amber McKernan, Jose Rafael Zuzuarregui, Meredith Bock, Aliss Wang, Andrew Penn, Josh Woolley, Aoife O'Donovan (2026). \textit{356. Psilocybin Therapy is Associated With Decreases in Markers of Mitochondrial Stress and Inflammation in an Open-Label Clinical Trial of Parkinson’s Disease}. Biological Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.biopsych.2026.03.590}{doi:10.1016/j.biopsych.2026.03.590}.
\item Joshua Poulin, Nic Viulet, Ashley Liu, Bradley J. MacIntosh, Sean M. Nestor (2026). \textit{483. Acute Functional Brain Changes Associated With Psilocybin in Depression and Healthy Adults: A Systematic Review and Coordinate-Based Meta-Analysis}. Biological Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.biopsych.2026.03.717}{doi:10.1016/j.biopsych.2026.03.717}.
\item Broc Pagni, Stephen Ross, Yuna Kim, Michael Bogenschutz (2026). \textit{6. Open-Label Extension of Psilocybin-Assisted Therapy in Patients With Alcohol Use Disorder: Continued Safety and Short-Term Efficacy Signal for Drinking, Craving, and Self-Efficacy}. Biological Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.biopsych.2026.03.240}{doi:10.1016/j.biopsych.2026.03.240}.
\item Joga Chaganti, Krista J Siefried, Veda S Vyakaranam, Liam Acheson, Jonathan Brett (2026). \textit{“Large-Scale and Local Functional Connectivity Changes Following Psilocybin Administration in Methamphetamine Use Disorder}. American Journal of Neuroradiology. [published; OpenAlex]. \href{https://doi.org/10.3174/ajnr.a9364}{doi:10.3174/ajnr.a9364}.
\item Askey T, Allen-Ross D, Luzyanin D, Lasrado R, Gilmour G, Hunt SP, Tamagnini F, Ahmed M, Stephens GJ, Maiarú M. (2026). \textit{Psilocybin ameliorates neuropathic pain-like behaviour in mice and facilitates gabapentin-mediated analgesia.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s42003-026-10065-7}{doi:10.1038/s42003-026-10065-7}.
\item Eli Stark-Elster, Mamosebetsi Sethathi, B. van der Merwe, Sandeep M. Nayak, David Bryce Yaden, Manvir Singh (2026). \textit{Psilocybin use among Basotho healers and non-healers in southern Africa}. Unknown journal. [published; OpenAlex]. \href{https://doi.org/10.31235/osf.io/429dw\_v1}{doi:10.31235/osf.io/429dw\_v1}.
\item Salinsky LM, Fox JL, Diaz KC, Timmons BC, Ferguson SM. (2026). \textit{Methamphetamine-Fentanyl Polysubstance Administration Produces Social Deficits and Corticolimbic Stress-Reward Circuit Adaptations}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-9306429/v1}{doi:10.21203/rs.3.rs-9306429/v1}.
\item Low ZXB. (2026). \textit{Serotonergic psychedelics for Autism spectrum disorder: Neurobiological mechanisms and translational prospects.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.pnpbp.2026.111717}{doi:10.1016/j.pnpbp.2026.111717}.
\item Portland VA Research Foundation, Inc (2026). \textit{Psilocybin-Enhanced Psychotherapy for Methamphetamine Use Disorder}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT04982796}{source link}.
\item Usona Institute (2026). \textit{A Randomized, Double-Blind Study of Single-Dose Psilocybin for Major Depressive Disorder (MDD)}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT03866174}{source link}.
\item Kyle Greenway (2026). \textit{Toward Patient-Tailored Care for Treatment-Resistant Depression: A Pilot Patient-Preference Clinical Trial of Music and Mindfulness in Psilocybin-Assisted Psychotherapy}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07373535}{source link}.
\item Hinchcliffe JK, Bartlett J, Thomas CW, Golden CT, Gilmour G, Bortolotto ZA, Robinson ES. (2026). \textit{Distinct Modulatory Effects on Affective Biases by Different Serotonergic Psychedelics and MDMA in Male Rats: Possible Implications for Antidepressant Effects}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.64898/2026.04.20.719483}{doi:10.64898/2026.04.20.719483}.
\item Deivid Antonio Cahuasqui-Mendoza (2026). \textit{Psilocybin as an alternative to conventional treatments: A systematic review}. Gaceta Médica de Caracas. [published; OpenAlex]. \href{https://doi.org/10.47307/gmc.2026.134.s2.32}{doi:10.47307/gmc.2026.134.s2.32}.
\item Kevin H. Yang, Avery Eun, Joseph J. Palamar (2026). \textit{Prevalence and Correlates of Past-Year Psilocybin Use in the United States}. American Journal of Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1176/appi.ajp.20251343}{doi:10.1176/appi.ajp.20251343}.
\item Baral A, Pan Y, Hlaing WM, Garcia-Romeu A, Pinheiro PS, Vidot DC. (2026). \textit{Classic psychedelic and cannabis use among U.S. cancer survivors aged ≥ 50 years: nationally representative estimates by cancer type/site.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s10552-026-02172-x}{doi:10.1007/s10552-026-02172-x}.
\item Knox CA, Woodburn SC, Gilbert AD, Schlotzhauer JM, Kwan AC. (2026). \textit{Structural plasticity and enhanced fear extinction following psilocybin in chronically stressed mice}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.64898/2026.04.21.720014}{doi:10.64898/2026.04.21.720014}.
\item Feldman R, Audette M, Leacock PR, Theobald J. (2026). \textit{A25-year analysis of Armillaria (honey mushroom) poisoning in Wisconsin.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.ajem.2026.04.033}{doi:10.1016/j.ajem.2026.04.033}.
\item University of Colorado, Denver (2026). \textit{Study of Psilocybin Assisted Psychotherapy to Address Fear of Recurrence in Patients Diagnosed With Early-stage Breast Cancer and Ovarian Cancer in Remission}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06430541}{source link}.
\item Mohsen Khosravi, Domenico De Berardis, Massimo Tusconi (2026). \textit{The efficacy and safety of psilocybin-assisted therapy for major depressive disorder: a meta-analytic review of clinical outcomes}. Mental Wellness. [published; OpenAlex]. \href{https://doi.org/10.4081/mw.2026.40}{doi:10.4081/mw.2026.40}.
\item Siti Nashria Rusdhy, Andrian Fajar Kusumadewi, Carla Raymondalexas Marchira, Mustika Suci Mahardikaningrum, Teresa Lalita Wiryarini, Devira Ayu Wulandari (2026). \textit{Efficacy and Safety of Psilocybin-Assisted Therapy for Depression: A Meta-Analysis of Randomised Controlled Trials}. Open Access Indonesian Journal of Medical Reviews. [published; OpenAlex]. \href{https://doi.org/10.37275/oaijmr.v6i2.883}{doi:10.37275/oaijmr.v6i2.883}.
\item Yacoub J, Bray E, Bayyat J, Glatfelter GC, Leake A, Buitrago EM, Maitland AD, Partilla J, Cavalco NG, Schalk SS, Lammers JC, Baumann MH, McCorvy J, Leahy JW, Gulick D, Witowski CG, von Salm JL. (2026). \textit{Serotonergic Polypharmacology of 2-Halogenated Tryptamines}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.64898/2026.04.16.718915}{doi:10.64898/2026.04.16.718915}.
\item Sivert Drange, Jacob Cohen, Sys Stybe Johansen, Ben Dunkley, Mikael Palner (2026). \textit{Case Report: Repeated low doses of psilocybin reduce perceived symptom severity but fail to restore cognitive flexibility in a case of severe obsessive-compulsive disorder: an observational case study of identical twins}. Frontiers in Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.3389/fpsyt.2026.1819962}{doi:10.3389/fpsyt.2026.1819962}.
\item Johns Hopkins University (2026). \textit{Open Label Psilocybin Brain Stimulation and Imaging Pilot Study}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06835699}{source link}.
\item Brinzei OV. (2026). \textit{Comparative Medico-Legal Frameworks for Psilocybin Regulation: A March 2026 Update}. Preprints.org. [preprint; Europe PMC]. \href{https://doi.org/10.20944/preprints202604.1423.v1}{doi:10.20944/preprints202604.1423.v1}.
\item Agnieszka Bysiek, Izabela Szpręgiel, Adam Wojtas, Marzena Maćkowiak, Agnieszka Wawrzczak-Bargieła, Monika Leśkiewicz, Ewa Trojan, Katarzyna Kamińska, Weronika Kumorek, Wiktor Bilecki, K Golembiowska (2026). \textit{Psilocybin restores behavioral and neuroplastic deficits induced by chronic stress in rats}. Progress in Neuro-Psychopharmacology and Biological Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.pnpbp.2026.111710}{doi:10.1016/j.pnpbp.2026.111710}.
\item Francisco Sacadura, Cláudia Marques, Andreia Machado Brito-da-Costa, Mariana Carvalho, Helena Carmo, Ricardo Jorge Dinis-Oliveira, Áurea Madureira-Carvalho, Diana Dias da Silva (2026). \textit{Impact of psilocybin and Psilocybe cubensis extract on gut microbiota in Wistar Han rats}. Science Letters. [published; OpenAlex]. \href{https://doi.org/10.48797/sl.2026.492}{doi:10.48797/sl.2026.492}.
\item Diana Dias da Silva, Andreia Machado Brito-da-Costa, Francisco Sacadura, Mariana Carvalho, Helena Carmo, Ricardo Jorge Dinis-Oliveira, Áurea Madureira-Carvalho (2026). \textit{Psilocybin and Psilocybe cubensis extract exhibit divergent behavioural and toxicological effects in rats}. Science Letters. [published; OpenAlex]. \href{https://doi.org/10.48797/sl.2026.497}{doi:10.48797/sl.2026.497}.
\item Beatriz P. Senra, Ricardo Jorge Dinis-Oliveira, Carlos J. A. Ribeiro (2026). \textit{Investigating Psychedelic Tryptamines: Extraction and Quantification from Psilocybe Mushrooms}. Science Letters. [published; OpenAlex]. \href{https://doi.org/10.48797/sl.2026.498}{doi:10.48797/sl.2026.498}.
\item Cassidy R. LoParco, Carlton Bone, Annalynn M. Galvin, Matthew E. Rossheim, Carla Berg (2026). \textit{Oregon’s Psilocybin Services: A summary and public health commentary}. New Prairie Press (Kansas State University). [published; OpenAlex]. \href{https://newprairiepress.org/hbr/vol9/iss1/20}{source link}.
\item Juan Moisés de la Serna de la Serna (2026). \textit{Neural Entropy and Cognitive Flexibility: A Research Agenda for Psilocybin-Assisted Therapy [FUTURE DIRECTIONS v1.0]}. Zenodo (CERN European Organization for Nuclear Research). [published; OpenAlex]. \href{https://doi.org/10.5281/zenodo.19620938}{doi:10.5281/zenodo.19620938}.
\item King's College London (2026). \textit{Probing the Functional Magnetic Resonance Imaging Response to Psilocybin in Functional Neurological Disorder (PsiFUND)}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05723276}{source link}.
\item Davoudian PA, Jiang Q, Knox CA, Savalia NK, Shao L, Wilson J, Weiner AM, Chong CW, Liao C, Nothnagel JD, Sakurai T, Kwan AC. (2026). \textit{Psilocybin reshapes cortical inhibition through selective interneuron recruitment}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.64898/2026.04.16.718963}{doi:10.64898/2026.04.16.718963}.
\item Klintefors P, Bhagavan C, Kanaan R, Bryson A, Berlowitz D, Attard Z, Carter O. (2026). \textit{Psilocybin’s Kinematic Effect on Manual Dexterity}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-9291780/v1}{doi:10.21203/rs.3.rs-9291780/v1}.
\item Jóźwiak-Bębenista M, Stasiak A, Sienkiewicz M, Kwiatkowski P, Kowalczyk E. (2026). \textit{Psilocybin in Older Adults: Therapeutic Opportunities in Inflammation-Driven Disorders of Aging-From Depression to Neurodegeneration}. Preprints.org. [preprint; Europe PMC]. \href{https://doi.org/10.20944/preprints202604.1125.v1}{doi:10.20944/preprints202604.1125.v1}.
\item JC Rodriguez, Yanice Duquesne-Maldonado, Julián M. Hernández Torres, Istoni Da'Luz Sant'Ana, Cruz M. Nazario (2026). \textit{Psilocybin use in Puerto Rico: Patterns, motivations, and personality correlates from an online survey}. Journal of Psychedelic Studies. [published; OpenAlex]. \href{https://doi.org/10.1556/2054.2026.00519}{doi:10.1556/2054.2026.00519}.
\item Keenan RJ, Haque RT, Jin X, Mustafa T, Homman-Ludiye J, Elysee K, Wee ZS, Simonds SE, Foldi CJ, Cowley MA. (2026). \textit{Effects of a single dose of psilocybin on diet-induced weight loss in obese mice.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41398-026-03995-7}{doi:10.1038/s41398-026-03995-7}.
\item Anthony L. Back, Bonnie A. McGregor, Leslie L. Thorn, Kalin Harvey, Dianna Blom, George Callan, John Guy, Sameet Kumar, Rob Hershberg, Melissa Layer, Jackie Levin, Susanna Myers, Juliana Perez, Kathy Salmonson, Peter Thompson, Joseph Whinney (2026). \textit{A phase 1 study of a second experience with Group Retreat Psilocybin Therapy for partial responders after a first experience}. Frontiers in Public Health. [published; OpenAlex]. \href{https://doi.org/10.3389/fpubh.2026.1810904}{doi:10.3389/fpubh.2026.1810904}.
\item Section for Affective Disorders; Northern Stockholm Psychiatry (2026). \textit{CAPSI - Cancer Related Major Depression Treated With a Single Dose of Psilocybin: A Multicenter Randomized Placebo Controlled Double Blind Clinical Trial}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06319378}{source link}.
\item Olsen AS, Larsen K, McCulloch DE, Ganz M, Madsen MK, Ozenne B, Knudsen GM, Rehman Nu, Fisher PM. (2026). \textit{Psilocybin acutely reduces low-frequency BOLD power and frequency-specific connectivity}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.64898/2026.04.09.717379}{doi:10.64898/2026.04.09.717379}.
\item J. Morgan Penberthy, Fatma Wise, Nicholas P. Cherup, Evaline Mitchell, Madeline Burns, Oluwafunmilayo Akinlade, David Chung, Harshit Parmar, Jonathan Singer (2026). \textit{Psilocybin for Treatment of Prolonged Grief Disorder: An Open-Label Feasibility Study Protocol}. Psychoactives. [published; OpenAlex]. \href{https://doi.org/10.3390/psychoactives5020012}{doi:10.3390/psychoactives5020012}.
\item Eric Rundquist, Diego Nicolás Monasterio López, Juan Jonathan Oyarzo Alvarado, Robin Carhart-Harris, Lorenzo Pasquini, Erin Vinson, Manesh Girn, Avery Ostrand, Kate Allison, Hannes Kettner, Catriona S. Miller, Sydney Griffith, Adam Gazzaley, Andrea Rosati, Jennifer Mitchell (2026). \textit{Observing the mind under psychedelics: conceptual metaphors used following four once-weekly macrodoses of psilocybin}. Philosophical Psychology. [published; OpenAlex]. \href{https://doi.org/10.1080/09515089.2026.2657452}{doi:10.1080/09515089.2026.2657452}.
\item D. P. Effinger, J. L. Hoffman, Sema G. Quadir, C. S. Rollison, D. Toedt, M. Echeveste Sanchez, M. W. High, C. W. Hodge, Melissa A. Herman (2026). \textit{Sex-specific increased reactivity of the PVT and prolonged PVT→CeA circuit engagement following psilocin administration}. Nature Communications. [published; OpenAlex]. \href{https://doi.org/10.1038/s41467-026-71481-1}{doi:10.1038/s41467-026-71481-1}.
\item Nikita Sanati Morel, Dea Siggaard Stenbaek, Johan Lundberg, Maria Beckman (2026). \textit{Additional file 1 of Evaluation of a facilitator training program in a randomized controlled trial of psilocybin treatment for depression}. Figshare. [published; OpenAlex]. \href{https://doi.org/10.6084/m9.figshare.32048850}{doi:10.6084/m9.figshare.32048850}.
\item Hollis Karoly, Kent E. Hutchison (2026). \textit{Psilocybin mushrooms are going mainstream, but scientific research and regulation lag behind}. Unknown journal. [published; OpenAlex]. \href{https://doi.org/10.64628/aai.6g7fw5d5c}{doi:10.64628/aai.6g7fw5d5c}.
\item Rumph JT, Winquist A, Troeschel AN, Pulver S, Schnall AH, Ebersole J, Yeh M, Burt B, Federman SL, Klontz K, Dasenbrock C, Leahy HL, Brady S, Stuteville H, Patel K, Daniel J, Chang A (2026). \textit{Severe Illness Associated with Eating Mushroom-Containing Chocolate Products - United States, January-October 2024.}. MMWR. Morbidity and mortality weekly report. [published; PubMed]. \href{https://doi.org/10.15585/mmwr.mm7513a2}{doi:10.15585/mmwr.mm7513a2}.
\item Baker JJ, Kogan E, Ma S, Lu J, Zuo Y. (2026). \textit{Dissociating the Hallucinogenic and Neuroplastic Effects of Psilocybin}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.64898/2026.04.06.716778}{doi:10.64898/2026.04.06.716778}.
\item Sin-Yee Yap, Fuad Noman, Junn Yong Loo, Devon Stoliker, M. Amin Khajehnejad, Raphaël C.-W. Phan, David L. Dowe, Adeel Razi, Chee-Ming Ting (2026). \textit{Brain-MGF: Multimodal Graph Fusion Network for EEG-FMRI Brain Connectivity Analysis Under Psilocybin}. Unknown journal. [published; OpenAlex]. \href{https://doi.org/10.1109/isbi61048.2026.11515300}{doi:10.1109/isbi61048.2026.11515300}.
\item Nikita Sanati Morel, Dea Siggaard Stenbaek, Johan Lundberg, Maria Beckman (2026). \textit{Evaluation of a facilitator training program in a randomized controlled trial of psilocybin treatment for depression}. BMC Medical Education. [published; OpenAlex]. \href{https://doi.org/10.1186/s12909-026-09124-8}{doi:10.1186/s12909-026-09124-8}.
\item University of California, Los Angeles (2026). \textit{Safety Profile of 25 mg Psilocybin in Individuals With Cocaine Use Disorder}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06102434}{source link}.
\item Gallardo LM. (2026). \textit{Altered States of Consciousness and the Subconscious Mind: A Comprehensive Comparative Review of Disciplines, Neurobiological Mechanisms, Clinical Applications, and Philosophical Frameworks - Including Life Between Lives and Transpersonal Hypnotherapy}. Preprints.org. [preprint; Europe PMC]. \href{https://doi.org/10.20944/preprints202604.0415.v1}{doi:10.20944/preprints202604.0415.v1}.
\item S. Parker Singleton, Brooke L. Sevchik, Analiese Lahey, Pim Cuijpers, Mathias Harrer, Megan T. Jones, Sandeep M. Nayak, Eric C. Strain, Simon Vandekar, Robert H. Dworkin, J. Cobb Scott, Theodore D. Satterthwaite (2026). \textit{A living systematic review, meta-analysis and open-data resource of randomized controlled trials of psilocybin treatment for symptoms of depression}. Nature Mental Health. [published; OpenAlex]. \href{https://doi.org/10.1038/s44220-026-00630-8}{doi:10.1038/s44220-026-00630-8}.
\item University of Wisconsin, Madison (2026). \textit{Role of Experience, Conscious Awareness, and Plasticity in Psilocybin's Behavioral Effects - Follow-Up Study (The RECAP 2 Study)}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06692192}{source link}.
\item University of Wisconsin, Madison (2026). \textit{Activating Neuroplasticity to ENHANCE the Perception Box Expanding Effects of Psilocybin}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05866471}{source link}.
\item Leonard Lerer (2026). \textit{Psilocybin and human longevity}. npj Aging. [published; OpenAlex]. \href{https://doi.org/10.1038/s41514-026-00380-y}{doi:10.1038/s41514-026-00380-y}.
\item University Hospital, Basel, Switzerland (2026). \textit{Acute Analgesic Effects of DMT on Experimentally Induced Acute Nociceptive Pain, Hyperalgesia and Allodynia in Healthy Participants}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06180759}{source link}.
\item Johns Hopkins University (2026). \textit{Effects of Psilocybin in Obsessive Compulsive Disorder}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05546658}{source link}.
\item Shakila Meshkat, Manish K. Jha, Venkat Bhat (2026). \textit{Therapeutic Potential of Psilocybin in Psychiatric Disorders: Mechanisms, Efficacy, and Clinical Implications}. FOCUS The Journal of Lifelong Learning in Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1176/appi.focus.20250043}{doi:10.1176/appi.focus.20250043}.
\item Adams DR, Xu KY, Cabassa LJ (2026). \textit{Psychedelic-Assisted Therapy: Breakthrough for Whom?}. Psychiatric services (Washington, D.C.). [published; PubMed]. \href{https://doi.org/10.1176/appi.ps.26077010}{doi:10.1176/appi.ps.26077010}.
\item Jon E. Grant, Sophia Boutouis, Margaret O’Brien, Laurie Avila, Megha Neelapu, Dustin Ehsan (2026). \textit{An Open-Label Study of Single-Dose Psilocybin for Borderline Personality Disorder With Co-Occurring Major Depressive Disorder}. Clinical Neuropharmacology. [published; OpenAlex]. \href{https://doi.org/10.1097/wnf.0000000000000683}{doi:10.1097/wnf.0000000000000683}.
\item Yong-Xing Qiao, Wei Dai, Yishan Yao, Qian-qian Wei, Chen-xing Yue, Yong-Yu Yin, Yun-feng Li, Liming Zhang (2026). \textit{The astrocytes in the prefrontal cortex contribute to the rapid antidepressant-like effects of psilocybin in the chronic restraint stress mouse model}. Progress in Neuro-Psychopharmacology and Biological Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.pnpbp.2026.111698}{doi:10.1016/j.pnpbp.2026.111698}.
\item Sebastian Schober, Lisa Dorfmann, Karl Walther, Felix Blei, A.R. Chadeayne, Markus Gressler, Stefan Bartram, Sarah E. O’Connor, Dirk Hoffmeister (2026). \textit{Specific and Multi-Product Clade I and Clade IV Sesquiterpene Synthases Contribute to the Psilocybe cubensis Volatilome}. ChemBioChem. [published; OpenAlex]. \href{https://doi.org/10.1002/cbic.70318}{doi:10.1002/cbic.70318}.
\item Helena Pichler (2026). \textit{Psilocybin: Wirksam, aber kein Wundermittel}. MMW - Fortschritte der Medizin. [published; OpenAlex]. \href{https://doi.org/10.1007/s15006-026-5871-5}{doi:10.1007/s15006-026-5871-5}.
\item Kamil Jurowski, Damian Kobylarz, Maciej Noga (2026). \textit{In-silico toxicity study of tryptamine, psilocin, psilocybin, N,N-dimethyltryptamine, 5’-methoxy-N,N-dimethyltryptamine and O-acetylpsilocin}. Archives of Toxicology. [published; OpenAlex]. \href{https://doi.org/10.1007/s00204-026-04365-4}{doi:10.1007/s00204-026-04365-4}.
\item Sunnybrook Health Sciences Centre (2026). \textit{Engaging Mood Brain Circuits With Psilocybin: a Randomized Neuroimaging Trial in Depression}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06072898}{source link}.
\item Indiana University (2026). \textit{Psilocybin Assisted Psychotherapy for Treatment Resistant Depression and Co-occurring Substance Use Disorder}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07499583}{source link}.
\item Linda M. Richmond (2026). \textit{MedCheck: FDA Approves Novel Antipsychotic Milsaperidone; Designates Psilocybin Analogue as Breakthrough Therapy for Postpartum Depression, and More!}. Psychiatric News. [published; OpenAlex]. \href{https://doi.org/10.1176/appi.pn.2026.04.4.3}{doi:10.1176/appi.pn.2026.04.4.3}.
\item Unknown authors (2026). \textit{Strong alliance, weak conclusions: Comment on Goodwin et al. (2026) “The role of therapeutic alliance in psilocybin treatment for treatment-resistant depression”}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/8s7xk\_v1}{source link}.
\item Katharine Smith, Edward Harcourt, Andrea Cipriani (2026). \textit{Psychedelics in NHS services: exploring a model for real-world implementation of psilocybin}. The British Journal of Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1192/bjp.2026.10612}{doi:10.1192/bjp.2026.10612}.
\item Graeme Knibb, Ruby Ward, Paul Christiansen, Carl Roberts (2026). \textit{Associations Between Psilocybin Use Motives and Cognitive, Affective, and Behavioural Self-Stigma}. Substance Use \& Misuse. [published; OpenAlex]. \href{https://doi.org/10.1080/10826084.2026.2643418}{doi:10.1080/10826084.2026.2643418}.
\item Federal University of Latin American Integration (2026). \textit{Psilocybe Cubensis Mushrooms With or Without Fluoxetine for Refractory Depression}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06898606}{source link}.
\item Christine Buchanan (2026). \textit{26-CCC-15854-ACC TALK ABOUT A BAD TRIP!: PSILOCYBIN USE WITH PRE-EXISTING CARDIOVASCULAR DISEASE, A CASE REPORT}. Journal of the American College of Cardiology. [published; OpenAlex]. \href{https://doi.org/10.1016/j.jacc.2026.02.3249}{doi:10.1016/j.jacc.2026.02.3249}.
\item Schmidt M, Hoffrichter A, Davoudi M, Horschitz S, Lau T, Meinhardt MW, Spanagel R, Ladewig J, Köhr G, Koch P. (2026). \textit{Psilocin fosters neuroplasticity in iPSC-derived human cortical neurons.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.7554/elife.104006}{doi:10.7554/elife.104006}.
\item Johnson JD, Tian R, Etemadi Y, Li Z. (2026). \textit{Psilocybin Attenuates Cortical Representations of Aversion in the Mouse Auditory Cortex}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.64898/2026.03.26.714498}{doi:10.64898/2026.03.26.714498}.
\item Unknown authors (2026). \textit{Safety and Efficacy of Psilocybin-Assisted Therapy for Alcohol Use Disorder: Open-Label Extension of a Phase II Randomized Controlled Trial}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/7xfek\_v1}{source link}.
\item Veronica Mäki-Marttunen (2026). \textit{Psilocybin shapes the slow, global propagation of brain activity over the cortical layout of 5HT2a receptors}. Communications Biology. [published; OpenAlex]. \href{https://doi.org/10.1038/s42003-026-09912-4}{doi:10.1038/s42003-026-09912-4}.
\item Piotr Skalski, Katarzyna Pękacka-Falkowska, Agnieszka Pluto-Prądzyńska, Michał K. Owecki (2026). \textit{Psilocybin in Neuropsychiatric Disorders: Seeking Valuable Evidence in History, Pure Science, Clinical Trials and Real-World Data (RWD)}. Brain Sciences. [published; OpenAlex]. \href{https://doi.org/10.3390/brainsci16040358}{doi:10.3390/brainsci16040358}.
\item Anders Fink-Jensen, MD, DMSci (2026). \textit{The QUANTUM Trip Trial - Psilocybin-assisted Therapy for Reducing Alcohol Intake in Patients With Alcohol Use Disorder: A Randomized, Double-blinded, Placebo-controlled Clinical Trial.}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05416229}{source link}.
\item Medical University of Vienna (2026). \textit{Elucidating the Relevance of the Psychedelic Experience to Psilocybin's Anti-Anhedonic Effects: A Randomized, Open-Label, Cross-Over Functional Magnetic Resonance Imaging Trial}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07490353}{source link}.
\item Shivaputra A. Patil, Holly C. Hunsberger (2026). \textit{Psilocybin: Chemical Foundations and Emerging Therapeutic Potential}. Mini-Reviews in Medicinal Chemistry. [published; OpenAlex]. \href{https://doi.org/10.2174/0113895575429775260119043318}{doi:10.2174/0113895575429775260119043318}.
\item Gillet A, Geron C, Vitello MM, Lejeune N. (2026). \textit{Pharmacotherapy in Disorders of Consciousness: A Mechanism-Based Review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s40263-026-01274-z}{doi:10.1007/s40263-026-01274-z}.
\item Taddei-Tardón M, Medina-Rodríguez L, Maltman JL, Hudson S, Potukanuma S, Jiménez JH, Martín-Guerrero SM, González-Maeso J, López-Giménez JF. (2026). \textit{Integrated 5-HT2A -TrkB and G protein signaling in serotonergic psychedelic responses}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.64898/2026.03.19.712961}{doi:10.64898/2026.03.19.712961}.
\item Guy M. Goodwin, Scott T. Aaronson, Oscar Alvarez, Robin Carhart-Harris, Megan Croal, David Feifel, David J. Hellerstein, Muhammad I. Husain, John R. Kelly, Namik Kirlić, Rasmus Wentzer Licht, Lindsey Marwood, Ania Nowakowska, Tomáš Páleníček, Dimitris Repantis, Robert A. Schoevers, Hollie Simmons, Jair C. Soares, Metten Somers, Joyce Tsai, Mourad Wahba, Ella Williams, Allan H. Young, Matthew B. Young, Sidney Zisook, Ekaterina Malievskaia (2026). \textit{The role of therapeutic alliance in psilocybin treatment for treatment-resistant depression: A post hoc path analysis}. Journal of Affective Disorders. [published; OpenAlex]. \href{https://doi.org/10.1016/j.jad.2026.121662}{doi:10.1016/j.jad.2026.121662}.
\item Denis Nößler (2026). \textit{Psilocybin, Lp(a), CAC, Niere und Darmkrebs - Evidenz-Quickies KW12}. EvidenzUpdate. [published; OpenAlex]. \href{https://doi.org/10.69156/quick/2026.03.00011}{doi:10.69156/quick/2026.03.00011}.
\item Taro Kishi, Kenji Sakuma, Masakazu Hatano, Hiroyuki Uchida, Nakao Iwata (2026). \textit{Psilocybin-assisted therapy for major depressive disorder: Perspective from meta-analysis}. Journal of Affective Disorders. [published; OpenAlex]. \href{https://doi.org/10.1016/j.jad.2026.121675}{doi:10.1016/j.jad.2026.121675}.
\item University of New Mexico (2026). \textit{Precision Phenotyping of Behavioral Risk and Response to Electromagnetic and Psychedelic Therapies}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07484906}{source link}.
\item Centre for Addiction and Mental Health (2026). \textit{Psilocybin for Treatment-Resistant Depression in Autism: a Pilot Trial With Pre-Post Brain and Cognitive Measurement to Understand Mechanism}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06731621}{source link}.
\item Portes MAM, Bertoglio LJ. (2026). \textit{Psychedelics and Mental Health in Endurance Athletes: A Cross-Sectional Study in Brazil.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/02791072.2026.2644865}{doi:10.1080/02791072.2026.2644865}.
\item Mingyu Sun, Xiaoyu Zhao, Fandi Kong, Jinsong Wang, Yunchang Lu, Liang Tong (2026). \textit{Raman Activity Investigation and Utilization of Psilocybin}. Journal of Raman Spectroscopy. [published; OpenAlex]. \href{https://doi.org/10.1002/jrs.70133}{doi:10.1002/jrs.70133}.
\item Anna Komarczewska, Michał Kociński, Patryk Iglewski, Michał Pietrasz, Jakub Idziński, Anna Lubomska (2026). \textit{PSILOCYBIN AS AN ADJUNCTIVE TREATMENT FOR DEPRESSION AND PSYCHOLOGICAL DISTRESS IN ONCOLOGY: CURRENT EVIDENCE AND CLINICAL IMPLICATIONS}. International Journal of Innovative Technologies in Social Science. [published; OpenAlex]. \href{https://doi.org/10.31435/ijitss.1(49).2026.5034}{doi:10.31435/ijitss.1(49).2026.5034}.
\item Àlvar Farré-Colomés, Olga Rublinetska, Óscar Soto-Angona (2026). \textit{Psilocybin effects on brain functional connectivity: a systematic review of fMRI studies}. Discover Mental Health. [published; OpenAlex]. \href{https://doi.org/10.1007/s44192-026-00384-w}{doi:10.1007/s44192-026-00384-w}.
\item Jenna Matsukubo, Erik Loewen Friesen, Rachael MacDonald-Spracklin, Rachael Iseman, Marco Solmi, J. G. Fiedorowicz, Benedikt Fischer, Daniel T. Myran (2026). \textit{Psilocybin retail stores in Canada: Changes in availability, commercialization, and geographic distribution}. Canadian Journal of Public Health. [published; OpenAlex]. \href{https://doi.org/10.17269/s41997-026-01178-x}{doi:10.17269/s41997-026-01178-x}.
\item Johns Hopkins University (2026). \textit{Pilot Study of Psilocybin-assisted Treatment for Cannabis Use Disorder}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06660381}{source link}.
\item Gustavo Vazquez (2026). \textit{Safety and Efficacy of Psilocybin-assisted Psychotherapy for Demoralization Syndrome in Patients Diagnosed With Advanced Stage Cancer: a Pilot Study}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06818994}{source link}.
\item Centre for Addiction and Mental Health (2026). \textit{Evaluating the Role of Psilocybin Monitors in Psilocybin Therapy for Treatment Resistant Depression: A Pilot Randomized Clinical Trial}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07211438}{source link}.
\item Lea J. Mertens, Michael Koslowski, Felix Betzler, Manuela Brand, Ricarda Evens, Laura Kärtner, Andrea Jungaberle, Henrik Jungaberle, Tomislav Majić, Christian N. Schmitz, Andreas Ströhle, Dennis Scharf, Moritz Spangemacher, Max Wolff, Zahra Assadi, Scharif Bahri, Lilith Becher, Luca V. Färber, Niklas Kirchen, Eugenia Kulakova, Linda C. Kunz, Andy Meijer, Barbara Rohrmoser, Stefan Wellek, Moritz Berger, Gerhard Gründer (2026). \textit{Efficacy and Safety of Psilocybin in Treatment-Resistant Major Depression}. JAMA Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1001/jamapsychiatry.2026.0132}{doi:10.1001/jamapsychiatry.2026.0132}.
\item J. Cramer Hudson, Harrison G. Pope (2026). \textit{Enlightenment in a Pill-Testing the Efficacy of Psilocybin}. JAMA Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1001/jamapsychiatry.2026.0070}{doi:10.1001/jamapsychiatry.2026.0070}.
\item Kate Brough, Corinna Lange (2026). \textit{A fungus among us: investigating queensland’s largest magic mushroom growing operation}. Australian Journal of Forensic Sciences. [published; OpenAlex]. \href{https://doi.org/10.1080/00450618.2026.2617320}{doi:10.1080/00450618.2026.2617320}.
\item Johns Hopkins University (2026). \textit{Pilot Study of Serotonin 2A Receptor (5-HT2A) Agonist Psilocybin for Depression in Patients With Mild Cognitive Impairment or Early Alzheimer's Disease}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT04123314}{source link}.
\item Akey Sungheetha, R. Rajesh Sharma, Oluwasegun Julius Aroba, Sheila Mahapatra, P. D. Mahendhiran (2026). \textit{Explainable AI framework for psilocybin depression treatment optimization}. Frontiers in Computer Science. [published; OpenAlex]. \href{https://doi.org/10.3389/fcomp.2025.1652190}{doi:10.3389/fcomp.2025.1652190}.
\item Johns Hopkins University (2026). \textit{Psilocybin Treatment of Major Depressive Disorder With Co-occurring Alcohol Use Disorder}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT04620759}{source link}.
\item Francisco A. Moreno, Katja Ehrmann Allen, Christopher B. Wiegand, Rajan Dunne, James I. Prickett, Brian Bayze, John J. B. Allen (2026). \textit{A randomized clinical trial of repeated doses of psilocybin for the treatment of obsessive-compulsive disorder}. Journal of Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1177/02698811261424214}{doi:10.1177/02698811261424214}.
\item Joshua C. Black, Gabrielle E. Bau, Ryan R. Cook, Elizabeth A. Bemis, Andrew A. Monte (2026). \textit{Psilocybin Trends in States That Decriminalized Use}. JAMA. [published; OpenAlex]. \href{https://doi.org/10.1001/jama.2026.1952}{doi:10.1001/jama.2026.1952}.
\item University of Alabama at Birmingham (2026). \textit{Exploratory Study of the Effects of Low-Dose Psilocybin on Sensory Processing, Neurophysiological Arousal, and Emotional Health}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05227742}{source link}.
\item University of Alabama at Birmingham (2026). \textit{Psilocybin-facilitated Treatment for Chronic Pain}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05068791}{source link}.
\item Yale University (2026). \textit{Safety, Feasibility, and Tolerability of Psilocybin Treatment for Individuals With Functional Impairment Related to Mood, Anxiety, Trauma and/or Addiction Symptoms: An Open-label Proof-of-concept Study}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06442423}{source link}.
\item Unknown authors (2026). \textit{Oregon's Emerging Psilocybin Services Workforce: A Survey of the First Legal Psilocybin Facilitators and Their Training Programs}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.1080/02791072.2025.2454474.}{doi:10.1080/02791072.2025.2454474.}.
\item Alexander J. Bradshaw, Cathy Sharp, B. van der Merwe, Keaton Tremble, Bryn T. M. Dentinger (2026). \textit{Discovery of the closest free-living relative of the domesticated ‘magic mushroom’ Psilocybe cubensis in Africa}. Proceedings of the Royal Society B Biological Sciences. [published; OpenAlex]. \href{https://doi.org/10.1098/rspb.2025.2270}{doi:10.1098/rspb.2025.2270}.
\item Gregorio GD, Basset S, Manmohan H, Nixon WC, Pogaku A, Zhou J, Sanderson DJ, Lengieza ML, Bocchio M. (2026). \textit{Age moderates the relationship between psychedelics use and mental health in naturalistic settings}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-9022170/v1}{doi:10.21203/rs.3.rs-9022170/v1}.
\item Floris G, Jefferson SJ, Rondeau J, Yu AL, Menniti FS, Kwan AC, De Aquino JP, Krystal JH, Pittenger C, Kaye AP. (2026). \textit{Enhancing cGMP signaling with psilocybin reduces head twitch and restructures the synaptic proteome while maintaining antidepressant response}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.64898/2026.03.06.710108}{doi:10.64898/2026.03.06.710108}.
\item Vorawut Wongumpornpinit, K Ingkaninan, Prapapan Temkitthawon, Neti Waranuch, Rhannanda Copetti Pivetta, Jieyu Zuo, Gabriel Lima Barros de Araújo, Nádia Bou-Chacra, Vijay Somayaji, Raimar Löebenberg (2026). \textit{Impact of formulation variables on the quality attributes of psilocybin-loaded oral thin films for early-phase development}. Journal of Drug Delivery Science and Technology. [published; OpenAlex]. \href{https://doi.org/10.1016/j.jddst.2026.108228}{doi:10.1016/j.jddst.2026.108228}.
\item MW Johnson, Gideon P. Naudé, Peter S. Hendricks, Albert Garcia-Romeu (2026). \textit{Psilocybin or Nicotine Patch for Smoking Cessation}. JAMA Network Open. [published; OpenAlex]. \href{https://doi.org/10.1001/jamanetworkopen.2026.0972}{doi:10.1001/jamanetworkopen.2026.0972}.
\item Suzanne "Sue" Sisley MD (2026). \textit{An Open-Label, Phase 1 Study of the Safety Pharmacokinetic Profile, and Preliminary Efficacy, of Organic Whole Psilocybin-Containing Mushrooms in Patients Suffering From PTSD}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07275970}{source link}.
\item Shore Ronald, Dobson Kat, Thomson Nina, Barnim Nigel, Bergman Hailey, Rideout Katie, McKeown Sandra, Olmstead Mary C., Goldie Craig, Dumont Eric (2026). \textit{Behavioural investigations of psilocybin in non-human animals 1962-2021: A scoping review}. Journal of Psychedelic Studies. [published; Crossref]. \href{https://doi.org/10.1556/2054.2025.00364}{doi:10.1556/2054.2025.00364}.
\item Shah S, Morrin H. (2026). \textit{Substance-induced manic psychosis in which delusions were corroborated by a chatbot - case report}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-8919841/v1}{doi:10.21203/rs.3.rs-8919841/v1}.
\item Michelle Priest, Beau Kilmer, Rajeev Ramchand, Samer Atshan (2026). \textit{Psilocybin microdosing in the United States: Insights from a nationally representative survey}. Addiction. [published; OpenAlex]. \href{https://doi.org/10.1111/add.70368}{doi:10.1111/add.70368}.
\item Fabiano N, Stubbs B, Lawrence DW, Rosenblat JD, Teixeira PJ, Wong S, Zhou C, Carhart-Harris R (2026). \textit{The combination of exercise and psychedelics for the treatment of major depressive disorder.}. Discover mental health. [published; PubMed]. \href{https://doi.org/10.1007/s44192-026-00408-5}{doi:10.1007/s44192-026-00408-5}.
\item Region Skane (2026). \textit{The Therapeutic Potential of Psilocybin in Anorexia Nervosa in Young Adults}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07169747}{source link}.
\item NYU Langone Health (2026). \textit{Pilot Proof of Concept Study Evaluating the Potential Psilocybin Assisted Psychotherapy (PAP) as a Therapeutic Tool for Patients Suffering From Severe Irritable Bowel Syndrome.}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06760533}{source link}.
\item Ohio State University (2026). \textit{Examining the Safety and Clinical Efficacy of Psilocybin Therapy for Veterans With PTSD: An Open-Label Proof-of-Concept Trial}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05554094}{source link}.
\item Claydon MDB, Hinchcliffe JK, Bartlett J, Golden CT, Thomas CW, Gilmour G, Mellor JR, Bortolotto ZA, Robinson ESJ. (2026). \textit{Inhibition of cortico-amygdala projections underlies affective bias modification by psilocybin}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.64898/2026.03.02.709133}{doi:10.64898/2026.03.02.709133}.
\item Griškova-Bulanova I, Vejmola Č, Páleníček T. (2026). \textit{Serotonergic modulation of cortical gamma synchronization: right-lateralized psilocin effects on 40 Hz auditory steady-state responses in rats.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1152/jn.00519.2025}{doi:10.1152/jn.00519.2025}.
\item Psyence Australia Pty Ltd (2026). \textit{A Phase 2b Double-blind, Randomized, Low-dose Comparator-controlled Clinical Trial to Assess the Efficacy and Safety of NPX-5 in Psilocybin-assisted Psychotherapy for the Treatment of Adjustment Disorder Associated With Cancer.}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07072728}{source link}.
\item Marissa Raymond-Flesch, MD, MPH (2026). \textit{Study of Psilocybin for Anorexia in Young Adults}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06399263}{source link}.
\item Samuel E. Williamson, Elise K. Burkhartzmeyer, Michael T. Faley, Rachel Friedman Ohana, Ilia A. Guzei, Mike Valley, James J. Cali, Alexander M. Sherwood (2026). \textit{Synthesis and Characterization of Psilocybin Metabolites and Deuterated Analogs}. ACS Chemical Neuroscience. [published; OpenAlex]. \href{https://doi.org/10.1021/acschemneuro.5c00879}{doi:10.1021/acschemneuro.5c00879}.
\item Johns Hopkins University (2026). \textit{Effects of Psilocybin on Electrophysiology and the Dynamic Content of Thought}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05301608}{source link}.
\item Unknown authors (2026). \textit{Multidimensional Ego-Dissolution Assessment (MEDA): Scale Development and Substance-Specific Comparisons}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/9c6xg\_v1}{source link}.
\item Zeinab Asghari, Gregory Robinson, Marta Gerasymchuk, Esmaeel Ghasemi Gojani, Timur Zanikov, Yasaman Rastamian, Olga Kovalchuk, Igor Kovalchuk* (2026). \textit{THE EFFECT OF PSILOCYBIN AND EUGENOL ON LIPOPOLYSACCHARIDE INDUCED INFLAMMATION IN SMALL AND LARGE INTESTINE OF MICE}. Zenodo (CERN European Organization for Nuclear Research). [published; OpenAlex]. \href{https://doi.org/10.5281/zenodo.18796594}{doi:10.5281/zenodo.18796594}.
\item Greg Corder, Sophie Rogers, Corinna Oswell (2026). \textit{Psilocybin Reshapes Anterior Cingulate Network Neuropathic Topology to Reduce Chronic Pain}. Journal of Pain. [published; OpenAlex]. \href{https://doi.org/10.1016/j.jpain.2025.105705}{doi:10.1016/j.jpain.2025.105705}.
\item David Wrathall, Hannah Gosnell, Fern Wickson, Erika Spanger, Associates* (2026). \textit{Journeying into Right Relations: Scientists Turn to Psilocybin to Shift Psychological Burdens of Global Environmental Change and Find Transformational Pathways Forward}. Action Research. [published; OpenAlex]. \href{https://doi.org/10.1177/14767503251404263}{doi:10.1177/14767503251404263}.
\item Alexander WB, Hansen ED, Anderson BT, Zarrabi AJ, Rogers AH, Loewen G, Ficarro ZR, Alexander MH, Schaefer D, Case AA (2026). \textit{Meaning and Psychedelics in Palliative Care: A Narrative Review.}. Journal of pain and symptom management. [published; PubMed]. \href{https://doi.org/10.1016/j.jpainsymman.2025.10.015}{doi:10.1016/j.jpainsymman.2025.10.015}.
\item Isis Koutrouli, Vojtěch Brejtr, Marek Schwendt, Kacper Witek, Chrysostomos Charalambous, K. Aleksič, N. Miniariková, Eva Lhotková, Martin Toman, M. Nikolič, Radek Jurok, Petra Cihlářová, Vladimír Mazoch, Pavel Ryšánek, Martin Kuchař, Klára Šíchová, Tomáš Páleníček (2026). \textit{Psilocybin and Ibogaine in Cocaine-Seeking: Extinction Enhancement Without Relapse Prevention}. Addiction Biology. [published; OpenAlex]. \href{https://doi.org/10.1111/adb.70111}{doi:10.1111/adb.70111}.
\item Mosurinjohn S, Ascough R (2026). \textit{Psychedelics, Eleusis, and the Invention of Religious Experience.}. Psychedelic medicine (New Rochelle, N.Y.). [published; PubMed]. \href{https://doi.org/10.1177/28314425251361835}{doi:10.1177/28314425251361835}.
\item Yosr Ziadi, Taehwan Park (2026). \textit{Cost-Effectiveness of Psilocybin-Assisted Therapy Versus Standard of Care for Patients With Treatment-Resistant Depression}. Value in Health Regional Issues. [published; OpenAlex]. \href{https://doi.org/10.1016/j.vhri.2026.101605}{doi:10.1016/j.vhri.2026.101605}.
\item Zhang J, Lin C, Lv X, Zhao H, Wang X. (2026). \textit{Psychedelics and the Extracellular Matrix: Rewiring Neuroplasticity and Metaplasticity for Next-Generation Psychiatric Therapies.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.biopsych.2026.02.011}{doi:10.1016/j.biopsych.2026.02.011}.
\item C Faria, Diana Dias da Silva, João José Sousa (2026). \textit{Psilocybin-assisted therapy for major depressive disorder: implications for clinical effectiveness, health economics, and regulatory decision-making}. Instituto Politécnico do Porto. [published; OpenAlex]. \href{https://doi.org/10.26537/prpaeh.v4i3.7173}{doi:10.26537/prpaeh.v4i3.7173}.
\item Linda M. Richmond (2026). \textit{MedCheck: FDA Reviews NDA for Narcolepsy Drug, Green-Lights Psilocybin Trial for PTSD, and More}. Psychiatric News. [published; OpenAlex]. \href{https://doi.org/10.1176/appi.pn.2026.03.3.5}{doi:10.1176/appi.pn.2026.03.3.5}.
\item Tianjie Li, Erin. E. Reynolds, Ziqi Wang, Michael P. Torrens-Spence, Jing-Ke Weng, Yi Wang (2026). \textit{Calcium activation mechanism of a noncanonical aromatic L-amino acid decarboxylase from psilocybin mushroom Psilocybe cubensis}. Communications Biology. [published; OpenAlex]. \href{https://doi.org/10.1038/s42003-026-09756-y}{doi:10.1038/s42003-026-09756-y}.
\item Shokr MM, Fawzy MN, Abdelaziz AM. (2026). \textit{Pharmacological regulation of adult brain neuroplasticity: Synergistic roles of neuropeptide signaling, psychedelics, and synaptic modulators.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.mcn.2026.104076}{doi:10.1016/j.mcn.2026.104076}.
\item Kengo Yonezawa, M. Hirata, Hiroaki Takano, Keisuke Kusudo, Sota Tomiyama, Lisa Harada, Kota Suzuki, DJ Nutt, H. Uchida, Hideaki Tani (2026). \textit{Psilocybin for psychiatric disorders: History, clinical trials, neuroimaging, and regulations}. Psychiatry and Clinical Neurosciences. [published; OpenAlex]. \href{https://doi.org/10.1111/pcn.70042}{doi:10.1111/pcn.70042}.
\item Diana Silva, Andreia Machado Brito-da-Costa, Mariana Carvalho, Ricardo Jorge Dinis-Oliveira, Áurea Madureira-Carvalho, Sérgio F. Sousa (2026). \textit{Psilocin as a Broad Inhibitor of CYP450 Enzymes: Integrated In Vitro and In Silico Evidence}. Instituto Politécnico do Porto. [published; OpenAlex]. \href{https://doi.org/10.26537/prpaeh.v4i3.7159}{doi:10.26537/prpaeh.v4i3.7159}.
\item Centre for Addiction and Mental Health (2026). \textit{Does Psilocybin Change Synaptic Density in the Brains of Patients With Amnestic Mild Cognitive Impairment}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06041152}{source link}.
\item Gabriella Gobbi (2026). \textit{The Effects of Psilocybin in Healthy Volunteers: Psychological, Biochemical and Electrophysiological Biomarkers.}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07433452}{source link}.
\item Albert Garcia-Romeu, Gideon P. Naudé, Alison W. Rebman, Sara So, Abigail Yaffe, Ian Geithner, Erica A. Kozero, Ting Yang, Mark J. Soloski, John N. Aucott (2026). \textit{Pilot study of psilocybin in patients with post-treatment lyme disease}. Scientific Reports. [published; OpenAlex]. \href{https://doi.org/10.1038/s41598-026-38091-9}{doi:10.1038/s41598-026-38091-9}.
\item Alan C. Courtes, Blake Myers, Noah Daly, Greg Jones, Jair C. Soares, Carlos A. Zarate, Rodrigo Machado-Vieira (2026). \textit{Advancing cancer neuroscience through stress modulation: Interdisciplinary potential of psilocybin and ketamine}. General Hospital Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.genhosppsych.2026.02.011}{doi:10.1016/j.genhosppsych.2026.02.011}.
\item Momoko Ishii, Mark Zervas (2026). \textit{SSRIs, Psilocybin, MDMA, and Disease Modeling: Strategies to Advance PTSD Treatment}. Unknown journal. [published; OpenAlex]. \href{https://doi.org/10.14293/pr2199.003034.v1}{doi:10.14293/pr2199.003034.v1}.
\item van der Meer PB, Schukking N, Dik M, van Reemst A, Fuentes JJ, Kaptein AA, Schoones JW, Verboeket S, de Waal MM, Goudriaan AE, Kramers C, Schellekens A, Bossong MG, Somers M, Batalla A. (2026). \textit{Efficacy and Safety of Psychoactive Tryptamines in Addiction: A Systematic Review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/28314425251364182}{doi:10.1177/28314425251364182}.
\item Johns Hopkins University (2026). \textit{Inpatient Buprenorphine Induction With Psilocybin for Opioid Use Disorder: a Randomized Double-blind Trial}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06005662}{source link}.
\item Johns Hopkins University (2026). \textit{Safety for Home Administration of Microdose Psilocybin Use}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06450210}{source link}.
\item Johns Hopkins University (2026). \textit{Investigation of Psychedelic Effects in Psychoactive Substances}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06772753}{source link}.
\item Shultz S, Allen J, O'Regan G, Brand J, Liknaitzky P, O'Brien T, Christie B, McDonald S. (2026). \textit{Delayed psilocybin treatment after repeated mild traumatic brain injury recovers chronic behavioural deficits, reduces microglial density, and enhances hippocampal neurogenesis in rats}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-8555503/v1}{doi:10.21203/rs.3.rs-8555503/v1}.
\item Petranker R, Farb N, Syed O, Li E, Shore D, Anderson T, Blackman A. (2026). \textit{Safety and Efficacy of Microdosing Psilocybin over 8 Weeks for Major Depressive Disorder: A Randomized Clinical Trial}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-8319478/v1}{doi:10.21203/rs.3.rs-8319478/v1}.
\item Anita Lino (2026). \textit{Cogumelos do gênero Psilocybe nas Américas e no Brasil}. Anthropology of Consciousness. [published; OpenAlex]. \href{https://doi.org/10.1111/anoc.70031}{doi:10.1111/anoc.70031}.
\item Unknown authors (2026). \textit{Ethical Complexities and Best Practices in Informed Consent for Psychedelic Services: A Qualitative Study on Expert Perspectives}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/mdz73\_v2}{source link}.
\item Marianne Skov-Skov Bergh, Inger Lise Bogen, Merete Vevelstad, Åse Marit Leere Øiestad (2026). \textit{Psilocin glucuronide in whole blood: a stable and useful biomarker of psilocybin intake}. Journal of Analytical Toxicology. [published; OpenAlex]. \href{https://doi.org/10.1093/jat/bkag015}{doi:10.1093/jat/bkag015}.
\item Jordan McDowell, Jada Middleton, Alanna Bluett, Alisa Kozachenko, Bayan Attar, Yuvraj Singh Saini, Jennifer Burke, Cayden McPhee, Mutahera Mutahera, Talya Ahmed, Nabila Ibrahim, Gilbert Atukwatsibwe, Sulabha Adhikari, Mohammad Esmaili, Jean-Vital Yambayamba (2026). \textit{Effects of Psilocybin and Select Pharmaceutical Interactions}. MacEwan University Student eJournal. [published; OpenAlex]. \href{https://doi.org/10.31542/bcek6t76}{doi:10.31542/bcek6t76}.
\item Marcel Nogueira, Solimary García-Hernández, Gleicy Sotéro Roberto, Daniel C. Rodrigues (2026). \textit{Regulatory ambiguity and governance challenges for psilocybin mushrooms in Brazil}. International Journal of Drug Policy. [published; OpenAlex]. \href{https://doi.org/10.1016/j.drugpo.2026.105198}{doi:10.1016/j.drugpo.2026.105198}.
\item Luca Magnani, Luca Ghirotto, Fabio Fesce, Tania Simona Re, Silvia Tanzi, Andrea Amerio, Alessandra Costanza (2026). \textit{Psilocybin-assisted psychotherapy for psycho-existential distress in advanced cancer: a narrative review}. BMJ Supportive \& Palliative Care. [published; OpenAlex]. \href{https://doi.org/10.1136/spcare-2025-005689}{doi:10.1136/spcare-2025-005689}.
\item Itishree Sahoo, Sairam Masadi, Ashwath Maheswari, Rachel Utama, Muhammad Abeer, Sima Soltanpour, Md Taufiq Nasseef, Tochi Chukwuemeka, Nandini Sinhal, Jyot Pandit, Richard J. Ortiz, Noah Cavallaro, Eric Brengel, Praveen Kulkarni, Michael A. Gitcho, Craig F. Ferris (2026). \textit{Sex-dependent developmental changes in behavior, brain structure, functional connectivity, and sensory perception following exposure to psilocybin during adolescence}. Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1038/s41386-026-02356-8}{doi:10.1038/s41386-026-02356-8}.
\item Zaynab Khan, Sterre Weaver, Rachael V. Dando, Anne Katrin Schlag, Joanna C. Neill, Verity Wainwright (2026). \textit{Sense-Making Around Psilocybin in UK Women Experiencing Cancer-Related Existential Distress: An Interpretative Phenomenological Analysis}. Qualitative Health Research. [published; OpenAlex]. \href{https://doi.org/10.1177/10497323261419338}{doi:10.1177/10497323261419338}.
\item Yvan Beaussant, MD, MSci (2026). \textit{Pilot Study of Psilocybin-Assisted Therapy for Demoralization in Patients Receiving Hospice Care - PATH Study}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT04950608}{source link}.
\item Unknown authors (2026). \textit{Mindfulness-Based Psilocybin-Assisted Therapy (MB-PAT) for cancer-related demoralization in Canada: the case for a hybrid group-based delivery model}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/yrgkf\_v1}{source link}.
\item Stéphanie Knatz Peck, Timothy D. Brewerton (2026). \textit{Rebuttal to “Questioning the recovery of dissociated traumatic memories under psilocybin”}. Journal of Eating Disorders. [published; OpenAlex]. \href{https://doi.org/10.1186/s40337-026-01532-x}{doi:10.1186/s40337-026-01532-x}.
\item Zeina Beidas, Anya Ragnhildstveit, Adam Blackman, Thomas Anderson, Emily C. Fewster, Omer A. Syed, Valentyne Sobolenko, Ismail Kaan Kanca, Magdalena Jaglinska, Tatiana Son, Norman Farb, Rotem Petranker (2026). \textit{Microdosing psilocybin for major depressive disorder: study protocol for a phase II double-blind placebo-controlled randomised partial crossover trial}. BJPsych Open. [published; OpenAlex]. \href{https://doi.org/10.1192/bjo.2025.10968}{doi:10.1192/bjo.2025.10968}.
\item Marten Kase, Kristjan Kaup, Jaan Aru (2026). \textit{Effects of LSD, DMT and psilocybin on cognitive and psychological functions: A systematic review of the literature}. Journal of Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1177/02698811251412012}{doi:10.1177/02698811251412012}.
\item Marc J. Weintraub, Jessica Jeffrey, Megan Ichinose, R. Lindsey Bergman, Benjamin Shapiro, Gregory Barnett, Hewa Artin, Marc Lynn, Anabel Salimian, Shelby Grody, Rahul Ramesh, Lauren Eales, Charles S. Grob, David J. Miklowitz (2026). \textit{Psilocybin-assisted cognitive behavioral therapy for major depressive disorder: A pilot trial}. Journal of Affective Disorders. [published; OpenAlex]. \href{https://doi.org/10.1016/j.jad.2026.121423}{doi:10.1016/j.jad.2026.121423}.
\item Zurika Murray, Angélique Lewies, Johannes F. Wentzel, Marietjie Schutte-Smith, Elizabeth Erasmus, Anwar E.M. Noreljaleel, Hendrik G. Visser, Anke Wilhelm, Abdul Rashid Issahaku (2026). \textit{Network pharmacology and molecular simulation reveal the entourage effect mechanisms of psilocybin-producing mushrooms on the brain}. Scientific Reports. [published; OpenAlex]. \href{https://doi.org/10.1038/s41598-026-39483-7}{doi:10.1038/s41598-026-39483-7}.
\item MycoMedica Life Sciences PBC (2026). \textit{A Phase 1 Translational Study to Assess Brain Activity Using Functional Magnetic Resonance Imaging (fMRI) and to Evaluate the Safety, Tolerability, and Pharmacokinetics of Multiple Doses of MLS101 (Psilocybin) in Healthy Volunteers}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07050368}{source link}.
\item Johns Hopkins University (2026). \textit{Psychedelic Healing: Adjunct Therapy Harnessing Opened Malleability}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07053917}{source link}.
\item Amanda L. Elyse (2026). \textit{Psilocybin and Animal Testing: Charting an End to the Use of Animals in Drug Development Research}. Digital Commons at University of Maryland Carey Law (University of Maryland Francis King Carey School of Law). [published; OpenAlex]. \href{https://digitalcommons.law.umaryland.edu/cgi/viewcontent.cgi?article=1002\&context=jhclp\_online\_issue}{source link}.
\item Trent Emerick (2026). \textit{Single Dose Psilocybin for a Post-surgical Trauma Inpatient Population for Pain, Mood, and Opioid Use Disorder}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07406828}{source link}.
\item Centre for Addiction and Mental Health (2026). \textit{Psilocybin-assisted Therapy for Comorbid Major Depressive Disorder and Alcohol Use Disorder: A Pilot Randomized Clinical Trial}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07405606}{source link}.
\item Matthew Hicks, Olivia Hicks, Ryan Bradley, Heather Zwickey (2026). \textit{Low-income group psilocybin assisted therapy for depression: An Oregon feasibility study}. Journal of Psychedelic Studies. [published; OpenAlex]. \href{https://doi.org/10.1556/2054.2026.00485}{doi:10.1556/2054.2026.00485}.
\item Johnston J, Jones G, Peng S, Yuan P, Yavi M, Kadriu B, Henter I, Quintanilla B, Elkahloun AG, Moaddel R, Schulmann A, Akula N, Kvarta M, McMahon F, Zarate C. (2026). \textit{Time-Dependent Effects of Rapid-Acting Antidepressants in iPSC-Derived Neurons from Treatment-Resistant Depression and Healthy Volunteers}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-8733841/v1}{doi:10.21203/rs.3.rs-8733841/v1}.
\item Ziping He, Yijie Wang, Jie Chen, Junzhe Cheng, Yuxin Feng, Shuliang Niu, J. Yan (2026). \textit{Therapeutic effects of psilocybin in major depressive disorder: a systematic review and meta-analysis exploring dose effects}. European Archives of Psychiatry and Clinical Neuroscience. [published; OpenAlex]. \href{https://doi.org/10.1007/s00406-025-02165-y}{doi:10.1007/s00406-025-02165-y}.
\item Erica Kaczmarek, Nelson B. Rodrigues, Noah Chisamore, Zoe Doyle, Shakila Meshkat, Marc G. Blainey, Ryan M. Brudner, Shaun Ali, Kayla M. Teopiz, Roger S. McIntyre, Joshua D. Rosenblat (2026). \textit{Examining the effects of psilocybin-assisted psychotherapy on anhedonia in treatment-resistant depression}. Journal of Affective Disorders. [published; OpenAlex]. \href{https://doi.org/10.1016/j.jad.2026.121385}{doi:10.1016/j.jad.2026.121385}.
\item Unknown authors (2026). \textit{Mystical but Not Challenging Experiences Predict Symptom Improvement After Psilocybin for Treatment-Resistant OCD}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/d94hb\_v1}{source link}.
\item Zen Revista (2026). \textit{Activity-Dependent Neural Rewiring: Mechanisms of Psilocybin-Induced Cortical Network Reorganization}. Zenodo (CERN European Organization for Nuclear Research). [published; OpenAlex]. \href{https://doi.org/10.5281/zenodo.18501568}{doi:10.5281/zenodo.18501568}.
\item Zen Revista (2026). \textit{Activity-Dependent Neural Rewiring by Psilocybin: A Monosynaptic Rabies Virus Tracing Study}. Zenodo (CERN European Organization for Nuclear Research). [published; OpenAlex]. \href{https://doi.org/10.5281/zenodo.18501514}{doi:10.5281/zenodo.18501514}.
\item Hadassah Medical Organization (2026). \textit{Safety and Psychological Effects of Psilocybin and D-Serine Formulation in Healthy Volunteers}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07079930}{source link}.
\item TRYP Therapeutics (2026). \textit{A Phase 2a, Open-label, Pilot Study to Assess the Safety and Efficacy of Oral Psilocybin (TRP-8802) Administration in Concert With Psychotherapy Among Adult Patients With Irritable Bowel Syndrome: A Randomized Delayed Treatment Control Design}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06206265}{source link}.
\item Nantes University Hospital (2026). \textit{Psilocybin AsSisted pSychotherapy for the treatmENt of Gambling disordER: a Pilot Study}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07391332}{source link}.
\item Ashlyn Tom, B. Sai Chaitanya Reddy, Manik Inder Singh Sethi, Suresh Bada Math (2026). \textit{India’s Unique Legal Framework for Psilocybin Mushroom Research: An Unprecedented Opportunity in Psychiatric Therapeutics}. Indian Journal of Psychological Medicine. [published; OpenAlex]. \href{https://doi.org/10.1177/02537176261416347}{doi:10.1177/02537176261416347}.
\item Frontiers Editorial Office (2026). \textit{Retraction: Acute psilocybin increased cortical activities in rats}. Frontiers in Neuroscience. [published; OpenAlex]. \href{https://doi.org/10.3389/fnins.2026.1787833}{doi:10.3389/fnins.2026.1787833}.
\item Junhong Liu, Y. Lynn Wang, Ke Xia, Jia-Bin Wu, Danhao Zheng, Aoling Cai, Haitao Yan, Ruibin Su (2026). \textit{Acute psilocin increased cortical activity in rat}. Frontiers in Neuroscience. [published; OpenAlex]. \href{https://doi.org/10.3389/fnins.2026.1593703}{doi:10.3389/fnins.2026.1593703}.
\item Sheida Shadani, Erika Greaves, Zane B. Andrews, Claire J. Foldi (2026). \textit{Psilocybin exerts differential effects on social behavior and inflammation in mice in contexts of activity-based anorexia}. Psychedelics.. [published; OpenAlex]. \href{https://doi.org/10.61373/pp026a.0003}{doi:10.61373/pp026a.0003}.
\item Anton T. Gregersen, Tobias Whelan, Caroline T. Golden, T. Blackmore, Mikael Palner (2026). \textit{Computational Analysis of Psilocybin Effects on Three-Choice Touchscreen Reversal Learning in Rats: A Pilot Study}. Psychedelic Medicine. [published; OpenAlex]. \href{https://doi.org/10.1177/28314425251386879}{doi:10.1177/28314425251386879}.
\item Pablo Mallaroni, S. Parker Singleton, Natasha L. Mason, Theodore D. Satterthwaite, Johannes G. Ramaekers (2026). \textit{Spatiotemporal mapping of brain organisation following the administration of 2C-B and psilocybin}. Molecular Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1038/s41380-026-03447-0}{doi:10.1038/s41380-026-03447-0}.
\item Ben-Zion Z, Simon G, Lazebnik T. (2026). \textit{Can LLMs Get High? A Dual-Metric Framework for Evaluating Psychedelic Simulation and Safety in Large Language Models}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-8682370/v1}{doi:10.21203/rs.3.rs-8682370/v1}.
\item Thomas Müller (2026). \textit{Psilocybin wirkt bei therapieresistenter Depression}. DNP - Die Neurologie \& Psychiatrie. [published; OpenAlex]. \href{https://doi.org/10.1007/s15202-025-6636-1}{doi:10.1007/s15202-025-6636-1}.
\item Jorge Encantado, Laura C. Carvalho, Pedro Mota, Catarina Cunha, Albert Garcia-Romeu, Matthew W. Johnson, Pedro J. Teixeira (2026). \textit{Attitudes and perceptions of Portuguese mental health professionals on the therapeutic use of psilocybin and methylenedioxymethamphetamine (MDMA).}. Professional Psychology Research and Practice. [published; OpenAlex]. \href{https://doi.org/10.1037/pro0000664}{doi:10.1037/pro0000664}.
\item Swainson J, Brietzke E, Khullar A, McIntyre RS, Soares CN (2026). \textit{Ketamine, Psychedelics, and Psychotherapy: Reframing, Redefining, Renaming Treatment Models.}. Canadian journal of psychiatry. Revue canadienne de psychiatrie. [published; PubMed]. \href{https://doi.org/10.1177/07067437251389090}{doi:10.1177/07067437251389090}.
\item Ansari M, Elliott SI, Holmes SE, Sanacora G (2026). \textit{Placebo Effects in the Treatment of Depression-Implications for the Psychedelic Renaissance.}. Neurologic clinics. [published; PubMed]. \href{https://doi.org/10.1016/j.ncl.2025.08.009}{doi:10.1016/j.ncl.2025.08.009}.
\item Olofsson M, Osika W, Goldberg SB, Hendricks PS, Petrovic P, White T, Stenfors CUD, Chaturvedi S, Simonsson O (2026). \textit{Difficulties following naturalistic psychedelic use and associations with adverse childhood experiences.}. The International journal on drug policy. [published; PubMed]. \href{https://doi.org/10.1016/j.drugpo.2025.105105}{doi:10.1016/j.drugpo.2025.105105}.
\item Rachel Ham, John Gardner, Adrian Carter, Paul Liknaitzky (2026). \textit{Participant Experiences of Therapeutic Touch in Psilocybin-Assisted Therapy}. Brain and Behavior. [published; OpenAlex]. \href{https://doi.org/10.1002/brb3.71262}{doi:10.1002/brb3.71262}.
\item Homon A, Laramie J, Hayward JJ, Trant JF (2026). \textit{We Licked the Toads so You Don't Have to: A Comprehensive Analysis of the Chemical Syntheses of the Classical Psychedelics Bufotenin(e) and 5-Methoxy-N,N-Dimethyltryptamine.}. ChemMedChem. [published; PubMed]. \href{https://doi.org/10.1002/cmdc.202500525}{doi:10.1002/cmdc.202500525}.
\item Kala K, Bederska-Lojewska D, Lazur J, Gasior K, Maslanka A, Szewczyk A, Sulkowska-Ziaja K, Turek J, Szewczyk B, Pilc A, Muszynska B. (2026). \textit{Bioactive compounds from Psilocybe cubensis mycelial cultures with transient anxiolytic effects in mice.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.26402/jpp.2026.1.07}{doi:10.26402/jpp.2026.1.07}.
\item Mehmet Bostancıklıoğlu, Davut Sinan Kaplan, Ramazan Bal, Elif Yiğit, Hasan Ulusal, Ebru Temiz (2026). \textit{MDMA and Psilocybin Regulate Oligodendrocyte-Lineage Cell Numbers and Anxiety-Like Behaviors in a Rat Model of Fear}. Biological Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.biopsych.2026.01.016}{doi:10.1016/j.biopsych.2026.01.016}.
\item Anna Maria Komarczewska, Filip Matusiak, Klaudia Brzoza, Michał Kociński, Patryk Iglewski, Michał Pietrasz (2026). \textit{Psilocybin-Induced Neuroplasticity and Sustained Antidepressant Effects}. Quality in Sport. [published; OpenAlex]. \href{https://doi.org/10.12775/qs.2026.51.68216}{doi:10.12775/qs.2026.51.68216}.
\item Jesper L. Kristensen (2026). \textit{Regarding “The molecular mechanisms through which psilocybin prevents suicide: evidence from network pharmacology and molecular docking analyses”}. Translational Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1038/s41398-026-03844-7}{doi:10.1038/s41398-026-03844-7}.
\item Lukasz Siwek, Marta Nowocien, Barbara Balajewicz, Angelika Samborska, Sara Szukalska, Marta Karczewska, Karolina Lichwala, Kamil Wroblewski, Paulina Wróblewska (2026). \textit{The Use of Psilocybin in the Treatment of Depressive Disorders: A Narrative Review}. Cureus. [published; OpenAlex]. \href{https://doi.org/10.7759/cureus.102694}{doi:10.7759/cureus.102694}.
\item James Downar, Julie Lapenskie, Koby Anderson, Gaelle Parsons, Nadia Polskaia, Genevieve Lalumiere, Peter G. Lawlor (2026). \textit{PSilocybin for psYCHological and existential distress in PALliative care (PSYCHED-PAL): A single arm unblinded clinical trial}. Palliative Medicine. [published; OpenAlex]. \href{https://doi.org/10.1177/02692163261416269}{doi:10.1177/02692163261416269}.
\item Philip Rebensburg (2026). \textit{Psilocybin and the Evolutionary Significance of Altered Neural States: Interaction-Based Perspectives Beyond Deterrence Models}. Unknown journal. [published; OpenAlex]. \href{https://doi.org/10.32942/x2v66q}{doi:10.32942/x2v66q}.
\item Łukasz Deska, Cezary Kosmecki, Dawid Głaz, Natalia Kamińska, Wojciech Sołtys, Magdalena Stolarczyk, Maksymilian Głaz, Mateusz Stronczyński, Aleksandra Jagura-Sukiennik, Julia Wawerska (2026). \textit{PSILOCYBIN IN PSYCHIATRIC PRACTICE AND PSYCHEDELIC-ASSISTED THERAPY FOR TREATMENT-RESISTANT DEPRESSION}. International Journal of Innovative Technologies in Social Science. [published; OpenAlex]. \href{https://doi.org/10.31435/ijitss.1(49).2026.4711}{doi:10.31435/ijitss.1(49).2026.4711}.
\item Bruyère Health Research Institute. (2026). \textit{PSilocybin Microdose for psYCHological and Existential Distress in PALliative Care (PSYCHED-PAL): A Multi-site Phase 3 Double-blind, Placebo-controlled, Parallel-arm Clinical Trial}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07063862}{source link}.
\item Cheng-Teng Ip, Sebastian Olbrich, Mateo de Bardeci, Anna Monn, Andres Ort, John W. Smallridge, Franz Vollenweider (2026). \textit{Psilocybin-induced alterations in EEG power, connectivity and network dynamics in healthy subjects: Correlations with subjective experience and implications for therapeutic applications}. Progress in Neuro-Psychopharmacology and Biological Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.pnpbp.2026.111626}{doi:10.1016/j.pnpbp.2026.111626}.
\item Fernando Mora López, Johynny Solís Solís, Ekaterina Daniela Hernández Baker, Olger Herrera Barboza, David Diaz Polo, Daniela Consumi Cordero (2026). \textit{The therapeutic efficacy of psilocybin in major depressive disorder: A review of recent clinical and mechanistic evidence}. Zenodo (CERN European Organization for Nuclear Research). [published; OpenAlex]. \href{https://doi.org/10.5281/zenodo.18375715}{doi:10.5281/zenodo.18375715}.
\item Marco Banzato, Martina Colognesi, Lorena Lucatello, Stefano Comai, Gianfranco Pasut, Francesca Capolongo, Laura Orian, Lucia Biasutto, Anna Signor, Daniela Gabbia, Paolo L. Manfredi, Sara De Martin, Andrea Mattarei (2026). \textit{Design, Synthesis, and Pharmacokinetic Profiling of Fluorinated Reversible N -Alkyl Carbamate Derivatives of Psilocin for Sub-Hallucinogenic Brain Exposure}. Journal of Medicinal Chemistry. [published; OpenAlex]. \href{https://doi.org/10.1021/acs.jmedchem.5c01797}{doi:10.1021/acs.jmedchem.5c01797}.
\item Jess Kerr-Gaffney, Samuel Myrtle, Famia Askari, Catherine Bird, Nadav Liam Modlin, Allan H. Young, James Rucker (2026). \textit{Effects of psilocybin on personality, psychiatric symptoms, and values: Exploring mediating effects of the acute psychedelic experience}. Journal of Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1177/02698811251408769}{doi:10.1177/02698811251408769}.
\item Rishika Scott, James Smith (2026). \textit{The Evaluation of the Efficacy and Safety of the Use of Psilocybin in the Treatment of Adults with Treatment-Resistant Depression}. Emerging Minds Journal for Student Research. [published; OpenAlex]. \href{https://doi.org/10.59973/emjsr.317}{doi:10.59973/emjsr.317}.
\item Omer A. Syed, Benjamin Tsang, Sean M. Nestor, Nir Lipsman, Muhammad Ishrat Husain, Fahad Alam, Peter Giacobbe (2026). \textit{Methodological moderators of psilocybin-assisted therapy in depression: A systematic review and meta-analysis}. Neuroscience \& Biobehavioral Reviews. [published; OpenAlex]. \href{https://doi.org/10.1016/j.neubiorev.2026.106573}{doi:10.1016/j.neubiorev.2026.106573}.
\item NYU Langone Health (2026). \textit{A Phase 2 Trial of Psilocybin as an Adjunctive Treatment for OUD Patients Who Continue to Use Illicit Opioids Despite Adherence to Methadone Treatment}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06796062}{source link}.
\item Jakub Klepacz, Radosław Swędrak, Marzena Swojnóg, Zuzanna Dobrakowska (2026). \textit{THE PSYCHEDELIC RENAISSANCE: A SYSTEMATIC REVIEW OF PSILOCYBIN AND LSD IN THE TREATMENT OF PSYCHIATRIC DISORDERS}. International Journal of Innovative Technologies in Social Science. [published; OpenAlex]. \href{https://doi.org/10.31435/ijitss.1(49).2026.4582}{doi:10.31435/ijitss.1(49).2026.4582}.
\item Marija Franka Žuljević, Antonija Mijatović, Renata Orhanović, Glenn Goasdoué, Diana Gujinović (2026). \textit{Consistency of protocol and safety data reporting in clinical trial registrations and corresponding publications of interventions involving MDMA and psilocybin}. Journal of Clinical Epidemiology. [published; OpenAlex]. \href{https://doi.org/10.1016/j.jclinepi.2026.112170}{doi:10.1016/j.jclinepi.2026.112170}.
\item Tripdatabase (2026). \textit{Is psilocybin only effective as part of psychotherapy?}. Zenodo (CERN European Organization for Nuclear Research). [published; OpenAlex]. \href{https://doi.org/10.5281/zenodo.18339347}{doi:10.5281/zenodo.18339347}.
\item Tripdatabase (2026). \textit{Does psilocybin help with mental health conditions?}. Zenodo (CERN European Organization for Nuclear Research). [published; OpenAlex]. \href{https://doi.org/10.5281/zenodo.18339283}{doi:10.5281/zenodo.18339283}.
\item Baylor College of Medicine (2026). \textit{The STARLIGHT Protocol: State-Funded Trial Assessing Recovery and Long-Term Impact of Guided Psilocybin for Healing Trauma}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06888128}{source link}.
\item Nicholas Gregory, Tyler E. Girard, Akila Ram, Austen B. Casey, RC Malenka, Vivianne L. Tawfik, Boris D. Heifets (2026). \textit{No evidence of immediate or persistent analgesic effect from a single dose of psilocybin in three mouse models of pain}. Nature Communications. [published; OpenAlex]. \href{https://doi.org/10.1038/s41467-026-68763-z}{doi:10.1038/s41467-026-68763-z}.
\item Ana Domi, Erika Lucente, Davide Cadeddu, Niklas Bengtsson, Erik Smedler, Louise Adermark (2026). \textit{Psilocin mediates long-term synaptic depression in the prelimbic cortex through 5-HT2A receptor-independent mechanisms}. Neuropharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/j.neuropharm.2026.110854}{doi:10.1016/j.neuropharm.2026.110854}.
\item Martina Colognesi, Daniela Gabbia, Anna Signor, Miles Sarill, Lucia Centofanti, Andrea Rinaldi, Luciano Cascione, Sara Nunziata, Marco Banzato, Andrea Mattarei, Giovanna Finzi, Sonia Sonda, Diana Pendin, Ilaria Zanotto, Stefano Comai, Gianfranco Pasut, Abdullah Alajati, Miriam Saponaro, Loredana Bucciarelli, Maria Elena Lunati, Andrea Alimonti, et al. (2026). \textit{Low, non-psychedelic doses of psilocybin as a novel treatment for MASLD, obesity and type 2 diabetes via 5-HT2B receptor-dependent mechanisms}. Repository for Publications and Research Data (ETH Zurich). [published; OpenAlex]. \href{https://doi.org/10.3929/ethz-c-000793359}{doi:10.3929/ethz-c-000793359}.
\item Piotr Olejnik, Katarzyna Kamińska, Krystyna Gołembiowska, Kaja Kasarełło (2026). \textit{Effects of psilocybin and chronic mild stress on microglial activation in rat spinal cord: an ex vivo analysis}. Pharmacological Reports. [published; OpenAlex]. \href{https://doi.org/10.1007/s43440-026-00824-y}{doi:10.1007/s43440-026-00824-y}.
\item Laura Mills, Susan L. Rossell, Sean Carruthers (2026). \textit{Insights into psilocybin use among people with bipolar disorder: A thematic analysis of Reddit posts}. Journal of Affective Disorders. [published; OpenAlex]. \href{https://doi.org/10.1016/j.jad.2026.121220}{doi:10.1016/j.jad.2026.121220}.
\item Mao-Qiang He, Wen-Qiang Yang, Dorji Phurbu, Fei Liu, Jiaxin Li, Bin Cao, Rui-Lin Zhao (2026). \textit{Systematic study of Panaeolus (Agaricales, Galeropsidaceae) sensu lato and psilocybin-producing traits of species from China}. IMA Fungus. [published; OpenAlex]. \href{https://doi.org/10.3897/imafungus.17.167329}{doi:10.3897/imafungus.17.167329}.
\item Zoe Doyle, Noah Chisamore, Erica Kaczmarek, Danica E. Johnson, Ryan M. Brudner, Geneva Weiglein, Marc G. Blainey, Jordan Bawks, Jeremy Riva-Cambrin, Rickinder Sethi, Roger S. McIntyre, Joshua D. Rosenblat (2026). \textit{Early response to psilocybin in adults with treatment-resistant depression as a predictor for antidepressant efficacy}. General Hospital Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.genhosppsych.2026.01.001}{doi:10.1016/j.genhosppsych.2026.01.001}.
\item Anthony L. Back, Bonnie A. McGregor, Leslie Lazar Thorn, Kelsey K. Baker, T. Gooley, Mendel Kaelen, Kalin Harvey, John M. Guy, Susanna Myers, Juliana Pérez, Peter Thompson, Lindsay Billingsley, Cheryl Sesnon (2026). \textit{Group Retreat Psilocybin Therapy for People with Metastatic Cancer with Symptoms of Anxiety and Depression: Safety and Efficacy Outcomes of a Phase 1/2 Study}. Psychedelic Medicine. [published; OpenAlex]. \href{https://doi.org/10.1177/28314425251413856}{doi:10.1177/28314425251413856}.
\item Damian Świeczkowski, Aleksander Kwaśny, Krzysztof Sadko, Wiesław Jerzy Cubała (2026). \textit{Bridging the reporting gap: Application of the ReSPCT guidelines in psilocybin clinical trial protocols}. European Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/j.euroneuro.2025.112746}{doi:10.1016/j.euroneuro.2025.112746}.
\item Unknown authors (2026). \textit{Aquahenosis: A non-pharmacological altered state of consciousness induced by Floatation-REST}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/6mj8n\_v1}{source link}.
\item Hinchcliffe JK, Thomas CW, Gilmour G, Robinson ES. (2026). \textit{Psilocybin rapidly, but not immediately, reverses reward learning deficits in a durable manner in an inflammatory rat model of depressive symptoms}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.64898/2026.01.14.699553}{doi:10.64898/2026.01.14.699553}.
\item Unknown authors (2026). \textit{Psilocybin for Treatment-Resistant OCD: A Randomized Controlled Trial}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/atfum\_v1}{source link}.
\item Celia Faye Jacobsen, Dea Siggaard Stenbæk, Stig Poulsen, Sophia Armand (2026). \textit{The Psychological Support Model in Psilocybin Research: Psychotherapy in Disguise?}. Psychiatric Research and Clinical Practice. [published; OpenAlex]. \href{https://doi.org/10.1176/appi.prcp.20250113}{doi:10.1176/appi.prcp.20250113}.
\item Kelsey T. Laird, Prabha Siddarth, Ashley Ramos, Rhianna Rich, Brittany Youssef, Grace M. Schwartz, Karina Sergi, Micah Linton, L. Schwartzberg, Daniel F. Kelly, Keith G. Heinzerling (2026). \textit{Intentions, Spirituality, Set, and Setting Are Associated with Mystical Experiences in Psilocybin-Assisted Therapy}. Psychedelic Medicine. [published; OpenAlex]. \href{https://doi.org/10.1177/28314425251413425}{doi:10.1177/28314425251413425}.
\item COMPASS Pathways (2026). \textit{A Phase III, Multicentre, Randomised, Double-blind, Controlled Study to Investigate the Efficacy, Safety, and Tolerability of Two Administrations of COMP360 in Participants With Treatment-resistant Depression}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05711940}{source link}.
\item Johns Hopkins University (2026). \textit{Effects of Psilocybin in Patients With Amyotrophic Lateral Sclerosis}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06656702}{source link}.
\item University of California, San Diego (2026). \textit{Behavioral and Neural Mechanisms Supporting Psilocybin-assisted Therapy for Phantom Limb Pain}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05224336}{source link}.
\item Zaynab Khan, Sterre Weaver, Rachael V. Dando, Anne Katrin Schlag, Joanna; id\_orcid 0000-0002-2717-9739 Neill, Verity; id\_orcid 0000-0002-9876-250X Wainwright (2026). \textit{Sense-making around psilocybin in UK women experiencing cancer-related existential distress: An Interpretative Phenomenological Analysis}. Research Explorer (The University of Manchester). [published; OpenAlex]. \href{https://research.manchester.ac.uk/en/publications/6f070f13-96c6-4cc4-9e40-f2837bdb79b3}{source link}.
\item Koch P, Schmidt M, Hoffrichter A, Davoudi M, Horschitz S, Lau T, Meinhardt M, Spanagel R, Ladewig J, Köhr G. (2026). \textit{Psilocin fosters neuroplasticity in iPSC-derived human cortical neurons}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-4242829/v3}{doi:10.21203/rs.3.rs-4242829/v3}.
\item Barovic A, Pittiglio MK, Barrett JM, Aretz CDJ, Tesfatsion TT, Ramirez GA, Cruces W. (2026). \textit{Presence of 4-Hydroxy-N-methyl-N-ethyltryptamine in Commercially Available Products.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/acsomega.5c10889}{doi:10.1021/acsomega.5c10889}.
\item Sian Lewis (2026). \textit{Psilocybin shapes neural plasticity in selective brain networks}. Nature reviews. Neuroscience. [published; OpenAlex]. \href{https://doi.org/10.1038/s41583-025-01019-9}{doi:10.1038/s41583-025-01019-9}.
\item Zuzanna Kościuk, Izabela Szpręgiel, Agnieszka Bysiek, K. Gołembiowska (2026). \textit{The effect of psilocin on neurotransmitters release in the claustrum and on rat behavior}. Pharmacological Reports. [published; OpenAlex]. \href{https://doi.org/10.1007/s43440-025-00817-3}{doi:10.1007/s43440-025-00817-3}.
\item Matheus G. Marques, Liliana Patarroyo-Rodríguez, Balwinder Singh (2026). \textit{Psilocybin and Bipolar Depression: Promise and Prudence}. CNS Drugs. [published; OpenAlex]. \href{https://doi.org/10.1007/s40263-025-01255-8}{doi:10.1007/s40263-025-01255-8}.
\item Jesse Dallery, Jennifer L. Miller, Jeff Boissoneault, Lauren Harvey, Lindsey Ives, Alexandra Knerr, Shelby Blaes, Morgan N. Ransom, Melissa S. Munson, James P. Gilligan, Michael H. Silverman, Peter R. Guzzo, Beverlee Loeser (2026). \textit{An open-label pilot study of psilocybin-assisted therapy for binge eating disorder}. Journal of Eating Disorders. [published; OpenAlex]. \href{https://doi.org/10.1186/s40337-025-01508-3}{doi:10.1186/s40337-025-01508-3}.
\item Slot J, Bradshaw A, Dentinger B, Borovička J, Konkel Z, Rockefeller A, Bollinger I. (2026). \textit{The one that abstained: Psilocybe fuscofulva genome suggests two recent origins of the psilocybin gene cluster in Psilocybe}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.64898/2025.12.30.697041}{doi:10.64898/2025.12.30.697041}.
\item Frederick D. Sancilio, Maghsoud Dariani, Purvi Chavda, Harsha Mysore Rajagopal, Lyl Tomlinson (2026). \textit{Daily Administration of Psilocin Mucate (L-130) Produces a Favorable Safety Profile and Anxiolytic Effects in Rodents Exposed to Chronic Unpredictable Mild Stress}. Journal of Psychoactive Drugs. [published; OpenAlex]. \href{https://doi.org/10.1080/02791072.2025.2607726}{doi:10.1080/02791072.2025.2607726}.
\item Reza Moshfeghinia, Sara Mostafavi, Kimia Jazi, Amir Reza Ghasemi, Yasamin Khosravaninezhad, Santhosshi Narayanan, Jamshid Ahmadi, Mehdi Pasalar (2026). \textit{The effects of psilocybin on psychological distress in cancer patients: a systematic review and meta-analysis}. BMC Psychology. [published; OpenAlex]. \href{https://doi.org/10.1186/s40359-025-03935-y}{doi:10.1186/s40359-025-03935-y}.
\item Ethan Klukas (2025). \textit{Motivation-based subtypes of psilocybin microdosers}. Open Collections. [published; OpenAlex]. \href{https://doi.org/10.14288/1.0452623}{doi:10.14288/1.0452623}.
\item Mahvash Khan, Muhammad Omar Malik, Sara Sajjad, Muhammad Uzair, Inayat Shah, Muhammad Ismail Bhatti (2025). \textit{COMBINATION OF PSILOCYBIN AND COGNITIVE BEHAVIORAL THERAPY IMPROVES OXYTOCIN LEVELS AND DEPRESSIVE SYMPTOMS IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER}. Genetics and Molecular Research. [published; OpenAlex]. \href{https://doi.org/10.4238/e91xh631}{doi:10.4238/e91xh631}.
\item Marta Gómez Álvarez, Javier Calleja-Conde, Víctor Echeverry-Alzate (2025). \textit{Psychedelics and Mental Health: Psilocybin and Depression. A Sistematic Review}. Open Science Framework. [published; OpenAlex]. \href{https://doi.org/10.17605/osf.io/yu3n9}{doi:10.17605/osf.io/yu3n9}.
\item E. Lopez, J O Lundberg, F. Hieronymus, M. Beckman, H. Yngwe, C.J. Ekman, M. Tiger, N. Edvall (2025). \textit{Symptom-level antidepressant response to psilocybin: exploratory outcomes comparing psilocybin treatment to niacin}. Neuroscience Applied. [published; OpenAlex]. \href{https://doi.org/10.1016/j.nsa.2026.106904}{doi:10.1016/j.nsa.2026.106904}.
\item I. Totomanova, E.C.H.M. Haijen, P.P.M. Hurks, NL Mason, JG Ramaekers, K.P.C. Kuypers (2025). \textit{Self-reported benefits and harms of microdosing with natural psilocybin: preliminary results from a naturalistic study}. Neuroscience Applied. [published; OpenAlex]. \href{https://doi.org/10.1016/j.nsa.2026.106942}{doi:10.1016/j.nsa.2026.106942}.
\item Y. Ge, T.P. Whelan, M. Dimitrov, C.L. Ellis, F. Moruzzi, J. Kangas, F.M. Ponteduro, N. Khalil, S. Fenn-Moltu, NA Puts, E. Daly, D.G.M. Murphy, G.M. McAlonan, D. Batalle (2025). \textit{Dynamic response of intrinsic connectivity networks to low-dose psilocybin during face matching in autistic adults}. Neuroscience Applied. [published; OpenAlex]. \href{https://doi.org/10.1016/j.nsa.2026.106906}{doi:10.1016/j.nsa.2026.106906}.
\item Yosr Ziadi, Taehwan Park (2025). \textit{Cost-Effectiveness of Psilocybin-Assisted Therapy (PAT) for Patients with Treatment-Resistant Depression}. Open MIND. [published; OpenAlex]. \href{https://doi.org/10.17605/osf.io/nrt59}{doi:10.17605/osf.io/nrt59}.
\item Jorge Oliveira (2025). \textit{Psilocybin-Assisted Therapy for Mood Disorders: A Comparative Literature Review of Australia, the United States, the United Kingdom, and Canada}. Unknown journal. [published; OpenAlex]. \href{https://doi.org/10.13140/rg.2.2.35623.10402}{doi:10.13140/rg.2.2.35623.10402}.
\item Mateus Araújo da Luz, Taynah Pereira Galdino, Lucas Matheus da S. Oliveira, H. Guedes, Anauara Silva, Victor I. Afonso, Suédina M. L. Silva, Antônio G. B. Lima, Marcus V. L. Fook, Maria C. M. Torres (2025). \textit{Optimization of Psilocybin Extraction from Psilocybe cubensis Mushrooms and Characterization of the Fungal Extract}. Journal of the Brazilian Chemical Society. [published; OpenAlex]. \href{https://doi.org/10.21577/0103-5053.20260049}{doi:10.21577/0103-5053.20260049}.
\item Jesse Dallery, Jennifer L. Miller, Jeff Boissoneault, Lauren Harvey, Lindsey Ives, Alexandra Knerr, Shelby Blaes, Morgan N. Ransom, Melissa S. Munson, James P. Gilligan, Michael H. Silverman, Peter R. Guzzo, Beverlee Loeser (2025). \textit{Additional file 1 of An open-label pilot study of psilocybin-assisted therapy for binge eating disorder}. Figshare. [published; OpenAlex]. \href{https://doi.org/10.6084/m9.figshare.31199186.v1}{doi:10.6084/m9.figshare.31199186.v1}.
\item Jesse Dallery, Jennifer L. Miller, Jeff Boissoneault, Lauren Harvey, Lindsey Ives, Alexandra Knerr, Shelby Blaes, Morgan N. Ransom, Melissa S. Munson, James P. Gilligan, Michael H. Silverman, Peter R. Guzzo, Beverlee Loeser (2025). \textit{Additional file 2 of An open-label pilot study of psilocybin-assisted therapy for binge eating disorder}. Figshare. [published; OpenAlex]. \href{https://doi.org/10.6084/m9.figshare.31199189.v1}{doi:10.6084/m9.figshare.31199189.v1}.
\item Hannah Whitmore, Maria Mangini, Heather Leutwyler, Brian Anderson (2025). \textit{Facing Mortality Together: A Constructivist Grounded Theory Analysis of Group Psilocybin Therapy Among Older Long-Term AIDS Survivor Gay Men}. Palliative Medicine Reports. [published; OpenAlex]. \href{https://doi.org/10.1177/26892820251401798}{doi:10.1177/26892820251401798}.
\item Unknown authors (2025). \textit{Psilocybin-Therapie vorteilhaft für Stimmungsstörungen von Parkinsonkranken}. Fortschritte der Neurologie · Psychiatrie. [published; OpenAlex]. \href{https://doi.org/10.1055/a-2700-8978}{doi:10.1055/a-2700-8978}.
\item Maurice Lam, C. Khor, S. Hultin, J. J. Cheung, N. A. Shah (2025). \textit{‘Shroom’ for concern: a case of psychedelic mushroom-induced acute kidney injury}. Internal Medicine Journal. [published; OpenAlex]. \href{https://doi.org/10.1111/imj.70313}{doi:10.1111/imj.70313}.
\item B. Richardson, V. Bruno, J. O'Byrne, G. Gobbi (2025). \textit{Electrical brain changes following psilocybin administration in sprague-dawley rats}. Neuroscience Applied. [published; OpenAlex]. \href{https://doi.org/10.1016/j.nsa.2025.106819}{doi:10.1016/j.nsa.2025.106819}.
\item T. Whelan, M. Dimitrov, C.L. Ellis, F. Moruzzi, J. Kangas, N. Khalil, G. Ivin, E. Daly, NA Puts, D.G.M. Murphy, G.M. McAlonan (2025). \textit{Low dose psilocybin differentially alters resting-state network connectivity in autistic and non-autistic people}. Neuroscience Applied. [published; OpenAlex]. \href{https://doi.org/10.1016/j.nsa.2025.105782}{doi:10.1016/j.nsa.2025.105782}.
\item L.J. Mertens, M. Koslowski, F. Betzler, M. Brand, R. Evens, L. Krätner, A. Jungaberle, H. Jungaberle, T. Majić, C.N. Schmitz, A. Ströhle, D. Scharf, M. Spangemacher, M. Wolff, Z. Assadi, B. Scharif, L. Becher, L.V. Färber, N. Kirchen, E. Kulakova, L. Kunz, A. Meijer, B. Rohrmoser, S. Wellek, M. Berger, G. Gründer (2025). \textit{Efficacy and safety of psilocybin in treatment-resistant major depression (EPIsoDE): Results of a randomized active placebo-controlled trial}. Neuroscience Applied. [published; OpenAlex]. \href{https://doi.org/10.1016/j.nsa.2025.105779}{doi:10.1016/j.nsa.2025.105779}.
\item L. Marwood, M. Young, J. Chai-Rees, S. Mistry, S. Maxwell, G.M. Goodwin (2025). \textit{The impact of COMP360 psilocybin on anhedonia: post-hoc analyses from a phase IIb randomised controlled trial}. Neuroscience Applied. [published; OpenAlex]. \href{https://doi.org/10.1016/j.nsa.2025.106572}{doi:10.1016/j.nsa.2025.106572}.
\item I.R.A. Koutrouli, K. Šíchová, W. Kacper, V. Brejtr, K. Aleksič, N. Miniariková, E. Lhotková, M. Nikolič, T. Páleníček (2025). \textit{Psilocybin and ibogaine as therapeutic candidates for cocaine addiction: Insights from a rat self-administration model}. Neuroscience Applied. [published; OpenAlex]. \href{https://doi.org/10.1016/j.nsa.2025.106393}{doi:10.1016/j.nsa.2025.106393}.
\item N. Mcgowan, J. Rucker, R. Yehuda, M. Agrawal, H. Simmons, S. Das, G. Goodwin (2025). \textit{An open-label study of single-dose COMP360 psilocybin for post-traumatic stress disorder: safety, tolerability, and secondary efficacy outcomes}. Neuroscience Applied. [published; OpenAlex]. \href{https://doi.org/10.1016/j.nsa.2025.106821}{doi:10.1016/j.nsa.2025.106821}.
\item L. Puhl, L. Kunz, M. Berger, G. Gründer, L. Mertens, M. Spangemacher (2025). \textit{Relationship between cardiovascular effects and psychedelic experiences under psilocybin in patients with treatment-resistant depression}. Neuroscience Applied. [published; OpenAlex]. \href{https://doi.org/10.1016/j.nsa.2025.106390}{doi:10.1016/j.nsa.2025.106390}.
\item Jensen, Hailey A (2025). \textit{Psilocybin Treatment for Refractory Depression: A Clinical Review}. Digital Commons - Gardner-Webb University (Gardner-Webb University). [published; OpenAlex]. \href{https://digitalcommons.gardner-webb.edu/pa-department-journal-of-medical-science/63}{source link}.
\item Sam Lasham, Rhys Ponton (2025). \textit{The impact of drug control on wider research: Psychedelic mushroom exploration}. Drug Science Policy and Law. [published; OpenAlex]. \href{https://doi.org/10.1177/20503245251412697}{doi:10.1177/20503245251412697}.
\item N. Martínez-Álvarez, I. Erkizia-Santamaría, A. Tomás-Alvarado, A.M. Erdozain, J.J. Meana, J.E. Ortega (2025). \textit{Preclinical evaluation of psilocybin as an anti-inflammatory agent}. Neuroscience Applied. [published; OpenAlex]. \href{https://doi.org/10.1016/j.nsa.2025.105853}{doi:10.1016/j.nsa.2025.105853}.
\item M. Benes, D. Gregus, P. Adamek, T. Páleníček, J. Horacek (2025). \textit{Psilocybin increases connectivity between unimodal and transmodal networks in healthy volunteers listening to music}. Neuroscience Applied. [published; OpenAlex]. \href{https://doi.org/10.1016/j.nsa.2025.106823}{doi:10.1016/j.nsa.2025.106823}.
\item O. Ollari, T.P. Whelan, C.L. Ellis, N. Khalil, F. Moruzzi, D.G.M. Murphy, E. Daly, L. Mason, N. Puts, G.M. McAlonan (2025). \textit{Effects of low-dose psilocybin on EEG markers of sensory processing in autistic and non-autistic adults}. Neuroscience Applied. [published; OpenAlex]. \href{https://doi.org/10.1016/j.nsa.2026.106903}{doi:10.1016/j.nsa.2026.106903}.
\item F. Sellitti, C. Weber, É. Tamura, Z. Li, J. Thomann, D. Luethi, L.D. Simmler (2025). \textit{Mismatch between psilocybin-induced head-twitch behaviour and psilocin brain levels in mice}. Neuroscience Applied. [published; OpenAlex]. \href{https://doi.org/10.1016/j.nsa.2025.106574}{doi:10.1016/j.nsa.2025.106574}.
\item I. Totomanova, E.C.H.M. Haijen, Petra P. M. Hurks, NL Mason, K.P.C. Kuypers (2025). \textit{Preliminary results from an ongoing naturalistic survey study investigating dose-finding practices and effects of self-administered small amounts of psilocybin}. Neuroscience Applied. [published; OpenAlex]. \href{https://doi.org/10.1016/j.nsa.2025.106822}{doi:10.1016/j.nsa.2025.106822}.
\item A. O'shea, JG Ramaekers, R. Schreiber, J.J. Briedé, J. Krauskopf, N. Mason, M.C.T. Verheijen (2025). \textit{Temporal effects of a single oral dose of psilocybin on plasma circulating miRNAs in humans}. Neuroscience Applied. [published; OpenAlex]. \href{https://doi.org/10.1016/j.nsa.2025.106576}{doi:10.1016/j.nsa.2025.106576}.
\item C. Weber, F. Sellitti, L. Ziming, J. von Arx, L.D. Simmler (2025). \textit{Behavioral and neuronal effects of psilocybin in mice}. Neuroscience Applied. [published; OpenAlex]. \href{https://doi.org/10.1016/j.nsa.2025.106575}{doi:10.1016/j.nsa.2025.106575}.
\item Islas-Vargas J, Armenta S, Rivera-Román ÁA, Hernández-León S, Méndez-Hernández JE, Arce-Cervantes O. (2025). \textit{Psilocybin: clinical potential, mechanistic insights, and biotechnological advances for scalable production}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/AGR/IND609383879}{source link}.
\item Thomas K. (2025). \textit{Toxicology and Pharmacological Interactions of Classic Psychedelics.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/7854\_2024\_508}{doi:10.1007/7854\_2024\_508}.
\item Holze F, Liechti ME, Müller F. (2025). \textit{Pharmacological Properties of Psychedelics with a Special Focus on Potential Harms.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/7854\_2024\_510}{doi:10.1007/7854\_2024\_510}.
\item Viljoen G, Betzler F (2025). \textit{Anxiety and Affective Symptoms Related to the Use of Classic Psychedelics: A Systematic Review.}. Current topics in behavioral neurosciences. [published; PubMed]. \href{https://doi.org/10.1007/7854\_2024\_534}{doi:10.1007/7854\_2024\_534}.
\item Bradberry MM, Appelbaum PS, Gukasyan N. (2025). \textit{Informed Consent in Psychedelic-Assisted Therapy.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/7854\_2024\_559}{doi:10.1007/7854\_2024\_559}.
\item Chwyl C, Wilson-Poe AR, Hoffman KA, Bazinet A, Pertl K, Luoma JB, des Jarlais D, Bielavitz S, Korthuis PT (2025). \textit{Building standards of psychedelic care: Qualitative examination of expert perspectives on safety, inclusion, and accountability.}. The International journal on drug policy. [published; PubMed]. \href{https://doi.org/10.1016/j.drugpo.2025.104938}{doi:10.1016/j.drugpo.2025.104938}.
\item Hirschfeld T, Blei F, Stegemann L, van der Gouwe D, Smit-Rigter L. (2025). \textit{Psychedelic Drug Checking: Analytical and Strategic Challenges in Harm Reduction for Classic Psychedelics.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/7854\_2025\_606}{doi:10.1007/7854\_2025\_606}.
\item Philip Kamilar-Britt, Alyssa B. Oliva, Mitch Earleywine (2025). \textit{Perceptions of Psilocybin-Assisted Psychotherapy and Standard Interventions for Nicotine Cessation}. Journal of Psychoactive Drugs. [published; OpenAlex]. \href{https://doi.org/10.1080/02791072.2025.2607724}{doi:10.1080/02791072.2025.2607724}.
\item Connor J. Maltby, Adam K. Klein, Enya Paschen, Jessica Pinto, Dino Dvořák, Joseph R. Hedde, Ashley N. Hanks, Massimiliano Bianchi, Zoe Hughes (2025). \textit{An exploration of the relationships between the effects of psilocybin on behavior, 5-HT2A receptor occupancy, and neuroplastic effects in mice}. Journal of Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1177/02698811251395386}{doi:10.1177/02698811251395386}.
\item Hediye Moghadam, Parisa Akbari, Elmira Beirami, Samaneh Nabavifard, Akram Ameli, Neda Valian (2025). \textit{The Effect of Magic Mushroom ( Psilocybe azurescens ) on Social Interaction, Anxiety- and Depressive-Like Behaviors in Male Rats; the Role of Neuroinflammation, Oxidative Stress, and Neurotrophic Factors}. Journal of Neuroscience Research. [published; OpenAlex]. \href{https://doi.org/10.1002/jnr.70107}{doi:10.1002/jnr.70107}.
\item Brunno Freitas da Costa, Paula Hartmann, Daniel Pagnin (2025). \textit{Pharmacological Management of Anxiety in End-of-Life Care: A Systematic Review of Benzodiazepines, Opioids, and Psilocybin}. Human Psychopharmacology Clinical and Experimental. [published; OpenAlex]. \href{https://doi.org/10.1002/hup.70032}{doi:10.1002/hup.70032}.
\item Ziran Huang, Xiaoyan Wei, Yihui Wang, Jin Tian, Jihui Dong, Bo Liang, Lin Lu, Wen Zhang (2025). \textit{Single-dose psilocybin promotes cell-type-specific changes of neurons in the orbitofrontal cortex}. Neurotherapeutics. [published; OpenAlex]. \href{https://doi.org/10.1016/j.neurot.2026.e00841}{doi:10.1016/j.neurot.2026.e00841}.
\item Bröcker AL, Majić T, Montag C. (2025). \textit{Psychedelic-Related Psychosis: From Model Psychosis to Psychotherapy.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/7854\_2026\_613}{doi:10.1007/7854\_2026\_613}.
\item Majić T, Gouzoulis-Mayfrank E, Evens R. (2025). \textit{Classifying Psychedelic-Related Complications.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/7854\_2026\_614}{doi:10.1007/7854\_2026\_614}.
\item Spiti A, Caldirola D, Perna G. (2025). \textit{New Antidepressant Development in the Treatment of Depression.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/978-981-95-6872-7\_23}{doi:10.1007/978-981-95-6872-7\_23}.
\item Olivier B, Olivier JDA. (2025). \textit{Psychedelics: Future Therapeutics in Major Depression?}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/978-981-95-6872-7\_25}{doi:10.1007/978-981-95-6872-7\_25}.
\item Kucukdereli H, Douglass AM. (2025). \textit{Neuroscience: What doesn't kill you makes you stronger.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.cub.2025.11.056}{doi:10.1016/j.cub.2025.11.056}.
\item Xia K, Gao T. (2025). \textit{[Clinical application and mechanistic studies of psychedelics for treatment of depression: progress and future challenges].}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.12122/j.issn.1673-4254.2026.01.01}{doi:10.12122/j.issn.1673-4254.2026.01.01}.
\item Thuery G, Crossen F, Mc Loone D, Hinds C, Duffy R, Jairaj C, Harkin A, Kelly JR (2025). \textit{Psychedelic therapy and postpartum depression: priorities and prospects.}. Therapeutic advances in psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1177/20451253251408280}{doi:10.1177/20451253251408280}.
\item Ashkan Veysi, Daniela Atanasovski, Maryam Ardalan, Nasrin Motamed, Elias Eriksson (2025). \textit{Psilocybin elicits a conserved glucocorticoid-responsive gene signature across five 5-HT2A receptor-rich brain regions in rat}. Acta Neuropsychiatrica. [published; OpenAlex]. \href{https://doi.org/10.1017/neu.2026.10075}{doi:10.1017/neu.2026.10075}.
\item Abramsky-Sze S, Marseille E, Matzopoulos R, Morlock R, Lerer L (2025). \textit{Correction: Characteristics and mental health of psychedelic mushroom and multi-psychedelic users relative to non-psychedelic users in American adults, 2020-2021.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2026.1834094}{doi:10.3389/fpsyt.2026.1834094}.
\item Petr Scholle, Štěpán Wenke, Tereza Nekovářová, Yulia Zaytseva, Filip Tylš, Martin Brunovský, Jiřı́ Horáček, Veronika Andrashko, Vlastimil Koudelka, Michaela Viktorinová, Vojtěch Viktorin, Kateřina Hájková, Martin Kuchař, T. Páleníček (2025). \textit{The effects of psilocybin on time perception in humans: A comparative analysis of subjective and objective measures}. Journal of Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1177/02698811251389552}{doi:10.1177/02698811251389552}.
\item Unknown authors (2025). \textit{Self-Transcendent Perceptual Dynamics and the Effects of Dispositional Mindfulness on Altered States of Consciousness: A Prospective Longitudinal Observational Study of a Naturalistic Psychedelic Retreat}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/6jf49\_v1}{source link}.
\item University of Calgary (2025). \textit{A Randomized Double-blinded Controlled Trial for the Treatment of Persisting Symptoms After Concussion With Psilocybin-assisted Therapy: A Safety and Feasibility Trial}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06615908}{source link}.
\item Rotem Petranker (2025). \textit{Microdosing Psychedelics to Improve Mood}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05259943}{source link}.
\item Christopher MW, Prentice BM, Garrett TJ. (2025). \textit{Distinguishing 4- vs 5-Hydroxy-N,N-Dimethyltryptamine (Psilocin vs Bufotenine) Using Hydrogen-Deuterium Back-Exchange.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/jasms.5c00421}{doi:10.1021/jasms.5c00421}.
\item Sophie Weiser, Sidney Jung, Bettina Bardl, Johann E. Kufs, Slavica Janevska, Vito Valiante, Dirk Hoffmeister, Lars Regestein (2025). \textit{Psilocybin Production With Genetically Modified Aspergillus nidulans Under Pressurized Conditions}. Biotechnology and Bioengineering. [published; OpenAlex]. \href{https://doi.org/10.1002/bit.70137}{doi:10.1002/bit.70137}.
\item Yale University (2025). \textit{Psilocybin in Chronic Low Back Pain: An Integrative Study of Lab-Based Mechanisms and Real-World Physical Therapy Outcomes}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07306364}{source link}.
\item Miguel Benjamín Cervera-Sánchez, Daniel San-Juan, Roberto Díaz-Peregrino, Evelin Zulema Camacho-Castillo, Sthefany Anahi Bringas-Ortiz, Christian Padilla-Cabezutd (2025). \textit{Psilocybin as a Serotonergic Therapy in Epilepsy: Narrative Review of Therapeutic Potentials and Seizure Risks}. Unknown journal. [published; OpenAlex]. \href{https://doi.org/10.22541/au.176701186.65064859/v1}{doi:10.22541/au.176701186.65064859/v1}.
\item Emmanuelle A. D. Schindler, Christopher Gottschalk, Brian Pittman, Deepak D'Souza (2025). \textit{Comparing single- and repeat-dose psilocybin with active placebo for migraine prevention in an exploratory randomized controlled clinical trial}. Headache The Journal of Head and Face Pain. [published; OpenAlex]. \href{https://doi.org/10.1111/head.70024}{doi:10.1111/head.70024}.
\item Rhianna Rich, Kelsey T. Laird, Prabha Siddarth, Brittany Youssef, Grace M. Schwartz, Ashley Ramos, Karina Sergi, Micah Linton, L. Schwartzberg, Daniel F. Kelly, Keith G. Heinzerling (2025). \textit{A Nature-Themed Video Intervention Increases Nature Relatedness in Psilocybin-Assisted Psychotherapy for Alcohol Use Disorder}. Psychedelic Medicine. [published; OpenAlex]. \href{https://doi.org/10.1177/28314425251387655}{doi:10.1177/28314425251387655}.
\item Houff J, Williams A, Allen O, Gisabella B, Pantazopoulos H, Del Arco A. (2025). \textit{Psilocybin decreases reward-seeking behavior accompanied by increased activity of parvalbumin neurons with perineuronal nets in the medial prefrontal cortex}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.64898/2025.12.22.696123}{doi:10.64898/2025.12.22.696123}.
\item Stocker K, Hartmann M, Schmid Y, Vogt SB, Becker AM, Ley L, Straumann I, Arikci D, Klaiber A, Erne L, Vizeli P, Holze F, Liechti ME. (2025). \textit{The 3D-ASCr scale: A revalidation of the core dimensions of the Altered States of Consciousness Rating Scale 5D(11)-ASC for psychedelic research.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811251397328}{doi:10.1177/02698811251397328}.
\item Fei Liu, Jiaxin Li, Wen-Qiang Yang, Mao-Qiang He, Bin Cao, Qi Wu, R. Cheewangkoon, Rui-Lin Zhao (2025). \textit{Evolution and horizontal transfer of the psilocybin biosynthetic gene cluster drive the diversification of magic mushrooms}. Mycosphere. [published; OpenAlex]. \href{https://doi.org/10.5943/mycosphere/16/1/28}{doi:10.5943/mycosphere/16/1/28}.
\item Sheppard Pratt Health System (2025). \textit{The Safety and Efficacy of Psilocybin in Patients With Treatment-resistant Depression and Chronic Suicidal Ideation}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05220410}{source link}.
\item University of Chicago (2025). \textit{An Open Label Study of Single-Dose Psilocybin for Major Depressive Disorder With Co-occurring Borderline Personality Disorder}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05399498}{source link}.
\item Bhagavan C, Carter O, Nielsen G, Berlowitz D, Issak S, Braat S, Zaloumis S, Attard Z, Oliver G, Mayne D, Rucker J, Butler M, Dandash O, Bryson A, Kanaan RA. (2025). \textit{A Randomised, Triple-Blind, Dose-Finding Study of the Impact of Psilocybin on Motor Function in Healthy Participants}. medRxiv. [preprint; medRxiv]. \href{https://doi.org/10.64898/2025.12.22.25342874}{doi:10.64898/2025.12.22.25342874}.
\item Anthony L. Back, Bonnie A. McGregor, Lindsay Billingsley, Dianna Blom, George Callan, Susanna Myers, John Guy, Sameet Kumar, Melissa Layer, Jackie Levin, Juliana Pérez, Peter Thompson, Kathy Salmonson, Joseph Whinney, Leslie Lazar Thorn (2025). \textit{Group Retreat Psilocybin Therapy for People with Metastatic Cancer with Anxiety and Depression: A Rite of Passage Facilitation Model for a Phase 1/2 Study}. Psychedelic Medicine. [published; OpenAlex]. \href{https://doi.org/10.1177/28314425251404460}{doi:10.1177/28314425251404460}.
\item Giuseppe Venturella, Manuela Rollini, Giulia Mirabile, Nicola Favia, Maria Letizia Gargano (2025). \textit{The genus Psilocybe in Italy}. Italian Botanist. [published; OpenAlex]. \href{https://doi.org/10.3897/italianbotanist.20.181001}{doi:10.3897/italianbotanist.20.181001}.
\item NYU Langone Health (2025). \textit{Effects of Psilocybin on Speech Fluency, Struggle, and Brain Activity in People Who Stutter}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07296328}{source link}.
\item Shadani S, McCoy K, Ong L, Greaves E, Conn K, Andrews ZB, Foldi CJ. (2025). \textit{Psilocybin modulates social behaviour in male and female mice in a time-dependent manner}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.64898/2025.12.18.695064}{doi:10.64898/2025.12.18.695064}.
\item Pallavicini C, Llobenes L, Cavanna F, de la Fuente LA, Muller S, Costa M, Gumiy N, Bruno N, D’Amelio T, Basran J, Plowright P, Stolkiner A, Namías M, Gilbert P, Tagliazucchi E. (2025). \textit{A Naturalistic Study on the Combined Neural and Psychological Effects of Psilocybin and Compassion Focused Imagery}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.64898/2025.12.17.694940}{doi:10.64898/2025.12.17.694940}.
\item Jonathan Brett, Toby Lea, Elizabeth Knock, Steven M. Albert, Liam Acheson, Krista J. Siefried, Sebastian Job (2025). \textit{A qualitative analysis of participant expectations and experiences of psilocybin-assisted psychotherapy for methamphetamine use disorder}. Addiction. [published; OpenAlex]. \href{https://doi.org/10.1111/add.70284}{doi:10.1111/add.70284}.
\item Carlson LE, Richardson H, Shore R, Albertyn CP, Balneaves LG, Bates A, Burnell M, Chochinov HM, Clements D, Deleemans J, Horlock H, Mathews J, McKenzie M, Savard C, Soares CN, Tu W, Williams M (2025). \textit{The CAnadian Network for Psychedelic-Assisted Cancer Therapy (CAN-PACT): A Multi-Phase Program Overview.}. Current oncology (Toronto, Ont.). [published; PubMed]. \href{https://doi.org/10.3390/curroncol33010007}{doi:10.3390/curroncol33010007}.
\item M. Haseeb Ul Rasool, Taha Hannan, Muhammad Imam (2025). \textit{Magic mushrooms and mood: exploring Psilocybin as a depression treatment}. Journal of the Pakistan Medical Association. [published; OpenAlex]. \href{https://doi.org/10.47391/jpma.30858}{doi:10.47391/jpma.30858}.
\item Amanda Husein, Madalynn Traylor, M. Frances Vest, Bo Jarrett Wood, Madison Brogan, Alfred Thomas, Shawn E. McNeil, M Alfrad Nobel Bhuiyan, Peter S. Hendricks, John R. Kelly, Andrew Gribben, Sultan Alqahtani, Kelsea Keys, Amber N. Edinoff, J C Patterson, Kevin S. Murnane (2025). \textit{Assessing The Readiness of Psychiatrists in Louisiana to Incorporate Psilocybin into Clinical Practice-Lessons Learned from a State Underrepresented in Clinical Psychedelic Research}. Psychedelic Medicine. [published; OpenAlex]. \href{https://doi.org/10.1177/28314425251381806}{doi:10.1177/28314425251381806}.
\item Qinqing Chen, Peiyuan Chen, Tao Wei, Sunita Chamyuang, Bai-Xiong Chen (2025). \textit{From fungi to pharmacy: Applied technologies in psilocybin production and its therapeutic applications}. Creative Science. [published; OpenAlex]. \href{https://doi.org/10.55674/cs.v18i1.264689}{doi:10.55674/cs.v18i1.264689}.
\item Mylène Cheng, Tatiana Aboulafia Brakha, Albert Buchard, Raya Anastasova, Léa Girani, Anna Breitenmoser, Sylvie Alaux, Cédric Mabilais, Caroline Amberger, Federico Seragnoli, Leonice Furtado, Gabriel Thorens, Daniele Zullino, Louise Penzenstadler (2025). \textit{Effects of LSD and Psilocybin on Heart Rate in Patients Receiving Psychedelic Treatment for Depressive and Anxiety Disorders: A Retrospective Observational Study}. Psychology International. [published; OpenAlex]. \href{https://doi.org/10.3390/psycholint8010001}{doi:10.3390/psycholint8010001}.
\item NYU Langone Health (2025). \textit{Neurobehavioral Mechanisms of Psilocybin-assisted Treatment for Alcohol Use Disorder}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06349083}{source link}.
\item Koning E, Gamberg S, Keshen A. (2025). \textit{Psilocybin Treatment as an Adjunct to Cognitive Behavioral Therapy for Eating Disorders: Therapeutic Rationale \& Considerations for Protocol Development}. Preprints.org. [preprint; Europe PMC]. \href{https://doi.org/10.20944/preprints202512.1705.v1}{doi:10.20944/preprints202512.1705.v1}.
\item Matthews Nicholass K, Flis I, Hanley M, Knight M, Lane S, Littlejohn G, Thom M, Billington R, Boden R, Cummins R, Green B, Griffin C, Jones S, Salmon D, Sleep I, Smirnoff N, Ellis J. (2025). \textit{Wherefore the magic? The evolutionary role of psilocybin in nature}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.64898/2025.12.17.694186}{doi:10.64898/2025.12.17.694186}.
\item COMPASS Pathways (2025). \textit{A Phase III, Multicentre, Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy, Safety, and Tolerability of COMP360 in Participants With Treatment-resistant Depression}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05624268}{source link}.
\item Gurjot Brar, T. R. JUN. BURKE, Andrew Gribben, Colm Harrington, Guillaume Thuery, John R. Kelly (2025). \textit{Psilocybin reporting in media (PRiMe) for the treatment of depression}. Irish Journal of Psychological Medicine. [published; OpenAlex]. \href{https://doi.org/10.1017/ipm.2025.10142}{doi:10.1017/ipm.2025.10142}.
\item Matos ARS, Silva AC, Rego L, Fernandes R, Gonçalves S. (2025). \textit{Psilocybin-assisted therapy for individuals with palliative care needs: A systematic review of safety and efficacy.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/02692163251383335}{doi:10.1177/02692163251383335}.
\item Unknown authors (2025). \textit{Exploring Psilocybin-Assisted Schema Therapy: A Conceptual Framework for Potential Therapeutic Synergies in Personality Disorders}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.47626/2237-6089-2025-1273}{doi:10.47626/2237-6089-2025-1273}.
\item Megan Dutton, Paul Schwenn, Jules Mitchell, Per Hoffmann, Neil W. Bailey, Paul B. Fitzgerald, Jim Lagopoulos, Adem Can (2025). \textit{Psilocybin in the real world: Regulatory, ethical, and operational challenges in Australia’s clinical landscape}. Australian \& New Zealand Journal of Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1177/00048674251398677}{doi:10.1177/00048674251398677}.
\item Faheem Ahmed Khan, Nuruliarizki Shinta Pandupuspitasari, Tewin Tencomnao, Siriporn Chuchawankul (2025). \textit{Breaking the chains of depression: A systematic review and meta-analysis of psilocybin therapy}. Journal of Affective Disorders. [published; OpenAlex]. \href{https://doi.org/10.1016/j.jad.2025.120882}{doi:10.1016/j.jad.2025.120882}.
\item Sophie Woodruff, Meghan Hibicke, Charles D. Nichols (2025). \textit{Preadministration of Lorazepam Negates the Long-Term Antidepressant-Like Effects of Psilocybin in Male Wistar Kyoto Rats}. Psychedelic Medicine. [published; OpenAlex]. \href{https://doi.org/10.1177/28314425251393186}{doi:10.1177/28314425251393186}.
\item Shannon Antoine-Hardy, D’Elia Bonilla (2025). \textit{Exploring Determinants of Psilocybin Acceptance as an Alternative Modality for Major Depressive Disorder: A Pilot Study}. Journal of Complementary and Alternative Medical Research. [published; OpenAlex]. \href{https://doi.org/10.9734/jocamr/2025/v26i11723}{doi:10.9734/jocamr/2025/v26i11723}.
\item Yvan Beaussant, MD, MSci (2025). \textit{Feasibility Phase 2 Study of Psilocybin-Assisted Therapy for Opioid-Refractory Pain in Patients With Advanced Cancer}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06001749}{source link}.
\item Anna C. Renner, Robert B. Kargbo (2025). \textit{Advances in Psychedelic Therapeutics: Multimodal Iboga Analogs, EEG-Guided Psilocybin Dosing, and Optimized Harmine-DMT Formulations}. ACS Medicinal Chemistry Letters. [published; OpenAlex]. \href{https://doi.org/10.1021/acsmedchemlett.5c00714}{doi:10.1021/acsmedchemlett.5c00714}.
\item Vollebregt R, Storm AEM, Lucassen PJ, Somers M. (2025). \textit{Psychedelic experiences elicited by serotonergic psychedelics: Molecular mechanisms and functional connectivity changes in the brain.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neubiorev.2025.106529}{doi:10.1016/j.neubiorev.2025.106529}.
\item Nicole Ledwos, Jenna Baer, Muhammad Ishrat Husain, Daniel M. Blumberger, Rachel Patterson, Elizabeth Hollingdrake, Ezmond S.L. Cheung, Colin Hawco, Christoph Zrenner, Brigitte Zrenner, Jamie D. Feusner, Susan L. Rossell, David Castle, Gwyneth Zai (2025). \textit{Psilocybin-assisted psychotherapy for treatment-resistant obsessive-compulsive disorder: protocol for an open-label pilot study}. BJPsych Open. [published; OpenAlex]. \href{https://doi.org/10.1192/bjo.2025.10895}{doi:10.1192/bjo.2025.10895}.
\item Carhart-Harris R. (2025). \textit{The entropic brain today}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/ubzq3\_v1}{doi:10.31234/osf.io/ubzq3\_v1}.
\item Unknown authors (2025). \textit{The entropic brain today}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/ubzq3\_v1}{source link}.
\item Pedro Rodrigues, Weliton Rodrigues dos Santos Júnior, Ivan de Sousa Araújo, Leonardo Maia Leony, Fernanda Adélia Almeida Custódio Pires Gomes, Tairone Matos de Lima Junior, Luís Felipe Freitas Moreira, Rafael Telles Santana, Manoel Carlos Matos Santos, R. Silva (2025). \textit{COMPARATIVE EFFICACY AND ACCEPTABILITY OF PSILOCYBIN-KETAMINE AND TYPICAL ANTIDEPRESSANTS FOR MAJOR DEPRESSIVE DISORDER MANAGEMENT: A NETWORK META-ANALYSIS}. Unknown journal. [published; OpenAlex]. \href{https://doi.org/10.55905/edicon.978-65-83115-47-8\_8}{doi:10.55905/edicon.978-65-83115-47-8\_8}.
\item Samuel Hosford, Heather Austin-Robillard (2025). \textit{Psilocybin and MDMA in Couples Therapy: Investigating Treatment for Substance Use Disorders and Codependency}. Contemporary Family Therapy. [published; OpenAlex]. \href{https://doi.org/10.1007/s10591-025-09766-8}{doi:10.1007/s10591-025-09766-8}.
\item Unknown authors (2025). \textit{Age and cannabis co-use are associated with differences in experience and perceived benefits of psilocybin: a retrospective study}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/dczw2\_v2}{source link}.
\item Jungwirth J, Westenhöfer S, Aicher H, Provaznikova B, Kronenberg G, Seifritz E, Prinz S, Olbrich S. (2025). \textit{Real-World Psilocybin Therapy for Treatment-Resistant Depression: a Retrospective Observational Study}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-8079137/v1}{doi:10.21203/rs.3.rs-8079137/v1}.
\item T. H. W. Ching, B. Stahnke, S. Shnayder, G. Agin-Liebes, T. G. Adams, L. Amoroso, O. Baiz, A. Belser, C. Bohner, M. Burke, E. D’Amico, G. DePalmer, J. Eilbott, G. Fram, R. Grazioplene, J. Hokanson, A. Jankovsky, S. A. Kichuk, B. Martins, P. Purohit, H. Schaer, Y. P. Sierra, C. Witherow, C. Pittenger, B. Kelmendi (2025). \textit{Acute and post-dosing effects of single-dose psilocybin for obsessive-compulsive disorder in a randomized, double-blind, placebo-controlled trial: an interpretative phenomenological analysis}. Frontiers in Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.3389/fpsyt.2025.1726818}{doi:10.3389/fpsyt.2025.1726818}.
\item Suspène J, Huet S, Berteina-Raboin S, Benyamina A, Baril P, Morisset-Lopez S, Serreau R. (2025). \textit{Psilocybin in Alcohol Use Disorder Maintains Abstinence Efficacy: A Scoping Review}. Qeios. [preprint; Europe PMC]. \href{https://doi.org/10.32388/xcfsag.2}{doi:10.32388/xcfsag.2}.
\item Gerasimos Konstantinou, Joshua D. Rosenblat, Sarah Hales, Muhammad Ishrat Husain, Daniel M. Blumberger (2025). \textit{Psilocybin in late-life mental health: Addressing depression, loneliness, and existential anxiety}. General Hospital Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.genhosppsych.2025.12.005}{doi:10.1016/j.genhosppsych.2025.12.005}.
\item Namik Kirlić, Merve Atli, Sunil Mistry, Michael Gold, Guy M. Goodwin (2025). \textit{The Relationship Between Participant Pretreatment Clinical Presentation and the Quality of Psilocybin Experience}. Journal of Clinical Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1097/jcp.0000000000002119}{doi:10.1097/jcp.0000000000002119}.
\item Wohlfarth, Gale, Hardy, Susan, Ray, Herman (2025). \textit{Are Magic Mushrooms the Magic to Healing?}. DigitalCommons - Kennesaw State University (Kennesaw State University). [published; OpenAlex]. \href{https://digitalcommons.kennesaw.edu/undergradsymposiumksu/fall2025/fall2025/134}{source link}.
\item Mohammad Reza Mirzadeh, Khalid Moinuddin, Vasso Apostolopoulos, Caine Barlow, Jianhua Zhang (2025). \textit{Unlocking the power of tryptamine alkaloids in Psilocybe fungi: chemistry, mental health potential and legal challenges}. Mycological Progress. [published; OpenAlex]. \href{https://doi.org/10.1007/s11557-025-02106-y}{doi:10.1007/s11557-025-02106-y}.
\item Reid MR, Song J, Boehnke KF, Buchanan NT, Aday JS. (2025). \textit{Disengaged: A systematic review of community engagement in psychedelic-assisted therapy research.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neubiorev.2025.106516}{doi:10.1016/j.neubiorev.2025.106516}.
\item Teopiz KM, Le GH, Wong S, McIntyre RS. (2025). \textit{The effect of dextromethorphan on reward-related behaviors: A systematic review of preclinical and clinical evidence.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jad.2025.120836}{doi:10.1016/j.jad.2025.120836}.
\item Imperial College London (2025). \textit{Investigating the Effects of a Psychedelic-augmented Mental Imagery-based Intervention for Young People With Self-harm Behaviour: an Experimental Medicine Study}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06798636}{source link}.
\item University of British Columbia (2025). \textit{Standardized Natural Psilocybin-assisted Psychotherapy for Tapering of Opioid Medication in Patients With Chronic Pain: an Open-label Feasibility Study}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05585229}{source link}.
\item NYU Langone Health (2025). \textit{A Phase 2b, Randomized, Double-blind, Placebo-controlled, Multi-center Study of the Effects of Psilocybin-assisted Psychotherapy on Psychiatric and Existential Distress in Advanced Cancer}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05398484}{source link}.
\item Unknown authors (2025). \textit{Defining ‘psychedelic’}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/5ybhk\_v1}{source link}.
\item Samuli Kangaslampi, Max Wolff, Manoj K. Doss, Lilian Kloft, Henry Otgaar (2025). \textit{Questioning the recovery of dissociated traumatic memories under psilocybin: comment on “Therapeutic emergence of dissociated traumatic memories during psilocybin treatment for anorexia nervosa”}. Journal of Eating Disorders. [published; OpenAlex]. \href{https://doi.org/10.1186/s40337-025-01484-8}{doi:10.1186/s40337-025-01484-8}.
\item Dodds C, Dawson R, Lim A, Tye S, Nasrallah F. (2025). \textit{Novel psychedelic interventions for post-traumatic stress disorder and their promise for precision medicine.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/20451253251396255}{doi:10.1177/20451253251396255}.
\item Machado T, Rodrigues ASL, Costa J. (2025). \textit{Comment on: Effect of psilocybin therapy on suicidal ideation, attempts, and deaths in people with psychiatric diagnoses: a systematic review and meta-analysis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/20451253251397590}{doi:10.1177/20451253251397590}.
\item Spohn, Kyle (2025). \textit{Magic Mushrooms as Medicine: What the United States Can Learn from Jamaica’s Unregulated Psilocybin Industry as FDA Approval Nears}. eYLS (Yale Law School). [published; OpenAlex]. \href{https://repository.law.miami.edu/umialr/vol57/iss1/7}{source link}.
\item Morris Lintong Barimbing, Dian Pritasari Jeger, Made Edwin Sridana (2025). \textit{Efficacy of psilocybin on death anxiety in terminal patients: a narrative review}. Progress in Palliative Care. [published; OpenAlex]. \href{https://doi.org/10.1080/09699260.2026.2657096}{doi:10.1080/09699260.2026.2657096}.
\item Amin Reihani, Fatemeh Shaki (2025). \textit{Unexpected Detection of Psilocybin in a 100 mg Tramadol Tablet: A Forensic Case Report}. DOAJ (DOAJ: Directory of Open Access Journals). [published; OpenAlex]. \href{https://doi.org/10.22038/apjmt.2025.89401.1525}{doi:10.22038/apjmt.2025.89401.1525}.
\item S. Fereydouni (2025). \textit{Psilocybin and Neuroplasticity: Mechanisms, Therapeutic Potential, and Future Directions}. Emerging Trends in Drugs Addictions and Health. [published; OpenAlex]. \href{https://doi.org/10.1016/j.etdah.2025.100215}{doi:10.1016/j.etdah.2025.100215}.
\item Jones, Ariyah (2025). \textit{Taking a Trip into Nature’s Medicine Cabinet: A Country Comparison of Efforts to Reschedule Psilocybin and MDMA for Therapeutic Use}. eYLS (Yale Law School). [published; OpenAlex]. \href{https://digitalcommons.law.uga.edu/gjicl/vol53/iss2/7}{source link}.
\item Wopfner, Alexander, Soravia, Leila M. (2025). \textit{Psilocybin-assistierte Gruppenpsychotherapie bei Abhängigkeitserkrankungen}. Open Access CRIS of the University of Bern. [published; OpenAlex]. \href{https://doi.org/10.48620/92823}{doi:10.48620/92823}.
\item Philip Garrity, Alicia Danforth, Brian Anderson, Jason M. Thompson (2025). \textit{Meaning and Purpose Therapy Modified for Psilocybin (P-MaP): A Treatment Model for Palliative Care Patients}. Journal of Health Service Psychology. [published; OpenAlex]. \href{https://doi.org/10.1007/s42843-025-00145-3}{doi:10.1007/s42843-025-00145-3}.
\item Bukovsky D, Amaev A, Song J, Torres-Carmona E, Kyte S, Ueno F, Deluca V, Bowie C, Flint A, Husain I, Graff-Guerrero A, Gerretsen P. (2025). \textit{Safety, feasibility, and tolerability of psilocybin in older adults with amnestic MCI: Preliminary data from a SV2a PET imaging study}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC12740486}{source link}.
\item Madhu L, Somayaji Y, Kotian S, Attaluri S, Patel J, Panda P, Rao V, Kodali M, Shankar G, Rao S, Weintraub S, Shuai B, Rao X, Shetty A. (2025). \textit{Psilocybin Maintains Better Brain Function in an Alzheimer’s Disease Model with Reduced Neuroinflammation and Improved Hippocampal Neurogenesis}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC12739712}{source link}.
\item Buchard A, Seragnoli F, Sabe M, Eskinazi M, Aboulafia T, Furtado L, Briefer J, Roediger E, Penzenstadler L, Zullino D, Thorens G. (2025). \textit{Limited prognostic value of early maladaptive schemas for acute psychedelic experience and symptom improvement}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-8214817/v1}{doi:10.21203/rs.3.rs-8214817/v1}.
\item Aboulafia-Brakha T, Buchard A, Mabilais C, Alaux S, Amberger C, Furtado L, Seragnoli F, Briefer J, Thorens G, Sabé M, Szczesniak L, Iuga R, Zullino D, Penzenstadler L. (2025). \textit{Real-World Effectiveness and Safety of Psychedelic-Assisted Psychotherapy: Outcomes from a Large-Scale Compassionate Use Cohort in Switzerland}. medRxiv. [preprint; medRxiv]. \href{https://doi.org/10.1101/2025.12.01.25341335}{doi:10.1101/2025.12.01.25341335}.
\item Purple RJ, Gupta R, Thomas CW, Golden CT, Palomero-Gallagher N, Carhart-Harris R, Froudist-Walsh S, Jones MW. (2025). \textit{Correction: Short- and long-term modulation of rat prefrontal cortical activity following single doses of psilocybin.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41380-025-03231-6}{doi:10.1038/s41380-025-03231-6}.
\item Amanda E. Downey, Marlene Tai, Ellen Bradley, Josh Woolley (2025). \textit{Sudden Loss of Consciousness Following Psilocybin Ingestion}. American Journal of Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1176/appi.ajp.20250037}{doi:10.1176/appi.ajp.20250037}.
\item Nina Kleditzsch, James J Gattuso, Anthony J. Hannan, Thibault Renoir (2025). \textit{Acute Blockade of the Serotonin Transporter With Low Doses of Escitalopram Does Not Alter the Behavioural Responses to Acute Psilocybin}. European Journal of Neuroscience. [published; OpenAlex]. \href{https://doi.org/10.1111/ejn.70351}{doi:10.1111/ejn.70351}.
\item Nadav Liam Modlin, Victoria Williamson, Guy M. Goodwin, Ekaterina Malievskaia, Merve Atli, Zsofia Elek, Alice Gaillard, Don Koelpin, Anthony J. Cleare, Manish Agrawal, Rachel Yehuda, Namik Kirlić, James Rucker (2025). \textit{Investigational psilocybin treatment for post-traumatic stress disorder: a qualitative study of participant experience, trauma engagement, and differences from standard treatment}. EClinicalMedicine. [published; OpenAlex]. \href{https://doi.org/10.1016/j.eclinm.2025.103692}{doi:10.1016/j.eclinm.2025.103692}.
\item Tara Brach (2025). \textit{Effects of Psilocybin on Religious and Spiritual Attitudes and Behaviors in Clergy from Various Major World Religions: The Great Promise of Psychedelics: Evolving Human Consciousness}. Psychedelic Medicine. [published; OpenAlex]. \href{https://doi.org/10.1177/28314425251408081}{doi:10.1177/28314425251408081}.
\item Joseph G. Lorenz, Scott A. Hawkins, Bryan C. McCarthy (2025). \textit{Griffiths et al.’s Study of Psilocybin with Religious Professionals: A Theological Response from a Christian Perspective}. Psychedelic Medicine. [published; OpenAlex]. \href{https://doi.org/10.1177/28314425251406251}{doi:10.1177/28314425251406251}.
\item Harriet de Wit (2025). \textit{Effects of Psilocybin on Religious and Spiritual Attitudes and Behaviors in Clergy from Various Major World Religions, by Griffiths et al}. Psychedelic Medicine. [published; OpenAlex]. \href{https://doi.org/10.1177/28314425251409219}{doi:10.1177/28314425251409219}.
\item Kenneth I. Pargäment (2025). \textit{Psilocybin, Spirituality, and the Potential for Personal Transformation: Commentary on Effects of Psilocybin on Religious and Spiritual Attitudes and Behaviors in Clergy from Various Major World Religions by Griffiths et al}. Psychedelic Medicine. [published; OpenAlex]. \href{https://doi.org/10.1177/28314425251406613}{doi:10.1177/28314425251406613}.
\item University of Iowa (2025). \textit{Psilocybin vs Ketamine for Alcohol Use Disorder}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06405607}{source link}.
\item Roman Palitsky, George H. Grant (2025). \textit{Using Insights from a Study of Psilocybin with Clergy to Advance Research on Psychedelics, Spirituality, and the Sacred: Commentary on Griffiths et al. (2025)}. Psychedelic Medicine. [published; OpenAlex]. \href{https://doi.org/10.1177/28314425251393983}{doi:10.1177/28314425251393983}.
\item University College, London (2025). \textit{Digital Intervention for Psychedelic Preparation (DIPP): A Randomised Controlled Feasibility Trial Comparing Meditation and Music-Based Programs in Healthy Volunteers.}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06815653}{source link}.
\item University of Texas at Austin (2025). \textit{Assessing the Safety, Tolerability, and Efficacy of Psilocybin Therapy Followed by Accelerated Intermittent Theta Burst (aiTBS) Repetitive Transcranial Magnetic Stimulation (rTMS) for Treatment-Resistant Major Depressive Disorder}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06132178}{source link}.
\item Małgorzata Domżalska, Joanna Kwiatkowska, Iwona Cichoń, Ewa Sokołowska (2025). \textit{A comparative assessment of the antidepressant efficacy of ketamine, psilocybin, and fluoxetine in a chronic stress model}. Scientific Reports. [published; OpenAlex]. \href{https://doi.org/10.1038/s41598-025-29642-7}{doi:10.1038/s41598-025-29642-7}.
\item Jorge Ferreira (2025). \textit{Psilocybin reduces comorbid chronic pain and depression in mice}. Lab Animal. [published; OpenAlex]. \href{https://doi.org/10.1038/s41684-025-01663-9}{doi:10.1038/s41684-025-01663-9}.
\item Van Ameringen M, Patel V, Patterson B, Hopkinson P, Rahat M. (2025). \textit{New treatments for OCD? Evidence for cannabinoids and psychedelics.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jpsychires.2025.11.021}{doi:10.1016/j.jpsychires.2025.11.021}.
\item Charles S. Grob, M.D. (2025). \textit{Pragmatic Trial of Psilocybin Therapy in Palliative Care (PT2PC): A Multicenter Triple-blind Phase 2 Randomized Controlled Trial of Psilocybin Therapy for Demoralized Adults Near the End of Life}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05403086}{source link}.
\item J Pincombe, M.L. Williams, Sean Carruthers, Susan L. Rossell (2025). \textit{Qualitative Research on Psilocybin-Assisted Psychotherapy for the Treatment of Mental Disorders: A Scoping Review}. Psychedelic Medicine. [published; OpenAlex]. \href{https://doi.org/10.1177/28314425251394012}{doi:10.1177/28314425251394012}.
\item Sana Rasheed, Rida Arif, Ahmed Asad Raza, Abedin Samadi (2025). \textit{Advancing treatment paradigms: the role of psilocybin in managing major depressive disorder}. Annals of Medicine and Surgery. [published; OpenAlex]. \href{https://doi.org/10.1097/ms9.0000000000004349}{doi:10.1097/ms9.0000000000004349}.
\item Danica E. Johnson, Shakila Meshkat, Erica Kaczmarek, Jennifer S. Rabin, Ryan M. Brudner, Noah Chisamore, Zoe Doyle, Jordan Bawks, Jeremy Riva-Cambrin, Rodrigo B. Mansur, Orly Lipsitz, Roger S McIntyre, Krista L. Lanctôt, Joshua D. Rosenblat (2025). \textit{Cognitive outcomes following psilocybin-assisted therapy in treatment-resistant depression: A post-hoc analysis of a randomized, waitlist-controlled trial}. Progress in Neuro-Psychopharmacology and Biological Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.pnpbp.2025.111565}{doi:10.1016/j.pnpbp.2025.111565}.
\item Suspène J, Huet S, Berteina-Raboin S, Benyamina A, Baril P, Morisset-Lopez S, Serreau R. (2025). \textit{Psilocybin in Alcohol Use Disorder Maintains Abstinence Efficacy: A Scoping Review}. Qeios. [preprint; Europe PMC]. \href{https://doi.org/10.32388/xcfsag}{doi:10.32388/xcfsag}.
\item Holly Hepburn, Bart Ellenbroek, Jiun Youn (2025). \textit{Interactions between psilocybin, LSD, and serotonergic antidepressants: A qualitative analysis of user reports}. Psychedelics. [published; OpenAlex]. \href{https://doi.org/10.1016/j.psyche.2025.100005}{doi:10.1016/j.psyche.2025.100005}.
\item Alaina M. Jaster, Thomas M Hadlock, Belle Buzzi, Jessica L. Maltman, Gabriella Silva, Somdatta Saha, Eda Köşeli, Abby M Pondelick, Nikita Thakur, Xin Zhang, Gaoshan Li, Sandra Ledesma-Corvi, K. Moore, Hannah R. Peterson, Barbara Fujita, Alexia L. Zylko, Melissa J. Lewis, Justin L. Poklis, Matthew S. Halquist, Jennifer T. Wolstenholme, Dana E. Selley, Peter J. Hamilton, Chang Lu, M. Imad Damaj, Javier González-Maeso (2025). \textit{Sex-specific role of the 5-HT2A receptor in psilocybin-induced extinction of opioid reward}. Nature Communications. [published; OpenAlex]. \href{https://doi.org/10.1038/s41467-025-64887-w}{doi:10.1038/s41467-025-64887-w}.
\item Silvia Natoli, Arturo Cuomo, Maurizio Marchesini, Livio Luongo, Giuliano Lo Bianco, Vittorio Guardamagna, Shigeki Yamaguchi (2025). \textit{Psilocybin and Chronic Pain: A New Perspective for Future Pain Therapists?}. Medical Sciences. [published; OpenAlex]. \href{https://doi.org/10.3390/medsci13040277}{doi:10.3390/medsci13040277}.
\item University of Zurich (2025). \textit{Does Serotonin System Stimulation Increase Pro-social Behavior? - A Comparative Pharmacological Neuroscientific Study in Healthy Humans}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06081179}{source link}.
\item Beersheva Mental Health Center (2025). \textit{A Double-blind, Phase II Feasibility Study to Assess the Safety and Efficacy of Psilocybin Microdosing Combined With Psychotherapy in Treatment-resistant Depression}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07183748}{source link}.
\item Beersheva Mental Health Center (2025). \textit{Open Label, Phase 2 Study for Evaluating the Feasibility, Safety and Efficacy of Psychotherapy Assisted Psilocybin for Treatment of Severe Obsessive Compulsive Disorder (OCD) in Drug and/or Psychotherapy Resistant Patients.}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT04882839}{source link}.
\item Zhang W, Hwang SY, Luther J. (2025). \textit{Pharmacotherapy to Prevent Alcohol Relapse in Alcohol-Associated Liver Disease.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s11894-025-01026-x}{doi:10.1007/s11894-025-01026-x}.
\item Oblak, Aleš, Hudnik Korošec, Liam, Levačić, Anja, Elersič, Kristian, Pregelj, Peter, Bon, Jurij (2025). \textit{Salience, sensemaking, and setting in psilocybin microdosing}. Repository of the University of Ljubljana (University of Ljubljana). [published; OpenAlex]. \href{https://repozitorij.uni-lj.si/IzpisGradiva.php?id=176012}{source link}.
\item Peggy C Nopoulos (2025). \textit{Psilocybin-Assisted vs Ketamine-Assisted Psychotherapy for Alcohol Use Disorder}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05421065}{source link}.
\item Ioakimidis-MacDougall G, Gardner J, Liknaitzky P. (2025). \textit{Psilocybin Experiential Therapist Training: Insights from a World-First Study}. medRxiv. [preprint; medRxiv]. \href{https://doi.org/10.1101/2025.11.15.25340324}{doi:10.1101/2025.11.15.25340324}.
\item Rosal SRP, Faber SC. (2025). \textit{Standardization of Psilocybin Dosing in a Natural Product-Based Retreat Setting: A Practical Method for Dose Quantification and Adjustment Across Sessions}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-8000629/v1}{doi:10.21203/rs.3.rs-8000629/v1}.
\item Bhavaraju KP, Mason NL, Mallaroni P, Heinke D, Toennes SW, Ramaekers JG, Amico E. (2025). \textit{Unmixing the Psychedelic Connectome: Brain Network Traits of Psilocybin}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2025.11.17.688834}{doi:10.1101/2025.11.17.688834}.
\item Unknown authors (2025). \textit{Microdosing Psilocybin for Major Depressive Disorder: Study Protocol for a Phase II Double-Blind Placebo-Controlled Randomized Partial Crossover Trial}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/hmnsw\_v1}{source link}.
\item Meghan DellaCrosse, Shoval Gilead, Rafael Lancelotta, Ana María Ortiz Bernal, Christopher Timmermann, Alan K. Davis (2025). \textit{Qualitative insights into psilocybin and LSD experiences: Enhanced connection and emotion processing reported by Spanish-speaking survey respondents}. Psychedelics. [published; OpenAlex]. \href{https://doi.org/10.1016/j.psyche.2025.100004}{doi:10.1016/j.psyche.2025.100004}.
\item Presley Aspen, Presley Pham, Jennifer Mitchell (2025). \textit{Comparative Efficacy of Psilocybin and MDMA in PTSD Treatment: A Systematic Review of Long-Term Outcomes}. Berkeley Scientific Journal. [published; OpenAlex]. \href{https://doi.org/10.5070/bs329265627}{doi:10.5070/bs329265627}.
\item Marieke Martens, Bruna Giribaldi Cunha, David Erritzøe, David Nutt, Robin Carhart-Harris, Catherine J. Harmer (2025). \textit{Negative affective bias in depression following treatment with psilocybin or escitalopram - a secondary analysis from a randomized trial}. Translational Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1038/s41398-025-03693-w}{doi:10.1038/s41398-025-03693-w}.
\item Aung Phyo Oo, Sarah Tseu, Arvind Ponnusamy (2025). \textit{Acute Kidney Failure and Myocarditis Triggered by Magic Mushroom Toxicity in a Patient With Prior Cocaine Exposure}. Cureus. [published; OpenAlex]. \href{https://doi.org/10.7759/cureus.96718}{doi:10.7759/cureus.96718}.
\item Sian Lewis (2025). \textit{‘Magic’ mechanisms underlie psilocybin’s effects in chronic pain}. Nature reviews. Neuroscience. [published; OpenAlex]. \href{https://doi.org/10.1038/s41583-025-00999-y}{doi:10.1038/s41583-025-00999-y}.
\item Max Wolff, Samuli Kangaslampi (2025). \textit{Pharmacodynamic biomarker - or psychotherapeutic process? Comment on “The role of the psychedelic experience in psilocybin treatment for treatment-resistant depression”}. Journal of Affective Disorders. [published; OpenAlex]. \href{https://doi.org/10.1016/j.jad.2025.120637}{doi:10.1016/j.jad.2025.120637}.
\item Luisina Rodríguez (12333694), Guillermo Morera (22593717), Sandra Lupo (22593720), Danilo Davyt (2738347), Ignacio Carrera (1677175), Gonzalo Hernández Dossi (22593723) (2025). \textit{Novel qNMR Methodto Quantify Psilocybin and Psilocinin Psychedelic Mushrooms}. Figshare. [published; OpenAlex]. \href{https://doi.org/10.1021/acsomega.5c07092.s001}{doi:10.1021/acsomega.5c07092.s001}.
\item Luisina Castelli Rodríguez, Guillermo Morera, Sandra Lupo, Danilo Davyt, Ignacio Carrera, Gonzalo Hernández Dossi (2025). \textit{Novel qNMR Method to Quantify Psilocybin and Psilocin in Psychedelic Mushrooms}. ACS Omega. [published; OpenAlex]. \href{https://doi.org/10.1021/acsomega.5c07092}{doi:10.1021/acsomega.5c07092}.
\item Sarah N. Magee, Allison C. Sereno, Maria Echeveste-Sanchez, Elizabeth G. Shannon, Abir Mohsin, Sarah E. Mott, Sara Faccidomo, Clyde W. Hodge, Melissa A. Herman (2025). \textit{The Psychedelic Psilocin Suppresses Activity of Central Amygdala Corticotropin-Releasing Factor Receptor 1 Neurons and Decreases Ethanol Drinking in Female Mice}. Journal of Neuroscience. [published; OpenAlex]. \href{https://doi.org/10.1523/jneurosci.0652-25.2025}{doi:10.1523/jneurosci.0652-25.2025}.
\item Renner AC, Kargbo RB. (2025). \textit{Engineering the Next Generation of Psychedelic Therapeutics through Serotonergic Precision and Pharmacokinetic Control.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/acsmedchemlett.5c00661}{doi:10.1021/acsmedchemlett.5c00661}.
\item Zech JM, Richard J, Jones GM (2025). \textit{The Relationship Between Psychedelic Use and Alcohol Use Disorder in a Nationally Representative Sample.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2025.2583967}{doi:10.1080/02791072.2025.2583967}.
\item Allohverdi SG, Soltanzadeh M, Schmidt A, Charlton CE, Hauke DJ, Karvelis P, Vollenweider FX, Diaconescu AO. (2025). \textit{Ketamine and Psilocybin Differentially Impact Sensory Learning During the Mismatch Negativity}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2025.11.06.687023}{doi:10.1101/2025.11.06.687023}.
\item Højlund M, Kafali HY, Kırmızı B, Fusar-Poli P, Correll CU, Cortese S, Sabé M, Fiedorowicz J, Saraf G, Zein J, Berk M, Husain MI, Rosenblat JD, Rubaiyat R, Corace K, Wong S, Hatcher S, Kaluzienski M, Yatham LN, Cipriani A, Gosling CJ, Carhart-Harris R, Tanuseputro P, Myran DT, Fabiano N, Moher D, Mayo LM, Nicholls SG, White T, Prisco M, Radua J, Vieta E, Ladha KS, Katz J, Veroniki AA, Solmi M. (2025). \textit{Efficacy, all-cause discontinuation, and safety of serotonergic psychedelics and MDMA to treat mental disorders: A living systematic review with meta-analysis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.euroneuro.2025.09.011}{doi:10.1016/j.euroneuro.2025.09.011}.
\item AccessScience Editors (2025). \textit{A single dose of psilocybin alleviates chronic pain and associated anxiety and depression in mice}. Unknown journal. [published; OpenAlex]. \href{https://doi.org/10.1036/1097-8542.br2511031}{doi:10.1036/1097-8542.br2511031}.
\item Fadahunsi N, Lund J, Breum AW, Mathiesen CV, Larsen IB, Knudsen GM, Klein AB, Clemmensen C. (2025). \textit{Correction: Acute and long-term effects of psilocybin on energy balance and feeding behavior in mice.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41398-025-03729-1}{doi:10.1038/s41398-025-03729-1}.
\item Milad Soltanzadeh, Zheng Wang, Shona G. Allohverdi, Colleen E. Charlton, André Schmidt, Franz Xaver Vollenweider, Andreea O. Diaconescu (2025). \textit{Divergent effects of ketamine and psilocybin on EEG power spectral density in a mismatch negativity paradigm}. Universität Zürich, ZORA. [published; OpenAlex]. \href{https://doi.org/10.5167/uzh-292276}{doi:10.5167/uzh-292276}.
\item Yale University (2025). \textit{Psilocybin - Induced Neuroplasticity in the Treatment of Major Depressive Disorder}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT03554174}{source link}.
\item University of Washington (2025). \textit{A Phase 1/2 Study of a Group Model of Psilocybin-Assisted Therapy for Cancer-Related Anxiety in Patients With Metastatic Cancer}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05847686}{source link}.
\item Mennenga S, Hanson T, Semple M, Lifshitz D, Flores B, Balducci J, Harker S, Ford A, Lewis C. (2025). \textit{Psilocybin reduces depressive-like behavior and improves cognition in healthy aging mice via epigenetic regulation of plasticity- and immune-related genes}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-7890051/v1}{doi:10.21203/rs.3.rs-7890051/v1}.
\item Jevotovsky DS, Chopra H, Pak DJ, Durbhakula S, Shustorovich A, Juneja T, Broachwala MY, AlFarra T, Silver C, Kreitzer G, Oreoluwa P, Weissman BB, AlFarra A, Mayrsohn BG, Orhurhu V, Emerick T, Furnish T, Castellanos JP. (2025). \textit{Psilocybin and chronic neuropathic pain: a systematic review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1136/rapm-2024-105532}{doi:10.1136/rapm-2024-105532}.
\item Kent E. Hutchison, Jake F. Hooper, Hollis C. Karoly (2025). \textit{Psilocybin Outside the Clinic}. JAMA Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1001/jamapsychiatry.2025.3038}{doi:10.1001/jamapsychiatry.2025.3038}.
\item Cui Guo, Nguyen N T Luu, Maryem M Adwer, Hamed Hosseinzadeh, Venkatesh Balan, Yajun Yan, Yuheng Lin (2025). \textit{Engineering artificial biosynthetic pathways for efficient microbial production of psilocybin and psilocin}. Metabolic Engineering. [published; OpenAlex]. \href{https://doi.org/10.1016/j.ymben.2025.11.002}{doi:10.1016/j.ymben.2025.11.002}.
\item Josh Allen, Mujun Sun, Tamara L. Baker, Shannon Dames, Pamela Kryskow, Brian R. Christie, Stuart J. McDonald, Sandy R. Shultz (2025). \textit{Psilocybin mitigates chronic behavioral and neurobiological alterations in a rat model of recurrent intimate partner violence-related brain injury}. Molecular Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1038/s41380-025-03329-x}{doi:10.1038/s41380-025-03329-x}.
\item Chiranth Bhagavan, Alexander Bryson, Olivia Carter, Glenn Nielsen, David J. Berlowitz, Sara Issak, Sabine Braat, Sophie Zaloumis, Zachary Attard, Dina Eleftheriadis, Georgina Oliver, Deanne Mayne, Greg Roebuck, James Rucker, Matthew Butler, Richard Kanaan (2025). \textit{Psilocybin-assisted physiotherapy for refractory motor functional neurological disorder: protocol for a randomised dose-comparison pilot study}. Acta Neuropsychiatrica. [published; OpenAlex]. \href{https://doi.org/10.1017/neu.2025.10042}{doi:10.1017/neu.2025.10042}.
\item Srivastava AB, Gold MS (2025). \textit{A Tragedy of Errors: The State of Psychedelic Research in the Treatment of Alcohol Use Disorder.}. Brain sciences. [published; PubMed]. \href{https://doi.org/10.3390/brainsci15111190}{doi:10.3390/brainsci15111190}.
\item Yvan Beaussant, Zachary Sager, Caitlin W. Brennan, Isabel Kristan, Michael Ljuslin, Emanuele Mazzola, David R. Macdonald, M. Murphy, Kabir Nigam, Alden Doerner Rinaldi, Justin J. Sanders, Kristen G. Schaefer, Roxanne Sholevar, Lisa Summer, Alifia Waliji-Banglawala, Sandra Yudilevich-Espinoza, James A. Tulsky (2025). \textit{Psilocybin-assisted therapy for demoralisation in hospice patients: feasibility, safety and preliminary efficacy}. BMJ Supportive \& Palliative Care. [published; OpenAlex]. \href{https://doi.org/10.1136/spcare-2025-005773}{doi:10.1136/spcare-2025-005773}.
\item Faith Ekoh, Shanice Rerrie, James Angud, Ersilia Mirabelli (2025). \textit{Hormonal Influences on Psilocybin Responsivity Across the Female Lifespan: Toward Personalized Psychedelic-Assisted Therapy}. Psychoactives. [published; OpenAlex]. \href{https://doi.org/10.3390/psychoactives4040039}{doi:10.3390/psychoactives4040039}.
\item Luisa Prochazkova, Josephine Marschall, Michiel van Elk, Ben David Rifkin, Neil R Schon, Donatella Fiacchino, George Fejer, Martin Kuchař, Bernhard Hommel (2025). \textit{Microdosing psilocybin and its effect on creativity: Lessons learned from three double-blind placebo controlled longitudinal trials}. Neuropharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/j.neuropharm.2025.110732}{doi:10.1016/j.neuropharm.2025.110732}.
\item Unknown authors (2025). \textit{Lifetime Psychedelic Use and Opioid Use Disorder Severity: Substance-Use Pattern Specific and Mental Health-Dependent Associations in a National Survey}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.1016/j.addbeh.2026.108652}{doi:10.1016/j.addbeh.2026.108652}.
\item Tyler D. McGehee, Nicole Lacap, Adeel Iqbal, Alan M. Langlieb (2025). \textit{92. Mushrooms and Mania: Differentiating Psilocybin-Induced Mania From First-Break Bipolar Mania}. Journal of the Academy of Consultation-Liaison Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.jaclp.2025.10.094}{doi:10.1016/j.jaclp.2025.10.094}.
\item Richard Drexler, Belgin Yalçın, Rebecca Mancusi, Abigail Rogers, Kiarash Shamardani, Pamelyn J. Woo, Alexandre Ravel, Yahaya A Yabo, Carlos Alberto Oliveira de Biagi-Junior, Costanza Lo Cascio, Robert C. Malenka, Boris D. Heifets, Mariella G. Filbin, Dieter Henrik Heiland, Karl Deisseroth, Michelle Monje (2025). \textit{CNSC-36. PSILOCYBIN INDUCES SUSTAINED GLIOMA GROWTH THROUGH SEROTONERGIC AND TRKB PATHWAYS}. Neuro-Oncology. [published; OpenAlex]. \href{https://doi.org/10.1093/neuonc/noaf201.0244}{doi:10.1093/neuonc/noaf201.0244}.
\item Unknown authors (2025). \textit{Psilocybin bei Alkoholkonsumstörung}. Suchttherapie. [published; OpenAlex]. \href{https://doi.org/10.1055/a-2702-9616}{doi:10.1055/a-2702-9616}.
\item Unknown authors (2025). \textit{Metaanalyse: Wirksamkeit und Sicherheit von Psilocybin bei Major Depressionen}. Fortschritte der Neurologie · Psychiatrie. [published; OpenAlex]. \href{https://doi.org/10.1055/a-2576-6069}{doi:10.1055/a-2576-6069}.
\item Thomas Zandonai, Sofia Venturini, Ornella Corazza (2025). \textit{Ketamine and psilocybin for athletes: A therapeutic breakthrough or a slippery slope?}. Performance Enhancement \& Health. [published; OpenAlex]. \href{https://doi.org/10.1016/j.peh.2025.100386}{doi:10.1016/j.peh.2025.100386}.
\item Moujaes F, Rieser NM, Belinger L, Herdener M, Zahid Z, Preller KH (2025). \textit{The emotional architecture of the psychedelic brain.}. Trends in cognitive sciences. [published; PubMed]. \href{https://doi.org/10.1016/j.tics.2025.07.006}{doi:10.1016/j.tics.2025.07.006}.
\item Rahmani S, Crupi R, Riley AL, Davidson T (2025). \textit{The therapeutic use of psychedelic drugs: Legal, policy, and neuroscientific perspectives.}. Pharmacology, biochemistry, and behavior. [published; PubMed]. \href{https://doi.org/10.1016/j.pbb.2025.174087}{doi:10.1016/j.pbb.2025.174087}.
\item Jonathon Marinis, Sarah Clarke, Alexandre A. Guerin, Adam J. Guastella, Gillinder Bedi (2025). \textit{Reporting of side-effects in clinical trials of psilocybin-assisted psychotherapy for psychiatric conditions: systematic review}. BJPsych Open. [published; OpenAlex]. \href{https://doi.org/10.1192/bjo.2025.10847}{doi:10.1192/bjo.2025.10847}.
\item Luo W, Dai Q, van Beek TA, Zuilhof H, Chen B, Chen Z, Salentijn GI. (2025). \textit{Paper spray and direct mushroom spray mass spectrometry methods for the analysis of psycho-neurological disorder toxins}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/AGR/IND609225828}{source link}.
\item André Leão Dantas, Lara Moreira Jalles Milani, Saulo Gabriel Moreira Falci, João Américo da Silveira, Cristina Pereira Isolan, Lia Dietrich (2025). \textit{Use of psilocybin for chronic pain: a scoping review with current evidence and prospection of literature and technology for future applications}. Caderno Pedagógico. [published; OpenAlex]. \href{https://doi.org/10.54033/cadpedv22n12-345}{doi:10.54033/cadpedv22n12-345}.
\item Washington University School of Medicine (2025). \textit{Precision Functional Brain Mapping to Understand the Mechanisms of Psilocybin}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT04501653}{source link}.
\item d'Andrea G, Chiappini S, Ciavoni L, Tucci R, Martino F, Semeraro FM, Di Battista D, Mosca A, Miuli A, Di Carlo F, Russo M, Di Petta G, Fornaro M, Pettorruso M, Sensi SL, Martinotti G. (2025). \textit{Psychedelics and ketamine/esketamine in depressive disorders: biological mechanisms and associated neuroimaging and clinical changes.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41398-025-03654-3}{doi:10.1038/s41398-025-03654-3}.
\item Do A, Cloutier L, Hébert-Tremblay L, Thauvin C. (2025). \textit{Psilocybin use in bipolar disorder: A comprehensive review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jad.2025.120485}{doi:10.1016/j.jad.2025.120485}.
\item Ohio State University (2025). \textit{A Randomized, Double-Blind, Placebo-Controlled Mechanistic Study to Assess a Single Oral Dose of CYB003 in Participants With Major Depressive Disorder (MDD) and Moderate to Severe Anxiety}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06820723}{source link}.
\item Rubén García-Cabrerizo, Itziar Beruete-Fresnillo, Pedro Bergas-Cladera, M. Julia García-Fuster (2025). \textit{Psilocybin as a fast-acting and long-lasting antidepressant for adolescence: Proposing NeuroD1 as a biomarker of its long-term plasticity}. Biomedicine \& Pharmacotherapy. [published; OpenAlex]. \href{https://doi.org/10.1016/j.biopha.2025.118720}{doi:10.1016/j.biopha.2025.118720}.
\item Anna Rose Childress, Ph.D. (2025). \textit{A Wellcome Leap for the Opioid Crisis: Can the 5HT2A Agonist Psilocybin Improve Brain, Behavioral, and Clinical Outcomes in Opioid Use Disorder (OUD)?}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06786325}{source link}.
\item James J Gattuso, Bilgenur Bezcioglu, Carey Wilson, Kato Havaux, Anthony J. Hannan, Thibault Renoir (2025). \textit{Psilocybin's effects on obsessive-compulsive behaviors: A systematic review of preclinical and clinical evidence}. Psychedelics.. [published; OpenAlex]. \href{https://doi.org/10.61373/pp025i.0044}{doi:10.61373/pp025i.0044}.
\item Candice Richardson, Cindy Chan, Emily Macgregor, Crystal Hare, Breffni Hannon, SarahRose Black, Evan E. Schneider, Daniel Z. Buchman, Stella Wang, Valeria E. Rac, Lusine Abrahamyan, Ella Huszti, Rinat Nissim, Madeline Li, Camilla Zimmermann, Emma Hapke, Daniel M. Rosenbaum, Sarah Hales (2025). \textit{Psilocybin-assisted Existential, Attachment and RelationaL (PEARL) therapy for patients with advanced cancer: protocol for a multi-method feasibility trial}. Pilot and Feasibility Studies. [published; OpenAlex]. \href{https://doi.org/10.1186/s40814-025-01706-5}{doi:10.1186/s40814-025-01706-5}.
\item Keighley EE, Abo Hamza E, Bedewy DA, Nalla S, Moustafa AA. (2025). \textit{A Systematic Review and Meta-Analysis Investigating the Efficacy of Various Psychedelic Drugs for the Treatment of Substance Use Disorder.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/healthcare13212668}{doi:10.3390/healthcare13212668}.
\item Bukovsky D, Amaev A, Song J, Kyte S, Carmona-Torres E, Ueno F, Deluca V, Strafella AP, Husain MI, Graff-Guerrero A, Gerretsen P. (2025). \textit{Adverse event reporting and management in psilocybin therapy clinical trials: A systematic review to guide clinical and research protocol development.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.pnpbp.2025.111541}{doi:10.1016/j.pnpbp.2025.111541}.
\item Sabnis RW. (2025). \textit{Novel Psilocin Derivatives as Serotonergic Psychedelic Agents for Treating CNS Disorders.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/acsmedchemlett.5c00608}{doi:10.1021/acsmedchemlett.5c00608}.
\item University of California, Berkeley (2025). \textit{Investigating the Persisting Effects of a Single Dose of Psilocybin on Structural Plasticity in Healthy Older Adults}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06367738}{source link}.
\item University of California, Berkeley (2025). \textit{Investigating the Mechanisms of the Effects of Psilocybin on Visual Perception and Visual Representations in the Brain}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05265546}{source link}.
\item Uyar A, Forbrich L, Lueken U, Evens R. (2025). \textit{Landscape analysis of pre-registered clinical trials involving classical psychedelics.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811251371690}{doi:10.1177/02698811251371690}.
\item special to C EN Mara Johnson-Groh (2025). \textit{Is there more to magic mushrooms than psilocybin?}. C\&EN Global Enterprise. [published; OpenAlex]. \href{https://doi.org/10.1021/cen-10322-feature2}{doi:10.1021/cen-10322-feature2}.
\item Martin HM, Cofre R, Destexhe A. (2025). \textit{Simulated 5-HT2A receptor activation accounts for the high complexity of brain activity during psychedelic states}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2025.10.20.683366}{doi:10.1101/2025.10.20.683366}.
\item de Oliveira AL, de Oliveira DP, Dos Santos RG, Hallak JEC. (2025). \textit{Psychedelic-induced behavioral and developmental effects on zebrafish: a systematic review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.pnpbp.2025.111534}{doi:10.1016/j.pnpbp.2025.111534}.
\item Suspene J, Huet S, Berteina-Raboin S, Benyamina A, Baril P, Morisset-Lopez S, Serreau R. (2025). \textit{Psilocybin in Alcohol Use Disorder Maintains Abstinence Efficacity: A Scoping Review}. Preprints.org. [preprint; Europe PMC]. \href{https://doi.org/10.20944/preprints202510.1355.v1}{doi:10.20944/preprints202510.1355.v1}.
\item Vale LN, Ibrahim M, Fávaro-Pereira L, Soares JC, Meyer TD. (2025). \textit{Contemplating versus having used psychedelics in bipolar disorder - What makes the difference?}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jad.2025.120437}{doi:10.1016/j.jad.2025.120437}.
\item Luisa Prochazkova, Josephine Marschall, Dominique P. Lippelt, Neil R Schon, Martin Kuchař, Bernhard Hommel (2025). \textit{Cognitive and subjective effects of psilocybin microdosing: Results from two double-blind placebo-controlled longitudinal trials}. Neuropharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/j.neuropharm.2025.110722}{doi:10.1016/j.neuropharm.2025.110722}.
\item Wong S, Jones BDM, Thiyagarajah MT, Sabbah SG, Thompson C, Solmi M, Umer M, Zrenner C, Voineskos D, Rosenblat JD, Mulsant BH, Blumberger DM, Husain MI. (2025). \textit{Biological markers of treatment response to serotonergic psychedelic therapies: a systematic review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/20451253251384513}{doi:10.1177/20451253251384513}.
\item Douglas B. Craig (2025). \textit{Analysis of Serotonin in Caenorhabditis Elegans Subjected to Micro-Dosing with Psilocybin| Iris Publishers}. Insights in Chemistry and Biochemistry. [published; OpenAlex]. \href{https://doi.org/10.33552/icbc.2025.03.000562}{doi:10.33552/icbc.2025.03.000562}.
\item University of Wisconsin, Madison (2025). \textit{Phase I Study of the Safety and Adjunctive Effects of Psilocybin in Adults With Opioid Use Disorder Maintained on a Buprenorphine/Naloxone Formulation}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT04161066}{source link}.
\item Shadani S, Greaves E, Andrews ZB, Foldi CJ. (2025). \textit{Psilocybin exerts differential effects on social behaviour and inflammation in mice in contexts of activity-based anorexia (ABA)}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2025.10.14.682467}{doi:10.1101/2025.10.14.682467}.
\item University of Washington (2025). \textit{A Phase 1 Study of a Second Psilocybin Group Retreat for Partial Responders With Anxiety Associated With Metastatic Cancer}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06644170}{source link}.
\item Johns Hopkins University (2025). \textit{Psilocybin and Affective Function in Chronic Lower Back Pain Depression}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06355414}{source link}.
\item Kolbman N, Huels ER, Nelson A, Summerfield R, Byraju K, Groenhout T, Liu T, Hudetz AG, Vanini G, Pal D. (2025). \textit{Intravenous Administration of Serotonergic Psychedelics Produce Short-lasting Changes in Sleep-Wake Behavior and High Gamma Functional Connectivity in Rats}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2025.10.12.681880}{doi:10.1101/2025.10.12.681880}.
\item Padawer-Curry JA, Krentzman OJ, Kuo CC, Wang X, Bice AR, Nicol GE, Snyder AZ, Siegel JS, McCall JG, Bauer AQ. (2025). \textit{Psychedelic 5-HT2A receptor agonism alters neurovascular coupling and differentially affects neuronal and hemodynamic measures of brain function.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41593-025-02069-z}{doi:10.1038/s41593-025-02069-z}.
\item St Pierre M, Argento E, Cates J, Kryskow P, Harvey K, Stamets P, Santos-Brault E, Paschall SA, Kuypers KPC, Rootman J, Walsh Z (2025). \textit{Daily self-assessment within a regimen of microdosing indicates enhanced psychological functioning on microdosing days relative to non-microdosing days.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-025-06913-9}{doi:10.1007/s00213-025-06913-9}.
\item Yvan Beaussant, Elise C. Tarbi, Kabir Nigam, Skye A. Miner, Zachary Sager, Justin J. Sanders, Michael Ljuslin, Benjamin Guérin, Roxanne Sholevar, Kimberly Roddy, James A. Tulsky, Manish Agrawal (2025). \textit{Set and setting in psilocybin-assisted therapy: A qualitative study of patients with cancer and depression}. General Hospital Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.genhosppsych.2025.10.010}{doi:10.1016/j.genhosppsych.2025.10.010}.
\item Unknown authors (2025). \textit{Control group improvement lower in psilocybin trials for depression}. The Brown University Psychopharmacology Update. [published; OpenAlex]. \href{https://doi.org/10.1002/pu.31371}{doi:10.1002/pu.31371}.
\item Oregon Health and Science University (2025). \textit{Psilocybin for Chronic Pelvic Pain (CPP) in Women: A Pilot Feasibility Study}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06988319}{source link}.
\item Johansen A, Plavén-Sigray P, Madsen MK, Søndergaard A, Messel C, Geisler M, Nasser A, McCulloch DE, Beliveau V, Vassilieva A, Lund A, Lehel S, Ozenne B, Stenbæk DS, Fisher PM, Svarer C, Knudsen GM. (2025). \textit{Psilocybin’s effect on human brain synaptic plasticity}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-7469144/v1}{doi:10.21203/rs.3.rs-7469144/v1}.
\item Moskovitz M (2025). \textit{The Research Deficit and Expert Disagreement Regarding Music Selection for Psychedelic Assisted Therapy.}. ACS pharmacology \& translational science. [published; PubMed]. \href{https://doi.org/10.1021/acsptsci.5c00583}{doi:10.1021/acsptsci.5c00583}.
\item Renner AC, Kargbo RB. (2025). \textit{Stabilizing Psilocybin Pharmacology and Tuning Safety with Atypical Antipsychotic Cotherapy.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/acsmedchemlett.5c00595}{doi:10.1021/acsmedchemlett.5c00595}.
\item Goodwin GM, Aaronson ST, Alvarez O, Carhart-Harris R, Chai-Rees J, Croal M, DeBattista C, Dunlop BW, Feifel D, Hellerstein DJ, Husain MI, Kelly JR, Kirlic N, Licht RW, Marwood L, Meyer TD, Mistry S, Nowakowska A, Páleníček T, Repantis D, Schoevers RA, Simmons H, Somers M, Teoh E, Tsai J, Wahba M, Williams S, Young AH, Young MB, Zisook S, Malievskaia E. (2025). \textit{Corrigendum to "The role of the psychedelic experience in psilocybin treatment for treatment-resistant depression" [Journal of Affective Disorders, Volume 372 (2025), Pages 523-532].}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jad.2025.120352}{doi:10.1016/j.jad.2025.120352}.
\item Renner AC, Kargbo RB. (2025). \textit{Toward Precision Psychedelic Therapies: Chemical, Computational, and Neuromodulatory Innovations.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/acsmedchemlett.5c00597}{doi:10.1021/acsmedchemlett.5c00597}.
\item Mallaroni P, Mason NL, Preller KH, Razi A, Ereira S, Ramaekers JG. (2025). \textit{Neurocomputational evidence of sustained Self-Other mergence after psychedelics}. medRxiv. [preprint; medRxiv]. \href{https://doi.org/10.1101/2025.10.07.25337510}{doi:10.1101/2025.10.07.25337510}.
\item Brown KA, Ajibola MI, Medeiros GC, Gould TD. (2025). \textit{Synaptic priming: A framework for pharmacotherapy in depression.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neuron.2025.09.010}{doi:10.1016/j.neuron.2025.09.010}.
\item Kevin Murnane (2025). \textit{A Pilot Study in North Louisiana to Assess the Tolerability of Psilocybin as Well as Its Capacity to Promote Abstinence From Methamphetamine}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06899594}{source link}.
\item Centre Hospitalier St Anne (2025). \textit{Efficacy of Psilocybin and Trazodone Combination in Treatment-resistant Depression: a Randomized Controlled Proof-of-concept Study (PSILOTRAZ)}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07210112}{source link}.
\item Domzalska M, Kwiatkowska J, Cichon I, Sokolowska E. (2025). \textit{Towards Novel Antidepressant Strategies: A Comparative Study of Ketamine, Psilocybin, and Fluoxetine in a Chronic Stress Model}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-7269356/v1}{doi:10.21203/rs.3.rs-7269356/v1}.
\item M Loganathan, A Saravanakumar, P. Parthiban, G Anandharaj, S Gobika, D Dharshana, Mohamed Safir Ali (2025). \textit{Neurobiological and Therapeutic Potential of Psilocybin in Psychiatric Disorders}. Journal of Pharma Insights and Research.. [published; OpenAlex]. \href{https://doi.org/10.69613/thv1dn30}{doi:10.69613/thv1dn30}.
\item Dutton C, North E, Chun Tie Y, Oliva J, Skeffington P (2025). \textit{Harm reduction practises for users of psychedelic drugs: a scoping review.}. Harm reduction journal. [published; PubMed]. \href{https://doi.org/10.1186/s12954-025-01264-2}{doi:10.1186/s12954-025-01264-2}.
\item Bodhi Norton (2025). \textit{An Evaluation of Therapeutic Harm Reduction and Psilocybin-Assisted Therapy Within Oregon's Measure 109}. PDXScholar (Portland State University). [published; OpenAlex]. \href{https://pdxscholar.library.pdx.edu/open\_access\_etds/6963}{source link}.
\item Mohamad Chweikh (2025). \textit{Legal and Regulatory Barriers to Medical Psilocybin Use: An International Overview}. Unknown journal. [published; OpenAlex]. \href{https://doi.org/10.31219/osf.io/dy5cu\_v1}{doi:10.31219/osf.io/dy5cu\_v1}.
\item University Hospital, Geneva (2025). \textit{Retrospective Observational Study of Intensity Effects in Psychedelic-assisted Treatment}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07164287}{source link}.
\item Ahmad Hammo, Stephen Wisser, Joseph Cichon (2025). \textit{Single-dose psilocybin rapidly and sustainably relieves allodynia and anxiodepressive-like behaviors in mouse models of chronic pain}. Nature Neuroscience. [published; OpenAlex]. \href{https://doi.org/10.1038/s41593-025-02068-0}{doi:10.1038/s41593-025-02068-0}.
\item Rupika Delgoda, Kimberley Foster, Isaac Morrison, Marshall Tyler, William Irvine, Lavonne Wilson, Babumon M. Thankappan, Shemar Daniel (2025). \textit{Understanding psilocybin mushrooms and aiding in setting standards for a burgeoning industry in Jamaica}. Phytochemistry Letters. [published; OpenAlex]. \href{https://doi.org/10.1016/j.phytol.2025.103139}{doi:10.1016/j.phytol.2025.103139}.
\item Kangaslampi S, Lietz M (2025). \textit{Psychedelics and autobiographical memory - six open questions.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-025-06771-5}{doi:10.1007/s00213-025-06771-5}.
\item Johns Hopkins University (2025). \textit{Psilocybin and MDMA for Post-traumatic Stress Disorder (PTSD)}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06989957}{source link}.
\item Courtney Y, Anderson JM, Lagares-Linares C, Wenthur CJ, Lehtinen MK. (2025). \textit{Gestational LSD exposure in mouse rapidly reaches embryonic CSF and is associated with altered choroid plexus signaling, cerebral cortical development, and offspring behavior}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2025.09.30.677638}{doi:10.1101/2025.09.30.677638}.
\item Borgogna NC, Owen T, Petrovitch D, Vaughn J, Johnson DAL, Pagano LA, Aita SL, Hill BD. (2025). \textit{Correction to: Incremental efficacy systematic review and meta-analysis of psilocybin-for-depression RCTs.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s00213-025-06818-7}{doi:10.1007/s00213-025-06818-7}.
\item Rajwani K, Jacobs E, Bruce L, Hokanson J, Almonte MT, Feroz F, Waldman E, Cheung K, Levy N, Savulescu J, Singh I, Yaden DB, Earp BD. (2025). \textit{Clinical psychedelic research in adolescents: a scoping review and overview of ethical considerations.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/s2352-4642(25)00208-1}{doi:10.1016/s2352-4642(25)00208-1}.
\item Shao LX, Liao C, Davoudian PA, Savalia NK, Jiang Q, Wojtasiewicz C, Tan D, Nothnagel JD, Liu RJ, Woodburn SC, Bilash OM, Kim H, Che A, Kwan AC (2025). \textit{Publisher Correction: Psilocybin's lasting action requires pyramidal cell types and 5-HT2A receptors.}. Nature. [published; PubMed]. \href{https://doi.org/10.1038/s41586-025-09671-y}{doi:10.1038/s41586-025-09671-y}.
\item Brandon Richardson, Antonio Inserra, Michael Pileggi, Thomas Prudhomme, Vítor Bruno, Derek Wan-Yan-Chan, Ilia Shareghi-Ghahreman, Sofia Nasini, Tadhg Strand, Marco Leyton, Nahum Sonenberg, Danilo De Gregorio, Jeffrey Sprouse, Francis Rodriguez Bambico, Gabriella Gobbi (2025). \textit{Differential effects of psilocybin and lisuride on serotonin and dopamine neuronal activity and behavior}. Progress in Neuro-Psychopharmacology and Biological Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.pnpbp.2025.111522}{doi:10.1016/j.pnpbp.2025.111522}.
\item Cassandra J. Hatzipantelis, Min Liu, A. H. G. Love, Sadie J. Leventhal, Hero Maera, Srinidhi Viswanathan, Emily Avetisyan, Liana Belinsky, McKenna M. Rangel, Nina J. Jain, Max Kelly, C. Copeland, Yara A. Khatib, Oliver Fiehn, David E. Olson, Danielle S. Stolzenberg (2025). \textit{Psilocybin during the postpartum period induces long-lasting adverse effects in both mothers and offspring}. Nature Communications. [published; OpenAlex]. \href{https://doi.org/10.1038/s41467-025-64371-5}{doi:10.1038/s41467-025-64371-5}.
\item Du X, Liu J, Wang X, Wang X. (2025). \textit{The transformational power of psychedelics: catalysts for creativity, consciousness, and mental health.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41380-025-03291-8}{doi:10.1038/s41380-025-03291-8}.
\item Caporuscio C, Poppe C, Gieselmann A, Repantis D. (2025). \textit{Ethical issues with psychedelic-assisted treatments in psychiatry: A systematic scoping review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1017/s0033291725101761}{doi:10.1017/s0033291725101761}.
\item University of Southern California (2025). \textit{An Exploratory Study of Feasibility, Efficacy, and Mechanisms of Mindfulness-Assisted Psychedelic Therapy}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06233344}{source link}.
\item Unknown authors (2025). \textit{“So many relationships in the room”: Participant perspectives on the affordances and challenges of co-therapy in psychedelic assisted therapy}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/4cn5r\_v1}{source link}.
\item Greguš D, Hlinka J, Tylš F, Viktorin V, Viktorinová M, Bravermanová A, Androvičová R, Andrashko V, Korčák J, Nikolič M, Adámek P, Beneš M, Páleníček T, Horáček J. (2025). \textit{Regional Specificity of the Cingulate Cortex Thickness Association with the Intensity of Psilocybin Experience: A Replication Study}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-7544401/v1}{doi:10.21203/rs.3.rs-7544401/v1}.
\item Saadet Inan, Paige E. Morris, Scott M. Rawls, Stephanie E. Daws (2025). \textit{Psilocybin inhibits formalin-induced nociception through 5-hydroxytryptamine 2A receptor in rats}. Behavioural Pharmacology. [published; OpenAlex]. \href{https://doi.org/10.1097/fbp.0000000000000856}{doi:10.1097/fbp.0000000000000856}.
\item Healing Advocacy Fund (2025). \textit{Observational Pilot Study to Explore the Social and Health Impacts of a New Model of Care in Oregon: Psilocybin Services on Alcoholism}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07189988}{source link}.
\item Keshen A, Touyz S, Lacroix E, Hay P, McElroy SL. (2025). \textit{Innovative Pharmacological Approaches to Eating Disorder Treatment.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.psc.2025.08.014}{doi:10.1016/j.psc.2025.08.014}.
\item Dorczok MC, Mittmann G, Ettl T, Steiner-Hofbauer V. (2025). \textit{Psilocybin-assisted psychotherapy in adults with depression - A literature review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.pnpbp.2025.111508}{doi:10.1016/j.pnpbp.2025.111508}.
\item Hosein MM, Reid MJ, Walser S, Charney S, Fonzo GA, Lewis BR, Yaden DB, Suppes T, Cordner ZA, Barrett FS. (2025). \textit{Considerations and cautions for the integration of psilocybin into routine clinical care: a consensus statement from the US National Network of Depression Centers' Task Group on Psychedelics and Related Compounds.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.eclinm.2025.103517}{doi:10.1016/j.eclinm.2025.103517}.
\item Gerhard Gründer, Lea J. Mertens, Andrea Jungaberle, Henrik Jungaberle, Moritz Spangemacher (2025). \textit{Compassionate use of psilocybin for treatment-resistant depression in Germany}. The Lancet Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/s2215-0366(25)00277-9}{doi:10.1016/s2215-0366(25)00277-9}.
\item Hunt T. (2025). \textit{Electrodynamics of the Psychedelic Experience}. Preprints.org. [preprint; Europe PMC]. \href{https://doi.org/10.20944/preprints202509.1813.v1}{doi:10.20944/preprints202509.1813.v1}.
\item Vítor Bruno, Martha López-Canul, Brandon Richardson, Rosana Camarini, Tânia Marcourakis, Gabriella Gobbi (2025). \textit{High dose of psilocybin induces acute behavioral changes without inducing conditioned place preference in Sprague-Dawley rats}. Journal of Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1177/02698811251368361}{doi:10.1177/02698811251368361}.
\item Tim Schäfer, Fabian Haun, Bernhard Rupp, Dirk Hoffmeister (2025). \textit{Unterschiedliche Reaktionen und Enzyme in der Psilocybin- Biosynthese bei Inocybe- und Psilocybe -Pilzen}. Angewandte Chemie. [published; OpenAlex]. \href{https://doi.org/10.1002/ange.202512017}{doi:10.1002/ange.202512017}.
\item Tim Schäfer, Fabian Haun, Bernhard Rupp, Dirk Hoffmeister (2025). \textit{Dissimilar Reactions and Enzymes for Psilocybin Biosynthesis in Inocybe and Psilocybe Mushrooms}. Angewandte Chemie International Edition. [published; OpenAlex]. \href{https://doi.org/10.1002/anie.202512017}{doi:10.1002/anie.202512017}.
\item Elizabeth Knock, Krista J. Siefried, Gillinder Bedi, Steven M. Albert, Richard O. Day, Nadine Ezard, Margaret Ross, Paul Liknaitzky, Jonathan Brett (2025). \textit{Psilocybin-assisted psychotherapy for methamphetamine use disorder: A pilot open-label safety and feasibility study}. Addiction. [published; OpenAlex]. \href{https://doi.org/10.1111/add.70187}{doi:10.1111/add.70187}.
\item Benjamin R. Lewis (22279166), John Hendrick (22279169), Kevin Byrne (1610821), Madeleine Odette (22279172), Chaorong Wu (8444343), Eric L. Garland (4666660) (2025). \textit{S1 Appendix - Psilocybin-assisted group psychotherapy and mindfulness-based stress reduction for frontline healthcare provider COVID-19-related depression and burnout: A randomized controlled trial}. Figshare. [published; OpenAlex]. \href{https://doi.org/10.1371/journal.pmed.1004519.s001}{doi:10.1371/journal.pmed.1004519.s001}.
\item Delgado-Sallent C, Ahmed SA, Khawaja-Lopez A, Lee BS, Senne R, Scott BB, Ramirez S. (2025). \textit{Psychedelics Relax Priors and Reshape Orbitofrontal Dynamics}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2025.09.18.677110}{doi:10.1101/2025.09.18.677110}.
\item Beaglehole B, Manuel J. (2025). \textit{Reappraisal of the hype and hope offered by psilocybin treatment of depression.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.26635/6965.7138}{doi:10.26635/6965.7138}.
\item Benjamin R. Lewis, John Hendrick, Kevin Byrne, Madeleine Odette, Chaorong Wu, Eric L. Garland (2025). \textit{Psilocybin-assisted group psychotherapy and mindfulness-based stress reduction for frontline healthcare provider COVID-19-related depression and burnout: A randomized controlled trial}. PLoS Medicine. [published; OpenAlex]. \href{https://doi.org/10.1371/journal.pmed.1004519}{doi:10.1371/journal.pmed.1004519}.
\item Anastasia Calin, Ana Flavia Burlec, Cornelia Mircea, Irina Macovei, Monica Hăncianu, Andreia Corciovă (2025). \textit{Evolution and Comparative Analysis of Clinical Trials on Psilocybin in the Treatment of Psychopathologies: Trends in the EU and the US}. Journal of Clinical Medicine. [published; OpenAlex]. \href{https://doi.org/10.3390/jcm14186613}{doi:10.3390/jcm14186613}.
\item Johns Hopkins University (2025). \textit{PRoMiSS: Psilocybin and the Role of Music in Set and Setting}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07180108}{source link}.
\item Askey T, Allen-Ross D, Luzyanin D, Lasrado R, Gilmour G, Hunt SP, Tamagnini F, Ahmed M, Stephens GJ, Maiarú M. (2025). \textit{Psilocybin ameliorates neuropathic pain-like behaviour in mice and facilitates gabapentin-mediated analgesia}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2025.09.15.676273}{doi:10.1101/2025.09.15.676273}.
\item Maastricht University (2025). \textit{The Impact of Psilocybin on Pain in Fibromyalgia Patients: a Multicentre Trial.}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06368492}{source link}.
\item Taynah Pereira Galdino, Antônio Braz de Medeiros Bisneto, Marcelo da Silva Pedro, Lucas Cordeiro de Oliveira, Mateus Araújo da Luz, Antônio Gilson Barbosa de Lima, Suédina Maria de Lima Silva, Marcus Vinícius Lia Fook (2025). \textit{Multianalytical Investigation of Psilocybe cubensis Mushrooms: Physicochemical Characterization and Biological Evaluation of Psilocybin and Psilocin Compounds}. ACS Omega. [published; OpenAlex]. \href{https://doi.org/10.1021/acsomega.5c05606}{doi:10.1021/acsomega.5c05606}.
\item Zhifan He, Rui Tang, Min Feng, Xiaohui Li, Changhong Zhang, Jing Li (2025). \textit{Dynamic myocardial injury and variable hallucination latency in Psilocybe keralensis poisoning: a molecularly confirmed case series from China}. Clinical Toxicology. [published; OpenAlex]. \href{https://doi.org/10.1080/15563650.2025.2552438}{doi:10.1080/15563650.2025.2552438}.
\item Sonda S, Pendin D, Comai S, De Martin S, Manfredi P, Mattarei A. (2025). \textit{Emerging mechanisms of psilocybin-induced neuroplasticity.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.tips.2025.08.012}{doi:10.1016/j.tips.2025.08.012}.
\item Sabbah SG, Li S, Wong S, Le GH, Badulescu S, Hawco C, Rosenblat JD, McIntyre RS. (2025). \textit{Temporal dynamics in neuroimaging as correlates of therapeutic response to psilocybin in major depressive disorder: A systematic review and critical appraisal.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jad.2025.120335}{doi:10.1016/j.jad.2025.120335}.
\item Sapienza J, Spangaro M, Comai S, Sabé M, La Torre J, Buonarroti M, Cavallaro R, Bosia M (2025). \textit{Microdosing Psychedelics to Restore Synaptic Density in Schizophrenia.}. International journal of molecular sciences. [published; PubMed]. \href{https://doi.org/10.3390/ijms26188949}{doi:10.3390/ijms26188949}.
\item Bonniwell EM, Alabdali R, Hennessey JJ, McKee JL, Cavalco NG, Lammers JC, Moore EJ, Franchini L, Orlandi C, McCorvy JD. (2025). \textit{Serotonin 5-HT2C Receptor Signaling Analysis Reveals Psychedelic Biased Agonism.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/acschemneuro.5c00647}{doi:10.1021/acschemneuro.5c00647}.
\item Masjedi NS, Razi A. (2025). \textit{Effective connectivity of the human claustrum: Triple networks, subcortical circuits, and psychedelic modulation}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2025.09.07.674759}{doi:10.1101/2025.09.07.674759}.
\item Chwyl C, Spata A, Lucas W, Luoma JB. (2025). \textit{Mindset Over Molecule: Comparing Self-Transcendent and Mystical Experiences Across Recreational Psilocybin, MDMA, and Cannabis Use}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-7266162/v1}{doi:10.21203/rs.3.rs-7266162/v1}.
\item Ariane Bélanger, Sue-Ling Chang, Jean-François Stephan, Florence Moureaux, Diane Tapp, Robert Foxman, Pierre Gagnon, Johanne Hébert, Houman Farzin, Michel Dorval (2025). \textit{Supporting Meaningful Choices: A Decision Aid for Individuals Facing Existential Distress and Considering Psilocybin-Assisted Therapy}. Healthcare. [published; OpenAlex]. \href{https://doi.org/10.3390/healthcare13182290}{doi:10.3390/healthcare13182290}.
\item Tap SC, Thomas K, Páleníček T, Stenbæk DS, Oliveira-Maia AJ, van Dalfsen JH, Schoevers RA. (2025). \textit{Concomitant use of antidepressants and classic psychedelics: A scoping review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811251368360}{doi:10.1177/02698811251368360}.
\item Gattuso JJ, Kong G, Bezcioglu B, Lu D, Ekwudo MN, Wilson C, Gubert C, Hannan AJ, Renoir T. (2025). \textit{Corrigendum to "Chronic psilocybin administration increases sociability and alters the gut microbiome in male wild-type mice but not in a preclinical model of obsessive-compulsive disorder" [Neuropharmacology 279 (2025) 110648].}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neuropharm.2025.110679}{doi:10.1016/j.neuropharm.2025.110679}.
\item Tereza Dleštíková (2025). \textit{The Legal Perspective on Psilocybin for Medical Use in Czechia: A Key Milestone and the Case for Broader Consideration Beyond the Clinical Setting}. Psychoactives. [published; OpenAlex]. \href{https://doi.org/10.3390/psychoactives4030034}{doi:10.3390/psychoactives4030034}.
\item Richard B. van Breemen, Daniel Simchuk, Bjorn Fritzsche, Daniel H. Huson, Scott Kuzdzal, J. W. Ferguson (2025). \textit{Active Constituents of Psilocybin Mushroom Edibles}. JAMA Network Open. [published; OpenAlex]. \href{https://doi.org/10.1001/jamanetworkopen.2025.31345}{doi:10.1001/jamanetworkopen.2025.31345}.
\item Wierzbicka M, Kopczyk R, Gerlach A, Rymaszewska J. (2025). \textit{Correction: Therapeutic and legal aspects of psilocybin in cancer-related depression.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fpsyt.2025.1698185}{doi:10.3389/fpsyt.2025.1698185}.
\item John A. Razidlo, Noelle Cataldo, Cody J. Wenthur (2025). \textit{Psilocybin Enhances Cued Fear Extinction and Extinction Recall in Stress-Naïve, Acutely Stressed, and Chronically Stressed Mice}. ACS Pharmacology \& Translational Science. [published; OpenAlex]. \href{https://doi.org/10.1021/acsptsci.5c00462}{doi:10.1021/acsptsci.5c00462}.
\item King's College London (2025). \textit{Measurement of Serum Cytokine Levels in Samples Collected as Part of a Clinical Trial of Psilocybin for Treatment-resistant Depression.}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07164755}{source link}.
\item Rachel Yehuda (2025). \textit{Processing Intergenerational Trauma With Psilocybin-Assisted Therapy}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06899165}{source link}.
\item Wong S, Meckling G, Fabiano N, Lee S, Jones BDM, Shorr R, Dargel A, Davis AK, Fiedorowicz JG, Solmi M, Rosenblat JD, Mulsant BH, Blumberger DM, Husain MI. (2025). \textit{Effect of psilocybin therapy on suicidal ideation, attempts, and deaths in people with psychiatric diagnoses: a systematic review and meta-analysis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/20451253251372449}{doi:10.1177/20451253251372449}.
\item Alan K. Davis, Meghan DellaCrosse, Nathan D. Sepeda, Adam W. Levin, Mary P Cosimano, Hillary Shaub, Washington Taylor, Peter M. Gooch, Shoval Gilead, Skylar J. Gaughan, Stacey B. Armstrong, Frederick S. Barrett (2025). \textit{Five-year outcomes of psilocybin-assisted therapy for Major Depressive Disorder}. Journal of Psychedelic Studies. [published; OpenAlex]. \href{https://doi.org/10.1556/2054.2025.00461}{doi:10.1556/2054.2025.00461}.
\item Aday JS, Carhart-Harris R, Boehnke KF. (2025). \textit{Blunted psychedelic drug effects in older adults}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/yz4cd\_v2}{doi:10.31234/osf.io/yz4cd\_v2}.
\item Unknown authors (2025). \textit{Blunted psychedelic drug effects in older adults}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/yz4cd\_v2}{source link}.
\item Andrade FRT, Buchborn T, Thalheimer G, Meinhardt MW, Joca S, de Almeida RMM. (2025). \textit{Therapeutic Use of Psilocybin in Depression: a Systematic Review of Clinical Evidence.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1017/neu.2025.10039}{doi:10.1017/neu.2025.10039}.
\item Brownstien M, Lazar M, Botvinnik A, Pogodin I, Lifschytz T, Lerer B. (2025). \textit{Reply to Gattuso et al.: "Comments on 'Striking long-term beneficial effects of single-dose psilocybin and psychedelic mushroom extract in the SAPAP3 rodent model of OCD-like excessive self-grooming' by Brownstien et al. (2024)".}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41380-025-03173-z}{doi:10.1038/s41380-025-03173-z}.
\item Khyber Medical University Peshawar (2025). \textit{Effect of Psilocybin Only and Psilocybin Assisted Cognitive Behavioral Therapy in the Management of Major Depressive Disorder and Associated Metabolic, Immune, Inflammatory, Neuroplasticity and Electrical Activity Markers: a Randomized Controlled Trial}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06746441}{source link}.
\item Chris Simms (2025). \textit{We may know why psilocybin helps treat mental health conditions}. The New Scientist. [published; OpenAlex]. \href{https://doi.org/10.1016/s0262-4079(25)01446-0}{doi:10.1016/s0262-4079(25)01446-0}.
\item M Mercier, Cédric Mabilais, Vasileios Chytas, Leonice Furtado, Federico Seragnoli, Albert Buchard, Tatiana Aboulafia Brakha, Gabriel Thorens, Daniele Zullino, Louise Penzenstadler (2025). \textit{Psilocybin-Assisted Psychotherapy for Chronic Somatoform Pain Disorder: A Case Report}. Psychoactives. [published; OpenAlex]. \href{https://doi.org/10.3390/psychoactives4030030}{doi:10.3390/psychoactives4030030}.
\item Anna Blazhkova, Magdalena Czaja, Hanna Sitka, Sven Solisch, Anna Susłow, Ewa Szczęsna (2025). \textit{PSYCHEDELICS IN PSYCHIATRY - OVERVIEW OF PSILOCYBIN RESEARCH}. International Journal of Innovative Technologies in Social Science. [published; OpenAlex]. \href{https://doi.org/10.31435/ijitss.3(47).2025.3650}{doi:10.31435/ijitss.3(47).2025.3650}.
\item Sudhakaran G, Chakraborty S, Aung San, Bharti SAK, Csaba V, Valan Arasu M, Namasivayam SKR, Arockiaraj J. (2025). \textit{Biochemical Insights into Diverse Psilocybe Mushrooms and Their Metabolites as Sources of Neuroactive Agents: A Review}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/AGR/IND609227368}{source link}.
\item McCoy K, Reed F, Conn K, Foldi CJ. (2025). \textit{Separate or inseparable? Serotonin and dopamine system interactions may underlie the therapeutic potential of psilocybin for anorexia nervosa}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/AGR/IND609297819}{source link}.
\item Beck SA, Barlow C, Engel L, Barratt MJ. (2025). \textit{“Wood-lover paralysis”: Describing a toxidrome with symptoms of weakness caused by some lignicolous “wood-loving” Psilocybe mushrooms}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/AGR/IND609301091}{source link}.
\item Jaime Moreno-Chaparro, Gabriela Castañeda-Millán, Javier Eslava-Schmalbach (2025). \textit{Psilocybin Use in the Autism Spectrum Disorder: A Scoping Review}. Clinical Neuropharmacology. [published; OpenAlex]. \href{https://doi.org/10.1097/wnf.0000000000000653}{doi:10.1097/wnf.0000000000000653}.
\item Sally Meikle, Olivia Carter, Paul Liknaitzky, Lauren Johansen, Ravi Iyer, Nigel Strauss, M.L. Williams, David Castle, Susan L. Rossell (2025). \textit{Psilocybin with psychotherapeutic support for treatment-resistant depression: a pilot clinical trial}. Therapeutic Advances in Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1177/20451253251377187}{doi:10.1177/20451253251377187}.
\item Juan Carlos C. Montoy, Ralph C. Wang, Allison R. Coker, Craig G. Smollin, B. Anderson (2025). \textit{US Poison Center Encounters for Psilocybin-Related Exposures: 2013-2022}. Journal of the American College of Emergency Physicians Open. [published; OpenAlex]. \href{https://doi.org/10.1016/j.acepjo.2025.100231}{doi:10.1016/j.acepjo.2025.100231}.
\item Anton L.V. Avanceña, Linh N. Vuong, James G. Kahn, Elliot Marseille (2025). \textit{Psilocybin-assisted therapy for treatment-resistant depression in the US: a model-based cost-effectiveness analysis}. Translational Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1038/s41398-025-03556-4}{doi:10.1038/s41398-025-03556-4}.
\item Niall M. McGowan, James Rucker, Rachel Yehuda, Manish Agrawal, Nadav Liam Modlin, Hollie Simmons, Agata Tofil-Kaluza, Shriya Das, Guy M. Goodwin (2025). \textit{Investigating the safety and tolerability of single-dose psilocybin for post-traumatic stress disorder: A nonrandomized open-label clinical trial}. Journal of Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1177/02698811251362390}{doi:10.1177/02698811251362390}.
\item Nathan Brashares Sackett (2025). \textit{A Phase 2 Single-site, Double-blind, Placebo-controlled, Randomized Clinical Trial With an Open-label Extension Phase to Examine the Safety, Subjective Experiences, Acute Effects, and Suitability of Psilocybin Combined With Psychological Support (Psi-PS) for Military Veterans and First Responders With Co-occurring Alcohol Use Disorder (AUD) and Posttraumatic Stress Disorder (PTSD)}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06853912}{source link}.
\item Fernandes-Nascimento MH, Viana-Ferreira K, Negrão AB. (2025). \textit{Overview and Specificity of Psilocybin Use in the Treatment of Mental Disorders: A Scientometric Analysis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1089/psymed.2024.0031}{doi:10.1089/psymed.2024.0031}.
\item Islam S, Salam S, Hasan MN. (2025). \textit{Unsupervised Extractive Summarization of Psychedelic User Experience Reports}. medRxiv. [preprint; medRxiv]. \href{https://doi.org/10.1101/2025.08.22.25334176}{doi:10.1101/2025.08.22.25334176}.
\item Guy A. Higgins, Cam MacMillan, Inés de Lannoy, Carolyn M. Tyler, Malik Slassi (2025). \textit{Pharmacological characterisation of psilocybin and 5-MeO-DMT discriminative cues in the rat and their translational value for identifying novel psychedelics}. Journal of Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1177/02698811251361453}{doi:10.1177/02698811251361453}.
\item Andres-Olivera P, de la Iglesia J, Dominguez-Alvarez E, Soto’Gonzalez P, Rodriguez C, Munaiz-Cossio C, Gonzalez-Bolaños R, Brito-Rey R, Marín-Lorenzo C, Arribas-Simon B. (2025). \textit{Psilocybin: Systematic review of its use in the treatment of depression}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC12436869}{source link}.
\item Ross J. Purple, Rahul Gupta, Christopher W. Thomas, Caroline T. Golden, Nicola Palomero-Gallagher, Robin Carhartt-Harris, Seán Froudist-Walsh, Matthew W. Jones (2025). \textit{Short- and long-term modulation of rat prefrontal cortical activity following single doses of psilocybin}. Molecular Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1038/s41380-025-03182-y}{doi:10.1038/s41380-025-03182-y}.
\item Elise C. Tarbi, Skye A. Miner, Kabir Nigam, Zachary Sager, Justin J. Sanders, Michael Ljuslin, Benjamin Guérin, Kimberly Roddy, James A. Tulsky, Manish Agrawal, Yvan Beaussant (2025). \textit{“To Have the Encounter with Our Own Finiteness in that Existential Way”: Descriptions of Existential Experience in Patients with Cancer and Major Depression Participating in Psilocybin-Assisted Group Therapy}. Psychedelic Medicine. [published; OpenAlex]. \href{https://doi.org/10.1177/28314425251370303}{doi:10.1177/28314425251370303}.
\item Drewko AJ, Habets RLP, Brunt TM. (2025). \textit{Above the threshold, beyond the trip: the role of the 5-HT2A receptor in psychedelic-induced neuroplasticity and antidepressant effects.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41380-025-03169-9}{doi:10.1038/s41380-025-03169-9}.
\item Greaves MD, Barta T, Novelli L, Stoliker D, Razi A. (2025). \textit{Context-dependent structurally informed effective connectivity under psilocybin}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2025.08.18.671000}{doi:10.1101/2025.08.18.671000}.
\item Zeifman R, Danias G, Agin-Liebes G, Pagni B, Kettner H, Bhat V, Ross S, Erritzoe D, Carhart-Harris R. (2025). \textit{Psychedelic Therapy, Positive Emotional Experiences, and the Central Role of Self-Compassion}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-7420529/v1}{doi:10.21203/rs.3.rs-7420529/v1}.
\item Centre Hospitalier Universitaire de Nīmes (2025). \textit{Evaluation of the Effect of a Single Dose of Psilocybin on Neural Correlates of Cognitive Control in Patients With Psychogenic Nonepileptic Seizures}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06647056}{source link}.
\item Bilenker D, Avena NM. (2025). \textit{Psychedelics and the Serotonin Hypothesis of Eating Disorders.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/brainsci15080893}{doi:10.3390/brainsci15080893}.
\item James J Gattuso, Geraldine Kong, Bilgenur Bezcioglu, Da Lu, Millicent N. Ekwudo, Carey Wilson, Carolina Gubert, Anthony J. Hannan, Thibault Renoir (2025). \textit{Chronic psilocybin administration increases sociability and alters the gut microbiome in male wild-type mice but not in a preclinical model of obsessive-compulsive disorder}. Neuropharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/j.neuropharm.2025.110648}{doi:10.1016/j.neuropharm.2025.110648}.
\item Centre Hospitalier Universitaire de Nīmes (2025). \textit{Effect of Psilocybin on the Positive Valence System in Treatment-resistant Depression: a Pilot Clinical Neuroimaging Study}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06650800}{source link}.
\item Johns Hopkins University (2025). \textit{Effects of Psilocybin in Post-Treatment Lyme Disease}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05305105}{source link}.
\item Koenig HG. (2025). \textit{Psilocybin-assisted psychotherapy, combined antipsychotic and antidepressant treatment for bipolar depression, duration of birth control pill use and risk of depression, handgrip strength and cognitive function, mood disorders in epilepsy, and mental health issues among physicians.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/00912174251369880}{doi:10.1177/00912174251369880}.
\item COMPASS Pathways (2025). \textit{A Phase II, Multicentre, Randomised, Double-blind, Controlled Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of COMP360 in Participants With Recurrent Major Depressive Disorder}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05733546}{source link}.
\item Schuman HD, Deleemans JM, Nguyen T, Savard C, Mina R, Carlson LE. (2025). \textit{Attitudes Toward Psychedelic-Assisted Therapies for Cancer-Related Psychosocial Symptoms: A Multi- Stakeholder Analysis}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-6941009/v1}{doi:10.21203/rs.3.rs-6941009/v1}.
\item Maxwell B. Madden, Chloe Schaefgen, Binita Vedak, Jian Kwon, Kiara S. Dresp Pedra, Samuel H. Sheats, Adam C. Puché, Steffen B. E. Wolff, Brian N. Mathur (2025). \textit{Serotonin and psilocybin activate 5-HT1B receptors to suppress cortical signaling through the claustrum}. Nature Communications. [published; OpenAlex]. \href{https://doi.org/10.1038/s41467-025-62980-8}{doi:10.1038/s41467-025-62980-8}.
\item Li Y, Li H, Wang H, Wang X. (2025). \textit{Exploring the therapeutic potential of psychedelics in treating substance use disorders.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41380-025-03168-w}{doi:10.1038/s41380-025-03168-w}.
\item Garcia ACM, Maia LO. (2025). \textit{Psychedelic-assisted therapies for existential and spiritual suffering in palliative care.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/bs.pbr.2025.07.002}{doi:10.1016/bs.pbr.2025.07.002}.
\item Hughes B, Mirza S, Ponamala M, Sagaser J, Paredes R, Hematillake N, Tailor C, Khan R, Pemminati S. (2025). \textit{Exploring the Therapeutic Potential of Ketamine and Psilocybin in Comparison to Current Treatment Regimens for Treatment-Resistant Depression, Mood Disorders, and Post-traumatic Stress Disorder in the Pediatric Population: A Narrative Review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.7759/cureus.90425}{doi:10.7759/cureus.90425}.
\item Singleton SP, Sevchik BL, Lahey A, Cuijpers P, Harrer M, Jones MT, Nayak SM, Strain EC, Vandekar SN, Dworkin RH, Scott JC, Satterthwaite TD. (2025). \textit{Psilocybin treatment for symptoms of depression: a living systematic review, meta-analysis, and data resource}. medRxiv. [preprint; medRxiv]. \href{https://doi.org/10.1101/2025.08.13.25333530}{doi:10.1101/2025.08.13.25333530}.
\item Kargbo RB. (2025). \textit{Therapeutic Divergence in 5-HT2A Agonism: Psilocybin and Phenalkylamines for Demoralization Syndrome.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/acsmedchemlett.5c00475}{doi:10.1021/acsmedchemlett.5c00475}.
\item Kimberley Foster, Isaac Morrison, Shemar Daniel, Johann M.R. Antoine, Babumon M. Thankappan, Winston De La Haye, Marshall Tyler, Charles N. Grant, Rupika Delgoda (2025). \textit{Toward Standardized Products Containing Biomass of Psilocybe Cubensis Fungi}. Journal of AOAC International. [published; OpenAlex]. \href{https://doi.org/10.1093/jaoacint/qsaf072}{doi:10.1093/jaoacint/qsaf072}.
\item Margaret Ross, Ravi Iyer, M.L. Williams, Mark Boughey, Clare O’Callaghan, Richard Hiscock, Justin Dwyer (2025). \textit{Psilocybin-assisted psychotherapy for depression and anxiety associated with life threatening illness: A phase 2b randomized controlled trial}. General Hospital Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.genhosppsych.2025.08.001}{doi:10.1016/j.genhosppsych.2025.08.001}.
\item Silczuk A, Madejek RJ, Koweszko T, Mularczyk-Tomczewska P, Adamska E, Gujski M, Szulc A. (2025). \textit{Psychedelic-Assisted Therapy: Potential Benefits and Challenges in Mental Health Treatment.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.12659/msm.948302}{doi:10.12659/msm.948302}.
\item Im JJH, Sandoe CH (2025). \textit{Psychedelics and Headache Disorders: an Update.}. Current neurology and neuroscience reports. [published; PubMed]. \href{https://doi.org/10.1007/s11910-025-01446-2}{doi:10.1007/s11910-025-01446-2}.
\item Trevor R. Norman (2025). \textit{The psychedelic renaissance: psilocybin, a breakthrough for treatment resistant depression?}. Exploration of neuroscience. [published; OpenAlex]. \href{https://doi.org/10.37349/en.2025.1006105}{doi:10.37349/en.2025.1006105}.
\item Rebolledo-Pérez L, Hernández-Bello J, Martínez-Ramos A, Castañeda-Arellano R, Fernández-Quezada D, Sandoval-García F, Aguilar-García IG. (2025). \textit{Substance Abuse and Cognitive Decline: The Critical Role of Tau Protein as a Potential Biomarker.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/ijms26157638}{doi:10.3390/ijms26157638}.
\item Jiang Q, Shao L, Yao S, Savalia NK, Gilbert AD, Davoudian PA, Nothnagel JD, Tian G, Hung TS, Lai H, Beier KT, Zeng H, Kwan AC. (2025). \textit{Psilocybin triggers an activity-dependent rewiring of large-scale cortical networks}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2025.08.06.668927}{doi:10.1101/2025.08.06.668927}.
\item Wang X, Jun F, Lin C, Wang X (2025). \textit{Psychedelics and the Gut Microbiome: Unraveling the Interplay and Therapeutic Implications.}. ACS chemical neuroscience. [published; PubMed]. \href{https://doi.org/10.1021/acschemneuro.5c00418}{doi:10.1021/acschemneuro.5c00418}.
\item Grace Blest-Hopley, Giuseppe Pasculli, Simon Ruffell, WaiFung Tsang, Olateju Emmanuel, Kathryn M. Pate, Hannes Kettner, Leor Roseman, David Erritzøe, Robin Carhart-Harris (2025). \textit{Improved mental health outcomes and normalised spontaneous EEG activity in veterans reporting a history of traumatic brain injuries following participation in a psilocybin retreat}. Frontiers in Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.3389/fpsyt.2025.1594307}{doi:10.3389/fpsyt.2025.1594307}.
\item Totomanova I, Haijen ECHM, Hurks PPM, Ramaekers JG, Kuypers KPC. (2025). \textit{Between enhancement and risk: A critical review of psychedelic microdosing.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.copsyc.2025.102129}{doi:10.1016/j.copsyc.2025.102129}.
\item Dotun Adeleye Adeyinka, Dayna Forsyth, Suzanne Currie, Nicoletta Faraone (2025). \textit{Neurobiology of psilocybin: a comprehensive overview and comparative analysis of experimental models}. Frontiers in Systems Neuroscience. [published; OpenAlex]. \href{https://doi.org/10.3389/fnsys.2025.1585367}{doi:10.3389/fnsys.2025.1585367}.
\item Hultgren J, Hafsteinsson MH, Brulin JG. (2025). \textit{A dose of therapy with psilocybin - A meta-analysis of the relationship between the amount of therapy hours and treatment outcomes in psychedelic-assisted therapy.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.genhosppsych.2025.07.020}{doi:10.1016/j.genhosppsych.2025.07.020}.
\item Unknown authors (2025). \textit{Response to emotional stimuli weaker in SSRI users compared with psilocybin}. The Brown University Psychopharmacology Update. [published; OpenAlex]. \href{https://doi.org/10.1002/pu.31349}{doi:10.1002/pu.31349}.
\item Małgorzata Wierzbicka, Renata Kopczyk, Aleksandra Gerlach, Joanna Rymaszewska (2025). \textit{Therapeutic and legal aspects of psilocybin in cancer-related depression}. Frontiers in Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.3389/fpsyt.2025.1591864}{doi:10.3389/fpsyt.2025.1591864}.
\item Miller M, Meyers M, Krainak K, Lewis SP. (2025). \textit{Interventions to support spirituality among adults with cancer: a scoping review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s00520-025-09787-x}{doi:10.1007/s00520-025-09787-x}.
\item Mickaël Naassïla (2025). \textit{Psychedelics as treatment of alcohol use disorders: insights from preclinical models and comparison of the different psychedelics psilocybin, LSD and ketamine}. Neuroscience. [published; OpenAlex]. \href{https://doi.org/10.1016/j.neuroscience.2025.05.064}{doi:10.1016/j.neuroscience.2025.05.064}.
\item Unknown authors (2025). \textit{519. PSILOCYBIN ASSISTED PSYCHOTHERAPY FOR OBSESSIVE COMPULSIVE DISORDER, BODY DYSMORPHIC DISORDER, AND ANOREXIA NERVOSA: STUDY PROTOCOL}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC12359785}{source link}.
\item Unknown authors (2025). \textit{631. PSILOCYBIN AND KETANSERIN VS RTMS IN TREATMENT-RESISTANT DEPRESSION: ENHANCING TOLERABILITY BY MITIGATING PSYCHEDELIC EFFECTS}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC12359594}{source link}.
\item Unknown authors (2025). \textit{317. PSILOCYBIN DOES NOT INDUCE CONDITIONED PLACE PREFERENCE, BUT MODIFIES BEHAVIORAL PATTERNS IN SPRAGUE-DAWLEY RATS}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC12359800}{source link}.
\item Unknown authors (2025). \textit{164. PSILOCYBIN DURING THE POSTPARTUM PERIOD INDUCES LONG-LASTING ADVERSE EFFECTS IN BOTH MOTHERS AND OFFSPRING}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC12359495}{source link}.
\item Unknown authors (2025). \textit{620. IDENTIFICATION OF BLOOD BIOMARKERS OF PSILOCYBIN-ASSISTED THERAPY TREATMENT RESPONSE FOR GENERALISED ANXIETY DISORDER}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC12359512}{source link}.
\item Unknown authors (2025). \textit{426. THE MGLUR2/3 ANTAGONIST ENHANCES THE BEHAVIORAL AND CELLULAR ANTIDEPRESSANT-LIKE EFFECTS OF PSILOCYBIN AND SCOPOLAMINE}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC12359596}{source link}.
\item Unknown authors (2025). \textit{694. INVESTIGATING THE POTENTIAL OF PSILOCYBIN FOR COMPULSIVE EATING IN A RAT MODEL OF BINGE EATING}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC12359587}{source link}.
\item Unknown authors (2025). \textit{363. DIFFERENTIAL EFFECTS OF PSILOCYBIN AND LISURIDE ON SEROTONIN AND DOPAMINE NEURONAL ACTIVITY AND BEHAVIOR}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC12359530}{source link}.
\item Unknown authors (2025). \textit{229. PSILOCYBIN WITH PSYCHOTHERAPEUTIC SUPPORT FOR TREATMENT-RESISTANT DEPRESSION: A PILOT CLINICAL TRIAL}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC12359778}{source link}.
\item Unknown authors (2025). \textit{205. SYNERGISTIC BEHAVIORAL AND NEUROPLASTIC EFFECTS OF PSILOCYBIN-NMDAR MODULATOR ADMINISTRATION}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC12359736}{source link}.
\item Unknown authors (2025). \textit{564. TOWARD AN UNDERSTANDING OF THE THERAPEUTICALLY RELEVANT MECHANISMS OF PSILOCYBIN FOR ANOREXIA NERVOSA}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC12359394}{source link}.
\item Unknown authors (2025). \textit{476. ACUTE AND CHRONIC PSILOCYBIN IN MOUSE MODELS OF PSYCHIATRIC DISORDERS}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC12359791}{source link}.
\item Unknown authors (2025). \textit{597. ARE SIDE EFFECTS NECESSARY FOR ANTIDEPRESSIVE TREATMENT: THE PSILOCYBIN EXPERIENCE}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC12359505}{source link}.
\item Ley L, Liechti ME, Becker AM, Straumann I, Klaiber A, Holze F, Vogt SB, Arikci D, Schmid Y (2025). \textit{Motivation and retrospective appraisal of psychedelic study participation: a qualitative study in healthy volunteers.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-025-06772-4}{doi:10.1007/s00213-025-06772-4}.
\item Sulstarova A, Scheuerlein L, Monari S, Seragnoli F, Gabriel T, Preller K, Böge K, Sentissi O, Kaiser S, Solmi M, Kirschner M, Sabé M (2025). \textit{Treatment approaches and efficacy in psychedelic-induced psychosis: A systematic review.}. Asian journal of psychiatry. [published; PubMed]. \href{https://doi.org/10.1016/j.ajp.2025.104604}{doi:10.1016/j.ajp.2025.104604}.
\item Adebo M, Bonnet M, Laouej O, Defaix C, McGowan JC, Butlen-Ducuing F, David DJ, Poupon E, Tritschler L, Gardier AM. (2025). \textit{Psilocybin as Transformative Fast-Acting Antidepressant: Pharmacological Properties and Molecular Mechanisms.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1111/fcp.70038}{doi:10.1111/fcp.70038}.
\item Unknown authors (2025). \textit{Correction to "Acceptability of psilocybin-assisted group therapy in patients with cancer and major depressive disorder: Qualitative analysis".}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1002/cncr.70003}{doi:10.1002/cncr.70003}.
\item Liechti ME, Gasser P, Aicher HD, Mueller F, Hawrot T, Schmid Y. (2025). \textit{Implementing psychedelic-assisted therapy: History and characteristics of the Swiss limited medical use program.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.nsa.2025.105525}{doi:10.1016/j.nsa.2025.105525}.
\item Zirkel RT, Isaacson M, Liao C, Yi M, Yamaguchi K, Rivera D, Kuceyeski A, Nishimura N, Kwan AC, Schaffer CB. (2025). \textit{Psilocybin Prolongs the Neurovascular Coupling Response in Mouse Visual Cortex}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2025.07.25.666803}{doi:10.1101/2025.07.25.666803}.
\item Barbara Anna Zapalska, Antonina Teresa Witkowska, Anna Cukrowska, Artur Galus (2025). \textit{Psilocybin-assisted treatment of depression}. Medical Science. [published; OpenAlex]. \href{https://doi.org/10.54905/disssi.v29i161.e110ms3657}{doi:10.54905/disssi.v29i161.e110ms3657}.
\item Egger K, Meling D, Polat F, Seifritz E, Avram M, Scheidegger M. (2025). \textit{Meditation, Psychedelics, and Brain Connectivity: A Randomised Controlled Resting-State fMRI Study of N,N-Dimethyltryptamine and Harmine in a Meditation Retreat}. medRxiv. [preprint; medRxiv]. \href{https://doi.org/10.1101/2025.07.30.25332422}{doi:10.1101/2025.07.30.25332422}.
\item Rosa WE, Napolitano S, McAndrew N, Jenkins B, Lichtenthal WG, Applebaum AJ, Breitbart W, Agrawal M. (2025). \textit{Meaning-Centered Psychotherapy for Psilocybin-Assisted Therapy Among Patients with Advanced Cancer and Depression: Rationale and Preliminary Evaluation of MCP-PSIL.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/28314425251363983}{doi:10.1177/28314425251363983}.
\item Sutherland MH, Nicholas CR, Lennertz RC, Wenthur CJ, Krause BM, Sauder CJ, Riedner BA, Smith RF, Hutson PR, Raison CL, Banks MI. (2025). \textit{Electrophysiological effects of psilocybin co-administered with midazolam}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2025.07.25.666887}{doi:10.1101/2025.07.25.666887}.
\item Bevione F, Lacidogna MC, Lavalle R, Abbate Daga G, Preti A. (2025). \textit{Psilocybin in the treatment of eating disorders: a systematic review of the literature and registered clinical trials.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s40519-025-01771-y}{doi:10.1007/s40519-025-01771-y}.
\item Johns Hopkins University (2025). \textit{Outpatient Buprenorphine Induction With Psilocybin for Opioid Use Disorder: a Randomized Double-blind Trial}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06067737}{source link}.
\item King's College London (2025). \textit{Modulation of Serotonin Pathways Using Psilocybin in Adults With and Without Autism Spectrum Disorder (ASD)}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05651126}{source link}.
\item Egger K, Bozsak R, Aicher H, Sari H, Poetzsch S, Rominger A, Martin-Soelch C, Dornbierer D, Quednow B, Scheidegger M, Cumming P. (2025). \textit{Global Increases in Brain Glucose Metabolism Following Acute N,N-Dimethyltryptamine and Harmine Administration in Healthy Volunteers: An [¹⁸F]FDG-PET Study}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-7099164/v1}{doi:10.21203/rs.3.rs-7099164/v1}.
\item Rudy LM, Godlewski MM. (2025). \textit{Molecular Pathways Potentially Involved in Hallucinatory Experiences During Sleep Paralysis: The Emerging Role of β-Arrestin-2.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/ijms26157233}{doi:10.3390/ijms26157233}.
\item Askariyan K, Joghataei MT, Dehghan S, Nohesara S, Riahi Pour L, Mohammadi MH, Ahmadirad N. (2025). \textit{An overview of psilocybin, LSD, MDMA, and ketamine in revitalizing psychedelic-assisted therapy: Insights, limitations and future directions.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.pnpbp.2025.111461}{doi:10.1016/j.pnpbp.2025.111461}.
\item Yale University (2025). \textit{Mechanistic Studies of Psilocybin in Headache Disorders}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06464367}{source link}.
\item Amandine Luquiens, Dahbia Belahda, Carine Graux, Noe Igounenc, Chris Serrand, Paul A. Rochefort, Thibault Mura, Felix Sergent (2025). \textit{Psilocybin in alcohol use disorder and comorbid depressive symptoms: Results from a feasibility randomized clinical trial}. Addiction. [published; OpenAlex]. \href{https://doi.org/10.1111/add.70152}{doi:10.1111/add.70152}.
\item Emory University (2025). \textit{The Safety, Feasibility, and Acceptability of Psilocybin Combined With Multidisciplinary Palliative Care in Demoralized Cancer Survivors With Chronic Pain (P-PC)}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05506982}{source link}.
\item C. Gillespie, Jesse M. Bering (2025). \textit{Avoiding Stigma and Sensationalism in Therapeutic Psilocybin Communications: Considerations for Reaching Older Patients}. American Journal of Geriatric Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.jagp.2025.07.003}{doi:10.1016/j.jagp.2025.07.003}.
\item Patricia A. Cioe, Garrett S Stang, Danish Azam, Sarah Dugal (2025). \textit{“I’ve learned that I’m open-minded to this possibility”: A qualitative study to evaluate the acceptability of a psilocybin-aided smoking cessation treatment for people with HIV who smoke}. Addiction Science \& Clinical Practice. [published; OpenAlex]. \href{https://doi.org/10.1186/s13722-025-00563-0}{doi:10.1186/s13722-025-00563-0}.
\item Nicholas P. Cherup, Patrick H. Finan (2025). \textit{Psilocybin as a psychophysical adaptogen in chronic pain rehabilitation}. Journal of Pain. [published; OpenAlex]. \href{https://doi.org/10.1016/j.jpain.2025.105507}{doi:10.1016/j.jpain.2025.105507}.
\item The University of Texas Health Science Center, Houston (2025). \textit{Acceptability \& Safety of Two Sequential Doses of Psilocybin in Bipolar Disorder II Depression and Suicidality}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06706232}{source link}.
\item Urban MM, Zillich L, Rieser NM, Herdener M, Vollenweider FX, Spanagel R, Preller KH, Meinhardt MW. (2025). \textit{Epigenome-wide Association Study of Psilocybin-Induced Methylome Changes in Alcohol Use Disorder}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2025.07.18.664368}{doi:10.1101/2025.07.18.664368}.
\item Jain MK, Gumpper RH, Slocum ST, Schmitz GP, Madsen JS, Tummino TA, Suomivuori CM, Huang XP, Shub L, DiBerto JF, Kim K, DeLeon C, Krumm BE, Fay JF, Keiser M, Hauser AS, Dror RO, Shoichet B, Gloriam DE, Nichols DE, Roth BL. (2025). \textit{The polypharmacology of psychedelics reveals multiple targets for potential therapeutics.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neuron.2025.06.012}{doi:10.1016/j.neuron.2025.06.012}.
\item Kittur ME, Burgos M LA, Jones BDM, Blumberger DM, Mulsant BH, Rosenblat JD, Husain MI. (2025). \textit{Mapping psilocybin therapy: A systematic review of therapeutic frameworks, adaptations, and standardization across contemporary clinical trials.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jad.2025.119952}{doi:10.1016/j.jad.2025.119952}.
\item Ashutosh Bhave (2025). \textit{Rise of the Mushrooms: Effects of Psilocybin Reforms on Psychedelic Usage Patterns}. Journal of Public Policy \& Marketing. [published; OpenAlex]. \href{https://doi.org/10.1177/07439156251360774}{doi:10.1177/07439156251360774}.
\item Michael-Paul Schallmo, Sophia Jungers, Ranji Varghese, Kathryn R. Cullen, Michael D. Evans, Jessica L. Nielson, Link Swanson (2025). \textit{Stronger visual surround suppression under psilocybin: A psychophysical and EEG pilot study}. Journal of Vision. [published; OpenAlex]. \href{https://doi.org/10.1167/jov.25.9.2091}{doi:10.1167/jov.25.9.2091}.
\item Heller NH, Barrett FS, Buchborn T, Collerton D, Dupuis D, Halberstadt AL, Jardri R, Noorani TN, Preller KH, Taylor J, Waters F, Winston B, Leptourgos P. (2025). \textit{Visual Hallucinations in Serotonergic Psychedelics and Lewy Body Diseases}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/7x8q4\_v3}{doi:10.31234/osf.io/7x8q4\_v3}.
\item Sudhakaran G, Chakraborty S, Kumar A, Bharti SAK, Csaba V, Valan Arasu M, Namasivayam SKR, Arockiaraj J. (2025). \textit{Biochemical Insights into Diverse Psilocybe Mushrooms and Their Metabolites as Sources of Neuroactive Agents: A Review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s00284-025-04379-8}{doi:10.1007/s00284-025-04379-8}.
\item Unknown authors (2025). \textit{Visual Hallucinations in Serotonergic Psychedelics and Lewy Body Diseases}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/7x8q4\_v3}{source link}.
\item Plummer Z, Allen J, Brand J, Mayo LM, Shultz SR, Christie BR. (2025). \textit{Examining the potential of psilocybin and 5-MeO-DMT as therapeutics for traumatic brain injury.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.pnpbp.2025.111448}{doi:10.1016/j.pnpbp.2025.111448}.
\item Lacey C. (2025). \textit{Equitable access to psilocybin-assisted psychotherapy in New Zealand.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.26635/6965.e1618}{doi:10.26635/6965.e1618}.
\item Cohen ZZ, Blest-Hopley G (2025). \textit{Females in Psychedelic Research: A Perspective for Advancing Research and Practice.}. ACS pharmacology \& translational science. [published; PubMed]. \href{https://doi.org/10.1021/acsptsci.5c00255}{doi:10.1021/acsptsci.5c00255}.
\item Glenn DL, Choi SH, Zimmerman RS. (2025). \textit{A systematic review and narrative summary of the therapeutic potential of classic serotonergic psychedelics for smoking cessation and reduction.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811251353251}{doi:10.1177/02698811251353251}.
\item Taynah Pereira Galdino, Lucas Cordeiro de Oliveira, Mateus Araújo da Luz, R.C.A. Barbosa, M. Torres, Kátia Sivieri, Paula A. Fernandes, Márcio Luiz dos Santos, Antônio Gilson Barbosa de Lima, Suédina Maria de Lima Silva, Marcus Vinícius Lia Fook (2025). \textit{Exploring the Frontiers of Psychedelics: A New Chromatographic Method for Detection and Quantification of Psilocybin and Psilocin in Psilocybe cubensis Mushrooms}. ACS Omega. [published; OpenAlex]. \href{https://doi.org/10.1021/acsomega.5c02751}{doi:10.1021/acsomega.5c02751}.
\item Miller EA, Capone C, Eaton E, Swift RM, Haass-Koffler CL. (2025). \textit{Psychedelics for Alcohol Use Disorder: A Narrative Review with Candidate Mechanisms of Action.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s40263-025-01199-z}{doi:10.1007/s40263-025-01199-z}.
\item Jens Larsen, Pernille Kølbæk, Søren Dinesen Østergaard (2025). \textit{Treatment with LSD and psilocybin at the department of psychiatry at Frederiksberg Hospital in Denmark from 1960 to 1973: an analysis of 324 cases}. Nordic Journal of Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1080/08039488.2025.2529449}{doi:10.1080/08039488.2025.2529449}.
\item Miyuan Zhang (21677016), Haojiang Zhai (21677019), Longwei Yang (21677022), Haohong Li (5164970), Xiaohui Wang (19899) (2025). \textit{The Medial PrefrontalCortex Modulates Psychedelic-likeEffects of Psilocin}. Figshare. [published; OpenAlex]. \href{https://doi.org/10.1021/acsptsci.5c00324.s001}{doi:10.1021/acsptsci.5c00324.s001}.
\item Kosuke Kato, Jennifer Kleinhenz, Yoon-Joo Shin, Cristian Coarfa, Ali John Zarrabi, Louise Hecker (2025). \textit{Psilocybin treatment extends cellular lifespan and improves survival of aged mice}. npj Aging. [published; OpenAlex]. \href{https://doi.org/10.1038/s41514-025-00244-x}{doi:10.1038/s41514-025-00244-x}.
\item Miyuan Zhang, Haiyan Zhai, Longwei Yang, Haohong Li, Xiaohui Wang (2025). \textit{The Medial Prefrontal Cortex Modulates Psychedelic-like Effects of Psilocin}. ACS Pharmacology \& Translational Science. [published; OpenAlex]. \href{https://doi.org/10.1021/acsptsci.5c00324}{doi:10.1021/acsptsci.5c00324}.
\item Joga R, Yerram S, Patnam JD, Choudhary KK, Varpe P, Raghuvanshi RS, Srivastava S. (2025). \textit{Unraveling the policies, legislations, and regulations of psychedelics in Australia, Canada, Netherlands, New Zealand, and India.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.healthpol.2025.105392}{doi:10.1016/j.healthpol.2025.105392}.
\item Szigeti B. (2025). \textit{An open-label, dose-escalation trial of psilocybin-assisted therapy for bipolar 2 depression}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/97cqx\_v1}{doi:10.31234/osf.io/97cqx\_v1}.
\item Unknown authors (2025). \textit{An open-label, dose-escalation trial of psilocybin-assisted therapy for bipolar 2 depression}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/97cqx\_v1}{source link}.
\item Gregory NS, Girard TE, Ram A, Casey AB, Malenka RC, Tawfik VL, Heifets BD. (2025). \textit{Psilocybin has no immediate or persistent analgesic effect in acute and chronic mouse pain models}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2025.07.06.663398}{doi:10.1101/2025.07.06.663398}.
\item Park D, Lee G, Lee WG, Kim B, Lee Y, Kim JW. (2025). \textit{The therapeutic potential of psilocybin beyond psychedelia through shared mechanisms with ketamine.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41380-025-03100-2}{doi:10.1038/s41380-025-03100-2}.
\item Yutong Song (2025). \textit{Explore the effect of psilocybin on depression and anxiety}. Arts Culture and Language. [published; OpenAlex]. \href{https://doi.org/10.61173/rcg8me57}{doi:10.61173/rcg8me57}.
\item Pauline Braekow, Joachim Neumann, Uwe Kirchhefer, Ulrich Gergs (2025). \textit{Effects of Psilocin and Psilocybin on Human 5-HT4 Serotonin and H2 Histamine Receptors in Perfused Hearts of Transgenic Mice}. Pharmaceuticals. [published; OpenAlex]. \href{https://doi.org/10.3390/ph18071009}{doi:10.3390/ph18071009}.
\item Tolle HM, Luppi AI, Lawn T, Roseman L, Nutt D, Carhart-Harris RL, Mediano PAM. (2025). \textit{Accurate and Interpretable Prediction of Antidepressant Treatment Response from Receptor-informed Neuroimaging}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2025.07.02.662710}{doi:10.1101/2025.07.02.662710}.
\item Luca Pellegrini, Naomi Fineberg, Sorcha O'Connor, Ana Maria Frota Lisbôa Pereira de Souza, Kate Godfrey, Sara Reed, Joseph Peill, Mairead Healy, Cyrus Rohani-Shukla, Hakjun Lee, Robin Carhart-Harris, Trevor W. Robbins, David Nutt, David Erritzøe (2025). \textit{Single-dose (10 mg) psilocybin reduces symptoms in adults with obsessive-compulsive disorder: A pharmacological challenge study}. Comprehensive Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.comppsych.2025.152619}{doi:10.1016/j.comppsych.2025.152619}.
\item Unknown authors (2025). \textit{Psilocybin bei schwerer behandlungsresistenter Depression}. Fortschritte der Neurologie · Psychiatrie. [published; OpenAlex]. \href{https://doi.org/10.1055/a-2524-6277}{doi:10.1055/a-2524-6277}.
\item David W. Lawrence, Alex P. Di Battista, Michael G. Hutchison (2025). \textit{Psilocybin Use in an Intercollegiate Athlete with Persisting Symptoms After Concussion: A Case Report}. Psychoactives. [published; OpenAlex]. \href{https://doi.org/10.3390/psychoactives4030022}{doi:10.3390/psychoactives4030022}.
\item Atiq MA, Baker MR, Voort JLV, Vargas MV, Choi DS (2025). \textit{Disentangling the acute subjective effects of classic psychedelics from their enduring therapeutic properties.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-024-06599-5}{doi:10.1007/s00213-024-06599-5}.
\item Carrithers BM, Roberts DE, Weiss BM, King JD, Carhart-Harris RL, Gordon AR, Pagni BA, Moreau M, Ross S, Zeifman RJ (2025). \textit{Exploring serotonergic psychedelics as a treatment for personality disorders.}. Neuropharmacology. [published; PubMed]. \href{https://doi.org/10.1016/j.neuropharm.2025.110413}{doi:10.1016/j.neuropharm.2025.110413}.
\item Harding R, Singer N, Wall MB, Hendler T, Erritzoe D, Nutt D, Carhart-Harris R, Roseman L. (2025). \textit{Correction: Dissociable effects of psilocybin and escitalopram for depression on processing of musical surprises.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41380-025-03066-1}{doi:10.1038/s41380-025-03066-1}.
\item Beneš M, Páleníček T, Horáček J. (2025). \textit{What fMRI studies say about the nature of the psychedelic effect: a scoping review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fnins.2025.1606798}{doi:10.3389/fnins.2025.1606798}.
\item Judith Stirn, Christian D. Klein (2025). \textit{Efficient Acyloxymethylation of Psilocin and Other Tryptamines Yielding ACOM Prodrugs for Psychedelic-Assisted Therapy}. Archiv der Pharmazie. [published; OpenAlex]. \href{https://doi.org/10.1002/ardp.70022}{doi:10.1002/ardp.70022}.
\item Sofuoglu M, De Aquino JP, MacLean RR (2025). \textit{Psychedelic drugs for the treatment of substance use disorders.}. Expert review of clinical pharmacology. [published; PubMed]. \href{https://doi.org/10.1080/17512433.2025.2541103}{doi:10.1080/17512433.2025.2541103}.
\item Luz MA, Guedes HVS, Bisneto ABM, Jesus RA, Galdino TP, Oliveira LC, Afonso VI, Fook MVL, Lima AGB, Silva SML, Torres MCM. (2025). \textit{Chemical Composition and Biological Activities of Psilocybe Mushrooms: Gaps and Perspectives.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/ph18070989}{doi:10.3390/ph18070989}.
\item Hieronymus F, López E, Werin Sjögren H, Lundberg J. (2025). \textit{Control Group Outcomes in Trials of Psilocybin, SSRIs, or Esketamine for Depression: A Meta-Analysis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1001/jamanetworkopen.2025.24119}{doi:10.1001/jamanetworkopen.2025.24119}.
\item Rodney D. Brown, Niall M. Hamilton, Connor Mallon, James Stevenson, Michael T. Faley, Robert B. Kargbo, Alexander M. Sherwood, Balasubramaniam Upeandran (2025). \textit{Synthesis of Psilocin, Psilocybin and 5-MeO-DMT Succinate, All Labelled With Carbon-14 at the Indole 2-Position}. Journal of Labelled Compounds and Radiopharmaceuticals. [published; OpenAlex]. \href{https://doi.org/10.1002/jlcr.4155}{doi:10.1002/jlcr.4155}.
\item Samuel E Christen, Elias Bekka, Yasmin Schmid, Neal L. Benowitz, Evangelia Liakoni (2025). \textit{Caffeine, nicotine, cannabis, and psilocybin: Pharmacology, toxicology, and potential therapeutic uses of four naturally occurring psychoactive substances}. Swiss Medical Weekly. [published; OpenAlex]. \href{https://doi.org/10.57187/s.4346}{doi:10.57187/s.4346}.
\item Hynek Danda, Kristýna Mazochová, Klára Šíchová, Vladimír Mazoch, Lucie Olejníková Ladislavová, Kateřina Syrová, Bronislav Jurásek, Petra Cihlářová, Radek Jurok, Tomáš Páleníček, Martin Kuchař (2025). \textit{Behavioural and pharmacological evaluation of the psilocybin analogue baeocystin in Wistar rats}. Progress in Neuro-Psychopharmacology and Biological Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.pnpbp.2025.111439}{doi:10.1016/j.pnpbp.2025.111439}.
\item Islam S, Liden T, Goff R, Schug KA. (2025). \textit{Untargeted analysis of psilocybin and non-psilocybin mushrooms using liquid chromatography quadrupole time of flight mass spectrometry}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/AGR/IND609270047}{source link}.
\item Ciszowski K, Ziaja A, Niedzielska-Andres E, Pomierny-Chamioło L. (2025). \textit{Natural hallucinogens of fungal and animal origin: action and potentialapplications - a narrative review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.24425/fmc.2025.156119}{doi:10.24425/fmc.2025.156119}.
\item Ryan M. Brudner, Erica Kaczmarek, Marc G. Blainey, Christian Schulz, Shakila Meshkat, Zoe Doyle, Orly Lipsitz, Hilary Offman, Rickinder Sethi, Geneva Weiglein, Roger S. McIntyre, Joshua D. Rosenblat (2025). \textit{Examining mystical experiences as a predictor of psilocybin-assisted psychotherapy for treatment-resistant depression}. Journal of Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1177/02698811251346697}{doi:10.1177/02698811251346697}.
\item Rodrigo A. Petter, María D. Montero, Cinthia D. Gigliotti (2025). \textit{Prolonged hallucinogenic effects following Psilocybe cubensis ingestion: Case report}. The poison.. [published; OpenAlex]. \href{https://doi.org/10.62129/dmad8764}{doi:10.62129/dmad8764}.
\item Schuman HDM, Savard C, Mina R, Barkova S, Conradi HSW, Deleemans JM, Carlson LE. (2025). \textit{Psychedelic-Assisted Therapies for Psychosocial Symptoms in Cancer: A Systematic Review and Meta-Analysis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/curroncol32070380}{doi:10.3390/curroncol32070380}.
\item Nayiri Barton (2025). \textit{Evaluating Psilocybin as a Treatment for Neuropsychiatric Symptoms in Parkinson’s Disease}. Global Journal of Medical Research. [published; OpenAlex]. \href{https://doi.org/10.34257/gjmravol25is1pg1}{doi:10.34257/gjmravol25is1pg1}.
\item Carvalho LC, Encantado J, Kettner H, Timmermann C, Veiga D, Teixeira PJ. (2025). \textit{A Scoping Review of Research in Naturalistic Studies with Psychedelics.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/02791072.2025.2520221}{doi:10.1080/02791072.2025.2520221}.
\item University of Minnesota (2025). \textit{Visual Surround Suppression and Perceptual Expectation Under Psilocybin}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT04424225}{source link}.
\item Stoliker D, Bernasconi F, Blanke O, Razi A. (2025). \textit{Psilocybin Modulates TPJ Effective Connectivity during Out-of-Body Experiences}. medRxiv. [preprint; medRxiv]. \href{https://doi.org/10.1101/2025.06.24.25330245}{doi:10.1101/2025.06.24.25330245}.
\item Mathew A, Dongre R, Kim SH, Turner J, Mathew A, Cherryholmes E, Mehrinfar M, Kamprath S. (2025). \textit{The Clinical Applications of Psilocybin Therapies and Post-COVID Syndrome: A Comprehensive Narrative Review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.7759/cureus.86659}{doi:10.7759/cureus.86659}.
\item Vinarcsik L, Smoller C, Grossberg G. (2025). \textit{Use of Psychedelic Agents in Older Adults with Treatment-Resistant Major Depressive Disorder: What the Evidence Shows.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s40266-025-01221-5}{doi:10.1007/s40266-025-01221-5}.
\item Daroui D, Mastrostefano A, Davini F, Giuseppe G, Terracina S. (2025). \textit{The Emerging Use of Psilocybin in Adult Populations with Alcohol Use Disorder: A Scoping Review}. Preprints.org. [preprint; Europe PMC]. \href{https://doi.org/10.20944/preprints202506.1536.v1}{doi:10.20944/preprints202506.1536.v1}.
\item McCulloch DE, Larsen K, Johansen A, Reveles Jensen KH, Nykjaer CH, Holze F, Falck N, Neufeld VAB, Steenstrup E, Skov-Andersen PM, Spangaard A, Geisler M, Randrup PP, Jensen PS, Shulganov V, Johansen SS, Nielsen MKK, Andersen TL, Stenbaek DS, Svarer C, Fisher PM, Knudsen GM. (2025). \textit{Molecular, haemodynamic and functional effects of LSD in the human brain}. medRxiv. [preprint; medRxiv]. \href{https://doi.org/10.1101/2025.06.17.25329677}{doi:10.1101/2025.06.17.25329677}.
\item Subramanian S, Reneau TR, Perry D, Chacko R, Laumann TO, Flavin K, Horan C, Schweiger J, Metcalf N, Lenze EJ, Snyder AZ, Dosenbach NUF, Nicol G, Siegel JS (2025). \textit{Correction: Psilocybin's acute and persistent brain effects: a precision imaging drug trials.}. Scientific data. [published; PubMed]. \href{https://doi.org/10.1038/s41597-025-05397-8}{doi:10.1038/s41597-025-05397-8}.
\item Kevin Rebecchi (2025). \textit{“Diversity makes the richness of humanity”: The emergence and persistence of mental imagery after self-reported psilocybin truffles intake in an autistic woman with “blind imagination” (aphantasia): A33-month retrospective case report}. Journal of Psychedelic Studies. [published; OpenAlex]. \href{https://doi.org/10.1556/2054.2025.00320}{doi:10.1556/2054.2025.00320}.
\item Ying Zhang, Lei Yang, Qiuyu Zhang, Chao Li, Fuqiang Mao, Chuanjun Zhuo (2025). \textit{The molecular mechanisms through which psilocybin prevents suicide: evidence from network pharmacology and molecular docking analyses}. Translational Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1038/s41398-025-03410-7}{doi:10.1038/s41398-025-03410-7}.
\item Manish Agrawal, Kim Roddy, Betsy Jenkins, Celia Leeks, Ezekiel Emanuel (2025). \textit{Long-term benefits of single-dose psilocybin in depressed patients with cancer}. Cancer. [published; OpenAlex]. \href{https://doi.org/10.1002/cncr.35889}{doi:10.1002/cncr.35889}.
\item Ines Erkizia-Santamaría, Igor Horrillo, Nerea Martínez-Álvarez, Daniel Pérez-Martínez, Guadalupe Rivero, Amaia M. Erdozain, J. Javier Meana, Jorge E. Ortega (2025). \textit{Evaluation of behavioural and neurochemical effects of psilocybin in mice subjected to chronic unpredictable mild stress}. Translational Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1038/s41398-025-03421-4}{doi:10.1038/s41398-025-03421-4}.
\item Unknown authors (2025). \textit{Escitalopram/psilocybin}. Reactions Weekly. [published; OpenAlex]. \href{https://doi.org/10.1007/s40278-025-84088-2}{doi:10.1007/s40278-025-84088-2}.
\item COMPASS Pathways (2025). \textit{The Safety and Tolerability of COMP360 in Participants With Post-traumatic Stress Disorder}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05312151}{source link}.
\item Marco Pepe, Mohsen Hesami, Livia Fleishmann, Tom Hsiang, Andrew Maxwell Phineas Jones (2025). \textit{Mycelium Growth and Development of Psilocybe spp. Mother Cultures on Agar-Based Media}. Journal of Fungi. [published; OpenAlex]. \href{https://doi.org/10.3390/jof11060450}{doi:10.3390/jof11060450}.
\item MycoMedica Life Sciences PBC (2025). \textit{A Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Multiple Doses of MLS101 (Psilocybin) in Healthy Participants}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06643637}{source link}.
\item Luke Lanham, Alistair R. McTaggart, James R. Falconer (2025). \textit{Is there mush-room to improve the environmental sustainability of psilocybin production?}. Journal of CO2 Utilization. [published; OpenAlex]. \href{https://doi.org/10.1016/j.jcou.2025.103137}{doi:10.1016/j.jcou.2025.103137}.
\item Agin-Liebes G, Petridis P, Zeifman R, Link M, Cordova MJ, Bogenschutz M. (2025). \textit{Psilocybin-Assisted Therapy Increases Self-Compassion in Patients with Alcohol Use Disorder}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/f27jm\_v1}{doi:10.31234/osf.io/f27jm\_v1}.
\item University of California, San Francisco (2025). \textit{Comparison of the Effects of PEX20 (Oral Psilocin), PEX30 (Sublingual Psilocin), and PEX10 (Oral Psilocybin) in Healthy Adults}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05317689}{source link}.
\item Unknown authors (2025). \textit{Psilocybin-Assisted Therapy Increases Self-Compassion in Patients with Alcohol Use Disorder}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/f27jm\_v1}{source link}.
\item Fradet M, Kelly CM, Donnelly AJ, Suppes T. (2025). \textit{Psilocybin and hallucinogenic mushrooms - ERRATUM.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1017/s1092852925100291}{doi:10.1017/s1092852925100291}.
\item Sara Ellis, Catherine Bostian, Anna J. Donnelly, Wendy Feng, Katherine Eisen, Melanie Lean, Elizabeth Conlan, Michael J. Ostacher, Scott T. Aaronson, Trisha Suppes (2025). \textit{Long-term outcomes of single-dose psilocybin for U.S. military Veterans with severe treatment-resistant depression - 12-month data from an open-label pilot study}. Journal of Affective Disorders. [published; OpenAlex]. \href{https://doi.org/10.1016/j.jad.2025.119655}{doi:10.1016/j.jad.2025.119655}.
\item Modlin NL, Williamson V, Maggio C, Stubley J, Kirlic N, Cleare A, Rucker J. (2025). \textit{Clinical conceptualisation of PTSD in psilocybin treatment: disrupting a pre-determined and over-determined maladaptive interpretive framework.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/20451253251342319}{doi:10.1177/20451253251342319}.
\item Beck SA, Barlow C, Engel L, Barratt MJ. (2025). \textit{"Wood-lover paralysis": Describing a toxidrome with symptoms of weakness caused by some lignicolous "wood-loving" Psilocybe mushrooms.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.toxicon.2025.108450}{doi:10.1016/j.toxicon.2025.108450}.
\item Joshua Woolley, MD, PhD (2025). \textit{Psilocybin With Intracranial Neural Sensing}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06919640}{source link}.
\item Jylkkä J. (2025). \textit{Meditation and psychedelics facilitate similar types of mystical, psychological, and philosophical-existential insights predictive of wellbeing: A qualitative-quantitative approach}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/ugr69\_v2}{doi:10.31234/osf.io/ugr69\_v2}.
\item Wall MB, Carhart-Harris RL. (2025). \textit{Human neuroimaging: fMRI.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/bs.irn.2025.04.013}{doi:10.1016/bs.irn.2025.04.013}.
\item Czopek A, Jończyk J, Fryc M, Kluzik D, Zagórska A. (2025). \textit{Classic Psychedelics in Pain Modulation: Mechanisms, Clinical Evidence, and Future Perspectives.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/acschemneuro.5c00152}{doi:10.1021/acschemneuro.5c00152}.
\item Unknown authors (2025). \textit{Meditation and psychedelics facilitate similar types of mystical, psychological, and philosophical-existential insights predictive of wellbeing: A qualitative-quantitative approach}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/ugr69\_v2}{source link}.
\item Matthew Hicks (2025). \textit{Low-Income Group Psilocybin Assisted Therapy for Depression: A Feasibility Study}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06372197}{source link}.
\item National University of Natural Medicine (2025). \textit{Optimizing Microdosing and Meditation}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06560658}{source link}.
\item Subha Subramanian, Travis Rick Reneau, Demetrius Perry, Ravi V. Chacko, Timothy O. Laumann, Karin Flavin, Christine Horan, Julia Schweiger, Nicholas V. Metcalf, Eric J. Lenze, Abraham Z. Snyder, Nico U.F. Dosenbach, Ginger E. Nicol, Joshua S. Siegel (2025). \textit{Psilocybin’s acute and persistent brain effects: a precision imaging drug trial}. Scientific Data. [published; OpenAlex]. \href{https://doi.org/10.1038/s41597-025-05189-0}{doi:10.1038/s41597-025-05189-0}.
\item Lashgari NA, Khalaji M, Rana P, Badrabadi F, Rahnama M, Nasoori H, Momeni Roudsari N, Khosravi Nia MM, Shafaroodi H. (2025). \textit{Psychedelics in the Treatment of Neurologic and Psychiatric Disorders: Coincidence or a New Point of View.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s12035-025-05097-9}{doi:10.1007/s12035-025-05097-9}.
\item Judith Stirn, Raphael Berger, Harald Hübner, Peter Gmeiner, Christian D. Klein (2025). \textit{Towards "unmakable" psychedelics: SAR exploration of psilocin analogs obtained by a HATU-mediated amide coupling strategy}. European Journal of Medicinal Chemistry Reports. [published; OpenAlex]. \href{https://doi.org/10.1016/j.ejmcr.2025.100278}{doi:10.1016/j.ejmcr.2025.100278}.
\item Abigail M. Blanton, Pooja Parikh, Scott Zhou, Mohamed Mohamed, Rafael Ufret-Vincenty, Ronald Mancini (2025). \textit{Self-inflicted transorbital intracranial foreign body following ingestion of hallucinogenic psilocybin mushrooms}. American Journal of Ophthalmology Case Reports. [published; OpenAlex]. \href{https://doi.org/10.1016/j.ajoc.2025.102359}{doi:10.1016/j.ajoc.2025.102359}.
\item Cali James (2025). \textit{In vitro assessment of psilocin for CYP-dependent drug-drug interaction potential using rapid luminescent assays}. Drug Metabolism and Pharmacokinetics. [published; Crossref]. \href{https://doi.org/10.1016/j.dmpk.2025.101231}{doi:10.1016/j.dmpk.2025.101231}.
\item Kolasa M, Nikiforuk A, Korlatowicz A, Solich J, Potasiewicz A, Dziedzicka-Wasylewska M, Bugno R, Hogendorf A, Bojarski A, Faron-Górecka A (2025). \textit{Correction to: Unraveling psilocybin's therapeutic potential: behavioral and neuroplasticity insights in Wistar-Kyoto and Wistar male rat models of treatment-resistant depression.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-024-06654-1}{doi:10.1007/s00213-024-06654-1}.
\item Weleff J, Pulido-Saavedra A, Aghaei AM, Ing K, Arakelian M, Fontenele R, Nero N, Barnett BS, Anand A, Bassir Nia A, Angarita GA (2025). \textit{The therapeutic effects of psychedelics for opioid use disorder: A systematic review of clinical studies.}. Psychiatry research. [published; PubMed]. \href{https://doi.org/10.1016/j.psychres.2025.116446}{doi:10.1016/j.psychres.2025.116446}.
\item Klim C, VanDreese B, Meyerhoefer T, Breitinger S (2025). \textit{Innovation and inequity in psychedelic research at the Mayo Clinic.}. History of psychiatry. [published; PubMed]. \href{https://doi.org/10.1177/0957154x251318489}{doi:10.1177/0957154x251318489}.
\item Fonzo GA, Doss MK, Nemeroff CB. (2025). \textit{There's More Than One Way to Bring Health Back: Divergent Effects of Psilocybin and Escitalopram Treatment on Emotional Brain Function in Depression.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1176/appi.ajp.20250247}{doi:10.1176/appi.ajp.20250247}.
\item Toby A. Clark (2025). \textit{Mystical States \& Psilocybin. From Dissociation Towards Association: A Conversational Model Discussion}. The Therapeutic Conversation. [published; OpenAlex]. \href{https://doi.org/10.66330/100520252}{doi:10.66330/100520252}.
\item Berkovitch L, Fauvel B, Preller KH, Gaillard R. (2025). \textit{Neurocognitive effects of psilocybin: A systematic and comprehensive review of neuroimaging studies in humans.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neubiorev.2025.106239}{doi:10.1016/j.neubiorev.2025.106239}.
\item Joseph K, Collins J, Genovese T, Maxwell M, Lieberman JA, Osten P. (2025). \textit{Converging pathways: shared brain circuitry engaged by monoaminergic antidepressants, ketamine and psilocybin}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2025.05.26.655791}{doi:10.1101/2025.05.26.655791}.
\item Unknown authors (2025). \textit{Publisher’s Note re: “Effects of Psilocybin on Religious and Spiritual Attitudes and Behaviors in Clergy from Various Major World Religions” (doi: 10.1089/psymed.2023.0044)}. Psychedelic Medicine. [published; OpenAlex]. \href{https://doi.org/10.1089/psymed.2025.68798.pn}{doi:10.1089/psymed.2025.68798.pn}.
\item Yale University (2025). \textit{Exploration of Synaptotrophic Effects of Psilocybin in Opioid Use Disorder (OUD)}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06160284}{source link}.
\item Fitzgerald PB, Webb SL, Denning NC, Dowie T, Schweickle MM, Modak A, Chan G, Knight J, Waldron M, Gainsford K, Hawkes H, Zammit S, Sutanto NC, Fitzgibbon BM, Bailey NW. (2025). \textit{Understanding the Psychological Effects of Psilocybin and 3,4-Methylenedioxymethamphetamine in a Non-Clinical Population}. medRxiv. [preprint; medRxiv]. \href{https://doi.org/10.1101/2025.05.28.25328532}{doi:10.1101/2025.05.28.25328532}.
\item Araam Abboud, Clay M. Schiebrel, Ramzi W. Nahhas, Sam Durkin, Kyle Hua, Hannah Redding, Danielle Gainer (2025). \textit{Patients’ Attitudes Toward Hallucinogenic and Non-Hallucinogenic Psilocybin for Mental Health Treatment}. Journal of Psychoactive Drugs. [published; OpenAlex]. \href{https://doi.org/10.1080/02791072.2025.2511752}{doi:10.1080/02791072.2025.2511752}.
\item University Hospital, Basel, Switzerland (2025). \textit{Role of the Serotonin 2A Receptor in Psilocybin-induced Altered States of Consciousness (PDR-Study)}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06796361}{source link}.
\item Vella Y, Syrová K, Petrušková A, Koutrouli I, Kútna V, Pala J, Šíchová K, Nikolič M, Mazoch V, Jurok R, Kuchař M, Bendová Z, Páleníček T. (2025). \textit{Effects of serotonergic psychedelics on synaptogenesis and immediate early genes expression - comparison with ketamine, fluoxetine and lithium.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811251338232}{doi:10.1177/02698811251338232}.
\item Menge J, Evitt B. (2025). \textit{Pharmacologic interventions for alcohol use disorder.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1097/01.jaa.0000000000000106}{doi:10.1097/01.jaa.0000000000000106}.
\item Salma Laabi, Claire LeMmon, Callie Vogel, M. Chacón, Víctor M. Jiménez (2025). \textit{Psilocybin and psilocin regulate microglial immunomodulation and support neuroplasticity via serotonergic and AhR signaling}. International Immunopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/j.intimp.2025.114940}{doi:10.1016/j.intimp.2025.114940}.
\item Stéphanie Knatz Peck, Timothy D. Brewerton, Hannah M. Fisher, Julie Trim, Samantha Shao, Nadav Liam Modlin, Jessie Kim, Daphna M. Finn, Walter H. Kaye (2025). \textit{Therapeutic emergence of dissociated traumatic memories during psilocybin treatment for anorexia nervosa}. Journal of Eating Disorders. [published; OpenAlex]. \href{https://doi.org/10.1186/s40337-025-01274-2}{doi:10.1186/s40337-025-01274-2}.
\item Palmer C, Ferber AT, Greenwald BD. (2025). \textit{The Potential Role of Psilocybin in Traumatic Brain Injury Recovery: A Narrative Review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/brainsci15060572}{doi:10.3390/brainsci15060572}.
\item Johns Hopkins University (2025). \textit{Psilocybin-facilitated Smoking Cessation Treatment: A Pilot Study}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT01943994}{source link}.
\item Ines Erkizia-Santamaría, Nerea Martínez-Álvarez, Leyre Salinas-Novoa, J. Javier Meana, Jorge E. Ortega (2025). \textit{Role of endogenous serotonin in psychedelic-like effects of psilocybin in mice}. The International Journal of Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1093/ijnp/pyaf035}{doi:10.1093/ijnp/pyaf035}.
\item Charles Raison (2025). \textit{An Investigation of Strategies to Understand and Optimize the Antidepressant Effects of Psilocybin (The OPTIMIZE Study)}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06512194}{source link}.
\item Vogt SB, Liechti ME. (2025). \textit{Clinical pharmacology.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/bs.irn.2025.02.003}{doi:10.1016/bs.irn.2025.02.003}.
\item Hooper J, Williams S, Mueller R, Hutchison K. (2025). \textit{Age and cannabis co-use moderate experience and perceived benefits of psilocybin}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/dczw2\_v1}{doi:10.31234/osf.io/dczw2\_v1}.
\item Unknown authors (2025). \textit{Age and cannabis co-use moderate experience and perceived benefits of psilocybin}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/dczw2\_v1}{source link}.
\item Swieczkowski D, Kwaśny A, Sadko K, Pruc M, Gaca Z, Szarpak L, Cubała WJ. (2025). \textit{Lessons learned from the regulatory alignment in ketamine, esketamine and arketamine clinical trials: A cross-sectional analysis of protocols from ClinicalTrials.gov.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.psychres.2025.116559}{doi:10.1016/j.psychres.2025.116559}.
\item Hellman M (2025). \textit{We need to talk about shrooms.}. Nordisk alkohol- \& narkotikatidskrift: NAT. [published; PubMed]. \href{https://doi.org/10.1177/14550725251341722}{doi:10.1177/14550725251341722}.
\item McCoy K, Reed F, Conn K, Foldi CJ. (2025). \textit{Separate or inseparable? Serotonin and dopamine system interactions may underlie the therapeutic potential of psilocybin for anorexia nervosa.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.physbeh.2025.114957}{doi:10.1016/j.physbeh.2025.114957}.
\item Kit A, Conway K, Makarowski S, O'Regan G, Allen J, Shultz SR, Bodnar TS, Christie BR. (2025). \textit{Can the gut-brain axis provide insight into psilocybin's therapeutic value in reducing stress?}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.ynstr.2025.100732}{doi:10.1016/j.ynstr.2025.100732}.
\item Basedow LA, Lottes L, Falkenberg I, Vogelbacher C, Yildiz C. (2025). \textit{Under Pressure: Stronger depressive symptoms are associated with more positive expectations towards experimental treatments}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/6hjkm\_v1}{doi:10.31234/osf.io/6hjkm\_v1}.
\item University of Wisconsin, Madison (2025). \textit{Consciousness and Psilocybin Effects on Well-Being (The CoPE Study): Pilot Phase}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05592379}{source link}.
\item Unknown authors (2025). \textit{Under Pressure: Stronger depressive symptoms are associated with more positive expectations towards experimental treatments}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/6hjkm\_v1}{source link}.
\item Shelby A. McGriff, Jacquelin C Hecker, Alexander D. Maitland, John S. Partilla, Michael H. Baumann, Grant C. Glatfelter (2025). \textit{Psychedelic-like effects induced by 2,5-dimethoxy-4-iodoamphetamine, lysergic acid diethylamide, and psilocybin in male and female C57BL/6J mice}. Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1007/s00213-025-06795-x}{doi:10.1007/s00213-025-06795-x}.
\item Roland R. Griffiths, Robert L. Jesse, William A. Richards, Matthew W. Johnson, Nathan D. Sepeda, Anthony P. Bossis, Stephen Ross (2025). \textit{Effects of Psilocybin on Religious and Spiritual Attitudes and Behaviors in Clergy from Various Major World Religions}. Psychedelic Medicine. [published; OpenAlex]. \href{https://doi.org/10.1089/psymed.2023.0044}{doi:10.1089/psymed.2023.0044}.
\item Sara G. Gloeckler, Julien Thibault Lévesque, Alexandre Lehmann, Houman Farzin, Kyle T. Greenway (2025). \textit{Music and non-music approaches in psilocybin-assisted psychotherapy: The sound of silence}. Journal of Psychedelic Studies. [published; OpenAlex]. \href{https://doi.org/10.1556/2054.2024.00421}{doi:10.1556/2054.2024.00421}.
\item Abrahms ZN, Sen AK, Jones JA. (2025). \textit{Pathway engineering for the biosynthesis of psychedelics.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.copbio.2025.103314}{doi:10.1016/j.copbio.2025.103314}.
\item Icahn School of Medicine at Mount Sinai (2025). \textit{Investigating the Role of Serotonin in the Mechanism of Action of Psilocybin in Patients With Major Depressive Disorder}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06592833}{source link}.
\item Wingert AM, Agnorelli C, Peill J, Reed S, Nutt DJ, Erritzoe D. (2025). \textit{Serotonergic psychedelics for depression: A comprehensive overview.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/bs.irn.2025.04.009}{doi:10.1016/bs.irn.2025.04.009}.
\item Morris R, Keeler J, Treasure J, Himmerich H. (2025). \textit{The pharmacological treatment of anxiety in people with eating disorders: A systematic review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.phrs.2025.107782}{doi:10.1016/j.phrs.2025.107782}.
\item Longwei Yang, Haohong Li, Xiaohui Wang (2025). \textit{Psilocybin and Obsessive-Compulsive Disorder: Exploring New Therapeutic Horizons}. Neuroscience Bulletin. [published; OpenAlex]. \href{https://doi.org/10.1007/s12264-025-01415-2}{doi:10.1007/s12264-025-01415-2}.
\item Queen's University (2025). \textit{A Phase 2a, Placebo-Controlled Randomized, Double-Blind Trial to Evaluate the Safety, Tolerability, and Preliminary Efficacy of Psilocybin Oral Solution in Adults With Generalized Anxiety Disorder}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06969170}{source link}.
\item Muller S, Cavanna F, de la Fuente LA, Bruno N, D’Amelio TA, Pallavicini C, Tagliazucchi E. (2025). \textit{Psilocybin-induced modulation of visual salience processing}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2025.05.10.652897}{doi:10.1101/2025.05.10.652897}.
\item Estric C, Duron T, Kabani S, Lopez-Castroman J. (2025). \textit{Set and setting of psychedelics for therapeutic use in psychiatry: A systematic review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811251338214}{doi:10.1177/02698811251338214}.
\item Syed OA, Petranker R, Tsang B. (2025). \textit{The effect of psychedelic microdosing on animal behavior: A review with recommendations for the field.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neubiorev.2025.106204}{doi:10.1016/j.neubiorev.2025.106204}.
\item Chen MJQ, Chen-Li D, Chisamore N, Husain MI, Di Vincenzo JD, Mansur RB, Phan L, Johnson D, McIntyre RS, Rosenblat JD. (2025). \textit{Non-hallucinogenic psychedelics for mood and anxiety disorders: A systematic review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.psychres.2025.116532}{doi:10.1016/j.psychres.2025.116532}.
\item Wang H, Wang X (2025). \textit{Exploring the Role of Psychedelics in Modulating Ego and Treating Neuropsychiatric Disorders.}. ACS chemical neuroscience. [published; PubMed]. \href{https://doi.org/10.1021/acschemneuro.5c00247}{doi:10.1021/acschemneuro.5c00247}.
\item Grant Jones (2025). \textit{Race/ethnicity moderates the associations between lifetime psilocybin use and opioid use disorder}. PLoS ONE. [published; OpenAlex]. \href{https://doi.org/10.1371/journal.pone.0321461}{doi:10.1371/journal.pone.0321461}.
\item Sharmin Ghaznavi (2025). \textit{The Effects of Psilocybin on Self-Focus and Self-Related Processing in Major Depressive Disorder}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06247839}{source link}.
\item Wang Z, Robbins B, Zhuang R, Bruggen Rv, Sandini T, Li X, Zhang Y. (2025). \textit{Psilocybin Mitigates Behavioral Despair and Cognitive Impairment in Treatment-resistant Depression Model using Wistar Kyoto Rats}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-5493661/v1}{doi:10.21203/rs.3.rs-5493661/v1}.
\item Kratina S, Strike C, Schwartz R, Nayfeh A, Jopling S, Lo C, Rush B. (2025). \textit{A protocol for a scoping review of variations among psychedelic interventions for psychological suffering associated with the end-of-life.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1371/journal.pone.0318343}{doi:10.1371/journal.pone.0318343}.
\item Nick Zschoche, Sebastian Johannes Schober, Karl Walther, A.R. Chadeayne, Markus Gressler, Stefan Bartram, Sarah E. O’Connor, Dirk Hoffmeister (2025). \textit{Clade III Synthases Add Cyclic and Linear Terpenoids to the Psilocybe Metabolome}. ChemBioChem. [published; OpenAlex]. \href{https://doi.org/10.1002/cbic.202500167}{doi:10.1002/cbic.202500167}.
\item Vejmola Č, Šíchová K, Syrová K, Janečková L, Koudelka V, Tesař M, Nikolič M, Viktorinová M, Tylš F, Korčák J, Viktorin V, Kelemen E, Nekovářová T, Brunovský M, Horáček J, Kuchař M, Páleníček T. (2025). \textit{Cross-Species Evidence for Psilocin-Induced Visual Distortions: Apparent Motion Is Perceived by Both Humans and Rats.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.bpsgos.2025.100524}{doi:10.1016/j.bpsgos.2025.100524}.
\item Martina Colognesi, Daniela Gabbia, Anna Signor, Stefano Comai, Andrea Mattarei, Gianfranco Pasut, Lucia Centofanti, Stefano La Rosa, Giovanna Finzi, Franco Folli, M. Pappagallo, Paolo L. Manfredi, Sara De Martin (2025). \textit{FRI-407 Adding the serotonergic agonist psilocybin to semaglutide as a novel combination therapy to cure MASLD}. Journal of Hepatology. [published; OpenAlex]. \href{https://doi.org/10.1016/s0168-8278(25)01632-0}{doi:10.1016/s0168-8278(25)01632-0}.
\item Anna Lasch, Timo Schweikert, Eva Dora, Theresa Kolb, Hanne Lilian Schurig, Andreas Walther (2025). \textit{Psilocybin-gestützte Therapie von Depression, Angst und Suchtstörungen: Neurobiologische Grundlagen und klinische Anwendung}. Nervenheilkunde. [published; OpenAlex]. \href{https://doi.org/10.1055/a-2517-1621}{doi:10.1055/a-2517-1621}.
\item Jonathan A. Leighton, Carmen Lau, Aisha Savdo, L Granata (2025). \textit{Clinical treatment of cluster headache with the serotonergic indoleamine psychedelics psilocybin and LSD and with ketamine: A case series}. Cephalalgia Reports. [published; OpenAlex]. \href{https://doi.org/10.1177/25158163251345472}{doi:10.1177/25158163251345472}.
\item Inés de Lannoy, Lilia Magomedova, Julia Izhakova, Christina de Rivera, James Lanthier, Jason Atkinson, Guy A. Higgins, Malik Slassi, Joseph A. Araujo (2025). \textit{Pharmacokinetics (PK) of psilocybin and psilocin in plasma following intravenous administration of psilocin and oral administration of psilocybin to male beagle dogs}. Journal of Pharmacological and Toxicological Methods. [published; OpenAlex]. \href{https://doi.org/10.1016/j.vascn.2025.107663}{doi:10.1016/j.vascn.2025.107663}.
\item Romeo B, Kervadec E, Fauvel B, Strika-Bruneau L, Amirouche A, Bezo A, Piolino P, Benyamina A (2025). \textit{The intensity of the psychedelic experience is reliably associated with clinical improvements: A systematic review and meta-analysis.}. Neuroscience and biobehavioral reviews. [published; PubMed]. \href{https://doi.org/10.1016/j.neubiorev.2025.106086}{doi:10.1016/j.neubiorev.2025.106086}.
\item Weintraub MJ, Miklowitz DJ, Jeffrey JK. (2025). \textit{Divergent Effects of Psilocybin for 2 Patients Participating in a Psilocybin-assisted Cognitive Behavioral Therapy Trial for Major Depressive Disorder.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1097/pra.0000000000000853}{doi:10.1097/pra.0000000000000853}.
\item Acero VP, Flatt TA, Gooch PM, Gaughan SJ, Levin AW, Davis AK (2025). \textit{From molecules to meaning: unpacking the antidepressant mechanisms of psychedelic drugs.}. Expert review of clinical pharmacology. [published; PubMed]. \href{https://doi.org/10.1080/17512433.2025.2515866}{doi:10.1080/17512433.2025.2515866}.
\item Gale Wohlfarth (2025). \textit{Psilocybin Mushrooms: Identifying the Profile of the Most Likely Users}. DigitalCommons - Kennesaw State University (Kennesaw State University). [published; OpenAlex]. \href{https://digitalcommons.kennesaw.edu/undergradsymposiumksu/spring2025/spring2025/26}{source link}.
\item Kim Hoffman, Todd P. Korthuis, Kellie Pertl, David Morgan (2025). \textit{Improving Best Practice Indicators for Psilocybin Assisted Therapy Using a Mul-tiphase Mixed Methods Delphi Study}. International Journal of Multiple Research Approaches. [published; OpenAlex]. \href{https://doi.org/10.29034/ijmra.v17n1a1}{doi:10.29034/ijmra.v17n1a1}.
\item Unknown authors (2025). \textit{Psilocybin-assisted therapy shows range of benefits in cancer patients}. The Brown University Psychopharmacology Update. [published; OpenAlex]. \href{https://doi.org/10.1002/pu.31316}{doi:10.1002/pu.31316}.
\item Unknown authors (2025). \textit{Trial finds psilocybin improves symptoms in treatment-resistant depression}. The Brown University Psychopharmacology Update. [published; OpenAlex]. \href{https://doi.org/10.1002/pu.31317}{doi:10.1002/pu.31317}.
\item Wang Y, Li T, Reynolds E, Wang Z, Torrens-Spence M, Weng J. (2025). \textit{Calcium Activation Mechanism of a Noncanonical Aromatic L-Amino Acid Decarboxylase from Psilocybin Mushroom}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-6329392/v1}{doi:10.21203/rs.3.rs-6329392/v1}.
\item Shayla Frinton, Jill O. Robinson (2025). \textit{University Students’ Motives for Psilocybin Use: A Mixed-Methods Analysis}. Journal of Drug Issues. [published; OpenAlex]. \href{https://doi.org/10.1177/00220426251338187}{doi:10.1177/00220426251338187}.
\item Rebecca Harding, Neomi Singer, Matthew B. Wall, Talma Hendler, David Erritzøe, David Nutt, Robin Carhart-Harris, Leor Roseman (2025). \textit{Dissociable effects of psilocybin and escitalopram for depression on processing of musical surprises}. Molecular Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1038/s41380-025-03035-8}{doi:10.1038/s41380-025-03035-8}.
\item Centre for Addiction and Mental Health (2025). \textit{Treatment With Psilocybin for Chronic Neuropathic Pain and Depression (TRANSCEND): An Open-Label Clinical Trial}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06518720}{source link}.
\item Romeo B, Kervadec E, Fauvel B, Strika-Bruneau L, Amirouche A, Verroust V, Piolino P, Benyamina A (2025). \textit{Exploring Factors Affecting Psychological Flexibility After Psychedelic Experiences.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2025.2495937}{doi:10.1080/02791072.2025.2495937}.
\item Antonio Metastasio, Elisabeth Prevete, Sofia Venturini, Andrea Garofalo, Beatrice Cecconello, Nicola De Pisapia, Ornella Corazza (2025). \textit{The phenomenology of psilocybin: transformative insights for research and clinical practice}. Frontiers in Psychology. [published; OpenAlex]. \href{https://doi.org/10.3389/fpsyg.2025.1455902}{doi:10.3389/fpsyg.2025.1455902}.
\item Damian Świeczkowski, Aleksander Kwaśny, Michał Pruc, Zuzanna Gaca, Łukasz Szarpak, Wiesław Jerzy Cubała (2025). \textit{Psilocybin-assisted psychotherapy as a rapid-acting treatment for cancer-related depression and anxiety: Evidence from a network meta-analysis}. The International Journal of Psychiatry in Medicine. [published; OpenAlex]. \href{https://doi.org/10.1177/00912174251337572}{doi:10.1177/00912174251337572}.
\item Jérémie Richard, Jeremy Scott, Sandeep M. Nayak, Nathan D. Sepeda, Matthew X. Lowe, Heather Jackson, Albert Garcia-Romeu (2025). \textit{Patterns of Internalizing Problems, Substance Use and Cognitive Flexibility Before and After Naturalistic Psilocybin Use: A Repeated Measures Latent Profile Analysis}. International Journal of Mental Health and Addiction. [published; OpenAlex]. \href{https://doi.org/10.1007/s11469-025-01489-z}{doi:10.1007/s11469-025-01489-z}.
\item Williams ML, Rudin D, Schmid Y, von Salm J. (2025). \textit{Editorial: Beyond psilocybin: exploring the clinical potential of alternative and novel psychedelics.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fpsyt.2025.1600812}{doi:10.3389/fpsyt.2025.1600812}.
\item Cummins BR, Billac GB, Nichols DE, Nichols CD. (2025). \textit{5-HT2A receptors: Pharmacology and functional selectivity.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.pharmr.2025.100059}{doi:10.1016/j.pharmr.2025.100059}.
\item Borgogna NC, Owen T, Petrovitch D, Vaughn J, Johnson DAL, Pagano LA, Aita SL, Hill BD. (2025). \textit{Incremental efficacy systematic review and meta-analysis of psilocybin-for-depression RCTs.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s00213-025-06788-w}{doi:10.1007/s00213-025-06788-w}.
\item Butler M, Bird C, Maggio C, Durden A, Modlin N, Campbell-Coker K, Edwards M, Pick S, Millman LM, Lowery E, Bhagavan C, Kanaan R, Golder D, Mildon B, Mehta M, Rucker J, Nicholson TR. (2025). \textit{Probing the functional magnetic resonance imaging response to psilocybin in functional neurological disorder (PsiFUND): study protocol}. Wellcome Open Res. [preprint; Europe PMC]. \href{https://doi.org/10.12688/wellcomeopenres.22543.2}{doi:10.12688/wellcomeopenres.22543.2}.
\item Lapid MI, Pagali SR, Randall AL, Donovan KA, Bronars CA, Gauthier TA, Bock J, Lim SD, Carey EC, Sokolowski E, Ulrich AM, Hassett LC, Kung S, Whitford KJ, Olivier KR, D'Andre SD. (2025). \textit{Evaluating the effectiveness of psilocybin in alleviating distress among cancer patients: A systematic review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1017/s147895152500032x}{doi:10.1017/s147895152500032x}.
\item Jonathan Cohen, Liron Sulimani, Shiri Procaccia, Yaniv Lerenthal, Looz Milay, Ido Taran, Anna Shapira, David Meiri (2025). \textit{Comprehensive analysis of 42 psilocybin-producing fungal strains reveals metabolite diversity and species-specific clusters}. Scientific Reports. [published; OpenAlex]. \href{https://doi.org/10.1038/s41598-025-97710-z}{doi:10.1038/s41598-025-97710-z}.
\item Falchi-Carvalho M, Palhano-Fontes F, Wießner I, Barros H, Bolcont R, Laborde S, Ruschi B Silva S, Montanini D, C Barbosa D, Teixeira E, Florence-Vilela R, Almeida R, K A de Macedo R, Arichelle F, J Pantrigo É, V Costa-Macedo J, da Cruz Nunes JA, de Araújo Costa Neto LA, Nunes Ferreira LF, Dantas Corrêa L, da Costa Bezerra RB, Arcoverde E, Galvão-Coelho N, B Araujo D. (2025). \textit{Rapid and sustained antidepressant effects of vaporized N,N-dimethyltryptamine: a phase 2a clinical trial in treatment-resistant depression.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41386-025-02091-6}{doi:10.1038/s41386-025-02091-6}.
\item Godfrey K, Luan LX, Timmermann C. (2025). \textit{Effects of psychedelics on human oscillatory brain activity.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/bs.irn.2025.04.012}{doi:10.1016/bs.irn.2025.04.012}.
\item DuPont CM, Johnson MW. (2025). \textit{Psychedelics and substance use disorder treatment.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/bs.irn.2025.03.005}{doi:10.1016/bs.irn.2025.03.005}.
\item Nilubon Thaoboonruang, Ornrat Lohitnavy, Kimheang Ya, Manupat Lohitnavy (2025). \textit{Development of a PBPK model of psilocybin/psilocin from Psilocybe cubensis (magic mushroom) in mice, rats, and humans}. Scientific Reports. [published; OpenAlex]. \href{https://doi.org/10.1038/s41598-025-98202-w}{doi:10.1038/s41598-025-98202-w}.
\item Karilynn Rockhill, Joshua C. Black, Michael S. Ladka, Kanku B. Sumbundu, Heather Olsen, Jennifer S. Jewell, Joshua C. Hunt, R. Cameron Wolf, Karuna Nerurkar, Richard C. Dart, Andrew A. Monte (2025). \textit{The Rise of Psilocybin Use in the United States: A Multisource Observational Study}. Annals of Internal Medicine. [published; OpenAlex]. \href{https://doi.org/10.7326/annals-24-03145}{doi:10.7326/annals-24-03145}.
\item Mimms C, Sotelo K, Khaliq AS. (2025). \textit{Comparative Efficacy and Functional Outcomes of Psychedelic-Assisted Therapies in Treatment-Resistant Depression: A Systematic Review of Recent Clinical Trials.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.7759/cureus.82532}{doi:10.7759/cureus.82532}.
\item Michel Dorval, Sue-Ling Chang, Houman Farzin, Olivia Nguyen, Jean-François Stephan, Diane Tapp, P. Deschamps, Yann Joly, Florence Moureaux, Robert Foxman, Marianne Masse-Grenier, Jean-Sébastien Fallu (2025). \textit{Roadmap for Equitable Access and Responsible Use of Psilocybin-Assisted Psychotherapy in Palliative Care}. Palliative Medicine Reports. [published; OpenAlex]. \href{https://doi.org/10.1089/pmr.2024.0108}{doi:10.1089/pmr.2024.0108}.
\item Artur Pałasz, Marta Pukowiec, Katarzyna Bogus, Aleksandra Suszka-Świtek, Łukasz Filipczyk, Kinga Mordecka-Chamera, John J. Worthington, Maria Sygidus, Adam Wojtas, Agnieszka Bysiek, Krystyna Gołembiowska (2025). \textit{Psilocybin and ketamine affect novel neuropeptides gene expression in the rat hypothalamus}. Journal of Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1177/02698811251330783}{doi:10.1177/02698811251330783}.
\item Damian Świeczkowski, Aleksander Kwaśny, Michał Pruc, Zuzanna Gaca, Łukasz Szarpak, Wiesław Jerzy Cubała (2025). \textit{Regulatory Alignment of Psilocybin Clinical Trials in Major Depressive Disorder on ClinicalTrials.gov: A Cross-Sectional Analysis}. Pharmacopsychiatry. [published; OpenAlex]. \href{https://doi.org/10.1055/a-2529-7029}{doi:10.1055/a-2529-7029}.
\item Kevin Boehnke (2025). \textit{A Phase 2a, Open-label, Pilot Study to Assess the Safety and Efficacy of Psilocybin Administration in Concert With Psychotherapy Among Adult Patients With Fibromyalgia}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05128162}{source link}.
\item Madeleine R. Keller, Madeline G. McKinney, Abhishek K. Sen, Felicia G Guagliardo, Elle B. Hellwarth, Khondokar Nowshin Islam, Nicholas A. Kaplan, William J. Gibbons, Grace E Kemmerly, Chance Meers, Xin Wang, J. Andrew Jones (2025). \textit{Psilocybin biosynthesis enhancement through gene source optimization}. Metabolic Engineering. [published; OpenAlex]. \href{https://doi.org/10.1016/j.ymben.2025.04.003}{doi:10.1016/j.ymben.2025.04.003}.
\item Meshkat S, Malik G, Zeifman RJ, Swainson J, Balachandra K, Reichelt AC, Zhang Y, Burback L, Winkler O, Greenshaw A, Vermetten E, Mayo LM, Tanguay R, Jetly R, Bhat V. (2025). \textit{Efficacy and safety of psilocybin for the treatment of substance use disorders: A systematic review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neubiorev.2025.106163}{doi:10.1016/j.neubiorev.2025.106163}.
\item Arya Afrooghe, Elham Ahmadi, Ali Lesani, Mahya Soleymani Mehranjani, Mohammad Elahi, Mohammadreza Babaei, Maryam Shayan, Hamed Shafaroodi, Razieh Mohammad Jafari, Alireza Foroumadi, Mohammad Amin Manavi, Ahmad Reza Dehpour (2025). \textit{Psilocin alleviates acute itch in mice: possible involvement of 5-HT2A receptors and kynurenine pathway}. Naunyn-Schmiedeberg s Archives of Pharmacology. [published; OpenAlex]. \href{https://doi.org/10.1007/s00210-025-04152-5}{doi:10.1007/s00210-025-04152-5}.
\item Felix Mueller (2025). \textit{The Role of Personal Experience for the Therapeutic Attitude in the Context of Substance-assisted Therapy Training}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05570708}{source link}.
\item Effinger DP, Schalk SS, King JL, Strong JR, O’Connell CK, Calderon JR, McCorvy JD, Thompson SM. (2025). \textit{Assessing the potential cardiovascular risk of microdosing the psychedelic LSD in mice}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2025.04.08.647757}{doi:10.1101/2025.04.08.647757}.
\item Novelli L, Stoliker D, Barta T, Greaves MD, Chopra S, Jackson J, Kwee J, Williams ML, Razi A. (2025). \textit{PsiConnect: A Multimodal Neuroimaging Study of Psilocybin-Induced Changes in Brain and Behaviour}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2025.04.11.643415}{doi:10.1101/2025.04.11.643415}.
\item University Hospital, Basel, Switzerland (2025). \textit{Acute Dose-dependent Effects of DMT-bolus Applications in Healthy Subjects: A Placebo-controlled Cross-over Study (DMT BDR-Study).}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05695495}{source link}.
\item Turizo Smith AD, Botero Jsramillo N, Berrio Cuartas DM. (2025). \textit{Psilocybin as a Tool in the Management of Palliative Care: An Historical, Pharmacological, and Clinical Approach}. Preprints.org. [preprint; Europe PMC]. \href{https://doi.org/10.20944/preprints202504.0888.v1}{doi:10.20944/preprints202504.0888.v1}.
\item Kargbo RB. (2025). \textit{Targeting Phantom Pain with Psilocybin: Toward Integration with Adaptive Sensory Technologies.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/acsmedchemlett.5c00182}{doi:10.1021/acsmedchemlett.5c00182}.
\item Umbacia MA, Leon MX, Quintero JM, Castro LM, Paez V, Dodd S, Bustos RH. (2025). \textit{Exploring psilocybin's role in mental health and palliative medicine: a path to improved well-being.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/14728214.2025.2488786}{doi:10.1080/14728214.2025.2488786}.
\item Chuck T. Chen, Aidan D Tyrrell, Darryl Hudson, Ralph Landau, Adam H. Metherel, Richard P. Bazinet (2025). \textit{458. Microdoses of Psilocybin Combined With Eugenol are Absorbed and Induce Unique Cerebellar Gene Expression}. Biological Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.biopsych.2025.02.696}{doi:10.1016/j.biopsych.2025.02.696}.
\item Scott Aaronson, Tammy Miller, Audrey Shoultz, Bryce Lund, Jeffrey LaPratt, Margo Lauterbach, Kim Swartz, Andrew van der Vaart (2025). \textit{630. Synthetic Psilocybin (COMP360) for Chronic Active Suicidal Ideation: An Open-Label Study}. Biological Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.biopsych.2025.02.869}{doi:10.1016/j.biopsych.2025.02.869}.
\item Orly Lipsitz, Joshua D. Rosenblat (2025). \textit{194. Improving Workplace and Psychosocial Function in Treatment-Resistant Depression: Exploratory Outcomes From an Open-Label Feasibility Trial of Psilocybin-Assisted Psychotherapy}. Biological Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.biopsych.2025.02.431}{doi:10.1016/j.biopsych.2025.02.431}.
\item Erica Kaczmarek, Nelson B. Rodrigues, Noah Chisamore, Zoe Doyle, Roger S. McIntyre, Rodrigo B. Mansur, Joshua D. Rosenblat (2025). \textit{187. Changes in Symptoms of Anhedonia With Psilocybin-Assisted Psychotherapy: A Secondary Analysis of a Randomized Clinical Trial for Treatment-Resistant Depression}. Biological Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.biopsych.2025.02.424}{doi:10.1016/j.biopsych.2025.02.424}.
\item Danica E. Johnson, Erica Kaczmarek, Noah Chisamore, Orly Lipitz, Zoe Doyle, Rodrigo B. Mansur, Roger S. McIntyre, Joshua D. Rosenblat (2025). \textit{186. Assessing Cognitive Outcomes in Treatment-Resistant Depression Following Psilocybin-Assisted Psychotherapy}. Biological Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.biopsych.2025.02.423}{doi:10.1016/j.biopsych.2025.02.423}.
\item Ashton Barber, Sydney Gifford, Patrick H. Roseboom, Jonathan A. Oler, Nate Jones, Molly C. Pellitteri-Hahn, Cameron O. Scarlett, Cody J. Wenthur, Paul R. Hutson, Ned H. Kalin (2025). \textit{58. Acute Behavioral Effects of Psilocybin and Its Pharmacokinetics in Nonhuman Primates}. Biological Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.biopsych.2025.02.295}{doi:10.1016/j.biopsych.2025.02.295}.
\item Xue Zhang, Emily Zhai, Claire Bertrand, Sara Ellis, Isabelle Wydler, Anna J. Donnelly, Trisha Suppes, Leanne M. Williams (2025). \textit{166. Dynamic Mediodorsal Thalamus Activity Predicts and Reflects Longitudinal Treatment Outcomes in Psilocybin Therapy for Treatment-Resistant Depression}. Biological Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.biopsych.2025.02.403}{doi:10.1016/j.biopsych.2025.02.403}.
\item Danielle Bukovsky, Aron Amaev, Jianmeng Song, Edgardo Torres Carmona, S. Lauren Kyte, Fumihiko Ueno, Vincenzo De Luca, Christopher R. Bowie, Alastair J. Flint, Muhammad Ishrat Husain, Ariel Graff-Guerrero, Philip Gerretsen (2025). \textit{13. Safety, Feasibility, and Tolerability of Psilocybin in Older Adults With Amnestic MCI: Preliminary Data From a SV2a PET Imaging Study}. Biological Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.biopsych.2025.02.250}{doi:10.1016/j.biopsych.2025.02.250}.
\item Nathalie M. Rieser, Raoul Bitar, Halm Simon, Christina Rossgoderer, Ladina P Gubser, Maeva Thévenaz, Yara Kreis, Robin von Rotz, Carlos Nordt, Flora Moujaes, Etna Engeli, Andres Ort, Erich Seifritz, Franz X. Vollenweider, Katrin H. Preller (2025). \textit{595. Psilocybin-Assisted Therapy for Relapse Prevention in Alcohol Use Disorder: A RCT}. Biological Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.biopsych.2025.02.834}{doi:10.1016/j.biopsych.2025.02.834}.
\item Noah Chisamore, Erica Kaczmarek, Zoe Doyle, Danica E. Johnson, Rodrigo B. Mansur, Roger S. McIntyre, Joshua D. Rosenblat (2025). \textit{323. Comparing Antidepressant Effects of Psilocybin-Assisted Psychotherapy in Individuals That Were Unmedicated at Initial Screening Versus Individuals Discontinuing Medications for Study Participation}. Biological Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.biopsych.2025.02.561}{doi:10.1016/j.biopsych.2025.02.561}.
\item University of Otago (2025). \textit{Psilocybin-assisted Interpersonal Therapy for Depression}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05581797}{source link}.
\item Omidian H, Omidian A. (2025). \textit{The Emergence of Psilocybin in Psychiatry and Neuroscience.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/ph18040555}{doi:10.3390/ph18040555}.
\item Lu OD, White K, Raymond K, Liu C, Klein AS, Green N, Vaillancourt S, Gallagher A, Shindy L, Li A, Wallquist K, Li R, Zou M, Casey AB, Cameron LP, Pomrenze MB, Sohal V, Kheirbek MA, Gomez AM, Lammel S, Heifets BD, Malenka R. (2025). \textit{A multi-institutional investigation of psilocybin’s effects on mouse behavior}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2025.04.08.647810}{doi:10.1101/2025.04.08.647810}.
\item Tim Schäfer, Alexander M. Sherwood, Thomas A. Kirkland, Thomas Krüger, Jakob Worbs, Olaf Kniemeyer, Markus Gressler, Dirk Hoffmeister (2025). \textit{In Vitro Psilocybin Synthesis by Co-Immobilized Enzymes}. Chemistry - A European Journal. [published; OpenAlex]. \href{https://doi.org/10.1002/chem.202501037}{doi:10.1002/chem.202501037}.
\item Ellen Bradley, Kimberly Sakai, Gisele Fernandes-Osterhold, Balázs Szigeti, Connie Ludwig, Jill L. Ostrem, Caroline M. Tanner, Meredith Bock, Katiah Llerena, Patrick R. Finley, Aoife O’Donovan, José Rafael P. Zuzuárregui, Zachary Busby, Amber McKernan, Andrew Penn, Aliss C.C. Wang, Raymond C. Rosen, Joshua Woolley (2025). \textit{Psilocybin therapy for mood dysfunction in Parkinson’s disease: an open-label pilot trial}. Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1038/s41386-025-02097-0}{doi:10.1038/s41386-025-02097-0}.
\item Emmanuelle A. D. Schindler, Christopher Gottschalk, Deepak Cyril D’Souza (2025). \textit{Psilocybin’s Effects on Headache Frequency are Not Related to Acute Psychedelic Effects or Measures of Mental Health: Secondary Analysis of Clinical Trials in Migraine and Cluster Headache (P7-12.001)}. Neurology. [published; OpenAlex]. \href{https://doi.org/10.1212/wnl.0000000000210945}{doi:10.1212/wnl.0000000000210945}.
\item Ammineni D, Park R. (2025). \textit{The compulsive eating paradigm: can psychedelics help in treating obesity?}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1186/s40337-024-01186-7}{doi:10.1186/s40337-024-01186-7}.
\item Gattuso JJ, Wilson C, Hannan AJ, Renoir T. (2025). \textit{Letter to the editor: Comments on 'Striking long-term beneficial effects of single-dose psilocybin and psychedelic mushroom extract in the SAPAP3 rodent model of OCD-like excessive self-grooming' by Brownstien et al. (2024).}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41380-025-03005-0}{doi:10.1038/s41380-025-03005-0}.
\item Ana Cláudia Mesquita Garcia (2025). \textit{Therapeutic Potential of Psilocybin-Assisted Therapy in Hospice and Palliative Care}. Revista Cacto - Ciência Arte Comunicação em Transdisciplinaridade Online. [published; OpenAlex]. \href{https://doi.org/10.31416/cacto.v5i1.1448}{doi:10.31416/cacto.v5i1.1448}.
\item Totomanova I, Haijen ECHM, Hurks PPM, Ramaekers JG, Kuypers KPC. (2025). \textit{Potential therapeutic effects of psychedelics in small doses: Is there a role for microdosing in psychiatry?}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/bs.irn.2025.03.002}{doi:10.1016/bs.irn.2025.03.002}.
\item Agnorelli C, Spriggs M, Godfrey K, Sawicka G, Bohl B, Douglass H, Fagiolini A, Parastoo H, Carhart-Harris R, Nutt D, Erritzoe D. (2025). \textit{Neuroplasticity and psychedelics: A comprehensive examination of classic and non-classic compounds in pre and clinical models.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neubiorev.2025.106132}{doi:10.1016/j.neubiorev.2025.106132}.
\item Ling-Xiao Shao, Clara Liao, Pasha A. Davoudian, Neil K. Savalia, Quan Jiang, Cassandra Wojtasiewicz, Diran Tan, Jack D. Nothnagel, Rongjian Liu, Samuel C. Woodburn, Olesia M. Bilash, Hail Kim, Alicia Che, Alex C. Kwan (2025). \textit{Psilocybin’s lasting action requires pyramidal cell types and 5-HT2A receptors}. Nature. [published; OpenAlex]. \href{https://doi.org/10.1038/s41586-025-08813-6}{doi:10.1038/s41586-025-08813-6}.
\item Nathalie M. Rieser, Raoul Bitar, Simon Halm, Christina Rossgoderer, Ladina P Gubser, Maeva Thévenaz, Yara Kreis, Robin von Rotz, Carlos Nordt, Monika Visentini, Flora Moujaes, Etna Engeli, Andres Ort, Erich Seifritz, Franz Xaver Vollenweider, Marcus Herdener, Katrin H. Preller (2025). \textit{Psilocybin-assisted therapy for relapse prevention in alcohol use disorder: a phase 2 randomized clinical trial}. Universität Zürich, ZORA. [published; OpenAlex]. \href{https://doi.org/10.5167/uzh-284304}{doi:10.5167/uzh-284304}.
\item Niloufar Pouyan, Jacob S. Aday, David G. Williams, Kevin F. Boehnke, Steven E. Harte (2025). \textit{Pictorial Representation of Illness and Self Measure: A Putative Transdiagnostic Tool for Evaluating Therapeutic Effects of Psilocybin-Assisted Therapy in Fibromyalgia}. Journal of Pain. [published; OpenAlex]. \href{https://doi.org/10.1016/j.jpain.2025.105024}{doi:10.1016/j.jpain.2025.105024}.
\item Adriana Judit Batista, Hugo A. Almirón, Gisela Forlín, Natalia A. Ramírez, Orlando F. Popoff, Nicolás Niveiro (2025). \textit{Psilocybe cubensis y Panaeolus cyanescens (Basidiomycota, Agaricales), dos especies de hongos alucinógenos en el NE de Argentina}. Boletín de la Sociedad Argentina de Botánica. [published; OpenAlex]. \href{https://doi.org/10.31055/1851.2372.v60.n1.46185}{doi:10.31055/1851.2372.v60.n1.46185}.
\item Nicholas Gregory, Tyler E. Girard, Akila Ram, Austen B. Casey, Robert C. Malenka, Vivianne L. Tawfik, Boris D. Heifets (2025). \textit{Psilocybin Has No Analgesic Properties in Multiple Mouse Models of Acute and Chronic Pain}. Journal of Pain. [published; OpenAlex]. \href{https://doi.org/10.1016/j.jpain.2025.104862}{doi:10.1016/j.jpain.2025.104862}.
\item Octavian Brinzei (2025). \textit{Clarifying the legal landscape of psilocybin regulation: A medico-legal perspective}. Drug Science Policy and Law. [published; OpenAlex]. \href{https://doi.org/10.1177/20503245251337360}{doi:10.1177/20503245251337360}.
\item Unknown authors (2025). \textit{Psilocybin mushrooms (“Magic Mushrooms”)}. Organization of Teratology Information Specialists (OTIS), Brentwood (TN). [published; Europe PMC]. \href{https://europepmc.org/article/MED/35952083}{source link}.
\item Miller M, Meyers M, Martin A, Napolitano S, Dorsen C, Penn A, Rosa WE (2025). \textit{A Rapid Review of Psychedelic-Assisted Therapy in the Context of Palliative Care.}. Journal of hospice and palliative nursing: JHPN: the official journal of the Hospice and Palliative Nurses Association. [published; PubMed]. \href{https://doi.org/10.1097/njh.0000000000001113}{doi:10.1097/njh.0000000000001113}.
\item Jenna Matsukubo, Sarah Dickson, Jennifer Xiao, Erik Loewen Friesen, Marco Solmi, Jess G. Fiedorowicz, Benedikt Fischer, Daniel T. Myran (2025). \textit{Psilocybin Dispensaries and Online Health Claims in Canada}. JAMA Network Open. [published; OpenAlex]. \href{https://doi.org/10.1001/jamanetworkopen.2025.2853}{doi:10.1001/jamanetworkopen.2025.2853}.
\item Paul R. Hutson (2025). \textit{Psilocybin Dispensaries and Advertising-Buyer Beware}. JAMA Network Open. [published; OpenAlex]. \href{https://doi.org/10.1001/jamanetworkopen.2025.2858}{doi:10.1001/jamanetworkopen.2025.2858}.
\item Zhangrao Huang, Yongpeng Yao, Rong Di, Jianchao Zhang, Yuanyuan Pan, Gang Liu (2025). \textit{De Novo Biosynthesis of Antidepressant Psilocybin in Escherichia coli}. Microbial Biotechnology. [published; OpenAlex]. \href{https://doi.org/10.1111/1751-7915.70135}{doi:10.1111/1751-7915.70135}.
\item Lenka Seillier, Barbora Čechová, Alexandre Seillier, Romana Šlamberová (2025). \textit{Psilocybin has a narrow therapeutic window as an antidepressant treatment}. Progress in Neuro-Psychopharmacology and Biological Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.pnpbp.2025.111368}{doi:10.1016/j.pnpbp.2025.111368}.
\item Vanessa L. Beesley, Tom Kennedy, Fiona Maccallum, Margaret Ross, Renee Harvey, Susan L. Rossell, Jerome Sarris, Daniel Perkins, Rachel Ε. Neale, James Bennett-Levy, Shevaugn Johnson, Hanna Beebe, Natalie Roset, Jörg Strobel, Stephen Parker (2025). \textit{Psilocybin-Assisted suppoRtive psychoTherapy IN the treatment of prolonged Grief (PARTING) trial: protocol for an open-label pilot trial for cancer-related bereavement}. BMJ Open. [published; OpenAlex]. \href{https://doi.org/10.1136/bmjopen-2024-095992}{doi:10.1136/bmjopen-2024-095992}.
\item Keenan R, Haque R, Jin X, Mustafa T, Homman-Ludiye J, Elysee K, Wee ZS, Simonds S, Foldi C, Cowley M. (2025). \textit{Effects of a single dose of psilocybin on diet-induced weight loss in obese mice}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-6225000/v1}{doi:10.21203/rs.3.rs-6225000/v1}.
\item Thomson S, Thomacos N. (2025). \textit{Utilizing Psychedelics to Enhance Well-Being: A Systematic Review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/02791072.2025.2484380}{doi:10.1080/02791072.2025.2484380}.
\item Unity Health Toronto (2025). \textit{Psilocybin for Enhanced Analgesia in Chronic nEuropathic PAIN}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06731335}{source link}.
\item Unknown authors (2025). \textit{Visual Hallucinations in Serotonergic Psychedelics and Lewy Body Diseases}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.1093/schbul/sbaf068}{doi:10.1093/schbul/sbaf068}.
\item Heller NH, Barrett FS, Buchborn T, Collerton D, Dupuis D, Halberstadt AL, Jardri R, Noorani TN, Preller KH, Taylor J, Waters F, Winston B, Leptourgos P. (2025). \textit{Visual Hallucinations in Serotonergic Psychedelics and Lewy Body Diseases}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/7x8q4\_v2}{doi:10.31234/osf.io/7x8q4\_v2}.
\item Agnieszka Bysiek, Adam Wojtas, Izabela Szpręgiel, Agnieszka Wawrzczak-Bargieła, Marzena Maćkowiak, Krystyna Gołembiowska (2025). \textit{The effect of low-dose psilocybin on brain neurotransmission and rat behavior}. Progress in Neuro-Psychopharmacology and Biological Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.pnpbp.2025.111347}{doi:10.1016/j.pnpbp.2025.111347}.
\item Unknown authors (2025). \textit{Psilocybin-assisted therapy leads to personality shifts in patients with alcohol use disorder}. The Brown University Psychopharmacology Update. [published; OpenAlex]. \href{https://doi.org/10.1002/pu.31300}{doi:10.1002/pu.31300}.
\item Turkia M. (2025). \textit{Ayahuasca in the treatment of the consequences of chronic childhood sexual abuse in a religious community}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/mzkyv\_v1}{doi:10.31234/osf.io/mzkyv\_v1}.
\item University Hospital, Basel, Switzerland (2025). \textit{Direct Comparison of Altered States of Consciousness Induced by LSD, Psilocybin, and DMT in a Randomized, Placebo-controlled, Cross-over Trial in Healthy Participants (LPD-Study)}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06899334}{source link}.
\item Unknown authors (2025). \textit{Ayahuasca in the treatment of the consequences of chronic childhood sexual abuse in a religious community}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/mzkyv\_v1}{source link}.
\item Bires J. (2025). \textit{Existing evidence for the use of psychedelics in patients with cancer and other serious illness: A narrative review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/07347332.2025.2482917}{doi:10.1080/07347332.2025.2482917}.
\item Brian H. Silverstein, Nicholas Kolbman, Amanda Nelson, Tiecheng Liu, Peter R. Guzzo, Jim Gilligan, UnCheol Lee, George A. Mashour, Giancarlo Vanini, Dinesh Pal (2025). \textit{Intravenous psilocybin induces dose-dependent changes in functional network organization in rat cortex}. Translational Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1038/s41398-025-03308-4}{doi:10.1038/s41398-025-03308-4}.
\item Meshkat S, Al-Shamali H, Perivolaris A, Tullu T, Zeifman RJ, Zhang Y, Burback L, Winkler O, Greenshaw A, Husain MI, C Reichelt A, Vermetten E, Jha MK, Jetly R, Loebenberg R, Bhat V. (2025). \textit{Pharmacokinetics of Psilocybin: A Systematic Review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/pharmaceutics17040411}{doi:10.3390/pharmaceutics17040411}.
\item Noah Chisamore, Erica Kaczmarek, Zoe Doyle, Danica E. Johnson, Geneva Weiglein, Shakila Meshkat, Ryan M. Brudner, Marc G. Blainey, Jeremy Riva-Cambrin, Roger S. McIntyre, Joshua D. Rosenblat (2025). \textit{Comparing Antidepressant Effects of Psilocybin-Assisted Psychotherapy in Individuals That Were Unmedicated at Initial Screening Versus Individuals Discontinuing Medications for Study Participation: Comparaison des effets antidépresseurs de la psychothérapie assistée par la psilocybine (PAP) chez les personnes non médicamentées à la sélection initiale et les personnes ayant arrêté les médicaments pour participer à l’étude}. The Canadian Journal of Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1177/07067437251328316}{doi:10.1177/07067437251328316}.
\item Ghaznavi S, Richter SG. (2025). \textit{Classic Psychedelics for the Treatment of Depression: Potential Benefits and Challenges.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s40265-025-02172-2}{doi:10.1007/s40265-025-02172-2}.
\item Serretti A. (2025). \textit{Anhedonia: Current and future treatments.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1002/pcn5.70088}{doi:10.1002/pcn5.70088}.
\item Gregory Ian Robinson, Marta Gerasymchuk, Timur Zanikov, Esmaeel Ghasemi Gojani, Shima Asghari, Alyssa Groves, Lucie Haselhorst, Sanjana Nandakumar, Cora Stahl, Ceejay Cruz, Mackenzie Cameron, Yeva Zahoruiko, Dongping Li, Rocio Rodriguez-Juarez, Alex Snelling, Darryl Hudson, Anna Fiselier, Olga Kovalchuk, Igor Kovalchuk (2025). \textit{LPS-Induced Liver Inflammation Is Inhibited by Psilocybin and Eugenol in Mice}. Pharmaceuticals. [published; OpenAlex]. \href{https://doi.org/10.3390/ph18040451}{doi:10.3390/ph18040451}.
\item Chunyan Meng, Wenting Guo, Xiao Chuan, Yan Wen, Xudong Zhu, Qingrong Zhang, Yuxuan Liang, Hongwei Li, Sha Xu, Yuntan Qiu, Haitao Chen, Wei-Jye Lin, Baixing Wu (2025). \textit{Structural basis for psilocybin biosynthesis}. Nature Communications. [published; OpenAlex]. \href{https://doi.org/10.1038/s41467-025-58239-x}{doi:10.1038/s41467-025-58239-x}.
\item Henry J, Giribaldi B, Nutt DJ, Erritzoe D, Carhart-Harris R, Lyons T. (2025). \textit{The effects of psilocybin therapy versus escitalopram on cognitive bias: A secondary analysis of a randomized controlled trial}. medRxiv. [preprint; medRxiv]. \href{https://doi.org/10.1101/2025.03.17.25324123}{doi:10.1101/2025.03.17.25324123}.
\item Portes MAM, Werle I, Bertoglio LJ. (2025). \textit{Is there a place for psychedelics in sports practice?}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1017/neu.2025.13}{doi:10.1017/neu.2025.13}.
\item Kim SH, Yang S, Jung J, Choi J, Kang M, Joo JY. (2025). \textit{Psychedelic Drugs in Mental Disorders: Current Clinical Scope and Deep Learning-Based Advanced Perspectives.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1002/advs.202413786}{doi:10.1002/advs.202413786}.
\item Julia Eklund, Ulf Bremberg, Jessica Larsson, Edvard Torkelsson, Johan Wennerberg, Symantha Zandelin, Luke R. Odell (2025). \textit{Synthesis and In Vitro Profiling of Psilocin Derivatives: Improved Stability and Synthetic Properties}. Journal of Medicinal Chemistry. [published; OpenAlex]. \href{https://doi.org/10.1021/acs.jmedchem.4c02612}{doi:10.1021/acs.jmedchem.4c02612}.
\item McMaster University (2025). \textit{An 8-week Phase 2 Clinical Trial to Evaluate the Safety, Tolerability and Efficacy of Psilocybin-assisted-psychotherapy in Adults With Cannabis Use Disorder: A Proof-of-Concept Study}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06225232}{source link}.
\item Insel Gruppe AG, University Hospital Bern (2025). \textit{Molecular Imaging Study of Harmine/DMT: a Basic Research Approach}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06252506}{source link}.
\item Centre Hospitalier Universitaire de Nīmes (2025). \textit{Psilocybin in Alcohol Use Disorder With Comorbid Depression}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06235411}{source link}.
\item University of Washington (2025). \textit{A Randomized, Placebo-controlled Trial of Psychedelic-assisted Psychotherapy With Single Dose Psilocybin for Frontline Clinicians Experiencing COVID-related Symptoms of Depression and Burnout}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05163496}{source link}.
\item Ram Harari, Dmitriy Getselter, Evan Elliott (2025). \textit{The psychedelic psilocybin and light exposure have similar and synergistic effects on gene expression patterns in the visual cortex}. Molecular Brain. [published; OpenAlex]. \href{https://doi.org/10.1186/s13041-025-01191-0}{doi:10.1186/s13041-025-01191-0}.
\item Kurkova V, Winkler O, Greenshaw A, Jetly R, Swainson J, Lodewyk K, Saghafi P, Dennett E, Burback L. (2025). \textit{Exploring the potential of psychedelic-assisted psychotherapy for moral injury: A scoping review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.pnpbp.2025.111333}{doi:10.1016/j.pnpbp.2025.111333}.
\item Dino F. (2025). \textit{A Modern Overview of the Potential Therapeutic Effects of Psilocybin in the Treatment of Depressive Disorders, Treatment-Resistant Depression, and End-of-Life Distress.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.7759/cureus.80707}{doi:10.7759/cureus.80707}.
\item Eda Köşeli, Belle Buzzi, Torin Honaker, Yogesh Rakholia, Melissa J. Lewis, Maya Gaines-Smith, Alaina M. Jaster, Javier González-Maeso, M. Imad Damaj (2025). \textit{IUPHAR Article: Psilocybin induces long-lasting effects via 5-HT2A receptors in mouse models of chronic pain}. Pharmacological Research. [published; OpenAlex]. \href{https://doi.org/10.1016/j.phrs.2025.107699}{doi:10.1016/j.phrs.2025.107699}.
\item Lukas Bobak, Ian Dorney, Alexsandra Kovacevich, Brian S. Barnett (2025). \textit{Therapeutic Potential of Psilocybin for Treating Neuropsychiatric Long COVID Symptoms: A Reddit Investigation}. Journal of Psychoactive Drugs. [published; OpenAlex]. \href{https://doi.org/10.1080/02791072.2025.2478097}{doi:10.1080/02791072.2025.2478097}.
\item Shimal Yonuis Abdulhadi, Noor Alaubidi, Walla H. Shuker, Sanabel A. Abd Almajeed (2025). \textit{BIOLOGICAL ACTIVITY OF PSILOCYBIN EXTRACTS FROM THE FRUITING BODIES OF PSILOCYBE CUBENSIS ANTIOXIDANT AND ANTIMICROBIAL POTENTIAL}. Journal of Microbiology Biotechnology and Food Sciences. [published; OpenAlex]. \href{https://doi.org/10.55251/jmbfs.12097}{doi:10.55251/jmbfs.12097}.
\item Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center (2025). \textit{Effects of Psilocybin in Advanced-Stage Cancer Patients With Anxiety}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT00302744}{source link}.
\item Dr Hafiz Shafique Ahmad, Muhammad Waqar Ali, Usman Ul Haq (2025). \textit{PSYCHEDELIC PHARMACOLOGY IN PSYCHIATRY: THE MECHANISMS AND THERAPEUTIC POTENTIAL OF PSILOCYBIN, MDMA, AND LSD IN MENTAL HEALTH DISORDERS}. Journal of medical \& health sciences review.. [published; OpenAlex]. \href{https://doi.org/10.62019/r713mw08}{doi:10.62019/r713mw08}.
\item Kangaslampi S, Lietz MP. (2025). \textit{Psychedelics and autobiographical memory - Six open questions}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/su7ch\_v2}{doi:10.31234/osf.io/su7ch\_v2}.
\item Stoliker D, Novelli L, Khajehnejad M, Biabani M, Greaves MD, Barta T, Williams M, Chopra S, Bazin O, Simonsson O, Chambers R, Barrett F, Deco G, Preller KH, Carhart-Harris R, Seth A, Sundram S, Egan GF, Razi A. (2025). \textit{Psychedelics Align Brain Activity with Context}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2025.03.09.642197}{doi:10.1101/2025.03.09.642197}.
\item Song C, Chang T, Buchborn T, Knöpfel T. (2025). \textit{Lasting effect of psilocybin on sociability can be blocked by DNA methyltransferase inhibition}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2025.03.10.642385}{doi:10.1101/2025.03.10.642385}.
\item Unknown authors (2025). \textit{Psychedelics and autobiographical memory - Six open questions}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/su7ch\_v2}{source link}.
\item Quah S, Glick C, Roseman L, Pasquini L, Carhart-Harris R, Saggar M. (2025). \textit{Revealing Changes in Linear and Nonlinear Functional Connectivity After Psilocybin and Escitalopram Treatment in Patients with Depression}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2025.03.05.641592}{doi:10.1101/2025.03.05.641592}.
\item Paolo Cardone, Pablo Núñez, Naji Alnagger, Charlotte Martial, Glenn van der Lande, Robin Sandell, Robin Carhart-Harris, Olivia Gosseries (2025). \textit{Psilocybin for disorders of consciousness: A case-report study}. Clinical Neurophysiology. [published; OpenAlex]. \href{https://doi.org/10.1016/j.clinph.2025.02.264}{doi:10.1016/j.clinph.2025.02.264}.
\item Repple J, Bayas M, Möser C, Kobayashi NF, Reif A. (2025). \textit{Current Evidence for the Role of Rapid-Acting Antidepressants in Bipolar Depression: A Perspective and Plan for Action.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.biopsych.2025.02.903}{doi:10.1016/j.biopsych.2025.02.903}.
\item Biba B, O'Shea B. (2025). \textit{Exploring Public Sentiments of Psychedelics Versus Other Substances: A Reddit-Based Natural Language Processing Study}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/6xgu8\_v2}{doi:10.31234/osf.io/6xgu8\_v2}.
\item Galdino TP, Oliveira LC, Luz MA, Jesus RA, Lima EPN, Torres MCM, Sivieri K, Afonso VI, Delgado JMPQ, Lima AGB, Silva SML, Fook MVL. (2025). \textit{Extraction Yields of Psilocybin and Psilocin: A Short Review of Current Methods and Their Implications.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/ph18030380}{doi:10.3390/ph18030380}.
\item Hu S, Lin C, Wang H, Wang X. (2025). \textit{Psychedelics and Eating Disorders: Exploring the Therapeutic Potential for Anorexia Nervosa and Beyond.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/acsptsci.5c00094}{doi:10.1021/acsptsci.5c00094}.
\item Unknown authors (2025). \textit{Exploring Public Sentiments of Psychedelics Versus Other Substances: A Reddit-Based Natural Language Processing Study}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/6xgu8\_v2}{source link}.
\item Modzelewski S, Stankiewicz A, Waszkiewicz N, Łukasiewicz K. (2025). \textit{Side effects of microdosing lysergic acid diethylamide and psilocybin: A systematic review of potential physiological and psychiatric outcomes.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neuropharm.2025.110402}{doi:10.1016/j.neuropharm.2025.110402}.
\item Michał Orzechowski, Joanna Orzechowska, Paulina Fijałek, Jan Karczmarz, Aleksandra Paprocka, Marika Gutowska, Agnieszka Kosińska, Urszula Świrk, Wiktoria Belcarz, Katarzyna Kalinowska (2025). \textit{Risks of using psilocybin in treatment of treatment-resistant depression}. Journal of Education Health and Sport. [published; OpenAlex]. \href{https://doi.org/10.12775/jehs.2025.79.58319}{doi:10.12775/jehs.2025.79.58319}.
\item University Hospital, Basel, Switzerland (2025). \textit{Acute Effects of 2C-B Compared With MDMA and Psilocybin in Healthy Subjects}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05523401}{source link}.
\item Aicher HD, Müller F, Gasser P. (2025). \textit{Further education in psychedelic-assisted therapy - experiences from Switzerland.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1186/s12909-025-06871-y}{doi:10.1186/s12909-025-06871-y}.
\item Craig, Danny R, Blalock, Eric M. (2025). \textit{Could psilocin rescue chronic, stress-accelerated, transcriptional aging in brain?}. UKnowledge (University of Kentucky). [published; OpenAlex]. \href{https://uknowledge.uky.edu/jpns/vol2/iss1/1}{source link}.
\item Ahmed Al-Imam, Riccardo Lora, Marek Motyka, E Marletta, Michele Vezzaro, Jerzy Moczko, Manal M. Younus, Michał Michalak (2025). \textit{Opinion Mining of Erowid’s Experience Reports on LSD and Psilocybin-Containing Mushrooms}. Drug Safety. [published; OpenAlex]. \href{https://doi.org/10.1007/s40264-025-01530-z}{doi:10.1007/s40264-025-01530-z}.
\item Unknown authors (2025). \textit{Psilocybin therapy might help frontline pandemic workers}. The Brown University Psychopharmacology Update. [published; OpenAlex]. \href{https://doi.org/10.1002/pu.31292}{doi:10.1002/pu.31292}.
\item Barnett BS, Mauney EE, King F. (2025). \textit{Psychedelic-assisted therapy: An overview for the internist.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3949/ccjm.92a.24032}{doi:10.3949/ccjm.92a.24032}.
\item Guy M. Goodwin, Ania Nowakowska, Merve Atli, Boadie W. Dunlop, David Feifel, David J. Hellerstein, Lindsey Marwood, Zainib Shabir, Sunil Mistry, S. C. Stansfield, Emma Teoh, Joyce Tsai, Matthew B. Young, Ekaterina Malievskaia (2025). \textit{Results From a Long-Term Observational Follow-Up Study of a Single Dose of Psilocybin for a Treatment-Resistant Episode of Major Depressive Disorder}. The Journal of Clinical Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.4088/jcp.24m15449}{doi:10.4088/jcp.24m15449}.
\item Elmira Zolali, Mahfuz Sakib, Jenny L. Wilkerson, Lance Richard McMahon, Samuel Obeng (2025). \textit{Evaluating the Influence of CYP450 Enzyme Inducers on the Efficacy of Psilocybin as a Treatment for Neuropsychiatric Disorders (Abstract ID: 167358)}. Journal of Pharmacology and Experimental Therapeutics. [published; OpenAlex]. \href{https://doi.org/10.1016/j.jpet.2024.100843}{doi:10.1016/j.jpet.2024.100843}.
\item Otto ME, van der Heijden KV, Schoones JW, van Esdonk MJ, Borghans LGJM, Jacobs GE, van Hasselt JGC. (2025). \textit{Correction: Clinical Pharmacokinetics of Psilocin After Psilocybin Administration: A Systematic Review and Post-Hoc Analysis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s40262-025-01487-3}{doi:10.1007/s40262-025-01487-3}.
\item Metten Somers, Floortje E. Scheepers (2025). \textit{Irremediable Psychiatric Suffering, a Potential Indication for Psilocybin Treatment}. American Journal of Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1176/appi.ajp.20240121}{doi:10.1176/appi.ajp.20240121}.
\item Belitzky E, Ravani Carvalho LV, Taylor M, Ortiz CN, Baum L, Fiellin DA, Lustberg MB. (2025). \textit{Psychedelics for Cancer Pain and Associated Psychological Distress: A Narrative Review of a Potential Strategy.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1002/cam4.70586}{doi:10.1002/cam4.70586}.
\item Petrovitch D, Hosford S, Littlefield AK, Austin-Robillard H. (2025). \textit{Sociodemographic and mental-health characteristics of psychedelic-assisted therapy participants: Latent class analysis of a cross-sectional, purposive online sample}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/26tz7\_v1}{doi:10.31234/osf.io/26tz7\_v1}.
\item Hodge A, Forsyth A, Noorani T, Muthukumaraswamy S, Rolleston A, McHugh P. (2025). \textit{Tū Wairua: Development of an Indigenous Rongoā Māori Approach to Healing with Psilocybin Containing Mushrooms}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/93x5h\_v3}{doi:10.31234/osf.io/93x5h\_v3}.
\item Unknown authors (2025). \textit{Sociodemographic and mental-health characteristics of psychedelic-assisted therapy participants: Latent class analysis of a cross-sectional, purposive online sample}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/26tz7\_v1}{source link}.
\item Hodge A, Forsyth A, Noorani T, Muthukumaraswamy S, Rolleston A, McHugh P. (2025). \textit{Tū Wairua: Development of an Indigenous Rongoā Māori Approach to Healing with Psilocybin Containing Mushrooms}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/93x5h\_v2}{doi:10.31234/osf.io/93x5h\_v2}.
\item Unknown authors (2025). \textit{Tū Wairua: Development of an Indigenous Rongoā Māori Approach to Healing with Psilocybin Containing Mushrooms}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/93x5h\_v3}{source link}.
\item John Perna, Justin Trop, Roman Palitsky, Zachary Bosshardt, Helen Vantine, Boadie W. Dunlop, Ali John Zarrabi (2025). \textit{Prolonged adverse effects from repeated psilocybin use in an underground psychedelic therapy training program: a case report}. BMC Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1186/s12888-024-06303-z}{doi:10.1186/s12888-024-06303-z}.
\item Yaden DB, Graziosi M, Owen AM, Agin-Liebes G, Aaronson ST, Allen KE, Barrett FS, Bogenschutz MP, Carhart-Harris R, Ching THW, Cosimano MP, Danforth A, Davis AK, Garcia-Romeu A, Griffiths R, Grob CS, Gründer G, Gukasyan N, Heinzerling KG, Hendricks PS, Holze F, Horton DM, Johnson MW, Kelmendi B, Knatz Peck S, Koslowski M, Liechti ME, Mertens LJ, Moreno FA, Nayak SM, Nicholas CR, Preller KH, Rieser NM, Ross S, Sergi K, Sloshower J, Smigielski L, Stenbæk DS, Vollenweider FX, Weiss B, Wolff M, Yaden ME. (2025). \textit{A Field-Wide Review and Analysis of Study Materials Used in Psilocybin Trials: Assessment of Two Decades of Research.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1089/psymed.2024.0019}{doi:10.1089/psymed.2024.0019}.
\item Silva F, Butlen-Ducuing F, Guizzaro L, Balabanov P. (2025). \textit{A review of psychedelics trials completed in depression, informed by European regulatory perspectives.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.nsa.2025.105516}{doi:10.1016/j.nsa.2025.105516}.
\item Hitchins K, Reynolds J. (2025). \textit{The Impact of Communicating the Benefits and Safety of Psilocybin on Policy Support: A Survey Based Experiment.}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/48yg7\_v2}{doi:10.31234/osf.io/48yg7\_v2}.
\item Mohammad Balabandian, Mohammad Amin Manavi, Ali Lesani, Razieh Mohammad Jafari, Hamed Shafaroodi, Neda Heidari, Javad Mirnajafi-Zadeh, Alireza Foroumadi, Arya Afrooghe, Ahmad Reza Dehpour (2025). \textit{Psilocin, A Psychedelic Drug, Exerts Anticonvulsant Effects Against PTZ- and MES-Induced Seizures in Mice via 5-HT1A and CB1 Receptors: Involvement of Nitrergic, Opioidergic, and Kynurenine Pathways}. Pharmacology Research \& Perspectives. [published; OpenAlex]. \href{https://doi.org/10.1002/prp2.70079}{doi:10.1002/prp2.70079}.
\item Unknown authors (2025). \textit{The Impact of Communicating the Benefits and Safety of Psilocybin on Policy Support: A Survey Based Experiment.}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/48yg7\_v2}{source link}.
\item Hitchins K, Reynolds J. (2025). \textit{The Impact of Communicating the Benefits and Safety of Psilocybin on Policy Support: A Survey Based Experiment.}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/48yg7\_v1}{doi:10.31234/osf.io/48yg7\_v1}.
\item Romeo B, Kervadec E, Fauvel B, Strika-Bruneau L, Amirouche A, Verroust V, Piolino P, Benyamina A. (2025). \textit{Exploring factors associated with the intensity of a mystical experience following naturalistic psychedelic use: A retrospective survey.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.pnpbp.2025.111300}{doi:10.1016/j.pnpbp.2025.111300}.
\item Yasmo Perez JP, Chegwin Angarita C, Saldarriaga Ochoa OD, Urrego Restrepo SA. (2025). \textit{Development and validation of a HPLC-DAD method for determining the content of tryptamines in methanolic extracts of fruiting bodies of mushrooms belonging to species of the Psilocybe genus.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.talanta.2025.127777}{doi:10.1016/j.talanta.2025.127777}.
\item Meshkat S, Malik T, Zeifman R, Swainson J, Zhang Y, Burback L, Winkler O, Greenshaw AJ, Claire Reichelt A, Vermetten E, Erritzoe D, Jha MK, Dunn W, Jetly R, Husain MI, Bhat V. (2025). \textit{Psychedelics and Suicide-Related Outcomes: A Systematic Review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/jcm14051416}{doi:10.3390/jcm14051416}.
\item Dave M, Shore R, Cupido T, Haley C, Clinkard D. (2025). \textit{Anaesthetic implications of psilocybin and lysergic acid diethylamide: what is old is now new: A narrative review on psychedelics and anaesthesia.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1097/eja.0000000000002138}{doi:10.1097/eja.0000000000002138}.
\item Mauney E, King F, Burton-Murray H, Kuo B. (2025). \textit{Psychedelic-assisted Therapy as a Promising Treatment for Irritable Bowel Syndrome.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1097/mcg.0000000000002149}{doi:10.1097/mcg.0000000000002149}.
\item Ahuja S, Zaher F, Palaniyappan L. (2025). \textit{Quantitative natural language processing markers of psychoactive drug effects: A pre-registered systematic review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811251319455}{doi:10.1177/02698811251319455}.
\item Fábio Nogueira Pereira, Ana Carina Rothechedl Cavalieri, João Paulo Crespo Ferreira, Kelly De Souza Ventura (2025). \textit{Esse quam Videre: Critical Reflections on the Use of Psilocybin as an Adjuvant in Psychedelic-Assisted Psychotherapy}. Polymatheia.. [published; OpenAlex]. \href{https://doi.org/10.52521/poly.v18i1.14945}{doi:10.52521/poly.v18i1.14945}.
\item Heller NH, Barrett FS, Buchborn T, Collerton D, Dupuis D, Halberstadt AL, Jardri R, Noorani TN, Preller KH, Taylor J, Waters F, Winston B, Leptourgos P. (2025). \textit{Visual Hallucinations in Serotonergic Psychedelics and Lewy Body Diseases}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/7x8q4\_v1}{doi:10.31234/osf.io/7x8q4\_v1}.
\item Coleton Windsor, Anna E. Kreynes, Jeff Chilton, William A Chioffi, Christopher Niebergall, Kelsey Dodds (2025). \textit{Development of Psilocybe Mushroom Species Reference Material-Cultivation Parameters and Chemical Profiles}. Journal of AOAC International. [published; OpenAlex]. \href{https://doi.org/10.1093/jaoacint/qsaf007}{doi:10.1093/jaoacint/qsaf007}.
\item Hartter, Nina, Däumichen, Marvin, Schmidt, Christopher, Wolff, Max, Gründer, Gerhard, Jungaberle, Henrik (2025). \textit{Akzeptanz psilocybin-assistierter Therapie in den deutschsprachigen Ländern}. edoc Publication server (Humboldt University of Berlin). [published; OpenAlex]. \href{https://doi.org/10.18452/35395}{doi:10.18452/35395}.
\item Unknown authors (2025). \textit{CORRECTION: Efficacy of psilocybin for treating symptoms of depression: systematic review and meta-analysis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1136/bmj.r111}{doi:10.1136/bmj.r111}.
\item Aqil M, de Hollander G, Vreugdenhil N, Knapen T, Dumoulin SO. (2025). \textit{Psilocybin alters visual contextual computations}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2025.02.06.636848}{doi:10.1101/2025.02.06.636848}.
\item Ari Brouwer, Joshua K. Brown, Earth Erowid, Fire Erowid, Sylvia Thyssen, Charles L. Raison, Robin Carhart-Harris (2025). \textit{A qualitative analysis of the psychedelic mushroom come-up and come-down}. npj Mental Health Research. [published; OpenAlex]. \href{https://doi.org/10.1038/s44184-024-00095-6}{doi:10.1038/s44184-024-00095-6}.
\item Fuini E, Chang A, Ortiz RJ, Nasseef T, Edwards J, Latta M, Gonzalez E, Woodward TJ, Bradshaw HB, Axe B, Maheswari A, Cavallaro N, Kulkarni PP, Ferris CF. (2025). \textit{Dose-dependent changes in global brain activity and functional connectivity following exposure to psilocybin: a BOLD MRI study in awake rats}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2025.02.01.636078}{doi:10.1101/2025.02.01.636078}.
\item Lucido MJ, Dunlop BW. (2025). \textit{Emerging Medications for Treatment-Resistant Depression: A Review with Perspective on Mechanisms and Challenges.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/brainsci15020161}{doi:10.3390/brainsci15020161}.
\item Hogea L, Tabugan DC, Costea I, Albai O, Nussbaum L, Cojocaru A, Corsaro L, Anghel T. (2025). \textit{The Therapeutic Potential of Psychedelics in Treating Substance Use Disorders: A Review of Clinical Trials.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/medicina61020278}{doi:10.3390/medicina61020278}.
\item Brengel EK, Axe B, Maheswari A, Abeer MI, Ortiz RJ, Woodward TJ, Walhof R, Utama R, Sawada C, Balaji S, Kulkarni PP, Bradshaw HB, Gitcho MA, Ferris CF. (2025). \textit{Psilocybin as a Treatment for Repetitive Mild Head Injury: Evidence from Neuroradiology and Molecular Biology}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2025.02.03.636248}{doi:10.1101/2025.02.03.636248}.
\item Shannon Hughes, Lucia Terpak, Reilly Capps, Pam Peters, Nicole Lilly, Dylan Rivard (2025). \textit{Psilocybin mushroom stewardship: A qualitative inquiry into practices and priorities of “underground” psilocybin mushroom practitioners}. Journal of Psychedelic Studies. [published; OpenAlex]. \href{https://doi.org/10.1556/2054.2025.00375}{doi:10.1556/2054.2025.00375}.
\item de Miranda AS, C B Toscano E, Venna VR, Graeff FG, Teixeira AL. (2025). \textit{Investigating novel pharmacological strategies for treatment-resistant depression: focus on new mechanisms and approaches.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/17460441.2025.2460674}{doi:10.1080/17460441.2025.2460674}.
\item Vanessa Fleury, Emilie Tomkova, Sabina Catalano Chiuvé, Louise Penzenstadler (2025). \textit{Psilocybin-assisted psychotherapy for Parkinson's disease without depression: A case-report}. Journal of Parkinson s Disease. [published; OpenAlex]. \href{https://doi.org/10.1177/1877718x241312604}{doi:10.1177/1877718x241312604}.
\item Martina Colognesi, Daniela Gabbia, A. Signor, Stefano Comai, Andrea Mattarei, Gianfranco Pasut, Franco Folli, Lucia Centofanti, S. La Rosa, G Finzi, M. Pappagallo, Paolo Manfredi, Sara De Martin (2025). \textit{Beneficial effect of the combination psilocybin-semaglutide in a murine model of Steatotic Liver Disease}. Digestive and Liver Disease. [published; OpenAlex]. \href{https://doi.org/10.1016/j.dld.2025.01.135}{doi:10.1016/j.dld.2025.01.135}.
\item A. Signor, Martina Colognesi, Daniela Gabbia, Ilaria Zanotto, Y. Frion-Herrera, Stefano Comai, Andrea Mattarei, Gianfranco Pasut, Franco Folli, M. Pappagallo, Paolo Manfredi, S. De Martin (2025). \textit{Direct effects of psilocybin on serotonin receptors regulate lipid accumulation in hepatic cells and adipocytes}. Digestive and Liver Disease. [published; OpenAlex]. \href{https://doi.org/10.1016/j.dld.2025.01.134}{doi:10.1016/j.dld.2025.01.134}.
\item Matthew Weirick Johnson (2025). \textit{Clinical Trial Comparing Psilocybin to Nicotine Patch for Tobacco Addiction}. Drug and Alcohol Dependence. [published; OpenAlex]. \href{https://doi.org/10.1016/j.drugalcdep.2024.112187}{doi:10.1016/j.drugalcdep.2024.112187}.
\item Myfanwy Graham, Wayne Hall, Rosalie Liccardo Pacula, David Hammond (2025). \textit{International Drug Policy Study Trends With Psychedelic Drugs: A Spotlight on Psilocybin, LSD, and MDMA}. Drug and Alcohol Dependence. [published; OpenAlex]. \href{https://doi.org/10.1016/j.drugalcdep.2024.112089}{doi:10.1016/j.drugalcdep.2024.112089}.
\item Jérémie Richard, Sandeep M. Nayak, Nathan D. Sepeda, Albert Garcia-Romeu (2025). \textit{Latent Class Analysis of Changes in Substance Use and Depressive Symptoms following Naturalistic Psilocybin Use: Results from a Prospective Longitudinal Survey}. Drug and Alcohol Dependence. [published; OpenAlex]. \href{https://doi.org/10.1016/j.drugalcdep.2024.112184}{doi:10.1016/j.drugalcdep.2024.112184}.
\item Destiny Carbello, Tomáš Páleníček (2025). \textit{Source Localized Auditory Erp Sensory and Preattentive Correlates of Psilocybin-Induced Ego-Dissolution Related Effects}. Drug and Alcohol Dependence. [published; OpenAlex]. \href{https://doi.org/10.1016/j.drugalcdep.2024.112090}{doi:10.1016/j.drugalcdep.2024.112090}.
\item Tamara A. Millay, Nae Won, Anna Wang, Joseph J. Palamar, Linda B. Cottler (2025). \textit{Prevalence of Use of Psilocybin and MDMA in Multiple US Cities}. Drug and Alcohol Dependence. [published; OpenAlex]. \href{https://doi.org/10.1016/j.drugalcdep.2024.112186}{doi:10.1016/j.drugalcdep.2024.112186}.
\item Kellie Pertl, Kim Hoffman, Adrianne R. Wilson-Poe, Jason B. Luoma, Alissa Bazinet, Sarann Bielavitz, Dennis McCarty, Christopher S. Stauffer, Cameron Wolf, P. Todd Korthuis (2025). \textit{Oregon’s Emerging Psilocybin Services Workforce: An Environmental Scan}. Drug and Alcohol Dependence. [published; OpenAlex]. \href{https://doi.org/10.1016/j.drugalcdep.2024.111569}{doi:10.1016/j.drugalcdep.2024.111569}.
\item Amanda L. Elmore, Marina Bolser, Matt Richey (2025). \textit{Lifetime Psilocybin Use and Opioid Use Disorder in Pregnant and Non-Pregnant Women of Reproductive Age}. Drug and Alcohol Dependence. [published; OpenAlex]. \href{https://doi.org/10.1016/j.drugalcdep.2024.111723}{doi:10.1016/j.drugalcdep.2024.111723}.
\item Unknown authors (2025). \textit{PSILOCYBIN MITIGATES BEHAVIORAL DESPAIR AND COGNITIVE RECOGNITION IMPAIRMENTS BY REGULATING THE HYPOTHALAMIC- PITUITARY-ADRENAL (HPA) AXIS VIA THE BRAIN-DERIVED NEUROTROPHIC FACTOR (BDNF) SIGNALING PATHWAY MEDIATED BY THE ENDOCANNABINOID SYSTEM (ECS)}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC11814968}{source link}.
\item Unknown authors (2025). \textit{ANXIOLYTIC- AND PROCOGNITIVE-LIKE EFFECTS OF A30-DAY CHRONIC TREATMENT WITH A LOW NON-PSYCHEDELIC DOSE OF PSILOCYBIN IN C57BL/6J MICE}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC11815219}{source link}.
\item Unknown authors (2025). \textit{BEHAVIORAL PHENOTYPING AND METABOLOMIC COMPARISON OF CHEMICALLY SYNTHESIZED PSILOCYBIN AND PSYCHEDELIC MUSHROOM EXTRACT IN A ZEBRAFISH DEPRESSION MODEL}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC11815225}{source link}.
\item Unknown authors (2025). \textit{ASSOCIATIONS BETWEEN ESCITALOPRAM AND PSILOCYBIN THERAPY AND BRAIN RESTING-STATE FUNCTIONAL CONNECTIVITY IN MAJOR DEPRESSIVE DISORDER}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC11814992}{source link}.
\item Unknown authors (2025). \textit{EFFECT OF ACUTE PSILOCYBIN ON THERMAL AND NEUROPATHIC PAIN IN RODENTS}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC11814656}{source link}.
\item Marazziti D, Weiss F, Gurrieri R, Russomanno G, Gambini M, Magnesa A, Coccoglioniti A, Perugi G (2025). \textit{Evaluating the value and risks of psychedelics for psychiatric medicine: a clinical perspective.}. Expert review of neurotherapeutics. [published; PubMed]. \href{https://doi.org/10.1080/14737175.2024.2445016}{doi:10.1080/14737175.2024.2445016}.
\item Allen F. Shaughnessy (2025). \textit{Among Psychedelics, Only Psilocybin Has Demonstrated Benefit to Treat Depression.}. PubMed. [published; OpenAlex]. \href{https://pubmed.ncbi.nlm.nih.gov/39964936}{source link}.
\item Noback M, Kenton JA, Klein AK, Hughes ZA, Kruegel AC, Schmid Y, Halberstadt AL, Young JW. (2025). \textit{Low (micro)doses of 2,5-dimethoxy-4-propylamphetamine (DOPR) increase effortful motivation in low-performing mice.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neuropharm.2025.110334}{doi:10.1016/j.neuropharm.2025.110334}.
\item de Deus JL, Maia JM, Soriano RN, Amorim MR, Branco LGS. (2025). \textit{Psychedelics in neuroinflammation: Mechanisms and therapeutic potential.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.pnpbp.2025.111278}{doi:10.1016/j.pnpbp.2025.111278}.
\item Piper T, Small F, Brown S, Kelleher M, Mitcheson L, Rucker J, Young AH, Marsden J. (2025). \textit{Psychedelic-assisted treatment for substance use disorder: A narrative systematic review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1111/add.16762}{doi:10.1111/add.16762}.
\item O'Connor S, Godfrey K, Reed S, Peill J, Rohani-Shukla C, Healy M, Robbins T, Frota Lisboa Pereira de Souza A, Tyacke R, Papasyrou M, Stenbæk D, Castro-Rodrigues P, Chiera M, Lee H, Martell J, Carhart-Harris R, Pellegrini L, Fineberg NA, Nutt D, Erritzoe D. (2025). \textit{Correction: Study Protocol for 'PsilOCD: A Pharmacological Challenge Study Evaluating the Effects of the 5-HT2A Agonist Psilocybin on the Neurocognitive and Clinical Correlates of Compulsivity'.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.7759/cureus.c209}{doi:10.7759/cureus.c209}.
\item Sorcha O'Connor, Kate Godfrey, Sara Reed, Joseph Peill, Cyrus Rohani-Shukla, Mairead Healy, Trevor W. Robbins, Ana Frota Lisboa Pereira de Souza, Robin J. Tyacke, Maria Papasyrou, Dea Siggaard Stenbæk, Pedro Castro-Rodrigues, Martina Chiera, Hakjun Lee, Jonny Martell, Robin Carhart-Harris, Luca Pellegrini, Naomi Fineberg, David Nutt, David Erritzøe (2025). \textit{Study Protocol for ‘PsilOCD: A Pharmacological Challenge Study Evaluating the Effects of the 5-HT2A Agonist Psilocybin on the Neurocognitive and Clinical Correlates of Compulsivity’}. Cureus. [published; OpenAlex]. \href{https://doi.org/10.7759/cureus.78171}{doi:10.7759/cureus.78171}.
\item Kinderlehrer DA. (2025). \textit{Mushrooms, Microdosing, and Mental Illness: The Effect of Psilocybin on Neurotransmitters, Neuroinflammation, and Neuroplasticity.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.2147/ndt.s500337}{doi:10.2147/ndt.s500337}.
\item Kargbo RB. (2025). \textit{Psychiatric Treatments with Short-Duration Psychedelics and AI-Driven Behavioral Monitoring.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/acsmedchemlett.5c00031}{doi:10.1021/acsmedchemlett.5c00031}.
\item Felix Müller, Thomas Sauer, Corina Hänny, Markus Mühlhauser, Undine E. Lang (2025). \textit{Suicide of a patient shortly after psilocybin-assisted psychedelic therapy: A case report}. Psychiatry Research. [published; OpenAlex]. \href{https://doi.org/10.1016/j.psychres.2025.116381}{doi:10.1016/j.psychres.2025.116381}.
\item Paloma C. Frautschi, Ajay Paul Singh, Nicholas A. Stowe, Sean M. Grady, Zarmeen Zahid, Matthew I. Banks, John-Paul J. Yu (2025). \textit{Effects of Psilocybin on Mouse Brain Microstructure}. American Journal of Neuroradiology. [published; OpenAlex]. \href{https://doi.org/10.3174/ajnr.a8634}{doi:10.3174/ajnr.a8634}.
\item Kurzbaum E, Páleníček T, Shrchaton A, Azerrad S, Dekel Y. (2025). \textit{Exploring Psilocybe cubensis Strains: Cultivation Techniques, Psychoactive Compounds, Genetics and Research Gaps.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/jof11020099}{doi:10.3390/jof11020099}.
\item James J Gattuso, Carey Wilson, Shanshan Li, Anthony J. Hannan, Thibault Renoir (2025). \textit{Mice lacking the serotonin transporter do not respond to the behavioural effects of psilocybin}. European Journal of Pharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/j.ejphar.2025.177304}{doi:10.1016/j.ejphar.2025.177304}.
\item Niklas Viohl, Ali Asghar Hakami Zanjani, Himanshu Khandelia (2025). \textit{Molecular insights into the modulation of the 5 HT2 A receptor by serotonin, psilocin, and the G protein subunit Gqα}. FEBS Letters. [published; OpenAlex]. \href{https://doi.org/10.1002/1873-3468.15099}{doi:10.1002/1873-3468.15099}.
\item Yousefi P, Lietz MP, O'Higgins FJ, Rippe RCA, Hasler G, van Elk M, Enriquez-Geppert S. (2025). \textit{Acute effects of psilocybin on attention and executive functioning in healthy volunteers: a systematic review and multilevel meta-analysis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s00213-024-06742-2}{doi:10.1007/s00213-024-06742-2}.
\item Louis Plourde, Sue-Ling Chang, Houman Farzin, Jean-François Stephan, Jean-Sébastien Fallu, Michel Dorval (2025). \textit{Experiential dimension of psilocybin-assisted therapy training: Necessity or hindrance to wider accessibility?}. Journal of Psychedelic Studies. [published; OpenAlex]. \href{https://doi.org/10.1556/2054.2024.00431}{doi:10.1556/2054.2024.00431}.
\item Ganguly A, James M, Alici Y (2025). \textit{When death is desired: A case of MAiD \& the CL psychiatrist.}. Palliative \& supportive care. [published; PubMed]. \href{https://doi.org/10.1017/s1478951524002037}{doi:10.1017/s1478951524002037}.
\item Central Institute of Mental Health, Mannheim (2025). \textit{A Phase II Randomized, Double-blind, Active Placebo-controlled Parallel Group Trial to Examine the Efficacy and Safety of Psilocybin in Treatment-resistant Major Depression}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT04670081}{source link}.
\item Liebnau J, Betzler F, Kerber A. (2025). \textit{Catalyst for change: Psilocybin's antidepressant mechanisms-A systematic review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811241312866}{doi:10.1177/02698811241312866}.
\item Melani A, Bonaso M, Biso L, Zucchini B, Conversano C, Scarselli M. (2025). \textit{Uncovering Psychedelics: From Neural Circuits to Therapeutic Applications.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/ph18010130}{doi:10.3390/ph18010130}.
\item Shakila Meshkat, Richard J. Zeifman, Kathleen E. Stewart, Reinhard Janssen-Aguilar, Wendy Lou, Rakesh Jetly, Candice M. Monson, Venkat Bhat (2025). \textit{Psilocybin-assisted massed cognitive processing therapy for chronic posttraumatic stress disorder: Protocol for an open-label pilot feasibility trial}. PLoS ONE. [published; OpenAlex]. \href{https://doi.org/10.1371/journal.pone.0313741}{doi:10.1371/journal.pone.0313741}.
\item Richardson E, Patterson R, Meltzer-Brody S, McClure R, Tow A. (2025). \textit{Transformative Therapies for Depression: Postpartum Depression, Major Depressive Disorder, and Treatment-Resistant Depression.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1146/annurev-med-050423-095712}{doi:10.1146/annurev-med-050423-095712}.
\item Henderson I, Elsaadany R, Chan G, Bajaj V, Duarte D, Goodman S, Grunstein M, Vadhan NP, Duarte RA. (2025). \textit{Exploring the Potential of Psychedelics in the Treatment of Headache Disorders: Clinical Considerations and Exploratory Insights.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s11916-024-01321-8}{doi:10.1007/s11916-024-01321-8}.
\item Krawczyk N, Miller M, Gu EY, Irvine N, Ramirez E, Santaella-Tenorio J, Lippincott T, Bogenschutz M, Bunting AM, Meacham MC (2025). \textit{Self-reported experiences and perspectives on using psychedelics to manage opioid use among participants of two Reddit communities.}. Addiction (Abingdon, England). [published; PubMed]. \href{https://doi.org/10.1111/add.16767}{doi:10.1111/add.16767}.
\item Otto ME, van der Heijden KV, Schoones JW, van Esdonk MJ, Borghans LGJM, Jacobs GE, van Hasselt JGC. (2025). \textit{Clinical Pharmacokinetics of Psilocin After Psilocybin Administration: A Systematic Review and Post-Hoc Analysis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s40262-024-01454-4}{doi:10.1007/s40262-024-01454-4}.
\item Zylko A, Rakoczy R, Roberts B, Wilson M, Powell A, Page A, Heitkamp M, Fiest D, Jones J, McMurray M. (2025). \textit{Age- and estrous-dependent effects of psilocybin in rats}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2025.01.10.632408}{doi:10.1101/2025.01.10.632408}.
\item Amin Sharifan (2025). \textit{What are the benefits and harms of classical psychedelics (psilocybin and LSD) for treating anxiety, depression, and existential distress in people with life-threatening diseases?}. Cochrane Clinical Answers. [published; OpenAlex]. \href{https://doi.org/10.1002/cca.4512}{doi:10.1002/cca.4512}.
\item Roman Palitsky, Jessica L. Maples-Keller, Caroline Peacock, Boadie W. Dunlop, Tanja Mletzko, George H. Grant, Charles L. Raison, Sam Chao, Isabelle Shub, Michal Mendelbaum-Kweller, Liam Smolyar, Deanna M. Kaplan, Barbara O. Rothbaum, Ali John Zarrabi (2025). \textit{A critical evaluation of psilocybin-assisted therapy protocol components from clinical trial patients, facilitators, and caregivers.}. Psychotherapy. [published; OpenAlex]. \href{https://doi.org/10.1037/pst0000551}{doi:10.1037/pst0000551}.
\item Valerie A. Canady (2025). \textit{Study finds encouraging results in psilocybin treatment for TRD patients}. Mental Health Weekly. [published; OpenAlex]. \href{https://doi.org/10.1002/mhw.34292}{doi:10.1002/mhw.34292}.
\item Brooks BM, Cordero FJ, Alchermes SL, Brooks BM. (2025). \textit{Social pain: A systematic review on interventions.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.12688/f1000research.159561.1}{doi:10.12688/f1000research.159561.1}.
\item Haft SL, Downey AE, Raymond-Flesch M, Fernandes-Osterhold G, Bradley ER, O'Donovan A, Woolley J. (2025). \textit{A systematic review of participant diversity in psychedelic-assisted psychotherapy trials.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.psychres.2025.116359}{doi:10.1016/j.psychres.2025.116359}.
\item Schuler H, Zhou D, Savignac C, Cvetkovska V, Tse Y, Meccia J, Lopez J, Harutyunyan AS, Ragoussis J, Bzdok D, Bagot RC. (2025). \textit{Cell-type specific transcriptional modulation by psilocybin induces sustained plasticity in mouse medial prefrontal cortex}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2025.01.08.631940}{doi:10.1101/2025.01.08.631940}.
\item Fernando Espí Forcén (2025). \textit{A Psilocybin Experience Gone Wrong: The Importance of Psychedelic Assisted Psychotherapy}. Journal of Psychoactive Drugs. [published; OpenAlex]. \href{https://doi.org/10.1080/02791072.2025.2449918}{doi:10.1080/02791072.2025.2449918}.
\item Strand NH, Whitney M, Johnson B, Dunn T, Attanti S, Maloney J, Misra L, Gomez D, Viswanath O, Emami E, Leathem J. (2025). \textit{Pain and Perception: Exploring Psychedelics as Novel Therapeutic Agents in Chronic Pain Management.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s11916-024-01353-0}{doi:10.1007/s11916-024-01353-0}.
\item Constantino JL, van Dalfsen JH, Massetti S, Kamphuis J, Schoevers RA. (2025). \textit{Neurobiological mechanisms of antidepressant properties of psilocybin: A systematic review of blood biomarkers.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.pnpbp.2025.111251}{doi:10.1016/j.pnpbp.2025.111251}.
\item Mona Irrmischer, Drew Puxty, Barış Onur Yıldırım, J.B. Deijen, Hessel Engelbregt (2025). \textit{Moderating factors in psilocybin-assisted treatment affecting mood and personality: A naturalistic, open-label investigation}. Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1007/s00213-024-06733-3}{doi:10.1007/s00213-024-06733-3}.
\item Cook SG, Lee S, Ference E, Shi Y, Rojas-Carvajal M, Hen R, Bains JS, Füzesi T, Turi GF. (2025). \textit{Psilocybin induces sex- and context-specific recruitment of the stress axis}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2025.01.06.631556}{doi:10.1101/2025.01.06.631556}.
\item Erkizia-Santamaría I, Horrillo I, Meana JJ, Ortega JE. (2025). \textit{Clinical and preclinical evidence of psilocybin as antidepressant. A narrative review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.pnpbp.2025.111249}{doi:10.1016/j.pnpbp.2025.111249}.
\item Sutherland I, Ho MF, Croarkin PE. (2025). \textit{Psychedelic Treatments in Adolescent Psychopharmacology: Considering Safety, Ethics, and Scientific Rigor.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1089/cap.2024.0082}{doi:10.1089/cap.2024.0082}.
\item Liao C, O’Farrell E, Weiner AM, Qalieh Y, Savalia NK, Girgenti MJ, Kwan KY, Kwan AC. (2025). \textit{Single-nucleus transcriptomics reveals cell type-specific and time-dependent effects of psilocybin and ketamine on gene expression}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2025.01.04.631335}{doi:10.1101/2025.01.04.631335}.
\item Chen J, Wang Z, Yong CY, Goh EML, Moy HY, Chan ECY. (2025). \textit{Elucidating the Phase I metabolism of psilocin in vitro.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s00204-024-03952-7}{doi:10.1007/s00204-024-03952-7}.
\item Socoró Garrigosa M, Sanz Perl Y, Kringelbach ML, Carhart-Harris R, Vohryzek J, Deco G. (2025). \textit{Perturbing whole-brain models of brain hierarchy: an application for depression following pharmacological treatment}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2025.01.01.631011}{doi:10.1101/2025.01.01.631011}.
\item Tuğcan MO, Akpınar AA. (2025). \textit{Mushroom poisoning: An updated review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.4103/tjem.tjem\_129\_24}{doi:10.4103/tjem.tjem\_129\_24}.
\item Caitlyn S. Greenspun (2024). \textit{The Right to 'Trip:' Navigating Psilocybin-Assisted Psychotherapy Under the Right to Try Pathway}. eYLS (Yale Law School). [published; OpenAlex]. \href{https://lawecommons.luc.edu/luclj/vol56/iss3/6}{source link}.
\item Godinho de Oliveira, Elisabete (2024). \textit{Psilocybin-containing mushrooms as a prospective therapeutic for Parkinson’s disease. Pre-clinical study}. Southern Cross Research Portal (Southern Cross University). [published; OpenAlex]. \href{https://doi.org/10.25918/thesis.558}{doi:10.25918/thesis.558}.
\item Jimmy Nicolas Hernandez Herrera, Marian Daniela Guio Sierra (2024). \textit{Clinical use of psilocybin in mental disorders:: a bibliometric analysis in Scopus and Web of Science}. Dialnet (Universidad de la Rioja). [published; OpenAlex]. \href{https://dialnet.unirioja.es/servlet/oaiart?codigo=10631403}{source link}.
\item Patricia A. Cioe, Garrett S Stang, Danish Azam, Sarah Dugal (2024). \textit{Additional file 1 of “I’ve learned that I’m open-minded to this possibility”: A qualitative study to evaluate the acceptability of a psilocybin-aided smoking cessation treatment for people with HIV who smoke}. Figshare. [published; OpenAlex]. \href{https://doi.org/10.6084/m9.figshare.29615217}{doi:10.6084/m9.figshare.29615217}.
\item Siddhant Pusdekar (2024). \textit{Psilocybin rewires specific mouse cortical networks in lasting ways}. The Transmitter. [published; OpenAlex]. \href{https://doi.org/10.53053/pkim3530}{doi:10.53053/pkim3530}.
\item Hancock, Mackenzie, Shambhu Prasad Adhikari, Getz, Nicole (2024). \textit{Psilocybin-Assisted Therapy for Trauma-Related Disorders: A Scoping Review of a Depression-Dominated Evidence Base with Implications for Intimate Partner Violence-Related PTSD}. Open Science Framework. [published; OpenAlex]. \href{https://doi.org/10.17605/osf.io/ar2s4}{doi:10.17605/osf.io/ar2s4}.
\item Henrique Tofoli Vieira Machado, GEOVANA MENDES DE SEIXAS, L. Silva, Mariana Duarte Garcia Brito, Gabriella Assink de Castro (2024). \textit{Alternative therapy for neurological and psychiatric disorders using psilocybin}. Unknown journal. [published; OpenAlex]. \href{https://doi.org/10.5327/1516-3180.cpn.1123}{doi:10.5327/1516-3180.cpn.1123}.
\item Madison M. H. Simounet, Joy Drinnon (2024). \textit{Attitudes Towards Psilocybin: A General Population’s Opinions on Psilocybin and Psilocybin-Assisted Therapies}. Psi Chi Journal of Psychological Research. [published; OpenAlex]. \href{https://doi.org/10.24839/2325-7342.jn30.4.345}{doi:10.24839/2325-7342.jn30.4.345}.
\item Emma Cinotti (2024). \textit{Political Attitudes towards the Legalization of Cannabis and Psilocybin}. SSRN Electronic Journal. [published; OpenAlex]. \href{https://doi.org/10.2139/ssrn.5258746}{doi:10.2139/ssrn.5258746}.
\item Rebecca Harding, Natalie Ertl, Rabia Zafar, Magnus Wall, Rajkanya Das, David Erritzøe, David Nutt, Robin Carhart-Harris (2024). \textit{Effects of escitalopram and psilocybin therapy on mesolimbic resting-state functional connectivity in depression}. Neuroscience Applied. [published; OpenAlex]. \href{https://doi.org/10.1016/j.nsa.2025.105421}{doi:10.1016/j.nsa.2025.105421}.
\item Michal Brownstien (2024). \textit{Long-term effects of single-dose psilocybin and psychedelic mushroom extract in the SAPAP3 model of OCD-like behavior}. Neuroscience Applied. [published; OpenAlex]. \href{https://doi.org/10.1016/j.nsa.2025.105450}{doi:10.1016/j.nsa.2025.105450}.
\item Tess L. Veuthey, Prasad Shirvalkar (2024). \textit{Uncovering the dynamics of psilocybin in human neural pain circuits with intracranial neural recordings}. Brain stimulation. [published; OpenAlex]. \href{https://doi.org/10.1016/j.brs.2024.12.653}{doi:10.1016/j.brs.2024.12.653}.
\item Friederike Klein (2024). \textit{Therapieresistente Depression: Studie zur Psilocybin-augmentierten Psychotherapie nicht erfolgreich}. InFo Neurologie + Psychiatrie. [published; OpenAlex]. \href{https://doi.org/10.1007/s15005-024-4209-z}{doi:10.1007/s15005-024-4209-z}.
\item Unknown authors (2024). \textit{Supplemental Material for A Critical Evaluation of Psilocybin-Assisted Therapy Protocol Components From Clinical Trial Patients, Facilitators, and Caregivers}. Psychotherapy. [published; OpenAlex]. \href{https://doi.org/10.1037/pst0000551.supp}{doi:10.1037/pst0000551.supp}.
\item RM Moosa-Battey (2024). \textit{Psilocybin: revealing the enigmas of a revolutionary fungi}. SA pharmaceutical journal.. [published; OpenAlex]. \href{https://doi.org/10.36303/sapj.0982}{doi:10.36303/sapj.0982}.
\item Charles S. Brennan, Yanyi Huang, Margaret A. Brennan (2024). \textit{Mushroom bioactives-polysaccharides to psilocybin: a viewpoint on the therapeutic use of mushrooms for consumers and patients for health and neuroplasticity}. Translational Food Sciences. [published; OpenAlex]. \href{https://doi.org/10.1093/trfood/vxaf001}{doi:10.1093/trfood/vxaf001}.
\item Azimjon Karimov, Dilshodbek Rasulov (2024). \textit{Moral Considerations and the Experience of Ego Dissolution: Insights from Psilocybin}. Asian Journal of Ethics in Health and Medicine. [published; OpenAlex]. \href{https://doi.org/10.51847/ml10ckoxsw}{doi:10.51847/ml10ckoxsw}.
\item Joshua Woolley, MD, PhD (2024). \textit{Psilocybin Therapy for Depression and Anxiety in Parkinson's Disease: a Pilot Study}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT04932434}{source link}.
\item Hadley M, Halliday A, Stone JM (2024). \textit{Association of Hallucinogen Persisting Perception Disorder with Trait Neuroticism and Mental Health Symptoms.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2023.2287081}{doi:10.1080/02791072.2023.2287081}.
\item Barnett BS, Vest MF, Delatte MS, King Iv F, Mauney EE, Coulson AJ, Nayak SM, Hendricks PS, Greer GR, Murnane KS (2024). \textit{Practical considerations in the establishment of psychedelic research programs.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-024-06722-6}{doi:10.1007/s00213-024-06722-6}.
\item Namik Kirlić, Molly Lennard-Jones, Merve Atli, Ekaterina Malievskaia, Nadav Liam Modlin, Stéphanie Knatz Peck, Alice Gaillard, Guy M. Goodwin, Don Koelpin (2024). \textit{Compass Psychological Support Model for COMP360 Psilocybin Treatment of Serious Mental Health Conditions}. American Journal of Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1176/appi.ajp.20230884}{doi:10.1176/appi.ajp.20230884}.
\item O'Donnell KC, Grigsby J, Grob CS (2024). \textit{Healing, Harms, and Humility: Expanding the Scope of Psychedelic-Assisted Psychotherapy Research.}. The American journal of psychiatry. [published; PubMed]. \href{https://doi.org/10.1176/appi.ajp.20230785}{doi:10.1176/appi.ajp.20230785}.
\item Fonzo GA, Wolfgang AS, Barksdale BR, Krystal JH, Carpenter LL, Kraguljac NV, Grzenda A, McDonald WM, Widge AS, Rodriguez CI, Nemeroff CB. (2024). \textit{Psilocybin: From Psychiatric Pariah to Perceived Panacea.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1176/appi.ajp.20230682}{doi:10.1176/appi.ajp.20230682}.
\item Ramaekers JG, Reckweg JT, Mason NL. (2024). \textit{Benefits and Challenges of Ultra-Fast, Short-Acting Psychedelics in the Treatment of Depression.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1176/appi.ajp.20230890}{doi:10.1176/appi.ajp.20230890}.
\item Scott T. Aaronson, Andrew van der Vaart, Tammy Miller, Jeffrey LaPratt, Kimberly Swartz, Audrey Shoultz, Margo Lauterbach, Trisha Suppes, Harold A. Sackeïm (2024). \textit{Single-Dose Psilocybin for Depression With Severe Treatment Resistance: An Open-Label Trial}. American Journal of Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1176/appi.ajp.20231063}{doi:10.1176/appi.ajp.20231063}.
\item Wolfgang AS, McClair VL, Schnurr PP, Holtzheimer PE, Woolley JD, Stauffer CS, Wolf RC, States LJ, Benedek DM, Capaldi VF, Bradley J, Fuller MA, Smyth MJ, Hermes EDA, Tenhula W, Wiechers IR (2024). \textit{Research and Implementation of Psychedelic-Assisted Therapy in the Veterans Health Administration.}. The American journal of psychiatry. [published; PubMed]. \href{https://doi.org/10.1176/appi.ajp.20240751}{doi:10.1176/appi.ajp.20240751}.
\item Broc A. Pagni, Richard J. Zeifman, Sarah E. Mennenga, Brennan M. Carrithers, Noam Goldway, Snehal Bhatt, Kelley C. O’Donnell, Stephen Ross, Michael P. Bogenschutz (2024). \textit{Multidimensional Personality Changes Following Psilocybin-Assisted Therapy in Patients With Alcohol Use Disorder: Results From a Double-Blind, Placebo-Controlled Clinical Trial}. American Journal of Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1176/appi.ajp.20230887}{doi:10.1176/appi.ajp.20230887}.
\item Manzano-Nunez R, Gomez DA, Toledo-Mendoza C, Perez-Otero M, Matilla IL, Prats C, Perez-Lopez E, Pardo H, Díaz-Pellicer P, De La Torre-Fornell R, Aldea AM. (2024). \textit{Exploring Psychedelics Pharmacology: A Scoping Review Charting the Course of Psilocybin Pharmacokinetics.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1097/wnf.0000000000000617}{doi:10.1097/wnf.0000000000000617}.
\item Lewis BR, Hendrick J, Byrne K, Odette M, Wu C, Garland EL. (2024). \textit{Psilocybin-Assisted Group Psychotherapy + Mindfulness Based Stress Reduction (MBSR) for Frontline Healthcare Provider COVID-19 Related Depression and Burnout: A Randomized Clinical Trial}. medRxiv. [preprint; medRxiv]. \href{https://doi.org/10.1101/2024.12.31.24319806}{doi:10.1101/2024.12.31.24319806}.
\item Cohen IG, Marks M (2024). \textit{Psychedelic Medicine Exceptionalism.}. The American journal of bioethics: AJOB. [published; PubMed]. \href{https://doi.org/10.1080/15265161.2025.2434398}{doi:10.1080/15265161.2025.2434398}.
\item Wijesekara T, Xu B. (2024). \textit{Insights into therapeutic potential and practical applications of natural toxins from poisonous mushrooms.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/09603271251323134}{doi:10.1177/09603271251323134}.
\item Cumming P, Egger K, Knudsen GM (2024). \textit{Molecular brain imaging of psychedelic action.}. International review of neurobiology. [published; PubMed]. \href{https://doi.org/10.1016/bs.irn.2025.02.005}{doi:10.1016/bs.irn.2025.02.005}.
\item Bostoen T, Tap S, Breeksema J, Schoevers R (2024). \textit{Post-traumatic stress disorder in psychedelic research.}. International review of neurobiology. [published; PubMed]. \href{https://doi.org/10.1016/bs.irn.2025.02.004}{doi:10.1016/bs.irn.2025.02.004}.
\item Tap S, Bostoen T, Breeksema J, Schoevers R (2024). \textit{Psychedelics for the treatment of end-of-life distress in patients with a life-threatening disease.}. International review of neurobiology. [published; PubMed]. \href{https://doi.org/10.1016/bs.irn.2025.03.001}{doi:10.1016/bs.irn.2025.03.001}.
\item Sommer WH, Spanagel R (2024). \textit{Behavioral Neurobiology of Alcohol Addiction: A Decade of Great Challenges, New Hopes, and Hypes.}. Current topics in behavioral neurosciences. [published; PubMed]. \href{https://doi.org/10.1007/7854\_2025\_586}{doi:10.1007/7854\_2025\_586}.
\item D M Schuman H, Barkova S, Mina R, Deleemans JM, Nguyen T, Carlson LE (2024). \textit{"" A Qualitative Analysis of Patient Perspectives on Psychedelic-Assisted Therapy for Cancer-Related Psychosocial Symptoms.}. Integrative cancer therapies. [published; PubMed]. \href{https://doi.org/10.1177/15347354251370982}{doi:10.1177/15347354251370982}.
\item Farzaneh Norouzkhani, Esmaeel Ghasemi Gojani, Bo Wang, DongPing Li, Salma Shujat, Aadarsh Shrestha, Rocio Rodriguez-Juarez, Olga Kovalchuk, Igor Kovalchuk (2024). \textit{Psilocybin alleviates high-glucose and high-lipid-induced skin aging in BJ5Ta fibroblasts}. Biochemistry and Cell Biology. [published; OpenAlex]. \href{https://doi.org/10.1139/bcb-2025-0250}{doi:10.1139/bcb-2025-0250}.
\item Zitong Wang, Brett Robbins, Ryan Zhuang, Thaísa Meira Sandini, Rebekah van Bruggen, Xin-Min Li, Yanbo Zhang (2024). \textit{Early psilocybin intervention alleviates behavioral despair and cognitive impairment in stressed Wistar rats}. Progress in Neuro-Psychopharmacology and Biological Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.pnpbp.2024.111243}{doi:10.1016/j.pnpbp.2024.111243}.
\item Abramsky-Sze S, Marseille E, Matzopoulos R, Morlock R, Lerer L (2024). \textit{Characteristics and mental health of psychedelic mushroom and multi-psychedelic users relative to non-psychedelic users in American adults, 2020-2021.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2025.1508811}{doi:10.3389/fpsyt.2025.1508811}.
\item Stefan Jerotić (2024). \textit{Is there room for ethics of authenticity in psilocybin research?}. Neuroscience Applied. [published; OpenAlex]. \href{https://doi.org/10.1016/j.nsa.2025.105519}{doi:10.1016/j.nsa.2025.105519}.
\item Tunstad PA, Kvam TM, Uthaug MV, Stewart LH, Andersen KAA, Grønnerød C (2024). \textit{Contextual and experiential aspects of the psychedelic experience predicting improvement in subjective wellbeing: results from a Norwegian internet convenience sample.}. Frontiers in pharmacology. [published; PubMed]. \href{https://doi.org/10.3389/fphar.2025.1556299}{doi:10.3389/fphar.2025.1556299}.
\item Dwyer J, Johnston RB, O'Callaghan C, Kallianis V, Ross ML (2024). \textit{Music as a collaborating actor: new insights into the nature and role of music in psychedelic-assisted psychotherapy.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2025.1541528}{doi:10.3389/fpsyt.2025.1541528}.
\item Marek J, Domek-Gumprecht M, Macionga A, Szafoni S, Więckiewicz G (2024). \textit{PolDrugs 2025: results of the third edition of the nationwide study on psychoactive substance use in the context of psychiatry and harm reduction.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2025.1591658}{doi:10.3389/fpsyt.2025.1591658}.
\item Katherine Cheung, Maxwell Brodie, Sue-Ling Chang, P. Deschamps, Jean-Sébastien Fallu, Houman Farzin, Johanne Hébert, Jean-François Stephan, Michel Dorval, Yann Joly, for the P3A Study Group (2024). \textit{Psychedelic Treatment with Psilocybin: Addressing Medical Malpractice Risk and Physicians’ Concerns}. The Journal of Law Medicine \& Ethics. [published; OpenAlex]. \href{https://doi.org/10.1017/jme.2025.10109}{doi:10.1017/jme.2025.10109}.
\item Houman Farzin, Benjamin Koren, Helen Ferrier, Justin J. Sanders, Nicolas Garel (2024). \textit{Home-based psilocybin-assisted therapy for a patient with advanced cancer: A case report}. Palliative \& Supportive Care. [published; OpenAlex]. \href{https://doi.org/10.1017/s1478951525100941}{doi:10.1017/s1478951525100941}.
\item McHerron D, Barber M, Ham R, Liknaitzky P, Carter A, Gardner J (2024). \textit{The ethical use of therapeutic touch in psychedelic-assisted therapy: a qualitative study of researcher perspectives and experiences.}. Therapeutic advances in psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1177/20451253251377191}{doi:10.1177/20451253251377191}.
\item Elena Koning, Pedro Starzynski Bacchi, Cristiano Chaves, Fabiano A. Gomes, Elisa Brietzke (2024). \textit{Which Psychotherapy Model Should be Used in Psilocybin Treatment for Depression?}. Trends in Psychiatry and Psychotherapy. [published; OpenAlex]. \href{https://doi.org/10.47626/2237-6089-2025-1197}{doi:10.47626/2237-6089-2025-1197}.
\item Unknown authors (2024). \textit{Theoretical Description for Psilocin and Coprine Electrochemical Determination in Mushroom Pulp and Biological Liquids over Cobalt (II) Oxyhydroxide-Modified Electrode}. Letters in Applied NanoBioScience. [published; Crossref]. \href{https://doi.org/10.33263/lianbs134.173}{doi:10.33263/lianbs134.173}.
\item Koning E, Chaves C, Kirkpatrick RH, Brietzke E. (2024). \textit{Exploring the neurobiological correlates of psilocybin-assisted psychotherapy in eating disorders: a review of potential methodologies and implications for the psychedelic study design.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1186/s40337-024-01185-8}{doi:10.1186/s40337-024-01185-8}.
\item Ian M. Bollinger, Harte Singer, Jordan Jacobs, Marshall Tyler, Kelsey L. Scott, Christopher S. Pauli, Dusty R. Miller, Caine Barlow, Alan Rockefeller, Jason C. Slot, Victor Angel-Mosti (2024). \textit{High-quality draft genomes of ecologically and geographically diverse Psilocybe species}. Microbiology Resource Announcements. [published; OpenAlex]. \href{https://doi.org/10.1128/mra.00250-24}{doi:10.1128/mra.00250-24}.
\item Miguel Farinha-Ferreira, Catarina Miranda-Lourenço, Chloé Galipeau, Zsolt Lenkei, Ana M. Sebastião (2024). \textit{Concurrent stress modulates the acute and post-acute effects of psilocybin in a sex-dependent manner}. Neuropharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/j.neuropharm.2024.110280}{doi:10.1016/j.neuropharm.2024.110280}.
\item Swieczkowski D, Kwaśny A, Pruc M, Gaca Z, Szarpak L, Cubała WJ. (2024). \textit{Efficacy and safety of psilocybin in the treatment of Major Depressive Disorder (MDD): A dose-response network meta-analysis of randomized placebo-controlled clinical trials.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.psychres.2024.116337}{doi:10.1016/j.psychres.2024.116337}.
\item Vohryzek J, Garcia Guzman E, Kringelbach ML, Lopez-Sola E, Timmermann C, Roseman L, Tagliazucchi E, Ruffini G, Carhart-Harris R, Deco G, Sanz Perl Y. (2024). \textit{Brain dynamics of classical psychedelics show paradoxical hierarchical flattening with increased complexity}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2024.12.21.629922}{doi:10.1101/2024.12.21.629922}.
\item García-Cabrerizo R, Beruete-Fresnillo I, García-Fuster MJ. (2024). \textit{Characterizing psilocybin as an antidepressant for adolescence in male and female rats}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2024.12.20.629571}{doi:10.1101/2024.12.20.629571}.
\item Bakshi B, Yerraguntla S, Armon C, Barkhaus P, Bertorini T, Bowser R, Breevoort S, Bromberg M, Brown A, Carter GT, Chang V, Crayle J, Fullam T, Greene M, Heiman-Patterson T, Jackson C, Jhooty S, Mallon E, Cadavid JM, Mcdermott CJ, Pattee G, Pierce K, Ratner D, Sun Y, Wang O, Wicks P, Wiedau M, Bedlack R. (2024). \textit{ALSUntangled \#77: Psilocybin.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/21678421.2024.2441274}{doi:10.1080/21678421.2024.2441274}.
\item Geller J, Whitney E. (2024). \textit{Therapeutic Potential of MDMA- and Psychedelic-Assisted Psychotherapy for Adolescent Depression and Trauma.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s11920-024-01577-2}{doi:10.1007/s11920-024-01577-2}.
\item Calder AE, Qualls C, Hasler G, Elmiger D, Strassman R. (2024). \textit{The Hallucinogen Rating Scale: Updated Factor Structure in a Large, Multistudy Sample.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.bpsgos.2024.100436}{doi:10.1016/j.bpsgos.2024.100436}.
\item Miller M, Meyers M, Martin A, Napolitano S, Dorsen C, Penn A, Rosa WE. (2024). \textit{A Rapid Review of Psychedelic-Assisted Therapy in the Context of Palliative Care.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1097/njh.0000000000001096}{doi:10.1097/njh.0000000000001096}.
\item Croarkin PE, Sutherland I, Ho MF. (2024). \textit{Psychedelic Therapeutics for Adolescents: Ethics, Safety, Opportunities, and Equipoise.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jaac.2024.12.003}{doi:10.1016/j.jaac.2024.12.003}.
\item Guy M. Goodwin, Scott T. Aaronson, Oscar Alvarez, Robin Carhart-Harris, J. Chai-Rees, Megan Croal, Charles DeBattista, Boadie W. Dunlop, David Feifel, David J. Hellerstein, Muhammad Ishrat Husain, John R. Kelly, Namik Kirlić, Rasmus Wentzer Licht, Lindsey Marwood, Thomas D. Meyer, Sunil Mistry, Ania Nowakowska, Tomáš Páleníček, Dimitris Repantis, Robert A. Schoevers, Hollie Simmons, Metten Somers, Emma Teoh, Joyce Tsai, Mourad Wahba, Sam Williams, Allan H. Young, Matthew B. Young, Sidney Zisook, Ekaterina Malievskaia (2024). \textit{The role of the psychedelic experience in psilocybin treatment for treatment-resistant depression}. Journal of Affective Disorders. [published; OpenAlex]. \href{https://doi.org/10.1016/j.jad.2024.12.061}{doi:10.1016/j.jad.2024.12.061}.
\item Johannes Jungwirth, Robin von Rotz, Isabel Dziobek, Franz X. Vollenweider, Katrin H. Preller (2024). \textit{Psilocybin increases emotional empathy in patients with major depression}. Molecular Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1038/s41380-024-02875-0}{doi:10.1038/s41380-024-02875-0}.
\item Barnett JH, Todd KT, Benetatos J, Rabichow BE, Gibson KA, Olney KC, Fryer JD. (2024). \textit{Psilocybin causes sex, time, and dose dependent alterations in brain signaling pathways}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2024.12.16.628764}{doi:10.1101/2024.12.16.628764}.
\item Ferreira AE, Reis-Pina P. (2024). \textit{Exploring the role of psychedelic-assisted therapy in enhancing spirituality and mystical experiences in patients with life-threatening illnesses: A systematic review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jpsychores.2024.112020}{doi:10.1016/j.jpsychores.2024.112020}.
\item Gitte Moos Knudsen (2024). \textit{The Neurobiological Effect of 5-HT2AR Modulation}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT03289949}{source link}.
\item Purple RJ, Gupta R, Thomas CW, Golden CT, Froudist-Walsh S, Jones MW. (2024). \textit{Short- and long-term reconfiguration of rat prefrontal cortical networks following single doses of psilocybin}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2024.12.10.627734}{doi:10.1101/2024.12.10.627734}.
\item Freitas RR, Gotsis ES, Gallo AT, Fitzgibbon BM, Bailey NW, Fitzgerald PB. (2024). \textit{The safety of psilocybin-assisted psychotherapy: A systematic review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/00048674241289024}{doi:10.1177/00048674241289024}.
\item Meyer TD, Ibrahim M, Vale LN, Soares JC. (2024). \textit{Psychedelic use and bipolar disorder - An investigation of recreational use and its impact on mental health.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jad.2024.12.044}{doi:10.1016/j.jad.2024.12.044}.
\item Schonholz SM, Appel JM, Bursztajn HJ, Nair M, MacIntyre MR. (2024). \textit{Legal and Ethics Concerns of Psilocybin as Medicine.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.29158/jaapl.240089-24}{doi:10.29158/jaapl.240089-24}.
\item Scala M, Fabbri C, Fusar-Poli P, Di Lorenzo G, Ferrara M, Amerio A, Fusar-Poli L, Pichiecchio A, Asteggiano C, Menchetti M, De Ronchi D, MNESYS - Mood and Psychosis Sub-Project (Spoke 5), Fanelli G, Serretti A. (2024). \textit{The revival of psilocybin between scientific excitement, evidence of efficacy, and real-world challenges.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1017/s1092852924002268}{doi:10.1017/s1092852924002268}.
\item Ethan G. Dutcher, Andrew D. Krystal (2024). \textit{Treatment Expectancies and Psilocybin vs Escitalopram for Depression}. JAMA Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1001/jamapsychiatry.2024.4387}{doi:10.1001/jamapsychiatry.2024.4387}.
\item Marchi M, Farina R, Rachedi K, Laonigro F, Žuljević MF, Pingani L, Ferrari S, Somers M, Boks MPM, Galeazzi GM. (2024). \textit{Psychedelics as an intervention for psychological, existential distress in terminally ill patients: A systematic review and network meta-analysis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811241303594}{doi:10.1177/02698811241303594}.
\item Seybert C, Schimmers N, Silva L, Breeksema JJ, Veraart J, Bessa BS, d'Orsi D, Schoevers RA, Oliveira-Maia AJ. (2024). \textit{Quality of reporting on psychological interventions in psychedelic treatments: a systematic review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/s2215-0366(24)00333-x}{doi:10.1016/s2215-0366(24)00333-x}.
\item Yumin Kim, Rachel Bigley, Aubrey DeVinney, Paul S. Nestadt (2024). \textit{The many faces of psilocybin-related psychosis: A case series}. Psychiatry Research Case Reports. [published; OpenAlex]. \href{https://doi.org/10.1016/j.psycr.2024.100243}{doi:10.1016/j.psycr.2024.100243}.
\item Jonathan Brett, Elizabeth Knock, Kathy Watson, Steven M. Albert, Krista J. Siefried, Jeffrey Guss (2024). \textit{Psilocybin-assisted psychotherapy for methamphetamine dependence: a case report involving daily methamphetamine use}. Frontiers in Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.3389/fpsyt.2024.1490907}{doi:10.3389/fpsyt.2024.1490907}.
\item Anthony L. Back, Timara K. Freeman-Young, Ladybird Morgan, Tanmeet Sethi, Kelsey K. Baker, Susanna Myers, Bonnie A. McGregor, Kalin Harvey, Marlene Tai, Austin Kollefrath, Brandon J. Thomas, Dennis Sorta, Mendel Kaelen, Benjamin Kelmendi, Ted Gooley (2024). \textit{Psilocybin Therapy for Clinicians With Symptoms of Depression From Frontline Care During the COVID-19 Pandemic}. JAMA Network Open. [published; OpenAlex]. \href{https://doi.org/10.1001/jamanetworkopen.2024.49026}{doi:10.1001/jamanetworkopen.2024.49026}.
\item COMPASS Pathways (2024). \textit{Efficacy and Safety of COMP360 Psilocybin Therapy in Anorexia Nervosa: a Proof-of-concept Study}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05481736}{source link}.
\item Shinozuka K, Jerotic K, Mediano P, Zhao AT, Preller KH, Carhart-Harris R, Kringelbach ML. (2024). \textit{Synergistic, multi-level understanding of psychedelics: three systematic reviews and meta-analyses of their pharmacology, neuroimaging and phenomenology.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41398-024-03187-1}{doi:10.1038/s41398-024-03187-1}.
\item Terao I, Kodama W. (2024). \textit{Comparative antidepressant effects and safety of intravenous racemic ketamine, psilocybin and theta burst stimulation for major depressive disorder: A systematic review and network meta-analyses of randomized controlled trials.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1002/pcn5.70042}{doi:10.1002/pcn5.70042}.
\item Humphreys K, Todd Korthuis P, Stjepanović D, Hall W. (2024). \textit{Therapeutic Potential of Psychedelic Drugs: Navigating High Hopes, Strong Claims, Weak Evidence, and Big Money.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1146/annurev-psych-020124-023532}{doi:10.1146/annurev-psych-020124-023532}.
\item Menon V, Ramamurthy P, Venu S, Andrade C. (2024). \textit{Randomized Controlled Trials of Psilocybin-Assisted Therapy in the Treatment of Major Depressive Disorder: Systematic Review and Meta-Analysis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1111/acps.13778}{doi:10.1111/acps.13778}.
\item Unknown authors (2024). \textit{Correction to: A Bayesian Reanalysis of a Trial of Psilocybin Versus Escitalopram for Depression by Nayak, et al. Psychedelic Med 2023;1(1):18-26; doi: 10.1089/psymed.2022.0002.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1089/psymed.2022.0002.correx}{doi:10.1089/psymed.2022.0002.correx}.
\item Piercey CJ, Gray B, Sung A, Henry D, Karoly HC. (2024). \textit{Protective Behavioral Strategies for Psychedelic Use: A Mini Review of the Evidence.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1089/psymed.2023.0052}{doi:10.1089/psymed.2023.0052}.
\item George Tewfik, Adejuyigbe Adaralegbe, Sangel Gomez, Rania Aziz, Faraz Chaudhry, Daniel Rodriguez-Correa, Dorisanne O. Adaralegbe (2024). \textit{Narrative review of psilocybin, an important psychoactive substance with potential peri-anesthetic implications}. Trends in Anaesthesia and Critical Care. [published; OpenAlex]. \href{https://doi.org/10.1016/j.tacc.2024.101514}{doi:10.1016/j.tacc.2024.101514}.
\item Juan Scuro (2024). \textit{God hasn’t died, it has merely been encapsulated - Psilocybin and ayahuasca in the psychedelic renaissance: Intersections between religion, indigenous cosmologies, spirituality, and science}. Social Compass. [published; OpenAlex]. \href{https://doi.org/10.1177/00377686241301923}{doi:10.1177/00377686241301923}.
\item Hinkle JT, Graziosi M, Nayak SM, Yaden DB. (2024). \textit{Adverse Events in Studies of Classic Psychedelics: A Systematic Review and Meta-Analysis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1001/jamapsychiatry.2024.2546}{doi:10.1001/jamapsychiatry.2024.2546}.
\item Collins HM. (2024). \textit{Psychedelics for the Treatment of Obsessive-Compulsive Disorder: Efficacy and Proposed Mechanisms.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1093/ijnp/pyae057}{doi:10.1093/ijnp/pyae057}.
\item Fradet M, Kelly CM, Donnelly AJ, Suppes T. (2024). \textit{Psilocybin and hallucinogenic mushrooms.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1017/s1092852924002487}{doi:10.1017/s1092852924002487}.
\item Spangemacher M, Mertens LJ, Färber LV, Jungaberle A, Jungaberle H, Gründer G. (2024). \textit{Psilocybin as a Disease-Modifying Drug-A Salutogenic Approach in Psychiatry.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3238/arztebl.m2024.0224}{doi:10.3238/arztebl.m2024.0224}.
\item Arman Fard, Allison Cohen (2024). \textit{Exploring Psychotherapeutic Benefits of Psilocybin and Psychedelics In Controlled Medical Settings}. Journal of Student Research. [published; OpenAlex]. \href{https://doi.org/10.47611/jsrhs.v13i4.7602}{doi:10.47611/jsrhs.v13i4.7602}.
\item de Jonge D, van der Meer PB, Kramers C, Schellekens A. (2024). \textit{Psychedelic Research for Alcohol Use Disorder with Comorbid Major Depressive Disorder: An Unmet Need.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s11920-024-01567-4}{doi:10.1007/s11920-024-01567-4}.
\item Calder AE, Hase A, Hasler G. (2024). \textit{Effects of psychoplastogens on blood levels of brain-derived neurotrophic factor (BDNF) in humans: a systematic review and meta-analysis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41380-024-02830-z}{doi:10.1038/s41380-024-02830-z}.
\item Ben-Tal T, Pogodin I, Botvinnik A, Lifschytz T, Heresco-Levy U, Lerer B. (2024). \textit{Synergistic Behavioral and Neuroplastic Effects of Psilocybin-NMDAR Modulator Administration}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2024.11.28.625811}{doi:10.1101/2024.11.28.625811}.
\item Sabé M, Sulstarova A, Glangetas A, De Pieri M, Mallet L, Curtis L, Richard-Lepouriel H, Penzenstadler L, Seragnoli F, Thorens G, Zullino D, Preller K, Böge K, Leucht S, Correll CU, Solmi M, Kaiser S, Kirschner M. (2024). \textit{Reconsidering evidence for psychedelic-induced psychosis: an overview of reviews, a systematic review, and meta-analysis of human studies.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41380-024-02800-5}{doi:10.1038/s41380-024-02800-5}.
\item Noah D. Gold, Broc A. Pagni, Petros Petridis, Michael P. Bogenschutz (2024). \textit{Psilocybin-Assisted Therapy May Enhance Conservation Values in Patients with Alcohol Use Disorder}. Psychedelic Medicine. [published; OpenAlex]. \href{https://doi.org/10.1089/psymed.2024.0030}{doi:10.1089/psymed.2024.0030}.
\item Miller CE, Zoladz PR. (2024). \textit{Evaluating the potential for psilocybin as a treatment for post-traumatic stress disorder.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1124/jpet.124.002237}{doi:10.1124/jpet.124.002237}.
\item Yale University (2024). \textit{Psilocybin Treatment in Obsessive-Compulsive Disorder: a Preliminary Efficacy Study and Exploratory Investigation of Neural Correlates.}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT03356483}{source link}.
\item TRYP Therapeutics (2024). \textit{A Phase 2a Safety and Feasibility Study Evaluating Psilocybin (TRP-8802) Administration in Concert With Psychotherapy in the Treatment of Binge Eating Disorder}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05035927}{source link}.
\item Shakila Meshkat, Erica Kaczmarek, Zoe Doyle, Ryan M. Brudner, Fabiano A. Gomes, Marc G. Blainey, Geneva Weiglein, Roger S McIntyre, Rodrigo B. Mansur, Joshua D. Rosenblat (2024). \textit{Psilocybin-Assisted Psychotherapy for Treatment-Resistant Depression in Bipolar II Disorder}. Psychedelic Medicine. [published; OpenAlex]. \href{https://doi.org/10.1089/psymed.2024.0032}{doi:10.1089/psymed.2024.0032}.
\item Raj Nashikkar, Kavita Mane, Rajendra Patil (2024). \textit{Psilocybin Fungi Unveiled: Morphological Characteristics and Pharmacological Potentials}. International Journal for Research in Applied Science and Engineering Technology. [published; OpenAlex]. \href{https://doi.org/10.22214/ijraset.2024.65160}{doi:10.22214/ijraset.2024.65160}.
\item Erin Y. Wang, David S. Mathai, Natalie Gukasyan, Sandeep M. Nayak, Albert Garcia-Romeu (2024). \textit{Knowledge, attitudes, and concerns about psilocybin and MDMA as novel therapies among U.S. healthcare professionals}. Scientific Reports. [published; OpenAlex]. \href{https://doi.org/10.1038/s41598-024-78736-1}{doi:10.1038/s41598-024-78736-1}.
\item Zech JM, Yaden DB, Jones GM. (2024). \textit{Associations between psychedelic use and cannabis use disorder in a nationally representative sample.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.drugalcdep.2024.112502}{doi:10.1016/j.drugalcdep.2024.112502}.
\item Reid MJ, Kettner H, Blanken TF, Weiss B, Carhart-Harris R. (2024). \textit{Preliminary Evidence of Sleep Improvements Following Psilocybin Administration, and their Involvement in Antidepressant Therapeutic Action.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s11920-024-01539-8}{doi:10.1007/s11920-024-01539-8}.
\item Reza Ghaffarzadegan, Mokhtar Karimi, Behnaz Hedayatjoo, Hamidreza Behnoud, Eghbal Jasemi, Mahsa Mohammadi, Samira Roustaei, Ali Razmi, Salar Vaseghi (2024). \textit{The Effect of Psilocybe cubensis on Spatial Memory and BDNF Expression in Male Rats Exposed to Chronic Unpredictable Mild Stress}. Journal of Psychoactive Drugs. [published; OpenAlex]. \href{https://doi.org/10.1080/02791072.2024.2428241}{doi:10.1080/02791072.2024.2428241}.
\item University of Utah (2024). \textit{PAPR: Psilocybin-assisted Psychotherapy + Mindfulness-Based Stress Reduction (MBSR) for Front-line Healthcare Provider COVID-19 Related Burnout}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05557643}{source link}.
\item Unknown authors (2024). \textit{Mushroom Therapy: Psilocybin's Role in Treating Substance Use Disorders (P3-9.018).}. Neurology. [published; PubMed]. \href{https://doi.org/10.1212/wnl.0000000000209686}{doi:10.1212/wnl.0000000000209686}.
\item Zhang M, Yang Y, Yang Z, Wen X, Zhang C, Xiao P, Wang Y, Sun J, Wang H, Wang X. (2024). \textit{Structural insights into tryptamine psychedelics: The role of hydroxyl indole ring site in 5-HT2A receptor activation and psychedelic-like activity.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.ejmech.2024.117049}{doi:10.1016/j.ejmech.2024.117049}.
\item Kargbo RB. (2024). \textit{Advances in Psychedelic Therapeutics: Novel Prodrugs and Derivatives for Enhanced Mental Health Treatment.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/acsmedchemlett.4c00519}{doi:10.1021/acsmedchemlett.4c00519}.
\item Kargbo RB. (2024). \textit{Advanced Delivery Systems and Novel Psilocin Derivatives for Enhanced Therapeutic Applications.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/acsmedchemlett.4c00521}{doi:10.1021/acsmedchemlett.4c00521}.
\item Jiwon Lee, Kaylyssa Philip, Duminda N. Wijeysundera, Hance Clarke, Cheryl Pritlove, Joel Katz, Paul Ritvo, Akash Goel, Muhammad Ishrat Husain, Karim S. Ladha (2024). \textit{Prospective Preference Assessment for the Psilocybin for Enhanced Analgesia in Chronic nEuropathic PAIN (PEACE-PAIN) Trial}. Canadian Journal of Pain. [published; OpenAlex]. \href{https://doi.org/10.1080/24740527.2024.2406285}{doi:10.1080/24740527.2024.2406285}.
\item Stéphanie Knatz Peck, Hannah M. Fisher, Jessie Kim, Samantha Shao, Julie Trim, Walter H. Kaye (2024). \textit{Psychedelic treatment for anorexia nervosa: A first-hand view of how psilocybin treatment did and did not help}. Psychedelics.. [published; OpenAlex]. \href{https://doi.org/10.61373/pp024e.0034}{doi:10.61373/pp024e.0034}.
\item Hodge A, Forsyth A, Noorani T, Muthukumaraswamy S, Rolleston A, McHugh P. (2024). \textit{Tū Wairua: Development of an Indigenous Rongoā Māori Approach to Healing with Psilocybin Containing Mushrooms}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/93x5h}{doi:10.31234/osf.io/93x5h}.
\item Hodge A, Forsyth A, Noorani T, Muthukumaraswamy S, Rolleston A, McHugh P. (2024). \textit{Tū Wairua: Development of an Indigenous Rongoā Māori Approach to Healing with Psilocybin Containing Mushrooms}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/93x5h\_v1}{doi:10.31234/osf.io/93x5h\_v1}.
\item Pasquini L, Vohryzek J, Escrichs A, Sanz Perl Y, Ponce-Alvarez A, Idesis S, Girn M, Roseman L, Mitchell JM, Gazzaley A, Kringelbach M, Nutt DJ, Lyons T, Carhart-Harris RL, Deco G. (2024). \textit{Long-term effects of psilocybin on dynamic and effectivity connectivity of fronto-striatal-thalamic circuits}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2024.11.06.622302}{doi:10.1101/2024.11.06.622302}.
\item Andrew Gribben, T. R. JUN. BURKE, Colm Harrington, Amanda Husein, Kevin S. Murnane, Peter S. Hendricks, Katy Tobin, Jo-Hanna Ivers, Guillaume Thuery, Andrew Harkin, John R. Kelly (2024). \textit{Amid magic and menace: psychiatrists’ attitudes to psilocybin therapy}. Irish Journal of Psychological Medicine. [published; OpenAlex]. \href{https://doi.org/10.1017/ipm.2024.49}{doi:10.1017/ipm.2024.49}.
\item Imperial College London (2024). \textit{PsilOCD: Evaluating the Effects of the 5-HT2A Agonist Psilocybin on the Neurocognitive and Clinical Correlates of Compulsivity (A Pharmacological-Challenge Feasibility Study)}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06258031}{source link}.
\item Barstowe A, Kajonius PJ. (2024). \textit{Masking Influences: A Systematic Review of Placebo Control and Masking in Psychedelic Studies.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/02791072.2024.2424272}{doi:10.1080/02791072.2024.2424272}.
\item Link Swanson, Sophia Jungers, Ranji Varghese, Kathryn R. Cullen, Michael D. Evans, Jessica L. Nielson, Michael-Paul Schallmo (2024). \textit{Enhanced visual contrast suppression during peak psilocybin effects: Psychophysical results from a pilot randomized controlled trial}. Journal of Vision. [published; OpenAlex]. \href{https://doi.org/10.1167/jov.24.12.5}{doi:10.1167/jov.24.12.5}.
\item Valdez T, Patel V, Senesombath N, Hatahet-Donovan Z, Hornick M. (2024). \textit{Therapeutic Potential of Psychedelic Compounds for Substance Use Disorders.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/ph17111484}{doi:10.3390/ph17111484}.
\item Marcel Nogueira, Solimary García-Hernández, Gleicy Sotéro Roberto, Leonardo Zanella Marques (2024). \textit{Psilocybin Mushrooms and Public Health in Brazil: Insights from a Retrospective Analysis of Adverse Events and Their Implications for Regulatory Discussions}. International journal of medicinal mushrooms. [published; OpenAlex]. \href{https://doi.org/10.1615/intjmedmushrooms.2024057053}{doi:10.1615/intjmedmushrooms.2024057053}.
\item Aday JS, McAfee J, Conroy DA, Hosanagar A, Tarnal V, Weston C, Scott K, Horowitz D, Harte SE, Pouyan N, Glynos NG, Baker AK, Guss J, Davis AK, Burgess HJ, Mashour GA, Clauw DJ, Boehnke KF. (2024). \textit{Preliminary safety and effectiveness of psilocybin-assisted therapy in adults with fibromyalgia: An open-label, pilot clinical trial}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/j8zb5}{doi:10.31234/osf.io/j8zb5}.
\item Unknown authors (2024). \textit{Preliminary safety and effectiveness of psilocybin-assisted therapy in adults with fibromyalgia: An open-label, pilot clinical trial}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/j8zb5\_v1}{source link}.
\item Shao L, Liao C, Davoudian PA, Savalia NK, Jiang Q, Wojtasiewicz C, Tan D, Nothnagel JD, Liu R, Woodburn SC, Bilash OM, Kim H, Che A, Kwan AC. (2024). \textit{Pyramidal cell types and 5-HT2A receptors are essential for psilocybin’s lasting drug action}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2024.11.02.621692}{doi:10.1101/2024.11.02.621692}.
\item Mourad Wahba, Caroline Hayes, Maartje Kletter, R. Hamish McAllister-Williams (2024). \textit{Worsening suicidal ideation and prolonged adverse event following psilocybin administration in a clinical setting: case report and thematic analysis of one participant's experience}. BJPsych Open. [published; OpenAlex]. \href{https://doi.org/10.1192/bjo.2024.768}{doi:10.1192/bjo.2024.768}.
\item Emese Prandovszky O’Donnell, Zachary A. Cordner, Hua Liu, Shuojia Yang, Lindsey Macias, Kellie L. Tamashiro, Frederick S. Barrett, Robert H. Yolken (2024). \textit{Psilocybin alters the circulating metabolomic profile in both non-clinical and clinical models}. Brain Behavior and Immunity. [published; OpenAlex]. \href{https://doi.org/10.1016/j.bbi.2024.12.146}{doi:10.1016/j.bbi.2024.12.146}.
\item Lamia Özgör (2024). \textit{Psilocybin-unterstützte Psychotherapie reduziert Ängste und Depressionen}. InFo Hämatologie + Onkologie. [published; OpenAlex]. \href{https://doi.org/10.1007/s15004-024-0785-9}{doi:10.1007/s15004-024-0785-9}.
\item D Silva, Antônio Carlos Pereira de Menezes Filho, Aurélio Ferreira Melo, Porshia Sharma, Tullyo Henrique Lima Machado, Vanêcia Oliveira Cunha Machado, Matheus Vinícius Abadia Ventura (2024). \textit{Phytochemical screening, phenolic and flavonoid contents, psilocybin, antioxidant, and acetylcholinesterase inhibition activities of the aqueous extract from the fungi Cyathus striatus, Laternea dringii, and Marasmius haematocephalus}. Brazilian Journal of Science. [published; OpenAlex]. \href{https://doi.org/10.14295/bjs.v3i11.694}{doi:10.14295/bjs.v3i11.694}.
\item Slavica Janevska, Sophie Weiser, Ying Huang, Jun Lin, Sandra Hoefgen, Katarina Jojić, Amelia E. Barber, Tim Schäfer, Janis Fricke, Dirk Hoffmeister, Lars Regestein, Vito Valiante, Johann E. Kufs (2024). \textit{Optimized psilocybin production in tryptophan catabolism-repressed fungi}. Microbial Biotechnology. [published; OpenAlex]. \href{https://doi.org/10.1111/1751-7915.70039}{doi:10.1111/1751-7915.70039}.
\item Mourad Wahba, Caroline Hayes, Maartje Kletter, R. Hamish McAllister-Williams (2024). \textit{Worsening suicidal ideation and prolonged adverse event following psilocybin administration in a clinical setting: case report and thematic analysis of one participant's experience}. BJPsych Open. [published; OpenAlex]. \href{https://doi.org/10.1192/bjo.2024.768}{source link}.
\item Luoma JB, Wilson-Poe A, Pertl K, Hoffman K, Bazinet A, Stauffer C, McCarty D, Korthuis P. (2024). \textit{Personal Psychedelic Experience as a Training Qualification for Facilitators: A Thematic Analysis of Qualitative Interviews with Psilocybin Experts}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/dwhcu\_v1}{doi:10.31234/osf.io/dwhcu\_v1}.
\item Unknown authors (2024). \textit{Personal Psychedelic Experience as a Training Qualification for Facilitators: A Thematic Analysis of Qualitative Interviews with Psilocybin Experts}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/dwhcu\_v1}{source link}.
\item Sepehr Aghajanian, Arman Shafiee, Samira Parvizi Omran, Aida Rezaei Nejad, Kyana Jafarabady, Omid Kohandel Gargari, Shahryar Rajai Firouzabadi, Ida Mohammadi, Touran Bahrami Babaheidari, Mahmood Bakhtiyari (2024). \textit{Psilocybin for major depressive disorder: An updated systematic review and meta-analysis of randomized clinical trials}. Journal of Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1177/02698811241287542}{doi:10.1177/02698811241287542}.
\item Filament Health Corp. (2024). \textit{A Registered Clinical Trial of PEX010-Assisted Therapy for Stimulant Use Disorder: A Safety, Feasibility and Efficacy Study}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06666010}{source link}.
\item Min H, Park SY, Park J, Na S, Lee HS, Kim T, Ham J, Park YT. (2024). \textit{A narrative exploration of psilocybin's potential in mental health.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fpsyt.2024.1429373}{doi:10.3389/fpsyt.2024.1429373}.
\item Pamela Kryskow, Paul Stamets, Joseph La Torre, Kathy Sattler, Vivian W. L. Tsang, Monnica T. Williams (2024). \textit{“The mushroom was more alive and vibrant”: Patient reports of synthetic versus organic forms of psilocybin}. Journal of Psychedelic Studies. [published; OpenAlex]. \href{https://doi.org/10.1556/2054.2024.00379}{doi:10.1556/2054.2024.00379}.
\item Kennedy R. Wiens, Noah A. H. Brooks, Ishvin Riar, Bridget K. Greuel, Ivan A. Lindhout, Andis Klegeris (2024). \textit{Psilocin, the Psychoactive Metabolite of Psilocybin, Modulates Select Neuroimmune Functions of Microglial Cells in a 5-HT2 Receptor-Dependent Manner}. Molecules. [published; OpenAlex]. \href{https://doi.org/10.3390/molecules29215084}{doi:10.3390/molecules29215084}.
\item Imperial College London (2024). \textit{Psilocybin vs Escitalopram for Major Depressive Disorder: Comparative Mechanisms}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT03429075}{source link}.
\item Gattuso JJ, Wilson C, Hannan AJ, Renoir T. (2024). \textit{Psilocybin Reduces Grooming in the SAPAP3 Knockout Mouse Model of Compulsive Behaviour}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2024.10.23.619763}{doi:10.1101/2024.10.23.619763}.
\item Perez Rosal SR, La Torre JT, Birnkammer S, Chernoloz O, Williams MT, Faber SC. (2024). \textit{Expert recommendations for Germany's integration of psychedelic-assisted therapy.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1186/s12909-024-06141-3}{doi:10.1186/s12909-024-06141-3}.
\item Kai Rogge, Tobias Wagner, Dirk Hoffmeister, Bernhard Rupp, Sebastiaan Werten (2024). \textit{Substrate recognition by the 4-hydroxytryptamine kinase PsiK in psilocybin biosynthesis}. FEBS Letters. [published; OpenAlex]. \href{https://doi.org/10.1002/1873-3468.15042}{doi:10.1002/1873-3468.15042}.
\item Mott, Sarah E., Clyde W. Hodge, Jessica L. Hoffman, Maria Echeveste Sanchez, Christian S. Rollison, Margaret W. High, Devin P. Effinger, Melissa A. Herman, Sarah N. Magee, Daniel Toedt, Sema G. Quadir (2024). \textit{Increased reactivity of the paraventricular nucleus of the hypothalamus and decreased threat responding in male rats following psilocin administration}. UNC Libraries. [published; OpenAlex]. \href{https://doi.org/10.17615/kg31-1v38}{doi:10.17615/kg31-1v38}.
\item Majic T, Schmidt TT, Gröticke A, Gasser P, Richards WA, Riemer TG, Evens R. (2024). \textit{The Afterglow Inventory (AGI) - validation of a new instrument for measuring subacute effects of classic serotonergic psychedelics}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/s6bzc}{doi:10.31234/osf.io/s6bzc}.
\item Mallaroni P, Singleton P, Mason NL, Satterthwaite TD, Ramaekers JG. (2024). \textit{The forgotten psychedelic: Spatiotemporal mapping of brain organisation following the administration of 2C-B and psilocybin}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2024.10.22.619393}{doi:10.1101/2024.10.22.619393}.
\item Grant Jones, Matthew X. Lowe, Sandeep M. Nayak, Nathan D. Sepeda, Hannes Kettner, Robin Carhart-Harris, Heather Jackson, Albert Garcia-Romeu (2024). \textit{Examining differences in the effects and contexts of naturalistic psilocybin use for White participants vs. Participants of Color: A longitudinal online survey study}. Journal of Affective Disorders. [published; OpenAlex]. \href{https://doi.org/10.1016/j.jad.2024.10.058}{doi:10.1016/j.jad.2024.10.058}.
\item Unknown authors (2024). \textit{The Afterglow Inventory (AGI) - validation of a new instrument for measuring subacute effects of classic serotonergic psychedelics}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/s6bzc\_v1}{source link}.
\item Fleury S, Nautiyal KM. (2024). \textit{The serotonin 1B receptor is required for some of the behavioral effects of psilocybin in mice}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2024.10.18.618582}{doi:10.1101/2024.10.18.618582}.
\item Stefanie Enriquez-Geppert, Jaroslav Krc, Fiachra O'Higgins, Morten Peter Lietz (2024). \textit{Psilocybin-assisted neurofeedback for the improvement of executive functions: a randomized semi-naturalistic-lab feasibility study}. Philosophical Transactions of the Royal Society B Biological Sciences. [published; OpenAlex]. \href{https://doi.org/10.1098/rstb.2023.0095}{doi:10.1098/rstb.2023.0095}.
\item Hooper J, Gyongyosi E, Hutchison K, Mueller R. (2024). \textit{Aesthetic quality of psychedelic experience is linked to greater insight and improved psychological outcomes.}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/u9yeg\_v1}{doi:10.31234/osf.io/u9yeg\_v1}.
\item University Health Network, Toronto (2024). \textit{Neurobiological Effects of Psilocybin in Treatment Resistant Bipolar Depression: An Emotional-Processing fMRI Pilot Study}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06506019}{source link}.
\item Hooper J, Gyongyosi E, Hutchison K, Mueller R. (2024). \textit{Aesthetic quality of psychedelic experience is linked to greater insight and improved psychological outcomes.}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/u9yeg}{doi:10.31234/osf.io/u9yeg}.
\item Unknown authors (2024). \textit{Aesthetic quality of psychedelic experience is linked to greater insight and improved psychological outcomes.}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/u9yeg\_v1}{source link}.
\item Olami A, Peled-Avron L. (2024). \textit{Effects of classical psychedelics on implicit and explicit emotional empathy and cognitive empathy: a meta-analysis of MET task.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41598-024-74810-w}{doi:10.1038/s41598-024-74810-w}.
\item Valdez T, Patel V, Senesombath D, Hatahet-Donovan Z, Hornick MG. (2024). \textit{Therapeutic Potential of Psychedelic Compounds for Substance Use Disorders}. Preprints.org. [preprint; Europe PMC]. \href{https://doi.org/10.20944/preprints202410.1406.v1}{doi:10.20944/preprints202410.1406.v1}.
\item Szpręgiel I, Bysiek A. (2024). \textit{Psilocybin and the glutamatergic pathway: implications for the treatment of neuropsychiatric diseases.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s43440-024-00660-y}{doi:10.1007/s43440-024-00660-y}.
\item Jesse Hudspeth, Kai Rogge, Tobias Wagner, Maximilian Müll, Dirk Hoffmeister, Bernhard Rupp, Sebastiaan Werten (2024). \textit{The Second Methylation in Psilocybin Biosynthesis Is Enabled by a Hydrogen Bonding Network Extending into the Secondary Sphere Surrounding the Methyltransferase Active Site}. ChemBioChem. [published; OpenAlex]. \href{https://doi.org/10.1002/cbic.202400497}{doi:10.1002/cbic.202400497}.
\item Kargbo RB. (2024). \textit{Expanding the Therapeutic Horizons of Psilocybin in Mental Health.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/acsmedchemlett.4c00488}{doi:10.1021/acsmedchemlett.4c00488}.
\item Danica E. Johnson, Joshua D. Rosenblat (2024). \textit{Psilocybin-assisted psychotherapy as an ‘anti-distressant’ with multidimensional properties}. Nature Mental Health. [published; OpenAlex]. \href{https://doi.org/10.1038/s44220-024-00332-z}{doi:10.1038/s44220-024-00332-z}.
\item Lyons T, Spriggs M, Kerkelä L, Rosas F, Roseman L, Mediano P, Timmermann C, Oestreich L, Pagni B, Zeifman R, Hampshire A, Trender W, Douglass H, Girn M, Godfrey K, Kettner H, Sharif F, Espasiano L, Gazzaley A, Wall M, Erritzoe D, Nutt D, Carhart-Harris R. (2024). \textit{Human brain changes after first psilocybin use}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2024.10.11.617955}{doi:10.1101/2024.10.11.617955}.
\item Barnett BS. (2024). \textit{A survey investigating United States federal grant submissions proposing to investigate therapeutic applications of psychedelics}. medRxiv. [preprint; medRxiv]. \href{https://doi.org/10.1101/2024.10.12.24315367}{doi:10.1101/2024.10.12.24315367}.
\item Karthiyayini B, Kalyani NN, Gowdhami B, Muthuselvam M, Dharumadurai D. (2024). \textit{Characterization and Identification of an Antimicrobial Compound Psilocybin from Psychedelic Mushroom.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s12088-024-01396-2}{doi:10.1007/s12088-024-01396-2}.
\item de la Fuente Revenga M, González-Maeso J. (2024). \textit{Snapshot of 5-HT2A receptor activation in the mouse brain via IP1 detection}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2024.10.11.617861}{doi:10.1101/2024.10.11.617861}.
\item Lindsey Marwood, Megan Croal, Sunil Mistry, Hollie Simmons, Joyce Tsai, Matthew B. Young, Guy M. Goodwin (2024). \textit{The impact of antidepressant discontinuation prior to treatment with psilocybin for treatment-resistant depression}. Journal of Psychiatric Research. [published; OpenAlex]. \href{https://doi.org/10.1016/j.jpsychires.2024.10.009}{doi:10.1016/j.jpsychires.2024.10.009}.
\item Hannah Douglass (2024). \textit{The therapeutic potential and mechanisms of action of psilocybin-assisted therapy in anorexia nervosa treatment}. Open MIND. [published; OpenAlex]. \href{https://doi.org/10.25560/118978}{doi:10.25560/118978}.
\item Morgan Justin, Kerry Watrin (2024). \textit{Does psilocybin reduce symptoms of depression in adults with major depressive disorder or life-threatening cancer?}. Evidence-Based Practice. [published; OpenAlex]. \href{https://doi.org/10.1097/ebp.0000000000002281}{doi:10.1097/ebp.0000000000002281}.
\item James Rucker, Matthew Butler, Sadie Hambleton, Catherine Bird, Mathieu Seynaeve, Sanjay Cheema, Kete Campbell-Coker, Carolina Maggio, Fiona Dunbar, Giorgio Lambru, Manjit Matharu (2024). \textit{Plain Language Summary Publication: Low-dose psilocybin in short-lasting unilateral neuralgiform headache attacks: Results from an open-label phase Ib ascending dose study}. Headache The Journal of Head and Face Pain. [published; OpenAlex]. \href{https://doi.org/10.1111/head.14846}{doi:10.1111/head.14846}.
\item Jesper Dunell (2024). \textit{A psilocybin haven: the use of comparison to legitimate transgression at a psychedelic retreat}. Drugs Education Prevention and Policy. [published; OpenAlex]. \href{https://doi.org/10.1080/09687637.2024.2412636}{doi:10.1080/09687637.2024.2412636}.
\item MycoMedica Life Sciences PBC (2024). \textit{A Phase 1 Dose Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MLS101 (psilocybin) in Healthy Participants}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06326606}{source link}.
\item Imperio CG, Levin FR, Martinez D. (2024). \textit{The Neurocircuitry of Substance Use Disorder, Treatment, and Change: A Resource for Clinical Psychiatrists.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1176/appi.ajp.20231023}{doi:10.1176/appi.ajp.20231023}.
\item Li JR, Chiang KT, Kao YC, Yu CL, Yang FC, Liang CS, Hsu TW. (2024). \textit{The association between study design and antidepressant effects in psychedelic-assisted therapy: A meta-analysis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jad.2024.10.016}{doi:10.1016/j.jad.2024.10.016}.
\item Seong-Jin Yu, Kuo-Jen Wu, Yu-Syuan Wang, Eun-Kyung Bae, Fabio Chianelli, Nicholas C. Bambakidis, Yun Wang (2024). \textit{Neuroprotective effects of psilocybin in a rat model of stroke}. BMC Neuroscience. [published; OpenAlex]. \href{https://doi.org/10.1186/s12868-024-00903-x}{doi:10.1186/s12868-024-00903-x}.
\item Pincombe J, Williams M, Carruthers S, Rossell S. (2024). \textit{Qualitative Research on Psilocybin-Assisted Psychotherapy for the Treatment of Mental Health Disorders: A Scoping Review Protocol}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/ga9p2}{doi:10.31234/osf.io/ga9p2}.
\item Unknown authors (2024). \textit{Qualitative Research on Psilocybin-Assisted Psychotherapy for the Treatment of Mental Health Disorders: A Scoping Review Protocol}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/ga9p2\_v1}{source link}.
\item Petros Petridis, Jack Grinband, Gabrielle Agin-Liebes, Connor J. Kinslow, Richard J. Zeifman, Michael P. Bogenschutz, Roland R. Griffiths, Stephen Ross (2024). \textit{Psilocybin-assisted psychotherapy improves psychiatric symptoms across multiple dimensions in patients with cancer}. Nature Mental Health. [published; OpenAlex]. \href{https://doi.org/10.1038/s44220-024-00331-0}{doi:10.1038/s44220-024-00331-0}.
\item Jack D. C. Dahan, David Dadiomov, Tijmen Bostoen, Albert Dahan (2024). \textit{Meta-correlation of the effect of ketamine and psilocybin induced subjective effects on therapeutic outcome}. npj Mental Health Research. [published; OpenAlex]. \href{https://doi.org/10.1038/s44184-024-00091-w}{doi:10.1038/s44184-024-00091-w}.
\item Victorita E. Ivan, David P. Tomàs-Cuesta, Ingrid M. Esteves, Artur Luczak, Majid H. Mohajerani, Bruce L. McNaughton, Aaron J. Gruber (2024). \textit{Psilocybin reduces functional correlation and the encoding of spatial information by neurons in mouse retrosplenial cortex}. European Journal of Neuroscience. [published; OpenAlex]. \href{https://doi.org/10.1111/ejn.16558}{doi:10.1111/ejn.16558}.
\item Junges LH, Müller-Santos M. (2024). \textit{Exploring the biocatalysis of psilocybin and other tryptamines: Enzymatic pathways, synthetic strategies, and industrial implications.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1002/btpr.3513}{doi:10.1002/btpr.3513}.
\item Choi C, Johnson DE, Chen-Li D, Rosenblat J. (2024). \textit{Mechanisms of psilocybin on the treatment of posttraumatic stress disorder.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811241286771}{doi:10.1177/02698811241286771}.
\item Johan Lundberg, Guusje Haver (2024). \textit{Does psilocybin really provide long-term relief from depression, as new study suggests?}. Unknown journal. [published; OpenAlex]. \href{https://doi.org/10.64628/ab.ywdthqf9c}{doi:10.64628/ab.ywdthqf9c}.
\item Daniel Spinosa, Stacy M. Fischer, Richard J. Zeifman, Carolyn Lefkowits, Petros Petridis, Stephen Ross (2024). \textit{PR012/\#955 Psilocybin assisted psychotherapy for patients with ovarian caner: a subset analysis of a randomized, double-blind, placebo-controlled, phase II clinical trial}. International Journal of Gynecological Cancer. [published; OpenAlex]. \href{https://doi.org/10.1136/ijgc-2024-igcs.54}{doi:10.1136/ijgc-2024-igcs.54}.
\item Schenberg EE. (2024). \textit{From efficacy to effectiveness: evaluating psychedelic randomised controlled trials for trustworthy evidence-based policy and practice.}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/uxhv7}{doi:10.31234/osf.io/uxhv7}.
\item Schenberg EE. (2024). \textit{From efficacy to effectiveness: evaluating psychedelic randomised controlled trials for trustworthy evidence-based policy and practice.}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/uxhv7\_v1}{doi:10.31234/osf.io/uxhv7\_v1}.
\item Sarris J, Halman A, Urokohara A, Lehrner M, Perkins D (2024). \textit{Artificial intelligence and psychedelic medicine.}. Annals of the New York Academy of Sciences. [published; PubMed]. \href{https://doi.org/10.1111/nyas.15229}{doi:10.1111/nyas.15229}.
\item Marianne Masse-Grenier, Sue-Ling Chang, Ariane Bélanger, Jean-François Stephan, Johanne Hébert, P. Deschamps, Louis Plourde, François Provost, Houman Farzin, Jean-Sébastien Fallu, Michel Dorval (2024). \textit{What do health professionals think about implementing psilocybin-assisted therapy in palliative care for existential distress? A World Café qualitative study}. Palliative \& Supportive Care. [published; OpenAlex]. \href{https://doi.org/10.1017/s1478951524001494}{doi:10.1017/s1478951524001494}.
\item Meshkat S, Tello-Gerez TJ, Gholaminezhad F, Dunkley BT, Reichelt AC, Erritzoe D, Vermetten E, Zhang Y, Greenshaw A, Burback L, Winkler O, Jetly R, Mayo LM, Bhat V. (2024). \textit{Impact of psilocybin on cognitive function: A systematic review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1111/pcn.13741}{doi:10.1111/pcn.13741}.
\item Unknown authors (2024). \textit{From efficacy to effectiveness: evaluating psychedelic randomised controlled trials for trustworthy evidence-based policy and practice.}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.1002/prp2.70097}{doi:10.1002/prp2.70097}.
\item Lane CP, Tarka VM, Valentin O, Lehmann A, Hamel E, de Villers-Sidani E. (2024). \textit{Psilocybin prevents habituation to familiar stimuli and preserves sensitivity to sound following repeated stimulation in mouse primary auditory cortex}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2024.09.27.614985}{doi:10.1101/2024.09.27.614985}.
\item Elizabeth L. Fisher, Ryan Smith, Kyna-Anne Conn, Andrew W. Corcoran, Laura K Milton, Jakob Hohwy, Claire J. Foldi (2024). \textit{Psilocybin increases optimistic engagement over time: computational modelling of behaviour in rats}. Translational Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1038/s41398-024-03103-7}{doi:10.1038/s41398-024-03103-7}.
\item Lafrance A, Spriggs MJ, Gukasyan N, Peck SK (2024). \textit{Beyond the numbers: reimagining healing with psychedelics for eating disorders.}. Journal of eating disorders. [published; PubMed]. \href{https://doi.org/10.1186/s40337-024-01111-y}{doi:10.1186/s40337-024-01111-y}.
\item Colloca L, Fava M. (2024). \textit{What should constitute a control condition in psychedelic drug trials?}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s44220-024-00321-2}{doi:10.1038/s44220-024-00321-2}.
\item Halman A, Conyers R, Moore C, Khatri D, Sarris J, Perkins D. (2024). \textit{Harnessing Pharmacogenomics in Clinical Research on Psychedelic-Assisted Therapy.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1002/cpt.3459}{doi:10.1002/cpt.3459}.
\item Ordovich-Clarkson RD, Jabbour M, Pelayo DA, Lara D, La Croix S, Mumman M, Stukas S, Anderson R, Meraz D, Bangura A, Anderson B, Bamrud L, Blake C. (2024). \textit{Comparing psilocybin to metformin as neuroprotective agents against Parkinson's dementia: A systematic review of evidence and efficacy.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.pnpbp.2024.111155}{doi:10.1016/j.pnpbp.2024.111155}.
\item Carlos Henrique Marchiori, Marco Vinícios de Oliveira Santana, Klebert de Paula Malheiros (2024). \textit{The Action on Psilocybin in Neural Plasticity, Brain Reorganization and Cognitive Enhancement}. Middle East Research Journal of Biological Sciences. [published; OpenAlex]. \href{https://doi.org/10.36348/merjbs.2024.v04i05.001}{doi:10.36348/merjbs.2024.v04i05.001}.
\item Western University, Canada (2024). \textit{The Effects of Psilocybin on Shared Experience in Film Processing}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06529939}{source link}.
\item Lee J, Tantillo DJ, Wang LP, Fiehn O. (2024). \textit{Impact of Protonation Sites on Collision-Induced Dissociation-MS/MS Using CIDMD Quantum Chemistry Modeling.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/acs.jcim.4c00761}{doi:10.1021/acs.jcim.4c00761}.
\item Sara Ellis, Catherine Bostian, Wendy Feng, E. Grace Fischer, Garrett Schwartz, Katherine Eisen, Melanie Lean, Elizabeth Conlan, Michael J. Ostacher, Scott T. Aaronson, Trisha Suppes (2024). \textit{Single-dose psilocybin for U.S. military Veterans with severe treatment-resistant depression - A first-in-kind open-label pilot study}. Journal of Affective Disorders. [published; OpenAlex]. \href{https://doi.org/10.1016/j.jad.2024.09.133}{doi:10.1016/j.jad.2024.09.133}.
\item Aleš Oblak, Liam Korošec Hudnik, Anja Levačić, Kristian Elersič, Peter Pregelj, Jurij Bon (2024). \textit{Salience, sensemaking, and setting in psilocybin microdosing: Methodological lessons and preliminary findings of a mixed method qualitative study}. Philosophical Psychology. [published; OpenAlex]. \href{https://doi.org/10.1080/09515089.2024.2393690}{doi:10.1080/09515089.2024.2393690}.
\item Allohverdi S, Soltanzadeh M, Schmidt A, Charlton C, Hauke D, Karvelis P, Vollenweider F, Diaconescu A. (2024). \textit{Ketamine and Psilocybin Differentially Impact Sensory Learning During the Mismatch Negativity}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-4492873/v1}{doi:10.21203/rs.3.rs-4492873/v1}.
\item University of California, San Francisco (2024). \textit{An Open-Label Pilot Study Examining the Feasibility, Safety, and Effectiveness of Psilocybin Therapy for Depression in Bipolar II Disorder}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05065294}{source link}.
\item Vamvakopoulou IA, Nutt DJ. (2024). \textit{Psychedelics: From Cave Art to 21st-Century Medicine for Addiction.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1159/000540062}{doi:10.1159/000540062}.
\item Abe Y, Sugiura Y, Maeda R, Taira S, Yoshida K, Ibi D, Moritoh S, Hashimoto K, Yagishita S, Tanaka KF. (2024). \textit{Distinct classes of antidepressants commonly act to shape pallidal structure and function in mice}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2024.09.23.614626}{doi:10.1101/2024.09.23.614626}.
\item Xi Zhu, Chen Zhang, David J. Hellerstein, Jamie D. Feusner, Michael G. Wheaton, Gloria J. Gomez, Franklin R. Schneier (2024). \textit{Single-dose psilocybin alters resting state functional networks in patients with body dysmorphic disorder}. Psychedelics.. [published; OpenAlex]. \href{https://doi.org/10.61373/pp024r.0028}{doi:10.61373/pp024r.0028}.
\item Brian L. Quick, Ethan Morrow, Sam R. Wilson, Minhey Chung, Daniel E. Hartman, Brenda Koester (2024). \textit{Psilocybin legalization in the United States and psychological reactance: A test of evidence uncertainty, controlling language, and an ambiguous call to action.}. Motivation Science. [published; OpenAlex]. \href{https://doi.org/10.1037/mot0000361}{doi:10.1037/mot0000361}.
\item Lazar M, Brownstien M, Botvinnik A, Shevakh C, Shahar O, Lifschytz T, Lerer B. (2024). \textit{Premorbid Characteristics of the SAPAP3-Mouse Model of Obsessive-Compulsive Disorder: Behavior, Neuroplasticity, and Psilocybin Treatment}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2024.09.22.614317}{doi:10.1101/2024.09.22.614317}.
\item Li LJ, Mo Y, Shi ZM, Huang XB, Ning YP, Wu HW, Yang XH, Zheng W. (2024). \textit{Psilocybin for major depressive disorder: a systematic review of randomized controlled studies.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fpsyt.2024.1416420}{doi:10.3389/fpsyt.2024.1416420}.
\item David Erritzøe, Tommaso Barba, Kyle T. Greenway, Roberta Murphy, Jonny Martell, Bruna Giribaldi, Christopher Timmermann, Ashleigh Murphy-Beiner, Michelle Baker Jones, David Nutt, Brandon Weiss, Robin Carhart-Harris (2024). \textit{Effect of psilocybin versus escitalopram on depression symptom severity in patients with moderate-to-severe major depressive disorder: observational 6-month follow-up of a phase 2, double-blind, randomised, controlled trial}. EClinicalMedicine. [published; OpenAlex]. \href{https://doi.org/10.1016/j.eclinm.2024.102799}{doi:10.1016/j.eclinm.2024.102799}.
\item Larsen K, Lindberg U, Ozenne B, McCulloch DE, Armand S, Madsen MK, Johansen A, Stenbæk DS, Knudsen GM, Fisher PM. (2024). \textit{Acute psilocybin and ketanserin effects on cerebral blood flow: 5-HT2AR neuromodulation in healthy humans}. medRxiv. [preprint; medRxiv]. \href{https://doi.org/10.1101/2024.09.19.24313958}{doi:10.1101/2024.09.19.24313958}.
\item Unknown authors (2024). \textit{AEs reported after use of psychedelics such as psilocybin}. Reactions Weekly. [published; OpenAlex]. \href{https://doi.org/10.1007/s40278-024-66868-8}{doi:10.1007/s40278-024-66868-8}.
\item Askey T, Allen-Ross D, Lasrado R, Gilmour G, Hunt S, Tamagnini F, Ahmed M, Stephens G, Maiarú M. (2024). \textit{Psilocybin ameliorates neuropathic pain-like behaviour in mice and facilitates the gabapentin-mediated analgesia}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-5026806/v1}{doi:10.21203/rs.3.rs-5026806/v1}.
\item James Rucker, Matthew Butler, Sadie Hambleton, Catherine Bird, Mathieu Seynaeve, Sanjay Cheema, Kete Campbell-Coker, Carolina Maggio, Fiona Dunbar, Giorgio Lambru, Manjit Matharu (2024). \textit{Low-dose psilocybin in short-lasting unilateral neuralgiform headache attacks: results from an open-label phase Ib ascending dose study}. Headache The Journal of Head and Face Pain. [published; OpenAlex]. \href{https://doi.org/10.1111/head.14837}{doi:10.1111/head.14837}.
\item Kumar Katragunta, Bharathi Avula, Amar G. Chittiboyina, Hemant Lata, Ikhlas A Khan (2024). \textit{Quantitative LC-QToF-MS Analysis of Mycochemicals in Amanita muscaria, Psilocybe spp. (Agaricomycetes), and Consumer Products}. International journal of medicinal mushrooms. [published; OpenAlex]. \href{https://doi.org/10.1615/intjmedmushrooms.2024056373}{doi:10.1615/intjmedmushrooms.2024056373}.
\item University Hospital, Ghent (2024). \textit{Psilocybin-assisted Psychotherapy in the Treatment of Patients Hospitalized for Treatment-resistant Depression: an Open-label Feasibility Study with an Experiential and Systemic Focus}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06378229}{source link}.
\item Gobbi G. (2024). \textit{CCNP Innovations in Neuropsychopharmacology Award: The psychopharmacology of psychedelics: where the brain meets spirituality.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1503/jpn.240037}{doi:10.1503/jpn.240037}.
\item Armstrong SB, Davis AK. (2024). \textit{Psychedelic research at a crossroads.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1126/science.adt1024}{doi:10.1126/science.adt1024}.
\item Werle I, Bertoglio LJ. (2024). \textit{Psychedelics: A review of their effects on recalled aversive memories and fear/anxiety expression in rodents.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neubiorev.2024.105899}{doi:10.1016/j.neubiorev.2024.105899}.
\item Mageean S, Daniel A, Tai S. (2024). \textit{Exploring U.K. cancer doctors’ attitudes toward psilocybin-assisted psychotherapy for cancer-related distress}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-4862438/v1}{doi:10.21203/rs.3.rs-4862438/v1}.
\item Danielle B Rodrigues (2024). \textit{Use of Psilocybin in the Treatment of Mental Disorders: Systematic Review of Clinal Trials}. Journal of Complementary Medicine \& Alternative Healthcare. [published; OpenAlex]. \href{https://doi.org/10.19080/jcmah.2024.13.555852}{doi:10.19080/jcmah.2024.13.555852}.
\item Spoelstra SK, Schoevers RA, Venema SD, Knegtering H. (2024). \textit{Psychedelics as a potential treatment for tobacco use disorder: a systematic review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s44192-024-00095-0}{doi:10.1007/s44192-024-00095-0}.
\item Behera HK, Joga R, Yerram S, Karnati P, Mergu T, Gandhi K, M S, Nathiya D, Singh RP, Srivastava S, Kumar S. (2024). \textit{Exploring the regulatory framework of psychedelics in the US \& Europe.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.ajp.2024.104242}{doi:10.1016/j.ajp.2024.104242}.
\item Savides IA, Outhoff K. (2024). \textit{Less is more? A review of psilocybin microdosing.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811241278769}{doi:10.1177/02698811241278769}.
\item Li G, Facchini PJ. (2024). \textit{New frontiers in the biosynthesis of psychoactive specialized metabolites.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.pbi.2024.102626}{doi:10.1016/j.pbi.2024.102626}.
\item Gartner HT, Wan HZ, Simmons RE, Sollee DR, Sheikh S. (2024). \textit{Psychedelic mushroom-containing chocolate exposures: Case series.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.ajem.2024.09.038}{doi:10.1016/j.ajem.2024.09.038}.
\item Syed F. Rab, Charles L. Raison, Elliot Marseille (2024). \textit{An estimate of the number of people with clinical depression eligible for psilocybin-assisted therapy in the United States}. Psychedelics.. [published; OpenAlex]. \href{https://doi.org/10.61373/pp024r.0025}{doi:10.61373/pp024r.0025}.
\item James Perry, Cara C. Young, Julie Williams (2024). \textit{B - 61 Psilocybin as a First-Line Treatment of ADHD in Adult Populations}. Archives of Clinical Neuropsychology. [published; OpenAlex]. \href{https://doi.org/10.1093/arclin/acae067.222}{doi:10.1093/arclin/acae067.222}.
\item Schipper S, Nigam K, Schmid Y, Piechotta V, Ljuslin M, Beaussant Y, Schwarzer G, Boehlke C. (2024). \textit{Psychedelic-assisted therapy for treating anxiety, depression, and existential distress in people with life-threatening diseases.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1002/14651858.cd015383.pub2}{doi:10.1002/14651858.cd015383.pub2}.
\item Jean-François Stephan, Sani Karam (2024). \textit{Psilocybin-Assisted Therapy for Brain Cancer Related Existential Distress: A Case-Report}. Journal of Palliative Medicine. [published; OpenAlex]. \href{https://doi.org/10.1089/jpm.2024.0277}{doi:10.1089/jpm.2024.0277}.
\item Nikolic M, Mediano P, Froese T, Reydellet D, Palenicek T. (2024). \textit{Psilocybin alters brain activity related to sensory and cognitive processing in a time-dependent manner}. medRxiv. [preprint; medRxiv]. \href{https://doi.org/10.1101/2024.09.09.24313316}{doi:10.1101/2024.09.09.24313316}.
\item Thaoboonruang N, Lohitnavy M, Lohitnavy O. (2024). \textit{Pharmacokinetics of Psilocybin, a Tryptamine Alkaloid in Magic Mushroom (Psilocybe cubensis): A Systematic Review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/02791072.2024.2399128}{doi:10.1080/02791072.2024.2399128}.
\item Ana Ferreira, Sharon Martindale, David Luke (2024). \textit{Change in occupational burnout measures in emergency medical service workers after a psychedelic experience induced by a single self-administered dose of psilocybin mushrooms}. Journal of Psychedelic Studies. [published; OpenAlex]. \href{https://doi.org/10.1556/2054.2024.00368}{doi:10.1556/2054.2024.00368}.
\item Low ZXB, Ng WS, Lim ESY, Goh BH, Kumari Y. (2024). \textit{The immunomodulatory effects of classical psychedelics: A systematic review of preclinical studies.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.pnpbp.2024.111139}{doi:10.1016/j.pnpbp.2024.111139}.
\item Cynthia Duan, Navid Farkhondehpay, Viana Safa, Emma Yuan (2024). \textit{Usage of Psilocybin to Treat Huntington's Disease: A Research Protocol}. Undergraduate Research in Natural and Clinical Science and Technology (URNCST) Journal. [published; OpenAlex]. \href{https://doi.org/10.26685/urncst.644}{doi:10.26685/urncst.644}.
\item Veronika Pohořalá, Martin Kuchař, Rainer Spanagel, Rick E. Bernardi (2024). \textit{Psilocybin administered following extinction sessions does not affect subsequent cocaine cue reinstatement in male and female rats and mice}. Neuroscience. [published; OpenAlex]. \href{https://doi.org/10.1016/j.neuroscience.2024.09.006}{doi:10.1016/j.neuroscience.2024.09.006}.
\item Zhen Z, Sun X, Yuan S, Zhang J. (2024). \textit{Psychoactive substances for the treatment of neuropsychiatric disorders.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.ajp.2024.104193}{doi:10.1016/j.ajp.2024.104193}.
\item Anna Graue, Sören Kuitunen-Paul, Henry G. Harder, Lisa Emily Richter (2024). \textit{Psilocybin-induzierte mystische Erfahrungen in subjektiven Berichten: Ein Scoping Review mit qualitativer Inhaltsanalyse.}. Suchttherapie. [published; OpenAlex]. \href{https://doi.org/10.1055/s-0044-1790396}{doi:10.1055/s-0044-1790396}.
\item Arnim Quante (2024). \textit{Einmalig Psilocybin: antidepressive Effekte}. PSYCH up2date. [published; OpenAlex]. \href{https://doi.org/10.1055/a-2185-5208}{doi:10.1055/a-2185-5208}.
\item Rogers J. (2024). \textit{Psilocybin desynchronization persists in the human brain.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41583-024-00854-6}{doi:10.1038/s41583-024-00854-6}.
\item Caspani G, Ruffell SGD, Tsang W, Netzband N, Rohani-Shukla C, Swann JR, Jefferies WA (2024). \textit{Mind over matter: the microbial mindscapes of psychedelics and the gut-brain axis.}. Pharmacological research. [published; PubMed]. \href{https://doi.org/10.1016/j.phrs.2024.107338}{doi:10.1016/j.phrs.2024.107338}.
\item Treviranus GRS. (2024). \textit{Rapidly Trading Down Depression's 3 Pillars to 5HT3-Receptors Through ECT or Psilocybin?}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/39378462}{source link}.
\item Loizaga-Velder A, Loizaga Pazzi A. (2024). \textit{Traditional Medicine, Culture, and Psychedelic Science: New Pathways for Recovery From Substance Use Disorders.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.15288/jsad.23-00011}{doi:10.15288/jsad.23-00011}.
\item Smith CL, Sackett N, Stark BC, Dinh V, Romesburg EW, Roll J (2024). \textit{Understanding Psychedelic-Assisted Psychotherapy Providers' Perspective and Insights: A Qualitative Analysis.}. Psychedelic medicine (New Rochelle, N.Y.). [published; PubMed]. \href{https://doi.org/10.1089/psymed.2023.0074}{doi:10.1089/psymed.2023.0074}.
\item David S. Jevotovsky, Harman Chopra, Court Wing, Carlton J. Spotswood, Joel Castellanos (2024). \textit{Refractory CRPS pain treated with psilocybin: A case report}. Clinical Case Reports. [published; OpenAlex]. \href{https://doi.org/10.1002/ccr3.9421}{doi:10.1002/ccr3.9421}.
\item University of Arizona (2024). \textit{Psilocybin for Treatment of Obsessive Compulsive Disorder}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT03300947}{source link}.
\item Yoo M, Sakopoulos S. (2024). \textit{The Birth of the Psychedelic Industry: Capitalizing on the Psychedelic Renaissance}. Authorea Preprints. [preprint; Europe PMC]. \href{https://doi.org/10.22541/au.172496618.87990987/v1}{doi:10.22541/au.172496618.87990987/v1}.
\item Jungwirth J, Bavato F, Quednow BB. (2024). \textit{[Psychedelic and dissociative agents in psychiatry: challenges in the treatment].}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s00115-024-01727-0}{doi:10.1007/s00115-024-01727-0}.
\item Najib J. (2024). \textit{The role of psilocybin in depressive disorders.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/03007995.2024.2396536}{doi:10.1080/03007995.2024.2396536}.
\item Tsang V. (2024). \textit{A Cohort Based Case Series: Learnings from an Iterative Group Therapy Model to Support Psilocybin-Assisted Therapy for Patients with a Terminal Diagnosis}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC11860442}{source link}.
\item Tsang V, Roney C. (2024). \textit{Improving Access to Psilocybin-Assisted Therapy: Barriers, Challenges, and Recommendations}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC11861878}{source link}.
\item Klučková T, Nikolič M, Tylš F, Viktorin V, Vejmola Č, Viktorinová M, Bravermanová A, Androvičová R, Andrashko V, Korčák J, Zach P, Hájková K, Kuchař M, Balíková M, Brunovský M, Horáček J, Páleníček T. (2024). \textit{The phenomenology of psilocybin’s experience mediates subsequent persistent psychological effects independently of sex, previous experience or setting}. medRxiv. [preprint; medRxiv]. \href{https://doi.org/10.1101/2024.08.26.24311611}{doi:10.1101/2024.08.26.24311611}.
\item Mark A. Frye, Balwinder Singh, Scott Breitinger, Tyler Oesterle (2024). \textit{Selective Serotonin Reuptake Inhibitor Discontinuation for Psilocybin Treatment and Contributions to Alcohol Addiction Relapse}. The Journal of Clinical Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.4088/jcp.24cr15378}{doi:10.4088/jcp.24cr15378}.
\item Jensen ME, Stenbæk DS, Messell CD, Poulsen ED, Varga TV, Fisher PM, Nielsen MKK, Johansen SS, Volkow ND, Knudsen GM, Fink-Jensen A. (2024). \textit{­­­­Single-Dose Psilocybin Therapy for Alcohol Use Disorder: Pharmacokinetics, Feasibility, Safety, and Efficacy in an Open-Label Study}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-4947184/v1}{doi:10.21203/rs.3.rs-4947184/v1}.
\item Lodetti G, de Bitencourt RM, Rico EP. (2024). \textit{Classic psychedelics and the treatment for alcoholism.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.pnpbp.2024.111129}{doi:10.1016/j.pnpbp.2024.111129}.
\item Bethany A. Gray, Olivia L. Bolts, Deborah J. Fidler, Mark A. Prince (2024). \textit{Identifying Three Psilocybin Use Patterns by Frequency and Quantity}. Journal of Studies on Alcohol and Drugs. [published; OpenAlex]. \href{https://doi.org/10.15288/jsad.23-00312}{doi:10.15288/jsad.23-00312}.
\item Hsu TW, Tsai CK, Kao YC, Thompson T, Carvalho AF, Yang FC, Tseng PT, Hsu CW, Yu CL, Tu YK, Liang CS. (2024). \textit{Comparative oral monotherapy of psilocybin, lysergic acid diethylamide, 3,4-methylenedioxymethamphetamine, ayahuasca, and escitalopram for depressive symptoms: systematic review and Bayesian network meta-analysis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1136/bmj-2023-078607}{doi:10.1136/bmj-2023-078607}.
\item Kargbo RB. (2024). \textit{Exploring the Therapeutic Potential of Entheogens in Postoperative Cognitive Decline and Psychological Resilience.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/acsmedchemlett.4c00412}{doi:10.1021/acsmedchemlett.4c00412}.
\item Kargbo RB. (2024). \textit{Current Trends in Psychedelic Science: Integrating Modified Lysergic Acid Derivatives and Psilocybin in Modern Medicine.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/acsmedchemlett.4c00414}{doi:10.1021/acsmedchemlett.4c00414}.
\item Doğancan Sönmez, Aslı Enzel Koç (2024). \textit{Psilocybin in the Treatment of Mental Disorders}. DergiPark (Istanbul University). [published; OpenAlex]. \href{https://doi.org/10.30708/mantar.1535344}{doi:10.30708/mantar.1535344}.
\item Alnagger NL, Cardone P, Martial C, Sanz Perl Y, Mindlin I, Sitt JD, Roseman L, Carhart-Harris R, Nutt D, Mallaroni P, Mason NL, Ramaekers JG, Bonhomme V, Laureys S, Deco G, Gosseries O, Nunez P, Annen J. (2024). \textit{A virtual clinical trial of psychedelics to treat patients with disorders of consciousness}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2024.08.16.608251}{doi:10.1101/2024.08.16.608251}.
\item Salvetti G, Saccenti D, Moro AS, Lamanna J, Ferro M. (2024). \textit{Comparison between Single-Dose and Two-Dose Psilocybin Administration in the Treatment of Major Depression: A Systematic Review and Meta-Analysis of Current Clinical Trials.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/brainsci14080829}{doi:10.3390/brainsci14080829}.
\item Kim A, Halton B, Shah A, Seecof OM, Ross S. (2024). \textit{Psilocybin-assisted psychotherapy for existential distress: practical considerations for therapeutic application-a review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.21037/apm-24-35}{doi:10.21037/apm-24-35}.
\item Clairvoyant Therapeutics (2024). \textit{A24-Week, Multicentre, Randomised, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Clinical Trial to Evaluate Efficacy and Safety of Psilocybin-Assisted Psychotherapy in Adults With Alcohol Use Disorder (AUD)}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05646303}{source link}.
\item Holas P, Kaminska J. (2024). \textit{Prevalence and Correlates of Psychedelic Use in Poland: A Study on a Representative Sample of Polish Adults}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-4860906/v1}{doi:10.21203/rs.3.rs-4860906/v1}.
\item Frederick A. Bagdasarian, Hanne D. Hansen, Chi-Hyeon Yoo, Michael S. Placzek, Jacob M. Hooker, Hsiao-Ying Wey (2024). \textit{Acute Effects of Psilocybin and Salvinorin-A on Functional Connectivity}. Proceedings on CD-ROM - International Society for Magnetic Resonance in Medicine. Scientific Meeting and Exhibition/Proceedings of the International Society for Magnetic Resonance in Medicine, Scientific Meeting and Exhibition. [published; OpenAlex]. \href{https://doi.org/10.58530/2023/3494}{doi:10.58530/2023/3494}.
\item Chen MH, Cheng SL, Kao YC, Tseng PT, Hsu CW, Yu CL, Yang FC, Thompson T, Hsu TW, Liang CS. (2024). \textit{The association between diverse psychological protocols and the efficacy of psilocybin-assisted therapy for clinical depressive symptoms: a Bayesian meta-analysis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fpsyt.2024.1439347}{doi:10.3389/fpsyt.2024.1439347}.
\item Madden K, Flood B, Young Shing D, Ade-Conde M, Kashir I, Mark M, MacKillop J, Bhandari M, Adili A. (2024). \textit{Psilocybin for clinical indications: A scoping review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811241269751}{doi:10.1177/02698811241269751}.
\item Oliver Rumle Hovmand, M. Madsen, Patrick M. Fisher, Dea Siggaard Stenbæk (2024). \textit{Altered states of consciousness in Danish healthy volunteers and recreational users of psilocybin and the possible impact of setting and intention: Danish validation of the five-dimensional altered states of consciousness questionnaire}. Journal of Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1177/02698811241269669}{doi:10.1177/02698811241269669}.
\item Rodolfo Myronn de Melo Rodrigues (2024). \textit{Psilocybin-assisted psychotherapy: Advancements, challenges, and future directions for treating resistant depression}. Psychedelics.. [published; OpenAlex]. \href{https://doi.org/10.61373/pp024c.0022}{doi:10.61373/pp024c.0022}.
\item Marinho EAV, Serra YA, Oliveira-Lima AJ, Marcourakis T, Berro LF. (2024). \textit{Ayahuasca for the treatment of alcohol use disorder.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/bs.irn.2024.07.007}{doi:10.1016/bs.irn.2024.07.007}.
\item Ashley Glowiak (2024). \textit{Resurrecting Ancestral Familial Health: A Role for Psilocybin?}. The Family Journal. [published; OpenAlex]. \href{https://doi.org/10.1177/10664807241269505}{doi:10.1177/10664807241269505}.
\item Sheppard Pratt Health System (2024). \textit{An Open Label Study of the Safety and Efficacy of Psilocybin in Participants With Treatment-Resistant Depression (P-TRD)}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT04433858}{source link}.
\item Ottawa Hospital Research Institute (2024). \textit{PSilocybin for psYCHological and Existential Distress in PALliative Care (PSYCHED-PAL): A Multi-site, Open-label, Single Arm Phase I/II Proof-of-concept, Dose-finding, and Feasibility Clinical Trial}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT04754061}{source link}.
\item Vella Y, Syrova K, Petruskova A, Koutrouli I, Kutna V, Pala J, Nikolic M, Sichova K, Mazoch V, Jurok R, Kuchar M, Bendova Z, Palenicek T. (2024). \textit{Effects of serotonergic psychedelics on synaptogenesis and immediate early genes expression - comparison with ketamine, fluoxetine and lithium}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2024.08.07.606965}{doi:10.1101/2024.08.07.606965}.
\item Yang X, Kuang W. (2024). \textit{Letter to editor regarding "Psilocybin-assisted therapy for depression: A systematic review and meta-analysis".}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.psychres.2024.116136}{doi:10.1016/j.psychres.2024.116136}.
\item Brugmann University Hospital (2024). \textit{Psilocybin-Assisted Therapy for Severe Alcohol Use Disorder: Feasibility, Clinical Efficacy \& (Neuro)Cognitive Mechanisms}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06160232}{source link}.
\item Gustavo Deco, Yonatan Sanz Perl, Samuel Johnson, Niamh Bourke, Robin Carhart-Harris, Morten L. Kringelbach (2024). \textit{Different hierarchical reconfigurations in the brain by psilocybin and escitalopram for depression}. Nature Mental Health. [published; OpenAlex]. \href{https://doi.org/10.1038/s44220-024-00298-y}{doi:10.1038/s44220-024-00298-y}.
\item Benjamin Y. Fong (2024). \textit{Psilocybin legislation is helping psychedelic drugs make a comeback - a drug researcher explains the challenges they face}. Unknown journal. [published; OpenAlex]. \href{https://doi.org/10.64628/aai.npnrnvdyw}{doi:10.64628/aai.npnrnvdyw}.
\item Sarah Jane Palmer (2024). \textit{Insights into the efficacy of psilocybin in treating depression and other disorders}. British Journal of Neuroscience Nursing. [published; OpenAlex]. \href{https://doi.org/10.12968/bjnn.2024.0046}{doi:10.12968/bjnn.2024.0046}.
\item Nicky J. Mehtani, Mallory O. Johnson, Peter S. Hendricks, Jennifer Mitchell, B. Anderson (2024). \textit{Psilocybin-assisted therapy and HIV-related shame}. Scientific Reports. [published; OpenAlex]. \href{https://doi.org/10.1038/s41598-024-68908-4}{doi:10.1038/s41598-024-68908-4}.
\item Unknown authors (2024). \textit{Precipitous Increases in Psilocybin Exposure in Youths}. AAP Grand Rounds. [published; OpenAlex]. \href{https://doi.org/10.1542/gr.52-2-19}{doi:10.1542/gr.52-2-19}.
\item Véliz-García O, Domic M. (2024). \textit{Latin American adults who regularly use macrodoses of psychedelics: a cross-sectional study}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-4706910/v1}{doi:10.21203/rs.3.rs-4706910/v1}.
\item Aday JS, Horton D, Fernandes-Osterhold G, O'Donovan A, Bradley ER, Rosen RC, Woolley JD (2024). \textit{Psychedelic-assisted psychotherapy: where is the psychotherapy research?}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-024-06620-x}{doi:10.1007/s00213-024-06620-x}.
\item Mograbi DC, Rodrigues R, Bienemann B, Huntley J (2024). \textit{Brain Networks, Neurotransmitters and Psychedelics: Towards a Neurochemistry of Self-Awareness.}. Current neurology and neuroscience reports. [published; PubMed]. \href{https://doi.org/10.1007/s11910-024-01353-y}{doi:10.1007/s11910-024-01353-y}.
\item Kaiserman A, Vanderjist L, Kornreich C. (2024). \textit{CURRENT STATE OF PSILOCYBIN-ASSISTED THERAPY IN MOOD DISORDERS.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.24869/psyd.2024.174}{doi:10.24869/psyd.2024.174}.
\item Owe-Larsson M, Kamińska K, Buchalska B, Mirowska-Guzel D, Cudnoch-Jędrzejewska A. (2024). \textit{Psilocybin in pharmacotherapy of obsessive-compulsive disorder.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s43440-024-00633-1}{doi:10.1007/s43440-024-00633-1}.
\item V Suresh, Jitendra Lakhani, R Balaraman (2024). \textit{Psilocybin - A Drug to be Considered for the Treatment of Anxiety and Depression in Cancer Patients}. Journal of Natural Remedies. [published; OpenAlex]. \href{https://doi.org/10.18311/jnr/2024/35676}{doi:10.18311/jnr/2024/35676}.
\item Michiel van Elk (2024). \textit{We now know what a brain looks like on psilocybin - but what does that tell us?}. Unknown journal. [published; OpenAlex]. \href{https://doi.org/10.64628/ab.uq37weyjh}{doi:10.64628/ab.uq37weyjh}.
\item Karen O’Leary (2024). \textit{How psilocybin affects the brain}. Nature Medicine. [published; OpenAlex]. \href{https://doi.org/10.1038/d41591-024-00055-9}{doi:10.1038/d41591-024-00055-9}.
\item david J, Berkovich-Ohana A, Dor-Ziderman Y. (2024). \textit{Embracing Change: Impermanence Acceptance Mediates Differences in Death Processing Between Ayahuasca Users and Non-users}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/tmeb3}{doi:10.31234/osf.io/tmeb3}.
\item Unknown authors (2024). \textit{Embracing Change: Impermanence Acceptance Mediates Differences in Death Processing Between Ayahuasca Users and Non-users}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/tmeb3\_v1}{source link}.
\item Washington University School of Medicine (2024). \textit{Psilocybin for the Treatment of Major Depressive Disorder}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05675800}{source link}.
\item Ibrahim Lanre Folorunsho, Nkechinyere Mary Harry, Chukwubueze Obiajunwa, Oluwatosin Arubuolawe, Adeniyi Kayode Busari, Chidalu Ibeneme, Gibson Anugwom (2024). \textit{PTSD Treatment: An Inquiry into the Promising Potential of Psilocybin}. Journal of Advances in Medicine and Medical Research. [published; OpenAlex]. \href{https://doi.org/10.9734/jammr/2024/v36i85525}{doi:10.9734/jammr/2024/v36i85525}.
\item Butler M, Bird C, Maggio C, Durden A, Modlin N, Campbell-Coker K, Edwards M, Pick S, Millman LM, Lowery E, Bhagavan C, Kanaan R, Golder D, Mildon B, Mehta M, Rucker J, Nicholson TR. (2024). \textit{Probing the functional magnetic resonance imaging response to psilocybin in functional neurological disorder (PsiFUND): study protocol}. Wellcome Open Res. [preprint; Europe PMC]. \href{https://doi.org/10.12688/wellcomeopenres.22543.1}{doi:10.12688/wellcomeopenres.22543.1}.
\item Viohl N, Zanjani AAH, Khandelia H. (2024). \textit{Molecular insights into the modulation of the 5HT 2A receptor by serotonin, psilocin, and the G protein subunit Gqα}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2024.07.23.604750}{doi:10.1101/2024.07.23.604750}.
\item Chiranth Bhagavan, Richard Kanaan, Olivia Carter, Glenn Nielsen, David J. Berlowitz, Sara Issak, Sabine Braat, Sophie Zaloumis, Zachary Attard, Georgina Oliver, Deanne Mayne, David McKernon, Greg Roebuck, James Rucker, Matthew Butler, Alexander Bryson (2024). \textit{Psilocybin and Motor Function: A Triple-Blind, Dose-Finding Study in Healthy Participants}. Psychiatric Research and Clinical Practice. [published; OpenAlex]. \href{https://doi.org/10.1176/appi.prcp.20240047}{doi:10.1176/appi.prcp.20240047}.
\item Gomez-Escolar A, Folch-Sanchez D, Stefaniuk J, Swithenbank Z, Nisa A, Braddick F, Idrees Chaudhary N, van der Meer PB, Batalla A. (2024). \textit{Current Perspectives on the Clinical Research and Medicalization of Psychedelic Drugs for Addiction Treatments: Safety, Efficacy, Limitations and Challenges.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s40263-024-01101-3}{doi:10.1007/s40263-024-01101-3}.
\item Max Kozlov (2024). \textit{Your brain on shrooms - how psilocybin resets neural networks}. Nature. [published; OpenAlex]. \href{https://doi.org/10.1038/d41586-024-02275-y}{doi:10.1038/d41586-024-02275-y}.
\item Sara de la Salle, Hannes Kettner, Julien Thibault Lévesque, Nicolas Garel, Shannon Dames, Ryan Patchett-Marble, Soham Rej, Sara G. Gloeckler, David Erritzøe, Robin Carhart-Harris, Kyle T. Greenway (2024). \textit{Longitudinal experiences of Canadians receiving compassionate access to psilocybin-assisted psychotherapy}. Scientific Reports. [published; OpenAlex]. \href{https://doi.org/10.1038/s41598-024-66817-0}{doi:10.1038/s41598-024-66817-0}.
\item Joshua S. Siegel, Subha Subramanian, Demetrius Perry, Benjamin P. Kay, Evan M. Gordon, Timothy O. Laumann, Travis R. Reneau, Nicholas V. Metcalf, Ravi V. Chacko, Caterina Gratton, Christine Horan, Samuel R. Krimmel, Joshua S. Shimony, Julia Schweiger, Dean F. Wong, David A. Bender, Kristen M. Scheidter, Forrest I. Whiting, Jonah A. Padawer-Curry, Russell T. Shinohara, Yong Chen, Julia Moser, Essa Yacoub, Steven M. Nelson, Luca Vizioli, Damien A. Fair, Eric J. Lenze, Robin Carhart-Harris, Charles L. Raison, Marcus E. Raichle, Abraham Z. Snyder, Ginger E. Nicol, Nico U.F. Dosenbach (2024). \textit{Psilocybin desynchronizes the human brain}. Nature. [published; OpenAlex]. \href{https://doi.org/10.1038/s41586-024-07624-5}{doi:10.1038/s41586-024-07624-5}.
\item André Do, Vanessa Michaud, Jean-François Stephan, Miltiadis Moreau, Élise Benoît, Felix-Antoine Berubé, Antoine Bibaud-De Serres, Alain Taillefer, Philippe Vincent (2024). \textit{Serotoninergic antidepressants combination in psilocybin-assisted psychotherapy: a case report}. Frontiers in Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.3389/fpsyt.2024.1394962}{doi:10.3389/fpsyt.2024.1394962}.
\item Anders Fink-Jensen, MD, DMSci (2024). \textit{Psilocybin for Treatment of Alcohol Use Disorder: a Feasibility Study}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT04718792}{source link}.
\item Nogueira M, García-Hernández S, Roberto GS, Marques LZ. (2024). \textit{Psilocybin mushrooms and public health in Brazil: a low-risk adverse event profile calls for evidence-based regulatory discussions}. medRxiv. [preprint; medRxiv]. \href{https://doi.org/10.1101/2024.07.11.24310147}{doi:10.1101/2024.07.11.24310147}.
\item Ahuja S, Zaher F, Palaniyappan L. (2024). \textit{Quantitative Natural Language Processing Markers of Psychoactive Drug Effects: A Pre-Registered Systematic Review}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-4534997/v1}{doi:10.21203/rs.3.rs-4534997/v1}.
\item Zheng S, Ma R, Yang Y, Li G. (2024). \textit{Psilocybin for the treatment of Alzheimer's disease.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fnins.2024.1420601}{doi:10.3389/fnins.2024.1420601}.
\item Ashutosh Bhave (2024). \textit{Magic of the Mushrooms: Effects of Psilocybin Decriminalization}. Journal of Psychoactive Drugs. [published; OpenAlex]. \href{https://doi.org/10.1080/02791072.2024.2376755}{doi:10.1080/02791072.2024.2376755}.
\item West CL, Imai F, Bastos G, Hornick MA, Rachmany L, Duran A, Nadeem S, Ricci D, Rader Groves AM, Wargo JA, Van Leeuwen N, Sershen H, Yaragudri Vinod K, Peterka DS, Hamm JP. (2024). \textit{Psychedelics relax predictive processing in the post-acute period by remodeling cortico-cortical feedback circuits}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2024.07.03.601959}{doi:10.1101/2024.07.03.601959}.
\item Hussein El Bourji, Aziz Farhat, Zahi Hamdan, Ritvij Satodiya, Rashmi Shukla, Samer El Hayek (2024). \textit{Psilocybin in the Management of Substance Use Disorders: A Summary ofCurrent Evidence}. Current Psychopharmacologye. [published; OpenAlex]. \href{https://doi.org/10.2174/0122115560288779240628043307}{doi:10.2174/0122115560288779240628043307}.
\item Amir Khajavinia, Déborah Michel, Udoka C. Ezeaka, Randy W. Purves, Robert B. Laprairie, Anas El-Aneed (2024). \textit{Addressing a major interference in the quantification of psilocin in mouse plasma: Development of a validated liquid chromatography tandem mass spectrometry method}. Journal of Chromatography A. [published; OpenAlex]. \href{https://doi.org/10.1016/j.chroma.2024.465123}{doi:10.1016/j.chroma.2024.465123}.
\item Yao Y, Zhang YZ, Liang JQ, Liu F, Li ZF, Li HJ, Xu F. (2024). \textit{Mushroom poisoning of Panaeolus subbalteatus from Ningxia, northwest China, with species identification and tryptamine detection.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.toxicon.2024.107849}{doi:10.1016/j.toxicon.2024.107849}.
\item Magdalena Kolasa, Agnieszka Nikiforuk, Agata Korlatowicz, Joanna Solich, Agnieszka Potasiewicz, Marta Dziedzicka-Wasylewska, Ryszard Bugno, Adam S. Hogendorf, Andrzej J. Bojarski, Agata Faron-Górecka (2024). \textit{Unraveling psilocybin’s therapeutic potential: behavioral and neuroplasticity insights in Wistar-Kyoto and Wistar male rat models of treatment-resistant depression}. Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1007/s00213-024-06644-3}{doi:10.1007/s00213-024-06644-3}.
\item Joshua M. Poulin, Gregory E. Bigford, Krista L. Lanctôt, Peter Giacobbe, Ayal Schaffer, Mark Sinyor, Jennifer S. Rabin, Mario Masellis, Amit Singnurkar, Christopher B. Pople, Nir Lipsman, Muhammad Ishrat Husain, Joshua D. Rosenblat, Xingshan Cao, Bradley J. MacIntosh, Sean M. Nestor (2024). \textit{Engaging Mood Brain Circuits with Psilocybin (EMBRACE): a study protocol for a randomized, placebo-controlled and delayed-start, neuroimaging trial in depression}. Trials. [published; OpenAlex]. \href{https://doi.org/10.1186/s13063-024-08268-6}{doi:10.1186/s13063-024-08268-6}.
\item Jasmine Shakir, Megan Pedicini, Brianna C Bullock, Penn W Hoen, Lindsey Macias, Jackson Freiman, Mikhail V Pletnikov, Kellie L. Tamashiro, Zachary A. Cordner (2024). \textit{Effects of psilocybin on body weight, body composition, and metabolites in male and female mice}. Physiology \& Behavior. [published; OpenAlex]. \href{https://doi.org/10.1016/j.physbeh.2024.114627}{doi:10.1016/j.physbeh.2024.114627}.
\item Nae Won, Anna Wang, Joseph J. Palamar, Nicole D. Fitzgerald, MeLisa R. Creamer, Catherine W. Striley, Linda B. Cottler (2024). \textit{Regional Differences of Self-Reported Past-12-month Marijuana, Psilocybin, and Cocaine Use: Results From NDEWS Rapid Street Reporting 2021-2022}. Drug and Alcohol Dependence. [published; OpenAlex]. \href{https://doi.org/10.1016/j.drugalcdep.2023.110222}{doi:10.1016/j.drugalcdep.2023.110222}.
\item Denise C. Vidot, Amrit Baral, Bria-Necole Diggs, Sitara M. Weerakoon, Moudou Baquai, Ramessu Iyi, Michelle Weiner, Sarah Messiah (2024). \textit{Prevalence of Psilocybin and Cannabis Concurrent Use During the COVID-19 Pandemic: An Analysis of the COVID-19 Cannabis Health Study}. Drug and Alcohol Dependence. [published; OpenAlex]. \href{https://doi.org/10.1016/j.drugalcdep.2023.110578}{doi:10.1016/j.drugalcdep.2023.110578}.
\item Broc A. Pagni, Noah D. Gold, Michael P. Bogenschutz (2024). \textit{SPONTANEOUS CHANGES IN CIGARETTE SMOKING FOLLOWING PSILOCYBIN-ASSISTED TREATMENT FOR ALCOHOL USE DISORDER}. Drug and Alcohol Dependence. [published; OpenAlex]. \href{https://doi.org/10.1016/j.drugalcdep.2023.110063}{doi:10.1016/j.drugalcdep.2023.110063}.
\item Denise C. Vidot, Bria-Necole Diggs, Amrit Baral, Michaela E. Larson, Sitara M. Weerakoon, Moudou Baquai, Ramessu Iyi, Michelle Weiner, Marlene Camacho-Rivera, Sarah Messiah (2024). \textit{High Blood Pressure Among Psilocybin and Cannabis Consumers During the COVID-19 Pandemic: An Analysis of the COVID-19 Cannabis Health Study}. Drug and Alcohol Dependence. [published; OpenAlex]. \href{https://doi.org/10.1016/j.drugalcdep.2023.110575}{doi:10.1016/j.drugalcdep.2023.110575}.
\item Alan K. Davis, Adam W. Levin, Rafael Lancelotta, Nathan D. Sepeda, Natalie Gukasyan, Sandeep M. Nayak, Frederick S. Barrett, Roland R. Griffiths (2024). \textit{Acute Psychedelic Effects and Clinical Outcomes are Associated With Therapeutic Alliance Among Participants Receiving Psilocybin Therapy}. Drug and Alcohol Dependence. [published; OpenAlex]. \href{https://doi.org/10.1016/j.drugalcdep.2023.110609}{doi:10.1016/j.drugalcdep.2023.110609}.
\item Shelby A. McGriff, Grant C. Glatfelter, David R. Manke, A.R. Chadeayne, Charles W. Schindler, Michaël Baumann (2024). \textit{Physiological Effects of Psilocybin, Psilacetin, and DOI in Rats}. Drug and Alcohol Dependence. [published; OpenAlex]. \href{https://doi.org/10.1016/j.drugalcdep.2023.110445}{doi:10.1016/j.drugalcdep.2023.110445}.
\item Lauren Gorfinkel, Julia M. Bujno, Claire Walsh, Dvora Shmulewitz, Deborah S. Hasin (2024). \textit{Lifetime Depression and Psilocybin Mushroom Use in U.S. Adults, 2008-2019}. Drug and Alcohol Dependence. [published; OpenAlex]. \href{https://doi.org/10.1016/j.drugalcdep.2023.110267}{doi:10.1016/j.drugalcdep.2023.110267}.
\item Ryan K. Lanier, Michael P. Bogenschutz, Emmanuelle A. D. Schindler, Benjamin Kelmendi, Caitlyn Durgin, Judy Ashworth (2024). \textit{Differing Approaches to Investigating the Therapeutic Efficacy of Psilocybin Across Diverse Indications}. Drug and Alcohol Dependence. [published; OpenAlex]. \href{https://doi.org/10.1016/j.drugalcdep.2023.110862}{doi:10.1016/j.drugalcdep.2023.110862}.
\item Rafael Lancelotta, Christopher Timmerman, Ana María Ortiz Bernal, Sandeep M. Nayak, Nathan D. Sepeda, Aki Nikolaidis, Roland R. Griffiths, Alan K. Davis (2024). \textit{Associations Between Harm Reduction Strategy Use and Acute Psychedelic Effects in Spanish Speakers who Used LSD or Psilocybin}. Drug and Alcohol Dependence. [published; OpenAlex]. \href{https://doi.org/10.1016/j.drugalcdep.2023.110861}{doi:10.1016/j.drugalcdep.2023.110861}.
\item P. Todd Korthuis, Kim Hoffman, Adrianne R. Wilson-Poe, Jason B. Luoma, Alissa Bazinet, David Morgan, Sarann Bielavitz, Dennis McCarty, Christopher S. Stauffer (2024). \textit{Developing Core Consensus Measures for Assessment of Psilocybin Services}. Drug and Alcohol Dependence. [published; OpenAlex]. \href{https://doi.org/10.1016/j.drugalcdep.2023.110268}{doi:10.1016/j.drugalcdep.2023.110268}.
\item Stéphanie Knatz Peck, Samantha Shao, Tessa Gruen, Kevin H. Yang, Alexandra Babakanian, Julie Trim, Daphna M. Finn, Walter H. Kaye (2024). \textit{Psilocybin Therapy for Females With Anorexia Nervosa: A Phase 1, Open-Label Feasibility Study}. FOCUS The Journal of Lifelong Learning in Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1176/appi.focus.24022013}{doi:10.1176/appi.focus.24022013}.
\item S. Parker Singleton, Amy Kuceyeski (2024). \textit{Bridging Psilocybin-Induced Changes in the Brain’s Dynamic Functional Connectome With an Individual’s Subjective Experience}. Biological Psychiatry Cognitive Neuroscience and Neuroimaging. [published; OpenAlex]. \href{https://doi.org/10.1016/j.bpsc.2024.05.003}{doi:10.1016/j.bpsc.2024.05.003}.
\item Shadani S, Conn K, Andrews ZB, Foldi CJ (2024). \textit{Potential Differences in Psychedelic Actions Based on Biological Sex.}. Endocrinology. [published; PubMed]. \href{https://doi.org/10.1210/endocr/bqae083}{doi:10.1210/endocr/bqae083}.
\item Amanda Paige Hanstein, Chance Felchlin (2024). \textit{Treating Anxiety and Depression With Psilocybin Therapy.}. PubMed. [published; OpenAlex]. \href{https://pubmed.ncbi.nlm.nih.gov/39079732}{source link}.
\item DeBattista C, Schatzberg AF. (2024). \textit{The Black Book of Psychotropic Dosing and Monitoring.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.64719/pb.4493}{doi:10.64719/pb.4493}.
\item Bader H, Farraj H, Maghnam J, Abu Omar Y. (2024). \textit{Investigating the therapeutic efficacy of psilocybin in advanced cancer patients: A comprehensive review and meta-analysis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.5306/wjco.v15.i7.908}{doi:10.5306/wjco.v15.i7.908}.
\item Daisuke Ibi (2024). \textit{Up-to-Date on clinical and preclinical studies of psilocybin therapy}. Folia Pharmacologica Japonica. [published; OpenAlex]. \href{https://doi.org/10.1254/fpj.24007}{doi:10.1254/fpj.24007}.
\item Brownstien M, Lazar M, Botvinnik A, Shevakh C, Blakolmer K, Lerer L, Lifschytz T, Lerer B. (2024). \textit{Striking Long Term Beneficial Effects of Single Dose Psilocybin and Psychedelic Mushroom Extract in the SAPAP3 Rodent Model of OCD-Like Excessive Self-Grooming}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2024.06.25.600634}{doi:10.1101/2024.06.25.600634}.
\item Bennett Lange, Luke Morgan, Christopher Mattox, Suhrud Pathak, Keyi Liu, Rishi Nadar, Jun Ren, Jeyaram Bharathi Jeyabalan, Timothy Moore, Muralikrishnan Dhanasekaran (2024). \textit{Historical Perspectives and Pharmacodynamic Actions of the Magic Mushroom (Psilocybin) for Future Global Healthcare}. Trends in Medical Research. [published; OpenAlex]. \href{https://doi.org/10.3923/tmr.2024.245.273}{doi:10.3923/tmr.2024.245.273}.
\item Unknown authors (2024). \textit{Review identifies factors associated with response to psilocybin}. The Brown University Psychopharmacology Update. [published; OpenAlex]. \href{https://doi.org/10.1002/pu.31193}{doi:10.1002/pu.31193}.
\item Lake S, Lucas P. (2024). \textit{The Global Psychedelic Survey: Consumer characteristics, patterns of use, and access in primarily anglophone regions around the world.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.drugpo.2024.104507}{doi:10.1016/j.drugpo.2024.104507}.
\item Manoj K. Doss, Pablo Mallaroni, Natasha L. Mason, Johannes G. Ramaekers (2024). \textit{Psilocybin and 2C-B at Encoding Distort Episodic Familiarity}. Biological Psychiatry Cognitive Neuroscience and Neuroimaging. [published; OpenAlex]. \href{https://doi.org/10.1016/j.bpsc.2024.06.008}{doi:10.1016/j.bpsc.2024.06.008}.
\item Van Maldegem M, Vohryzek J, Atasoy S, Alnagger N, Cardone P, Bonhomme V, Vanhaudenhuyse A, Demertzi A, Jaquet O, Bahri MA, Kringelbach ML, Stamatakis EA, Luppi AI. (2024). \textit{Ketamine-Induced Unresponsiveness Shows a Harmonic Shift from Global to Localised Functional Organisation}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2024.06.20.599885}{doi:10.1101/2024.06.20.599885}.
\item Frederick A. Bagdasarian, Hanne D. Hansen, Jingyuan Chen, Chi-Hyeon Yoo, Michael S. Placzek, Jacob M. Hooker, Hsiao-Ying Wey (2024). \textit{Acute Effects of Hallucinogens on Functional Connectivity: Psilocybin and Salvinorin-A}. ACS Chemical Neuroscience. [published; OpenAlex]. \href{https://doi.org/10.1021/acschemneuro.4c00245}{doi:10.1021/acschemneuro.4c00245}.
\item Mary P. Clark (2024). \textit{Psilocybin: Medicine for My Soul. Relief from Emotional and Spiritual Pain as a Hospice Nurse Diagnosed with Cancer}. Journal of Palliative Medicine. [published; OpenAlex]. \href{https://doi.org/10.1089/jpm.2024.0066}{doi:10.1089/jpm.2024.0066}.
\item Empower Research Inc (2024). \textit{Assessing the Feasibility of a Custom Psychedelic-assisted Group Program on Mental and Physical Health in First Responders}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06471959}{source link}.
\item Grant Jones, Jocelyn A. Ricard, Matthew K. Nock (2024). \textit{Race and ethnicity moderate the associations between lifetime psilocybin use and past year hypertension}. Frontiers in Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.3389/fpsyt.2024.1169686}{doi:10.3389/fpsyt.2024.1169686}.
\item David S. Jacobs, Alina Bogachuk, Chloé L. Le Moing, Bita Moghaddam (2024). \textit{Effects of psilocybin on uncertain punishment learning}. Neurobiology of Learning and Memory. [published; OpenAlex]. \href{https://doi.org/10.1016/j.nlm.2024.107954}{doi:10.1016/j.nlm.2024.107954}.
\item Brian S. Barnett, Curtis J. Koons, Vincent Van den Eynde, Peter Kenneth Gillman, J. Alexander Bodkin (2024). \textit{Hypertensive Emergency Secondary to Combining Psilocybin Mushrooms, Extended Release Dextroamphetamine-Amphetamine, and Tranylcypromine}. Journal of Psychoactive Drugs. [published; OpenAlex]. \href{https://doi.org/10.1080/02791072.2024.2368617}{doi:10.1080/02791072.2024.2368617}.
\item Fluyau D, Kailasam VK, Revadigar N. (2024). \textit{Rapid and prolonged antidepressant and antianxiety effects of psilocybin, lysergic acid diethylamide, ayahuasca, and 3, 4-methylenedioxy-methamphetamine. A systematic review and meta-analysis of randomized controlled trials}. medRxiv. [preprint; medRxiv]. \href{https://doi.org/10.1101/2024.06.17.24308787}{doi:10.1101/2024.06.17.24308787}.
\item Appiani FJ, Caroff SN. (2024). \textit{The cyclical revival of psychedelics in psychiatric treatment.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/03007995.2024.2368725}{doi:10.1080/03007995.2024.2368725}.
\item Guo Q, Guo L, Wang Y, Shang S. (2024). \textit{Efficacy and safety of eight enhanced therapies for treatment-resistant depression: A systematic review and network meta-analysis of RCTs.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.psychres.2024.116018}{doi:10.1016/j.psychres.2024.116018}.
\item Johns Hopkins University (2024). \textit{Effects of Psilocybin-facilitated Experience on the Psychology and Effectiveness of Professional Leaders in Religion}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT02243813}{source link}.
\item P. Todd Korthuis, Kim Hoffman, Adrianne R. Wilson-Poe, Jason B. Luoma, Alissa Bazinet, Kellie Pertl, David L. Morgan, Ryan Cook, Sarann Bielavitz, Renae Myers, R. Cameron Wolf, Dennis McCarty, Christopher S. Stauffer (2024). \textit{Developing the Open Psychedelic Evaluation Nexus consensus measures for assessment of supervised psilocybin services: An e-Delphi study}. Journal of Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1177/02698811241257839}{doi:10.1177/02698811241257839}.
\item Imperial College London (2024). \textit{Psilocybin as a Treatment for Anorexia Nervosa: A Pilot Study}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT04505189}{source link}.
\item Torrado Pacheco A, Moghaddam B. (2024). \textit{Licit use of illicit drugs for treating depression: the pill and the process.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1172/jci180217}{doi:10.1172/jci180217}.
\item Downey AE, Bradley ER, Lerche AS, O'Donovan A, Krystal AD, Woolley J. (2024). \textit{A Plea for Nuance: Should People with a Family History of Bipolar Disorder Be Excluded from Clinical Trials of Psilocybin Therapy?}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1089/psymed.2023.0051}{doi:10.1089/psymed.2023.0051}.
\item Madeline Stanger, Harmony O. Soffer, Angela D. Bryan, Carillon J. Skrzynski (2024). \textit{Comparing Cannabis Use Motivations and Dependence Across Regular Cannabis Users Who Have or Have Not Recently Used Psilocybin}. Cannabis and Cannabinoid Research. [published; OpenAlex]. \href{https://doi.org/10.1089/can.2024.0059}{doi:10.1089/can.2024.0059}.
\item Ippolito A, Vasudevan S, Hurley S, Gilmour G, Westhorpe F, Churchill G, Sharp T. (2024). \textit{Increased 5-HT2A receptor signalling efficacy differentiates serotonergic psychedelics from non-psychedelics}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2024.06.13.594677}{doi:10.1101/2024.06.13.594677}.
\item Polito V, Liknaitzky P. (2024). \textit{Is microdosing a placebo? A rapid review of low-dose LSD and psilocybin research.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811241254831}{doi:10.1177/02698811241254831}.
\item Nicholas CR, Banks MI, Lennertz RL, Wenthur CJ, Krause BM, Riedner BA, Smith RF, Hutson PR, Sauder CJ, Dunne JD, Roseman L, Raison CL. (2024). \textit{Co-administration of midazolam and psilocybin: Differential effects on subjective quality versus memory of the psychedelic experience}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2024.06.13.598878}{doi:10.1101/2024.06.13.598878}.
\item Joachim Neumann, Kiril Dimov, Karyna Azatsian, Britt Hofmann, Ulrich Gergs (2024). \textit{Effects of psilocin and psilocybin on human 5-HT4 serotonin receptors in atrial preparations of transgenic mice and humans}. Toxicology Letters. [published; OpenAlex]. \href{https://doi.org/10.1016/j.toxlet.2024.06.006}{doi:10.1016/j.toxlet.2024.06.006}.
\item Sandra Szafoni, Piotr Gręblowski, Klaudia Grabowska, Gniewko Więckiewicz (2024). \textit{Unlocking the healing power of psilocybin: an overview of the role of psilocybin therapy in major depressive disorder, obsessive-compulsive disorder and substance use disorder}. Frontiers in Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.3389/fpsyt.2024.1406888}{doi:10.3389/fpsyt.2024.1406888}.
\item Linda Nguyen, Sona Regonda, Adam Gaisinsky (2024). \textit{Therapeutic Potential of Fungally Derived Psilocybin Extract in Morphine-Dependent Mice: A Research Protocol}. Undergraduate Research in Natural and Clinical Science and Technology (URNCST) Journal. [published; OpenAlex]. \href{https://doi.org/10.26685/urncst.588}{doi:10.26685/urncst.588}.
\item Petrovitch D, Mitchell SM, Van Allen J, Littlefield AK. (2024). \textit{Who believes psychedelic-assisted therapies work? Risky cannabis use and other factors are associated with positive treatment-outcome expectancies}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/adnpg}{doi:10.31234/osf.io/adnpg}.
\item University of Sydney (2024). \textit{A Multi-centre, Double-blinded, Placebo-controlled, Randomised, Phase II Clinical Trial for Psilocybin-assisted Therapy for Alcohol Use Disorder}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06444243}{source link}.
\item Unknown authors (2024). \textit{Who believes psychedelic-assisted therapies work? Risky cannabis use and other factors are associated with positive treatment-outcome expectancies}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/adnpg\_v1}{source link}.
\item Turkia M. (2024). \textit{5-MeO-DMT in the complete resolution of the consequences of chronic, severe sexual abuse in early childhood-a retrospective case study}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/bvk2f}{doi:10.31234/osf.io/bvk2f}.
\item Calder A, Hasler G. (2024). \textit{Validation of the Swiss Psychedelic Side Effects Inventory: Standardized assessment of adverse effects in studies of psychedelics and MDMA}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/um2cy}{doi:10.31234/osf.io/um2cy}.
\item Unknown authors (2024). \textit{5-MeO-DMT in the complete resolution of the consequences of chronic, severe sexual abuse in early childhood-a retrospective case study}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/bvk2f\_v1}{source link}.
\item Unknown authors (2024). \textit{Validation of the Swiss Psychedelic Side Effects Inventory: Standardized assessment of adverse effects in studies of psychedelics and MDMA}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/um2cy\_v1}{source link}.
\item Ramos L, Vicente SG. (2024). \textit{The effects of psilocybin on cognition and emotional processing in healthy adults and adults with depression: a systematic literature review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/13803395.2024.2363343}{doi:10.1080/13803395.2024.2363343}.
\item Julia Bornemann, James B. Close, Kirran Ahmad, Tommaso Barba, Kate Godfrey, Lauren Macdonald, David Erritzøe, David Nutt, Robin Carhart-Harris (2024). \textit{Study protocol for “Psilocybin in patients with fibromyalgia: brain biomarkers of action”}. Frontiers in Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.3389/fpsyt.2024.1320780}{doi:10.3389/fpsyt.2024.1320780}.
\item Holikulov U, Kazachenko AS, Issaoui N, Kazachenko AS, Raja M, Al-Dossary OM, Xiang Z. (2024). \textit{The molecular structure, vibrational spectra, solvation effect, non-covalent interactions investigations of psilocin.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.saa.2024.124600}{doi:10.1016/j.saa.2024.124600}.
\item Wang CK, Kim G, Aleksandrova LR, Panenka WJ, Barr AM. (2024). \textit{A scoping review of the effects of mushroom and fungus extracts in rodent models of depression and tests of antidepressant activity.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fphar.2024.1387158}{doi:10.3389/fphar.2024.1387158}.
\item Ryan J. Rakoczy, Grace N. Runge, Abhishek K. Sen, Oscar Sandoval, Hunter G. Wells, Quynh Nguyen, B. Roberts, Jon H. Sciortino, William J. Gibbons, Lucas M. Friedberg, J. Andrew Jones, Matthew S. McMurray (2024). \textit{Pharmacological and behavioural effects of tryptamines present in psilocybin-containing mushrooms}. British Journal of Pharmacology. [published; OpenAlex]. \href{https://doi.org/10.1111/bph.16466}{doi:10.1111/bph.16466}.
\item Martina Colognesi, Daniela Gabbia, Andrea Rinaldi, Luciano Cascione, Ilaria Zanotto, Stefano Comai, Katia Sayaf, Andrea Mattarei, Marco Banzato, Gianfranco Pasut, Franco Folli, Lucia Centofanti, Sergio Traversa, M. Pappagallo, Paolo L. Manfredi, Sara De Martin (2024). \textit{THU-285 Lownonpsychedelic dosed of psilocybin for the therapy of MASLD}. Journal of Hepatology. [published; OpenAlex]. \href{https://doi.org/10.1016/s0168-8278(24)01739-2}{doi:10.1016/s0168-8278(24)01739-2}.
\item Jessica L. Maltman, Derrick Zhao, Alaina M. Jaster, Yunling Tai, Jing Zeng, Javier Maeso-Gonzalez, Huiping Zhou, Jasmohan S. Bajaj (2024). \textit{WED-123 Female mice with cirrhosis are more prone to acute and chronic effects of psilocybin exposure without tolerance compared to male mice}. Journal of Hepatology. [published; OpenAlex]. \href{https://doi.org/10.1016/s0168-8278(24)00826-2}{doi:10.1016/s0168-8278(24)00826-2}.
\item Amrit Baral, Yue Pan, Alberto J. Caban Martinez, Paulo S. Pinheiro, WayWay M. Hlaing, Denise C. Vidot (2024). \textit{Psilocybin, peyote, mescaline, and lysergic acid diethylamide (LSD) use in a nationally representative population by cancer history.}. Journal of Clinical Oncology. [published; OpenAlex]. \href{https://doi.org/10.1200/jco.2024.42.16\_suppl.e22518}{doi:10.1200/jco.2024.42.16\_suppl.e22518}.
\item Nikola Lash, George Tadros, Eman Tadros (2024). \textit{Therapeutic Implications of Psilocybin in the Wake of Decriminalization}. Integrative and Complementary Therapies. [published; OpenAlex]. \href{https://doi.org/10.1089/ict.2024.27206.nl}{doi:10.1089/ict.2024.27206.nl}.
\item Aaronson ST, van der Vaart A, Miller T, LaPratt J, Swartz K, Shoultz A, Lauterbach M, Sackeim HA, Suppes T. (2024). \textit{Single-Dose Synthetic Psilocybin With Psychotherapy for Treatment-Resistant Bipolar Type II Major Depressive Episodes: A Nonrandomized Open-Label Trial.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1001/jamapsychiatry.2023.4685}{doi:10.1001/jamapsychiatry.2023.4685}.
\item Haniff Z, Bocharova M, Mantingh T, Rucker J, Velayudhan L, Taylor D, Young A, Aarsland D, Vernon A, Thuret S. (2024). \textit{Psilocybin for dementia prevention? The potential role of psilocybin to alter mechanisms associated with major depression and neurodegenerative diseases}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC11847495}{source link}.
\item Aaronson ST, van der Vaart A, Sackeim HA. (2024). \textit{Treating Bipolar Depression Using Psilocybin-Validity Threats Regarding Efficacy and Safety-Reply.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1001/jamapsychiatry.2024.0423}{doi:10.1001/jamapsychiatry.2024.0423}.
\item Floris G, Dabrowski KR, Zanda MT, Daws SE. (2024). \textit{Psilocybin reduces heroin seeking behavior and modulates inflammatory gene expression in the nucleus accumbens and prefrontal cortex of male rats}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2024.05.28.596205}{doi:10.1101/2024.05.28.596205}.
\item Vohryzek J, Luppi A, Atasoy S, Deco G, Timmermann C, Carhart-Harris RL, Kringelbach ML. (2024). \textit{Time-resolved coupling between connectome harmonics and subjective experience under the psychedelic DMT}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2024.05.30.596410}{doi:10.1101/2024.05.30.596410}.
\item Chisamore N, Johnson D, Chen MJQ, Offman H, Chen-Li D, Kaczmarek ES, Doyle Z, McIntyre RS, Rosenblat JD. (2024). \textit{Protocols and practices in psilocybin assisted psychotherapy for depression: A systematic review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jpsychires.2024.05.051}{doi:10.1016/j.jpsychires.2024.05.051}.
\item Adam T. Brockett, Nikolas A. Francis (2024). \textit{Psilocybin decreases neural responsiveness and increases functional connectivity while preserving pure-tone frequency selectivity in mouse auditory cortex}. Journal of Neurophysiology. [published; OpenAlex]. \href{https://doi.org/10.1152/jn.00124.2024}{doi:10.1152/jn.00124.2024}.
\item Harris E (2024). \textit{Therapeutic Psilocybin's Adverse Effects Mostly Resolved Within 2 Days.}. JAMA. [published; PubMed]. \href{https://doi.org/10.1001/jama.2024.6733}{doi:10.1001/jama.2024.6733}.
\item Harman Chopra, Timothy Furnish, Monica Verduzco-Gutierrez, David S. Jevotovsky, Joel Castellanos (2024). \textit{Long-COVID symptoms improved after MDMA and psilocybin therapy: A case report}. Clinical Case Reports. [published; OpenAlex]. \href{https://doi.org/10.1002/ccr3.8791}{doi:10.1002/ccr3.8791}.
\item Sharmin Ghaznavi, Lourdes M Bernardez, Theodore A. Stern (2024). \textit{Medical Uses and Adverse Effects of Psilocybin}. The Primary Care Companion For CNS Disorders. [published; OpenAlex]. \href{https://doi.org/10.4088/pcc.23f03652}{doi:10.4088/pcc.23f03652}.
\item McGovern H, Wellman N, Hutchinson B, Oestreich LKL, Cooper SE, Fonzo G, Doss M. (2024). \textit{Resetting the Hippocampal Buffer: A Neurocognitive Account of Psychedelic Therapy for Anxiety-Related Psychopathology}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/y8sb7}{doi:10.31234/osf.io/y8sb7}.
\item Unknown authors (2024). \textit{Resetting the Hippocampal Buffer: A Neurocognitive Account of Psychedelic Therapy for Anxiety-Related Psychopathology}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/y8sb7\_v1}{source link}.
\item Aboharb F, Davoudian PA, Shao L, Liao C, Rzepka GN, Wojtasiewicz C, Indajang J, Dibbs M, Rondeau J, Sherwood AM, Kaye AP, Kwan AC. (2024). \textit{Classification of psychedelics and psychoactive drugs based on brain-wide imaging of cellular c-Fos expression}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2024.05.23.590306}{doi:10.1101/2024.05.23.590306}.
\item Hoyer D. (2024). \textit{On serotonin, psychedelics, entactogens and psychoplastogens in depression, anxiety, post-traumatic stress, and related disorders.}. Authorea Preprints. [preprint; Europe PMC]. \href{https://doi.org/10.22541/au.171648613.31141136/v1}{doi:10.22541/au.171648613.31141136/v1}.
\item Ehrenkranz R, Agrawal M, Penberthy JK, Yaden DB. (2024). \textit{Narrative review of the potential for psychedelics to treat Prolonged Grief Disorder.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/09540261.2024.2357668}{doi:10.1080/09540261.2024.2357668}.
\item Fang Q, Chan VKY, Chan SSM, Jiao Y, Wang J, Li X. (2024). \textit{Efficacy and safety of psilocybin on treatment-resistant depression: A systematic review and meta-analysis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.psychres.2024.115960}{doi:10.1016/j.psychres.2024.115960}.
\item Korkmaz ND, Cikrikcili U, Akan M, Yucesan E. (2024). \textit{Psychedelic therapy in depression and substance use disorders.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1111/ejn.16421}{doi:10.1111/ejn.16421}.
\item Shane Darke, Johan Duflou, Amy Peacock, Michael Farrell, Wayne Hall, Julia Lappin (2024). \textit{A retrospective study of the characteristics and toxicology of cases of lysergic acid diethylamide (LSD)- and psilocybin-related death in Australia}. Addiction. [published; OpenAlex]. \href{https://doi.org/10.1111/add.16518}{doi:10.1111/add.16518}.
\item S Morris (2024). \textit{A Case Report of Psilocybin-induced Psychosis in a Predisposed Patient}. Clinical Psychopharmacology and Neuroscience. [published; OpenAlex]. \href{https://doi.org/10.9758/cpn.24.1180}{doi:10.9758/cpn.24.1180}.
\item Andrea Casanova, Andres Ort, John W Smallridge, Katrin H. Preller, Erich Seifritz, Franz X. Vollenweider (2024). \textit{The influence of psilocybin on subconscious and conscious emotional learning}. iScience. [published; OpenAlex]. \href{https://doi.org/10.1016/j.isci.2024.110034}{doi:10.1016/j.isci.2024.110034}.
\item Marinis J, Clarke ST, Bedi G. (2024). \textit{Methodological issues undermine evidence about adverse effects of psilocybin-assisted psychotherapy}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/4bk2p}{doi:10.31234/osf.io/4bk2p}.
\item Unknown authors (2024). \textit{Methodological issues undermine evidence about adverse effects of psilocybin-assisted psychotherapy}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/4bk2p\_v1}{source link}.
\item Fisher EL, Smith R, Corcoran AW, Milton LK, Conn K, Hohwy J, Foldi CJ. (2024). \textit{Psilocybin increases optimistic engagement over time: computational modelling of behavior in rats}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2024.05.16.594614}{doi:10.1101/2024.05.16.594614}.
\item Mateusz Pawlicki, Aleksandra Kłos, Karol Stachyrak, Dawid Mika, Bartosz Mazur, Kamila Turek, Maciej Lambach, Anna Gregułą, Aleksandra Mazurek, Wiktoria Wilanowska (2024). \textit{Psilocybin as a new way for depression treatment}. Journal of Education Health and Sport. [published; OpenAlex]. \href{https://doi.org/10.12775/jehs.2024.68.50168}{doi:10.12775/jehs.2024.68.50168}.
\item Mat­thias Zeller, Stephan D. Parent, N. Schultheiss (2024). \textit{Structural characterization and comparative analysis of polymorphic forms of psilocin (4-hydroxy-N,N-dimethyltryptamine)}. Acta Crystallographica Section E Crystallographic Communications. [published; OpenAlex]. \href{https://doi.org/10.1107/s2056989024004201}{doi:10.1107/s2056989024004201}.
\item Yu Z, Burback L, Winkler O, Xu L, Dennett L, Vermetten E, Greenshaw A, Li XM, Milne M, Wang F, Cao B, Winship IR, Zhang Y, Chan AW. (2024). \textit{Alterations in brain network connectivity and subjective experience induced by psychedelics: a scoping review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fpsyt.2024.1386321}{doi:10.3389/fpsyt.2024.1386321}.
\item M. Imad Damaj, Javier González-Maeso, Belle Buzzi (2024). \textit{The Classical Psychedelic Psilocybin Mitigates Oxycodone Withdrawal}. Journal of Pharmacology and Experimental Therapeutics. [published; OpenAlex]. \href{https://doi.org/10.1124/jpet.320.935210}{doi:10.1124/jpet.320.935210}.
\item N. Jones, John A. Razidlo, Zarmeen Zahid, Cody J. Wenthur (2024). \textit{Psilocybin-induced anxiolytic effects supported by transient elevation of corticosterone}. Journal of Pharmacology and Experimental Therapeutics. [published; OpenAlex]. \href{https://doi.org/10.1124/jpet.337.128335}{doi:10.1124/jpet.337.128335}.
\item Viña S. (2024). \textit{Psychedelics Use and the Risk of Reduced Formal Mental Health Care}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-4378944/v1}{doi:10.21203/rs.3.rs-4378944/v1}.
\item Terri D’Arrigo (2024). \textit{Calls to Poison Centers Involving Psilocybin Rising in Youth}. Psychiatric News. [published; OpenAlex]. \href{https://doi.org/10.1176/appi.pn.2024.06.6.2}{doi:10.1176/appi.pn.2024.06.6.2}.
\item Jeffrey JK, Weintraub MJ, Grob CS. (2024). \textit{Clinical Research Trials of Psychedelic-Assisted Therapy in Adolescents Aged 16 to 17 Years: Rationale Balanced With Caution.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jaac.2024.03.021}{doi:10.1016/j.jaac.2024.03.021}.
\item Nova Mentis Life Science Corp (2024). \textit{An Open-Label Investigation of the Effects of Sub-Perceptual Repeat Dosing of Psilocybin on the Behavioural and Cognitive Symptoms of Fragile X Syndrome in Adult Patients}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05832255}{source link}.
\item Warren AL, Lankri D, Cunningham MJ, Serrano IC, Parise LF, Kruegel AC, Duggan P, Zilberg G, Capper MJ, Havel V, Russo SJ, Sames D, Wacker D. (2024). \textit{Structural pharmacology and therapeutic potential of 5-methoxytryptamines.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41586-024-07403-2}{doi:10.1038/s41586-024-07403-2}.
\item Kargbo RB. (2024). \textit{Advancements in Psychoactive Alkaloid Delivery, Neuroenhancement, and Psychedelic Therapies: Exploring the Frontiers of Modern Pharmacology.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/acsmedchemlett.4c00181}{doi:10.1021/acsmedchemlett.4c00181}.
\item Anthony L. Back, Susanna Myers, John Guy, Juliana Pérez, Leslie Lazar Thorn, Bonnie A. McGregor (2024). \textit{Evolving Guidelines for the Use of Touch During a Clinical Trial of Group Psilocybin-Assisted Therapy}. Psychedelic Medicine. [published; OpenAlex]. \href{https://doi.org/10.1089/psymed.2023.0069}{doi:10.1089/psymed.2023.0069}.
\item Barri Babow (2024). \textit{The Psilocybin Connection: Psychedelics, the Transformation of Consciousness, and Evolution on the Planet}. World Futures. [published; OpenAlex]. \href{https://doi.org/10.1080/02604027.2024.2340772}{doi:10.1080/02604027.2024.2340772}.
\item University of Calgary (2024). \textit{Mechanisms Supporting Psilocybin-assisted Psychotherapy for Alcohol Use Disorder: A Randomized, Controlled Clinical Trial}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05995769}{source link}.
\item Woodburn SC, Levitt CM, Koester AM, Kwan AC. (2024). \textit{Psilocybin facilitates fear extinction: importance of dose, context, and serotonin receptors}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2024.05.04.592469}{doi:10.1101/2024.05.04.592469}.
\item Olami A, Peled-Avron L. (2024). \textit{Effects of Classical Psychedelics on Implicit and Explicit Emotional Empathy and Cognitive Empathy: A Meta-analysis of MET task}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2024.05.02.592231}{doi:10.1101/2024.05.02.592231}.
\item British Medical Journal Publishing Group (2024). \textit{EXPRESSION OF CONCERN: Efficacy of psilocybin for treating symptoms of depression: systematic review and meta-analysis}. BMJ. [published; OpenAlex]. \href{https://doi.org/10.1136/bmj.q1025}{doi:10.1136/bmj.q1025}.
\item Jérôme Jeanblanc, Romain Bordy, Grégory Fouquet, Virginie Jeanblanc, Mickaël Naassïla (2024). \textit{Psilocybin reduces alcohol self-administration via selective left nucleus accumbens activation in rats}. Brain. [published; OpenAlex]. \href{https://doi.org/10.1093/brain/awae136}{doi:10.1093/brain/awae136}.
\item Hanna Brancaccio (2024). \textit{Efficacy of Psilocybin in the Treatment of Substance and Alcohol Use Disorders}. Unknown journal. [published; OpenAlex]. \href{https://doi.org/10.31986/issn.2689-0690\_rdw.stratford\_research\_day.149\_2024}{doi:10.31986/issn.2689-0690\_rdw.stratford\_research\_day.149\_2024}.
\item Claire Parker, Bethany Wood (2024). \textit{At the Forefront: Social Workers’ Role in Psilocybin Treatment for Depression and Substance Misuse}. Social Work. [published; OpenAlex]. \href{https://doi.org/10.1093/sw/swae019}{doi:10.1093/sw/swae019}.
\item Unknown authors (2024). \textit{PSYCHEDELIC PSILOCYBIN-ASSISTED THERAPY REDUCES DEPRESSIVE SYMPTOMS IN ADULTS WITH CANCER AND DEPRESSION.}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/38740403}{source link}.
\item Schmid Y, Bershad AK (2024). \textit{Altered States and Social Bonds: Effects of MDMA and Serotonergic Psychedelics on Social Behavior as a Mechanism Underlying Substance-Assisted Therapy.}. Biological psychiatry. Cognitive neuroscience and neuroimaging. [published; PubMed]. \href{https://doi.org/10.1016/j.bpsc.2024.02.001}{doi:10.1016/j.bpsc.2024.02.001}.
\item Shafiee A, Arabzadeh Bahri R, Rafiei MA, Esmaeilpur Abianeh F, Razmara P, Jafarabady K, Amini MJ (2024). \textit{The effect of psychedelics on the level of brain-derived neurotrophic factor: A systematic review and meta-analysis.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811241234247}{doi:10.1177/02698811241234247}.
\item Romeo B, Kervadec E, Fauvel B, Strika-Bruneau L, Amirouche A, Verroust V, Piolino P, Benyamina A (2024). \textit{Safety and risk assessment of psychedelic psychotherapy: A meta-analysis and systematic review.}. Psychiatry research. [published; PubMed]. \href{https://doi.org/10.1016/j.psychres.2024.115880}{doi:10.1016/j.psychres.2024.115880}.
\item De Giorgi R, Ede R. (2024). \textit{Psilocybin for depression.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1136/bmj.q798}{doi:10.1136/bmj.q798}.
\item Metaxa AM, Clarke M. (2024). \textit{Efficacy of psilocybin for treating symptoms of depression: systematic review and meta-analysis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1136/bmj-2023-078084}{doi:10.1136/bmj-2023-078084}.
\item Zeller M, Parent S, Schultheiss N. (2024). \textit{Structural characterization and comparative analysis of polymorphic forms of psilocin (4-hy­droxy-N,N-di­methyl­tryptamine)}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC11151301}{source link}.
\item Kimberly Sakai, Ellen Bradley, Joseph A. Zamaria, Gabrielle Agin-Liebes, D. Parker Kelley, Alexander Fish, Valeria Martini, Michelle C. Ferris, Emma Morton, Erin E. Michalak, Aoife O’Donovan, Joshua Woolley (2024). \textit{Content analysis of Reddit posts about coadministration of selective serotonin reuptake inhibitors and psilocybin mushrooms}. Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1007/s00213-024-06585-x}{doi:10.1007/s00213-024-06585-x}.
\item Manoj K. Doss, Pablo Mallaroni, Natasha L. Mason, Jan Ramaekers (2024). \textit{1. Psilocybin and 4-Bromo-2,5-Dimethoxyphenethylamine (2C-B) at Encoding Distort Episodic Familiarity and Positively Bias Emotional Metamemory}. Biological Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.biopsych.2024.02.179}{doi:10.1016/j.biopsych.2024.02.179}.
\item Jan Thomann, Karolina E. Kolaczynska, Oliver V Stoeckmann, Deborah Rudin, Patrick Vizeli, Marius C. Hoener, Christopher R. Pryce, Franz X. Vollenweider, Matthias E. Liechti, Urs Duthaler (2024). \textit{In vitro and in vivo metabolism of psilocybin’s active metabolite psilocin}. Frontiers in Pharmacology. [published; OpenAlex]. \href{https://doi.org/10.3389/fphar.2024.1391689}{doi:10.3389/fphar.2024.1391689}.
\item Soliman PS, Curley DE, Capone C, Eaton E, Haass-Koffler CL. (2024). \textit{In the new era of psychedelic assisted therapy: A systematic review of study methodology in randomized controlled trials.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s00213-024-06598-6}{doi:10.1007/s00213-024-06598-6}.
\item Xiangting Zhao, Yingjie Du, Yishan Yao, Wei Dai, Yong-Yu Yin, Guyan Wang, Yunfeng Li, Liming Zhang (2024). \textit{Psilocybin promotes neuroplasticity and induces rapid and sustained antidepressant-like effects in mice}. Journal of Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1177/02698811241249436}{doi:10.1177/02698811241249436}.
\item Val Bellman (2024). \textit{Review of Psilocybin Use for Depression among Cancer Patients after Approval in Oregon}. Cancers. [published; OpenAlex]. \href{https://doi.org/10.3390/cancers16091702}{doi:10.3390/cancers16091702}.
\item Kyna-Anne Conn, Laura K Milton, Kaixin Huang, Hermany Munguba, Janika Ruuska, M. B. Lemus, Erin Greaves, Jihane Homman-Ludiye, Brian J. Oldfield, Claire J. Foldi (2024). \textit{Psilocybin restrains activity-based anorexia in female rats by enhancing cognitive flexibility: contributions from 5-HT1A and 5-HT2A receptor mechanisms}. Molecular Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1038/s41380-024-02575-9}{doi:10.1038/s41380-024-02575-9}.
\item University Hospital, Basel, Switzerland (2024). \textit{Acute Dose-dependent Effects of DMT in Healthy Subjects: A Placebo-controlled Cross-over Study}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05384678}{source link}.
\item Tobias P. Whelan, Eileen Daly, Nicolaas A.J. Puts, Paula Smith, Carrie Allison, Simon Baron-Cohen, Ekaterina Malievskaia, Declan Murphy, Gráinne McAlonan (2024). \textit{The ‘PSILAUT’ protocol: an experimental medicine study of autistic differences in the function of brain serotonin targets of psilocybin}. BMC Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1186/s12888-024-05768-2}{doi:10.1186/s12888-024-05768-2}.
\item Paula Sophie Seibold, Sebastian Dörner, Janis Fricke, Tim Schäfer, Christine Beemelmanns, Dirk Hoffmeister (2024). \textit{Genetic regulation of l-tryptophan metabolism in Psilocybe mexicana supports psilocybin biosynthesis}. Fungal Biology and Biotechnology. [published; OpenAlex]. \href{https://doi.org/10.1186/s40694-024-00173-6}{doi:10.1186/s40694-024-00173-6}.
\item Petrovitch D, Van Allen J, Mitchell SM, Littlefield AK. (2024). \textit{Do undergraduates’ views of psychedelics relate to the context for psychedelic use?}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/xnu5c}{doi:10.31234/osf.io/xnu5c}.
\item Pagni B, Petridis P, Podrebarac S, Grinband J, Claus E, Bogenschutz M. (2024). \textit{300 Psilocybin-induced changes in neural reactivity to alcohol and emotional cues in patients with alcohol use disorder: An fMRI pilot study}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC11033768}{source link}.
\item Downey AE, Chaphekar AV, Woolley J, Raymond-Flesch M. (2024). \textit{Psilocybin therapy and anorexia nervosa: a narrative review of safety considerations for researchers and clinicians.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1186/s40337-024-01005-z}{doi:10.1186/s40337-024-01005-z}.
\item Unknown authors (2024). \textit{Do undergraduates’ views of psychedelics relate to the context for psychedelic use?}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/xnu5c\_v1}{source link}.
\item Terri D’Arrigo (2024). \textit{MedCheck: Psilocybin for Depression, LSD for Anxiety, Donanemab, LSD, and More}. Psychiatric News. [published; OpenAlex]. \href{https://doi.org/10.1176/appi.pn.2024.05.5.1}{doi:10.1176/appi.pn.2024.05.5.1}.
\item Singer B, Meling D, Hirsch-Hoffmann M, Michels L, Kometer M, Smigielski L, Dornbierer D, Seifritz E, Vollenweider FX, Scheidegger M. (2024). \textit{Author Correction: Psilocybin enhances insightfulness in meditation: a perspective on the global topology of brain imaging during meditation.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41598-024-59897-5}{doi:10.1038/s41598-024-59897-5}.
\item Jensen AA, Cecchi CR, Hibicke M, Bach AH, Kaadt E, Märcher-Rørsted E, Nichols CD, Elfving B, Kristensen JL. (2024). \textit{The selective 5-HT2A receptor agonist LPH-5 induces persistent and robust antidepressant-like effects in rodents}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2024.04.19.590212}{doi:10.1101/2024.04.19.590212}.
\item Ivan V, Tomas-Cuesta D, Esteves I, Luczak A, Mohajerani M, McNaughton B, Gruber A. (2024). \textit{Psilocybin reduces functional connectivity and the encoding of spatial information by neurons in mouse retrosplenial cortex}. Authorea Preprints. [preprint; Europe PMC]. \href{https://doi.org/10.22541/au.171378690.00112411/v1}{doi:10.22541/au.171378690.00112411/v1}.
\item Tipado Z, Kuypers KPC, Sorger B, Ramaekers JG. (2024). \textit{Visual hallucinations originating in the retinofugal pathway under clinical and psychedelic conditions.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.euroneuro.2024.04.011}{doi:10.1016/j.euroneuro.2024.04.011}.
\item Section for Affective Disorders; Northern Stockholm Psychiatry (2024). \textit{The Effect of Psilocybin on MDD Symptom Severity and Synaptic Density - A Single Dose Randomized, Double Blind, Placebo- Controlled Phase 2 Positron Emission Tomography Study}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT04630964}{source link}.
\item Elad Lerer, Alexander Botvinnik, Orr Shahar, Meitar Grad, Karin Blakolmer, Noam Shomron, Amit Lotan, Bernard Lerer, Tzuri Lifschytz (2024). \textit{Effects of psilocybin, psychedelic mushroom extract and 5-hydroxytryptophan on brain immediate early gene expression: Interaction with serotonergic receptor modulators}. Frontiers in Pharmacology. [published; OpenAlex]. \href{https://doi.org/10.3389/fphar.2024.1391412}{doi:10.3389/fphar.2024.1391412}.
\item Julia R. Wang, Samuel J. Mendez Araque, Gina Micciche, Andrew McMillan, Emily Coughlin, Rosalie Mattiola, Diana P. English, Kristopher Kaliebe (2024). \textit{Palliative care patients’ attitudes and openness towards psilocybin-assisted psychotherapy for existential distress}. Frontiers in Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.3389/fpsyt.2024.1301960}{doi:10.3389/fpsyt.2024.1301960}.
\item Köhne S, Hillemacher T, Glahn A, Bach P. (2024). \textit{Emerging drugs in phase II and III clinical development for the treatment of alcohol use disorder.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/14728214.2024.2342951}{doi:10.1080/14728214.2024.2342951}.
\item Jordan Sloshower, Richard J. Zeifman, Jeffrey Guss, Robert Krause, Hamideh Safi-Aghdam, Surbhi Pathania, Brian Pittman, Deepak Cyril D’Souza (2024). \textit{Psychological flexibility as a mechanism of change in psilocybin-assisted therapy for major depression: results from an exploratory placebo-controlled trial}. Scientific Reports. [published; OpenAlex]. \href{https://doi.org/10.1038/s41598-024-58318-x}{doi:10.1038/s41598-024-58318-x}.
\item Rahman SM, Salem Y, Hussain A. (2024). \textit{Trips Through the Skin: Reviewing Cutaneous Drug Reactions to Psychedelics and Hallucinogens.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1089/derm.2023.0292}{doi:10.1089/derm.2023.0292}.
\item Hatfield SP, Thornton NL, Greenstien K, Glozier N. (2024). \textit{A taxonomy of regulatory and policy matters relevant to psychedelic-assisted therapy in Australia.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/00048674241240597}{doi:10.1177/00048674241240597}.
\item Juliani A, Chelu V, Graesser L, Safron A. (2024). \textit{A dual-receptor model of serotonergic psychedelics}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2024.04.12.589282}{doi:10.1101/2024.04.12.589282}.
\item Eiko I. Fried, Ioana A. Cristea, Florian Naudet (2024). \textit{Treating Bipolar Depression Using Psilocybin-Validity Threats Regarding Efficacy and Safety}. JAMA Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1001/jamapsychiatry.2024.0420}{doi:10.1001/jamapsychiatry.2024.0420}.
\item Ram Harari, Ipsita Chatterjee, Dmitriy Getselter, Evan Elliott (2024). \textit{Psilocybin induces acute anxiety and changes in amygdalar phosphopeptides independently from the 5-HT2A receptor}. iScience. [published; OpenAlex]. \href{https://doi.org/10.1016/j.isci.2024.109686}{doi:10.1016/j.isci.2024.109686}.
\item Haniff ZR, Bocharova M, Mantingh T, Rucker JJ, Velayudhan L, Taylor DM, Young AH, Aarsland D, Vernon AC, Thuret S. (2024). \textit{Psilocybin for dementia prevention? The potential role of psilocybin to alter mechanisms associated with major depression and neurodegenerative diseases.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.pharmthera.2024.108641}{doi:10.1016/j.pharmthera.2024.108641}.
\item Brian Pilecki, Jason B. Luoma, Kati M. Lear (2024). \textit{A pilot study of the effect of group-administered psilocybin on psychological flexibility and outcomes}. Journal of Psychedelic Studies. [published; OpenAlex]. \href{https://doi.org/10.1556/2054.2024.00295}{doi:10.1556/2054.2024.00295}.
\item López E, Yngwe H, Beckman M, Tiger M, Hieronymus F, Lundberg J. (2024). \textit{[Psychedelic psychiatry].}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/38572715}{source link}.
\item M. Nordin, Jón Ingi Hlynsson, Jakob Håkansson Eklund, Per Carlbring (2024). \textit{A double-edged sword: Insights from practitioners on the short and long-term negative effects of psilocybin-assisted psychological interventions}. Journal of Psychedelic Studies. [published; OpenAlex]. \href{https://doi.org/10.1556/2054.2024.00337}{doi:10.1556/2054.2024.00337}.
\item University Health Network, Toronto (2024). \textit{Psilocybin-Assisted Psychotherapy for Treatment-Resistant Depression: A Randomized Phase II Clinical Trial Comparing One Versus Two Psychedelic Doses of Psilocybin (PSI-1V2)}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06341426}{source link}.
\item Emmanuelle A. D. Schindler, R. Andrew Sewell, Christopher Gottschalk, L. Taylor Flynn, Yutong Zhu, Brian Pittman, Nicholas V. Cozzi, Deepak Cyril D’Souza (2024). \textit{Psilocybin pulse regimen reduces cluster headache attack frequency in the blinded extension phase of a randomized controlled trial}. Journal of the Neurological Sciences. [published; OpenAlex]. \href{https://doi.org/10.1016/j.jns.2024.122993}{doi:10.1016/j.jns.2024.122993}.
\item J. S. Seo (2024). \textit{Current situation regarding psychedelics and magic mushroom in Korea}. European Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1192/j.eurpsy.2024.1695}{doi:10.1192/j.eurpsy.2024.1695}.
\item Eva Maria Schindowski, Franz X. Vollenweider (2024). \textit{Fallbeispiele zur Therapie der rezidivierenden Depression mit Psilocybin}. Nervenheilkunde. [published; OpenAlex]. \href{https://doi.org/10.1055/a-2283-0221}{doi:10.1055/a-2283-0221}.
\item Unknown authors (2024). \textit{Depressionen: Remission durch Psilocybin bei laufender SSRI-Therapie}. Fortschritte der Neurologie · Psychiatrie. [published; OpenAlex]. \href{https://doi.org/10.1055/a-2254-0360}{doi:10.1055/a-2254-0360}.
\item Wilson Lavonne, Babumon Muthiramalil T., Irvine William, Morrison Isaac, Foster Kimberly, Delgoda Rupika (2024). \textit{Inhibition of cytochrome P450 3A4 enzyme activity by alkaloid psilocin from magic mushrooms: potential for drug interactions}. Drug Metabolism and Pharmacokinetics. [published; Crossref]. \href{https://doi.org/10.1016/j.dmpk.2023.100829}{doi:10.1016/j.dmpk.2023.100829}.
\item Simonsson O, Osika W, Stenfors CUD, Goldberg SB, Honk L, Hendricks PS (2024). \textit{Longitudinal associations between psychedelic use and meditation practices in the United States and the United Kingdom.}. Psychological medicine. [published; PubMed]. \href{https://doi.org/10.1017/s0033291723003082}{doi:10.1017/s0033291723003082}.
\item Yerubandi A, Thomas JE, Bhuiya NMMA, Harrington C, Villa Zapata L, Caballero J. (2024). \textit{Acute Adverse Effects of Therapeutic Doses of Psilocybin: A Systematic Review and Meta-Analysis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1001/jamanetworkopen.2024.5960}{doi:10.1001/jamanetworkopen.2024.5960}.
\item Sarah A. Norring, Michael G. Spigarelli (2024). \textit{The Promise of Therapeutic Psilocybin: An Evaluation of the 134 Clinical Trials, 54 Potential Indications, and 0 Marketing Approvals on ClinicalTrials.gov}. Drug Design Development and Therapy. [published; OpenAlex]. \href{https://doi.org/10.2147/dddt.s443177}{doi:10.2147/dddt.s443177}.
\item Le GH, Wong S, Badulescu S, Au H, Di Vincenzo JD, Gill H, Phan L, Rhee TG, Ho R, Teopiz KM, Kwan ATH, Rosenblat JD, Mansur RB, McIntyre RS. (2024). \textit{Spectral signatures of psilocybin, lysergic acid diethylamide (LSD) and ketamine in healthy volunteers and persons with major depressive disorder and treatment-resistant depression: A systematic review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jad.2024.03.165}{doi:10.1016/j.jad.2024.03.165}.
\item Jesse Hudspeth, Kai Rogge, Sebastian Dörner, Maximilian Müll, Dirk Hoffmeister, Bernhard Rupp, Sebastiaan Werten (2024). \textit{Methyl transfer in psilocybin biosynthesis}. Nature Communications. [published; OpenAlex]. \href{https://doi.org/10.1038/s41467-024-46997-z}{doi:10.1038/s41467-024-46997-z}.
\item Yao Y, Guo D, Lu TS, Liu FL, Huang SH, Diao MQ, Li SX, Zhang XJ, Kosten TR, Shi J, Bao YP, Lu L, Han Y. (2024). \textit{Efficacy and safety of psychedelics for the treatment of mental disorders: A systematic review and meta-analysis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.psychres.2024.115886}{doi:10.1016/j.psychres.2024.115886}.
\item Terri D’Arrigo (2024). \textit{MedCheck; Psilocybin, Roluperidone, Latozinemab, Lacosamide}. Psychiatric News. [published; OpenAlex]. \href{https://doi.org/10.1176/appi.pn.2024.04.4.1}{doi:10.1176/appi.pn.2024.04.4.1}.
\item Berit Singer, Daniel Meling, Matthias Hirsch-Hoffmann, Lars Michels, Michael Kometer, Lukasz Smigielski, Dario Dornbierer, Erich Seifritz, Franz X. Vollenweider, Milan Scheidegger (2024). \textit{Psilocybin enhances insightfulness in meditation: a perspective on the global topology of brain imaging during meditation}. Scientific Reports. [published; OpenAlex]. \href{https://doi.org/10.1038/s41598-024-55726-x}{doi:10.1038/s41598-024-55726-x}.
\item David Erritzøe, Tommaso Barba, Meg J. Spriggs, Fernando E. Rosas, David Nutt, Robin Carhart-Harris (2024). \textit{Effects of discontinuation of serotonergic antidepressants prior to psilocybin therapy versus escitalopram for major depression}. Journal of Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1177/02698811241237870}{doi:10.1177/02698811241237870}.
\item University of Utah (2024). \textit{A Pilot Study of Psilocybin Enhanced Group Psychotherapy in Patients With Cancer}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT04522804}{source link}.
\item Aleksandr V. Kulikov, Ilya Yu. Zheleznyak (2024). \textit{Problems of Qualification of Trafficking in Plants and Plant Parts Containing Psychoactive Substances and Mushrooms Containing Psilocybin and (or) Psilocin}. Drug control. [published; OpenAlex]. \href{https://doi.org/10.18572/2072-4160-2024-1-23-26}{doi:10.18572/2072-4160-2024-1-23-26}.
\item Adam W. Levin, Rafael Lancelotta, Nathan D. Sepeda, Natalie Gukasyan, Sandeep M. Nayak, Theodore L. Wagener, Frederick S. Barrett, Roland R. Griffiths, Alan K. Davis (2024). \textit{The therapeutic alliance between study participants and intervention facilitators is associated with acute effects and clinical outcomes in a psilocybin-assisted therapy trial for major depressive disorder}. PLoS ONE. [published; OpenAlex]. \href{https://doi.org/10.1371/journal.pone.0300501}{doi:10.1371/journal.pone.0300501}.
\item Hiroshi Ito, Minori Fujita, Daiki Kobayashi (2024). \textit{Psilocybin poisoning from Psilocybe argentipes ingestion}. Visual Journal of Emergency Medicine. [published; OpenAlex]. \href{https://doi.org/10.1016/j.visj.2024.101939}{doi:10.1016/j.visj.2024.101939}.
\item Robert Gerlai (2024). \textit{Magic mushroom and zebrafish: A new recipe?}. Lab Animal. [published; OpenAlex]. \href{https://doi.org/10.1038/s41684-024-01350-1}{doi:10.1038/s41684-024-01350-1}.
\item Brandon Weiss, Leor Roseman, Bruna Giribaldi, David Nutt, Robin Carhart-Harris, David Erritzøe (2024). \textit{Unique Psychological Mechanisms Underlying Psilocybin Therapy Versus Escitalopram Treatment in the Treatment of Major Depressive Disorder}. International Journal of Mental Health and Addiction. [published; OpenAlex]. \href{https://doi.org/10.1007/s11469-024-01253-9}{doi:10.1007/s11469-024-01253-9}.
\item Unknown authors (2024). \textit{Patients with bipolar II disorder benefit from single dose of psilocybin}. The Brown University Psychopharmacology Update. [published; OpenAlex]. \href{https://doi.org/10.1002/pu.31143}{doi:10.1002/pu.31143}.
\item Velit-Salazar MR, Shiroma PR, Cherian E. (2024). \textit{A Systematic Review of the Neurocognitive Effects of Psychedelics in Healthy Populations: Implications for Depressive Disorders and Post-Traumatic Stress Disorder.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/brainsci14030248}{doi:10.3390/brainsci14030248}.
\item Henning Hintzsche (2024). \textit{Psilocybin zur Behandlung depressiver Erkrankungen}. BIOspektrum. [published; OpenAlex]. \href{https://doi.org/10.1007/s12268-024-2157-2}{doi:10.1007/s12268-024-2157-2}.
\item Wood ME, Brown GJ, Karschner EL, Seither JZ, Brown JT, Knittel JL, Walterscheid JP. (2024). \textit{Screening and confirmation of psilocin, mitragynine, phencyclidine, ketamine and ketamine metabolites by liquid chromatography-tandem mass spectrometry.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1093/jat/bkae002}{doi:10.1093/jat/bkae002}.
\item Burton J. Tabaac, Kenneth Shinozuka, Alejandro Arenas, Bryce D. Beutler, Kirsten Cherian, Viviana D. Evans, Chelsey Fasano, Owen S. Muir (2024). \textit{Psychedelic Therapy: A Primer for Primary Care Clinicians-Psilocybin}. American Journal of Therapeutics. [published; OpenAlex]. \href{https://doi.org/10.1097/mjt.0000000000001724}{doi:10.1097/mjt.0000000000001724}.
\item Clarice Ho, John R. Crawford (2024). \textit{Neuroimaging features of psilocybin-induced toxic-metabolic encephalopathy in an adolescent}. BMJ Case Reports. [published; OpenAlex]. \href{https://doi.org/10.1136/bcr-2024-259721}{doi:10.1136/bcr-2024-259721}.
\item Norred MA, Zuschlag ZD, Hamner MB. (2024). \textit{A Neuroanatomic and Pathophysiologic Framework for Novel Pharmacological Approaches to the Treatment of Post-traumatic Stress Disorder.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s40265-023-01983-5}{doi:10.1007/s40265-023-01983-5}.
\item Dana DiRenzo, Frederick S. Barrett, Jamie Perin, Erika Darrah, Lisa Christopher-Stine, Roland R. Griffiths (2024). \textit{Impact of Psilocybin on Peripheral Cytokine Production}. Psychedelic Medicine. [published; OpenAlex]. \href{https://doi.org/10.1089/psymed.2023.0039}{doi:10.1089/psymed.2023.0039}.
\item Débora Copa, David Erritzøe, Bruna Giribaldi, David Nutt, Robin Carhart-Harris, Enzo Tagliazucchi (2024). \textit{Predicting the outcome of psilocybin treatment for depression from baseline fMRI functional connectivity}. Journal of Affective Disorders. [published; OpenAlex]. \href{https://doi.org/10.1016/j.jad.2024.02.089}{doi:10.1016/j.jad.2024.02.089}.
\item Hashimoto K. (2024). \textit{Are "mystical experiences" essential for antidepressant actions of ketamine and the classic psychedelics?}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s00406-024-01770-7}{doi:10.1007/s00406-024-01770-7}.
\item Rita Farah, Abigail F. Kerns, A. C. MURRAY, Christopher P. Holstege (2024). \textit{Psilocybin Exposures Reported to U.S. Poison Centers: National Trends Over a Decade}. Journal of Adolescent Health. [published; OpenAlex]. \href{https://doi.org/10.1016/j.jadohealth.2024.01.027}{doi:10.1016/j.jadohealth.2024.01.027}.
\item Avisha D Amarnani, Melissa F Free, Ritika Baweja (2024). \textit{Psilocybin and the Development of Serotonin Toxicity}. The Primary Care Companion For CNS Disorders. [published; OpenAlex]. \href{https://doi.org/10.4088/pcc.23cr03648}{doi:10.4088/pcc.23cr03648}.
\item Brouwer A, Brown JK, Erowid E, Erowid F, Thyssen S, Raison CL, Carhart-Harris RL. (2024). \textit{The Temporal Trajectory of the Psychedelic Mushroom Experience Mimics the Narrative Arc of the Hero’s Journey}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-3941205/v1}{doi:10.21203/rs.3.rs-3941205/v1}.
\item Salma Laabi, Claire LeMmon, Callie Vogel, M. Chacón, Víctor M. Jiménez (2024). \textit{Deciphering psilocybin: Cytotoxicity, anti-inflammatory effects, and mechanistic insights}. International Immunopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/j.intimp.2024.111753}{doi:10.1016/j.intimp.2024.111753}.
\item Habelt B, Afanasenkau D, Schwarz C, Domanegg K, Kuchar M, Werner C, Minev IR, Spanagel R, Meinhardt MW, Bernhardt N. (2024). \textit{Prefrontal Electrophysiological Biomarkers and Mechanism-Based Drug Effects in a Rat Model of Alcohol Addiction}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-3905152/v1}{doi:10.21203/rs.3.rs-3905152/v1}.
\item Kush Bhatt, Cory R. Weissman (2024). \textit{The effect of psilocybin on empathy and prosocial behavior: a proposed mechanism for enduring antidepressant effects}. npj Mental Health Research. [published; OpenAlex]. \href{https://doi.org/10.1038/s44184-023-00053-8}{doi:10.1038/s44184-023-00053-8}.
\item Orr Shahar, Alexander Botvinnik, Amit Shwartz, Elad Lerer, Peretz Golding, Alex Buko, Ethan Hamid, Dani Kahn, Miles Guralnick, Karin Blakolmer, Gilly Wolf, Amit Lotan, Leonard Lerer, Bernard Lerer, Tzuri Lifschytz (2024). \textit{Effect of chemically synthesized psilocybin and psychedelic mushroom extract on molecular and metabolic profiles in mouse brain}. Molecular Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1038/s41380-024-02477-w}{doi:10.1038/s41380-024-02477-w}.
\item Nicholas Spiers, Beatriz Caiuby Labate, Anna O. Ermakova, Patrick Farrell, Osiris Sinuhé González Romero, Ibrahim Gabriell, Nidia Olvera (2024). \textit{Indigenous psilocybin mushroom practices: An annotated bibliography}. Journal of Psychedelic Studies. [published; OpenAlex]. \href{https://doi.org/10.1556/2054.2023.00297}{doi:10.1556/2054.2023.00297}.
\item Agor D, Knettel BA, Daici K, Meanley S. (2024). \textit{The Intersection of Mental Health and Sexual and Gender Minority Identities for Older Adults Living with Human Immunodeficiency Virus: A Narrative Review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.cnur.2024.01.005}{doi:10.1016/j.cnur.2024.01.005}.
\item Alison Knopf (2024). \textit{NIDA: Psilocybin mushroom seizures rose significantly}. Alcoholism \& Drug Abuse Weekly. [published; OpenAlex]. \href{https://doi.org/10.1002/adaw.34037}{doi:10.1002/adaw.34037}.
\item Ching THW, Amoroso L, Bohner C, D'Amico E, Eilbott J, Entezar T, Fitzpatrick M, Fram G, Grazioplene R, Hokanson J, Jankovsky A, Kichuk SA, Martins B, Patel P, Schaer H, Shnayder S, Witherow C, Pittenger C, Kelmendi B. (2024). \textit{Corrigendum: Safety, feasibility, tolerability, and clinical effects of repeated psilocybin dosing combined with non-directive support in the treatment of obsessive-compulsive disorder: protocol for a randomized, waitlist-controlled trial with blinded ratings.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fpsyt.2024.1372373}{doi:10.3389/fpsyt.2024.1372373}.
\item Frautschi PC, Singh AP, Stowe NA, Yu JJ. (2024). \textit{Multimodal Neuroimaging of the Effect of Serotonergic Psychedelics on the Brain.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3174/ajnr.a8118}{doi:10.3174/ajnr.a8118}.
\item Fang S, Yang X, Zhang W. (2024). \textit{Efficacy and acceptability of psilocybin for primary or secondary depression: A systematic review and meta-analysis of randomized controlled trials.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fpsyt.2024.1359088}{doi:10.3389/fpsyt.2024.1359088}.
\item Scott T. Aaronson, Zofia Kozak (2024). \textit{New evidence for flexible psilocybin dosing in patients with treatment-resistant depression}. Med. [published; OpenAlex]. \href{https://doi.org/10.1016/j.medj.2024.01.014}{doi:10.1016/j.medj.2024.01.014}.
\item Joshua D. Rosenblat, Shakila Meshkat, Zoe Doyle, Erica Kaczmarek, Ryan M. Brudner, Kevin Kratiuk, Rodrigo B. Mansur, Christian Schulz, Rickinder Sethi, Amanda Abate, Shaun Ali, Jordan Bawks, Marc G. Blainey, Elisa Brietzke, Victoria Cronin, Jessica Danilewitz, Shalini Dhawan, Anthony Di Fonzo, M. Di Fonzo, Pawel Drzadzewski, William Dunlop, Hajnalka Fiszter, Fabiano A. Gomes, Smrita Grewal, Marisa Leon-Carlyle, Marilyn McCallum, Niki Mofidi, Hilary Offman, Jeremy Riva-Cambrin, Joel E. Schmidt, Mark E. Smolkin, Joan M. Quinn, Andrea Zumrova, Michelle Marlborough, Roger S. McIntyre (2024). \textit{Psilocybin-assisted psychotherapy for treatment resistant depression: A randomized clinical trial evaluating repeated doses of psilocybin}. Med. [published; OpenAlex]. \href{https://doi.org/10.1016/j.medj.2024.01.005}{doi:10.1016/j.medj.2024.01.005}.
\item Shenvi RA. (2024). \textit{Natural Product Synthesis in the 21st Century: Beyond the Mountain Top.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/acscentsci.3c01518}{doi:10.1021/acscentsci.3c01518}.
\item Kargbo RB. (2024). \textit{Pioneering Methods in Brain Optimization and Mental Health Treatment.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/acsmedchemlett.4c00058}{doi:10.1021/acsmedchemlett.4c00058}.
\item Hatzipantelis CJ, Olson DE (2024). \textit{The Effects of Psychedelics on Neuronal Physiology.}. Annual review of physiology. [published; PubMed]. \href{https://doi.org/10.1146/annurev-physiol-042022-020923}{doi:10.1146/annurev-physiol-042022-020923}.
\item Silverstein BH, Kolbman N, Nelson A, Liu T, Guzzo P, Gilligan J, Lee U, Mashour GA, Vanini G, Pal D. (2024). \textit{Psilocybin induces dose-dependent changes in functional network organization in rat cortex}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2024.02.09.579718}{doi:10.1101/2024.02.09.579718}.
\item Yale University (2024). \textit{Repeat Dosing of Psilocybin in Headache Disorders}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT04218539}{source link}.
\item Broc A. Pagni, Petros Petridis, Samantha K. Podrebarac, Jack Grinband, Eric D. Claus, Michael P. Bogenschutz (2024). \textit{Psilocybin-induced changes in neural reactivity to alcohol and emotional cues in patients with alcohol use disorder: an fMRI pilot study}. Scientific Reports. [published; OpenAlex]. \href{https://doi.org/10.1038/s41598-024-52967-8}{doi:10.1038/s41598-024-52967-8}.
\item Joseph J. Palamar, Nicole D. Fitzgerald, Thomas H. Carr, Caroline Rutherford, Katherine M. Keyes, Linda B. Cottler (2024). \textit{National and regional trends in seizures of shrooms (psilocybin) in the United States, 2017-2022}. Drug and Alcohol Dependence. [published; OpenAlex]. \href{https://doi.org/10.1016/j.drugalcdep.2024.111086}{doi:10.1016/j.drugalcdep.2024.111086}.
\item Joost J. Breeksema, Alistair Niemeijer, Erwin Krediet, T.L. Karsten, Jeanine Kamphuis, Eric Vermetten, Wim van den Brink, Robert A. Schoevers (2024). \textit{Patient perspectives and experiences with psilocybin treatment for treatment-resistant depression: a qualitative study}. Scientific Reports. [published; OpenAlex]. \href{https://doi.org/10.1038/s41598-024-53188-9}{doi:10.1038/s41598-024-53188-9}.
\item Julian D. Sandbrink, Kyle Johnson, Maureen Gill, David B. Yaden, Julian Savulescu, Ivar R. Hannikainen, Brian D. Earp (2024). \textit{Strong Bipartisan Support for Controlled Psilocybin Use as Treatment or Enhancement in a Representative Sample of US Americans: Need for Caution in Public Policy Persists}. AJOB Neuroscience. [published; OpenAlex]. \href{https://doi.org/10.1080/21507740.2024.2303154}{doi:10.1080/21507740.2024.2303154}.
\item Dong L, Li L, Wu Y, Zhao X, Zhong H, Cheng X, Liu L, Cheng C, Ouyang M, Tao L. (2024). \textit{A Systematic Review of Interventions for Demoralization in Patients with Chronic Diseases.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s12529-024-10262-w}{doi:10.1007/s12529-024-10262-w}.
\item Rogers SA, Heller EA, Corder G. (2024). \textit{Psilocybin-enhanced fear extinction linked to bidirectional modulation of cortical ensembles}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2024.02.04.578811}{doi:10.1101/2024.02.04.578811}.
\item Johns Hopkins University (2024). \textit{A Randomized, Double-Blind Study of Psilocybin for Opioid Use Disorder in Patients on Methadone Maintenance With Ongoing Opioid Use}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05242029}{source link}.
\item Thomas Müller (2024). \textit{Psilocybin gegen Depressionen}. CME. [published; OpenAlex]. \href{https://doi.org/10.1007/s11298-023-3754-y}{doi:10.1007/s11298-023-3754-y}.
\item Sara De Martin, Daniela Gabbia, Martina Colognesi, Andrea Rinaldi, Luciano Cascione, Ilaria Zanotto, Katia Sayaf, Stefano Comai, Andrea Mattarei, Marco Banzato, Gianfranco Pasut, Franco Folli, Lucia Centofanti, Sergio Traversa, M. Pappagallo, Paolo L. Manfredi (2024). \textit{Non-psychedelic doses of psilocybin as a novel therapeutic approach for MASLD}. Digestive and Liver Disease. [published; OpenAlex]. \href{https://doi.org/10.1016/j.dld.2024.01.104}{doi:10.1016/j.dld.2024.01.104}.
\item Alexandra Le Bras (2024). \textit{Effect of psilocybin on pain}. Lab Animal. [published; OpenAlex]. \href{https://doi.org/10.1038/s41684-024-01323-4}{doi:10.1038/s41684-024-01323-4}.
\item Borissova A, Rucker JJ. (2024). \textit{The development of psilocybin therapy for treatment-resistant depression: an update.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1192/bjb.2023.25}{doi:10.1192/bjb.2023.25}.
\item Sicignano D, Hernandez AV, Schiff B, Elmahy N, White CM (2024). \textit{The impact of psychedelics on patients with alcohol use disorder: a systematic review with meta-analysis.}. Current medical research and opinion. [published; PubMed]. \href{https://doi.org/10.1080/03007995.2023.2296968}{doi:10.1080/03007995.2023.2296968}.
\item Cho M, Rosenbaum D, Schneider E, Hales S. (2024). \textit{Letter to the Editor: Will Psilocybin-Assisted Therapy Reduce the Incidence of Medical Assistance in Dying?}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1089/jpm.2023.0668}{doi:10.1089/jpm.2023.0668}.
\item Holze F, Singh N, Liechti ME, D'Souza DC. (2024). \textit{Serotonergic Psychedelics: A Comparative Review of Efficacy, Safety, Pharmacokinetics, and Binding Profile.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.bpsc.2024.01.007}{doi:10.1016/j.bpsc.2024.01.007}.
\item Houman Farzin (2024). \textit{Psilocybin-assisted psychotherapy for cancer patients}. International Journal of Whole Person Care. [published; OpenAlex]. \href{https://doi.org/10.26443/ijwpc.v11i1.390}{doi:10.26443/ijwpc.v11i1.390}.
\item Esmaeel Ghasemi Gojani, Bo Wang, Dongping Li, Olga Kovalchuk, Igor Kovalchuk (2024). \textit{The Impact of Psilocybin on High Glucose/Lipid-Induced Changes in INS-1 Cell Viability and Dedifferentiation}. Genes. [published; OpenAlex]. \href{https://doi.org/10.3390/genes15020183}{doi:10.3390/genes15020183}.
\item Esmaeel Ghasemi Gojani, Bo Wang, Dongping Li, Olga Kovalchuk, Igor Kovalchuk (2024). \textit{The Effects of Psilocybin on Lipopolysaccharide-Induced Inflammation in THP-1 Human Macrophages}. Psychoactives. [published; OpenAlex]. \href{https://doi.org/10.3390/psychoactives3010004}{doi:10.3390/psychoactives3010004}.
\item Timur Zanikov, Marta Gerasymchuk, Gregory Ian Robinson, Esmaeel Ghasemi Gojani, Shima Asghari, Alyssa Groves, Mackenzie Cameron, Rocio Rodriguez-Juarez, Alexandra Snelling, Darryl Hudson, Anna Fiselier, Olga Kovalchuk, Igor Kovalchuk (2024). \textit{Psilocybin and eugenol prevent DSS-induced neuroinflammation in mice}. Biocatalysis and Agricultural Biotechnology. [published; OpenAlex]. \href{https://doi.org/10.1016/j.bcab.2024.103033}{doi:10.1016/j.bcab.2024.103033}.
\item University Hospital, Basel, Switzerland (2024). \textit{Comparative Acute Effects of LSD, Psilocybin and Mescaline in a Random-Order Placebo-Controlled Cross-Over Study in Healthy Subjects}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT04227756}{source link}.
\item Massachusetts General Hospital (2024). \textit{The Effects of Psilocybin on Self-Focus and Self-Related Processing in Treatment Resistant MDD}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05381974}{source link}.
\item Louis Plourde, Sue-Ling Chang, Houman Farzin, Pierre Gagnon, Johanne Hébert, Robert Foxman, P. Deschamps, François Provost, Marianne Masse-Grenier, Jean-François Stephan, Katherine Cheung, Yann Joly, Jean-Sébastien Fallu, Michel Dorval, for the P3A Study Group (2024). \textit{Social acceptability of psilocybin-assisted therapy for existential distress at the end of life: A population-based survey}. Palliative Medicine. [published; OpenAlex]. \href{https://doi.org/10.1177/02692163231222430}{doi:10.1177/02692163231222430}.
\item Balázs Szigeti, Brandon Weiss, Fernando E. Rosas, David Erritzøe, David Nutt, Robin Carhart-Harris (2024). \textit{Assessing expectancy and suggestibility in a trial of escitalopram v. psilocybin for depression}. Psychological Medicine. [published; OpenAlex]. \href{https://doi.org/10.1017/s0033291723003653}{doi:10.1017/s0033291723003653}.
\item Brockett AT, Francis NA. (2024). \textit{Psilocybin biphasically modulates cortical and behavioral activity in mice}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2024.01.18.576229}{doi:10.1101/2024.01.18.576229}.
\item Modlin NL, Creed M, Sarang M, Maggio C, Rucker JJ, Williamson V. (2024). \textit{Trauma-Informed Care in Psychedelic Therapy Research: A Qualitative Literature Review of Evidence-Based Psychotherapy Interventions in PTSD and Psychedelic Therapy Across Conditions.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.2147/ndt.s432537}{doi:10.2147/ndt.s432537}.
\item Imperial College London (2024). \textit{Psilocybin in Patients With Fibromyalgia: EEG-measured Brain Biomarkers of Action}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05548075}{source link}.
\item Bouchet L, Sager Z, Yrondi A, Nigam KB, Anderson BT, Ross S, Petridis PD, Beaussant Y. (2024). \textit{Older adults in psychedelic-assisted therapy trials: A systematic review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811231215420}{doi:10.1177/02698811231215420}.
\item Zahra Ghofrani-Jahromi, Sarah Nouri-Darehno, Mehrsa Rahimi-Danesh, Nastaran Talaee, Eghbal Jasemi, Ali Razmi, Salar Vaseghi (2024). \textit{Psilocybe cubensis extract potently prevents fear memory recall and freezing behavior in short- but not long-term in a rat model of posttraumatic stress disorder.}. Behavioral Neuroscience. [published; OpenAlex]. \href{https://doi.org/10.1037/bne0000579}{doi:10.1037/bne0000579}.
\item Wong S, Kwan ATH, Teopiz KM, Le GH, Meshkat S, Ho R, d'Andrea G, Cao B, Di Vincenzo JD, Rosenblat JD, McIntyre RS. (2024). \textit{A comparison between psilocybin and esketamine in treatment-resistant depression using number needed to treat (NNT): A systematic review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jad.2024.01.142}{doi:10.1016/j.jad.2024.01.142}.
\item Kelsey Klute, Lou Lukas, Soonjo Hwang, Yeongjin Gwon, Mridula Krishnan, Jean L. Grem, Sunil R. Hingorani, Jody Koenig Kellas (2024). \textit{Abstract C001: A pilot study of palliadelic treatment with psilocybin to reduce psychological distress and improve quality of life in patients with advanced pancreatic adenocarcinoma}. Cancer Research. [published; OpenAlex]. \href{https://doi.org/10.1158/1538-7445.panca2023-c001}{doi:10.1158/1538-7445.panca2023-c001}.
\item Kaadt E, Søkilde R, Hansen H, Raval N, Lundgaard L, Just J, Knudsen G, Elfving B. (2024). \textit{MicroRNAs underlying the antidepressant effect of psilocybin - Establishing an nCounter pipeline for microRNA-quantification in the pig brain}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-3787179/v1}{doi:10.21203/rs.3.rs-3787179/v1}.
\item Rouaud A, Calder AE, Hasler G. (2024). \textit{Microdosing psychedelics and the risk of cardiac fibrosis and valvulopathy: Comparison to known cardiotoxins.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811231225609}{doi:10.1177/02698811231225609}.
\item Jørgen Østensjø (2024). \textit{Psilocybin virker godt mot depresjon}. Tidsskrift for Den norske legeforening. [published; OpenAlex]. \href{https://doi.org/10.4045/tidsskr.23.0712}{doi:10.4045/tidsskr.23.0712}.
\item Swanson L, Jungers S, Varghese R, Cullen KR, Evans MD, Nielson J, Schallmo M. (2024). \textit{Enhanced visual contrast suppression during peak psilocybin effects: A psychophysical study}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/5rm62}{doi:10.31234/osf.io/5rm62}.
\item Unknown authors (2024). \textit{Enhanced visual contrast suppression during peak psilocybin effects: A psychophysical study}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/5rm62\_v1}{source link}.
\item E-Wen McCulloch D, Liechti ME, Kuypers KP, Nutt D, Lundberg J, Stenbæk DS, Goodwin GM, Gründer G, Butlen-Ducuing F, Haberkamp M, Thirstrup S, Knudsen GM. (2024). \textit{Knowledge gaps in psychedelic medicalisation: Clinical studies and regulatory aspects.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.nsa.2024.103938}{doi:10.1016/j.nsa.2024.103938}.
\item Felicia Reed, Claire J. Foldi (2024). \textit{Do the therapeutic effects of psilocybin involve actions in the gut?}. Trends in Pharmacological Sciences. [published; OpenAlex]. \href{https://doi.org/10.1016/j.tips.2023.12.007}{doi:10.1016/j.tips.2023.12.007}.
\item Terence H. W. Ching, Lucia Amoroso, Calvin Bohner, Elizabeth J. D’Amico, Jeffrey Eilbott, Tara Entezar, Madison Fitzpatrick, Geena Fram, Rachael Grazioplene, Jamila Hokanson, Anastasia Jankovsky, Stephen A. Kichuk, Bradford Martins, Prerana Patel, Henry Schaer, Sarah Shnayder, Chelsea Witherow, Christopher Pittenger, Benjamin Kelmendi (2024). \textit{Safety, feasibility, tolerability, and clinical effects of repeated psilocybin dosing combined with non-directive support in the treatment of obsessive-compulsive disorder: protocol for a randomized, waitlist-controlled trial with blinded ratings}. Frontiers in Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.3389/fpsyt.2023.1278823}{doi:10.3389/fpsyt.2023.1278823}.
\item N. Jones, Laura M. Wagner, Molly C. Pellitteri Hahn, Cameron O. Scarlett, Cody J. Wenthur (2024). \textit{In vivo validation of psilacetin as a prodrug yielding modestly lower peripheral psilocin exposure than psilocybin}. Frontiers in Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.3389/fpsyt.2023.1303365}{doi:10.3389/fpsyt.2023.1303365}.
\item Huang Z, Wei X, Wang Y, Tian J, Dong J, Liang B, Lu L, Zhang W. (2024). \textit{Psilocybin Promotes Cell-Type-Specific Changes in the Orbitofrontal Cortex Revealed by Single-Nucleus RNA-seq}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2024.01.07.573163}{doi:10.1101/2024.01.07.573163}.
\item L. Richter, Jozef Al-Gousous, Gabriel Lima Barros de Araújo, Neal M. Davies, Raimar Löbenberg (2024). \textit{Assessing the utility of in silico tools in early drug development: The case of a pharmaceutically relevant formulation of the prodrug psilocybin}. Journal of Drug Delivery Science and Technology. [published; OpenAlex]. \href{https://doi.org/10.1016/j.jddst.2023.105305}{doi:10.1016/j.jddst.2023.105305}.
\item Haakon B. Benestad (2024). \textit{Usikker effekt av psilocybin ved anoreksi}. Tidsskrift for Den norske legeforening. [published; OpenAlex]. \href{https://doi.org/10.4045/tidsskr.23.0734}{doi:10.4045/tidsskr.23.0734}.
\item Johns Hopkins University (2024). \textit{Safety and Tolerability of Psilocybin in Post-Traumatic Stress Disorder}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05562973}{source link}.
\item Shore R, Dobson K, Thomson N, Barnim N, Bergman H, Rideout K, McKeown S, Olmstead MC, Goldie C, Dumont E. (2024). \textit{Behavioural Investigations of Psilocybin in Animals 1962-2021: A Scoping Review}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2024.01.04.574146}{doi:10.1101/2024.01.04.574146}.
\item Devon Stoliker, Leonardo Novelli, Franz X. Vollenweider, Gary F. Egan, Katrin H. Preller, Adeel Razi (2024). \textit{Neural Mechanisms of Resting-State Networks and the Amygdala Underlying the Cognitive and Emotional Effects of Psilocybin}. Biological Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.biopsych.2024.01.002}{doi:10.1016/j.biopsych.2024.01.002}.
\item Vanderijst L, Hever F, Buot A, Dauré C, Benoit J, Hanak C, Veeser J, Morgiève M, Campanella S, Kornreich C, Mallet L, Leys C, Noël X. (2024). \textit{Psilocybin-Assisted Therapy for Severe Alcohol Use Disorder: Protocol for a Double-Blind, Randomized, Placebo-Controlled, 7-month Parallel-Group Phase II Superiority Trial}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-3829237/v1}{doi:10.21203/rs.3.rs-3829237/v1}.
\item Douglas Funk, Joseph A. Araujo, Malik Slassi, James Lanthier, Jason Atkinson, Daniel Feng, Winnie Lau, Anh Lê, Guy A. Higgins (2024). \textit{Effect of a single psilocybin treatment on Fos protein expression in male rat brain}. Neuroscience. [published; OpenAlex]. \href{https://doi.org/10.1016/j.neuroscience.2024.01.001}{doi:10.1016/j.neuroscience.2024.01.001}.
\item Barajas, Carlos (2023). \textit{Psilocybin’s Role in Major Depressive Disorder: A Scoping Review}. Digital Commons - George Fox University (George Fox University). [published; OpenAlex]. \href{https://digitalcommons.georgefox.edu/dmsc/31}{source link}.
\item R.S. Treviranus, Gottfried (2023). \textit{RAPIDLY TRADING DOWN DEPRESSION'S3 PILLARS TO 5HT3-RECEPTORS THROUGH ECT OR PSILOCYBIN?}. University of Zagreb University Computing Centre (SRCE). [published; OpenAlex]. \href{https://doi.org/10.24869/psyd.2024.134}{doi:10.24869/psyd.2024.134}.
\item Sebastiaan Werten (2023). \textit{Referee report. For: A whole genome atlas of 81 Psilocybe genomes as a resource for psilocybin production. [version 2; peer review: 1 approved with reservations, 1 not approved]}. Faculty of 1000 Research Ltd. [published; OpenAlex]. \href{https://doi.org/10.5256/f1000research.80786.r276698}{doi:10.5256/f1000research.80786.r276698}.
\item Manoj K. Doss (2023). \textit{Referee report. For: Probing the functional magnetic resonance imaging response to psilocybin in functional neurological disorder (PsiFUND): study protocol [version 1; peer review: 2 approved with reservations]}. Faculty of 1000 Research Ltd. [published; OpenAlex]. \href{https://doi.org/10.21956/wellcomeopenres.24838.r96124}{doi:10.21956/wellcomeopenres.24838.r96124}.
\item Rayyan Zafar (2023). \textit{Referee report. For: Probing the functional magnetic resonance imaging response to psilocybin in functional neurological disorder (PsiFUND): study protocol [version 1; peer review: 1 approved, 3 approved with reservations]}. Faculty of 1000 Research Ltd. [published; OpenAlex]. \href{https://doi.org/10.21956/wellcomeopenres.24838.r96127}{doi:10.21956/wellcomeopenres.24838.r96127}.
\item Manesh Girn (2023). \textit{Referee report. For: Probing the functional magnetic resonance imaging response to psilocybin in functional neurological disorder (PsiFUND): study protocol [version 1; peer review: 1 approved with reservations]}. Faculty of 1000 Research Ltd. [published; OpenAlex]. \href{https://doi.org/10.21956/wellcomeopenres.24838.r93854}{doi:10.21956/wellcomeopenres.24838.r93854}.
\item Lorenzo Pasquini (2023). \textit{Referee report. For: Probing the functional magnetic resonance imaging response to psilocybin in functional neurological disorder (PsiFUND): study protocol [version 1; peer review: 3 approved with reservations]}. Faculty of 1000 Research Ltd. [published; OpenAlex]. \href{https://doi.org/10.21956/wellcomeopenres.24838.r95501}{doi:10.21956/wellcomeopenres.24838.r95501}.
\item Bridget Verhaaren (2023). \textit{Panini and Psilocybin}. Dialogue A Journal of Mormon Thought. [published; OpenAlex]. \href{https://doi.org/10.5406/15549399.57.4.08}{doi:10.5406/15549399.57.4.08}.
\item Matthew B. Young, J. Chai-Rees, Anna Nowakowska, Jeng-Yu Tsai, Guy M. Goodwin (2023). \textit{Changes in positive and negative affect in participants with treatment-resistant depression following COMP360 psilocybin treatment}. Neuroscience Applied. [published; OpenAlex]. \href{https://doi.org/10.1016/j.nsa.2024.104163}{doi:10.1016/j.nsa.2024.104163}.
\item Thomas Barba, David Erritzøe, Kyle T. Greenway, Rinki Murphy, John Martell, Christopher Timmermann, Ashleigh Murphy-Beiner, Bruna Giribaldi, Michelle Baker Jones, Brandon Weiss, Robin Carhart-Harris (2023). \textit{Psilocybin vs Escitalopram for depression: 6-month follow-up}. Neuroscience Applied. [published; OpenAlex]. \href{https://doi.org/10.1016/j.nsa.2024.104377}{doi:10.1016/j.nsa.2024.104377}.
\item Kristoffer Brendstrup-Brix, Patrick M. Fisher, Dea Siggaard Stenbæk, Anja Sofie Petersen, Stéphane Armand, Drummond E-Wen McCulloch, Maja Rou Marstrand-Joergensen, Sara Marie Ulv Larsen, Annette Johansen, Rigmor Jensen, Gitte M. Knudsen, M. Madsen (2023). \textit{Effects of psilocybin and sleep quality on brain water diffusivity and microstructure in healthy individuals and chronic cluster headache patients}. Neuroscience Applied. [published; OpenAlex]. \href{https://doi.org/10.1016/j.nsa.2024.105131}{doi:10.1016/j.nsa.2024.105131}.
\item C. Schmitz, Hana Adolphi, Michael Frank, E. Seeger, Maciej Musiał, Moritz Spangemacher, Michael Koslowski, Lea J. Mertens, Florian Schlagenhauf, Gerhard Gründer (2023). \textit{Neural effects of psilocybin-treatment in patients with treatment-resistant depression}. Neuroscience Applied. [published; OpenAlex]. \href{https://doi.org/10.1016/j.nsa.2024.105028}{doi:10.1016/j.nsa.2024.105028}.
\item Kyna-Anne Conn, Laura K Milton, Kaixin Huang, Hermany Munguba, Jaana Ruuska, Mónica Lemus, Erin Greaves, Jihane Homman-Ludiye, Brian J. Oldfield, Claire J. Foldi (2023). \textit{Insights into the serotonergic mechanisms of psilocybin-induced improvements in anorexia-like behaviour in female rats}. Neuroscience Applied. [published; OpenAlex]. \href{https://doi.org/10.1016/j.nsa.2024.104774}{doi:10.1016/j.nsa.2024.104774}.
\item L. Belinger, Flora Moujaes, Robin von Rotz, Nathalie M. Rieser, Marcus Herdener, Franz X. Vollenweider, Katrin H. Preller (2023). \textit{Associations between behavioral and neuronal changes in self-referential processing following a single, moderate dose of psilocybin in depressed patients}. Neuroscience Applied. [published; OpenAlex]. \href{https://doi.org/10.1016/j.nsa.2024.104768}{doi:10.1016/j.nsa.2024.104768}.
\item Nerea Martínez-Álvarez, Ines Erkizia-Santamaría, Elena Hernández-Hernández, Amaia M. Erdozain, J. Javier Meana, J.E. Ortega (2023). \textit{Evaluation of the long-term cognitive effects of psilocybin in a chronic stress mouse model}. Neuroscience Applied. [published; OpenAlex]. \href{https://doi.org/10.1016/j.nsa.2024.104783}{doi:10.1016/j.nsa.2024.104783}.
\item Unknown authors (2023). \textit{Government-funded trial will test psilocybin as treatment for opioid use disorder}. Pharmaceutical journal/The pharmaceutical journal. [published; OpenAlex]. \href{https://doi.org/10.1211/pj.2024.1.335169}{doi:10.1211/pj.2024.1.335169}.
\item Tessa Watford (2023). \textit{The Therapeutic Potential of Psilocybin for Depression}. Unknown journal. [published; OpenAlex]. \href{https://doi.org/10.33548/scientia1082}{doi:10.33548/scientia1082}.
\item Unknown authors (2023). \textit{Psilocybin may be as effective as escitalopram in treating depression, study suggests}. Pharmaceutical journal/The pharmaceutical journal. [published; OpenAlex]. \href{https://doi.org/10.1211/pj.2024.1.327949}{doi:10.1211/pj.2024.1.327949}.
\item Elena Markos (2023). \textit{Cannabis and Psilocybin: Insurance Reimbursement, Legalization, and Rescheduling}. Health Law Outlook. [published; OpenAlex]. \href{https://doi.org/10.60095/gatb5689}{doi:10.60095/gatb5689}.
\item Agata Korlatowicz, Katarzyna Latocha, Paulina Pabian, Ryszard Bugno, Adam S. Hogendorf, Tamás Kovács, Andrzej J. Bojarski, Zoltán V. Varga, Agata Faron-Górecka (2023). \textit{Exploring the molecular basis of treatment-resistant depression: Discoveries from a rat model and psilocybin therapy}. Neuroscience Applied. [published; OpenAlex]. \href{https://doi.org/10.1016/j.nsa.2024.104020}{doi:10.1016/j.nsa.2024.104020}.
\item Correa RMS (2023). \textit{Psychedelic Mushrooms: The Use of Psilocybin in the Treatment of Mental Disorders}. Annals of Bioethics \& Clinical Applications. [published; OpenAlex]. \href{https://doi.org/10.23880/abca-16000266}{doi:10.23880/abca-16000266}.
\item N. Hewitt, J. Chai-Rees, Megan Croal, S. Mistry, Jeng-Yu Tsai, Matthew B. Young, Guy M. Goodwin (2023). \textit{Investigational COMP360 psilocybin treatment for treatment-resistant depression: assessing altered states of consciousness}. Neuroscience Applied. [published; OpenAlex]. \href{https://doi.org/10.1016/j.nsa.2024.104391}{doi:10.1016/j.nsa.2024.104391}.
\item Rakesh Khanna (2023). \textit{Psilocybin for the treatment of posttraumatic stress disorder: A magic to treat a harmony of illusions?}. Journal of Indira Gandhi Institute Of Medical Sciences. [published; OpenAlex]. \href{https://doi.org/10.4103/jigims.jigims\_60\_23}{doi:10.4103/jigims.jigims\_60\_23}.
\item Ewald Kolesnik, Ma Luisa Masó Navarro, Nakul Ravi Raval, Brice Ozenne, Hanne D. Hansen (2023). \textit{Pharmacological characterization of psilocin affinity towards different 5-HT receptors and receptor regulation after psilocybin administration in pigs}. Neuroscience Applied. [published; OpenAlex]. \href{https://doi.org/10.1016/j.nsa.2024.105133}{doi:10.1016/j.nsa.2024.105133}.
\item Gukasyan N, Narayan SK (2023). \textit{Menstrual Changes and Reversal of Amenorrhea Induced by Classic Psychedelics: A Case Series.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2022.2157350}{doi:10.1080/02791072.2022.2157350}.
\item Jacobs E, Murphy-Beiner A, Rouiller I, Nutt D, Spriggs MJ (2023). \textit{When the Trial Ends: The Case for Post-Trial Provisions in Clinical Psychedelic Research.}. Neuroethics. [published; PubMed]. \href{https://doi.org/10.1007/s12152-023-09536-z}{doi:10.1007/s12152-023-09536-z}.
\item Nutt DJ, Peill JM, Weiss B, Godfrey K, Carhart-Harris RL, Erritzoe D. (2023). \textit{Psilocybin and Other Classic Psychedelics in Depression.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/7854\_2023\_451}{doi:10.1007/7854\_2023\_451}.
\item Jerotic K, Vuust P, Kringelbach ML (2023). \textit{Psychedelia: The interplay of music and psychedelics.}. Annals of the New York Academy of Sciences. [published; PubMed]. \href{https://doi.org/10.1111/nyas.15082}{doi:10.1111/nyas.15082}.
\item Yaden DB, Berghella AP, Hendricks PS, Yaden ME, Levine M, Rohde JS, Nayak S, Johnson MW, Garcia-Romeu A (2023). \textit{IUPHAR-review: The integration of classic psychedelics into current substance use disorder treatment models.}. Pharmacological research. [published; PubMed]. \href{https://doi.org/10.1016/j.phrs.2023.106998}{doi:10.1016/j.phrs.2023.106998}.
\item Simonsson O, Hendricks PS, Stenfors CU, Goldberg SB, Honk L, Osika W (2023). \textit{Longitudinal associations between psychedelic use and unusual visual experiences in the United States and the United Kingdom.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811231218931}{doi:10.1177/02698811231218931}.
\item O'Donnell KC, Anderson BT, Barrett FS, Bogenschutz MP, Grob CS, Hendricks PS, Kelmendi B, Nayak SM, Nicholas CR, Paleos CA, Stauffer CS, Gukasyan N. (2023). \textit{Misinterpretations and Omissions: A Critical Response to Goodwin and Colleagues' Commentary on Psilocybin-Assisted Therapy.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1176/appi.ajp.20230661}{doi:10.1176/appi.ajp.20230661}.
\item Schenberg EE, King F, da Fonseca JE, Roseman L. (2023). \textit{Is Poorly Assisted Psilocybin Treatment an Increasing Risk?}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1176/appi.ajp.20230664}{doi:10.1176/appi.ajp.20230664}.
\item Earleywine M, De Leo J, Bhayana D, Rajanna B, Scott K. (2023). \textit{Psilocybin Without Psychotherapy: A Cart Without a Horse?}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1176/appi.ajp.20230572}{doi:10.1176/appi.ajp.20230572}.
\item Goodwin GM, Malievskaia E, Fonzo GA, Nemeroff CB. (2023). \textit{Psychological Support for Psilocybin Treatment: Reply to Letters on Our Commentary.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1176/appi.ajp.20230905}{doi:10.1176/appi.ajp.20230905}.
\item Smith WR, Sisti DA, Appelbaum PS. (2023). \textit{The safety of supported psilocybin use in Oregon.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41591-023-02727-4}{doi:10.1038/s41591-023-02727-4}.
\item M. Madsen, Anja Sofie Petersen, Dea Siggaard Stenbæk, Inger Marie Sørensen, Harald Schiønning, Tobias Fjeld, Charlotte H. Nykjær, Sara Marie Ulv Larsen, Maria Zofia Grzywacz, Tobias Mathiesen, Ida L. Klausen, Oliver Overgaard-Hansen, Kristoffer Brendstrup-Brix, Kristían Línnet, Sys Stybe Johansen, Patrick M. Fisher, Rigmor Jensen, Gitte M. Knudsen (2023). \textit{CCH attack frequency reduction after psilocybin correlates with hypothalamic functional connectivity}. Headache The Journal of Head and Face Pain. [published; OpenAlex]. \href{https://doi.org/10.1111/head.14656}{doi:10.1111/head.14656}.
\item Zaretsky TG, Jagodnik KM, Barsic R, Antonio JH, Bonanno PA, MacLeod C, Pierce C, Carney H, Morrison MT, Saylor C, Danias G, Lepow L, Yehuda R. (2023). \textit{The Psychedelic Future of Post-Traumatic Stress Disorder Treatment.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.2174/1570159x22666231027111147}{doi:10.2174/1570159x22666231027111147}.
\item Olivier B, Olivier JDA. (2023). \textit{Efficacy, Safety, and Tolerability of Psychedelics in Treatment-Resistant Depression (TRD).}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/978-981-97-4402-2\_3}{doi:10.1007/978-981-97-4402-2\_3}.
\item Martire G, Sipple D, Baron D, Gold MS, Lewandowski KU, Dennen CA, Sharafshah A, Elman I, Thanos PK, Modestino EJ, Badgaiyan RD, Pinhasov A, Bowirrat A, Makale M, Roy AK, Sunder K, Murphy KT, Mahajan S, Mahajan Y, Levin C, Blum K (2023). \textit{Theorizing that Psychedelic Assisted Therapy May Play a Role in the Treatment of Trauma-Induced Personality Disorders.}. Journal of addiction psychiatry. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/39634920/}{source link}.
\item Petranker R, Anderson T, Fewster EC, Aberman Y, Hazan M, Gaffrey M, Seli P (2023). \textit{Keeping the promise: a critique of the current state of microdosing research.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2024.1217102}{doi:10.3389/fpsyt.2024.1217102}.
\item Isabelle Straumann, Friederike Holze, A. Becker, Laura Ley, Nepomuk Halter, Matthias E. Liechti (2023). \textit{Safety pharmacology of acute psilocybin administration in healthy participants}. Neuroscience Applied. [published; OpenAlex]. \href{https://doi.org/10.1016/j.nsa.2024.104060}{doi:10.1016/j.nsa.2024.104060}.
\item Marthe Vandevelde, Andreas Simoens, Bavo Vandekerckhove, Christian V. Stevens (2023). \textit{Synthesis and bioactivity of psilocybin analogues containing a stable carbon-phosphorus bond}. RSC Medicinal Chemistry. [published; OpenAlex]. \href{https://doi.org/10.1039/d4md00043a}{doi:10.1039/d4md00043a}.
\item Thomas KL, Jesse R, Mehtani NJ, Mitchell JM, Anderson BT (2023). \textit{Commentary: Evidence-Informed Recommendation to Achieve Approximate Parity in the Allowed Number of Doses for Common Psychedelics.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2023.2201244}{doi:10.1080/02791072.2023.2201244}.
\item Žuljević MF, Breški N, Kaliterna M, Hren D (2023). \textit{Attitudes of European psychiatrists on psychedelics: a qualitative study.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2024.1411234}{doi:10.3389/fpsyt.2024.1411234}.
\item DeBonis K (2023). \textit{Revisiting psychiatry's relationship with spirituality.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2024.1441922}{doi:10.3389/fpsyt.2024.1441922}.
\item Amberger C, Szczesniak L (2023). \textit{[The nursing role in psychedelic-assisted psychotherapy].}. Revue de l'infirmiere. [published; PubMed]. \href{https://doi.org/10.1016/j.revinf.2024.07.014}{doi:10.1016/j.revinf.2024.07.014}.
\item Baeleigh VanderZwaag, Albert Garcia-Romeu, Mauricio A. García-Barrera (2023). \textit{Exploring psychedelic use in athletes and their attitudes toward psilocybin-assisted therapy in concussion recovery}. Therapeutic Advances in Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1177/20451253241264812}{doi:10.1177/20451253241264812}.
\item Karolina Wąsik, Sebastian Tomaszuk, Magda Wojtuś (2023). \textit{Psilocybin - new remedy for patients with psychiatric disorders? Critical analysis of the current state of knowledge}. Journal of Education Health and Sport. [published; OpenAlex]. \href{https://doi.org/10.12775/jehs.2023.50.01.005}{doi:10.12775/jehs.2023.50.01.005}.
\item Sophia Armand, Kristian Larsen, M. Madsen, Brice Ozenne, Katrin H. Preller, Gitte M. Knudsen, Dea Siggaard Stenbæk, Patrick M. Fisher (2023). \textit{Amygdala response to emotional faces following acute administration of psilocybin in healthy individuals}. Neuroscience Applied. [published; OpenAlex]. \href{https://doi.org/10.1016/j.nsa.2023.103934}{doi:10.1016/j.nsa.2023.103934}.
\item Tianran Liu (2023). \textit{The Therapeutic Effect and Potential Application of Psilocybin}. Highlights in Science Engineering and Technology. [published; OpenAlex]. \href{https://doi.org/10.54097/3cfwjn09}{doi:10.54097/3cfwjn09}.
\item Poulin JM, Bigford GE, Lanctot KL, Giacobbe P, Schaffer A, Sinyor M, Rabin JS, Masellis M, Singnurkar A, Pople CB, Lipsman N, MacIntosh BJ, Nestor SM. (2023). \textit{Engaging Mood Brain Circuits with Psilocybin (EMBRACE): a study protocol for a randomized, proof-of-principle, placebo-controlled and crossover, neuroimaging trial in depression}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-3474764/v1}{doi:10.21203/rs.3.rs-3474764/v1}.
\item Tabaac BJ, Shinozuka K, Arenas A, Beutler BD, Cherian K, Evans VD, Fasano C, Muir OS. (2023). \textit{Psychedelic Therapy: A Primer for Primary Care Clinicians - Part I. Historical Perspective and Overview}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/byms6}{doi:10.31234/osf.io/byms6}.
\item Tabaac BJ, Shinozuka K, Arenas A, Beutler BD, Cherian K, Evans VD, Fasano C, Muir OS. (2023). \textit{Psychedelic Therapy: A Primer for Primary Care Clinicians - Part IV. Psilocybin}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/a8xwk}{doi:10.31234/osf.io/a8xwk}.
\item Multidisciplinary Association for Psychedelic Studies (2023). \textit{Psilocybin-assisted Psychotherapy in the Management of Anxiety Associated With Stage IV Melanoma.}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT00979693}{source link}.
\item Unknown authors (2023). \textit{Psychedelic Therapy: A Primer for Primary Care Clinicians - Part I. Historical Perspective and Overview}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/byms6\_v1}{source link}.
\item Unknown authors (2023). \textit{Psychedelic Therapy: A Primer for Primary Care Clinicians - Part IV. Psilocybin}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/a8xwk\_v1}{source link}.
\item Śladowska K, Kawalec P, Brzostek T, Pilc A. (2023). \textit{Potential use of psilocybin drugs in the treatment of depression.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/14728214.2023.2264180}{doi:10.1080/14728214.2023.2264180}.
\item Paul Fletcher, Zhaoxia Li, Xiao Dong Ji, Anh D. Lê (2023). \textit{Established sensitization of ethanol-induced locomotor activity is not reversed by psilocybin or the 5-HT2A receptor agonist TCB-2 in male DBA/2J mice}. Pharmacology Biochemistry and Behavior. [published; OpenAlex]. \href{https://doi.org/10.1016/j.pbb.2023.173703}{doi:10.1016/j.pbb.2023.173703}.
\item Wojtas A, Gołembiowska K. (2023). \textit{Molecular and Medical Aspects of Psychedelics.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/ijms25010241}{doi:10.3390/ijms25010241}.
\item Munchelou M Gomonit, Britni Skillman, Madeleine J. Swortwood (2023). \textit{Quantification of psilocin in human whole blood using liquid chromatography-tandem mass spectrometry (LC-MS/MS)}. Journal of Forensic Sciences. [published; OpenAlex]. \href{https://doi.org/10.1111/1556-4029.15454}{doi:10.1111/1556-4029.15454}.
\item Jingxuan Chen (2023). \textit{Application of psilocybin in mental health disorders}. Theoretical and Natural Science. [published; OpenAlex]. \href{https://doi.org/10.54254/2753-8818/21/20230859}{doi:10.54254/2753-8818/21/20230859}.
\item Nogueira GN, Vasconcelos MMA, Souza FGM, Bisol LW. (2023). \textit{Is there credible evidence to assert psilocybin-assisted therapy for depression?}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.euroneuro.2023.11.003}{doi:10.1016/j.euroneuro.2023.11.003}.
\item Shah FI, Shehzadi S, Akram F, Haq IU, Javed B, Sabir S, Kazim Y, Ashfaq S. (2023). \textit{Unveiling the Psychedelic Journey: An Appraisal of Psilocybin as a Profound Antidepressant Therapy.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s12033-023-00994-7}{doi:10.1007/s12033-023-00994-7}.
\item Trevor Steward (2023). \textit{Endocrinology-informed neuroimaging in eating disorders: GLP1, orexins, and psilocybin}. Trends in Molecular Medicine. [published; OpenAlex]. \href{https://doi.org/10.1016/j.molmed.2023.12.001}{doi:10.1016/j.molmed.2023.12.001}.
\item Roman Goff, Morgan Smith, Sabrina Islam, Sue Sisley, J. W. Ferguson, Scott Kuzdzal, Sunil Badal, Arun Kumar, Uma Sreenivasan, Kevin A. Schug (2023). \textit{Determination of psilocybin and psilocin content in multiple Psilocybe cubensis mushroom strains using liquid chromatography - tandem mass spectrometry}. Analytica Chimica Acta. [published; OpenAlex]. \href{https://doi.org/10.1016/j.aca.2023.342161}{doi:10.1016/j.aca.2023.342161}.
\item Yvan Beaussant, Elise C. Tarbi, Kabir Nigam, Skye A. Miner, Zachary Sager, Justin J. Sanders, Michael Ljuslin, Benjamin Guérin, Paul Thambi, James A. Tulsky, Manish Agrawal (2023). \textit{Acceptability of psilocybin-assisted group therapy in patients with cancer and major depressive disorder: Qualitative analysis}. Cancer. [published; OpenAlex]. \href{https://doi.org/10.1002/cncr.35024}{doi:10.1002/cncr.35024}.
\item Thrul J, Kozak Z, Carducci MA, Garcia-Romeu A, Yaden DB. (2023). \textit{Innovations in group-based psilocybin-assisted therapy of major depression in patients with cancer.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1002/cncr.35127}{doi:10.1002/cncr.35127}.
\item Manish Agrawal, William A. Richards, Yvan Beaussant, Sarah Shnayder, Rezvan Ameli, Kimberly Roddy, Norma Stevens, Brian D. Richards, Nick Schor, Heather Honstein, Betsy Jenkins, Mark Bates, Paul Thambi (2023). \textit{Psilocybin-assisted group therapy in patients with cancer diagnosed with a major depressive disorder}. Cancer. [published; OpenAlex]. \href{https://doi.org/10.1002/cncr.35010}{doi:10.1002/cncr.35010}.
\item Yale University (2023). \textit{Safety and Efficacy of Psilocybin for the Treatment of Headache Disorders}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT02981173}{source link}.
\item Gregory Ian Robinson, Dongping Li, Bo Wang, Tahiat Rahman, Marta Gerasymchuk, Darryl Hudson, Olga Kovalchuk, Igor Kovalchuk (2023). \textit{Psilocybin and Eugenol Reduce Inflammation in Human 3D EpiIntestinal Tissue}. Life. [published; OpenAlex]. \href{https://doi.org/10.3390/life13122345}{doi:10.3390/life13122345}.
\item McCulloch DE, Lopez JP, Dalla C, Castrén E, Erritzoe D, Frokjaer VG, Lundberg J, Preller KH, Fisher PM, Knudsen GM. (2023). \textit{Knowledge gaps in psychedelic medicalisation: Preclinical and neuroimaging mechanisms.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.nsa.2023.103929}{doi:10.1016/j.nsa.2023.103929}.
\item Jonathan Reinwald, Christian N. Schmitz, Ivan Skorodumov, Martin Kuchař, Wolfgang Weber-Fahr, Rainer Spanagel, Marcus W. Meinhardt (2023). \textit{Psilocybin-induced default mode network hypoconnectivity is blunted in alcohol-dependent rats}. Translational Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1038/s41398-023-02690-1}{doi:10.1038/s41398-023-02690-1}.
\item Conn K, Milton L, Huang K, Munguba H, Ruuska J, Lemus M, Greaves E, Homman-Ludiye J, Oldfield B, Foldi C. (2023). \textit{Psilocybin prevents activity-based anorexia in female rats by enhancing cognitive flexibility: contributions from 5-HT1A and 5-HT2A receptor mechanisms}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2023.12.12.571374}{doi:10.1101/2023.12.12.571374}.
\item Brennan W, Kelman AR, Belser AB. (2023). \textit{A Systematic Review of Reporting Practices in Psychedelic Clinical Trials: Psychological Support, Therapy, and Psychosocial Interventions.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1089/psymed.2023.0007}{doi:10.1089/psymed.2023.0007}.
\item Ivana Turek (2023). \textit{Psychotropics: A scientific, regulatory, and public view on the medicinal uses of cannabinoids and psilocybin}. Medical Writing. [published; OpenAlex]. \href{https://doi.org/10.56012/tsen2260}{doi:10.56012/tsen2260}.
\item Nguyên Hà Trần, Đặng Đức Khanh, Phạm Đức Trọng, Nguyễn Xuân Trường (2023). \textit{CHIẾT XUẤT PSILOCIN TỪ NẤM THỨC THẦN LÀM NGUYÊN LIỆU THIẾT LẬP CHUẨN}. Tạp chí Y học Quân sự. [published; OpenAlex]. \href{https://doi.org/10.59459/1859-1655/jmm.282}{doi:10.59459/1859-1655/jmm.282}.
\item Unknown authors (2023). \textit{Drugs for depressionr.}. The Medical letter on drugs and therapeutics. [published; PubMed]. \href{https://doi.org/10.58347/tml.2023.1691a}{doi:10.58347/tml.2023.1691a}.
\item Foster K, Morrison I, Tyler M, Delgoda R. (2023). \textit{The effect of casing and gypsum on the yield and psychoactive tryptamine content of Psilocybe cubensis (Earle) Singer.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.funbio.2023.12.001}{doi:10.1016/j.funbio.2023.12.001}.
\item Starkey J, Carhart-Harris RL, Pigorini A, Nobili L, Barrett AB. (2023). \textit{Statistical diversity distinguishes global states of consciousness}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2023.12.05.570101}{doi:10.1101/2023.12.05.570101}.
\item David B. Yaden, Natalie Gukasyan, Sandeep M. Nayak (2023). \textit{Psilocybin in Bipolar II Study Provides Preliminary Data on Safety}. JAMA Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1001/jamapsychiatry.2023.4680}{doi:10.1001/jamapsychiatry.2023.4680}.
\item Nicoletta Faraone (2023). \textit{Flies on ’Shrooms: Studying the Psychotherapeutic Potential of Psilocybin using Drosophila}. American Entomologist. [published; OpenAlex]. \href{https://doi.org/10.1093/ae/tmad063}{doi:10.1093/ae/tmad063}.
\item Kolasa M, Faron-Górecka A (2023). \textit{Preclinical models of treatment-resistant depression: challenges and perspectives.}. Pharmacological reports: PR. [published; PubMed]. \href{https://doi.org/10.1007/s43440-023-00542-9}{doi:10.1007/s43440-023-00542-9}.
\item Holas P, Kamińska J (2023). \textit{Mindfulness meditation and psychedelics: potential synergies and commonalities.}. Pharmacological reports: PR. [published; PubMed]. \href{https://doi.org/10.1007/s43440-023-00551-8}{doi:10.1007/s43440-023-00551-8}.
\item Gary Ahlskog (2023). \textit{Psilocybin's Erasure of EGO}. The Psychoanalytic Review. [published; OpenAlex]. \href{https://doi.org/10.1521/prev.2023.110.4.457}{doi:10.1521/prev.2023.110.4.457}.
\item Christopher R. Nicholas, David Horton, Julia Malicki, Amelia Baltes, Paul R. Hutson, Randall Brown (2023). \textit{Psilocybin for Opioid Use Disorder in Two Adults Stabilized on Buprenorphine: A Technical Report on Study Modifications and Preliminary Findings}. Psychedelic Medicine. [published; OpenAlex]. \href{https://doi.org/10.1089/psymed.2023.0012}{doi:10.1089/psymed.2023.0012}.
\item Nicholas Kolbman, Tiecheng Liu, Peter R. Guzzo, Jim Gilligan, George A. Mashour, Giancarlo Vanini, Dinesh Pal (2023). \textit{Intravenous psilocybin attenuates mechanical hypersensitivity in a rat model of chronic pain}. Current Biology. [published; OpenAlex]. \href{https://doi.org/10.1016/j.cub.2023.10.016}{doi:10.1016/j.cub.2023.10.016}.
\item Duan W, Cao D, Wang S, Cheng J. (2023). \textit{Serotonin 2A Receptor (5-HT2AR) Agonists: Psychedelics and Non-Hallucinogenic Analogues as Emerging Antidepressants.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/acs.chemrev.3c00375}{doi:10.1021/acs.chemrev.3c00375}.
\item Wang SM, Kim S, Choi WS, Lim HK, Woo YS, Pae CU, Bahk WM. (2023). \textit{Current Understanding on Psilocybin for Major Depressive Disorder: A Review Focusing on Clinical Trials.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.9758/cpn.23.1134}{doi:10.9758/cpn.23.1134}.
\item Apex Labs Ltd. (2023). \textit{A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability and Efficacy of Psilocybin-Assisted Psychotherapy in Treating Severe Depression Among Adults With Post-Traumatic Stress Disorder (PTSD).}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06141876}{source link}.
\item Adam Waldbillig, Maria Baranova, Sarah Neumann, Jonathan Andrade, Sharan Sidhu (2023). \textit{Exploring Psilocybe spp. mycelium and fruiting body chemistry for potential therapeutic compounds}. Frontiers in Fungal Biology. [published; OpenAlex]. \href{https://doi.org/10.3389/ffunb.2023.1295223}{doi:10.3389/ffunb.2023.1295223}.
\item Gattuso JJ, Wilson C, Hannan AJ, Renoir T. (2023). \textit{Psilocybin as a lead candidate molecule in preclinical therapeutic studies of psychiatric disorders: A systematic review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1111/jnc.16017}{doi:10.1111/jnc.16017}.
\item George Danias, Jacob M. Appel (2023). \textit{Public Interest in Psilocybin and Psychedelic Therapy in the Context of the COVID-19 Pandemic: Google Trends Analysis}. JMIR Formative Research. [published; OpenAlex]. \href{https://doi.org/10.2196/43850}{doi:10.2196/43850}.
\item Elena PhD (2023). \textit{Psilocybin shows promise for treating eating disorders, but more controlled research is needed}. Unknown journal. [published; OpenAlex]. \href{https://doi.org/10.64628/aam.jwfsyj9g9}{doi:10.64628/aam.jwfsyj9g9}.
\item van der Schuur-Saleem R, Visser E, Robben H, Zwols M, den Besten-Berthololee D. (2023). \textit{[Feeling unwell after eating a piece of chocolate].}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/38175555}{source link}.
\item Geyer MA. (2023). \textit{A Brief Historical Overview of Psychedelic Research.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.bpsc.2023.11.003}{doi:10.1016/j.bpsc.2023.11.003}.
\item McAlpine R, Krajnović K, Khan M, Morometescu L, Simonsson O, Sacchet M, Kamboj S. (2023). \textit{Development of a Digital Intervention for Psychedelic Preparation (DIPP): a theory- and person-centred approach}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/9ev27}{doi:10.31234/osf.io/9ev27}.
\item Unknown authors (2023). \textit{Development of a Digital Intervention for Psychedelic Preparation (DIPP): a theory- and person-centred approach}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/9ev27\_v1}{source link}.
\item Elizabeth Boudreau, Krissa Orlowski (2023). \textit{Psilocybin therapy to reduce depression following a terminal diagnosis}. JAAPA. [published; OpenAlex]. \href{https://doi.org/10.1097/01.jaa.0000994952.07847.2d}{doi:10.1097/01.jaa.0000994952.07847.2d}.
\item Halman A, Kong G, Sarris J, Perkins D. (2023). \textit{Drug-drug interactions involving classic psychedelics: A systematic review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811231211219}{doi:10.1177/02698811231211219}.
\item McTaggart A, Scarlett K, Slot J, Barlow C, Appleyard C, Gardiner D, Fechner N, Tilden J, Hass D, Voogelbreinder S, Lording W, Lloyd R, Shuey L, Drenth A, James T. (2023). \textit{Wood-loving magic mushrooms from Australia are saprotrophic invaders in the northern hemisphere}. Authorea Preprints. [preprint; Europe PMC]. \href{https://doi.org/10.22541/au.170019739.91075425/v1}{doi:10.22541/au.170019739.91075425/v1}.
\item Hovmand OR, Poulsen ED, Arnfred S. (2023). \textit{Assessment of the acute subjective psychedelic experience: A review of patient-reported outcome measures in clinical research on classical psychedelics.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811231200019}{doi:10.1177/02698811231200019}.
\item Hernandez-Leon A, Escamilla-Orozco RI, Tabal-Robles AR, Martínez-Vargas D, Romero-Bautista L, Escamilla-Soto G, González-Romero OS, Torres-Valencia M, González-Trujano ME. (2023). \textit{Antidepressant- and anxiolytic-like activities and acute toxicity evaluation of the Psilocybe cubensis mushroom in experimental models in mice.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jep.2023.117415}{doi:10.1016/j.jep.2023.117415}.
\item Bahji A, Lunsky I, Gutierrez G, Vazquez G. (2023). \textit{Efficacy and Safety of Four Psychedelic-Assisted Therapies for Adults with Symptoms of Depression, Anxiety, and Posttraumatic Stress Disorder: A Systematic Review and Meta-Analysis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/02791072.2023.2278586}{doi:10.1080/02791072.2023.2278586}.
\item Kamilė Žalkauskaitė, Justina Kirdeikytė, Vilius Ogenskas (2023). \textit{The potential use of psilocybin in psychiatry}. Lithuanian University of Health Sciences. [published; OpenAlex]. \href{https://hdl.handle.net/20.500.12512/239546}{source link}.
\item Schoeller F, Jain A, Adrien V, Maes P, Reggente N. (2023). \textit{Aesthetic Chills Mitigate Maladaptive Cognition In Depression}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-3582420/v1}{doi:10.21203/rs.3.rs-3582420/v1}.
\item Raj P, Rauniyar S, Sapkale B. (2023). \textit{Psychedelic Drugs or Hallucinogens: Exploring Their Medicinal Potential.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.7759/cureus.48719}{doi:10.7759/cureus.48719}.
\item Wolinsky D, Barrett FS, Vandrey R. (2023). \textit{The psychedelic effects of cannabis: A review of the literature.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811231209194}{doi:10.1177/02698811231209194}.
\item COMPASS Pathways (2023). \textit{The Safety and Efficacy Of Psilocybin as an Adjunctive Therapy in Participants With Treatment Resistant Depression}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT04739865}{source link}.
\item Rosas FE, Mediano PA, Timmermann C, Luppi AI, Candia-Rivera D, Abbasi-Asl R, Gazzaley A, Kringelbach ML, Muthukumaraswamy S, Bor D, Garfinkel S, Carhart-Harris RL. (2023). \textit{The entropic heart: Tracking the psychedelic state via heart rate dynamics}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2023.11.07.566008}{doi:10.1101/2023.11.07.566008}.
\item Heresco-Levy U, Lerer B. (2023). \textit{Synergistic psychedelic - NMDAR modulator treatment for neuropsychiatric disorders.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41380-023-02312-8}{doi:10.1038/s41380-023-02312-8}.
\item Elizabeth Sugiarto, Rebecca Leung, Jamie Yuen (2023). \textit{Pharmacists’ perspectives on psilocybin in Canada}. JAPhA Practice Innovations. [published; OpenAlex]. \href{https://doi.org/10.1016/j.japhpi.2023.100003}{doi:10.1016/j.japhpi.2023.100003}.
\item Lucas A. Paul, Cyril T. Namba-Nzanguim, Aidani Telesphory, Jehoshaphat Oppong Mensah, Denis Mteremko, Rene Costa, Saidi Mohamedi Katundu, Lucas P. Kwiyukwa, Naserian Daniel Kambaine, Julius Juvenary, Sixberth Mlowe, Geradius Deogratias, Daniel M. Shadrack, Andrew S. Paluch (2023). \textit{Investigation of the structure, stability, and relative solubility of psilocybin in water and pure organic solvents: A molecular simulation study}. Journal of Molecular Liquids. [published; OpenAlex]. \href{https://doi.org/10.1016/j.molliq.2023.123479}{doi:10.1016/j.molliq.2023.123479}.
\item Chruścicka-Smaga B, Machaczka A, Szewczyk B, Pilc A. (2023). \textit{Interaction of hallucinogenic rapid-acting antidepressants with mGlu2/3 receptor ligands as a window for more effective therapies.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s43440-023-00547-4}{doi:10.1007/s43440-023-00547-4}.
\item Wojtas A. (2023). \textit{The possible place for psychedelics in pharmacotherapy of mental disorders.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s43440-023-00550-9}{doi:10.1007/s43440-023-00550-9}.
\item Madrid-Gambin F, Fabregat-Safont D, Gomez-Gomez A, Olesti E, Mason NL, Ramaekers JG, Pozo OJ. (2023). \textit{Present and future of metabolic and metabolomics studies focused on classical psychedelics in humans.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.biopha.2023.115775}{doi:10.1016/j.biopha.2023.115775}.
\item Ana-Maria Iorgu, Andrei-Nicolae Vasilescu, Natascha Pfeiffer, Rainer Spanagel, Anne Stephanie Mallien, Dragoš Inta, Peter Gass (2023). \textit{Psilocybin does not induce the vulnerability marker HSP70 in neurons susceptible to Olney’s lesions}. European Archives of Psychiatry and Clinical Neuroscience. [published; OpenAlex]. \href{https://doi.org/10.1007/s00406-023-01699-3}{doi:10.1007/s00406-023-01699-3}.
\item Van Der Walt J, Parker R. (2023). \textit{LSD and psilocybin for chronic nociplastic pain: A narrative review of the literature supporting the use of classic psychedelic agents in chronic pain.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.7196/samj.2023.v113i11.814}{doi:10.7196/samj.2023.v113i11.814}.
\item Schäfer E, Seibold PS, Bartram S, Trottmann F, Haensch VG, Gressler M, Chadeayne AR, Hertweck C, O'Connor SE, Hoffmeister D (2023). \textit{A "Magic Mushroom" Multi-Product Sesquiterpene Synthase.}. Chembiochem: a European journal of chemical biology. [published; PubMed]. \href{https://doi.org/10.1002/cbic.202300511}{doi:10.1002/cbic.202300511}.
\item Rhee TG, Davoudian PA, Sanacora G, Wilkinson ST. (2023). \textit{Psychedelic renaissance: Revitalized potential therapies for psychiatric disorders.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.drudis.2023.103818}{doi:10.1016/j.drudis.2023.103818}.
\item Miller DR, Jacobs JT, Rockefeller A, Singer H, Bollinger IM, Conway J, Slot JC, Cliffel DE. (2023). \textit{Cultivation, chemistry, and genome of Psilocybe zapotecorum}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2023.11.01.564784}{doi:10.1101/2023.11.01.564784}.
\item Crist N. Filer (2023). \textit{The remarkable reimagining of psilocybin}. Natural Product Research. [published; OpenAlex]. \href{https://doi.org/10.1080/14786419.2023.2272285}{doi:10.1080/14786419.2023.2272285}.
\item Emese Prandovszky, Zachary A. Cordner, Hua Liu, Megan Pedicini, Lindsey Macias, Kellie L. Tamashiro, Robert H. Yolken (2023). \textit{Anxiolytic behavior accompanied by the alteration of the intestinal bacteriome during psilocybin treatment}. Brain Behavior and Immunity. [published; OpenAlex]. \href{https://doi.org/10.1016/j.bbi.2024.01.164}{doi:10.1016/j.bbi.2024.01.164}.
\item Roxanne Sholevar (2023). \textit{Peak Experiences: Lessons Learned from a Feasibility Study of Psilocybin-assisted Therapy for Demoralization in Patients Receiving Hospice Care}. Journal of the Academy of Consultation-Liaison Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.jaclp.2023.11.229}{doi:10.1016/j.jaclp.2023.11.229}.
\item Muller S, Cavanna F, de la Fuente L, Bruno N, D’Amelio TA, Pallavicini C, Tagliazucchi E. (2023). \textit{Acute effects of psilocybin on the dynamics of gaze fixations during visual aesthetic perception}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2023.10.27.564413}{doi:10.1101/2023.10.27.564413}.
\item Cameron LP, Benetatos J, Lewis V, Bonniwell EM, Jaster AM, Moliner R, Castrén E, McCorvy JD, Palner M, Aguilar-Valles A. (2023). \textit{Beyond the 5-HT2A Receptor: Classic and Nonclassic Targets in Psychedelic Drug Action.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1523/jneurosci.1384-23.2023}{doi:10.1523/jneurosci.1384-23.2023}.
\item Kurt Stocker, Matthias Hartmann, Laura Ley, A. Becker, Friederike Holze, Matthias E. Liechti (2023). \textit{The revival of the psychedelic experience scale: Revealing its extended-mystical, visual, and distressing experiential spectrum with LSD and psilocybin studies}. Journal of Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1177/02698811231199112}{doi:10.1177/02698811231199112}.
\item Unknown authors (2023). \textit{Single dose of psilocybin improves depressive symptoms in Phase 2 study}. The Brown University Psychopharmacology Update. [published; OpenAlex]. \href{https://doi.org/10.1002/pu.31093}{doi:10.1002/pu.31093}.
\item Kaminski D, Reinert JP. (2023). \textit{The Tolerability and Safety of Psilocybin in Psychiatric and Substance-Dependence Conditions: A Systematic Review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/10600280231205645}{doi:10.1177/10600280231205645}.
\item Banushi B, Polito V (2023). \textit{A Comprehensive Review of the Current Status of the Cellular Neurobiology of Psychedelics.}. Biology. [published; PubMed]. \href{https://doi.org/10.3390/biology12111380}{doi:10.3390/biology12111380}.
\item Kratina S, Lo C, Schwartz R, Strike C, Jopling S, Nayfeh A, Rush B. (2023). \textit{A protocol for a scoping review of psychedelic interventions to alleviate psychological suffering in populations coping with end-of-life issues}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/4gfyd}{doi:10.31234/osf.io/4gfyd}.
\item Unknown authors (2023). \textit{A protocol for a scoping review of psychedelic interventions to alleviate psychological suffering in populations coping with end-of-life issues}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/4gfyd\_v1}{source link}.
\item Natasha Biscoe, Amanda Bonson, Max Slavin, Walter Busuttil, Deirdre MacManus, Andrew T. Cox, Dominic Murphy (2023). \textit{Psilocybin-assisted psychotherapy for the treatment of PTSD in UK armed forces veterans: A feasibility study protocol}. European Journal of Trauma \& Dissociation. [published; OpenAlex]. \href{https://doi.org/10.1016/j.ejtd.2023.100359}{doi:10.1016/j.ejtd.2023.100359}.
\item Takaba R, Ibi D, Yoshida K, Hosomi E, Kawase R, Kitagawa H, Goto H, Achiwa M, Mizutani K, Maeda K, González-Maeso J, Kitagaki S, Hiramatsu M. (2023). \textit{Ethopharmacological evaluation of antidepressant-like effect of serotonergic psychedelics in C57BL/6J male mice.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s00210-023-02778-x}{doi:10.1007/s00210-023-02778-x}.
\item Wsół A. (2023). \textit{Cardiovascular safety of psychedelic medicine: current status and future directions.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s43440-023-00539-4}{doi:10.1007/s43440-023-00539-4}.
\item Rakoczy RJ, Runge GN, Sen AK, Sandoval O, Nguyen Q, Roberts BR, Sciortino JH, Gibbons WJ, Friedberg LM, Andrew Jones J, McMurray MS. (2023). \textit{Pharmacological and behavioral effects of tryptamines present in psilocybin-containing mushrooms}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2023.10.19.563138}{doi:10.1101/2023.10.19.563138}.
\item Lucia Carbajal, Tessa E. Moore, R. H. Barry Sample, Joseph Nelson (2023). \textit{Is psilocybin effective for treatment of depression?}. Evidence-Based Practice. [published; OpenAlex]. \href{https://doi.org/10.1097/ebp.0000000000002021}{doi:10.1097/ebp.0000000000002021}.
\item Brian Macallan (2023). \textit{Christian Responses to Psilocybin-Assisted Therapy and Potential Religious and Spiritual Experiences}. Religions. [published; OpenAlex]. \href{https://doi.org/10.3390/rel14101312}{doi:10.3390/rel14101312}.
\item Arya Rahbarnia, Zhaoxia Li, Paul Fletcher (2023). \textit{Effects of psilocybin, the 5-HT2A receptor agonist TCB-2, and the 5-HT2A receptor antagonist M100907 on visual attention in male mice in the continuous performance test}. Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1007/s00213-023-06474-9}{doi:10.1007/s00213-023-06474-9}.
\item Natalia Malikowska-Racia, Maciej Koniewski, Joanna Gołębiowska, Piotr Popik (2023). \textit{Acute but not long-lasting antidepressant-like effect of psilocybin in differential reinforcement of low-rate 72 schedule in rats}. Journal of Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1177/02698811231205692}{doi:10.1177/02698811231205692}.
\item Watford T, Masood N. (2023). \textit{Psilocybin, an Effective Treatment for Major Depressive Disorder in Adults - A Systematic Review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.9758/cpn.23.1120}{doi:10.9758/cpn.23.1120}.
\item Mathai DS, Roberts DE, Nayak SM, Sepeda ND, Lehrner A, Johnson M, Lowe MX, Jackson H, Garcia-Romeu A. (2023). \textit{Shame, guilt and psychedelic experience: Results from a prospective, longitudinal survey of real-world psilocybin use}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/hm6jn}{doi:10.31234/osf.io/hm6jn}.
\item Mathai DS, Roberts DE, Nayak SM, Sepeda ND, Lehrner A, Johnson M, Lowe MX, Jackson H, Garcia-Romeu A. (2023). \textit{Shame, guilt and psychedelic experience: Results from a prospective, longitudinal survey of real-world psilocybin use}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/hm6jn\_v1}{doi:10.31234/osf.io/hm6jn\_v1}.
\item Nathalie M. Rieser, Ladina P Gubser, Flora Moujaes, Patricia Duerler, Candace R. Lewis, Lars Michels, Franz X. Vollenweider, Katrin H. Preller (2023). \textit{Psilocybin-induced changes in cerebral blood flow are associated with acute and baseline inter-individual differences}. Scientific Reports. [published; OpenAlex]. \href{https://doi.org/10.1038/s41598-023-44153-z}{doi:10.1038/s41598-023-44153-z}.
\item Unknown authors (2023). \textit{Shame, guilt and psychedelic experience: Results from a prospective, longitudinal survey of real-world psilocybin use}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/hm6jn\_v1}{source link}.
\item Ian B. Hickie, Allan H. Young, F. Markus Leweke (2023). \textit{Repurposing of recreational drugs: will these new ‘medicines’ (e.g., psychedelics, psilocybin, cannabinoids, LSD, MDMA, ketamine) deliver short- or longer-term benefits for those with depressive or other mood disorders?}. Research Directions Depression. [published; OpenAlex]. \href{https://doi.org/10.1017/dep.2023.21}{doi:10.1017/dep.2023.21}.
\item Payman Baharmand, Amardeep Kambo (2023). \textit{Assessing Metro Vancouver Residents’ Knowledge and Opinions of Psilocybin}. BCIT Environmental Public Health Journal. [published; OpenAlex]. \href{https://doi.org/10.47339/ephj.2023.229}{doi:10.47339/ephj.2023.229}.
\item Yale University (2023). \textit{Safety and Efficacy of Psilocybin for the Treatment of Headache Disorders: Sub-Study II}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT03806985}{source link}.
\item Yale University (2023). \textit{Safety and Efficacy of Psilocybin for the Treatment of Headache Disorders: Sub-Study I}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT03341689}{source link}.
\item Keeler JL, Kan C, Treasure J, Himmerich H. (2023). \textit{Novel treatments for anorexia nervosa: Insights from neuroplasticity research.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1002/erv.3039}{doi:10.1002/erv.3039}.
\item Enriquez-Geppert S, Krc J, O'Higgins F, Lietz MP. (2023). \textit{Psilocybin-assisted neurofeedback for the improvement of executive functions: a randomised semi-naturalistic-lab feasibility study}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/jqasf}{doi:10.31234/osf.io/jqasf}.
\item Unknown authors (2023). \textit{Psilocybin-assisted neurofeedback for the improvement of executive functions: a randomised semi-naturalistic-lab feasibility study}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/jqasf\_v1}{source link}.
\item Haikazian S, Chen-Li DCJ, Johnson DE, Fancy F, Levinta A, Husain MI, Mansur RB, McIntyre RS, Rosenblat JD. (2023). \textit{Psilocybin-assisted therapy for depression: A systematic review and meta-analysis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.psychres.2023.115531}{doi:10.1016/j.psychres.2023.115531}.
\item Anna Douglas, Daniel Staas, Anna Hampton, Kylie Burns, F. Suter (2023). \textit{Psilocybin, Depression, and Synaptogenesis: Insights into the Field’s Past, Present, and Future}. Georgetown Scientific Research Journal. [published; OpenAlex]. \href{https://doi.org/10.48091/gsr.v3i2.62}{doi:10.48091/gsr.v3i2.62}.
\item Kiffer G. Card, Ashmita Grewal, Kalysha Closson, Gina Martin, Laura Baracaldo, Sandra Allison, Daniel J. Kruger, Zach Walsh (2023). \textit{Therapeutic Potential of Psilocybin for Treating Psychological Distress among Survivors of Adverse Childhood Experiences: Evidence on Acceptability and Potential Efficacy of Psilocybin Use}. Journal of Psychoactive Drugs. [published; OpenAlex]. \href{https://doi.org/10.1080/02791072.2023.2268640}{doi:10.1080/02791072.2023.2268640}.
\item Shinozuka K, Jerotic K, Mediano P, Zhao AT, Preller KH, Carhart-Harris R, Kringelbach ML. (2023). \textit{Synergistic, Multi-level Understanding of Psychedelics: Three Systematic Reviews and Meta-analyses of Their Pharmacology, Neuroimaging and Phenomenology}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2023.10.06.561183}{doi:10.1101/2023.10.06.561183}.
\item Linguiti S, Vogel JW, Sydnor VJ, Pines A, Wellman N, Basbaum A, Eickhoff CR, Eickhoff SB, Edwards RR, Larsen B, McKinstry-Wu A, Scott JC, Roalf DR, Sharma V, Strain EC, Corder G, Dworkin RH, Satterthwaite TD. (2023). \textit{Functional imaging studies of acute administration of classic psychedelics, ketamine, and MDMA: Methodological limitations and convergent results.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neubiorev.2023.105421}{doi:10.1016/j.neubiorev.2023.105421}.
\item Unknown authors (2023). \textit{Psilocybin shows promising results in subjects continuing to use an antidepressant}. The Brown University Psychopharmacology Update. [published; OpenAlex]. \href{https://doi.org/10.1002/pu.31089}{doi:10.1002/pu.31089}.
\item Chloé Galipeau, Miguel Farinha-Ferreira, Jean-Charles Mariani, Samuel Diebolt, Louis Barthe, Renata Santos, Zsolt Lenkei, Ana M. Sebastião (2023). \textit{UNRAVELLING THE ROLE OF5-HT2AR ACTIVATION IN THE LONG-LASTING BEHAVIORAL EFFECTS OF PSILOCYBIN}. IBRO Neuroscience Reports. [published; OpenAlex]. \href{https://doi.org/10.1016/j.ibneur.2023.08.1116}{doi:10.1016/j.ibneur.2023.08.1116}.
\item Ines Erkizia-Santamaría, J. Javier Meana, Igor Horrillo, Jorge E. Ortega (2023). \textit{PSILOCYBIN EXERTS ANTIDEPRESSANT EFFECTS IN A CHRONIC UNPREDICTABLE MILD STRESS (CUMS) ANIMAL MODEL}. IBRO Neuroscience Reports. [published; OpenAlex]. \href{https://doi.org/10.1016/j.ibneur.2023.08.1097}{doi:10.1016/j.ibneur.2023.08.1097}.
\item Tomáš Páleníček, Tereza Klučková, M. Nikolič, Čestmír Vejmola, Filip Tylš, Vojtěch Viktorin, Jiřı́ Horáček, Martin Brunovský (2023). \textit{DOES THE PHENOMENOLOGY OF THE PSILOCYBIN EXPERIENCE PREDICT LONG-TERM EFFECTS ON MOOD AND WELL-BEING IN HEALTHY VOLUNTEERS?}. IBRO Neuroscience Reports. [published; OpenAlex]. \href{https://doi.org/10.1016/j.ibneur.2023.08.1240}{doi:10.1016/j.ibneur.2023.08.1240}.
\item Amanda E. Downey (2023). \textit{6.3 Psilocybin Therapy for the Treatment of Young Adults With Anorexia Nervosa: State of the Research}. Journal of the American Academy of Child \& Adolescent Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.jaac.2023.07.666}{doi:10.1016/j.jaac.2023.07.666}.
\item Čestmír Vejmola, Kateřina Syrová, Klára Šíchová, Vlastimil Koudelka, Jan Hubený, Tereza Klučková, M. Nikolič, Eduard Kelemen, Tomáš Páleníček (2023). \textit{CROSS-SPECIES EVIDENCE FOR PSILOCIN-INDUCED VISUAL HALLUCINATIONS: RATS PERCEIVE QUALITATIVELY SIMILAR CHANGES AS HUMANS}. IBRO Neuroscience Reports. [published; OpenAlex]. \href{https://doi.org/10.1016/j.ibneur.2023.08.1471}{doi:10.1016/j.ibneur.2023.08.1471}.
\item Gold ND, Mallard AJ, Hermann JC, Zeifman RJ, Pagni BA, Bogenschutz MP, Ross S (2023). \textit{Exploring the Potential Utility of Psychedelic Therapy for Patients With Amyotrophic Lateral Sclerosis.}. Journal of palliative medicine. [published; PubMed]. \href{https://doi.org/10.1089/jpm.2022.0604}{doi:10.1089/jpm.2022.0604}.
\item Goel A, Rai Y, Sivadas S, Diep C, Clarke H, Shanthanna H, Ladha KS. (2023). \textit{Use of Psychedelics for Pain: A Scoping Review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1097/aln.0000000000004673}{doi:10.1097/aln.0000000000004673}.
\item Wall MB, Harding R, Zafar R, Rabiner EA, Nutt DJ, Erritzoe D. (2023). \textit{Neuroimaging in psychedelic drug development: past, present, and future.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41380-023-02271-0}{doi:10.1038/s41380-023-02271-0}.
\item Thomas Müller (2023). \textit{Psilocybin kann offenbar Depressionen lindern}. MMW - Fortschritte der Medizin. [published; OpenAlex]. \href{https://doi.org/10.1007/s15006-023-3025-6}{doi:10.1007/s15006-023-3025-6}.
\item University of New Mexico (2023). \textit{Effects and Therapeutic Potential of Psilocybin in Alcohol Dependence}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT01534494}{source link}.
\item Chiu Y, Deutch AY, Wang W, Schmitz GP, Huang KL, Kocak DD, Llorach P, Bowyer K, Liu B, Sciaky N, Hua K, Chen C, Mott SE, Niehaus J, DiBerto JF, English J, Walsh JJ, Scherrer G, Herman MA, Wu Z, Wetsel WC, Roth BL. (2023). \textit{A suite of engineered mice for interrogating psychedelic drug actions}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2023.09.25.559347}{doi:10.1101/2023.09.25.559347}.
\item Thomas J. Kelly, Emma M. Bonniwell, Lianwei Mu, Xiaojie Liu, Ying Hu, Vladislav Friedman, Hao Yu, Wantang Su, John D. McCorvy, Qing-song Liu (2023). \textit{Psilocybin analog 4-OH-DiPT enhances fear extinction and GABAergic inhibition of principal neurons in the basolateral amygdala}. Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1038/s41386-023-01744-8}{doi:10.1038/s41386-023-01744-8}.
\item Wojtas A, Bysiek A, Wawrzczak-Bargiela A, Maćkowiak M, Gołembiowska K. (2023). \textit{Limbic System Response to Psilocybin and Ketamine Administration in Rats: A Neurochemical and Behavioral Study}. Preprints.org. [preprint; Europe PMC]. \href{https://doi.org/10.20944/preprints202309.1649.v1}{doi:10.20944/preprints202309.1649.v1}.
\item Padawer-Curry JA, Krentzman OJ, Kuo C, Wang X, Bice AR, Nicol GE, Snyder AZ, Siegel JS, McCall JG, Bauer AQ. (2023). \textit{Psychedelic 5-HT2A receptor agonism: neuronal signatures and altered neurovascular coupling.}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2023.09.23.559145}{doi:10.1101/2023.09.23.559145}.
\item Mitch Earleywine, Maha N. Mian, Joseph A. De Leo (2023). \textit{Expectancies for Subjective and Antidepressant Effects in Psilocybin Users}. Journal of Humanistic Psychology. [published; OpenAlex]. \href{https://doi.org/10.1177/00221678231194798}{doi:10.1177/00221678231194798}.
\item Haniya J. Halim, Bradley G. Burk, Rachel E. Fargason, Badari Birur (2023). \textit{Manic episode following psilocybin use in a man with bipolar II disorder: a case report}. Frontiers in Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.3389/fpsyt.2023.1221131}{doi:10.3389/fpsyt.2023.1221131}.
\item Milan Scheidegger (2023). \textit{Mindfulness and Psychedelics: A Combined Neurophenomenological and Pharmacological Approach to the Characterization of Mindfulness States in Experienced Meditators}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05780216}{source link}.
\item University of Zurich (2023). \textit{Phase II, Randomized, Double Blind, Placebo Controlled, Parallel Group, Single Center Study of Psilocybin Efficacy and Mechanism in Alcohol Use Disorder}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT04141501}{source link}.
\item Sam Elias, Stephanie Spivak, Alexa Alverez, Alejandro Gili Olivares, Maria Ferrol, Julian Paul Keenan (2023). \textit{Self-perception and self-recognition while looking in the mirror on psilocybin}. Journal of Psychedelic Studies. [published; OpenAlex]. \href{https://doi.org/10.1556/2054.2023.00251}{doi:10.1556/2054.2023.00251}.
\item Sandeep M. Nayak, Hillary Jackson, Nathan D. Sepeda, David S. Mathai, Sara So, Abigail Yaffe, Hadi Zaki, Trey Brasher, Matthew X. Lowe, Del R. P. Jolly, Frederick S. Barrett, Roland R. Griffiths, Justin C. Strickland, Matthew W. Johnson, Heather Jackson, Albert Garcia-Romeu (2023). \textit{Naturalistic psilocybin use is associated with persisting improvements in mental health and wellbeing: results from a prospective, longitudinal survey}. Frontiers in Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.3389/fpsyt.2023.1199642}{doi:10.3389/fpsyt.2023.1199642}.
\item Mortaheb S, Fort LD, Mason NL, Mallaroni P, Ramaekers JG, Demertzi A. (2023). \textit{Dynamic Functional Hyperconnectivity after Psilocybin Intake is Primarily Associated with Oceanic Boundlessness}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2023.09.18.558309}{doi:10.1101/2023.09.18.558309}.
\item Keith G. Heinzerling, Karina Sergi, Micah Linton, Rhianna Rich, Brittany Youssef, Inez Bentancourt, Jennifer E. Bramen, Prabha Siddarth, L. Schwartzberg, Daniel F. Kelly (2023). \textit{Nature-themed video intervention may improve cardiovascular safety of psilocybin-assisted therapy for alcohol use disorder}. Frontiers in Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.3389/fpsyt.2023.1215972}{doi:10.3389/fpsyt.2023.1215972}.
\item Kargbo RB. (2023). \textit{Tryptamines and Mental Health: Activating the 5-HT Receptor for Therapeutic Potential.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/acsmedchemlett.3c00390}{doi:10.1021/acsmedchemlett.3c00390}.
\item Lobe Sciences Ltd. (2023). \textit{Phase 1, Open-Label, One-Treatment, Single-Dose, One-Period, Pharmacokinetic Study of Psilocin 4 mg as Its Mucic Acid Salt (L-130) Form, in Healthy Subjects Under Fasted Conditions}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06035900}{source link}.
\item NM Mahmudul Alam Bhuiya, Robin J. Jacobs, Karina Wang, Yiqun Sun, Brenda Nava, Luke Sampiere, Akhila Yerubandi, Joshua Caballero (2023). \textit{Predictors of Pharmacy Students' Attitudes About the Therapeutic Use of Psilocybin}. Cureus. [published; OpenAlex]. \href{https://doi.org/10.7759/cureus.45169}{doi:10.7759/cureus.45169}.
\item Julien Chupin, Jorge López-Castromán, Caroline Brière, Fabrício Pereira, Coraline Hingray, Ismaël Conejero (2023). \textit{Can a single dose of psilocybin improve cognitive control in functional dissociative seizures?}. Medical Hypotheses. [published; OpenAlex]. \href{https://doi.org/10.1016/j.mehy.2023.111163}{doi:10.1016/j.mehy.2023.111163}.
\item Wolfgang AS, Hoge CW. (2023). \textit{Psychedelic-Assisted Therapy in Military and Veterans Healthcare Systems: Clinical, Legal, and Implementation Considerations.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s11920-023-01446-4}{doi:10.1007/s11920-023-01446-4}.
\item Zhang R, Anguiano M, Aarrestad IK, Lin S, Chandra J, Vadde SS, Olson DE, Kim CK. (2023). \textit{Rapid, biochemical tagging of cellular activity history in vivo}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2023.09.06.556431}{doi:10.1101/2023.09.06.556431}.
\item Syed OA, Tsang B, Gerlai R. (2023). \textit{The zebrafish for preclinical psilocybin research.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neubiorev.2023.105381}{doi:10.1016/j.neubiorev.2023.105381}.
\item Natasha L. Mason, Attila Szabó, Kim P. C. Kuypers, Pablo Mallaroni, R. de la Torre Fornell, Johannes T. Reckweg, Desmond H. Y. Tse, Nadia R. P. W. Hutten, Amanda Feilding, Johannes G. Ramaekers (2023). \textit{Psilocybin induces acute and persisting alterations in immune status in healthy volunteers: An experimental, placebo-controlled study}. Brain Behavior and Immunity. [published; OpenAlex]. \href{https://doi.org/10.1016/j.bbi.2023.09.004}{doi:10.1016/j.bbi.2023.09.004}.
\item Marc J. Weintraub, Jessica Jeffrey, Charles S. Grob, Megan Ichinose, R. Lindsey Bergman, Ziva D. Cooper, David J. Miklowitz (2023). \textit{Psilocybin-Assisted Cognitive Behavioral Therapy for Adults with Major Depressive Disorder: Rationale and Treatment Development}. Psychedelic Medicine. [published; OpenAlex]. \href{https://doi.org/10.1089/psymed.2023.0018}{doi:10.1089/psymed.2023.0018}.
\item Sofia Audrey B. Gonzales, Christine Alexopoulos, Daniel G. Arkfeld (2023). \textit{Potential Benefits of Psilocybin for Lupus Pain: A Case Report}. Current Rheumatology Reviews. [published; OpenAlex]. \href{https://doi.org/10.2174/1573397119666230904150750}{doi:10.2174/1573397119666230904150750}.
\item Unknown authors (2023). \textit{Psilocybin, escitalopram have comparable effects on personality in patients with depression}. The Brown University Psychopharmacology Update. [published; OpenAlex]. \href{https://doi.org/10.1002/pu.31080}{doi:10.1002/pu.31080}.
\item Unknown authors (2023). \textit{Acute effects of psilocybin, LSD, mescaline found to be similar}. The Brown University Psychopharmacology Update. [published; OpenAlex]. \href{https://doi.org/10.1002/pu.31079}{doi:10.1002/pu.31079}.
\item Shannon L. Thomas, Colton Myers, Kevin A. Schug (2023). \textit{Comparison of fragrance and flavor components in non-psilocybin and psilocybin mushrooms using vacuum-assisted headspace high-capacity solid-phase microextraction and gas chromatography-mass spectrometry}. Advances in Sample Preparation. [published; OpenAlex]. \href{https://doi.org/10.1016/j.sampre.2023.100090}{doi:10.1016/j.sampre.2023.100090}.
\item Mark D. Sims, John Hendrick (2023). \textit{Psilocybin Use in Palliative Care \#464}. Journal of Palliative Medicine. [published; OpenAlex]. \href{https://doi.org/10.1089/jpm.2023.0180}{doi:10.1089/jpm.2023.0180}.
\item A. M. Costa, Mariana Silva-Carvalho, Áurea Madureira-Carvalho, Ricardo Jorge Dinis-Oliveira, D. Dias-da-Silva (2023). \textit{P05-02: Assessment of the CYP450 inhibitory activity of psilocybin, psilocin, LSD, 5-MeO-DMT and mescaline: An in vitro study}. Toxicology Letters. [published; OpenAlex]. \href{https://doi.org/10.1016/s0378-4274(23)00499-x}{doi:10.1016/s0378-4274(23)00499-x}.
\item Szigeti B, Phillips LD, Nutt D (2023). \textit{Bayesian analysis of real-world data as evidence for drug approval: Remembering Sir Michael Rawlins.}. British journal of clinical pharmacology. [published; PubMed]. \href{https://doi.org/10.1111/bcp.15841}{doi:10.1111/bcp.15841}.
\item Garakani A, Alexander JL, Sumner CR, Pine JH, Gross LS, Raison CL, Aaronson ST, Baron DA. (2023). \textit{Psychedelics, With a Focus on Psilocybin: Issues for the Clinician.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1097/pra.0000000000000729}{doi:10.1097/pra.0000000000000729}.
\item Miller M, Rosa WE, Doerner Rinaldi A, Addicott K, Spence D, Beaussant Y (2023). \textit{Applying Key Lessons from the Hospice and Palliative Care Movement to Inform Psychedelic-Assisted Therapy.}. Psychedelic medicine (New Rochelle, N.Y.). [published; PubMed]. \href{https://doi.org/10.1089/psymed.2022.0009}{doi:10.1089/psymed.2022.0009}.
\item Kat F. Kiilerich, Joe Lorenz, Malthe B. Scharff, Nikolaj Speth, T Brandt, Julia Czurylo, Mengfei Xiong, Naja S. Jessen, Agata Casado-Sainz, Vladimir Shalgunov, Celia Kjærby, Grzegorz Satała, Andrzej J. Bojarski, Anders A. Jensen, Matthias M. Herth, Paul Cumming, Agnete Overgaard, Mikael Palner (2023). \textit{Repeated low doses of psilocybin increase resilience to stress, lower compulsive actions, and strengthen cortical connections to the paraventricular thalamic nucleus in rats}. Molecular Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1038/s41380-023-02280-z}{doi:10.1038/s41380-023-02280-z}.
\item David W. Lawrence (2023). \textit{Self-administration of Psilocybin for the Acute Treatment of Migraine: A Case Report.}. PubMed. [published; OpenAlex]. \href{https://pubmed.ncbi.nlm.nih.gov/37817818}{source link}.
\item Kalfas M, Taylor RH, Tsapekos D, Young AH. (2023). \textit{Psychedelics for treatment resistant depression: are they game changers?}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/14656566.2023.2281582}{doi:10.1080/14656566.2023.2281582}.
\item Evelyn Attia, Joanna Steinglass (2023). \textit{Psilocybin for anorexia nervosa: If it helps, let’s learn how}. Med. [published; OpenAlex]. \href{https://doi.org/10.1016/j.medj.2023.08.003}{doi:10.1016/j.medj.2023.08.003}.
\item Herrmann Z, Levin AW, Cole SP, Slabaugh S, Barnett B, Penn A, Jain R, Raison C, Rajanna B, Jain S (2023). \textit{Psychedelic Use Among Psychiatric Medication Prescribers: Effects on Well-Being, Depression, Anxiety, and Associations with Patterns of Use, Reported Harms, and Transformative Mental States.}. Psychedelic medicine (New Rochelle, N.Y.). [published; PubMed]. \href{https://doi.org/10.1089/psymed.2023.0030}{doi:10.1089/psymed.2023.0030}.
\item Pepe M, Hesami M, de la Cerda KA, Perreault ML, Hsiang T, Jones AMP. (2023). \textit{A journey with psychedelic mushrooms: From historical relevance to biology, cultivation, medicinal uses, biotechnology, and beyond.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.biotechadv.2023.108247}{doi:10.1016/j.biotechadv.2023.108247}.
\item Sharma P, Nguyen QA, Matthews SJ, Carpenter E, Mathews DB, Patten CA, Hammond CJ. (2023). \textit{Psilocybin history, action and reaction: A narrative clinical review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811231190858}{doi:10.1177/02698811231190858}.
\item Charles L. Raison, Gerard Sanacora, Joshua Woolley, Keith G. Heinzerling, Boadie W. Dunlop, Randall Brown, Rishi Kakar, Michael Hassman, Rupal Trivedi, Reid Robison, Natalie Gukasyan, Sandeep M. Nayak, Xiaojue Hu, Kelley C. O’Donnell, Benjamin Kelmendi, Jordan Sloshower, Andrew Penn, Ellen Bradley, Daniel F. Kelly, Tanja Mletzko, Christopher R. Nicholas, Paul R. Hutson, Gary Tarpley, Malynn Utzinger, Kelsey Lenoch, Kasia Warchol, Theraysa Gapasin, Mike C. Davis, Courtney Nelson-Douthit, Steffanie H Wilson, Carrie Brown, William Linton, Matthew W. Johnson, Stephen Ross, Roland R. Griffiths (2023). \textit{Single-Dose Psilocybin Treatment for Major Depressive Disorder}. JAMA. [published; OpenAlex]. \href{https://doi.org/10.1001/jama.2023.14530}{doi:10.1001/jama.2023.14530}.
\item Alexsandra Kovacevich, Jeremy Weleff, Benjamin Claytor, Brian S. Barnett (2023). \textit{Three Cases of Reported Improvement in Microsmia and Anosmia Following Naturalistic Use of Psilocybin and LSD}. Journal of Psychoactive Drugs. [published; OpenAlex]. \href{https://doi.org/10.1080/02791072.2023.2253538}{doi:10.1080/02791072.2023.2253538}.
\item David S. Mathai, Samantha Hilbert, Nathan D. Sepeda, Justin C. Strickland, Roland R. Griffiths, Albert Garcia-Romeu (2023). \textit{Double-Blind Comparison of the Two Hallucinogens Dextromethorphan and Psilocybin: Experience-Dependent and Enduring Psychological Effects in Healthy Volunteers}. Psychedelic Medicine. [published; OpenAlex]. \href{https://doi.org/10.1089/psymed.2023.0035}{doi:10.1089/psymed.2023.0035}.
\item Xuehan Du (2023). \textit{Pharmacology and Therapeutic Effects of Psilocybin}. Highlights in Science Engineering and Technology. [published; OpenAlex]. \href{https://doi.org/10.54097/hset.v65i.11331}{doi:10.54097/hset.v65i.11331}.
\item Kolbman N, Liu T, Guzzo P, Gilligan JP, Mashour GA, Vanini G, Pal D. (2023). \textit{Intravenous psilocybin administration attenuates mechanical hypersensitivity in a rat model of chronic pain}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2023.08.26.554802}{doi:10.1101/2023.08.26.554802}.
\item Marilia Santoro Cardoso, Kelly Francisco da Cunha, Izabelly Geraldes Silva, Taís Regina Fiorentin, Eduardo Geraldo de Campos, José Luiz Costa (2023). \textit{Development and validation of a sensitive LC-MS-MS method to quantify psilocin in authentic oral fluid samples}. Journal of Analytical Toxicology. [published; OpenAlex]. \href{https://doi.org/10.1093/jat/bkad064}{doi:10.1093/jat/bkad064}.
\item Grant Jones, Maha Al-Suwaidi, Franchesca Castro-Ramirez, Taylor C. McGuire, Patrick Mair, Matthew K. Nock (2023). \textit{Race and ethnicity moderate the associations between lifetime psilocybin use and crime arrests}. Frontiers in Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.3389/fpsyt.2023.1169692}{doi:10.3389/fpsyt.2023.1169692}.
\item Siegel JS, Subramanian S, Perry D, Kay B, Gordon E, Laumann T, Reneau R, Gratton C, Horan C, Metcalf N, Chacko R, Schweiger J, Wong D, Bender D, Padawer-Curry J, Raison C, Raichle M, Lenze EJ, Snyder AZ, Dosenbach NU, Nicol G. (2023). \textit{Psilocybin desynchronizes brain networks}. medRxiv. [preprint; medRxiv]. \href{https://doi.org/10.1101/2023.08.22.23294131}{doi:10.1101/2023.08.22.23294131}.
\item Wong S, Yu AY, Fabiano N, Finkelstein O, Pasricha A, Jones BDM, Rosenblat JD, Blumberger DM, Mulsant BH, Husain MI. (2023). \textit{Beyond Psilocybin: Reviewing the Therapeutic Potential of Other Serotonergic Psychedelics in Mental and Substance Use Disorders.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/02791072.2023.2251133}{doi:10.1080/02791072.2023.2251133}.
\item Richard J. Zeifman, Hannes Kettner, Broc A. Pagni, Austin J. Mallard, Daniel E. Roberts, David Erritzøe, Stephen Ross, Robin Carhart-Harris (2023). \textit{Co-use of MDMA with psilocybin/LSD may buffer against challenging experiences and enhance positive experiences}. Scientific Reports. [published; OpenAlex]. \href{https://doi.org/10.1038/s41598-023-40856-5}{doi:10.1038/s41598-023-40856-5}.
\item Benjamin M. Ross, James T. Neill (2023). \textit{Exploring the relationship between mental health, drug use, personality, and attitudes towards psilocybin-assisted therapy}. Journal of Psychedelic Studies. [published; OpenAlex]. \href{https://doi.org/10.1556/2054.2023.00264}{doi:10.1556/2054.2023.00264}.
\item Antonio F. Pagán, Claudia Lex, Jair C. Soares, Thomas D. Meyer (2023). \textit{Medical Students' Attitudes and Beliefs Toward Psilocybin: Does Terminology and Personal Experience with Psychedelics Matter?}. Psychedelic Medicine. [published; OpenAlex]. \href{https://doi.org/10.1089/psymed.2023.0022}{doi:10.1089/psymed.2023.0022}.
\item Raúl Escamilla, María Eva González-Trujano, Jesús M. González Mariscal, J. Martı́n Torres-Valencia, Héctor Guzmán-González, José Luis Vega, Anja Loizaga-Velder (2023). \textit{A Proposal to Study the Safety and Efficacy of Psilocybe cubensis in Preclinical and Clinical Studies as a Therapeutic Alternative for Major Depressive Disorder}. Journal of Psychoactive Drugs. [published; OpenAlex]. \href{https://doi.org/10.1080/02791072.2023.2246459}{doi:10.1080/02791072.2023.2246459}.
\item Marie Crowe, Jenni Manuel, Dave Carlyle, Cameron Lacey (2023). \textit{Psilocybin-assisted psychotherapy for treatment-resistant depression: Which psychotherapy?}. International Journal of Mental Health Nursing. [published; OpenAlex]. \href{https://doi.org/10.1111/inm.13214}{doi:10.1111/inm.13214}.
\item Robert Gramling, Emily Bennett, Keith Curtis, William A. Richards, Donna M. Rizzo, Francesca Arnoldy, Logan P Hegg, Jon Porter, Heather Honstein, Susanna Pratt, Elise C. Tarbi, Maija Reblin, Paul Thambi, Manish Agrawal (2023). \textit{Developing a Direct Observation Measure of Therapeutic Connection in Psilocybin-Assisted Therapy: A Feasibility Study}. Journal of Palliative Medicine. [published; OpenAlex]. \href{https://doi.org/10.1089/jpm.2023.0189}{doi:10.1089/jpm.2023.0189}.
\item Rebecchi K. (2023). \textit{“Diversity makes the richness of humanity”: the emergence of mental imagery after self-reported psilocybin mushrooms intake in an autistic woman with “blind imagination” (aphantasia): a 1-year retrospective case report}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/c9fpj}{doi:10.31234/osf.io/c9fpj}.
\item Unknown authors (2023). \textit{“Diversity makes the richness of humanity”: the emergence of mental imagery after self-reported psilocybin mushrooms intake in an autistic woman with “blind imagination” (aphantasia): a 1-year retrospective case report}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/c9fpj\_v1}{source link}.
\item Justyna Woźniak, Rafał BOGACZ, Magdalena Gaik, Ewa URAM, Inga MAGDA, Karol Womperski, Magdalena OSUCH (2023). \textit{use of psilocybin in the treatment of psychiatric disorders - review}. Journal of Education Health and Sport. [published; OpenAlex]. \href{https://doi.org/10.12775/jehs.2023.43.01.009}{doi:10.12775/jehs.2023.43.01.009}.
\item Usona Institute (2023). \textit{A Phase 1, Two-Part Study in Healthy Volunteers to Evaluate The Effect of Psilocybin on Cardiac Repolarization and The Effect of Food on Psilocybin Pharmacokinetics}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05478278}{source link}.
\item Robinson GI, Li D, Wang B, Zahoruiko Y, Gerasymchuk M, Hudson D, Kovalchuk O, Kovalchuk I. (2023). \textit{Anti-Inflammatory Effects of Serotonin Receptor and Transient Receptor Potential Channel Ligands in Human Small Intestinal Epithelial Cells.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/cimb45080427}{doi:10.3390/cimb45080427}.
\item Tagen M, Mantuani D, van Heerden L, Holstein A, Klumpers LE, Knowles R. (2023). \textit{The risk of chronic psychedelic and MDMA microdosing for valvular heart disease.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811231190865}{doi:10.1177/02698811231190865}.
\item Anna Jaremek, Joanna Kępa, Norbert Kandefer, Michał Wyszkowski, Aleksandra Grabarczyk, Anna Pawlak, Sylwia Grad, Małgorzata Gregorek, Paweł Gregorek (2023). \textit{Psilocybin's Emerging Role in Combating Depressive Disorder}. Journal of Education Health and Sport. [published; OpenAlex]. \href{https://doi.org/10.12775/jehs.2023.40.01.011}{doi:10.12775/jehs.2023.40.01.011}.
\item Amanda E. Downey, Maxine Boyd, Anita V. Chaphekar, Joshua Woolley, Marissa Raymond-Flesch (2023). \textit{“But the reality is it's happening”: A qualitative study of eating disorder providers about psilocybin-assisted psychotherapy}. International Journal of Eating Disorders. [published; OpenAlex]. \href{https://doi.org/10.1002/eat.24041}{doi:10.1002/eat.24041}.
\item Pilozzi A, Foster S, Mischoulon D, Fava M, Huang X (2023). \textit{A Brief Review on the Potential of Psychedelics for Treating Alzheimer's Disease and Related Depression.}. International journal of molecular sciences. [published; PubMed]. \href{https://doi.org/10.3390/ijms241512513}{doi:10.3390/ijms241512513}.
\item Perez N, Langlest F, Mallet L, De Pieri M, Sentissi O, Thorens G, Seragnoli F, Zullino D, Kirschner M, Kaiser S, Solmi M, Sabé M. (2023). \textit{Psilocybin-assisted therapy for depression: A systematic review and dose-response meta-analysis of human studies.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.euroneuro.2023.07.011}{doi:10.1016/j.euroneuro.2023.07.011}.
\item Schindler EAD. (2023). \textit{The Potential of Psychedelics for the Treatment of Episodic Migraine.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s11916-023-01145-y}{doi:10.1007/s11916-023-01145-y}.
\item Ruzmayuddin Mamat, Rusdi Abd Rashid, Maw Shin Sim, Baharudin Ibrahim, Suzaily Wahab, Azmir Ahmad (2023). \textit{Prevalence of psilocybin use in vaping and associated factors: a study among amphetamine-type stimulants (ATS) use disorder in Malaysia}. Journal of Addictive Diseases. [published; OpenAlex]. \href{https://doi.org/10.1080/10550887.2023.2240932}{doi:10.1080/10550887.2023.2240932}.
\item N. Jones, Zarmeen Zahid, Sean M. Grady, Ziyad W. Sultan, Zhen Zheng, John A. Razidlo, Matthew I. Banks, Cody J. Wenthur (2023). \textit{Transient Elevation of Plasma Glucocorticoids Supports Psilocybin-Induced Anxiolysis in Mice}. ACS Pharmacology \& Translational Science. [published; OpenAlex]. \href{https://doi.org/10.1021/acsptsci.3c00123}{doi:10.1021/acsptsci.3c00123}.
\item Moritz Spangemacher (2023). \textit{Psilocybin und Funktionalität bei Depression}. InFo Neurologie + Psychiatrie. [published; OpenAlex]. \href{https://doi.org/10.1007/s15005-023-3336-2}{doi:10.1007/s15005-023-3336-2}.
\item Jing X, Hoeh NR, Menkes DB. (2023). \textit{Psychedelic medicines for end-of-life care: Pipeline clinical trial review 2022.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1017/s147895152300069x}{doi:10.1017/s147895152300069x}.
\item Majić T, Ehrlich S. (2023). \textit{Psilocybin for the treatment of anorexia nervosa.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41591-023-02458-6}{doi:10.1038/s41591-023-02458-6}.
\item Ibrahim IB, Videbech P, Straszek SPV. (2023). \textit{Psychedelic drugs in the treatment of psychiatric disorders.}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/37615227}{source link}.
\item Benjamin A. Korman (2023). \textit{On the mushrooming reports of “quiet quitting”: Employees’ lifetime psilocybin use predicts their overtime hours worked}. Journal of Psychoactive Drugs. [published; OpenAlex]. \href{https://doi.org/10.1080/02791072.2023.2242358}{doi:10.1080/02791072.2023.2242358}.
\item Brain and Cognition Discovery Foundation (2023). \textit{The Efficacy and Tolerability of Psilocybin in Participants With Treatment-Resistant Depression: a Phase 2, Randomized Feasibility Study}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05029466}{source link}.
\item Finkelstein C, Soha O, Roy A, Phillipou A, Rossell S. (2023). \textit{“Why would you open someone’s brain up?” Lived experience insights inform a psilocybin-assisted psychotherapy treatment manual for body image disturbance}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-3189970/v1}{doi:10.21203/rs.3.rs-3189970/v1}.
\item The Roots to Thrive Society for Psychedelic Therapy (2023). \textit{An Open Label Pragmatic Feasibility Study on a Resilience Focused Community of Practice Program With Psilocybin-assisted Therapy (PaT) for End-of-Life Patients.}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05958758}{source link}.
\item Jahanabadi S, Amiri S, Karkeh-Abadi M, Razmi A. (2023). \textit{Natural psychedelics in the treatment of depression; a review focusing on neurotransmitters.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.fitote.2023.105620}{doi:10.1016/j.fitote.2023.105620}.
\item Simonsson O, Carlbring P, Carhart-Harris R, Davis AK, Nutt DJ, Griffiths RR, Erritzoe D, Goldberg SB. (2023). \textit{Assessing the risk of symptom worsening in psilocybin-assisted therapy for depression: A systematic review and individual participant data meta-analysis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.psychres.2023.115349}{doi:10.1016/j.psychres.2023.115349}.
\item Shahar O, Botvinnik A, Shwartz A, Lerer E, Buko A, Hamid E, Kahn D, Guralnick M, Blakolmer K, Wolf G, Lerer L, Lerer B, Lifschytz T. (2023). \textit{Distinctive Molecular and Metabolic Profiles of Chemically Synthesized Psilocybin and Psychedelic Mushroom Extract}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-3146433/v1}{doi:10.21203/rs.3.rs-3146433/v1}.
\item Goodwin G, Marwood L, Mistry S, Nowakowska A, Simmons H, Tsai J, Williams S, Young M, Malievskaia E. (2023). \textit{Improvement in Depression Symptoms Measured by Montgomery-Åsberg Depression Rating Scale and Quick Inventory of Depressive Symptomatology-Self Rated Items after Randomised Double-blind COMP360 Psilocybin Therapy for Treatment-resistant Depression}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC10595939}{source link}.
\item Husain M, Blumberger D, Castle D, Kloiber S, Ortiz A, Rosenblat J, Mulsant B. (2023). \textit{A proof-of concept randomized controlled trial to show that the antidepressant effect of psilocybin does not require a psychedelic experience: study protocol}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC10660879}{source link}.
\item Kuypers K. (2023). \textit{Psychedelics for depression: from neurobiology to treatment}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC10417770}{source link}.
\item Sousa R, Costa L, Brás J, Vaz R, Martins J, Abreu J, Almeida E, Castro N, Andrade R, Cunha N. (2023). \textit{Knocking on the Doors of Perception: the role of psilocybin in substance use disorder treatment}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC10596667}{source link}.
\item Ramírez González J, Fernández Márquez I, Ferreiro González S, Ruíz E. (2023). \textit{The therapeutic potential of psilocybin in depression resistant to psychotropic drugs}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC10479004}{source link}.
\item Bhanot S, Lin M, Bains S, Monroe A, Tsang V. (2023). \textit{A systematic review to assess the use of psilocybin in the treatment of headaches}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC10660046}{source link}.
\item Lin M, Lee H, Tsang V, Chai B, Howard A, Uy C, Elefante J. (2023). \textit{Systematic Review on the Mechanisms of Action of Psilocybin in the Treatment of Depression}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC10434693}{source link}.
\item Zeiss R. (2023). \textit{Psilocybin as an antidepressant strategy - a review of safety aspects}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC10405689}{source link}.
\item Weiss B, Ginige I, Shannon L, Giribaldi B, Murphy-Beiner A, Murphy R, Baker-Jones M, Martell J, Nutt DJ, Carhart-Harris RL, Erritzoe D. (2023). \textit{Personality Change in a Trial of Psilocybin Therapy vs Escitalopram Treatment for Depression - CORRIGENDUM.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1017/s0033291723002039}{doi:10.1017/s0033291723002039}.
\item Unknown authors (2023). \textit{A Systematic Review of Reporting Practices in Psychedelic Clinical Trials: Psychological Support, Therapy, and Psychosocial Interventions}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.1089/psymed.2023.00071}{doi:10.1089/psymed.2023.00071}.
\item Brennan B, Kelman A, Belser AB. (2023). \textit{A Systematic Review of Reporting Practices in Psychedelic Clinical Trials: Psychological Support, Therapy, and Psychosocial Interventions}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/2ab59}{doi:10.31234/osf.io/2ab59}.
\item Nkadimeng SM, Hay L, Steinmann CM, Eloff JN. (2023). \textit{Administration effects of four psilocybin mushroom extracts on serotonin levels and endothelial nitric oxide synthase activity levels in vivo and in vitro after one hour}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-3088850/v1}{doi:10.21203/rs.3.rs-3088850/v1}.
\item Dan Yaniv, Lois M. Ramondetta, Lorenzo Cohen, Moran Amit (2023). \textit{Psilocybin-assisted psychotherapy for cancer-related anxiety and depression}. International Journal of Gynecological Cancer. [published; OpenAlex]. \href{https://doi.org/10.1136/ijgc-2023-004659}{doi:10.1136/ijgc-2023-004659}.
\item Guy M. Goodwin, Megan Croal, David Feifel, John R. Kelly, Lindsey Marwood, Sunil Mistry, Veronica O’Keane, Stéphanie Knatz Peck, Hollie Simmons, Claudia Sisa, S. C. Stansfield, Joyce Tsai, Sam Williams, Ekaterina Malievskaia (2023). \textit{Psilocybin for treatment resistant depression in patients taking a concomitant SSRI medication}. Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1038/s41386-023-01648-7}{doi:10.1038/s41386-023-01648-7}.
\item Guy M. Goodwin, Ekaterina Malievskaia, Gregory A. Fonzo, Charles B. Nemeroff (2023). \textit{Must Psilocybin Always “Assist Psychotherapy”?}. American Journal of Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1176/appi.ajp.20221043}{doi:10.1176/appi.ajp.20221043}.
\item Bianca Nogrady (2023). \textit{Australia’s approval of MDMA and psilocybin for PTSD and depression is premature, say critics}. BMJ. [published; OpenAlex]. \href{https://doi.org/10.1136/bmj.p1599}{doi:10.1136/bmj.p1599}.
\item Takaba R, Ibi D, Yoshida K, Hosomi E, Kawase R, Kitagawa H, Goto H, Achiwa M, Mizutani K, Maede K, González-Maeso J, Kitagaki S, Hiramatsu M. (2023). \textit{Ethopharmacological evaluation of antidepressant-like effect of serotonergic psychedelics in C57BL/6J male mice}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-3138705/v1}{doi:10.21203/rs.3.rs-3138705/v1}.
\item Tetem J, Fischmann T, Möller TJ. (2023). \textit{Psychoactive substances in psychotherapy - A vision for the future? - A systematic review on Psilocybin}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/ztyxh}{doi:10.31234/osf.io/ztyxh}.
\item Cybin Therapeutics Inc. (2023). \textit{Evaluating the Effect of Length of Time on Selective Serotonin Reuptake Inhibitors (SSRIs) on the Response to Psilocybin-assisted Therapy in Individuals With Mild-moderate Major Depressive Disorder (MDD)}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05594667}{source link}.
\item Unknown authors (2023). \textit{Psychoactive substances in psychotherapy - A vision for the future? - A systematic review on Psilocybin}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/ztyxh\_v1}{source link}.
\item Hovmand OR, Poulsen ED, Arnfred S, Storebø OJ. (2023). \textit{Risk of bias in randomized clinical trials on psychedelic medicine: A systematic review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811231180276}{doi:10.1177/02698811231180276}.
\item McCulloch DE, Olsen AS, Ozenne B, Stenbaek DS, Armand S, Madsen MK, Knudsen GM, Fisher PM. (2023). \textit{Navigating the chaos of psychedelic fMRI brain-entropy via multi-metric evaluations of acute psilocybin effects}. medRxiv. [preprint; medRxiv]. \href{https://doi.org/10.1101/2023.07.03.23292164}{doi:10.1101/2023.07.03.23292164}.
\item Bonnieux JN, VanderZwaag B, Premji Z, Garcia-Romeu A, Garcia-Barrera MA. (2023). \textit{Psilocybin's effects on cognition and creativity: A scoping review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811231179801}{doi:10.1177/02698811231179801}.
\item Grace Wade (2023). \textit{Psychedelic drug psilocybin shows promise treating anorexia in early trials}. The New Scientist. [published; OpenAlex]. \href{https://doi.org/10.1016/s0262-4079(23)01394-5}{doi:10.1016/s0262-4079(23)01394-5}.
\item McIntyre RS. (2023). \textit{Serotonin 5-HT2B receptor agonism and valvular heart disease: implications for the development of psilocybin and related agents.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/14740338.2023.2248883}{doi:10.1080/14740338.2023.2248883}.
\item McIntyre RS. (2023). \textit{Is the psychedelic experience an essential aspect of the therapeutic effect of serotonergic psychedelics? Conceptual, discovery, development and implementation implications for psilocybin and related agents.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/14740338.2023.2253144}{doi:10.1080/14740338.2023.2253144}.
\item Kozak Z, Johnson MW, Aaronson ST. (2023). \textit{Assessing potential of psilocybin for depressive disorders.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/13543784.2023.2273493}{doi:10.1080/13543784.2023.2273493}.
\item Muhammad Ishrat Husain, Daniel M. Blumberger, David Castle, Nicole Ledwos, Elise Fellows, Brett D. M. Jones, Abigail Ortiz, Stefan Kloiber, Wei Wang, Joshua D. Rosenblat, Benoit H. Mulsant (2023). \textit{Psilocybin for treatment-resistant depression without psychedelic effects: study protocol for a 4-week, double-blind, proof-of-concept randomised controlled trial}. BJPsych Open. [published; OpenAlex]. \href{https://doi.org/10.1192/bjo.2023.535}{doi:10.1192/bjo.2023.535}.
\item Gwyther M, Aspell JE. (2023). \textit{Alterations to self consciousness during mindfulness meditation and Flotation REST a comparative study}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/8ncj6}{doi:10.31234/osf.io/8ncj6}.
\item Unknown authors (2023). \textit{Alterations to self consciousness during mindfulness meditation and Flotation REST a comparative study}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/8ncj6\_v1}{source link}.
\item Jachimowski A, Kucia K. (2023). \textit{Classical psychedelics in psychiatry - renaissance of interest and therapeutic perspectives.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.12740/pp/150053}{doi:10.12740/pp/150053}.
\item Rich Haridy (2023). \textit{Australia to prescribe MDMA and psilocybin for PTSD and depression in world first}. Nature. [published; OpenAlex]. \href{https://doi.org/10.1038/d41586-023-02093-8}{doi:10.1038/d41586-023-02093-8}.
\item Patrick D. Skosnik, Jordan Sloshower, Hamideh Safi-Aghdam, Surbhi Pathania, Shariful A. Syed, Brian Pittman, Deepak Cyril D’Souza (2023). \textit{Sub-acute effects of psilocybin on EEG correlates of neural plasticity in major depression: Relationship to symptoms}. Journal of Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1177/02698811231179800}{doi:10.1177/02698811231179800}.
\item Scala M, Fanelli G, De Ronchi D, Serretti A, Fabbri C. (2023). \textit{Clinical specificity profile for novel rapid acting antidepressant drugs.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1097/yic.0000000000000488}{doi:10.1097/yic.0000000000000488}.
\item Halucenex Life Sciences Inc. (2023). \textit{Investigating the Therapeutic Effects of Psilocybin in Treatment-Resistant Post-Traumatic Stress Disorder}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05243329}{source link}.
\item Lee HJ, Tsang VW, Chai BS, Lin MC, Howard A, Uy C, Elefante JO. (2023). \textit{Psilocybin's Potential Mechanisms in the Treatment of Depression: A Systematic Review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/02791072.2023.2223195}{doi:10.1080/02791072.2023.2223195}.
\item Vojin Rakić (2023). \textit{Psilocybin: The most effective moral bio-enhancer?}. Bioethics. [published; OpenAlex]. \href{https://doi.org/10.1111/bioe.13196}{doi:10.1111/bioe.13196}.
\item Hecker L, kato k, Kleinhenz JMK, Shin Y, Papageorgiou J, Zarrabi A. (2023). \textit{Psilocybin decelerates cellular senescence}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-2921423/v1}{doi:10.21203/rs.3.rs-2921423/v1}.
\item Chen T, Cheng L, Ma J, Yuan J, Pi C, Xiong L, Chen J, Liu H, Tang J, Zhong Y, Zhang X, Liu Z, Zuo Y, Shen H, Wei Y, Zhao L. (2023). \textit{Molecular mechanisms of rapid-acting antidepressants: New perspectives for developing antidepressants.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.phrs.2023.106837}{doi:10.1016/j.phrs.2023.106837}.
\item Filip Tylš, Čestmír Vejmola, Vlastimil Koudelka, Václava Piorecká, L. Kadeřábek, Marcel Bochin, Tomáš Novák, Martin Kuchař, Zdeňka Bendová, Martin Brunovský, Jiřı́ Horáček, Tomáš Pálení ček (2023). \textit{Underlying pharmacological mechanisms of psilocin-induced broadband desynchronization and disconnection of EEG in rats}. Frontiers in Neuroscience. [published; OpenAlex]. \href{https://doi.org/10.3389/fnins.2023.1152578}{doi:10.3389/fnins.2023.1152578}.
\item Bheatrix Bienemann, Amanda Rocha Barbosa, Lucas Villar Magalhães da Cruz, Marco Multedo, Daniel C. Mograbi (2023). \textit{Health Benefits and Positive Acute Effects of Psilocybin Consumption: A Quantitative Textual Analysis of User Self-Reported Data}. Journal of Psychoactive Drugs. [published; OpenAlex]. \href{https://doi.org/10.1080/02791072.2023.2226414}{doi:10.1080/02791072.2023.2226414}.
\item Calder A, Mock S, Friedli N, Pasi P, Hasler G. (2023). \textit{Psychedelics in the treatment of eating disorders: Rationale and potential mechanisms.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.euroneuro.2023.05.008}{doi:10.1016/j.euroneuro.2023.05.008}.
\item Jessica E. Flower, William J. Gibbons, Alexandra M. Adams, Xin Wang, Caroline N. Broude, J. Andrew Jones (2023). \textit{“Biosynthesis of psilocybin and its nonnatural derivatives by a promiscuous psilocybin synthesis pathway in Escherichia coli”}. Biotechnology and Bioengineering. [published; OpenAlex]. \href{https://doi.org/10.1002/bit.28480}{doi:10.1002/bit.28480}.
\item M. Nikolič, Vojtěch Viktorin, Peter Zach, Filip Tylš, Daniela Dudysová, Karolína Janků, Jana Kopřivová, Martin Kuchař, Martin Brunovský, Jiřı́ Horáček, Tomáš Páleníček (2023). \textit{Psilocybin intoxication did not affect daytime or sleep-related declarative memory consolidation in a small sample exploratory analysis}. European Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/j.euroneuro.2023.04.019}{doi:10.1016/j.euroneuro.2023.04.019}.
\item Gina Ratkovic, Mike Sosteric, Tristan Sosteric (2023). \textit{A case-study evaluation of the “Copenhagen Music Program” for psilocybin-assisted therapy}. Frontiers in Psychology. [published; OpenAlex]. \href{https://doi.org/10.3389/fpsyg.2023.1156852}{doi:10.3389/fpsyg.2023.1156852}.
\item Benjamin R. Lewis, Eric L. Garland, Kevin Byrne, Tyler Durns, John Hendrick, Anna C. Beck, Paul Thielking (2023). \textit{HOPE: A Pilot Study of Psilocybin Enhanced Group Psychotherapy in Patients With Cancer}. Journal of Pain and Symptom Management. [published; OpenAlex]. \href{https://doi.org/10.1016/j.jpainsymman.2023.06.006}{doi:10.1016/j.jpainsymman.2023.06.006}.
\item Turkia M. (2023). \textit{The treatment of abandonment anxiety with MDMA and LSD}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/pw2tf}{doi:10.31234/osf.io/pw2tf}.
\item Nayak SM, White S, Hilbert S, Lowe MX, Jackson H, Griffiths RR, Garcia-Romeu A, Yaden DB. (2023). \textit{Naturalistic Psilocybin Use Increases Mind Perception but not Atheist-Believer status: A Prospective Longitudinal Study}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/auycp}{doi:10.31234/osf.io/auycp}.
\item Turkia M. (2023). \textit{Self-treatment of parental neglect-induced mixed anxiety and depressive disorder with psilocybin - A retrospective case study}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/qyce5}{doi:10.31234/osf.io/qyce5}.
\item Unknown authors (2023). \textit{The treatment of abandonment anxiety with MDMA and LSD}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/pw2tf\_v1}{source link}.
\item Nayak SM, White SH, Hilbert S, Lowe MX, Jackson H, Griffiths RR, Garcia-Romeu A, Yaden DB. (2023). \textit{Naturalistic Psilocybin Use Increases Mind Perception but not Atheist-Believer status: A Prospective Longitudinal Study}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/auycp\_v1}{doi:10.31234/osf.io/auycp\_v1}.
\item Unknown authors (2023). \textit{Naturalistic Psilocybin Use Increases Mind Perception but not Atheist-Believer status: A Prospective Longitudinal Study}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/auycp\_v1}{source link}.
\item Unknown authors (2023). \textit{Self-treatment of parental neglect-induced mixed anxiety and depressive disorder with psilocybin - A retrospective case study}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/qyce5\_v1}{source link}.
\item O'Grady C. (2023). \textit{No trip needed for psychedelics to lift mood?}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1126/science.adj1031}{doi:10.1126/science.adj1031}.
\item Natalie Gukasyan, Roland R. Griffiths, David B. Yaden, Denis Antoine, Sandeep M. Nayak (2023). \textit{Attenuation of psilocybin mushroom effects during and after SSRI/SNRI antidepressant use}. Journal of Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1177/02698811231179910}{doi:10.1177/02698811231179910}.
\item Nkadimeng SM, Steinmann CM, Eloff JN. (2023). \textit{Cardioprotective Potential of the Ethanol and Water Extracts of Four Psilocybin Mushrooms on Angiotensin II-Induced Hypertrophy and Oxidative Stress on H9C2 Cardiomyocytes}. Preprints.org. [preprint; Europe PMC]. \href{https://doi.org/10.20944/preprints202306.0362.v1}{doi:10.20944/preprints202306.0362.v1}.
\item Koning E, Brietzke E. (2023). \textit{Psilocybin-assisted psychotherapy as a potential treatment for eating disorders: a narrative review of preliminary evidence.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.47626/2237-6089-2022-0597}{doi:10.47626/2237-6089-2022-0597}.
\item Gabrielle Agin-Liebes, Elizabeth M. Nielson, Michael A. Zingman, Katherine Kim, Alexandra Haas, Lindsey T. Owens, Ursula Rogers, Michael P. Bogenschutz (2023). \textit{Reports of self-compassion and affect regulation in psilocybin-assisted therapy for alcohol use disorder: An interpretive phenomenological analysis.}. Psychology of Addictive Behaviors. [published; OpenAlex]. \href{https://doi.org/10.1037/adb0000935}{doi:10.1037/adb0000935}.
\item Schmidt TT, Costines C, Tagliazucchi E, Millière R, Garrido JM, Cuiule JI. (2023). \textit{The Altered Xperience Project (AXP): Quantitative and Qualitative Data from a Citizen Science Initiative on the Subjective Experience of Altered States of Consciousness}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/45z7w}{doi:10.31234/osf.io/45z7w}.
\item Polito V, Liknaitzky P. (2023). \textit{Is Microdosing a Placebo?}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/3ykst\_v1}{doi:10.31234/osf.io/3ykst\_v1}.
\item Unknown authors (2023). \textit{The Altered Xperience Project (AXP): Quantitative and Qualitative Data from a Citizen Science Initiative on the Subjective Experience of Altered States of Consciousness}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/45z7w\_v1}{source link}.
\item Polito V, Liknaitzky P. (2023). \textit{Is Microdosing a Placebo?}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/3ykst}{doi:10.31234/osf.io/3ykst}.
\item Unknown authors (2023). \textit{Is Microdosing a Placebo?}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/3ykst\_v1}{source link}.
\item Wall MB, Demetriou L, Giribaldi B, Roseman L, Ertl N, Erritzoe D, Nutt DJ, Carhart-Harris RL. (2023). \textit{Reduced brain responsiveness to emotional stimuli with escitalopram but not psilocybin therapy for depression}. medRxiv. [preprint; medRxiv]. \href{https://doi.org/10.1101/2023.05.29.23290667}{doi:10.1101/2023.05.29.23290667}.
\item Tooba Noor, Areej Shakil, Aimen Waqar Khan, Syeda Mahrukh Fatima Zaidi, Hussain Sohail Rangwala, Burhanuddin Sohail Rangwala (2023). \textit{Psilocybin therapy: A novel approach to treating depression}. International Journal of Surgery Global Health. [published; OpenAlex]. \href{https://doi.org/10.1097/gh9.0000000000000175}{doi:10.1097/gh9.0000000000000175}.
\item N. Jiten Singh (2023). \textit{Psilocybin (Magic Mushrooms)}. GFNPSS-International Journal of Multidisciplinary Research. [published; OpenAlex]. \href{https://doi.org/10.46376/ijmr/4.5.2023.2260-2265}{doi:10.46376/ijmr/4.5.2023.2260-2265}.
\item Federica Benvenuti, Daniele Colombo, Laura Soverchia, Nazzareno Cannella, Esi Domi, Roberto Ciccocioppo (2023). \textit{Psilocybin prevents reinstatement of alcohol seeking by disrupting the reconsolidation of alcohol-related memories}. Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1007/s00213-023-06384-w}{doi:10.1007/s00213-023-06384-w}.
\item Paul McCrone, Henry Fisher, Clare Knight, Rebecca Harding, Anne Katrin Schlag, David Nutt, Joanna C. Neill (2023). \textit{Cost-effectiveness of psilocybin-assisted therapy for severe depression: exploratory findings from a decision analytic model}. Psychological Medicine. [published; OpenAlex]. \href{https://doi.org/10.1017/s0033291723001411}{doi:10.1017/s0033291723001411}.
\item Brandon Weiss, Induni Ginige, Lu Shannon, Bruna Giribaldi, Ashleigh Murphy-Beiner, Roberta Murphy, Michelle Baker-Jones, Jonny Martell, David Nutt, Robin Carhart-Harris, David Erritzøe (2023). \textit{Personality change in a trial of psilocybin therapy v. escitalopram treatment for depression}. Psychological Medicine. [published; OpenAlex]. \href{https://doi.org/10.1017/s0033291723001514}{doi:10.1017/s0033291723001514}.
\item Manish Agrawal, Sarah Shnayder, Heather Honstein, Ezekiel Emanuel, Paul Thambi (2023). \textit{Long term efficacy of psilocybin in patients with cancer and major depressive disorder (MDD).}. Journal of Clinical Oncology. [published; OpenAlex]. \href{https://doi.org/10.1200/jco.2023.41.16\_suppl.12021}{doi:10.1200/jco.2023.41.16\_suppl.12021}.
\item Basant Pradhan, Ankit Rana, Edward Goldschmidt, Anthony L. Rostain (2023). \textit{ID: 212703 Augmenting rTMS With Psilocybin-Assisted Psychotherapy (PAP) for PTSD: A Proof-of-Concept Study Design}. Neuromodulation Technology at the Neural Interface. [published; OpenAlex]. \href{https://doi.org/10.1016/j.neurom.2023.04.144}{doi:10.1016/j.neurom.2023.04.144}.
\item Strauss D, Ghosh S, Murray Z, Gryzenhout M. (2023). \textit{Global species diversity and distribution of the psychedelic fungal genus Panaeolus}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/AGR/IND608043020}{source link}.
\item Halman A, Kong G, Sarris J, Perkins D. (2023). \textit{Drug-drug interactions between classic psychedelics and psychoactive drugs: a systematic review}. medRxiv. [preprint; medRxiv]. \href{https://doi.org/10.1101/2023.06.01.23290811}{doi:10.1101/2023.06.01.23290811}.
\item Holoyda B. (2023). \textit{The Perilous Policy of Oregon's Psilocybin Services.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.29158/jaapl.230023-23}{doi:10.29158/jaapl.230023-23}.
\item Gold ND, Podrebarac SK, White LA, Marini C, Simon NM, Mittelman MS, Ross S, Bogenschutz MP, Petridis PD (2023). \textit{Examining the Rationale for Studying Psychedelic-Assisted Psychotherapy for the Treatment of Caregiver Distress.}. Psychedelic medicine (New Rochelle, N.Y.). [published; PubMed]. \href{https://doi.org/10.1089/psymed.2022.0011}{doi:10.1089/psymed.2022.0011}.
\item Unknown authors (2023). \textit{Supplemental Material for Reports of Self-Compassion and Affect Regulation in Psilocybin-Assisted Therapy for Alcohol Use Disorder: An Interpretive Phenomenological Analysis}. Psychology of Addictive Behaviors. [published; OpenAlex]. \href{https://doi.org/10.1037/adb0000935.supp}{doi:10.1037/adb0000935.supp}.
\item Evens R, Schmidt ME, Majić T, Schmidt TT. (2023). \textit{The psychedelic afterglow phenomenon: a systematic review of subacute effects of classic serotonergic psychedelics.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/20451253231172254}{doi:10.1177/20451253231172254}.
\item Brown O. (2023). \textit{Letter to the editor on "Increased low-frequency brain responses to music after psilocybin therapy for depression".}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jad.2023.05.088}{doi:10.1016/j.jad.2023.05.088}.
\item James Rucker (2023). \textit{Evidence versus expectancy: the development of psilocybin therapy}. BJPsych Bulletin. [published; OpenAlex]. \href{https://doi.org/10.1192/bjb.2023.28}{doi:10.1192/bjb.2023.28}.
\item Heal DJ, Smith SL, Belouin SJ, Henningfield JE. (2023). \textit{Psychedelics: Threshold of a Therapeutic Revolution.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neuropharm.2023.109610}{doi:10.1016/j.neuropharm.2023.109610}.
\item Whelan TP, Daly E, Puts NA, Malievskaia E, Murphy DG, McAlonan GM. (2023). \textit{Bridging the translational neuroscience gap: Development of the ‘shiftability’ paradigm and an exemplar protocol to capture psilocybin-elicited ‘shift’ in neurobiological mechanisms in autism}. medRxiv. [preprint; medRxiv]. \href{https://doi.org/10.1101/2023.05.25.23290521}{doi:10.1101/2023.05.25.23290521}.
\item Combat Stress (2023). \textit{Evaluation of the Acceptability, Safety, Feasibility, and Efficacy of Psilocybin-assisted Psychotherapy (PaP) for the Treatment of Post-traumatic Stress Disorder (PTSD) in Military Veterans}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05876481}{source link}.
\item Keramatian K, Chakrabarty T, DuBow A, Saraf G, Yatham LN. (2023). \textit{New Pharmacologic Approaches to the Treatment of Bipolar Depression.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s40265-023-01872-x}{doi:10.1007/s40265-023-01872-x}.
\item Laura Ley, Friederike Holze, Denis Arikci, A. Becker, Isabelle Straumann, Aaron Klaiber, Fabio Coviello, Sophie Dierbach, Jan Thomann, Urs Duthaler, Dino Luethi, Nimmy Varghese, Anne Eckert, Matthias E. Liechti (2023). \textit{Comparative acute effects of mescaline, lysergic acid diethylamide, and psilocybin in a randomized, double-blind, placebo-controlled cross-over study in healthy participants}. Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1038/s41386-023-01607-2}{doi:10.1038/s41386-023-01607-2}.
\item Qasim S, Zaheer Z, Jawad MY, Shad MU. (2023). \textit{Neurobiological Correlates of Psilocybin Response in Depression.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.4088/pcc.22r03419}{doi:10.4088/pcc.22r03419}.
\item Junhong Liu, Yuanyuan Wang, Ke Xia, Jinfeng Wu, Danhao Zheng, Aoling Cai, Haitao Yan, Ruibin Su (2023). \textit{Acute psilocybin increased cortical activities in rats}. Frontiers in Neuroscience. [published; OpenAlex]. \href{https://doi.org/10.3389/fnins.2023.1168911}{doi:10.3389/fnins.2023.1168911}.
\item University of Wisconsin, Madison (2023). \textit{Recall of Experience and Conscious Awareness in Psilocybin Treatment of Depression (The RECAP Study): Pilot Phase in Healthy Adult Volunteers}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT04842045}{source link}.
\item Fonseka LN, Woo BK. (2023). \textit{Therapeutic role of psilocybin and 3,4-methylenedioxymethamphetamine in trauma: A literature review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.5498/wjp.v13.i5.182}{doi:10.5498/wjp.v13.i5.182}.
\item Lasch A, Schweikert T, Dora E, Kolb T, Schurig HL, Walther A. (2023). \textit{[Psilocybin-Assisted Treatment of Depression, Anxiety and Substance use Disorders: Neurobiological Basis and Clinical Application].}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1055/a-2046-5202}{doi:10.1055/a-2046-5202}.
\item Raithatha SA, Hagel JM, Matinkhoo K, Yu L, Press D, Cook SG, Sharma G, D D, Jensen G, Lee JB, Cai C, Gallant J, Bains JS, Tucker JE, Facchini PJ. (2023). \textit{Novel psilocin prodrugs with altered pharmacological properties as candidate therapies for treatment-resistant anxiety disorders}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2023.05.16.540994}{doi:10.1101/2023.05.16.540994}.
\item Meyer M, Slot J. (2023). \textit{The evolution and ecology of psilocybin in nature.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.fgb.2023.103812}{doi:10.1016/j.fgb.2023.103812}.
\item Strauss D, Ghosh S, Murray Z, Gryzenhout M. (2023). \textit{Global species diversity and distribution of the psychedelic fungal genus Panaeolus.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.heliyon.2023.e16338}{doi:10.1016/j.heliyon.2023.e16338}.
\item University of Wisconsin, Madison (2023). \textit{A Phase 1 Study Comparing the Pharmacokinetics and Safety of Intravenous and Oral Psilocybin}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05467761}{source link}.
\item THORENS G, PENZENSTADLER l, FURTADO LCDC, SERAGNOLI F, ROTHEN S, MABILAIS C, ZULLINO D. (2023). \textit{Exposure therapy under psilocybin for general anxiety disorder and claustrophobia}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-2859973/v1}{doi:10.21203/rs.3.rs-2859973/v1}.
\item Singleton SP, Timmermann C, Luppi AI, Eckernäs E, Roseman L, Carhart-Harris RL, Kuceyeski A. (2023). \textit{Time-resolved network control analysis links reduced control energy under DMT with the serotonin 2a receptor, signal diversity, and subjective experience}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2023.05.11.540409}{doi:10.1101/2023.05.11.540409}.
\item Kargbo RB. (2023). \textit{Microbiome-Gut-Brain Axis Modulation: New Approaches in Treatment of Neuropsychological and Gastrointestinal Functional Disorders.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/acsmedchemlett.3c00168}{doi:10.1021/acsmedchemlett.3c00168}.
\item Kisely S. (2023). \textit{The down-scheduling of MDMA and psilocybin(e): Too fast and too soon.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/00048674231174171}{doi:10.1177/00048674231174171}.
\item Suhwoo Bae, Michael Vaysblat, Edward Jong Bae, Ilja Dejanovic, Matthew Pierce (2023). \textit{Cardiac Arrest Associated With Psilocybin Use and Hereditary Hemochromatosis}. Cureus. [published; OpenAlex]. \href{https://doi.org/10.7759/cureus.38669}{doi:10.7759/cureus.38669}.
\item Johns Hopkins University (2023). \textit{Effects of Psilocybin in Anorexia Nervosa}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT04052568}{source link}.
\item Gaddis A, Lidstone DE, Nebel MB, Griffiths RR, Mostofsky SH, Mejia AF, Barrett FS. (2023). \textit{Corrigendum to 'Psilocybin induces spatially constrained alterations in thalamic functional organizaton and connectivity': Neuroimage 2022 Oct 15;260:119434.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neuroimage.2023.120130}{doi:10.1016/j.neuroimage.2023.120130}.
\item Rossell SL, Meikle SE, Williams ML, Castle DJ. (2023). \textit{Why didn't the TGA consult with Australian researchers and clinicians with experience in psilocybin-assisted psychotherapy for treatment-resistant major depressive disorder?}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/00048674231172691}{doi:10.1177/00048674231172691}.
\item Richard J. Zeifman, Anne Catherine Wagner, Candice M. Monson, Robin Carhart-Harris (2023). \textit{How does psilocybin therapy work? An exploration of experiential avoidance as a putative mechanism of change}. Journal of Affective Disorders. [published; OpenAlex]. \href{https://doi.org/10.1016/j.jad.2023.04.105}{doi:10.1016/j.jad.2023.04.105}.
\item Margaret Ross, Justin Dwyer (2023). \textit{Using Psilocybin Therapy for treating end of life distress trial}. The Ballarat naturalist.. [published; OpenAlex]. \href{https://doi.org/10.5962/p.388212}{doi:10.5962/p.388212}.
\item Goodwin GM, Croal M, Marwood L, Malievskaia E (2023). \textit{Unblinding and demand characteristics in the treatment of depression.}. Journal of affective disorders. [published; PubMed]. \href{https://doi.org/10.1016/j.jad.2023.02.030}{doi:10.1016/j.jad.2023.02.030}.
\item Alan K. Davis, Adam W. Levin, Paul Nagib, Stacey B. Armstrong, Rafael Lancelotta (2023). \textit{Study protocol of an open-label proof-of-concept trial examining the safety and clinical efficacy of psilocybin-assisted therapy for veterans with PTSD}. BMJ Open. [published; OpenAlex]. \href{https://doi.org/10.1136/bmjopen-2022-068884}{doi:10.1136/bmjopen-2022-068884}.
\item Dunn Harmony, Freeman Judy, Michael John Dochniak (2023). \textit{Psilocybin-Based Breakthroughs in Natural Medicine}. Case Reports and Reviews. [published; OpenAlex]. \href{https://doi.org/10.33425/2693-1516.1021}{doi:10.33425/2693-1516.1021}.
\item Dunn Harmony, Freeman Judy, D Michael (2023). \textit{Psilocybin-based mushrooms and usage}. Case Reports and Reviews. [published; OpenAlex]. \href{https://doi.org/10.33425/2693-1516.1022}{doi:10.33425/2693-1516.1022}.
\item McAlpine R, Blackburne G, Kamboj S. (2023). \textit{Development and psychometric validation of a novel scale for measuring ‘psychedelic preparedness’}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/gw9jp}{doi:10.31234/osf.io/gw9jp}.
\item Unknown authors (2023). \textit{Development and psychometric validation of a novel scale for measuring ‘psychedelic preparedness’}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/gw9jp\_v1}{source link}.
\item Eric N. Kramer, Kalyn Reddy, Bryan Shapiro (2023). \textit{A suicide attempt following psilocybin ingestion in a patient with no prior psychiatric history}. Psychiatry Research Case Reports. [published; OpenAlex]. \href{https://doi.org/10.1016/j.psycr.2023.100118}{doi:10.1016/j.psycr.2023.100118}.
\item Terence H. W. Ching, Rachael Grazioplene, Calvin Bohner, Stephen A. Kichuk, Giuliana DePalmer, Elizabeth J. D’Amico, Jeffrey Eilbott, Anastasia Jankovsky, Michelle Burke, Jamila Hokanson, Brad Martins, Chelsea Witherow, Prerana Patel, Lucia Amoroso, Henry Schaer, Christopher Pittenger, Benjamin Kelmendi (2023). \textit{Safety, tolerability, and clinical and neural effects of single-dose psilocybin in obsessive-compulsive disorder: protocol for a randomized, double-blind, placebo-controlled, non-crossover trial}. Frontiers in Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.3389/fpsyt.2023.1178529}{doi:10.3389/fpsyt.2023.1178529}.
\item Brandon Weiss, David Erritzøe, Bruna Giribaldi, David Nutt, Robin Carhart-Harris (2023). \textit{A critical evaluation of QIDS-SR-16 using data from a trial of psilocybin therapy versus escitalopram treatment for depression}. Journal of Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1177/02698811231167848}{doi:10.1177/02698811231167848}.
\item Elisabeth Jean Wood (2023). \textit{Psychedelic Sensationalism: An Analysis of the Schedule Classification of Psilocybin}. Vanderbilt Undergraduate Research Journal. [published; OpenAlex]. \href{https://doi.org/10.15695/vurj.v13i1.5403}{doi:10.15695/vurj.v13i1.5403}.
\item COMPASS Pathways (2023). \textit{The Safety and Efficacy of Psilocybin in Participants With Treatment Resistant Depression}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT03775200}{source link}.
\item Bennett JN, Blough MD, Mitchell I, Galloway L, Bains R. (2023). \textit{A Phase I trial to inform clinical protocols for the safe administration of psilocybin-assisted psychotherapy}. medRxiv. [preprint; medRxiv]. \href{https://doi.org/10.1101/2023.04.12.23288325}{doi:10.1101/2023.04.12.23288325}.
\item Braun D, Rosenberg A, Haruvi R, Malamud D, Barbara R, Kawashima T. (2023). \textit{High-resolution tracking of unconfined zebrafish behavior reveals stimulatory and anxiolytic effects of psilocybin}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2023.04.13.536830}{doi:10.1101/2023.04.13.536830}.
\item Whinkin E, Opalka M, Watters C, Jaffe A, Aggarwal S. (2023). \textit{Psilocybin in Palliative Care: An Update.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s13670-023-00383-7}{doi:10.1007/s13670-023-00383-7}.
\item Manish Agrawal, Ezekiel Emanuel, Brian D. Richards, William A. Richards, Kim Roddy, Paul Thambi (2023). \textit{Assessment of Psilocybin Therapy for Patients With Cancer and Major Depression Disorder}. JAMA Oncology. [published; OpenAlex]. \href{https://doi.org/10.1001/jamaoncol.2023.0351}{doi:10.1001/jamaoncol.2023.0351}.
\item Karina Wang, Yiqun Sun, Brenda Nava, Luke Sampiere, Robin J. Jacobs (2023). \textit{Predictors of Medical Students’ Perceptions of Psilocybin-Assisted Therapy for Use in Medical Practice}. Cureus. [published; OpenAlex]. \href{https://doi.org/10.7759/cureus.37450}{doi:10.7759/cureus.37450}.
\item Aron Amaev, Jianmeng Song, Yasaman Kambari, Fumihiko Ueno, Edgardo Torres-Carmona, Ali Abdolizadeh, Teruki Koizumi, Vincenzo De Luca, Bruce G. Pollock, Alastair J. Flint, Muhammad Ishrat Husain, Ariel Graff-Guerrero, Philip Gerretsen (2023). \textit{118. Does Psilocybin Change Synaptic Vesicular Density in the Brains of Patients With Mild Cognitive Impairment?}. Biological Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.biopsych.2023.02.358}{doi:10.1016/j.biopsych.2023.02.358}.
\item Xi Zhu, David J. Hellerstein, Jamie D. Feusner, Michael G. Wheaton, Gloria Gómez, Franklin R. Schneier (2023). \textit{347. Changes in Resting State Functional Connectivity After Psilocybin for Body Dysmorphic Disorder}. Biological Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.biopsych.2023.02.587}{doi:10.1016/j.biopsych.2023.02.587}.
\item Scott Aaronson, Tammy Miller, Samuel Rudow, MacKenzie Forbes, Audrey Shoultz, Trisha Suppes (2023). \textit{96. An Open Label Study of Synthetic Psilocybin in Bipolar Type II Depression}. Biological Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.biopsych.2023.02.336}{doi:10.1016/j.biopsych.2023.02.336}.
\item Volodymyr Tkach, Kucher Mykhailo, Kushnir Marta, Ivanushko Yana, Akınay Yüksel, Karakoyun Necdet, Yagodynets Petro, Kormosh Zholt (2023). \textit{The Theoretical Description for Psilocin Electrochemical Determination over Cobalt Oxyhydroxide}. Orbital: The Electronic Journal of Chemistry. [published; Crossref]. \href{https://doi.org/10.17807/orbital.v15i1.18012}{doi:10.17807/orbital.v15i1.18012}.
\item Jianmeng Song, Yasaman Kambari, Aron Amaev, Fumihiko Ueno, Edgardo Torres Carmona, Vincenzo De Luca, Bruce G. Pollock, Alastair J. Flint, Muhammad Ishrat Husain, Ariel Graff-Guerrero, Philip Gerretsen (2023). \textit{Psilocybin to promote synaptogenesis in the brains of patients with mild cognitive impairment}. Medical Hypotheses. [published; OpenAlex]. \href{https://doi.org/10.1016/j.mehy.2023.111068}{doi:10.1016/j.mehy.2023.111068}.
\item Khan I, Jaura TA, Tukruna A, Arif A, Tebha SS, Nasir S, Mukherjee D, Masroor N, Yosufi A. (2023). \textit{Use of Selective Alternative Therapies for Treatment of OCD.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.2147/ndt.s403997}{doi:10.2147/ndt.s403997}.
\item Ali Asghar Hakami Zanjani, Teresa Quynh Tram Nguyen, Luise Jacobsen, Himanshu Khandelia (2023). \textit{The molecular basis of the antidepressant action of the magic mushroom extract, psilocin}. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics. [published; OpenAlex]. \href{https://doi.org/10.1016/j.bbapap.2023.140914}{doi:10.1016/j.bbapap.2023.140914}.
\item Zia FZ, Baumann MH, Belouin SJ, Dworkin RH, Ghauri MH, Hendricks PS, Henningfield JE, Lanier RK, Ross S, Berger A. (2023). \textit{Are psychedelic medicines the reset for chronic pain? Preliminary findings and research needs.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neuropharm.2023.109528}{doi:10.1016/j.neuropharm.2023.109528}.
\item Julia Mertens L. (2023). \textit{Psilocybin zeigt Wirkung bei Depression.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s15006-023-2540-9}{doi:10.1007/s15006-023-2540-9}.
\item Simonsson O, Hendricks PS, Chambers R, Osika W, Goldberg SB (2023). \textit{Prevalence and associations of challenging, difficult or distressing experiences using classic psychedelics.}. Journal of affective disorders. [published; PubMed]. \href{https://doi.org/10.1016/j.jad.2023.01.073}{doi:10.1016/j.jad.2023.01.073}.
\item Simpson GHR, Chatwin C, van Hellemont E (2023). \textit{Liminal spaces, seasonal faces: Challenging drug market assumptions via an exploration of naturally occurring magic mushroom markets in rural Kent.}. The International journal on drug policy. [published; PubMed]. \href{https://doi.org/10.1016/j.drugpo.2023.103973}{doi:10.1016/j.drugpo.2023.103973}.
\item Wang Y, Sun H, Ji Q, Wei J, Zhu P. (2023). \textit{Systematic Review of Interventions for Demoralization in Patients With Cancer.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1097/nmd.0000000000001615}{doi:10.1097/nmd.0000000000001615}.
\item Simonsson C, Chambers R, Hendricks PS, Goldberg SB, Osika W, Schlosser M, Ryde A, Christersson E, Simonsson O (2023). \textit{Classic psychedelic use and current meditation practice.}. Mindfulness. [published; PubMed]. \href{https://doi.org/10.1007/s12671-023-02103-w}{doi:10.1007/s12671-023-02103-w}.
\item Dawood Hristova JJ, Pérez-Jover V. (2023). \textit{Psychotherapy with Psilocybin for Depression: Systematic Review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/bs13040297}{doi:10.3390/bs13040297}.
\item Feduccia A, Agin-Liebes G, Price CM, Grinsell N, Paradise S, Rabin DM. (2023). \textit{The need for establishing best practices and gold standards in psychedelic medicine.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jad.2023.03.083}{doi:10.1016/j.jad.2023.03.083}.
\item Yingjie Du, Yunfeng Li, Xiangting Zhao, Yishan Yao, Bin Wang, Liming Zhang, Guyan Wang (2023). \textit{Psilocybin facilitates fear extinction in mice by promoting hippocampal neuroplasticity}. Chinese Medical Journal. [published; OpenAlex]. \href{https://doi.org/10.1097/cm9.0000000000002647}{doi:10.1097/cm9.0000000000002647}.
\item University Hospital, Basel, Switzerland (2023). \textit{Role of the Serotonin 5-HT2A Receptor in Mescaline-induced Altered States of Consciousness}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT04849013}{source link}.
\item Ibi D. (2023). \textit{[Contribution of serotonin 5-HT2A receptor to antidepressant effect of serotonergic psychedelics].}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1254/fpj.22141}{doi:10.1254/fpj.22141}.
\item Franklin R. Schneier, Jamie D. Feusner, Michael G. Wheaton, Gloria J. Gomez, Giselle Cornejo, Akansha M. Naraindas, David J. Hellerstein (2023). \textit{Pilot study of single-dose psilocybin for serotonin reuptake inhibitor-resistant body dysmorphic disorder}. Journal of Psychiatric Research. [published; OpenAlex]. \href{https://doi.org/10.1016/j.jpsychires.2023.03.031}{doi:10.1016/j.jpsychires.2023.03.031}.
\item Kamal S, Jha MK, Radhakrishnan R. (2023). \textit{Role of Psychedelics in Treatment-Resistant Depression.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.psc.2023.02.004}{doi:10.1016/j.psc.2023.02.004}.
\item William Irvine, Marshall Tyler, Rupika Delgoda (2023). \textit{In silico characterization of the psilocybin biosynthesis pathway}. Computational Biology and Chemistry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.compbiolchem.2023.107854}{doi:10.1016/j.compbiolchem.2023.107854}.
\item Domanegg K, Sommer WH, Meinhardt MW. (2023). \textit{Psychedelic Targeting of Metabotropic Glutamate Receptor 2 and Its Implications for the Treatment of Alcoholism.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/cells12060963}{doi:10.3390/cells12060963}.
\item Rosenblat JD, Leon-Carlyle M, Ali S, Husain MI, McIntyre RS. (2023). \textit{Antidepressant Effects of Psilocybin in the Absence of Psychedelic Effects.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1176/appi.ajp.20220835}{doi:10.1176/appi.ajp.20220835}.
\item Tolle HM, Farah JC, Mallaroni P, Mason NL, Ramaekers JG, Amico E. (2023). \textit{The Unique Neural Signature of Your Trip: Functional Connectome Fingerprints of Subjective Psilocybin Experience}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2023.03.20.532894}{doi:10.1101/2023.03.20.532894}.
\item Optimi Health Corporation (2023). \textit{Mood and Cognitive Effects of Low Doses of Psilocybin Observed in Healthy Subjects ("MELO"): A Blinded, Placebo-Controlled, Dose-Finding Study}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05252598}{source link}.
\item Jordan Sloshower, Patrick D. Skosnik, Hamideh Safi-Aghdam, Surbhi Pathania, Shariful A. Syed, Brian Pittman, Deepak Cyril D’Souza (2023). \textit{Psilocybin-assisted therapy for major depressive disorder: An exploratory placebo-controlled, fixed-order trial}. Journal of Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1177/02698811231154852}{doi:10.1177/02698811231154852}.
\item Sharma R, Batchelor R, Sin J. (2023). \textit{Psychedelic Treatments for Substance Use Disorder and Substance Misuse: A Mixed Methods Systematic Review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/02791072.2023.2190319}{doi:10.1080/02791072.2023.2190319}.
\item Ching THW, Grazioplene R, Pittenger C, Kelmendi B. (2023). \textit{Yale Program for Psychedelic Science (YPPS) Manual for Psilocybin Combined with Non-Directive Support in the Treatment of OCD}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/ba42z}{doi:10.31234/osf.io/ba42z}.
\item Unknown authors (2023). \textit{Yale Program for Psychedelic Science (YPPS) Manual for Psilocybin Combined with Non-Directive Support in the Treatment of OCD}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/ba42z\_v1}{source link}.
\item Palamar JJ, Le A, Cleland CM, Keyes KM. (2023). \textit{Trends in drug use among nightclub and festival attendees in New York City, 2017-2022.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.drugpo.2023.104001}{doi:10.1016/j.drugpo.2023.104001}.
\item Ryan RS, Copello A, Fox AP (2023). \textit{Experiences of microdosing psychedelics in an attempt to support wellbeing and mental health.}. BMC psychiatry. [published; PubMed]. \href{https://doi.org/10.1186/s12888-023-04628-9}{doi:10.1186/s12888-023-04628-9}.
\item Timur Zanikov, Marta Gerasymchuk, Esmaeel Ghasemi Gojani, Gregory Ian Robinson, Shima Asghari, Alyssa Groves, Lucie Haselhorst, Sanjana Nandakumar, Cora Stahl, Mackenzie Cameron, Dongping Li, Rocio Rodriguez-Juarez, Alexandra Snelling, Darryl Hudson, Anna Fiselier, Olga Kovalchuk, Igor Kovalchuk (2023). \textit{The Effect of Combined Treatment of Psilocybin and Eugenol on Lipopolysaccharide-Induced Brain Inflammation in Mice}. Molecules. [published; OpenAlex]. \href{https://doi.org/10.3390/molecules28062624}{doi:10.3390/molecules28062624}.
\item Brett J, Knock E, Korthuis PT, Liknaitzky P, Murnane KS, Nicholas CR, Patterson JC, Stauffer CS. (2023). \textit{Exploring psilocybin-assisted psychotherapy in the treatment of methamphetamine use disorder.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fpsyt.2023.1123424}{doi:10.3389/fpsyt.2023.1123424}.
\item New York State Psychiatric Institute (2023). \textit{Safety and Efficacy of Psilocybin for Body Dysmorphic Disorder}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT04656301}{source link}.
\item Wulff AB, Nichols CD, Thompson SM. (2023). \textit{Preclinical perspectives on the mechanisms underlying the therapeutic actions of psilocybin in psychiatric disorders.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neuropharm.2023.109504}{doi:10.1016/j.neuropharm.2023.109504}.
\item Parker Emmerson (2023). \textit{Patternizing Psilocybin in Logic Space}. Zenodo (CERN European Organization for Nuclear Research). [published; OpenAlex]. \href{https://doi.org/10.5281/zenodo.7720548}{doi:10.5281/zenodo.7720548}.
\item Turkia M. (2023). \textit{Understanding psychedelic 'mystical experience'-A case example}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/dh92g}{doi:10.31234/osf.io/dh92g}.
\item Turkia M. (2023). \textit{Self-treatment of depression and complex post-traumatic stress disorder with psilocybin and LSD-A retrospective case study}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/wupvy}{doi:10.31234/osf.io/wupvy}.
\item Turkia M. (2023). \textit{Underground small-group therapy of treatment-resistant depression and complex post-traumatic stress disorder (C-PTSD) with psilocybin-A retrospective case study}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/t6k9b}{doi:10.31234/osf.io/t6k9b}.
\item Unknown authors (2023). \textit{Understanding psychedelic 'mystical experience'-A case example}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/dh92g\_v1}{source link}.
\item Unknown authors (2023). \textit{Self-treatment of depression and complex post-traumatic stress disorder with psilocybin and LSD-A retrospective case study}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/wupvy\_v1}{source link}.
\item Unknown authors (2023). \textit{Underground small-group therapy of treatment-resistant depression and complex post-traumatic stress disorder (C-PTSD) with psilocybin-A retrospective case study}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/t6k9b\_v1}{source link}.
\item Kalkman HO (2023). \textit{Inhibition of Microglial GSK3β Activity Is Common to Different Kinds of Antidepressants: A Proposal for an In Vitro Screen to Detect Novel Antidepressant Principles.}. Biomedicines. [published; PubMed]. \href{https://doi.org/10.3390/biomedicines11030806}{doi:10.3390/biomedicines11030806}.
\item Emma I Kopra, Jason Ferris, Adam Winstock, Kim P. C. Kuypers, Allan H. Young, James Rucker (2023). \textit{Investigation of self-treatment with lysergic acid diethylamide and psilocybin mushrooms: Findings from the Global Drug Survey 2020}. Journal of Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1177/02698811231158245}{doi:10.1177/02698811231158245}.
\item Lazur J, Hnatyk K, Kała K, Sułkowska-Ziaja K, Muszyńska B. (2023). \textit{Discovering the Potential Mechanisms of Medicinal Mushrooms Antidepressant Activity: A Review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/antiox12030623}{doi:10.3390/antiox12030623}.
\item Otterman LS (2023). \textit{Research into Psychedelic-Assisted Psychotherapy for Anorexia Nervosa Should be Funded.}. Journal of bioethical inquiry. [published; PubMed]. \href{https://doi.org/10.1007/s11673-022-10220-9}{doi:10.1007/s11673-022-10220-9}.
\item Zohairi F, Khandelia H, Hakami Zanjani AA (2023). \textit{Interaction of psychedelic tryptamine derivatives with a lipid bilayer.}. Chemistry and physics of lipids. [published; PubMed]. \href{https://doi.org/10.1016/j.chemphyslip.2023.105279}{doi:10.1016/j.chemphyslip.2023.105279}.
\item Jha MK, Mathew SJ. (2023). \textit{Pharmacotherapies for Treatment-Resistant Depression: How Antipsychotics Fit in the Rapidly Evolving Therapeutic Landscape.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1176/appi.ajp.20230025}{doi:10.1176/appi.ajp.20230025}.
\item Anne Karow (2023). \textit{Psychedelische Therapie mit Psilocybin und Psychotherapie - Wo stehen wir?}. PPmP - Psychotherapie · Psychosomatik · Medizinische Psychologie. [published; OpenAlex]. \href{https://doi.org/10.1055/a-2010-7640}{doi:10.1055/a-2010-7640}.
\item Daniel A Kinderlehrer (2023). \textit{The Effectiveness of Microdosed Psilocybin in the Treatment of Neuropsychiatric Lyme Disease: A Case Study}. International Medical Case Reports Journal. [published; OpenAlex]. \href{https://doi.org/10.2147/imcrj.s395342}{doi:10.2147/imcrj.s395342}.
\item Meghan Hibicke, Hannah M. Kramer, Charles D. Nichols (2023). \textit{A Single Administration of Psilocybin Persistently Rescues Cognitive Deficits Caused by Adolescent Chronic Restraint Stress Without Long-Term Changes in Synaptic Protein Gene Expression in a Rat Experimental System with Translational Relevance to Depression}. Psychedelic Medicine. [published; OpenAlex]. \href{https://doi.org/10.1089/psymed.2022.0012}{doi:10.1089/psymed.2022.0012}.
\item Gattuso JJ, Perkins D, Ruffell S, Lawrence AJ, Hoyer D, Jacobson LH, Timmermann C, Castle D, Rossell SL, Downey LA, Pagni BA, Galvão-Coelho NL, Nutt D, Sarris J. (2023). \textit{Default Mode Network Modulation by Psychedelics: A Systematic Review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1093/ijnp/pyac074}{doi:10.1093/ijnp/pyac074}.
\item Xi D, Berger A, Shurtleff D, Zia FZ, Belouin S. (2023). \textit{National Institutes of Health psilocybin research speaker series: State of the science, regulatory and policy landscape, research gaps, and opportunities.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neuropharm.2023.109467}{doi:10.1016/j.neuropharm.2023.109467}.
\item 飯倉 洋治, 馬場 實, 三河 春樹, 西間 三馨, 前田 和一, 赤坂 徹, 正木 拓朗, 有田 昌彦 (2023). \textit{Effect of psilocybin on decision-making and motivation in the healthy rat.}. PubMed. [published; OpenAlex]. \href{https://doi.org/10.1016/j.bbr.2022.114262}{doi:10.1016/j.bbr.2022.114262}.
\item Rijsketic DR, Casey AB, Barbosa DA, Zhang X, Hietamies TM, Ramirez-Ovalle G, Pomrenze M, Halpern CH, Williams LM, Malenka RC, Heifets BD. (2023). \textit{UNRAVELing the synergistic effects of psilocybin and environment on brain-wide immediate early gene expression in mice}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2023.02.19.528997}{doi:10.1101/2023.02.19.528997}.
\item Mallaroni P, Mason NL, Reckweg JT, Paci R, Ritscher S, Toennes SW, Theunissen EL, Kuypers KP, Ramaekers JG. (2023). \textit{Assessment of the acute effects of 2C-B vs psilocybin on subjective experience, mood and cognition}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2023.02.16.528808}{doi:10.1101/2023.02.16.528808}.
\item Crowe M, Manuel J, Carlyle D, Lacey C. (2023). \textit{Experiences of psilocybin treatment for clinical conditions: A qualitative meta-synthesis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1111/inm.13127}{doi:10.1111/inm.13127}.
\item Jeffery Heilman (2023). \textit{The History, Legalization and Potentials of Psilocybin-Assisted Psychotherapy}. Journal of Scientific Exploration. [published; OpenAlex]. \href{https://doi.org/10.31275/20222633}{doi:10.31275/20222633}.
\item van der Meer PB, Fuentes JJ, Kaptein AA, Schoones JW, de Waal MM, Goudriaan AE, Kramers K, Schellekens A, Somers M, Bossong MG, Batalla A. (2023). \textit{Therapeutic effect of psilocybin in addiction: A systematic review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fpsyt.2023.1134454}{doi:10.3389/fpsyt.2023.1134454}.
\item Henríquez-Hernández LA, Rojas-Hernández J, Quintana-Hernández DJ, Borkel LF. (2023). \textit{Hofmann vs. Paracelsus: Do Psychedelics Defy the Basics of Toxicology?-A Systematic Review of the Main Ergolamines, Simple Tryptamines, and Phenylethylamines.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/toxics11020148}{doi:10.3390/toxics11020148}.
\item Guy M. Goodwin, Scott T. Aaronson, Oscar Alvarez, Merve Atli, James Bennett, Megan Croal, Charles DeBattista, Boadie W. Dunlop, David Feifel, David J. Hellerstein, Muhammad Ishrat Husain, John R. Kelly, Molly Lennard-Jones, Rasmus Wentzer Licht, Lindsey Marwood, Sunil Mistry, Tomáš Páleníček, Ozlem Redjep, Dimitris Repantis, Robert A. Schoevers, Batya Septimus, Hollie Simmons, Jair C. Soares, Metten Somers, S. C. Stansfield, Jessica R. Stuart, Hannah H. Tadley, Nisha K. Thiara, Joyce Tsai, Mourad Wahba, Sam Williams, Rachel I. Winzer, Allan H. Young, Matthew B. Young, Sid Zisook, Ekaterina Malievskaia (2023). \textit{Single-dose psilocybin for a treatment-resistant episode of major depression: Impact on patient-reported depression severity, anxiety, function, and quality of life}. Journal of Affective Disorders. [published; OpenAlex]. \href{https://doi.org/10.1016/j.jad.2023.01.108}{doi:10.1016/j.jad.2023.01.108}.
\item Lea J. Mertens (2023). \textit{Wirkt Psilocybin nachhaltig antidepressiv?}. InFo Neurologie + Psychiatrie. [published; OpenAlex]. \href{https://doi.org/10.1007/s15005-023-3166-2}{doi:10.1007/s15005-023-3166-2}.
\item Aryan Sarparast (2023). \textit{More on psilocybin}. Current Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.12788/cp.0333}{doi:10.12788/cp.0333}.
\item Rucker JJ. (2023). \textit{Psilocybin therapy for depression. A good trip?}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/09638237.2023.2183492}{doi:10.1080/09638237.2023.2183492}.
\item Østergaard SD, Hieronymus F. (2023). \textit{Psilocybin for Treatment-Resistant Depression.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1056/nejmc2215459}{doi:10.1056/nejmc2215459}.
\item Oster E, Čudina N, Pavasović H, Prevendar Crnić A, Božić F, Fadel C, Giorgi M. (2023). \textit{Intoxication of dogs and cats with common stimulating, hallucinogenic and dissociative recreational drugs.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.vas.2023.100288}{doi:10.1016/j.vas.2023.100288}.
\item Washington University School of Medicine (2023). \textit{SV2A Marker of Synaptogenesis in a Clinical Trial of Psilocybin for Depression}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05601648}{source link}.
\item von Rotz R, Schindowski EM, Jungwirth J, Schuldt A, Rieser NM, Zahoranszky K, Seifritz E, Nowak A, Nowak P, Jäncke L, Preller KH, Vollenweider FX. (2023). \textit{Corrigendum to 'Single-dose psilocybin-assisted therapy in major depressive disorder: a placebo-controlled, double-blind, randomised clinical trial'.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.eclinm.2023.101841}{doi:10.1016/j.eclinm.2023.101841}.
\item Nadav Liam Modlin, Tammy M. Miller, James Rucker, Namik Kirlić, Molly Lennard-Jones, Danielle Schlosser, Scott T. Aaronson (2023). \textit{Optimizing outcomes in psilocybin therapy: Considerations in participant evaluation and preparation}. Journal of Affective Disorders. [published; OpenAlex]. \href{https://doi.org/10.1016/j.jad.2023.01.077}{doi:10.1016/j.jad.2023.01.077}.
\item Sellers EM, Romach MK. (2023). \textit{Psychedelics: Science sabotaged by Social Media.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neuropharm.2023.109426}{doi:10.1016/j.neuropharm.2023.109426}.
\item Stokłosa I, Więckiewicz G, Stokłosa M, Piegza M, Pudlo R, Gorczyca P. (2023). \textit{Medications for the Treatment of Alcohol Dependence-Current State of Knowledge and Future Perspectives from a Public Health Perspective.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/ijerph20031870}{doi:10.3390/ijerph20031870}.
\item Dragana Marković, Eleonora Čapelja (2023). \textit{Therapeutic potential of psilocybin: a promising agent in treating major depressive disorder}. AIDASCO Reviews. [published; OpenAlex]. \href{https://doi.org/10.59783/aire.2023.15}{doi:10.59783/aire.2023.15}.
\item Keith Heinzerling (2023). \textit{Pilot Trial of Visual Healing®, a Nature-themed Virtual Immersive Experience, to Optimize Set and Setting in Psilocybin-assisted Therapy for Alcohol Use Disorder}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT04410913}{source link}.
\item Anna Lutkajtis, Jules Evans (2023). \textit{Psychedelic integration challenges: Participant experiences after a psilocybin truffle retreat in the Netherlands}. Journal of Psychedelic Studies. [published; OpenAlex]. \href{https://doi.org/10.1556/2054.2022.00232}{doi:10.1556/2054.2022.00232}.
\item Pedicini M, Cordner ZA. (2023). \textit{Utility of preclinical models in the study of psilocybin - A comprehensive review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neubiorev.2023.105046}{doi:10.1016/j.neubiorev.2023.105046}.
\item White CM, Weisman N, Dalo J. (2023). \textit{Psychedelics for Patients With Cancer: A Comprehensive Literature Review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/10600280221144055}{doi:10.1177/10600280221144055}.
\item Capaldi JM, Shabanian J, Finster LB, Asher A, Wertheimer JC, Zebrack BJ, Shirazipour CH. (2023). \textit{Post-traumatic stress symptoms, post-traumatic stress disorder, and post-traumatic growth among cancer survivors: a systematic scoping review of interventions.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/17437199.2022.2162947}{doi:10.1080/17437199.2022.2162947}.
\item Kooijman NI, Willegers T, Reuser A, Mulleners WM, Kramers C, Vissers KCP, van der Wal SEI. (2023). \textit{Are psychedelics the answer to chronic pain: A review of current literature.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1111/papr.13203}{doi:10.1111/papr.13203}.
\item Mastinu A, Anyanwu M, Carone M, Abate G, Bonini SA, Peron G, Tirelli E, Pucci M, Ribaudo G, Oselladore E, Premoli M, Gianoncelli A, Uberti DL, Memo M. (2023). \textit{The Bright Side of Psychedelics: Latest Advances and Challenges in Neuropharmacology.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/ijms24021329}{doi:10.3390/ijms24021329}.
\item Jing Wang, Min Liang, Qing Shang, Hongyan Qian, Ran An, Hua Liu, Gaojie Shao, Tao Li, Xinshe Liu (2023). \textit{Psilocin suppresses methamphetamine-induced hyperlocomotion and acquisition of conditioned place preference via D2R-mediated ERK signaling}. CNS Neuroscience \& Therapeutics. [published; OpenAlex]. \href{https://doi.org/10.1111/cns.14054}{doi:10.1111/cns.14054}.
\item Pacheco AT, Olson RJ, Garza G, Moghaddam B. (2023). \textit{Acute psilocybin enhances cognitive flexibility in rats}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2023.01.09.523291}{doi:10.1101/2023.01.09.523291}.
\item Houman Farzin (2023). \textit{Healing at death’s door: one patient’s mystical experience with psilocybin}. International Journal of Whole Person Care. [published; OpenAlex]. \href{https://doi.org/10.26443/ijwpc.v10i1.373}{doi:10.26443/ijwpc.v10i1.373}.
\item Martinovic J. (2023). \textit{When art therapy went chemical: Alfred Bader, pharmacology, and art brut, c.1950-1970s.}. História Ciências Saúde-Manguinhos. [published; Europe PMC]. \href{https://doi.org/10.1590/s0104-59702022000500007}{doi:10.1590/s0104-59702022000500007}.
\item Baker KM, Ulrich CM, Meghani SH. (2023). \textit{An Integrative Review of Measures of Spirituality in Experimental Studies of Psilocybin in Serious Illness Populations.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/10499091221147700}{doi:10.1177/10499091221147700}.
\item Andersen S. (2023). \textit{Et psykoanalytisk og et postmoderne perspektiv på selv/egoopløsning i en psykedelisk kontekst}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/f26ce}{doi:10.31234/osf.io/f26ce}.
\item Unknown authors (2023). \textit{Et psykoanalytisk og et postmoderne perspektiv på selv/egoopløsning i en psykedelisk kontekst}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/f26ce\_v1}{source link}.
\item Kenneth Alper, Janelle Cange, Ria Sah, Deanna Schreiber-Gregory, Henry Sershen, K. Yaragudri Vinod (2023). \textit{Psilocybin sex-dependently reduces alcohol consumption in C57BL/6J mice}. Frontiers in Pharmacology. [published; OpenAlex]. \href{https://doi.org/10.3389/fphar.2022.1074633}{doi:10.3389/fphar.2022.1074633}.
\item Sebastian William Foster (2023). \textit{Cognitive liberty and the constitutionality of criminalising psilocybin mushrooms in South Africa}. South African Journal on Human Rights. [published; OpenAlex]. \href{https://doi.org/10.1080/02587203.2023.2202875}{doi:10.1080/02587203.2023.2202875}.
\item Poonam Bhadoria, V. Ramanathan (2023). \textit{Conformational Landscape and Hydrogen Bonding Pattern of Psilocin: Computational Insights}. ChemistrySelect. [published; OpenAlex]. \href{https://doi.org/10.1002/slct.202203994}{doi:10.1002/slct.202203994}.
\item Eklund, Julia (2022). \textit{Psilocin esters - An investigation of synthetic feasibility, chemical, and metabolic stability}. Zenodo (CERN European Organization for Nuclear Research). [published; OpenAlex]. \href{https://doi.org/10.5281/zenodo.16912635}{doi:10.5281/zenodo.16912635}.
\item Tucker, Kathryn L., Martinez, Holly, Morris, Ebony (2022). \textit{In Search of: A Federal Safe Harbor for State Legalization of Psilocybin}. Unknown journal. [published; OpenAlex]. \href{https://lawcommons.lclark.edu/lclr/vol26/iss4/6}{source link}.
\item Klaus Richter Larsen, Ulrich Lindberg, Brice Ozenne, Drummond E-Wen McCulloch, Sophia Armand, M. Madsen, Annette Johansen, Dea Siggaard Stenbæk, Gitte M. Knudsen, Patrick M. Fisher (2022). \textit{Acute neurovascular effects of psilocybin administration in healthy humans: Implications for cerebral blood flow measurements using arterial spin labelling}. Neuroscience Applied. [published; OpenAlex]. \href{https://doi.org/10.1016/j.nsa.2023.102665}{doi:10.1016/j.nsa.2023.102665}.
\item Ines Erkizia-Santamaría, Guadalupe Rivero, Igor Horrillo, J. Javier Meana, Jorge E. Ortega (2022). \textit{Psilocybin rescues depressive phenotype and modulates serotonin-2A and glucocorticoid receptor mRNA expression in brain cortex of a stress animal model}. Neuroscience Applied. [published; OpenAlex]. \href{https://doi.org/10.1016/j.nsa.2023.102452}{doi:10.1016/j.nsa.2023.102452}.
\item Guy M. Goodwin, Lindsey Marwood, S. Mistry, Anna Nowakowska, Zainib Shabir, H. Clifton Simmons, E.K. Teoh, Jeng-Yu Tsai, E. Malievskaia (2022). \textit{The safety and efficacy of COMP360 psilocybin therapy in treatment-resistant depression: results from a long-term observational follow-up study}. Neuroscience Applied. [published; OpenAlex]. \href{https://doi.org/10.1016/j.nsa.2023.102906}{doi:10.1016/j.nsa.2023.102906}.
\item Agata Machaczka, Jane Turek, Dorota Bederska-Łojewska, Bartłomiej Pochwat, Łukasz Gąsior, Bernadeta Szewczyk, Andrzej Pilc (2022). \textit{Effect of co-administration of low doses of psilocybin and mGluR2/3 antagonist LY341495 in chronic restraint stress model of depression}. Neuroscience Applied. [published; OpenAlex]. \href{https://doi.org/10.1016/j.nsa.2023.102939}{doi:10.1016/j.nsa.2023.102939}.
\item Sofia Nasini, Martina Colognesi, Sara Tidei, Sara De Martin, Marco Banzato, Andrea Mattarei, Franco Folli, P. Marco, Paolo L. Manfredi, Stefano Comai (2022). \textit{Behavioral effects of a 14-day repeated treatment with psilocybin at a low non-psychedelic dose: a preliminary study in C57BL/6J mice}. Neuroscience Applied. [published; OpenAlex]. \href{https://doi.org/10.1016/j.nsa.2023.103378}{doi:10.1016/j.nsa.2023.103378}.
\item Guy M. Goodwin, Megan Croal, J. Chai-Rees, Lindsey Marwood, S. Mistry, Anna Nowakowska, H. Clifton Simmons, Jeng-Yu Tsai (2022). \textit{Withdrawal of antidepressants does not impact the efficacy of COMP360 psilocybin therapy: results from a phase IIb randomised controlled trial}. Neuroscience Applied. [published; OpenAlex]. \href{https://doi.org/10.1016/j.nsa.2023.103487}{doi:10.1016/j.nsa.2023.103487}.
\item Miriam L. Navarro, Alberte Wollesen Breum, Annette Johansen, Brice Ozenne, Vibe G. Frøkjær, Gitte M. Knudsen (2022). \textit{Change in whole blood BDNF after escitalopram or psilocybin intervention in patients with depression and healthy controls}. Neuroscience Applied. [published; OpenAlex]. \href{https://doi.org/10.1016/j.nsa.2023.103646}{doi:10.1016/j.nsa.2023.103646}.
\item Drummond E-Wen McCulloch, Anders Smærup Olsen, Dea Siggaard Stenbæk, Sophia Armand, M. Madsen, Gitte M. Knudsen, Patrick M. Fisher (2022). \textit{A multi-metric evaluation of psilocybin effects on functional brain entropy in healthy volunteers}. Neuroscience Applied. [published; OpenAlex]. \href{https://doi.org/10.1016/j.nsa.2023.103723}{doi:10.1016/j.nsa.2023.103723}.
\item M. Nikolič, P. Mediano, Tom Froese, Tomáš Páleníček (2022). \textit{Investigating changes in EEG entropy rate in response to psilocybin - a comparison of lempel ziv and state-space entropy rate measures}. Neuroscience Applied. [published; OpenAlex]. \href{https://doi.org/10.1016/j.nsa.2023.103667}{doi:10.1016/j.nsa.2023.103667}.
\item Ling-Xiao Shao, Clara Liao, Ian Gregg, Pasha A. Davoudian, Neil K. Savalia, Kristina Delagarza, Alex C. Kwan (2022). \textit{Visualizing drug actions on dendrites: psilocybin and other classic psychedelics}. Unknown journal. [published; OpenAlex]. \href{https://doi.org/10.1364/brain.2023.btu2b.2}{doi:10.1364/brain.2023.btu2b.2}.
\item Peter Hess (2022). \textit{Going on Trial: Serotonin drug; psilocybin phase 2; placebo response data}. The Transmitter. [published; OpenAlex]. \href{https://doi.org/10.53053/etcr6498}{doi:10.53053/etcr6498}.
\item Peter Hess (2022). \textit{Company on brink takes psilocybin to trial for fragile X syndrome}. The Transmitter. [published; OpenAlex]. \href{https://doi.org/10.53053/mkkk7368}{doi:10.53053/mkkk7368}.
\item O. Shahar, A. Botvinik, T. Lifschytz, B. Lerer (2022). \textit{Therapeutic mechanism of psilocybin in the treatment of depression and other psychiatric disorders.}. Neuroscience Applied. [published; OpenAlex]. \href{https://doi.org/10.1016/j.nsa.2023.101067}{doi:10.1016/j.nsa.2023.101067}.
\item Peter Hess (2022). \textit{Going on Trial: Arbaclofen reboot; cell implants; psilocybin microdoses}. The Transmitter. [published; OpenAlex]. \href{https://doi.org/10.53053/nbdr8957}{doi:10.53053/nbdr8957}.
\item Andrew M. Robie (2022). \textit{Ego Birth: Measure 109, The NMHA, and Forward Movement in the Nascent Psilocybin Industry}. SSRN Electronic Journal. [published; OpenAlex]. \href{https://doi.org/10.2139/ssrn.4459584}{doi:10.2139/ssrn.4459584}.
\item Sebastian William Foster (2022). \textit{The right to privacy in the decriminalisation of psilocybin mushrooms in South Africa}. Law Democracy \& Development. [published; OpenAlex]. \href{https://doi.org/10.17159/2077-4907/2023/ldd.v27.1}{doi:10.17159/2077-4907/2023/ldd.v27.1}.
\item Hannah Douglass, Merle Spriggs, Kate Godfrey, Jennifer L. Danby, Francisco Magalhães, Kirsty L. Alderton, Liane Macdonald, Stephanie Archer, Tim Read, Adèle Lafrance, Dasha Nicholls, David Erritzøe, R. Park, David Nutt, Robin Carhart-Harris (2022). \textit{Psilocybin as a treatment for anorexia nervosa: 6-week and 3-month follow-up results}. Neuroscience Applied. [published; OpenAlex]. \href{https://doi.org/10.1016/j.nsa.2023.102878}{doi:10.1016/j.nsa.2023.102878}.
\item Brian S. Barnett, Noah Wiles Sweat, Peter S. Hendricks (2022). \textit{Case report: Prolonged amelioration of mild red-green color vision deficiency following psilocybin mushroom use}. Drug Science Policy and Law. [published; OpenAlex]. \href{https://doi.org/10.1177/20503245231172536}{doi:10.1177/20503245231172536}.
\item Octavian Dixon Ritchie, Cameron N Donley, Gabrielle Dixon Ritchie (2022). \textit{From prohibited to prescribed: The rescheduling of MDMA and psilocybin in Australia}. Drug Science Policy and Law. [published; OpenAlex]. \href{https://doi.org/10.1177/20503245231198472}{doi:10.1177/20503245231198472}.
\item Vejmola Č., Hubený J., Koudelka V., Griškova-Bulanova I., Páleníček T. (2022). \textit{Electrophysiological study of visual and auditory processing in psilocin-induced hallucinations: exploring evoked potentials and 5-HT2A receptor involvement}. Neuroscience Applied. [published; Crossref]. \href{https://doi.org/10.1016/j.nsa.2023.103662}{doi:10.1016/j.nsa.2023.103662}.
\item Simonsson O, Goldberg SB (2022). \textit{Linkages between Psychedelics and Meditation in a Population-Based Sample in the United States.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2021.2022816}{doi:10.1080/02791072.2021.2022816}.
\item Hadar A, David J, Shalit N, Roseman L, Gross R, Sessa B, Lev-Ran S (2022). \textit{The Psychedelic Renaissance in Clinical Research: A Bibliometric Analysis of Three Decades of Human Studies with Psychedelics.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2021.2022254}{doi:10.1080/02791072.2021.2022254}.
\item Kious B, Schwartz Z, Lewis B (2022). \textit{Should we be leery of being Leary? Concerns about psychedelic use by psychedelic researchers.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811221133461}{doi:10.1177/02698811221133461}.
\item Matthias Forstmann, Hannes Kettner, Christina Sagioglou, Alexander Irvine, Sam Gandy, Robin Carhart-Harris, David Luke (2022). \textit{Among psychedelic-experienced users, only past use of psilocybin reliably predicts nature relatedness}. Journal of Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1177/02698811221146356}{doi:10.1177/02698811221146356}.
\item Ezeaka UC, Kim HJJ, Laprairie RB. (2022). \textit{Addressing the Current Knowledge and Gaps in Research Surrounding Lysergic Acid Diethylamide (LSD), Psilocybin, and Psilocin in Rodent Models.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.2174/1568026623666230705151922}{doi:10.2174/1568026623666230705151922}.
\item Kotoula V, Evans JW, Punturieri C, Johnson SC, Zarate CA (2022). \textit{Functional MRI markers for treatment-resistant depression: Insights and challenges.}. Progress in brain research. [published; PubMed]. \href{https://doi.org/10.1016/bs.pbr.2023.04.001}{doi:10.1016/bs.pbr.2023.04.001}.
\item Rivera-García MT, Cruz SL. (2022). \textit{The Resurgence of Hallucinogen Drugs in Clinical Research.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.24875/ric.23000108}{doi:10.24875/ric.23000108}.
\item Ahmed H, Mushahid H, Arshad T. (2022). \textit{UNCOVERING THE UNTAPPED POTENTIAL OF PSILOCYBIN THERAPY IN ALLEVIATING CANCER-RELATED DEPRESSION: AN URGENT CALL TO RE-EVALUATE TREATMENT STRATEGIES.}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/37992112}{source link}.
\item Natalie Gukasyan (2022). \textit{On blinding and suicide risk in a recent trial of psilocybin-assisted therapy for treatment-resistant depression}. Med. [published; OpenAlex]. \href{https://doi.org/10.1016/j.medj.2022.12.003}{doi:10.1016/j.medj.2022.12.003}.
\item Mann JJ. (2022). \textit{Is psilocybin an effective antidepressant and what is its Mechanism of action?}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.xcrm.2022.100906}{doi:10.1016/j.xcrm.2022.100906}.
\item Lewis CR, McMurray M, Mennenga SE, Helms Tillery S (2022). \textit{Editorial: What is up with psychedelics anyway?}. Frontiers in neuroscience. [published; PubMed]. \href{https://doi.org/10.3389/fnins.2023.1161868}{doi:10.3389/fnins.2023.1161868}.
\item Vorobyeva N, Kozlova AA (2022). \textit{Corrigendum: Three naturally-occurring psychedelics and their significance in the treatment of mental health disorders.}. Frontiers in pharmacology. [published; PubMed]. \href{https://doi.org/10.3389/fphar.2023.1184726}{doi:10.3389/fphar.2023.1184726}.
\item Shaw L, Rea K, Lachowsky NJ, Roth EA (2022). \textit{Magic Mushroom Use: A Qualitative Interview Study of Post-Trip Impacts and Strategies for Optimizing Experiences.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2022.2054746}{doi:10.1080/02791072.2022.2054746}.
\item Fauvel B, Kangaslampi S, Strika-Bruneau L, Roméo B, Piolino P (2022). \textit{Validation of a French Version of the Mystical Experience Questionnaire with Retrospective Reports of the Most Significant Psychedelic Experience among French Users.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2022.2059796}{doi:10.1080/02791072.2022.2059796}.
\item Kelly JR, Clarke G, Harkin A, Corr SC, Galvin S, Pradeep V, Cryan JF, O'Keane V, Dinan TG (2022). \textit{Seeking the Psilocybiome: Psychedelics meet the microbiota-gut-brain axis.}. International journal of clinical and health psychology: IJCHP. [published; PubMed]. \href{https://doi.org/10.1016/j.ijchp.2022.100349}{doi:10.1016/j.ijchp.2022.100349}.
\item IsHak WW, Garcia P, Pearl R, Dang J, William C, Totlani J, Danovitch I. (2022). \textit{The Impact of Psilocybin on Patients Experiencing Psychiatric Symptoms: A Systematic Review of Randomized Clinical Trials.}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/37387703}{source link}.
\item Rankaduwa S, Owen AM (2022). \textit{Psychedelics, entropic brain theory, and the taxonomy of conscious states: a summary of debates and perspectives.}. Neuroscience of consciousness. [published; PubMed]. \href{https://doi.org/10.1093/nc/niad001}{doi:10.1093/nc/niad001}.
\item Mosurinjohn S, Roseman L, Girn M (2022). \textit{Psychedelic-induced mystical experiences: An interdisciplinary discussion and critique.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2023.1077311}{doi:10.3389/fpsyt.2023.1077311}.
\item Urban MM, Stingl MR, Meinhardt MW (2022). \textit{Mini-review: The neurobiology of treating substance use disorders with classical psychedelics.}. Frontiers in neuroscience. [published; PubMed]. \href{https://doi.org/10.3389/fnins.2023.1156319}{doi:10.3389/fnins.2023.1156319}.
\item Blest-Hopley G, Amit BH, O'Neill A, Ruffell SGD (2022). \textit{Editorial: Appropriateness and safety of using cannabinoid and psychedelic medicines as treatments for psychiatric disorders.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2023.1191970}{doi:10.3389/fpsyt.2023.1191970}.
\item Phan AN, Terry GE (2022). \textit{Systematic review and rationale of using psychedelics in the treatment of cannabis use disorder.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2023.1144276}{doi:10.3389/fpsyt.2023.1144276}.
\item Li I, Fong R, Hagen M, Tabaac B (2022). \textit{Medical student attitudes and perceptions of psychedelic-assisted therapies.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2023.1190507}{doi:10.3389/fpsyt.2023.1190507}.
\item Blond BN, Schindler EAD (2022). \textit{Case report: Psychedelic-induced seizures captured by intracranial electrocorticography.}. Frontiers in neurology. [published; PubMed]. \href{https://doi.org/10.3389/fneur.2023.1214969}{doi:10.3389/fneur.2023.1214969}.
\item Hartong V, van Emmerik A (2022). \textit{Psychedelic Microdosing, Mindfulness, and Anxiety: A Cross-Sectional Mediation Study.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2022.2080616}{doi:10.1080/02791072.2022.2080616}.
\item Lawson K (2022). \textit{What is the progress of experimental drug development for fibromyalgia?}. Expert opinion on investigational drugs. [published; PubMed]. \href{https://doi.org/10.1080/13543784.2023.2230118}{doi:10.1080/13543784.2023.2230118}.
\item Simonsson O, Stenfors CUD, Goldberg SB, Hendricks PS, Osika W (2022). \textit{Altered states of leadership: mindfulness meditation, psychedelic use, and leadership development.}. Frontiers in psychology. [published; PubMed]. \href{https://doi.org/10.3389/fpsyg.2023.1151626}{doi:10.3389/fpsyg.2023.1151626}.
\item Longo MSC, Bienemann B, Multedo M, Negreiros MA, Schenberg E, Mograbi DC (2022). \textit{The Association of Classic Serotonergic Psychedelic Use and Intention of Future Use with Nature Relatedness.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2022.2112788}{doi:10.1080/02791072.2022.2112788}.
\item Herrmann Z, Earleywine M, De Leo J, Slabaugh S, Kenny T, Rush AJ (2022). \textit{Scoping Review of Experiential Measures from Psychedelic Research and Clinical Trials.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2022.2125467}{doi:10.1080/02791072.2022.2125467}.
\item Kruger DJ, Glynos NG, Fields CW, Herberholz M, Boehnke KF (2022). \textit{An Assessment of Psychedelic Knowledge Among People Using Psychedelics Naturalistically.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2022.2142709}{doi:10.1080/02791072.2022.2142709}.
\item Acero VP, Cribas ES, Browne KD, Rivellini O, Burrell JC, O'Donnell JC, Das S, Cullen DK (2022). \textit{Bedside to bench: the outlook for psychedelic research.}. Frontiers in pharmacology. [published; PubMed]. \href{https://doi.org/10.3389/fphar.2023.1240295}{doi:10.3389/fphar.2023.1240295}.
\item Barnett BS, Bassir Nia A, Sackett NB, Weleff J (2022). \textit{Editorial: Psychedelics as treatments for substance use disorders: exploring therapeutic potential, risks, underlying mechanisms of action, and implementation challenges.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2023.1305478}{doi:10.3389/fpsyt.2023.1305478}.
\item Kruger DJ, Enghoff O, Herberholz M, Barron J, Boehnke KF (2022). \textit{"How Do I Learn More About this?": Utilization and Trust of Psychedelic Information Sources Among People Naturalistically Using Psychedelics.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2023.2201263}{doi:10.1080/02791072.2023.2201263}.
\item Freidel N, Kreuder L, Rabinovitch BS, Chen FY, Huang RST, Lewis EC (2022). \textit{Psychedelics, epilepsy, and seizures: a review.}. Frontiers in pharmacology. [published; PubMed]. \href{https://doi.org/10.3389/fphar.2023.1326815}{doi:10.3389/fphar.2023.1326815}.
\item Antonio Munafò, Davide Arillotta, Guido Mannaioni, Fabrizio Schifano, Renato Bernardini, Giuseppina Cantarella (2022). \textit{Psilocybin for Depression: From Credibility to Feasibility, What’s Missing?}. Pharmaceuticals. [published; OpenAlex]. \href{https://doi.org/10.3390/ph16010068}{doi:10.3390/ph16010068}.
\item Alistair R. McTaggart, Timothy Y. James, Jason C. Slot, Caine Barlow, Nigel Fechner, Louise S. Shuey, A. Drenth (2022). \textit{Genome sequencing progenies of magic mushrooms (Psilocybe subaeruginosa) identifies tetrapolar mating and gene duplications in the psilocybin pathway}. Fungal Genetics and Biology. [published; OpenAlex]. \href{https://doi.org/10.1016/j.fgb.2022.103769}{doi:10.1016/j.fgb.2022.103769}.
\item Vanessa Eveline VLAIC, Andreea ONA (2022). \textit{The Potential of Psilocybe Genus Fungi to Treat Depression and Some Addictions}. Hop and Medicinal Plants. [published; OpenAlex]. \href{https://doi.org/10.15835/hpm.v30i1-2.14453}{doi:10.15835/hpm.v30i1-2.14453}.
\item Serreau R, Amirouche A, Benyamina A, Berteina-Raboin S (2022). \textit{A Review of Synthetic Access to Therapeutic Compounds Extracted from.}. Pharmaceuticals (Basel, Switzerland). [published; PubMed]. \href{https://doi.org/10.3390/ph16010040}{doi:10.3390/ph16010040}.
\item Robin von Rotz, Eva Maria Schindowski, Johannes Jungwirth, Anna Schuldt, Nathalie M. Rieser, Katharina Zahoranszky, Erich Seifritz, Albina Nowak, Peter J.C.M. Nowak, Lutz Jäncke, Katrin H. Preller, Franz X. Vollenweider (2022). \textit{Single-dose psilocybin-assisted therapy in major depressive disorder: a placebo-controlled, double-blind, randomised clinical trial}. EClinicalMedicine. [published; OpenAlex]. \href{https://doi.org/10.1016/j.eclinm.2022.101809}{doi:10.1016/j.eclinm.2022.101809}.
\item Unknown authors (2022). \textit{High dose of psilocybin effective for treatment-resistant depression}. The Brown University Psychopharmacology Update. [published; OpenAlex]. \href{https://doi.org/10.1002/pu.30970}{doi:10.1002/pu.30970}.
\item Carhart-Harris RL, Chandaria S, Erritzoe DE, Gazzaley A, Girn M, Kettner H, Mediano PAM, Nutt DJ, Rosas FE, Roseman L, Timmermann C, Weiss B, Zeifman RJ, Friston KJ. (2022). \textit{Canalization and plasticity in psychopathology.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neuropharm.2022.109398}{doi:10.1016/j.neuropharm.2022.109398}.
\item Nick Zagorski (2022). \textit{Depression Improves Following Single Dose of Psilocybin}. Psychiatric News. [published; OpenAlex]. \href{https://doi.org/10.1176/appi.pn.2023.01.1.50}{doi:10.1176/appi.pn.2023.01.1.50}.
\item Meccia J, Lopez J, Bagot RC. (2022). \textit{Probing the antidepressant potential of psilocybin: integrating insight from human research and animal models towards an understanding of neural circuit mechanisms.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s00213-022-06297-0}{doi:10.1007/s00213-022-06297-0}.
\item Marks M. (2022). \textit{The varieties of psychedelic law.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neuropharm.2022.109399}{doi:10.1016/j.neuropharm.2022.109399}.
\item Priel Meir, Leslie Taylor, Jair C. Soares, Thomas D. Meyer (2022). \textit{Psychotherapists' openness to engage their patients in Psilocybin-Assisted Therapy for mental health treatment}. Journal of Affective Disorders. [published; OpenAlex]. \href{https://doi.org/10.1016/j.jad.2022.12.050}{doi:10.1016/j.jad.2022.12.050}.
\item Heal DJ, Gosden J, Smith SL, Atterwill CK. (2022). \textit{Experimental strategies to discover and develop the next generation of psychedelics and entactogens as medicines.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neuropharm.2022.109375}{doi:10.1016/j.neuropharm.2022.109375}.
\item Bradshaw AJ, Ramírez-Cruz V, Awan AR, Furci G, Guzmán-Dávalos L, Stamets P, Dentinger BT. (2022). \textit{Phylogenomics of the psychoactive mushroom genus Psilocybe and evolution of the psilocybin biosynthetic gene cluster}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2022.12.13.520147}{doi:10.1101/2022.12.13.520147}.
\item Meghan DellaCrosse, Mollie Pleet, Emma Morton, Amir Ashtari, Kimberly Sakai, Josh Woolley, Erin E. Michalak (2022). \textit{“A sense of the bigger picture:” A qualitative analysis of follow-up interviews with people with bipolar disorder who self-reported psilocybin use}. PLoS ONE. [published; OpenAlex]. \href{https://doi.org/10.1371/journal.pone.0279073}{doi:10.1371/journal.pone.0279073}.
\item Emma Morton, Kimberly Sakai, Amir Ashtari, Mollie Pleet, Erin E. Michalak, Josh Woolley (2022). \textit{Risks and benefits of psilocybin use in people with bipolar disorder: An international web-based survey on experiences of ‘magic mushroom’ consumption}. Journal of Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1177/02698811221131997}{doi:10.1177/02698811221131997}.
\item Friederike Holze, A. Becker, Karolina E. Kolaczynska, Urs Duthaler, Matthias E. Liechti (2022). \textit{Pharmacokinetics and Pharmacodynamics of Oral Psilocybin Administration in Healthy Participants}. Clinical Pharmacology \& Therapeutics. [published; OpenAlex]. \href{https://doi.org/10.1002/cpt.2821}{doi:10.1002/cpt.2821}.
\item Sarah Shnayder, Rezvan Ameli, Ninet Sinaii, Ann Berger, Manish Agrawal (2022). \textit{Psilocybin-assisted therapy improves psycho-social-spiritual well-being in cancer patients}. Journal of Affective Disorders. [published; OpenAlex]. \href{https://doi.org/10.1016/j.jad.2022.11.046}{doi:10.1016/j.jad.2022.11.046}.
\item Kelly DF, Kelly DF, Heinzerling K, Sharma A, Gowrinathan S, Sergi K, Mallari RJ. (2022). \textit{Psychedelic-Assisted Therapy and Psychedelic Science: A Review and Perspective on Opportunities in Neurosurgery and Neuro-Oncology.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1227/neu.0000000000002275}{doi:10.1227/neu.0000000000002275}.
\item Geoffrey M. Bove, David J. Mokler (2022). \textit{Effects of a single dose of psilocybin on cytokines, chemokines and leptin in rat serum}. Journal of Psychedelic Studies. [published; OpenAlex]. \href{https://doi.org/10.1556/2054.2022.00230}{doi:10.1556/2054.2022.00230}.
\item Daniel Burmester, M. Madsen, Attila Szabó, Sanjay S. Aripaka, Dea Siggaard Stenbæk, Vibe G. Frøkjær, Betina Elfving, Jens D. Mikkelsen, Gitte M. Knudsen, Patrick M. Fisher (2022). \textit{Subacute effects of a single dose of psilocybin on biomarkers of inflammation in healthy humans: An open-label preliminary investigation}. Comprehensive Psychoneuroendocrinology. [published; OpenAlex]. \href{https://doi.org/10.1016/j.cpnec.2022.100163}{doi:10.1016/j.cpnec.2022.100163}.
\item Lee HJ, Stein MB. (2022). \textit{Update on treatments for anxiety-related disorders.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1097/yco.0000000000000841}{doi:10.1097/yco.0000000000000841}.
\item Valeria Buzzelli, Emilia Carbone, Antonia Manduca, Sara Schiavi, Alessandro Feo, Julia V. Perederiy, Kyle Ambert, M Hausman, Viviana Trezza (2022). \textit{Psilocybin mitigates the cognitive deficits observed in a rat model of Fragile X syndrome}. Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1007/s00213-022-06286-3}{doi:10.1007/s00213-022-06286-3}.
\item Passie T, Guss J, Krähenmann R. (2022). \textit{Lower-dose psycholytic therapy - A neglected approach.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fpsyt.2022.1020505}{doi:10.3389/fpsyt.2022.1020505}.
\item Hang Wang, Ying Wang (2022). \textit{Matrix-assisted laser-desorption/ionization-mass spectrometric imaging of psilocybin and its analogues in psychedelic mushrooms using a cesium chloride-coated target plate}. Analytical and Bioanalytical Chemistry. [published; OpenAlex]. \href{https://doi.org/10.1007/s00216-022-04467-9}{doi:10.1007/s00216-022-04467-9}.
\item Prokopios Magiatis, Evangelos Dadiotis, Romanos Konstantinos Antonopoulos, K Ioannidis, V Mitsis, E Melliou, Zacharoula Gonou-Zagou (2022). \textit{Direct Quantitation of Psilocybin and Psilocin by One-Dimensional 1H and 31P qNMR in a revived Greek specimen of Psilocybe cyanescens}. Planta Medica. [published; OpenAlex]. \href{https://doi.org/10.1055/s-0042-1759062}{doi:10.1055/s-0042-1759062}.
\item Hartogsohn I, Petranker R (2022). \textit{Set and setting in microdosing: an oft-overlooked principle.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-022-06249-8}{doi:10.1007/s00213-022-06249-8}.
\item Gukasyan N, Schreyer CC, Griffiths RR, Guarda AS (2022). \textit{Psychedelic-Assisted Therapy for People with Eating Disorders.}. Current psychiatry reports. [published; PubMed]. \href{https://doi.org/10.1007/s11920-022-01394-5}{doi:10.1007/s11920-022-01394-5}.
\item Gregory Barber, Charles B. Nemeroff, Steven Siegel (2022). \textit{A Case of Prolonged Mania, Psychosis, and Severe Depression After Psilocybin Use: Implications of Increased Psychedelic Drug Availability}. American Journal of Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1176/appi.ajp.22010073}{doi:10.1176/appi.ajp.22010073}.
\item MacCallum CA, Lo LA, Pistawka CA, Deol JK. (2022). \textit{Therapeutic use of psilocybin: Practical considerations for dosing and administration.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fpsyt.2022.1040217}{doi:10.3389/fpsyt.2022.1040217}.
\item Benjamin Kelmendi, Stephen A. Kichuk, Giuliana DePalmer, Gayle Maloney, Terence H. W. Ching, Alexander Belser, Christopher Pittenger (2022). \textit{Single-dose psilocybin for treatment-resistant obsessive-compulsive disorder: A case report}. Heliyon. [published; OpenAlex]. \href{https://doi.org/10.1016/j.heliyon.2022.e12135}{doi:10.1016/j.heliyon.2022.e12135}.
\item Alexander J. Bradshaw, Talia Backman, Virginia Ramírez-Cruz, Dale L. Forrister, Jaclyn M. Winter, Laura Guzmán-Dávalos, Giuliana Furci, Paul Stamets, Bryn T. M. Dentinger (2022). \textit{DNA Authentication and Chemical Analysis of Psilocybe Mushrooms Reveal Widespread Misdeterminations in Fungaria and Inconsistencies in Metabolites}. Applied and Environmental Microbiology. [published; OpenAlex]. \href{https://doi.org/10.1128/aem.01498-22}{doi:10.1128/aem.01498-22}.
\item Marten Dooper (2022). \textit{Antidepressant properties of psilocybin might be related to changes in sleep}. Unknown journal. [published; OpenAlex]. \href{https://doi.org/10.55788/c6e5fc91}{doi:10.55788/c6e5fc91}.
\item Marten Dooper (2022). \textit{Fast and sustained effect of 2 administrations of psilocybin on depression}. Unknown journal. [published; OpenAlex]. \href{https://doi.org/10.55788/0629715f}{doi:10.55788/0629715f}.
\item Marten Dooper (2022). \textit{Mode of action of psilocybin}. Unknown journal. [published; OpenAlex]. \href{https://doi.org/10.55788/9af70cfc}{doi:10.55788/9af70cfc}.
\item Calderon SN, Bonson KR, Reissig CJ, Lloyd JM, Galati S, Chiapperino D. (2022). \textit{Considerations in assessing the abuse potential of psychedelics during drug development.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neuropharm.2022.109352}{doi:10.1016/j.neuropharm.2022.109352}.
\item Shukuroglou M, Roseman L, Wall M, Nutt D, Kaelen M, Carhart-Harris R. (2022). \textit{Changes in music-evoked emotion and ventral striatal functional connectivity after psilocybin therapy for depression.}. Journal of Psychopharmacology. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811221125354}{doi:10.1177/02698811221125354}.
\item Schindler EAD, Sewell RA, Gottschalk CH, Luddy C, Flynn LT, Zhu Y, Lindsey H, Pittman BP, Cozzi NV, D'Souza DC. (2022). \textit{Exploratory investigation of a patient-informed low-dose psilocybin pulse regimen in the suppression of cluster headache: Results from a randomized, double-blind, placebo-controlled trial.}. Headache The Journal of Head and Face Pain. [published; Europe PMC]. \href{https://doi.org/10.1111/head.14420}{doi:10.1111/head.14420}.
\item Irizarry R, Winczura A, Dimassi O, Dhillon N, Minhas A, Larice J. (2022). \textit{Psilocybin as a Treatment for Psychiatric Illness: A Meta-Analysis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.7759/cureus.31796}{doi:10.7759/cureus.31796}.
\item Schäfer T, Kramer K, Werten S, Rupp B, Hoffmeister D. (2022). \textit{Characterization of the Gateway Decarboxylase for Psilocybin Biosynthesis.}. ChemBioChem. [published; Europe PMC]. \href{https://doi.org/10.1002/cbic.202200551}{doi:10.1002/cbic.202200551}.
\item Messell C, Summer L, Bonde LO, Beck BD, Stenbæk DS. (2022). \textit{Music programming for psilocybin-assisted therapy: Guided Imagery and Music-informed perspectives.}. Frontiers in Psychology. [published; Europe PMC]. \href{https://doi.org/10.3389/fpsyg.2022.873455}{doi:10.3389/fpsyg.2022.873455}.
\item NWTraumatherapies (2022). \textit{NW Trauma Therapies, Chronic Illness of Chronic Depression, PTSD, MS, HIV, and SARS-CoV-2, Long Haulers Syndrome. Treatment of Unregulaaible Trauma by the Treatment of Enhanced Micro Dosing the Levels of 0.15, Thru 0.33, With a Maintenance Dose of 1 Gram Per Month for Neural Pathway Increase of Non Synthesized Psilocybin, Using the Actual Plant to Regulate the Highjacked Nervous System.}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05042466}{source link}.
\item Shahar O, Botvinnik A, Esh-Zuntz N, Brownstien M, Wolf R, Lotan A, Wolf G, Lerer B, Lifschytz T. (2022). \textit{Role of 5-HT2A, 5-HT2C, 5-HT1A and TAAR1 Receptors in the Head Twitch Response Induced by 5-Hydroxytryptophan and Psilocybin: Translational Implications.}. International Journal of Molecular Sciences. [published; Europe PMC]. \href{https://doi.org/10.3390/ijms232214148}{doi:10.3390/ijms232214148}.
\item Guss J, Krause R, Sloshower J. (2022). \textit{Manuel de Yale pour la Thérapie de la Dépression Assistée par la Psilocybine}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/r96tc}{doi:10.31234/osf.io/r96tc}.
\item Unknown authors (2022). \textit{Manuel de Yale pour la Thérapie de la Dépression Assistée par la Psilocybine}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/r96tc\_v1}{source link}.
\item Schmitz GP, Chiu Y, König GM, Kostenis E, Roth BL, Herman MA. (2022). \textit{Psychedelic compounds directly excite 5-HT2A Layer 5 Pyramidal Neurons in the Prefrontal Cortex through a 5-HT2A Gq -mediated activation mechanism}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2022.11.15.516655}{doi:10.1101/2022.11.15.516655}.
\item Gotvaldová K, Borovička J, Hájková K, Cihlářová P, Rockefeller A, Kuchař M. (2022). \textit{Extensive Collection of Psychotropic Mushrooms with Determination of Their Tryptamine Alkaloids.}. International Journal of Molecular Sciences. [published; Europe PMC]. \href{https://doi.org/10.3390/ijms232214068}{doi:10.3390/ijms232214068}.
\item Spriggs MJ, Giribaldi B, Lyons T, Rosas FE, Kärtner LS, Buchborn T, Douglass HM, Roseman L, Timmermann C, Erritzoe D, Nutt DJ, Carhart-Harris RL. (2022). \textit{Body mass index (BMI) does not predict responses to psilocybin.}. Journal of Psychopharmacology. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811221131994}{doi:10.1177/02698811221131994}.
\item Unknown authors (2022). \textit{Chlorothiazide/paracetamol/psilocybin}. Reactions Weekly. [published; OpenAlex]. \href{https://doi.org/10.1007/s40278-022-27543-0}{doi:10.1007/s40278-022-27543-0}.
\item NYU Langone Health (2022). \textit{A Double-Blind Trial of Psilocybin-Assisted Treatment of Alcohol Dependence}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT02061293}{source link}.
\item Strauss D, Ghosh S, Murray Z, Gryzenhout M. (2022). \textit{Psilocybin containing mushrooms: a rapidly developing biotechnology industry in the psychiatry, biomedical and nutraceutical fields.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s13205-022-03355-4}{doi:10.1007/s13205-022-03355-4}.
\item Gutman O, Tenne D, Bretler U. (2022). \textit{Psilocin - The "real deal" or an extraction byproduct.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1111/1556-4029.15167}{doi:10.1111/1556-4029.15167}.
\item Unknown authors (2022). \textit{Psilocybin-assisted therapy reduces heavy drinking in patients with AUD}. The Brown University Psychopharmacology Update. [published; OpenAlex]. \href{https://doi.org/10.1002/pu.30946}{doi:10.1002/pu.30946}.
\item Jefferson SJ, Gregg I, Dibbs M, Liao C, Wu H, Davoudian PA, Sprouse JS, Sherwood AM, Kaye AP, Pittenger C, Kwan AC. (2022). \textit{5-MeO-DMT modifies innate behaviors and promotes structural neural plasticity in mice}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2022.11.03.515044}{doi:10.1101/2022.11.03.515044}.
\item VanderZwaag J, Halvorson T, Dolhan K, Šimončičová E, Ben-Azu B, Tremblay MÈ. (2022). \textit{The Missing Piece? A Case for Microglia's Prominent Role in the Therapeutic Action of Anesthetics, Ketamine, and Psychedelics.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s11064-022-03772-0}{doi:10.1007/s11064-022-03772-0}.
\item Iacobucci G. (2022). \textit{Psilocybin reduces symptoms in treatment resistant depression, trial results show.}. BMJ. [published; Europe PMC]. \href{https://doi.org/10.1136/bmj.o2623}{doi:10.1136/bmj.o2623}.
\item Glatfelter GC, Pottie E, Partilla JS, Sherwood AM, Kaylo K, Pham DNK, Naeem M, Sammeta VR, DeBoer S, Golen JA, Hulley EB, Stove CP, Chadeayne AR, Manke DR, Baumann MH. (2022). \textit{Structure-Activity Relationships for Psilocybin, Baeocystin, Aeruginascin, and Related Analogues to Produce Pharmacological Effects in Mice.}. ACS Pharmacology \& Translational Science. [published; Europe PMC]. \href{https://doi.org/10.1021/acsptsci.2c00177}{doi:10.1021/acsptsci.2c00177}.
\item O'Donnell KC, Mennenga SE, Owens LT, Podrebarac SK, Baron T, Rotrosen J, Ross S, Forcehimes AA, Bogenschutz MP. (2022). \textit{Psilocybin for alcohol use disorder: Rationale and design considerations for a randomized controlled trial.}. Contemporary Clinical Trials. [published; Europe PMC]. \href{https://doi.org/10.1016/j.cct.2022.106976}{doi:10.1016/j.cct.2022.106976}.
\item Hamna Raheel, Unaiza Naeem, Asim Shaikh, Omer Ahmed Shaikh (2022). \textit{The psychedelic renaissance: can psilocybin possibly combat depression?}. International Journal of Surgery Global Health. [published; OpenAlex]. \href{https://doi.org/10.1097/gh9.0000000000000089}{doi:10.1097/gh9.0000000000000089}.
\item Syed Rizwan A. Bokhari, Ahmad Makmom Abdullah, Zamir A. Zamir, Raquel M. Rosen (2022). \textit{A Rare Case of Magic Mushroom (Psilocybin) Related AKI and Hypertensive Emergency}. Journal of the American Society of Nephrology. [published; OpenAlex]. \href{https://doi.org/10.1681/asn.20223311s1895a}{doi:10.1681/asn.20223311s1895a}.
\item Mason N, Szabo A, Kuypers K, Mallaroni P, de la Torre Fornell R, Reckweg J, Tse D, Hutten N, Feilding A, Ramaekers J. (2022). \textit{Psilocybin induces acute and persisting alterations in immune status and the stress response in healthy volunteers}. medRxiv. [preprint; medRxiv]. \href{https://doi.org/10.1101/2022.10.31.22281688}{doi:10.1101/2022.10.31.22281688}.
\item Calleja-Conde J, Morales-García JA, Echeverry-Alzate V, Bühler KM, Giné E, López-Moreno JA. (2022). \textit{Classic psychedelics and alcohol use disorders: A systematic review of human and animal studies.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1111/adb.13229}{doi:10.1111/adb.13229}.
\item Patchett-Marble R, O'Sullivan S, Tadwalkar S, Hapke E. (2022). \textit{Psilocybin mushrooms for psychological and existential distress: Treatment for a patient with palliative lung cancer.}. Canadian Family Physician. [published; Europe PMC]. \href{https://doi.org/10.46747/cfp.6811823}{doi:10.46747/cfp.6811823}.
\item Paganin W, Signorini S, Signorini S, Leccese V, Sciarretta A. (2022). \textit{[Treatment-resistant depression. From classification to new therapies.]}. Rivista di psichiatria. [published; Europe PMC]. \href{https://doi.org/10.1708/3922.39072}{doi:10.1708/3922.39072}.
\item Goodwin GM, Aaronson ST, Alvarez O, Arden PC, Baker A, Bennett JC, Bird C, Blom RE, Brennan C, Brusch D, Burke L, Campbell-Coker K, Carhart-Harris R, Cattell J, Daniel A, DeBattista C, Dunlop BW, Eisen K, Feifel D, Forbes M, Haumann HM, Hellerstein DJ, Hoppe AI, Husain MI, Jelen LA, Kamphuis J, Kawasaki J, Kelly JR, Key RE, Kishon R, Knatz Peck S, Knight G, Koolen MHB, Lean M, Licht RW, Maples-Keller JL, Mars J, Marwood L, McElhiney MC, Miller TL, Mirow A, Mistry S, Mletzko-Crowe T, Modlin LN, Nielsen RE, Nielson EM, Offerhaus SR, O'Keane V, Páleníček T, Printz D, Rademaker MC, van Reemst A, Reinholdt F, Repantis D, Rucker J, Rudow S, Ruffell S, Rush AJ, Schoevers RA, Seynaeve M, Shao S, Soares JC, Somers M, Stansfield SC, Sterling D, Strockis A, Tsai J, Visser L, Wahba M, Williams S, Young AH, Ywema P, Zisook S, Malievskaia E. (2022). \textit{Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression.}. New England Journal of Medicine. [published; Europe PMC]. \href{https://doi.org/10.1056/nejmoa2206443}{doi:10.1056/nejmoa2206443}.
\item Madras BK. (2022). \textit{Psilocybin in Treatment-Resistant Depression.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1056/nejme2210975}{doi:10.1056/nejme2210975}.
\item Wong A, Raz A. (2022). \textit{Microdosing with classical psychedelics: Research trajectories and practical considerations.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/13634615221129115}{doi:10.1177/13634615221129115}.
\item Li SN, Xu F, Long P, Liu F, Zhang P, Fan YG, Chen ZH. (2022). \textit{Five new species of Inosperma from China: Morphological characteristics, phylogenetic analyses, and toxin detection.}. Frontiers in Microbiology. [published; Europe PMC]. \href{https://doi.org/10.3389/fmicb.2022.1021583}{doi:10.3389/fmicb.2022.1021583}.
\item Jones GM. (2022). \textit{Race and ethnicity moderate the associations between lifetime psychedelic use (MDMA/ecstasy and psilocybin) and major depressive episodes.}. Journal of Psychopharmacology. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811221127304}{doi:10.1177/02698811221127304}.
\item Victor Lange, Marie, Sidsel (2022). \textit{Kan psilocybin forbedre vores moral?}. Research at the University of Copenhagen (University of Copenhagen). [published; OpenAlex]. \href{https://paradoks.nu/2022/09/29/kan-psilocybin-forbedre-vores-moral/}{source link}.
\item b2xvysw192 (2022). \textit{What Are Magic Mushrooms? Why They Are Popular In British Columbia}. Zenodo (CERN European Organization for Nuclear Research). [published; OpenAlex]. \href{https://doi.org/10.5281/zenodo.7262470}{doi:10.5281/zenodo.7262470}.
\item Gukasyan N, Griffiths RR, Yaden DB, Antoine D, Nayak SM. (2022). \textit{Serotonergic antidepressant use is associated with weaker psilocybin effects}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/2zys9}{doi:10.31234/osf.io/2zys9}.
\item Nayak SM, Bari BA, Yaden DB, Spriggs MJ, Rosas FE, Peill JM, Giribaldi B, Erritzoe D, Nutt DJ, Carhart-Harris R. (2022). \textit{A Bayesian Reanalysis of a Trial of Psilocybin versus Escitalopram for Depression.}. Psychedelic Medicine. [published; Europe PMC]. \href{https://doi.org/10.1089/psymed.2022.0002}{doi:10.1089/psymed.2022.0002}.
\item Unknown authors (2022). \textit{Serotonergic antidepressant use is associated with weaker psilocybin effects}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/2zys9\_v1}{source link}.
\item Olsen AS, Lykkebo-Valløe A, Ozenne B, Madsen MK, Stenbæk DS, Armand S, Mørup M, Ganz M, Knudsen GM, Fisher PM. (2022). \textit{Psilocybin modulation of time-varying functional connectivity is associated with plasma psilocin and subjective effects.}. NeuroImage. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neuroimage.2022.119716}{doi:10.1016/j.neuroimage.2022.119716}.
\item Sheppard Pratt Health System (2022). \textit{The Safety and Efficacy of Psilocybin in Participants With Type 2 Bipolar Disorder (BP-II) Depression.}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT04433845}{source link}.
\item Gandia A, Adamatzky A. (2022). \textit{Electrical spiking of psilocybin fungi.}. Communicative \& Integrative Biology. [published; Europe PMC]. \href{https://doi.org/10.1080/19420889.2022.2136118}{doi:10.1080/19420889.2022.2136118}.
\item Unknown authors (2022). \textit{Evidence for tolerance in psychedelic microdosing from the self-blinding microdose trial}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/s4qhf\_v1}{source link}.
\item Dupuis D, Veissière S. (2022). \textit{Culture, context, and ethics in the therapeutic use of hallucinogens: Psychedelics as active super-placebos?}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/13634615221131465}{doi:10.1177/13634615221131465}.
\item Balon R. (2022). \textit{Are Magic Mushrooms Really Magic?: Psilocybin in the Treatment of Depression.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1097/jcp.0000000000001610}{doi:10.1097/jcp.0000000000001610}.
\item Alison Knopf (2022). \textit{Psilocybin treatment for AUD: Promise in new study}. Alcoholism \& Drug Abuse Weekly. [published; OpenAlex]. \href{https://doi.org/10.1002/adaw.33584}{doi:10.1002/adaw.33584}.
\item Jensen ME, Jensen ME, Stenbæk DS, Juul TS, Fisher PM, Ekstrøm CT, Knudsen GM, Fink-Jensen A. (2022). \textit{Psilocybin-assisted therapy for reducing alcohol intake in patients with alcohol use disorder: protocol for a randomised, double-blinded, placebo-controlled 12-week clinical trial (The QUANTUM Trip Trial).}. BMJ Open. [published; Europe PMC]. \href{https://doi.org/10.1136/bmjopen-2022-066019}{doi:10.1136/bmjopen-2022-066019}.
\item Vamvakopoulou IA, Narine KAD, Campbell I, Dyck JRB, Nutt DJ. (2022). \textit{Mescaline: The forgotten psychedelic.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neuropharm.2022.109294}{doi:10.1016/j.neuropharm.2022.109294}.
\item Beckley Psytech Limited (2022). \textit{An Exploratory Open-Label, Phase 1b, Ascending Dose Study to Evaluate the Effects of Oral 3-[2-(Dimethylamino)Ethyl]-1h-indol-4-yl Dihydrogen Phosphate (Psilocybin, BPL-PSILO) on Cognition in Patients With Chronic Short-Lasting Unilateral Neuralgiform Headache Attacks (SUNHA)}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT04905121}{source link}.
\item Sottile RJ, Vida T. (2022). \textit{A proposed mechanism for the MDMA-mediated extinction of traumatic memories in PTSD patients treated with MDMA-assisted therapy.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fpsyt.2022.991753}{doi:10.3389/fpsyt.2022.991753}.
\item Goel DB, Zilate S. (2022). \textit{Potential Therapeutic Effects of Psilocybin: A Systematic Review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.7759/cureus.30214}{doi:10.7759/cureus.30214}.
\item Weleff J, Akiki TJ, Barnett BS. (2022). \textit{Bibliometric Analysis of Academic Journal Articles Reporting Results of Psychedelic Clinical Studies.}. Journal of Psychoactive Drugs. [published; Europe PMC]. \href{https://doi.org/10.1080/02791072.2022.2133757}{doi:10.1080/02791072.2022.2133757}.
\item Jones GM, Nock MK. (2022). \textit{Race and ethnicity moderate the associations between lifetime psychedelic use (MDMA and psilocybin) and psychological distress and suicidality.}. Scientific Reports. [published; Europe PMC]. \href{https://doi.org/10.1038/s41598-022-18645-3}{doi:10.1038/s41598-022-18645-3}.
\item Ko K, Kopra EI, Cleare AJ, Rucker JJ. (2022). \textit{Psychedelic therapy for depressive symptoms: A systematic review and meta-analysis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jad.2022.09.168}{doi:10.1016/j.jad.2022.09.168}.
\item Silberner J. (2022). \textit{Psilocybin: a revolution in psychedelic medicines in the US?}. BMJ. [published; Europe PMC]. \href{https://doi.org/10.1136/bmj.o2178}{doi:10.1136/bmj.o2178}.
\item Ching THW, Kichuk S, DePalmer G, Pittenger C, Kelmendi B. (2022). \textit{Yale Program for Psychedelic Science (YPPS) Manual for Psilocybin-OCD Session Monitors for Protocol HIC: 2000020355}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/85s9p}{doi:10.31234/osf.io/85s9p}.
\item McCartney AM, McGovern HT, De Foe A. (2022). \textit{Predictors of Psychedelic Experience: A Thematic Analysis.}. Journal of Psychoactive Drugs. [published; Europe PMC]. \href{https://doi.org/10.1080/02791072.2022.2129885}{doi:10.1080/02791072.2022.2129885}.
\item Unknown authors (2022). \textit{Yale Program for Psychedelic Science (YPPS) Manual for Psilocybin-OCD Session Monitors for Protocol HIC: 2000020355}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/85s9p\_v1}{source link}.
\item Søndergaard A, Madsen MK, Ozenne B, Armand S, Knudsen GM, Fisher PM, Stenbæk DS. (2022). \textit{Lasting increases in trait mindfulness after psilocybin correlate positively with the mystical-type experience in healthy individuals.}. Frontiers in Psychology. [published; Europe PMC]. \href{https://doi.org/10.3389/fpsyg.2022.948729}{doi:10.3389/fpsyg.2022.948729}.
\item Poonam Bhadoria, V. Ramanathan (2022). \textit{Conformational Landscape and Properties of Psilocybin: A Computational Approach}. ChemistrySelect. [published; OpenAlex]. \href{https://doi.org/10.1002/slct.202203026}{doi:10.1002/slct.202203026}.
\item Liu Y, Guo ZJ, Zhou XW (2022). \textit{Chinese Cordyceps: Bioactive Components, Antitumor Effects and Underlying Mechanism-A Review.}. Molecules (Basel, Switzerland). [published; PubMed]. \href{https://doi.org/10.3390/molecules27196576}{doi:10.3390/molecules27196576}.
\item Benjamin R. Lewis, Kevin Byrne, Anna C. Beck (2022). \textit{Group Format Psilocybin-Assisted Therapy: Commentary on the HOPE trial (HOPE: a pilot study of psilocybin-enhanced group psychotherapy in patients with cancer)}. Journal of Anesthesiology and Pain Therapy. [published; OpenAlex]. \href{https://doi.org/10.29245/2768-5365/2023/3.1145}{doi:10.29245/2768-5365/2023/3.1145}.
\item Singleton SP, Luppi AI, Carhart-Harris RL, Cruzat J, Roseman L, Nutt DJ, Deco G, Kringelbach ML, Stamatakis EA, Kuceyeski A. (2022). \textit{Receptor-informed network control theory links LSD and psilocybin to a flattening of the brain's control energy landscape.}. Nature Communications. [published; Europe PMC]. \href{https://doi.org/10.1038/s41467-022-33578-1}{doi:10.1038/s41467-022-33578-1}.
\item López-Arnau R, Camarasa J, Carbó ML, Nadal-Gratacós N, Puigseslloses P, Espinosa-Velasco M, Urquizu E, Escubedo E, Pubill D. (2022). \textit{3,4-Methylenedioxy methamphetamine, synthetic cathinones and psychedelics: From recreational to novel psychotherapeutic drugs.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fpsyt.2022.990405}{doi:10.3389/fpsyt.2022.990405}.
\item Ledwos N, Rosenblat JD, Blumberger DM, Castle DJ, McIntyre RS, Mulsant BH, Husain MI. (2022). \textit{A Critical Appraisal of Evidence on the Efficacy and Safety of Serotonergic Psychedelic Drugs as Emerging Antidepressants: Mind the Evidence Gap.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1097/jcp.0000000000001608}{doi:10.1097/jcp.0000000000001608}.
\item Natalie Gukasyan (2022). \textit{19.3 Psilocybin-Assisted Therapy for MDD: Current Evidence and Clinical Considerations}. Journal of the American Academy of Child \& Adolescent Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.jaac.2022.07.664}{doi:10.1016/j.jaac.2022.07.664}.
\item Timmermann C, Watts R, Dupuis D (2022). \textit{Towards psychedelic apprenticeship: Developing a gentle touch for the mediation and validation of psychedelic-induced insights and revelations.}. Transcultural psychiatry. [published; PubMed]. \href{https://doi.org/10.1177/13634615221082796}{doi:10.1177/13634615221082796}.
\item Dworkin RH, Anderson BT, Andrews N, Edwards RR, Grob CS, Ross S, Satterthwaite TD, Strain EC (2022). \textit{If the Doors of Perception Were Cleansed, Would Chronic Pain be Relieved? Evaluating the Benefits and Risks of Psychedelics.}. The journal of pain. [published; PubMed]. \href{https://doi.org/10.1016/j.jpain.2022.05.003}{doi:10.1016/j.jpain.2022.05.003}.
\item Barnett BS, Ziegler K, Doblin R, Carlo AD (2022). \textit{Is psychedelic use associated with cancer?: Interrogating a half-century-old claim using contemporary population-level data.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811221117536}{doi:10.1177/02698811221117536}.
\item Pochwat B, Krupa AJ, Siwek M, Szewczyk B (2022). \textit{New investigational agents for the treatment of major depressive disorder.}. Expert opinion on investigational drugs. [published; PubMed]. \href{https://doi.org/10.1080/13543784.2022.2113376}{doi:10.1080/13543784.2022.2113376}.
\item Simonsson O, Goldberg SB, Chambers R, Osika W, Long DM, Hendricks PS (2022). \textit{Prevalence and associations of classic psychedelic-related seizures in a population-based sample.}. Drug and alcohol dependence. [published; PubMed]. \href{https://doi.org/10.1016/j.drugalcdep.2022.109586}{doi:10.1016/j.drugalcdep.2022.109586}.
\item Bogenschutz MP, Ross S, Bhatt S, Baron T, Forcehimes AA, Laska E, Mennenga SE, O'Donnell K, Owens LT, Podrebarac S, Rotrosen J, Tonigan JS, Worth L. (2022). \textit{Percentage of Heavy Drinking Days Following Psilocybin-Assisted Psychotherapy vs Placebo in the Treatment of Adult Patients With Alcohol Use Disorder: A Randomized Clinical Trial.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1001/jamapsychiatry.2022.2096}{doi:10.1001/jamapsychiatry.2022.2096}.
\item Butler M, Jelen L, Rucker J (2022). \textit{Expectancy in placebo-controlled trials of psychedelics: if so, so what?}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-022-06221-6}{doi:10.1007/s00213-022-06221-6}.
\item Asher BF (2022). \textit{Why Otolaryngologists Should Be Interested in Psychedelic Medicine.}. Otolaryngologic clinics of North America. [published; PubMed]. \href{https://doi.org/10.1016/j.otc.2022.06.002}{doi:10.1016/j.otc.2022.06.002}.
\item Odland AU, Kristensen JL, Andreasen JT. (2022). \textit{Animal Behavior in Psychedelic Research.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1124/pharmrev.122.000590}{doi:10.1124/pharmrev.122.000590}.
\item Gobbi G, Inserra A, Greenway KT, Lifshitz M, Kirmayer LJ (2022). \textit{Psychedelic medicine at a crossroads: Advancing an integrative approach to research and practice.}. Transcultural psychiatry. [published; PubMed]. \href{https://doi.org/10.1177/13634615221119388}{doi:10.1177/13634615221119388}.
\item Cruzat J, Perl YS, Escrichs A, Vohryzek J, Timmermann C, Roseman L, Luppi AI, Ibañez A, Nutt D, Carhart-Harris R, Tagliazucchi E, Deco G, Kringelbach ML. (2022). \textit{Effects of classic psychedelic drugs on turbulent signatures in brain dynamics.}. Network Neuroscience. [published; Europe PMC]. \href{https://doi.org/10.1162/netn\_a\_00250}{doi:10.1162/netn\_a\_00250}.
\item Slomski A. (2022). \textit{Psilocybin for Treatment of Alcohol Use Disorder.}. JAMA. [published; Europe PMC]. \href{https://doi.org/10.1001/jama.2022.15436}{doi:10.1001/jama.2022.15436}.
\item Mohamed A, Touheed S, Ahmed M, Hor M, Fatima S (2022). \textit{The Efficacy of Psychedelic-Assisted Therapy in Managing Post-traumatic Stress Disorder (PTSD): A New Frontier?}. Cureus. [published; PubMed]. \href{https://doi.org/10.7759/cureus.30919}{doi:10.7759/cureus.30919}.
\item Dougherty RF, Clarke P, Alti M, Kuc J, Schlosser D, Dunlop BW, Hellerstein DJ, Aaronson ST, Zisook S, Young AH, Carhart-Harris R, Goodwin G, Ryslik GA. (2022). \textit{Psilocybin Therapy for Treatment Resistant Depression: Prediction of Clinical Outcome by Natural Language Processing}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/kh3cx}{doi:10.31234/osf.io/kh3cx}.
\item Unknown authors (2022). \textit{Psilocybin Therapy for Treatment Resistant Depression: Prediction of Clinical Outcome by Natural Language Processing}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/kh3cx\_v1}{source link}.
\item Søgaard Juul T, Ebbesen Jensen M, Fink-Jensen A. (2022). \textit{The use of classic psychedelics among adults: a Danish online survey study.}. Nordic Journal of Psychiatry. [published; Europe PMC]. \href{https://doi.org/10.1080/08039488.2022.2125069}{doi:10.1080/08039488.2022.2125069}.
\item Psiuk D, Nowak EM, Dycha N, Łopuszańska U, Kurzepa J, Samardakiewicz M. (2022). \textit{Esketamine and Psilocybin-The Comparison of Two Mind-Altering Agents in Depression Treatment: Systematic Review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/ijms231911450}{doi:10.3390/ijms231911450}.
\item COMPASS Pathways (2022). \textit{Multicentre Study To Assess Safety And Efficacy Of Psilocybin In Patients With Treatment-Resistant Depression Following Completion Of COMP001 And COMP003 Trials (P-TRD LTFU)}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT04519957}{source link}.
\item Barber GS, Aaronson ST. (2022). \textit{The Emerging Field of Psychedelic Psychotherapy.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s11920-022-01363-y}{doi:10.1007/s11920-022-01363-y}.
\item Vohryzek J, Cabral J, Lord L, Fernandes H, Roseman L, Nutt D, Carhart-Harris R, Deco G, Kringelbach M. (2022). \textit{Brain dynamics predictive of response to psilocybin for treatment-resistant depression}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-2060381/v1}{doi:10.21203/rs.3.rs-2060381/v1}.
\item Calder AE, Hasler G. (2022). \textit{Towards an understanding of psychedelic-induced neuroplasticity.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41386-022-01389-z}{doi:10.1038/s41386-022-01389-z}.
\item Gomathi Saminathan, Kavitha Kandasamy, Savitha Navaneethakrishnan, Mohana Ashokkumar, Brindha Veerappan, Krishnamoorthy Bellie Sundaram, G Aghajanian, G Marek, J.-C Bque, M Imad, L Mladenovic, J Gingrich, R Andrade, R Glennon, J Rosecrans, R Young, C Krumhansl, E Kessler, D Nichols, Psychedelics, Hallucinogens, P Delgado, F Moreno, C Nichols, B Liester, R Strassman, L Roseman, L Demetriou, M Wall, D Nutt, R Carhart-Harris, B Krishnamoorthy, S Kahlal, S Ghosh, J.-F Halet, Electronic, A Thakur, K Chakrahari, S Bose, P Hamon, T Roisnel, B Le Guennic, J.-Y Saillard, K Geetharani, S Mobin, F Neese, A Sherwood, R Kargbo, K Kaylo, N Cozzi, P Meisenheimer, J Kaduk, J Daniel, M Haberman, T Prisinzano, P Cumming, M Scheidegger, D Dornbierer, M Palner, B Quednow, C Martin-Soelch, A Rickli, O Moning, M Hoener, M Liechti, M Madsen, D Stenbaek, A Arvidsson, S Armand, M Marstrand-Joergensen, S Johansen, K Linnet, B Ozenne, G Knudsen, P Fisher, E Pottie, O Kupriyanova, A Brandt (2022). \textit{Molecular Structure, Reactivity and Spectroscopic Properties of Hallucinogens Psilocybin, Mescaline and their Derivatives - A Computational Study}. Letters in Applied NanoBioScience. [published; OpenAlex]. \href{https://doi.org/10.33263/lianbs124.105}{doi:10.33263/lianbs124.105}.
\item Kavita Golia (2022). \textit{Psilocybin as a healer}. Consciousness Spirituality \& Transpersonal Psychology. [published; OpenAlex]. \href{https://doi.org/10.53074/cstp.2022.37}{doi:10.53074/cstp.2022.37}.
\item Pouyan N, Halvaei Khankahdani Z, Younesi Sisi F, Lee Y, Rosenblat JD, Teopiz KM, Lui LMW, Subramaniapillai M, Lin K, Nasri F, Rodrigues N, Gill H, Lipsitz O, Cao B, Ho R, Castle D, McIntyre RS. (2022). \textit{A Research Domain Criteria (RDoC)-Guided Dashboard to Review Psilocybin Target Domains: A Systematic Review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s40263-022-00944-y}{doi:10.1007/s40263-022-00944-y}.
\item Stoliker D, Preller KH, Novelli L, Anticevic A, Egan GF, Vollenweider FX, Razi A. (2022). \textit{Neural mechanisms of psychedelic visual imagery}. medRxiv. [preprint; medRxiv]. \href{https://doi.org/10.1101/2022.09.07.22279700}{doi:10.1101/2022.09.07.22279700}.
\item Stoliker D, Novelli L, Vollenweider FX, Egan GF, Preller KH, Razi A. (2022). \textit{Effective connectivity of emotion and cognition under psilocybin}. medRxiv. [preprint; medRxiv]. \href{https://doi.org/10.1101/2022.09.06.22279626}{doi:10.1101/2022.09.06.22279626}.
\item Mellner C, Dahlen M, Simonsson O (2022). \textit{Association between Lifetime Classic Psychedelic Use and Sick Leave in a Population-Based Sample.}. International journal of environmental research and public health. [published; PubMed]. \href{https://doi.org/10.3390/ijerph191811353}{doi:10.3390/ijerph191811353}.
\item Lerer B, Singh S, Botvinnik A, Shahar O, Wolf G, Yakobi C, Saban M, Salama A, Lotan A, Lifschytz T. (2022). \textit{Effect of psilocybin on marble-burying in ICR mice: Role of 5-HT1A receptors and implications for the treatment of obsessive-compulsive disorder}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-2001983/v1}{doi:10.21203/rs.3.rs-2001983/v1}.
\item O'Leary K. (2022). \textit{Psilocybin therapy reduces heavy drinking.}. Nature Medicine. [published; Europe PMC]. \href{https://doi.org/10.1038/d41591-022-00093-1}{doi:10.1038/d41591-022-00093-1}.
\item Barba T, Buehler S, Kettner H, Radu C, Cunha BG, Nutt DJ, Erritzoe D, Roseman L, Carhart-Harris R. (2022). \textit{Effects of psilocybin versus escitalopram on rumination and thought suppression in depression.}. BJPsych Open. [published; Europe PMC]. \href{https://doi.org/10.1192/bjo.2022.565}{doi:10.1192/bjo.2022.565}.
\item Walsh CA, Livne O, Shmulewitz D, Stohl M, Hasin DS. (2022). \textit{Use of plant-based hallucinogens and dissociative agents: U.S. Time Trends, 2002-2019.}. Addictive Behaviors Reports. [published; Europe PMC]. \href{https://doi.org/10.1016/j.abrep.2022.100454}{doi:10.1016/j.abrep.2022.100454}.
\item Johnston CB, Mangini M, Grob C, Anderson B. (2022). \textit{The Safety and Efficacy of Psychedelic-Assisted Therapies for Older Adults: Knowns and Unknowns.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jagp.2022.08.007}{doi:10.1016/j.jagp.2022.08.007}.
\item Lyes M, Yang KH, Castellanos J, Furnish T. (2022). \textit{Microdosing psilocybin for chronic pain: a case series.}. Pain. [published; Europe PMC]. \href{https://doi.org/10.1097/j.pain.0000000000002778}{doi:10.1097/j.pain.0000000000002778}.
\item Diana Dias da Silva, Andreia Machado Brito-da-Costa, Silveira Martins, Ricardo Jorge Dinis-Oliveira, Áurea Madureira-Carvalho (2022). \textit{P03-21 Magic mushrooms and psilocybin: pharmacokinetics, pharmacodynamics, and clinical applications}. Toxicology Letters. [published; OpenAlex]. \href{https://doi.org/10.1016/j.toxlet.2022.07.283}{doi:10.1016/j.toxlet.2022.07.283}.
\item Henry A. Nasrallah (2022). \textit{From neuroplasticity to psychoplasticity: Psilocybin may reverse personality disorders and political fanaticism}. Current Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.12788/cp.0283}{doi:10.12788/cp.0283}.
\item Rodrigues J, Nombora O, Ribeiro L. (2022). \textit{Therapeutic potential of serotoninergic psychedelic substances in the treatment of Obsessive Compulsive Disorder}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC9567436}{source link}.
\item Girala N. (2022). \textit{Psychopathological descriptive model of hallucinogenic/psychedelic drugs effect in the treatment of depression and addictions}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC9567945}{source link}.
\item National Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Board on Health Sciences Policy; Forum on Neuroscience and Nervous System Disorders. (2022). \textit{Exploring Psychedelics and Entactogens as Treatments for Psychiatric Disorders: Proceedings of a Workshop}. National Academies Press (US), Washington (DC). [published; Europe PMC]. \href{https://europepmc.org/article/MED/36049038}{source link}.
\item Chue P, Andreiev A, Bucuci E, Els C, Chue J. (2022). \textit{A Review of Aeruginascin and Potential Entourage Effect in Hallucinogenic Mushrooms}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC9568164}{source link}.
\item Bhadoria P, Venkatnarayan R. (2022). \textit{Interplay of hydrogen bonding in deciding the conformers of psilocin: Computational insights}. Authorea Preprints. [preprint; Europe PMC]. \href{https://doi.org/10.22541/au.166200851.10677416/v1}{doi:10.22541/au.166200851.10677416/v1}.
\item Shah K, Trivedi C, Kamrai D, Akbar M, Tankersley W. (2022). \textit{Association of Psilocybin Use in Adolescents with Major Depressive Episode}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC9563652}{source link}.
\item Brito-da-Costa A.M., Madureira-Carvalho A., Dinis-Oliveira R.J., Silva D. Dias da (2022). \textit{P03-18 Simultaneous detection and quantification of psilocybin and psilocin by gas chromatography coupled to mass spectrometry (GC-MS)}. Toxicology Letters. [published; Crossref]. \href{https://doi.org/10.1016/j.toxlet.2022.07.280}{doi:10.1016/j.toxlet.2022.07.280}.
\item Johannesdottir A, Sigurdsson E. (2022). \textit{[The use of psilocybin for treatment-resistant depression].}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.17992/lbl.2022.09.706}{doi:10.17992/lbl.2022.09.706}.
\item Chomynová P, Kočárová R, Kňažek F, Plevková M, Bláhová B, Valeš K, Mravčík V. (2022). \textit{Use of psychedelics in the Czech Republic: results of recent population surveys.}. Central European Journal of Public Health. [published; Europe PMC]. \href{https://doi.org/10.21101/cejph.a7079}{doi:10.21101/cejph.a7079}.
\item McManus KR, Patrick R, Striepe MI, Drury MJ, Ozonsi R, Forester BP, Weinberg MS (2022). \textit{Psychedelics for Alzheimer's Disease Palliative Care.}. Advances in psychiatry and behavioral health. [published; PubMed]. \href{https://doi.org/10.1016/j.ypsc.2022.06.001}{doi:10.1016/j.ypsc.2022.06.001}.
\item Kurtz JS, Patel NA, Gendreau JL, Yang C, Brown N, Bui N, Picton B, Harris M, Hatter M, Beyer R, Sahyouni R, Diaz-Aguilar LD, Castellanos J, Schuster N, Abraham ME (2022). \textit{The Use of Psychedelics in the Treatment of Medical Conditions: An Analysis of Currently Registered Psychedelics Studies in the American Drug Trial Registry.}. Cureus. [published; PubMed]. \href{https://doi.org/10.7759/cureus.29167}{doi:10.7759/cureus.29167}.
\item Christensen JA, Fipps DC, Bostwick JM. (2022). \textit{To treat or not to treat? High-potency benzodiazepine use in a case of comorbid hallucinogen persisting perception disorder and alcohol use disorder.}. Experimental and Clinical Psychopharmacology. [published; Europe PMC]. \href{https://doi.org/10.1037/pha0000597}{doi:10.1037/pha0000597}.
\item Nutt D. (2022). \textit{Psychedelic Psychiatry}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC9565852}{source link}.
\item Yan YY, Zhang YZ, Vauras J, Zhao LN, Fan YG, Li HJ, Xu F. (2022). \textit{﻿ Pseudospermaarenarium (Inocybaceae), a new poisonous species from Eurasia, based on morphological, ecological, molecular and biochemical evidence.}. MycoKeys. [published; Europe PMC]. \href{https://doi.org/10.3897/mycokeys.92.86277}{doi:10.3897/mycokeys.92.86277}.
\item Erkizia-Santamaría I, Alles-Pascual R, Horrillo I, Meana JJ, Ortega JE. (2022). \textit{Serotonin 5-HT2A, 5-HT2c and 5-HT1A receptor involvement in the acute effects of psilocybin in mice. In vitro pharmacological profile and modulation of thermoregulation and head-twich response.}. Biomedicine \& Pharmacotherapy. [published; Europe PMC]. \href{https://doi.org/10.1016/j.biopha.2022.113612}{doi:10.1016/j.biopha.2022.113612}.
\item Kaypak AC, Raz A. (2022). \textit{Macrodosing to microdosing with psychedelics: Clinical, social, and cultural perspectives.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/13634615221119386}{doi:10.1177/13634615221119386}.
\item Breeksema JJ, Kuin BW, Kamphuis J, van den Brink W, Vermetten E, Schoevers RA. (2022). \textit{Adverse events in clinical treatments with serotonergic psychedelics and MDMA: A mixed-methods systematic review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811221116926}{doi:10.1177/02698811221116926}.
\item Sweeney MM, Nayak S, Hurwitz ES, Mitchell LN, Swift TC, Griffiths RR. (2022). \textit{Comparison of psychedelic and near-death or other non-ordinary experiences in changing attitudes about death and dying.}. PLoS ONE. [published; Europe PMC]. \href{https://doi.org/10.1371/journal.pone.0271926}{doi:10.1371/journal.pone.0271926}.
\item Doss MK, Barrett FS, Corlett PR. (2022). \textit{Skepticism about Recent Evidence That Psilocybin "Liberates" Depressed Minds.}. ACS Chemical Neuroscience. [published; Europe PMC]. \href{https://doi.org/10.1021/acschemneuro.2c00461}{doi:10.1021/acschemneuro.2c00461}.
\item Pilc A, Machaczka A, Kawalec P, Smith JL, Witkin JM. (2022). \textit{Where do we go next in antidepressant drug discovery? A new generation of antidepressants: a pivotal role of AMPA receptor potentiation and mGlu2/3 receptor antagonism.}. Expert Opinion on Drug Discovery. [published; Europe PMC]. \href{https://doi.org/10.1080/17460441.2022.2111415}{doi:10.1080/17460441.2022.2111415}.
\item Mark Molumby, Keith Gaynor, Suzanne Guérin, Róisín McNamara (2022). \textit{Examining Attitudes to Psilocybin: Should Candidates for Medical Psilocybin be Required to Pass a Contextual Suitability Test?}. Journal of Humanistic Psychology. [published; OpenAlex]. \href{https://doi.org/10.1177/00221678221110331}{doi:10.1177/00221678221110331}.
\item Yao S, Wei C, Lin H, Zhang P, Liu Y, Deng Y, Huang Q, Xie B. (2022). \textit{Cystathionine Gamma-Lyase Regulate Psilocybin Biosynthesis in Gymnopilus dilepis Mushroom via Amino Acid Metabolism Pathways.}. Journal of Fungi. [published; Europe PMC]. \href{https://doi.org/10.3390/jof8080870}{doi:10.3390/jof8080870}.
\item Henningfield JE, Coe MA, Griffiths RR, Belouin SJ, Berger A, Coker AR, Comer SD, Heal DJ, Hendricks PS, Nichols CD, Sapienza F, Vocci FJ, Zia FZ. (2022). \textit{Psychedelic drug abuse potential assessment research for new drug applications and Controlled Substances Act scheduling.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neuropharm.2022.109220}{doi:10.1016/j.neuropharm.2022.109220}.
\item Rosenblat JD, Husain MI, Lee Y, McIntyre RS, Mansur RB, Castle D, Offman H, Parikh SV, Frey BN, Schaffer A, Greenway KT, Garel N, Beaulieu S, Kennedy SH, Lam RW, Milev R, Ravindran AV, Tourjman V, Ameringen MV, Yatham LN, Taylor V. (2022). \textit{The Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Report: Serotonergic Psychedelic Treatments for Major Depressive Disorder.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/07067437221111371}{doi:10.1177/07067437221111371}.
\item Jesús M. González Mariscal, Paulina E. Sosa-Cortés (2022). \textit{Insights for Modern Applications of Psilocybin Therapy from a Case Study of Traditional Mazatec Medicine}. Anthropology of Consciousness. [published; OpenAlex]. \href{https://doi.org/10.1111/anoc.12168}{doi:10.1111/anoc.12168}.
\item María de Ángeles Equihua Orozco, Shana Harris (2022). \textit{Psilocybin and the Meaning Response: Exploring the Healing Process in a Retreat Setting in Jamaica}. Anthropology of Consciousness. [published; OpenAlex]. \href{https://doi.org/10.1111/anoc.12162}{doi:10.1111/anoc.12162}.
\item Belouin SJ, Averill LA, Henningfield JE, Xenakis SN, Donato I, Grob CS, Berger A, Magar V, Danforth AL, Anderson BT. (2022). \textit{Policy considerations that support equitable access to responsible, accountable, safe, and ethical uses of psychedelic medicines.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neuropharm.2022.109214}{doi:10.1016/j.neuropharm.2022.109214}.
\item Prouzeau D, Conejero I, Voyvodic PL, Becamel C, Abbar M, Lopez-Castroman J. (2022). \textit{Psilocybin Efficacy and Mechanisms of Action in Major Depressive Disorder: a Review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s11920-022-01361-0}{doi:10.1007/s11920-022-01361-0}.
\item Fadahunsi N, Lund J, Breum AW, Mathiesen CV, Larsen IB, Knudsen GM, Klein AB, Clemmensen C. (2022). \textit{Acute and long-term effects of psilocybin on energy balance and feeding behavior in mice.}. Translational Psychiatry. [published; Europe PMC]. \href{https://doi.org/10.1038/s41398-022-02103-9}{doi:10.1038/s41398-022-02103-9}.
\item Levin A, Nagib PB, Deiparine S, Gao T, Mitchell J, Davis AK. (2022). \textit{Inconsistencies between national drug policy and professional beliefs about psychoactive drugs among psychiatrists in the United States.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.drugpo.2022.103816}{doi:10.1016/j.drugpo.2022.103816}.
\item Gitte Moos Knudsen (2022). \textit{Prophylactic Effects of Psilocybin on Chronic Cluster Headache: an Open-label Clinical Trial and Neuroimaging Study}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT04280055}{source link}.
\item Jaster AM, Younkin J, Cuddy T, de la Fuente Revenga M, Poklis JL, Dozmorov MG, González-Maeso J. (2022). \textit{Differences across sexes on head-twitch behavior and 5-HT2A receptor signaling in C57BL/6J mice.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neulet.2022.136836}{doi:10.1016/j.neulet.2022.136836}.
\item Antonella Fagetti, Roberto E. Mercadillo (2022). \textit{Experiences With Sacred Mushrooms and Psilocybin In Dialogue: Transdisciplinary Interpretations Of The “Velada”}. Anthropology of Consciousness. [published; OpenAlex]. \href{https://doi.org/10.1111/anoc.12163}{doi:10.1111/anoc.12163}.
\item Watts R, Kettner H, Geerts D, Gandy S, Kartner L, Mertens L, Timmermann C, Nour MM, Kaelen M, Nutt D, Carhart-Harris R, Roseman L. (2022). \textit{The Watts Connectedness Scale: a new scale for measuring a sense of connectedness to self, others, and world.}. Psychopharmacology. [published; Europe PMC]. \href{https://doi.org/10.1007/s00213-022-06187-5}{doi:10.1007/s00213-022-06187-5}.
\item Clifton JM, Belcher AM, Greenblatt AD, Welsh CM, Cole TO, Davis AK. (2022). \textit{Psilocybin use patterns and perception of risk among a cohort of Black individuals with Opioid Use Disorder.}. Journal of Psychedelic Studies. [published; Europe PMC]. \href{https://doi.org/10.1556/2054.2022.00214}{doi:10.1556/2054.2022.00214}.
\item George Winter (2022). \textit{Psilocybin administration}. Journal of Prescribing Practice. [published; OpenAlex]. \href{https://doi.org/10.12968/jprp.2022.4.8.340}{doi:10.12968/jprp.2022.4.8.340}.
\item Cavanna F, Muller S, de la Fuente LA, Zamberlan F, Palmucci M, Janeckova L, Kuchar M, Pallavicini C, Tagliazucchi E. (2022). \textit{Microdosing with psilocybin mushrooms: a double-blind placebo-controlled study.}. Translational Psychiatry. [published; Europe PMC]. \href{https://doi.org/10.1038/s41398-022-02039-0}{doi:10.1038/s41398-022-02039-0}.
\item Unknown authors (2022). \textit{Depression: Psilocybin etwas besser als Escitalopram}. Zeitschrift für Phytotherapie. [published; OpenAlex]. \href{https://doi.org/10.1055/a-1857-9047}{doi:10.1055/a-1857-9047}.
\item Terri D’Arrigo (2022). \textit{Med Check: Psilocybin for OCD, Nuplazid Vote, and More}. Psychiatric News. [published; OpenAlex]. \href{https://doi.org/10.1176/appi.pn.2022.08.8.2}{doi:10.1176/appi.pn.2022.08.8.2}.
\item Rosa WE, Sager Z, Miller M, Bernstein I, Doerner Rinaldi A, Addicott K, Ljuslin M, Adrian C, Back AL, Beachy J, Bossis AP, Breitbart WS, Cosimano MP, Fischer SM, Guss J, Knighton E, Phelps J, Richards BD, Richards WA, Tulsky JA, Williams MT, Beaussant Y (2022). \textit{Top Ten Tips Palliative Care Clinicians Should Know About Psychedelic-Assisted Therapy in the Context of Serious Illness.}. Journal of palliative medicine. [published; PubMed]. \href{https://doi.org/10.1089/jpm.2022.0036}{doi:10.1089/jpm.2022.0036}.
\item Polito V, Liknaitzky P (2022). \textit{The emerging science of microdosing: A systematic review of research on low dose psychedelics (1955-2021) and recommendations for the field.}. Neuroscience and biobehavioral reviews. [published; PubMed]. \href{https://doi.org/10.1016/j.neubiorev.2022.104706}{doi:10.1016/j.neubiorev.2022.104706}.
\item Suleiman M, Basu A, Belal S, Jacob T. (2022). \textit{From Mushrooms to Myolysis: A Case of Rhabdo in Psilocybin-Induced Mood and Psychotic Disorder.}. The Journal of Nervous and Mental Disease. [published; Europe PMC]. \href{https://doi.org/10.1097/nmd.0000000000001489}{doi:10.1097/nmd.0000000000001489}.
\item Nygart VA, Pommerencke LM, Haijen E, Kettner H, Kaelen M, Mortensen EL, Nutt DJ, Carhart-Harris RL, Erritzoe D (2022). \textit{Antidepressant effects of a psychedelic experience in a large prospective naturalistic sample.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811221101061}{doi:10.1177/02698811221101061}.
\item Makin S. (2022). \textit{Mushrooms' Legal Trip: As psilocybin research ramps up, the drug's status under the law is shifting.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/scientificamerican0822-12}{doi:10.1038/scientificamerican0822-12}.
\item Gumpper RH, Fay JF, Roth BL. (2022). \textit{Molecular insights into the regulation of constitutive activity by RNA editing of 5HT2C serotonin receptors.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.celrep.2022.111211}{doi:10.1016/j.celrep.2022.111211}.
\item James A. Kaduk, Alexander M. Sherwood, Robert B. Kargbo, Kristi W. Kaylo, Poncho Meisenheimer, Nicholas V. Cozzi (2022). \textit{Psilocybin: crystal structure solutions enable phase analysis of prior art and recently patented examples}. Acta Crystallographica Section A Foundations and Advances. [published; OpenAlex]. \href{https://doi.org/10.1107/s2053273322097261}{doi:10.1107/s2053273322097261}.
\item Rootman JM, Kiraga M, Kryskow P, Harvey K, Stamets P, Santos-Brault E, Kuypers KPC, Walsh Z. (2022). \textit{Author Correction: Psilocybin microdosers demonstrate greater observed improvements in mood and mental health at one month relative to non-microdosing controls.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41598-022-17428-0}{doi:10.1038/s41598-022-17428-0}.
\item Golden CT, Chadderton P. (2022). \textit{Psilocybin reduces low frequency oscillatory power and neuronal phase-locking in the anterior cingulate cortex of awake rodents.}. Scientific Reports. [published; Europe PMC]. \href{https://doi.org/10.1038/s41598-022-16325-w}{doi:10.1038/s41598-022-16325-w}.
\item University of California, San Diego (2022). \textit{Evaluation of Psilocybin in Anorexia Nervosa: Safety and Efficacy}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT04661514}{source link}.
\item Shahar O, Botvinnik A, Esh-Zuntz N, Brownstien M, Wolf R, Wolf G, Lerer B, Lifschytz T. (2022). \textit{Role of 5-HT2A, 5-HT2C, 5-HT1A and TAAR1 receptors in the head twitch response induced by 5-hydroxytryptophan and psilocybin: Translational implications}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2022.07.22.501026}{doi:10.1101/2022.07.22.501026}.
\item y7fceaj128 (2022). \textit{9 Signs You Need Help With Magic Mushrooms uk}. Zenodo (CERN European Organization for Nuclear Research). [published; OpenAlex]. \href{https://doi.org/10.5281/zenodo.6847342}{doi:10.5281/zenodo.6847342}.
\item Meyer TD, Meir P, Lex C, Soares JC. (2022). \textit{Magic Mushrooms - an exploratory look at how mental health professionals feel and think about Psilocybin.}. Psychiatry Research. [published; Europe PMC]. \href{https://doi.org/10.1016/j.psychres.2022.114727}{doi:10.1016/j.psychres.2022.114727}.
\item Singh S, Botvinnik A, Shahar O, Wolf G, Yakobi C, Saban M, Salama A, Lotan A, Lerer B, Lifschytz T. (2022). \textit{Effect of psilocybin on marble-burying in ICR mice: Role of 5-HT1A receptors and implications for the treatment of obsessive-compulsive disorder}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2022.07.13.498401}{doi:10.1101/2022.07.13.498401}.
\item Luppi AI, Hansen JY, Adapa R, Carhart-Harris RL, Roseman L, Timmermann C, Golkowski D, Golkowski D, Ranft A, Ilg R, Jordan D, Bonhomme V, Vanhaudenhuyse A, Demertzi A, Jaquet O, Bahri MA, Alnagger NL, Cardone P, Peattie ARD, Manktelow AE, de Araujo DB, Sensi SL, Owen AM, Naci L, Menon DK, Misic B, Stamatakis EA. (2022). \textit{Mapping Pharmacologically-induced Functional Reorganisation onto the Brain’s Neurotransmitter Landscape}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2022.07.12.499688}{doi:10.1101/2022.07.12.499688}.
\item Ko K, Knight G, Rucker JJ, Cleare AJ. (2022). \textit{Psychedelics, Mystical Experience, and Therapeutic Efficacy: A Systematic Review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fpsyt.2022.917199}{doi:10.3389/fpsyt.2022.917199}.
\item Berens N, Kim SY. (2022). \textit{Rapid-Response Treatments for Depression and Requests for Physician-Assisted Death: An Ethical Analysis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jagp.2022.07.003}{doi:10.1016/j.jagp.2022.07.003}.
\item Dodd S, Norman TR, Eyre HA, Stahl SM, Phillips A, Carvalho AF, Berk M. (2022). \textit{Psilocybin in neuropsychiatry: a review of its pharmacology, safety, and efficacy.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1017/s1092852922000888}{doi:10.1017/s1092852922000888}.
\item Madsen MK, Petersen AS, Stenbæk DS, Sørensen IM, Schiønning H, Fjeld T, Nykjær CH, Ulv Larsen SM, Grzywacz M, Mathiesen T, Klausen IL, Overgaard-Hansen O, Brendstrup-Brix K, Linnet K, Johansen SS, Fisher PM, Jensen RH, Knudsen GM. (2022). \textit{Psilocybin-induced reduction in chronic cluster headache attack frequency correlates with changes in hypothalamic functional connectivity}. medRxiv. [preprint; medRxiv]. \href{https://doi.org/10.1101/2022.07.10.22277414}{doi:10.1101/2022.07.10.22277414}.
\item Zeifman R, Spriggs MJ, Kettner H, Lyons T, Rosas F, Mediano P, Erritzoe D, Carhart-Harris R. (2022). \textit{From Relaxed Beliefs Under Psychedelics (REBUS) to Revised Beliefs After Psychedelics (REBAS): Preliminary Development of the RElaxed Beliefs Questionnaire (REB-Q)}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/w8j6t}{doi:10.31234/osf.io/w8j6t}.
\item Unknown authors (2022). \textit{From Relaxed Beliefs Under Psychedelics (REBUS) to Revised Beliefs After Psychedelics (REBAS): Preliminary Development of the RElaxed Beliefs Questionnaire (REB-Q)}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/w8j6t\_v1}{source link}.
\item Kiraga MK, Kuypers KPC, Uthaug MV, Ramaekers JG, Mason NL. (2022). \textit{Decreases in State and Trait Anxiety Post-psilocybin: A Naturalistic, Observational Study Among Retreat Attendees.}. Frontiers in Psychiatry. [published; Europe PMC]. \href{https://doi.org/10.3389/fpsyt.2022.883869}{doi:10.3389/fpsyt.2022.883869}.
\item Rajkumar RP. (2022). \textit{Pharmacotherapy for the Secondary Prevention of Suicide: Leads from the Social Pain Hypothesis}. Preprints.org. [preprint; Europe PMC]. \href{https://doi.org/10.20944/preprints202207.0064.v1}{doi:10.20944/preprints202207.0064.v1}.
\item Bosch OG, Halm S, Seifritz E. (2022). \textit{Psychedelics in the treatment of unipolar and bipolar depression.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1186/s40345-022-00265-5}{doi:10.1186/s40345-022-00265-5}.
\item Glatfelter GC, Pham DNK, Walther D, Golen JA, Chadeayne AR, Baumann MH, Manke DR. (2022). \textit{Synthesis, Structural Characterization, and Pharmacological Activity of Novel Quaternary Salts of 4-Substituted Tryptamines.}. ACS Omega. [published; Europe PMC]. \href{https://doi.org/10.1021/acsomega.2c03476}{doi:10.1021/acsomega.2c03476}.
\item da Costa SC, Oesterle T, Rummans TA, Richelson E, Gold M. (2022). \textit{Psychedelic drugs for psychiatric disorders.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jns.2022.120332}{doi:10.1016/j.jns.2022.120332}.
\item Vohryzek J, Cabral J, Lord L, Fernandes HM, Roseman L, Nutt DJ, Carhart-Harris RL, Deco G, Kringelbach ML. (2022). \textit{Brain dynamics predictive of response to psilocybin for treatment-resistant depression}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2022.06.30.497950}{doi:10.1101/2022.06.30.497950}.
\item Sherif MA, Khalil MZ, Shukla R, Brown JC, Carpenter LL. (2022). \textit{Synapses, predictions, and prediction errors: a neocortical computational study of MDD using the temporal memory algorithm of HTM}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2022.06.29.498015}{doi:10.1101/2022.06.29.498015}.
\item Gandia A, Adamatzky A. (2022). \textit{Electrical spiking of psilocybin fungi}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2022.07.02.498545}{doi:10.1101/2022.07.02.498545}.
\item Gaddis A, Lidstone DE, Nebel MB, Griffiths RR, Mostofsky SH, Mejia AF, Barrett FS. (2022). \textit{Psilocybin induces spatially constrained alterations in thalamic functional organizaton and connectivity.}. NeuroImage. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neuroimage.2022.119434}{doi:10.1016/j.neuroimage.2022.119434}.
\item McCulloch DE, Knudsen GM, Barrett FS, Doss MK, Carhart-Harris RL, Rosas FE, Deco G, Kringelbach ML, Preller KH, Ramaekers JG, Mason NL, Müller F, Fisher PM (2022). \textit{Psychedelic resting-state neuroimaging: A review and perspective on balancing replication and novel analyses.}. Neuroscience and biobehavioral reviews. [published; PubMed]. \href{https://doi.org/10.1016/j.neubiorev.2022.104689}{doi:10.1016/j.neubiorev.2022.104689}.
\item Nayak SM, Bari BA, Yaden DB, Spriggs MJ, Rosas F, Peill JM, Giribaldi B, Erritzoe D, Nutt D, Carhart-Harris R. (2022). \textit{A Bayesian Reanalysis of a Trial of Psilocybin versus Escitalopram for Depression}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/sb5ur}{doi:10.31234/osf.io/sb5ur}.
\item Saeger HN, Olson DE (2022). \textit{Psychedelic-inspired approaches for treating neurodegenerative disorders.}. Journal of neurochemistry. [published; PubMed]. \href{https://doi.org/10.1111/jnc.15544}{doi:10.1111/jnc.15544}.
\item Pöllänen E, Osika W, Stenfors CUD, Simonsson O (2022). \textit{Classic Psychedelics and Human-Animal Relations.}. International journal of environmental research and public health. [published; PubMed]. \href{https://doi.org/10.3390/ijerph19138114}{doi:10.3390/ijerph19138114}.
\item Lyons A. (2022). \textit{Self-administration of Psilocybin in the Setting of Treatment-resistant Depression.}. PubMed. [published; Europe PMC]. \href{https://europepmc.org/article/MED/36204170}{source link}.
\item Farley M, Tran H, Towler S, Gevorkyan J, Pearring S, Rodda LN. (2022). \textit{A Single Method for 127 Recommended and Additional DUID Drugs in Blood and Urine by LC-MS-MS.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1093/jat/bkab075}{doi:10.1093/jat/bkab075}.
\item Unknown authors (2022). \textit{A Bayesian Reanalysis of a Trial of Psilocybin versus Escitalopram for Depression}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/sb5ur\_v1}{source link}.
\item Joseph M. Rootman, Maggie Kiraga, Pamela Kryskow, Kalin Harvey, Paul Stamets, Eesmyal Santos-Brault, Kim P.C. Kuypers, Zach Walsh (2022). \textit{Psilocybin microdosers demonstrate greater observed improvements in mood and mental health at one month relative to non-microdosing controls}. VIUspace. [published; OpenAlex]. \href{https://doi.org/10.25316/ir-20556}{doi:10.25316/ir-20556}.
\item Wake Network, Inc. (2022). \textit{Randomized Double Blind Placebo Controlled Assessing the Efficacy of Micro-dosed Psilocybin in Reducing Anxiety and or Depression Levels in Adults}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT04989972}{source link}.
\item Wall M, Harding R, Zafar R, Rabiner EA, Nutt D, Erritzoe D. (2022). \textit{Neuroimaging in psychedelic drug development: Past, present, and future}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/xwu4j}{doi:10.31234/osf.io/xwu4j}.
\item Rootman JM, Kiraga M, Kryskow P, Harvey K, Stamets P, Santos-Brault E, Kuypers KPC, Walsh Z. (2022). \textit{Psilocybin microdosers demonstrate greater observed improvements in mood and mental health at one month relative to non-microdosing controls.}. Scientific Reports. [published; Europe PMC]. \href{https://doi.org/10.1038/s41598-022-14512-3}{doi:10.1038/s41598-022-14512-3}.
\item Unknown authors (2022). \textit{Neuroimaging in psychedelic drug development: Past, present, and future}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/xwu4j\_v1}{source link}.
\item Vorobyeva N, Kozlova AA. (2022). \textit{Three Naturally-Occurring Psychedelics and Their Significance in the Treatment of Mental Health Disorders.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fphar.2022.927984}{doi:10.3389/fphar.2022.927984}.
\item Inouye A, Wolfgang A. (2022). \textit{3,4-Methylenedioxymethamphetamine (MDMA)-Assisted Therapy in Hawaii: A Brief Review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.7759/cureus.26402}{doi:10.7759/cureus.26402}.
\item Wang Q, Ren Y, Cui Y, Gao B, Zhang H, Jiang Q, Loor JJ, Deng Z, Xu C. (2022). \textit{Bacillus subtilis Produces Amino Acids to Stimulate Protein Synthesis in Ruminal Tissue Explants via the Phosphatidylinositol-4,5-Bisphosphate 3-Kinase Catalytic Subunit Beta-Serine/Threonine Kinase-Mammalian Target of Rapamycin Complex 1 Pathway.}. Frontiers in Veterinary Science. [published; Europe PMC]. \href{https://doi.org/10.3389/fvets.2022.852321}{doi:10.3389/fvets.2022.852321}.
\item Rusanen SS, De S, Schindler EAD, Artto VA, Storvik M. (2022). \textit{Self-Reported Efficacy of Treatments in Cluster Headache: a Systematic Review of Survey Studies.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s11916-022-01063-5}{doi:10.1007/s11916-022-01063-5}.
\item Jones G, Lipson J, Nock MK. (2022). \textit{Associations between classic psychedelics and nicotine dependence in a nationally representative sample.}. Scientific Reports. [published; Europe PMC]. \href{https://doi.org/10.1038/s41598-022-14809-3}{doi:10.1038/s41598-022-14809-3}.
\item Knudsen GM. (2022). \textit{Sustained effects of single doses of classical psychedelics in humans.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41386-022-01361-x}{doi:10.1038/s41386-022-01361-x}.
\item Schmidt C, Wolff M, Gründer G, Jungaberle H. (2022). \textit{[Attitudes of Mental Health Experts Towards Psilocybin].}. Fortschritte der Neurologie · Psychiatrie. [published; Europe PMC]. \href{https://doi.org/10.1055/a-1846-1161}{doi:10.1055/a-1846-1161}.
\item Viktorin V, Griškova-Bulanova I, Voicikas A, Dojčánová D, Zach P, Bravermanová A, Andrashko V, Tylš F, Korčák J, Viktorinová M, Koudelka V, Hájková K, Kuchař M, Horáček J, Brunovský M, Páleníček T. (2022). \textit{Psilocybin-Mediated Attenuation of Gamma Band Auditory Steady-State Responses (ASSR) Is Driven by the Intensity of Cognitive and Emotional Domains of Psychedelic Experience.}. Journal of Personalized Medicine. [published; Europe PMC]. \href{https://doi.org/10.3390/jpm12061004}{doi:10.3390/jpm12061004}.
\item Wojtas A, Bysiek A, Wawrzczak-Bargiela A, Szych Z, Majcher-Maślanka I, Herian M, Maćkowiak M, Gołembiowska K. (2022). \textit{Effect of Psilocybin and Ketamine on Brain Neurotransmitters, Glutamate Receptors, DNA and Rat Behavior.}. International Journal of Molecular Sciences. [published; Europe PMC]. \href{https://doi.org/10.3390/ijms23126713}{doi:10.3390/ijms23126713}.
\item Schindler EAD. (2022). \textit{Psychedelics as preventive treatment in headache and chronic pain disorders.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neuropharm.2022.109166}{doi:10.1016/j.neuropharm.2022.109166}.
\item Hibicke M, Nichols CD. (2022). \textit{Validation of the forced swim test in Drosophila, and its use to demonstrate psilocybin has long-lasting antidepressant-like effects in flies.}. Scientific Reports. [published; Europe PMC]. \href{https://doi.org/10.1038/s41598-022-14165-2}{doi:10.1038/s41598-022-14165-2}.
\item Dörner S, Rogge K, Fricke J, Schäfer T, Wurlitzer JM, Gressler M, Pham DNK, Manke DR, Chadeayne AR, Hoffmeister D. (2022). \textit{Genetic Survey of Psilocybe Natural Products.}. ChemBioChem. [published; Europe PMC]. \href{https://doi.org/10.1002/cbic.202200249}{doi:10.1002/cbic.202200249}.
\item Sanz C, Cavanna F, Muller S, de la Fuente L, Zamberlan F, Palmucci M, Janeckova L, Kuchar M, Carrillo F, García AM, Pallavicini C, Tagliazucchi E. (2022). \textit{Natural language signatures of psilocybin microdosing.}. Psychopharmacology. [published; Europe PMC]. \href{https://doi.org/10.1007/s00213-022-06170-0}{doi:10.1007/s00213-022-06170-0}.
\item Felsch CL, Kuypers KPC. (2022). \textit{Don't be afraid, try to meditate- potential effects on neural activity and connectivity of psilocybin-assisted mindfulness-based intervention for social anxiety disorder: A systematic review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neubiorev.2022.104724}{doi:10.1016/j.neubiorev.2022.104724}.
\item Polo-Castellano C, Álvarez JÁ, Palma M, Barbero GF, Ayuso J, Ferreiro-González M. (2022). \textit{Optimization through a Box-Behnken Experimental Design of the Microwave-Assisted Extraction of the Psychoactive Compounds in Hallucinogenic Fungi (Psylocibe cubensis).}. Journal of Fungi. [published; Europe PMC]. \href{https://doi.org/10.3390/jof8060598}{doi:10.3390/jof8060598}.
\item Fulmali A, Bharate SS. (2022). \textit{Phosphate moiety in FDA-approved pharmaceutical salts and prodrugs.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1002/ddr.21953}{doi:10.1002/ddr.21953}.
\item Anthony Principe (2022). \textit{Neuropharmacological analysis of the anti-addictive and therapeutic effects of psilocybin}. SURG Journal. [published; OpenAlex]. \href{https://doi.org/10.21083/surg.v14i1.6870}{doi:10.21083/surg.v14i1.6870}.
\item Manish Agrawal, Paul Thambi, Sarah Shnayder (2022). \textit{The safety and efficacy of psilocybin therapy in patients with cancer and major depressive disorder.}. Journal of Clinical Oncology. [published; OpenAlex]. \href{https://doi.org/10.1200/jco.2022.40.16\_suppl.12097}{doi:10.1200/jco.2022.40.16\_suppl.12097}.
\item Kaushal Shah, C. Trivedi, D. Kamrai, M. Akbar, W. Tankersley (2022). \textit{Association of Psilocybin Use in Adolescents with Major Depressive Episode}. European Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1192/j.eurpsy.2022.837}{doi:10.1192/j.eurpsy.2022.837}.
\item Malcolm B, Thomas K (2022). \textit{Serotonin toxicity of serotonergic psychedelics.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-021-05876-x}{doi:10.1007/s00213-021-05876-x}.
\item Vohra HZ, Saunders JM, Jaster AM, de la Fuente Revenga M, Jimenez J, Fernández-Teruel A, Wolstenholme JT, Beardsley PM, González-Maeso J (2022). \textit{Sex-specific effects of psychedelics on prepulse inhibition of startle in 129S6/SvEv mice.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-021-05913-9}{doi:10.1007/s00213-021-05913-9}.
\item van den Berg M, Magaraggia I, Schreiber R, Hillhouse TM, Porter JH (2022). \textit{How to account for hallucinations in the interpretation of the antidepressant effects of psychedelics: a translational framework.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-022-06106-8}{doi:10.1007/s00213-022-06106-8}.
\item Husain MI, Umer M, Mulsant BH (2022). \textit{Can the revival of serotonergic psychedelic drugs as treatments for mental disorders help to characterize their risks and benefits?}. Expert opinion on drug safety. [published; PubMed]. \href{https://doi.org/10.1080/14740338.2022.2063274}{doi:10.1080/14740338.2022.2063274}.
\item Smausz R, Neill J, Gigg J. (2022). \textit{Neural mechanisms underlying psilocybin's therapeutic potential - the need for preclinical in vivo electrophysiology.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811221092508}{doi:10.1177/02698811221092508}.
\item Jairaj C, Rucker JJ. (2022). \textit{Postpartum depression: A role for psychedelics?}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811221093793}{doi:10.1177/02698811221093793}.
\item Henner RL, Keshavan MS, Hill KP. (2022). \textit{Review of potential psychedelic treatments for PTSD.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jns.2022.120302}{doi:10.1016/j.jns.2022.120302}.
\item Al-Imam A, Motyka MA, Witulska Z, Younus M, Michalak M. (2022). \textit{Spatiotemporal Mapping of Online Interest in Cannabis and Popular Psychedelics before and during the COVID-19 Pandemic in Poland.}. International Journal of Environmental Research and Public Health. [published; Europe PMC]. \href{https://doi.org/10.3390/ijerph19116619}{doi:10.3390/ijerph19116619}.
\item Brandt SD, Kavanagh PV, Westphal F, Pulver B, Schwelm HM, Whitelock K, Stratford A, Auwärter V, Halberstadt AL. (2022). \textit{Analytical profile, in vitro metabolism and behavioral properties of the lysergamide 1P-AL-LAD.}. Drug Testing and Analysis. [published; Europe PMC]. \href{https://doi.org/10.1002/dta.3281}{doi:10.1002/dta.3281}.
\item Sotille R, Singh H, Weisman A, Vida T. (2022). \textit{Unraveling the Mysteries of Mental Illness With Psilocybin.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.7759/cureus.25414}{doi:10.7759/cureus.25414}.
\item Doss MK, Samaha J, Barrett FS, Griffiths RR, de Wit H, Gallo DA, Koen JD. (2022). \textit{Unique Effects of Sedatives, Dissociatives, Psychedelics, Stimulants, and Cannabinoids on Episodic Memory: A Review and Reanalysis of Acute Drug Effects on Recollection, Familiarity, and Metamemory}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2022.05.20.492842}{doi:10.1101/2022.05.20.492842}.
\item Richard Karel (2022). \textit{Psilocybin-Assisted Therapy Found to Improve Depression, Offer Other Benefits}. Psychiatric News. [published; OpenAlex]. \href{https://doi.org/10.1176/appi.pn.2022.06.6.30}{doi:10.1176/appi.pn.2022.06.6.30}.
\item Dominique Strauss, Soumya Ghosh, Zurika Murray, Marieka Gryzenhout (2022). \textit{An Overview on the Taxonomy, Phylogenetics and Ecology of the Psychedelic Genera Psilocybe, Panaeolus, Pluteus and Gymnopilus}. Frontiers in Forests and Global Change. [published; OpenAlex]. \href{https://doi.org/10.3389/ffgc.2022.813998}{doi:10.3389/ffgc.2022.813998}.
\item Mahmood D, Alenezi SK, Anwar MJ, Azam F, Qureshi KA, Jaremko M. (2022). \textit{New Paradigms of Old Psychedelics in Schizophrenia.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/ph15050640}{doi:10.3390/ph15050640}.
\item Elsouri KN, Kalhori S, Colunge D, Grabarczyk G, Hanna G, Carrasco C, Aleman Espino A, Francisco A, Borosky B, Bekheit B, Ighanifard M, Astudillo AA, Demory Beckler M. (2022). \textit{Psychoactive Drugs in the Management of Post Traumatic Stress Disorder: A Promising New Horizon.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.7759/cureus.25235}{doi:10.7759/cureus.25235}.
\item National Institute of Mental Health, Czech Republic (2022). \textit{Psilocybin Versus Ketamine - Fast Acting Antidepressant Strategies in Treatment-resistant Depression}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05383313}{source link}.
\item Edinoff AN, Fort JM, Singh C, Wagner SE, Rodriguez JR, Johnson CA, Cornett EM, Murnane KS, Kaye AM, Kaye AD. (2022). \textit{Alternative Options for Complex, Recurrent Pain States Using Cannabinoids, Psilocybin, and Ketamine: A Narrative Review of Clinical Evidence.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/neurolint14020035}{doi:10.3390/neurolint14020035}.
\item Huang J, Pham M, Panenka WJ, Honer WG, Barr AM. (2022). \textit{Chronic Treatment With Psilocybin Decreases Changes in Body Weight in a Rodent Model of Obesity.}. Frontiers in Psychiatry. [published; Europe PMC]. \href{https://doi.org/10.3389/fpsyt.2022.891512}{doi:10.3389/fpsyt.2022.891512}.
\item Lenz C, Dörner S, Trottmann F, Hertweck C, Sherwood A, Hoffmeister D. (2022). \textit{Assessment of Bioactivity-Modulating Pseudo-Ring Formation in Psilocin and Related Tryptamines.}. ChemBioChem. [published; Europe PMC]. \href{https://doi.org/10.1002/cbic.202200183}{doi:10.1002/cbic.202200183}.
\item Kotts WJ, Gamble DT, Dawson DK, Connor D. (2022). \textit{Psilocybin-induced takotsubo cardiomyopathy.}. BMJ Case Reports. [published; Europe PMC]. \href{https://doi.org/10.1136/bcr-2021-245863}{doi:10.1136/bcr-2021-245863}.
\item Andrew Hodge, Suporn Sukpraprut-Braaten, Robert Strayhan (2022). \textit{The Efficacy of Psilocybin in the Treatment of Depression andAnxiety: A Meta-Analysis}. Current Psychiatry Research and Reviews. [published; OpenAlex]. \href{https://doi.org/10.2174/2666082218666220513142002}{doi:10.2174/2666082218666220513142002}.
\item Mocanu V, Mackay L, Christie D, Argento E. (2022). \textit{Safety considerations in the evolving legal landscape of psychedelic-assisted psychotherapy.}. Substance Abuse Treatment Prevention and Policy. [published; Europe PMC]. \href{https://doi.org/10.1186/s13011-022-00468-0}{doi:10.1186/s13011-022-00468-0}.
\item Ortiz CE, Dourron HM, Sweat NW, Garcia-Romeu A, MacCarthy S, Anderson BT, Hendricks PS. (2022). \textit{Special considerations for evaluating psilocybin-facilitated psychotherapy in vulnerable populations.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neuropharm.2022.109127}{doi:10.1016/j.neuropharm.2022.109127}.
\item Carhart-Harris R, Daws RE, Nutt D. (2022). \textit{A critique of: Skepticism About Recent Evidence that Psilocybin Opens Depressed Minds}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/pdbf5}{doi:10.31234/osf.io/pdbf5}.
\item Unknown authors (2022). \textit{A critique of: Skepticism About Recent Evidence that Psilocybin Opens Depressed Minds}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/pdbf5\_v1}{source link}.
\item Nguyen TQT, Lund FW, Zanjani AAH, Khandelia H. (2022). \textit{Magic mushroom extracts in lipid membranes.}. Biochimica et Biophysica Acta (BBA) - Biomembranes. [published; Europe PMC]. \href{https://doi.org/10.1016/j.bbamem.2022.183957}{doi:10.1016/j.bbamem.2022.183957}.
\item Johansen L, Liknaitzky P, Nedeljkovic M, Mastin-Purcell L, Murray G (2022). \textit{The psychological processes of classic psychedelics in the treatment of depression: a systematic review protocol.}. Systematic reviews. [published; PubMed]. \href{https://doi.org/10.1186/s13643-022-01930-7}{doi:10.1186/s13643-022-01930-7}.
\item Grant C. Glatfelter, David R. Manke, Andrew R. Chadayne, Michael H. Baumann (2022). \textit{Receptor binding profiles and behavioral effects of psilocybin analogs}. The FASEB Journal. [published; OpenAlex]. \href{https://doi.org/10.1096/fasebj.2022.36.s1.r3639}{doi:10.1096/fasebj.2022.36.s1.r3639}.
\item Stein CA, Penn A, Van Hope S, Dorsen CG, Mangini M (2022). \textit{The Pharmacology and Clinical Applications of Psychedelic Medicines Within Midwifery Practice.}. Journal of midwifery \& women's health. [published; PubMed]. \href{https://doi.org/10.1111/jmwh.13371}{doi:10.1111/jmwh.13371}.
\item University of Zurich (2022). \textit{Phase II, Randomized, Double Blind, Placebo Controlled, Parallel Group, Single Center Study of Psilocybin Efficacy in Major Depression}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT03715127}{source link}.
\item Effinger D, Quadir S, Ramage M, Cone M, Herman M. (2022). \textit{Sex-Specific Effects of Psychedelic Drug Exposure on Central Amygdala Reactivity and Behavioral Responding}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2022.04.28.489882}{doi:10.1101/2022.04.28.489882}.
\item Scott Aaronson, Tammy Miller, Samuel Rudow, MacKenzie Forbes, Trisha Suppes (2022). \textit{P388. Open Label Psilocybin Administration in Severely Treatment Resistant Depression}. Biological Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.biopsych.2022.02.624}{doi:10.1016/j.biopsych.2022.02.624}.
\item Stéphanie Knatz Peck, Samatha Shao, Susan Murray, Walter H. Kaye (2022). \textit{P450. Pilot Study Evaluation of Psilocybin Therapy for Anorexia Nervosa: Safety, Acceptability, and Preliminary Efficacy}. Biological Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.biopsych.2022.02.686}{doi:10.1016/j.biopsych.2022.02.686}.
\item Doss M, Barrett FS, Corlett PR. (2022). \textit{Skepticism About Recent Evidence that Psilocybin Opens Depressed Minds}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/a25wb}{doi:10.31234/osf.io/a25wb}.
\item Unknown authors (2022). \textit{Skepticism About Recent Evidence that Psilocybin Opens Depressed Minds}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/a25wb\_v1}{source link}.
\item Rossi GN, Hallak JEC, Bouso Saiz JC, Dos Santos RG. (2022). \textit{Safety issues of psilocybin and LSD as potential rapid acting antidepressants and potential challenges.}. Expert Opinion on Drug Safety. [published; Europe PMC]. \href{https://doi.org/10.1080/14740338.2022.2066650}{doi:10.1080/14740338.2022.2066650}.
\item Raut SB, Marathe PA, van Eijk L, Eri R, Ravindran M, Benedek DM, Ursano RJ, Canales JJ, Johnson LR. (2022). \textit{Diverse therapeutic developments for post-traumatic stress disorder (PTSD) indicate common mechanisms of memory modulation.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.pharmthera.2022.108195}{doi:10.1016/j.pharmthera.2022.108195}.
\item Gill H, Puramat P, Patel P, Gill B, Marks CA, Rodrigues NB, Castle D, Cha DS, Mansur RB, Rosenblat JD, McIntyre RS. (2022). \textit{The Effects of Psilocybin in Adults with Major Depressive Disorder and the General Population: Findings from Neuroimaging Studies.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.psychres.2022.114577}{doi:10.1016/j.psychres.2022.114577}.
\item Girn M, Roseman L, Bernhardt B, Smallwood J, Carhart-Harris R, Nathan Spreng R. (2022). \textit{Serotonergic psychedelic drugs LSD and psilocybin reduce the hierarchical differentiation of unimodal and transmodal cortex.}. NeuroImage. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neuroimage.2022.119220}{doi:10.1016/j.neuroimage.2022.119220}.
\item Hayes C, Wahba M, Watson S. (2022). \textit{Will psilocybin lose its magic in the clinical setting?}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/20451253221090822}{doi:10.1177/20451253221090822}.
\item Rudzki S. (2022). \textit{Is PTSD an Evolutionary Survival Adaptation Initiated by Unrestrained Cytokine Signaling and Maintained by Epigenetic Change?}. Military Medicine. [published; Europe PMC]. \href{https://doi.org/10.1093/milmed/usac095}{doi:10.1093/milmed/usac095}.
\item Lowe H, Toyang N, Steele B, Grant J, Ali A, Gordon L, Ngwa W. (2022). \textit{Psychedelics: Alternative and Potential Therapeutic Options for Treating Mood and Anxiety Disorders.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/molecules27082520}{doi:10.3390/molecules27082520}.
\item Daws RE, Timmermann C, Giribaldi B, Sexton JD, Wall MB, Erritzoe D, Roseman L, Nutt D, Carhart-Harris R. (2022). \textit{Increased global integration in the brain after psilocybin therapy for depression.}. Nature Medicine. [published; Europe PMC]. \href{https://doi.org/10.1038/s41591-022-01744-z}{doi:10.1038/s41591-022-01744-z}.
\item Cátia Esteves, Elena M. M. de Redrojo, José Luis Manjón, Gabriel Moreno, Filipe E. Antunes, Gemma Montalvo, Fernando E. Ortega-Ojeda (2022). \textit{Combining FTIR-ATR and OPLS-DA methods for magic mushrooms discrimination}. Forensic Chemistry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.forc.2022.100421}{doi:10.1016/j.forc.2022.100421}.
\item Jones G, Ricard JA, Lipson J, Nock MK. (2022). \textit{Associations between classic psychedelics and opioid use disorder in a nationally-representative U.S. adult sample.}. Scientific Reports. [published; Europe PMC]. \href{https://doi.org/10.1038/s41598-022-08085-4}{doi:10.1038/s41598-022-08085-4}.
\item Kopra EI, Ferris JA, Winstock AR, Young AH, Rucker JJ. (2022). \textit{Adverse experiences resulting in emergency medical treatment seeking following the use of magic mushrooms.}. Journal of Psychopharmacology. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811221084063}{doi:10.1177/02698811221084063}.
\item Costa Fernandes Joana Margarida, Filho Cesar, Machado Brito-da-Costa Andreia, Marin-Bruzos Marieta, Saayman Jean, Sanders Daniel, Dinis-Oliveira Ricardo Jorge (2022). \textit{Production and extraction of psilocybin and psilocin from Psilocybe spp. mushrooms}. RevSALUS - Revista Científica da Rede Académica das Ciências da Saúde da Lusofonia. [published; Crossref]. \href{https://doi.org/10.51126/revsalus.v4isup.456}{doi:10.51126/revsalus.v4isup.456}.
\item Filho Cesar, Costa Fernandes Joana Margarida, Machado Brito-da-Costa Andreia, Marin-Bruzos Marieta, Saayman Jean, Sanders Daniel, Dinis-Oliveira Ricardo Jorge (2022). \textit{Evaluation of a quantitative analytical method for psilocin and psilocybin using HPLC-DAD}. RevSALUS - Revista Científica da Rede Académica das Ciências da Saúde da Lusofonia. [published; Crossref]. \href{https://doi.org/10.51126/revsalus.v4isup.455}{doi:10.51126/revsalus.v4isup.455}.
\item Lemos Martins Sofia, Machado Brito-da-Costa Andreia, Madureira-Carvalho Áurea, Dinis-Oliveira Ricardo Jorge, Dias da Silva Diana (2022). \textit{Psylocybin and Psilocin as new tools to fight depression: an overview of the Pharmacodynamic and pharmacokinetic mechanisms}. RevSALUS - Revista Científica da Rede Académica das Ciências da Saúde da Lusofonia. [published; Crossref]. \href{https://doi.org/10.51126/revsalus.v4isup.271}{doi:10.51126/revsalus.v4isup.271}.
\item Antonia Kuhn, Matthias F. Melzig (2022). \textit{Psilocybe mexicana R. Heim - Mexikanischer Kahlkopf}. Zeitschrift für Phytotherapie. [published; OpenAlex]. \href{https://doi.org/10.1055/a-1540-9907}{doi:10.1055/a-1540-9907}.
\item Unknown authors (2022). \textit{Psilocybin increases brain network integration in patients with depression.}. Nature Medicine. [published; Europe PMC]. \href{https://doi.org/10.1038/s41591-022-01769-4}{doi:10.1038/s41591-022-01769-4}.
\item Doss MK, Madden MB, Gaddis A, Nebel MB, Griffiths RR, Mathur BN, Barrett FS. (2022). \textit{Models of psychedelic drug action: modulation of cortical-subcortical circuits.}. Brain. [published; Europe PMC]. \href{https://doi.org/10.1093/brain/awab406}{doi:10.1093/brain/awab406}.
\item Hackl B, Todt H, Kubista H, Kubista H, Hilber K, Koenig X. (2022). \textit{Psilocybin Therapy of Psychiatric Disorders Is Not Hampered by hERG Potassium Channel-Mediated Cardiotoxicity.}. The International Journal of Neuropsychopharmacology. [published; Europe PMC]. \href{https://doi.org/10.1093/ijnp/pyab085}{doi:10.1093/ijnp/pyab085}.
\item Murphy R, Kettner H, Zeifman R, Giribaldi B, Kartner L, Martell J, Read T, Murphy-Beiner A, Baker-Jones M, Nutt D, Erritzoe D, Watts R, Carhart-Harris R. (2022). \textit{Therapeutic Alliance and Rapport Modulate Responses to Psilocybin Assisted Therapy for Depression.}. Frontiers in Pharmacology. [published; Europe PMC]. \href{https://doi.org/10.3389/fphar.2021.788155}{doi:10.3389/fphar.2021.788155}.
\item Zhai W, Li L, Zhao J, Xiang P, Liu M, Shi Y, Dang Y. (2022). \textit{Tentative identification of in vitro metabolites of O-acetylpsilocin (psilacetin, 4-AcO-DMT) by UHPLC-Q-Orbitrap MS.}. Drug Testing and Analysis. [published; Europe PMC]. \href{https://doi.org/10.1002/dta.3255}{doi:10.1002/dta.3255}.
\item Pots W, Chakhssi F. (2022). \textit{Psilocybin-Assisted Compassion Focused Therapy for Depression.}. Frontiers in Psychology. [published; Europe PMC]. \href{https://doi.org/10.3389/fpsyg.2022.812930}{doi:10.3389/fpsyg.2022.812930}.
\item Davis AK, Arterberry BJ, Xin Y, Agin-Liebes G, Schwarting C, Williams MT. (2022). \textit{Race, Ethnic, and Sex Differences in Prevalence of and Trends in Hallucinogen Consumption Among Lifetime Users in the United States Between 2015 and 2019.}. Frontiers in Epidemiology. [published; Europe PMC]. \href{https://doi.org/10.3389/fepid.2022.876706}{doi:10.3389/fepid.2022.876706}.
\item Earleywine M, Low F, Altman BR, De Leo J. (2022). \textit{How Important Is a Guide Who Has Taken Psilocybin in Psilocybin-Assisted Therapy for Depression?}. Journal of Psychoactive Drugs. [published; Europe PMC]. \href{https://doi.org/10.1080/02791072.2022.2047842}{doi:10.1080/02791072.2022.2047842}.
\item Davoudian PA, Shao L, Kwan AC. (2022). \textit{Shared and distinct brain regions targeted for immediate early gene expression by ketamine and psilocybin}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2022.03.18.484437}{doi:10.1101/2022.03.18.484437}.
\item McClure-Begley TD, Roth BL. (2022). \textit{The promises and perils of psychedelic pharmacology for psychiatry.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41573-022-00421-7}{doi:10.1038/s41573-022-00421-7}.
\item Dworatzyk K, Jansen T, Schmidt TT. (2022). \textit{Phenomenological assessment of psychedelics induced experiences: Translation and validation of the German Challenging Experience Questionnaire (CEQ) and Ego-Dissolution Inventory (EDI).}. PLoS ONE. [published; Europe PMC]. \href{https://doi.org/10.1371/journal.pone.0264927}{doi:10.1371/journal.pone.0264927}.
\item Adams AM, Anas NA, Sen AK, Hinegardner-Hendricks JD, O'Dell PJ, Gibbons WJ, Flower JE, McMurray MS, Jones JA. (2022). \textit{Development of an E. coli-based norbaeocystin production platform and evaluation of behavioral effects in rats.}. Metabolic Engineering Communications. [published; Europe PMC]. \href{https://doi.org/10.1016/j.mec.2022.e00196}{doi:10.1016/j.mec.2022.e00196}.
\item Kisely S, Connor M, Somogyi AA, Siskind D. (2022). \textit{A systematic literature review and meta-analysis of the effect of psilocybin and methylenedioxymethamphetamine on mental, behavioural or developmental disorders.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/00048674221083868}{doi:10.1177/00048674221083868}.
\item Meade E, Hehir S, Rowan N, Garvey M. (2022). \textit{Mycotherapy: Potential of Fungal Bioactives for the Treatment of Mental Health Disorders and Morbidities of Chronic Pain.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/jof8030290}{doi:10.3390/jof8030290}.
\item McCulloch DE, Grzywacz MZ, Madsen MK, Jensen PS, Ozenne B, Armand S, Knudsen GM, Fisher PM, Stenbæk DS. (2022). \textit{Psilocybin-Induced Mystical-Type Experiences are Related to Persisting Positive Effects: A Quantitative and Qualitative Report.}. Frontiers in Pharmacology. [published; Europe PMC]. \href{https://doi.org/10.3389/fphar.2022.841648}{doi:10.3389/fphar.2022.841648}.
\item Smedfors G, Glotfelty E, Kalani N, Hjelle CP, Horntvedt O, Wellfelt K, Brodin A, von Kieseritzky F, Olson L, Karlsson T. (2022). \textit{Psilocybin Combines Rapid Synaptogenic And Anti-Inflammatory Effects In Vitro}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-1321542/v1}{doi:10.21203/rs.3.rs-1321542/v1}.
\item Bates N, Bello JK, Osazuwa-Peters N, Sullivan MD, Scherrer JF. (2022). \textit{Depression and Long-Term Prescription Opioid Use and Opioid Use Disorder: Implications for Pain Management in Cancer.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s11864-022-00954-4}{doi:10.1007/s11864-022-00954-4}.
\item Mertens LJ, Koslowski M, Betzler F, Evens R, Gilles M, Jungaberle A, Jungaberle H, Majić T, Ströhle A, Wolff M, Wellek S, Gründer G. (2022). \textit{Methodological challenges in psychedelic drug trials: Efficacy and safety of psilocybin in treatment-resistant major depression (EPIsoDE) - Rationale and study design.}. Neuroscience Applied. [published; Europe PMC]. \href{https://doi.org/10.1016/j.nsa.2022.100104}{doi:10.1016/j.nsa.2022.100104}.
\item Sarparast A, Thomas K, Malcolm B, Stauffer CS. (2022). \textit{Drug-drug interactions between psychiatric medications and MDMA or psilocybin: a systematic review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s00213-022-06083-y}{doi:10.1007/s00213-022-06083-y}.
\item Sekula AD, Downey L, Puspanathan P. (2022). \textit{Virtual Reality as a Moderator of Psychedelic-Assisted Psychotherapy.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fpsyg.2022.813746}{doi:10.3389/fpsyg.2022.813746}.
\item Gaddis A, Lidstone DE, Nebel MB, Griffiths R, Mostofsky SH, Mejia A, Barrett F. (2022). \textit{Psilocybin induces spatially constrained alterations in thalamic functional organizaton and connectivity}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2022.02.28.482395}{doi:10.1101/2022.02.28.482395}.
\item Kiraga M, Kuypers KPC, Uthaug MV, Ramaekers J, Mason NL. (2022). \textit{Persisting decreases in state and trait anxiety post-psilocybin: A naturalistic, observational study among retreat attendees}. medRxiv. [preprint; medRxiv]. \href{https://doi.org/10.1101/2022.03.02.22271743}{doi:10.1101/2022.03.02.22271743}.
\item van Amsterdam J, van den Brink W. (2022). \textit{The therapeutic potential of psilocybin: a systematic review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/14740338.2022.2047929}{doi:10.1080/14740338.2022.2047929}.
\item Jaster AM, Elder H, Marsh SA, de la Fuente Revenga M, Negus SS, González-Maeso J. (2022). \textit{Effects of the 5-HT2A receptor antagonist volinanserin on head-twitch response and intracranial self-stimulation depression induced by different structural classes of psychedelics in rodents.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s00213-022-06092-x}{doi:10.1007/s00213-022-06092-x}.
\item Popik P, Hogendorf A, Bugno R, Khoo SY, Zajdel P, Malikowska-Racia N, Nikiforuk A, Golebiowska J. (2022). \textit{Effects of ketamine optical isomers, psilocybin, psilocin and norpsilocin on time estimation and cognition in rats.}. Psychopharmacology. [published; Europe PMC]. \href{https://doi.org/10.1007/s00213-021-06020-5}{doi:10.1007/s00213-021-06020-5}.
\item Schlag AK, Aday J, Salam I, Neill JC, Nutt DJ (2022). \textit{Adverse effects of psychedelics: From anecdotes and misinformation to systematic science.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811211069100}{doi:10.1177/02698811211069100}.
\item Wolff M, Mertens LJ, Walter M, Enge S, Evens R. (2022). \textit{The Acceptance/Avoidance-Promoting Experiences Questionnaire (APEQ): A theory-based approach to psychedelic drugs' effects on psychological flexibility.}. Journal of Psychopharmacology. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811211073758}{doi:10.1177/02698811211073758}.
\item Hodge AT, Sukpraprut-Braaten S, Narlesky M, Strayhan RC. (2022). \textit{The Use of Psilocybin in the Treatment of Psychiatric Disorders with Attention to Relative Safety Profile: A Systematic Review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/02791072.2022.2044096}{doi:10.1080/02791072.2022.2044096}.
\item Holze F, Ley L, Müller F, Becker AM, Straumann I, Vizeli P, Kuehne SS, Roder MA, Duthaler U, Kolaczynska KE, Varghese N, Eckert A, Liechti ME. (2022). \textit{Direct comparison of the acute effects of lysergic acid diethylamide and psilocybin in a double-blind placebo-controlled study in healthy subjects.}. Neuropsychopharmacology. [published; Europe PMC]. \href{https://doi.org/10.1038/s41386-022-01297-2}{doi:10.1038/s41386-022-01297-2}.
\item Thomas CW, Blanco-Duque C, Bréant BJ, Goodwin GM, Sharp T, Bannerman DM, Vyazovskiy VV. (2022). \textit{Psilocin acutely alters sleep-wake architecture and cortical brain activity in laboratory mice.}. Translational Psychiatry. [published; Europe PMC]. \href{https://doi.org/10.1038/s41398-022-01846-9}{doi:10.1038/s41398-022-01846-9}.
\item Sanz C, Cavanna F, Muller S, de la Fuente L, Zamberlan F, Palmucci M, Janeckova L, Kuchar M, Carrillo F, García AM, Pallavicini C, Tagliazucchi E. (2022). \textit{Natural language signatures of psilocybin microdosing}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2022.02.20.481177}{doi:10.1101/2022.02.20.481177}.
\item Jones GM, Nock MK. (2022). \textit{Exploring protective associations between the use of classic psychedelics and cocaine use disorder: a population-based survey study.}. Scientific Reports. [published; Europe PMC]. \href{https://doi.org/10.1038/s41598-022-06580-2}{doi:10.1038/s41598-022-06580-2}.
\item Wall MB, Lam C, Ertl N, Kaelen M, Roseman L, Nutt DJ, Carhart-Harris RL. (2022). \textit{Increased low-frequency brain responses to music after psilocybin therapy for depression}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2022.02.13.480302}{doi:10.1101/2022.02.13.480302}.
\item NYU Langone Health (2022). \textit{A Randomized Controlled Trial of the Effects of Psilocybin-Facilitated Experience on the Psychology and Effectiveness of Professional Leaders in Religion}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT02421263}{source link}.
\item Yu CL, Liang CS, Yang FC, Tu YK, Hsu CW, Carvalho AF, Stubbs B, Thompson T, Tsai CK, Yeh TC, Yang SN, Shin JI, Chu CS, Tseng PT, Su KP. (2022). \textit{Trajectory of Antidepressant Effects after Single- or Two-Dose Administration of Psilocybin: A Systematic Review and Multivariate Meta-Analysis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/jcm11040938}{doi:10.3390/jcm11040938}.
\item Van Court RC, Wiseman MS, Meyer KW, Ballhorn DJ, Amses KR, Slot JC, Dentinger BTM, Garibay-Orijel R, Uehling JK. (2022). \textit{Diversity, biology, and history of psilocybin-containing fungi: Suggestions for research and technological development.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.funbio.2022.01.003}{doi:10.1016/j.funbio.2022.01.003}.
\item Maia LO, Beaussant Y, Garcia ACM. (2022). \textit{The Therapeutic Potential of Psychedelic-assisted Therapies for Symptom Control in Patients Diagnosed With Serious Illness: A Systematic Review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jpainsymman.2022.01.024}{doi:10.1016/j.jpainsymman.2022.01.024}.
\item Coppola M, Bevione F, Mondola R. (2022). \textit{Psilocybin for Treating Psychiatric Disorders: A Psychonaut Legend or a Promising Therapeutic Perspective?}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/jox12010004}{doi:10.3390/jox12010004}.
\item Kargbo RB, Sherwood AM, Meisenheimer P, Lenoch K, Abebe S. (2022). \textit{Psilocybin: Characterization of the Metastable Zone Width (MSZW), Control of Anhydrous Polymorphs, and Particle Size Distribution (PSD).}. ACS Omega. [published; Europe PMC]. \href{https://doi.org/10.1021/acsomega.1c06708}{doi:10.1021/acsomega.1c06708}.
\item Yang Y, Meng G, Ni S, Zhang H, Dong C. (2022). \textit{Genomic Analysis of Stropharia rugosoannulata Reveals Its Nutritional Strategy and Application Potential in Bioremediation.}. Journal of Fungi. [published; Europe PMC]. \href{https://doi.org/10.3390/jof8020162}{doi:10.3390/jof8020162}.
\item Ziff S, Stern B, Lewis G, Majeed M, Gorantla VR. (2022). \textit{Analysis of Psilocybin-Assisted Therapy in Medicine: A Narrative Review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.7759/cureus.21944}{doi:10.7759/cureus.21944}.
\item Redden WM, Paracha SU, Sheheryar Q. (2022). \textit{Hallucinogen Use and Misuse in Older Adults.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.cger.2021.07.007}{doi:10.1016/j.cger.2021.07.007}.
\item Toby BH (2022). \textit{Crystallographic hallucinations.}. Acta crystallographica. Section C, Structural chemistry. [published; PubMed]. \href{https://doi.org/10.1107/s2053229622000511}{doi:10.1107/s2053229622000511}.
\item Gukasyan N, Davis AK, Barrett FS, Cosimano MP, Sepeda ND, Johnson MW, Griffiths RR. (2022). \textit{Efficacy and safety of psilocybin-assisted treatment for major depressive disorder: Prospective 12-month follow-up.}. Journal of Psychopharmacology. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811211073759}{doi:10.1177/02698811211073759}.
\item Averill LA, Abdallah CG (2022). \textit{Investigational drugs for assisting psychotherapy for posttraumatic stress disorder (PTSD): emerging approaches and shifting paradigms in the era of psychedelic medicine.}. Expert opinion on investigational drugs. [published; PubMed]. \href{https://doi.org/10.1080/13543784.2022.2035358}{doi:10.1080/13543784.2022.2035358}.
\item Gründer G, Brand M, Kärtner L, Scharf D, Schmitz C, Spangemacher M, Mertens LJ. (2022). \textit{[Are psychedelics fast acting antidepressant agents?]}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s00115-021-01255-1}{doi:10.1007/s00115-021-01255-1}.
\item Markopoulos A, Inserra A, De Gregorio D, Gobbi G. (2022). \textit{Evaluating the Potential Use of Serotonergic Psychedelics in Autism Spectrum Disorder.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fphar.2021.749068}{doi:10.3389/fphar.2021.749068}.
\item Cao D, Yu J, Wang H, Luo Z, Liu X, He L, Qi J, Fan L, Tang L, Chen Z, Li J, Cheng J, Wang S. (2022). \textit{Structure-based discovery of nonhallucinogenic psychedelic analogs.}. Science. [published; Europe PMC]. \href{https://doi.org/10.1126/science.abl8615}{doi:10.1126/science.abl8615}.
\item Fitzpatrick CM, Anderson BT, Agin-Liebes G, Guydish J. (2022). \textit{Comment and Response: (Lugo-Radillo \& Cortez-Lopez, 2020) Long-Term Amelioration of OCD Symptoms in a Patient with Chronic Consumption of Psilocybin-Containing Mushrooms.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/02791072.2021.1983673}{doi:10.1080/02791072.2021.1983673}.
\item Müller F, Kraus E, Holze F, Becker A, Ley L, Schmid Y, Vizeli P, Liechti ME, Borgwardt S. (2022). \textit{Flashback phenomena after administration of LSD and psilocybin in controlled studies with healthy participants.}. Psychopharmacology. [published; Europe PMC]. \href{https://doi.org/10.1007/s00213-022-06066-z}{doi:10.1007/s00213-022-06066-z}.
\item Miceli McMillan R, Jordens C. (2022). \textit{Psychedelic-assisted psychotherapy for the treatment of major depression: a synthesis of phenomenological explanations.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s11019-022-10070-7}{doi:10.1007/s11019-022-10070-7}.
\item Barrett FS, Zhou Y, Carbonaro TM, Roberts JM, Smith GS, Griffiths RR, Wong DF. (2022). \textit{Human Cortical Serotonin 2A Receptor Occupancy by Psilocybin Measured Using [11C]MDL100,907 Dynamic PET and a Resting-State fMRI-Based Brain Parcellation.}. Frontiers in Neuroergonomics. [published; Europe PMC]. \href{https://doi.org/10.3389/fnrgo.2021.784576}{doi:10.3389/fnrgo.2021.784576}.
\item Sakurai H, Yonezawa K, Tani H, Mimura M, Bauer M, Uchida H. (2022). \textit{Novel Antidepressants in the Pipeline (Phase II and III): A Systematic Review of the US Clinical Trials Registry.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1055/a-1714-9097}{doi:10.1055/a-1714-9097}.
\item Jurriaan F. M. Strous (2022). \textit{Psilocybine vergeleken met escitalopram bij depressie}. Pure Amsterdam UMC. [published; OpenAlex]. \href{https://pure.amsterdamumc.nl/en/publications/b99a8d48-a871-49d6-978c-969dd09a6dae}{source link}.
\item Strous JFM. (2022). \textit{[Psilocybin compared with escitalopram for depression].}. PubMed. [published; Europe PMC]. \href{https://europepmc.org/article/MED/35138714}{source link}.
\item Hase A, Erdmann M, Limbach V, Hasler G. (2022). \textit{Analysis of recreational psychedelic substance use experiences classified by substance.}. Psychopharmacology. [published; Europe PMC]. \href{https://doi.org/10.1007/s00213-022-06062-3}{doi:10.1007/s00213-022-06062-3}.
\item Khan FI, Hassan F, Lai D. (2022). \textit{In Silico Studies on Psilocybin Drug Derivatives Against SARS-CoV-2 and Cytokine Storm of Human Interleukin-6 Receptor.}. Frontiers in Immunology. [published; Europe PMC]. \href{https://doi.org/10.3389/fimmu.2021.794780}{doi:10.3389/fimmu.2021.794780}.
\item Bender D, Hellerstein DJ. (2022). \textit{Assessing the risk-benefit profile of classical psychedelics: a clinical review of second-wave psychedelic research.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s00213-021-06049-6}{doi:10.1007/s00213-021-06049-6}.
\item Glynos NG, Pierce J, Davis AK, McAfee J, Boehnke KF. (2022). \textit{Knowledge, Perceptions, and Use of Psychedelics among Individuals with Fibromyalgia.}. Journal of Psychoactive Drugs. [published; Europe PMC]. \href{https://doi.org/10.1080/02791072.2021.2022817}{doi:10.1080/02791072.2021.2022817}.
\item Jones GM, Nock MK. (2022). \textit{MDMA/ecstasy use and psilocybin use are associated with lowered odds of psychological distress and suicidal thoughts in a sample of US adults.}. Journal of Psychopharmacology. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811211058923}{doi:10.1177/02698811211058923}.
\item Jones GM, Nock MK. (2022). \textit{Lifetime use of MDMA/ecstasy and psilocybin is associated with reduced odds of major depressive episodes.}. Journal of Psychopharmacology. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811211066714}{doi:10.1177/02698811211066714}.
\item Rucker JJ, Marwood L, Ajantaival RJ, Bird C, Eriksson H, Harrison J, Lennard-Jones M, Mistry S, Saldarini F, Stansfield S, Tai SJ, Williams S, Weston N, Malievskaia E, Young AH. (2022). \textit{The effects of psilocybin on cognitive and emotional functions in healthy participants: Results from a phase 1, randomised, placebo-controlled trial involving simultaneous psilocybin administration and preparation.}. Journal of Psychopharmacology. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811211064720}{doi:10.1177/02698811211064720}.
\item Altman BR, Earleywine M, De Leo J. (2022). \textit{Exploring the Credibility of Psilocybin-assisted Therapy and Cognitive-behavioral Therapy for Depression.}. Journal of Psychoactive Drugs. [published; Europe PMC]. \href{https://doi.org/10.1080/02791072.2021.2020382}{doi:10.1080/02791072.2021.2020382}.
\item Klaus Richter Larsen, Drummond E-Wen McCulloch, Brice Ozenne, Ulrich Lindberg, Sophia Armand, M. Madsen, Dea Siggaard Stenbæk, Gitte M. Knudsen, Patrick M. Fisher (2021). \textit{Acute psilocybin and ketanserin effects on cerebral blood flow: 5-HT2AR neuromodulatory effects in healthy humans}. Neuroscience Applied. [published; OpenAlex]. \href{https://doi.org/10.1016/j.nsa.2022.100335}{doi:10.1016/j.nsa.2022.100335}.
\item A. Wojtas, A. Bysiek, Z. Szych, M. Herian, K. Gołembiowska (2021). \textit{Neurochemical properties of psilocybin in comparison to ketamine in vivo}. Neuroscience Applied. [published; OpenAlex]. \href{https://doi.org/10.1016/j.nsa.2022.100408}{doi:10.1016/j.nsa.2022.100408}.
\item E. Stojek, Jack Prenderville, F. Dunphy-Doherty (2021). \textit{Differential effects of repeated treatment with DOI and psilocybin on the head-twitch response (HTR), locomotor activity and anxiety-like behaviour}. Neuroscience Applied. [published; OpenAlex]. \href{https://doi.org/10.1016/j.nsa.2022.100764}{doi:10.1016/j.nsa.2022.100764}.
\item Nathalie M. Rieser, Ladina P Gubser, Franz X. Vollenweider, Meyer Lars, Katrin H. Preller (2021). \textit{Effects of psilocybin in relative and global cerebral blood flow and behavioural correlates}. Neuroscience Applied. [published; OpenAlex]. \href{https://doi.org/10.1016/j.nsa.2022.100702}{doi:10.1016/j.nsa.2022.100702}.
\item Ines Erkizia-Santamaría, R. Alles-Pascual, Igor Horrillo, Albert Adell, J. Javier Meana, J.E. Ortega (2021). \textit{Neurochemical and behavioural characterisation of the psychedelic 5HT2AR agonist psilocybin in mice}. Neuroscience Applied. [published; OpenAlex]. \href{https://doi.org/10.1016/j.nsa.2022.100407}{doi:10.1016/j.nsa.2022.100407}.
\item Lucie Olejníková, Klára Šíchová, K. Chona, Hynek Danda, Tomáš Páleníček (2021). \textit{The effect of psilocybin and sleep manipulation on neuroplasticity and sleep architecture in rats}. Neuroscience Applied. [published; OpenAlex]. \href{https://doi.org/10.1016/j.nsa.2022.100948}{doi:10.1016/j.nsa.2022.100948}.
\item K. Šíchová, K. Chona, Lucie Olejníková Ladislavová, T. Páleníček (2021). \textit{The role of psilocybin in memory consolidation in the animal model}. Neuroscience Applied. [published; OpenAlex]. \href{https://doi.org/10.1016/j.nsa.2022.100953}{doi:10.1016/j.nsa.2022.100953}.
\item Drummond E-Wen McCulloch, Anders Smærup Olsen, Dea Siggaard Stenbæk, Sophia Armand, M.K. Madsen, Gitte M. Knudsen, Patrick M. Fisher (2021). \textit{Acute change in functional brain entropy following psilocybin administration in healthy volunteers}. Neuroscience Applied. [published; OpenAlex]. \href{https://doi.org/10.1016/j.nsa.2022.100701}{doi:10.1016/j.nsa.2022.100701}.
\item Unknown authors (2021). \textit{Psilocybin may be effective for treatment-resistant depression}. Pharmaceutical journal/The pharmaceutical journal. [published; OpenAlex]. \href{https://doi.org/10.1211/pj.2022.1.164911}{doi:10.1211/pj.2022.1.164911}.
\item Unknown authors (2021). \textit{Psilocybin: a psychedelic alternative to antidepressants?}. Pharmaceutical journal/The pharmaceutical journal. [published; OpenAlex]. \href{https://doi.org/10.1211/pj.2022.1.169269}{doi:10.1211/pj.2022.1.169269}.
\item Russell J. Zwanka (2021). \textit{Exploratory review of psilocybin usage and awareness amongst college students and potential consumer goods tradeoffs resulting from increased usage}. International Journal of Research in Marketing Management and Sales. [published; OpenAlex]. \href{https://doi.org/10.33545/26633329.2022.v4.i1a.88}{doi:10.33545/26633329.2022.v4.i1a.88}.
\item Poonam Bhadoria, Manish K. Tripathi, V. Ramanathan (2021). \textit{Conformational Analysis of Psilocybin: A Computational Approach}. SSRN Electronic Journal. [published; OpenAlex]. \href{https://doi.org/10.2139/ssrn.4098712}{doi:10.2139/ssrn.4098712}.
\item Friederike Holze, Laura Ley, F. Müller, V. Nimmy, Anne Eckert, Matthias E. Liechti (2021). \textit{Comparison of subjective, autonomic, and endocrine effects of LSD and psilocybin in healthy subjects}. Neuroscience Applied. [published; OpenAlex]. \href{https://doi.org/10.1016/j.nsa.2022.100075}{doi:10.1016/j.nsa.2022.100075}.
\item Nathalie M. Rieser, Ladina P Gubser, C. Rossgoderer Da Silva, Franz X. Vollenweider, Marcus Herdener, Katrin H. Preller (2021). \textit{Investigating cue-reactivity as biomarker for treatment success in psilocybin-assisted therapy for alcohol use disorder}. Neuroscience Applied. [published; OpenAlex]. \href{https://doi.org/10.1016/j.nsa.2022.100102}{doi:10.1016/j.nsa.2022.100102}.
\item G. Goodwin, Scott T. Aaronson, Boadie W. Dunlop, D. Feifel, David J. Hellerstein, L. Marwood, S. Mistry, Metten Somers, S.C. Stansfield, J. Tsai, S. Williams, Allan H. Young, Sidney Zisook, E. Malievskaia (2021). \textit{The efficacy of COMP360 psilocybin therapy in treatment-resistant depression: exploratory results from a phase IIb randomised controlled trial}. Neuroscience Applied. [published; OpenAlex]. \href{https://doi.org/10.1016/j.nsa.2022.100213}{doi:10.1016/j.nsa.2022.100213}.
\item G.M. Goodwin, Scott T. Aaronson, Boadie W. Dunlop, David Feifel, David J. Hellerstein, N. Hewitt, L. Marwood, S. Mistry, Metten Somers, S.C. Stansfield, J. Tsai, S. Williams, Antony Young, Sidney Zisook, E. Malievskaia (2021). \textit{The safety and efficacy of COMP360 psilocybin therapy in treatment-resistant depression: results from a phase IIb randomised controlled trial}. Neuroscience Applied. [published; OpenAlex]. \href{https://doi.org/10.1016/j.nsa.2022.100511}{doi:10.1016/j.nsa.2022.100511}.
\item Friederike Holze, A. Becker, Karolina E. Kolaczynska, Urs Duthaler, Matthias E. Liechti (2021). \textit{Pharmacokinetics and pharmacokinetic-pharmacodynamic relationship of oral psilocybin administration in healthy subjects}. Neuroscience Applied. [published; OpenAlex]. \href{https://doi.org/10.1016/j.nsa.2022.100410}{doi:10.1016/j.nsa.2022.100410}.
\item Marcos Garcia de Teresa (2021). \textit{Selling the Priceless Mushroom: A History of Psilocybin Mushroom Trade in the Sierra Mazateca (Oaxaca)}. Journal of Illicit Economies and Development. [published; OpenAlex]. \href{https://doi.org/10.31389/jied.101}{doi:10.31389/jied.101}.
\item F. N. Smith, Joanna C. Neill, Verity Wainwright (2021). \textit{An Interpretative Phenomenological Analysis of the use of psilocybin by veterans with symptoms of trauma}. Drug Science Policy and Law. [published; OpenAlex]. \href{https://doi.org/10.1177/20503245221124117}{doi:10.1177/20503245221124117}.
\item Vejmola Č., Syrová K., Šíchová K., Vlastimil K., Klučková T., Kelemen E., Páleníček T. (2021). \textit{Rats hallucinate in a similar manner to humans after psilocin}. Neuroscience Applied. [published; Crossref]. \href{https://doi.org/10.1016/j.nsa.2022.100950}{doi:10.1016/j.nsa.2022.100950}.
\item Bhadoria Poonam, Venkatnarayan Ramanathan (2021). \textit{Unravelling a New Conformer of Psilocin Through Computational Methods}. SSRN Electronic Journal. [published; Crossref]. \href{https://doi.org/10.2139/ssrn.4162669}{doi:10.2139/ssrn.4162669}.
\item Garcia-Romeu A, Darcy S, Jackson H, White T, Rosenberg P (2021). \textit{Psychedelics as Novel Therapeutics in Alzheimer's Disease: Rationale and Potential Mechanisms.}. Current topics in behavioral neurosciences. [published; PubMed]. \href{https://doi.org/10.1007/7854\_2021\_267}{doi:10.1007/7854\_2021\_267}.
\item Liechti ME, Holze F. (2021). \textit{Dosing Psychedelics and MDMA.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/7854\_2021\_270}{doi:10.1007/7854\_2021\_270}.
\item Ehrmann K, Allen JJB, Moreno FA. (2021). \textit{Psilocybin for the Treatment of Obsessive-Compulsive Disorders.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/7854\_2021\_279}{doi:10.1007/7854\_2021\_279}.
\item Agin-Liebes G, Davis AK. (2021). \textit{Psilocybin for the Treatment of Depression: A Promising New Pharmacotherapy Approach.}. Current topics in behavioral neurosciences. [published; Europe PMC]. \href{https://doi.org/10.1007/7854\_2021\_282}{doi:10.1007/7854\_2021\_282}.
\item Sousa TR, Rema J, Machado S, Novais F. (2021). \textit{Psychedelics and Hallucinogens in Psychiatry: Finding New Pharmacological Targets.}. Current Topics in Medicinal Chemistry. [published; Europe PMC]. \href{https://doi.org/10.2174/1568026621666211201145800}{doi:10.2174/1568026621666211201145800}.
\item Sarris J, Pinzon Rubiano D, Day K, Galvão-Coelho NL, Perkins D. (2021). \textit{Psychedelic medicines for mood disorders: current evidence and clinical considerations.}. PubMed. [published; Europe PMC]. \href{https://doi.org/10.1097/yco.0000000000000759}{doi:10.1097/yco.0000000000000759}.
\item Rieser NM, Herdener M, Preller KH (2021). \textit{Psychedelic-Assisted Therapy for Substance Use Disorders and Potential Mechanisms of Action.}. Current topics in behavioral neurosciences. [published; PubMed]. \href{https://doi.org/10.1007/7854\_2021\_284}{doi:10.1007/7854\_2021\_284}.
\item Yaden DB, Nayak SM, Gukasyan N, Anderson BT, Griffiths RR (2021). \textit{The Potential of Psychedelics for End of Life and Palliative Care.}. Current topics in behavioral neurosciences. [published; PubMed]. \href{https://doi.org/10.1007/7854\_2021\_278}{doi:10.1007/7854\_2021\_278}.
\item Sherwood AM, Kargbo RB, Kaylo KW, Cozzi NV, Meisenheimer P, Kaduk JA. (2021). \textit{Psilocybin: crystal structure solutions enable phase analysis of prior art and recently patented examples.}. Acta Crystallographica Section C Structural Chemistry. [published; Europe PMC]. \href{https://doi.org/10.1107/s2053229621013164}{doi:10.1107/s2053229621013164}.
\item Jones GM, Nock MK. (2021). \textit{Psilocybin use is associated with lowered odds of crime arrests in US adults: A replication and extension.}. Journal of Psychopharmacology. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811211058933}{doi:10.1177/02698811211058933}.
\item Plotnik L, Gibbs G, Graham T. (2021). \textit{Psilocybin Conspectus: Status, Production Methods, and Considerations.}. International journal of medicinal mushrooms. [published; Europe PMC]. \href{https://doi.org/10.1615/intjmedmushrooms.2021041921}{doi:10.1615/intjmedmushrooms.2021041921}.
\item Schindler EAD. (2021). \textit{Psychedelics in the Treatment of Headache and Chronic Pain Disorders.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/7854\_2022\_365}{doi:10.1007/7854\_2022\_365}.
\item Flanagan TW, Nichols CD (2021). \textit{Psychedelics and Anti-inflammatory Activity in Animal Models.}. Current topics in behavioral neurosciences. [published; PubMed]. \href{https://doi.org/10.1007/7854\_2022\_367}{doi:10.1007/7854\_2022\_367}.
\item Johnson MW. (2021). \textit{Classic Psychedelics in Addiction Treatment: The Case for Psilocybin in Tobacco Smoking Cessation.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/7854\_2022\_327}{doi:10.1007/7854\_2022\_327}.
\item Khan AJ, Bradley E, O'Donovan A, Woolley J. (2021). \textit{Psilocybin for Trauma-Related Disorders.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/7854\_2022\_366}{doi:10.1007/7854\_2022\_366}.
\item Kiguchi Y. (2021). \textit{[A Novel System for Discovering High-affinity Antibody Mutants That Enables Immunoassays with Higher Sensitivities -Development and Application of Clonal Array Profiling (CAP)].}. YAKUGAKU ZASSHI. [published; Europe PMC]. \href{https://doi.org/10.1248/yakushi.22-00141}{doi:10.1248/yakushi.22-00141}.
\item Raison CL, Jain R, Penn AD, Cole SP, Jain S (2021). \textit{Effects of Naturalistic Psychedelic Use on Depression, Anxiety, and Well-Being: Associations With Patterns of Use, Reported Harms, and Transformative Mental States.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2022.831092}{doi:10.3389/fpsyt.2022.831092}.
\item Matzopoulos R, Morlock R, Morlock A, Lerer B, Lerer L (2021). \textit{Corrigendum: Psychedelic Mushrooms in the USA: Knowledge, Patterns of Use, and Association With Health Outcomes.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2022.877390}{doi:10.3389/fpsyt.2022.877390}.
\item Yaden DB, Earp D, Graziosi M, Friedman-Wheeler D, Luoma JB, Johnson MW (2021). \textit{Psychedelics and Psychotherapy: Cognitive-Behavioral Approaches as Default.}. Frontiers in psychology. [published; PubMed]. \href{https://doi.org/10.3389/fpsyg.2022.873279}{doi:10.3389/fpsyg.2022.873279}.
\item Frymann T, Whitney S, Yaden DB, Lipson J (2021). \textit{The Psychedelic Integration Scales: Tools for Measuring Psychedelic Integration Behaviors and Experiences.}. Frontiers in psychology. [published; PubMed]. \href{https://doi.org/10.3389/fpsyg.2022.863247}{doi:10.3389/fpsyg.2022.863247}.
\item Roseman L, Preller KH, Fotiou E, Winkelman MJ (2021). \textit{Editorial: Psychedelic sociality: Pharmacological and extrapharmacological perspectives.}. Frontiers in pharmacology. [published; PubMed]. \href{https://doi.org/10.3389/fphar.2022.979764}{doi:10.3389/fphar.2022.979764}.
\item Kuburi S, Di Passa AM, Tassone VK, Mahmood R, Lalovic A, Ladha KS, Dunlop K, Rizvi S, Demchenko I, Bhat V. (2021). \textit{Neuroimaging Correlates of Treatment Response with Psychedelics in Major Depressive Disorder: A Systematic Review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/24705470221115342}{doi:10.1177/24705470221115342}.
\item Davis AK, Agin-Liebes G, España M, Pilecki B, Luoma J (2021). \textit{Attitudes and Beliefs about the Therapeutic Use of Psychedelic Drugs among Psychologists in the United States.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2021.1971343}{doi:10.1080/02791072.2021.1971343}.
\item Simonsson O, Hendricks PS, Chambers R, Osika W, Goldberg SB (2021). \textit{Classic psychedelics, health behavior, and physical health.}. Therapeutic advances in psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1177/20451253221135363}{doi:10.1177/20451253221135363}.
\item Marseille E, Bertozzi S, Kahn JG (2021). \textit{The economics of psychedelic-assisted therapies: A research agenda.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2022.1025726}{doi:10.3389/fpsyt.2022.1025726}.
\item Mayer FP, Luethi D, Areal LB, Sitte HH (2021). \textit{Editorial: Old and new psychoactive substances: Pharmacology and potential applications.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2022.1087005}{doi:10.3389/fpsyt.2022.1087005}.
\item Husain MI, Ledwos N, Fellows E, Baer J, Rosenblat JD, Blumberger DM, Mulsant BH, Castle DJ (2021). \textit{Serotonergic psychedelics for depression: What do we know about neurobiological mechanisms of action?}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2022.1076459}{doi:10.3389/fpsyt.2022.1076459}.
\item Köck P, Froelich K, Walter M, Lang U, Dürsteler KM. (2021). \textit{A systematic literature review of clinical trials and therapeutic applications of ibogaine.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jsat.2021.108717}{doi:10.1016/j.jsat.2021.108717}.
\item University Hospital, Basel, Switzerland (2021). \textit{LSD Treatment in Persons Suffering From Anxiety Symptoms in Severe Somatic Diseases or in Psychiatric Anxiety Disorders: a Randomized, Double-blind, Placebo-controlled Phase II Study}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT03153579}{source link}.
\item McCartney A, McGovern H, De Foe A. (2021). \textit{Predictors of Psychedelic Experience: A Thematic Analysis}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/5d7fc}{doi:10.31234/osf.io/5d7fc}.
\item Unknown authors (2021). \textit{Predictors of Psychedelic Experience: A Thematic Analysis}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/5d7fc\_v1}{source link}.
\item Niles H, Fogg C, Kelmendi B, Lazenby M (2021). \textit{Palliative care provider attitudes toward existential distress and treatment with psychedelic-assisted therapies.}. BMC palliative care. [published; PubMed]. \href{https://doi.org/10.1186/s12904-021-00889-x}{doi:10.1186/s12904-021-00889-x}.
\item McKernan K, Kane L, Helbert Y, Zhang L, Houde N, McLaughlin S. (2021). \textit{A whole genome atlas of 81 Psilocybe genomes as a resource for psilocybin production.}. F1000Res. [preprint; Europe PMC]. \href{https://doi.org/10.12688/f1000research.55301.2}{doi:10.12688/f1000research.55301.2}.
\item Olsen AS, Lykkebo-Valløe A, Ozenne B, Madsen MK, Stenbæk DS, Armand S, Mørup M, Ganz M, Knudsen GM, Fisher PM. (2021). \textit{Psilocybin modulation of dynamic functional connectivity is associated with plasma psilocin and subjective effects}. medRxiv. [preprint; medRxiv]. \href{https://doi.org/10.1101/2021.12.17.21267992}{doi:10.1101/2021.12.17.21267992}.
\item Marschall J, Fejer G, Lempe P, Prochazkova L, Kuchar M, Hajkova K, van Elk M. (2021). \textit{Psilocybin microdosing does not affect emotion-related symptoms and processing: A preregistered field and lab-based study.}. Journal of Psychopharmacology. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811211050556}{doi:10.1177/02698811211050556}.
\item National Council of Scientific and Technical Research, Argentina (2021). \textit{Double-blind Placebo-controlled Naturalistic Study of Microdosing With Psilocybin: Effects on Brain Activity, Behavior, Cognition, Creativity, and Mental Health}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05160220}{source link}.
\item Elman I, Pustilnik A, Borsook D. (2021). \textit{Beating pain with psychedelics: Matter over mind?}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neubiorev.2021.12.005}{doi:10.1016/j.neubiorev.2021.12.005}.
\item Pearson C, Siegel J, Gold JA. (2021). \textit{Psilocybin-assisted psychotherapy for depression: Emerging research on a psychedelic compound with a rich history.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jns.2021.120096}{doi:10.1016/j.jns.2021.120096}.
\item Johns Hopkins University (2021). \textit{Effects of Psilocybin in Major Depressive Disorder}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT03181529}{source link}.
\item McCulloch DE, Grzywacz MZ, Madsen MK, Jensen PS, Ozenne B, Armand S, Knudsen GM, Fisher PM, Stenbæk DS. (2021). \textit{A Quantitative and Qualitative Report of Psilocybin Induced Mystical-Type Experiences and Their Relation to Lasting Positive Effects}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/xqzu2}{doi:10.31234/osf.io/xqzu2}.
\item Unknown authors (2021). \textit{A Quantitative and Qualitative Report of Psilocybin Induced Mystical-Type Experiences and Their Relation to Lasting Positive Effects}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/xqzu2\_v1}{source link}.
\item Vilca-Melendez S, Uthaug MV, Griffin JL. (2021). \textit{1H Nuclear Magnetic Resonance: A Future Approach to the Metabolic Profiling of Psychedelics in Human Biofluids?}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fpsyt.2021.742856}{doi:10.3389/fpsyt.2021.742856}.
\item Cavanna F, Muller S, de la Fuente LA, Zamberlan F, Palmucci M, Janeckova L, Kuchar M, Pallavicini C, Tagliazucchi E. (2021). \textit{Microevidence for microdosing with psilocybin mushrooms: a double-blind placebo-controlled study of subjective effects, behavior, creativity, perception, cognition, and brain activity}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2021.11.30.470657}{doi:10.1101/2021.11.30.470657}.
\item Whitfield HJ. (2021). \textit{A Spectrum of Selves Reinforced in Multilevel Coherence: A Contextual Behavioural Response to the Challenges of Psychedelic-Assisted Therapy Development.}. Frontiers in Psychiatry. [published; Europe PMC]. \href{https://doi.org/10.3389/fpsyt.2021.727572}{doi:10.3389/fpsyt.2021.727572}.
\item Drummond E-Wen McCulloch, M. Madsen, Dea Siggaard Stenbæk, Søren Kristiansen, Brice Ozenne, P.S. Jensen, Gitte M. Knudsen, Patrick M. Fisher (2021). \textit{P.0593 Lasting effects of a single psilocybin dose on resting-state functional connectivity in healthy individuals}. European Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/j.euroneuro.2021.10.557}{doi:10.1016/j.euroneuro.2021.10.557}.
\item Hannah Douglass, Meg J. Spriggs, R.J. Park, Tim Read, Jennifer L. Danby, Frederico José Coelho de Magalhães, Kirsty L. Alderton, Adèle Lafrance, Dasha Nicholls, David Erritzøe, David Nutt, Robin Carhart-Harris (2021). \textit{P.0353 Study protocol: psilocybin as a treatment for anorexia nervosa: a pilot study}. European Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/j.euroneuro.2021.10.335}{doi:10.1016/j.euroneuro.2021.10.335}.
\item Lea J. Mertens, Michael Koslowski, Felix Betzler, Ricarda Evens, Maria Gilles, Andrea Jungaberle, Henrik Jungaberle, Tomislav Majić, Max Wolff, Andreas Ströhle, Stefan Wellek, Gerhard Gründer (2021). \textit{P.0421 Efficacy and safety of psilocybin in treatment-resistant major depression (EPIsoDE) - study design, rationale and current status}. European Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/j.euroneuro.2021.10.394}{doi:10.1016/j.euroneuro.2021.10.394}.
\item Dea Siggaard Stenbæk, M. Madsen, Sophia Armand, Catharina Messel, Maria Zofia Grzywacz, David Erritzøe, Gitte M. Knudsen, Patrick M. Fisher (2021). \textit{P.0828 Psilocybin enhances emotional response to music in healthy individuals}. European Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/j.euroneuro.2021.10.687}{doi:10.1016/j.euroneuro.2021.10.687}.
\item Ines Erkizia-Santamaría, R. Alles-Pascual, Igor Horrillo, J. Javier Meana, Jorge E. Ortega (2021). \textit{P.0298 Evaluation of the acute mechanism of action of psilocybin in mice}. European Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/j.euroneuro.2021.10.282}{doi:10.1016/j.euroneuro.2021.10.282}.
\item A. Andreiev, E. Bucuci, James Chue, Charl Els, Pierre Chue (2021). \textit{P.0623 The clinical relevance of the pharmacokinetics of psilocybin}. European Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/j.euroneuro.2021.10.588}{doi:10.1016/j.euroneuro.2021.10.588}.
\item Matthew B. Wall, Cynthia Lam, Natalie Ertl, Mendel Kaelen, Leor Roseman, David Nutt, Robin Carhart-Harris (2021). \textit{P.0885 The effect of psilocybin therapy for depression on low-frequency brain activity in response to music}. European Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/j.euroneuro.2021.10.741}{doi:10.1016/j.euroneuro.2021.10.741}.
\item Sara Penedos, Caio Freitas Ramos, María José López Miguel, Márcio José Martins Alves, Luciana Campos Paulino, Adriano Valério S. Azevêdo, M. Magalhães, L. Moreno, N. Ribeiro, Inês Fonseca, Ana Margarida Romão Franco, Luís Madruga, A. Gamito (2021). \textit{P.0729 Highlights of psychedelic history and current research on psilocybin application for treatment of depression - a comprehensive literature review}. European Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/j.euroneuro.2021.10.797}{doi:10.1016/j.euroneuro.2021.10.797}.
\item Olejníková L., Danda H., Lhotková E., Kútná V., Šíchová K., Syrová K., Mazochová K., Páleníček T. (2021). \textit{P.0553 Effect of chronic microdosing of psilocin on cell proliferation and behavior in rats}. European Neuropsychopharmacology. [published; Crossref]. \href{https://doi.org/10.1016/j.euroneuro.2021.10.523}{doi:10.1016/j.euroneuro.2021.10.523}.
\item Vejmola Č., Syrová K., Koudelka V., Šíchová K., Tesař M., Dodoková A., Kelemen E., Páleníček T. (2021). \textit{P.0858 Psilocin induces perceptual alterations in rats: visual discrimination study}. European Neuropsychopharmacology. [published; Crossref]. \href{https://doi.org/10.1016/j.euroneuro.2021.10.715}{doi:10.1016/j.euroneuro.2021.10.715}.
\item Gibbons WJ, McKinney MG, O'Dell PJ, Bollinger BA, Jones JA. (2021). \textit{Homebrewed psilocybin: can new routes for pharmaceutical psilocybin production enable recreational use?}. Bioengineered. [published; Europe PMC]. \href{https://doi.org/10.1080/21655979.2021.1987090}{doi:10.1080/21655979.2021.1987090}.
\item Rucker J, Jafari H, Mantingh T, Bird C, Modlin NL, Knight G, Reinholdt F, Day C, Carter B, Young A. (2021). \textit{Psilocybin-assisted therapy for the treatment of resistant major depressive disorder (PsiDeR): protocol for a randomised, placebo-controlled feasibility trial.}. BMJ Open. [published; Europe PMC]. \href{https://doi.org/10.1136/bmjopen-2021-056091}{doi:10.1136/bmjopen-2021-056091}.
\item Slocum ST, DiBerto JF, Roth BL. (2021). \textit{Molecular insights into psychedelic drug action.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1111/jnc.15540}{doi:10.1111/jnc.15540}.
\item Enzo Tagliazucchi (2021). \textit{Microevidence for microdosing with psilocybin mushrooms: a double-blind placebo-controlled study of subjective effects, behavior, creativity, perception, cognition, and brain activity}. Zenodo (CERN European Organization for Nuclear Research). [published; OpenAlex]. \href{https://doi.org/10.5281/zenodo.5745892}{doi:10.5281/zenodo.5745892}.
\item Angenoorth TJF, Stankovic S, Niello M, Holy M, Brandt SD, Sitte HH, Maier J (2021). \textit{Interaction Profiles of Central Nervous System Active Drugs at Human Organic Cation Transporters 1-3 and Human Plasma Membrane Monoamine Transporter.}. International journal of molecular sciences. [published; PubMed]. \href{https://doi.org/10.3390/ijms222312995}{doi:10.3390/ijms222312995}.
\item Weleff J, Akiki TJ, Barnett BS. (2021). \textit{Bibliometric Analysis of Academic Journal Articles Reporting Results of Psychedelic Clinical Studies}. medRxiv. [preprint; medRxiv]. \href{https://doi.org/10.1101/2021.11.22.21266718}{doi:10.1101/2021.11.22.21266718}.
\item Strumila R, Nobile B, Korsakova L, Lengvenyte A, Olie E, Lopez-Castroman J, Guillaume S, Courtet P. (2021). \textit{Psilocybin, a Naturally Occurring Indoleamine Compound, Could Be Useful to Prevent Suicidal Behaviors.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/ph14121213}{doi:10.3390/ph14121213}.
\item Molumby M, Gaynor K, Guerin S. (2021). \textit{Examining attitudes to psilocybin: Should candidates for medical psilocybin be required to pass a contextual suitability test}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/6f9qp}{doi:10.31234/osf.io/6f9qp}.
\item Unknown authors (2021). \textit{Examining attitudes to psilocybin: Should candidates for medical psilocybin be required to pass a contextual suitability test}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/6f9qp\_v1}{source link}.
\item Schimmers N, Breeksema JJ, Smith-Apeldoorn SY, Veraart J, van den Brink W, Schoevers RA. (2021). \textit{Psychedelics for the treatment of depression, anxiety, and existential distress in patients with a terminal illness: a systematic review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s00213-021-06027-y}{doi:10.1007/s00213-021-06027-y}.
\item Becker AM, Holze F, Grandinetti T, Klaiber A, Toedtli VE, Kolaczynska KE, Duthaler U, Varghese N, Eckert A, Grünblatt E, Liechti ME. (2021). \textit{Acute Effects of Psilocybin After Escitalopram or Placebo Pretreatment in a Randomized, Double-Blind, Placebo-Controlled, Crossover Study in Healthy Subjects.}. Clinical Pharmacology \& Therapeutics. [published; Europe PMC]. \href{https://doi.org/10.1002/cpt.2487}{doi:10.1002/cpt.2487}.
\item Gary Enos (2021). \textit{Researchers hope psilocybin could improve quit rates for smokers}. Alcoholism \& Drug Abuse Weekly. [published; OpenAlex]. \href{https://doi.org/10.1002/adaw.33270}{doi:10.1002/adaw.33270}.
\item Rootman JM, Kryskow P, Harvey K, Stamets P, Santos-Brault E, Kuypers KPC, Polito V, Bourzat F, Walsh Z. (2021). \textit{Adults who microdose psychedelics report health related motivations and lower levels of anxiety and depression compared to non-microdosers.}. Scientific Reports. [published; Europe PMC]. \href{https://doi.org/10.1038/s41598-021-01811-4}{doi:10.1038/s41598-021-01811-4}.
\item Meinhardt MW, Pfarr S, Fouquet G, Rohleder C, Meinhardt ML, Barroso-Flores J, Hoffmann R, Jeanblanc J, Paul E, Wagner K, Hansson AC, Köhr G, Meier N, von Bohlen Und Halbach O, Bell RL, Endepols H, Neumaier B, Schönig K, Bartsch D, Naassila M, Spanagel R, Sommer WH. (2021). \textit{Psilocybin targets a common molecular mechanism for cognitive impairment and increased craving in alcoholism.}. Science Advances. [published; Europe PMC]. \href{https://doi.org/10.1126/sciadv.abh2399}{doi:10.1126/sciadv.abh2399}.
\item Ling S, Ceban F, Lui LMW, Lee Y, Teopiz KM, Rodrigues NB, Lipsitz O, Gill H, Subramaniapillai M, Mansur RB, Lin K, Ho R, Rosenblat JD, Castle D, McIntyre RS. (2021). \textit{Molecular Mechanisms of Psilocybin and Implications for the Treatment of Depression.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s40263-021-00877-y}{doi:10.1007/s40263-021-00877-y}.
\item Strickland JC, Johnson MW. (2021). \textit{Human behavioral pharmacology of psychedelics.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/bs.apha.2021.10.003}{doi:10.1016/bs.apha.2021.10.003}.
\item Gass P, Vasilescu AN, Inta D. (2021). \textit{[Rapid-acting antidepressants-neurobiological mechanisms of action].}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s00115-021-01225-7}{doi:10.1007/s00115-021-01225-7}.
\item Graham F. (2021). \textit{Daily briefing: Largest trial shows psilocybin is effective to treat depression.}. Nature. [published; Europe PMC]. \href{https://doi.org/10.1038/d41586-021-03413-6}{doi:10.1038/d41586-021-03413-6}.
\item Doss MK, Považan M, Rosenberg MD, Sepeda ND, Davis AK, Finan PH, Smith GS, Pekar JJ, Barker PB, Griffiths RR, Barrett FS. (2021). \textit{Psilocybin therapy increases cognitive and neural flexibility in patients with major depressive disorder.}. Translational Psychiatry. [published; Europe PMC]. \href{https://doi.org/10.1038/s41398-021-01706-y}{doi:10.1038/s41398-021-01706-y}.
\item Sam Wong (2021). \textit{Psilocybin steps closer to credibility}. The New Scientist. [published; OpenAlex]. \href{https://doi.org/10.1016/s0262-4079(21)02061-3}{doi:10.1016/s0262-4079(21)02061-3}.
\item Basky G. (2021). \textit{Policy in focus: Is psilocybin the next cannabis?}. Canadian Medical Association Journal. [published; Europe PMC]. \href{https://doi.org/10.1503/cmaj.1095974}{doi:10.1503/cmaj.1095974}.
\item Duerler P, Brem S, Fraga-González G, Neef T, Allen M, Zeidman P, Stämpfli P, Vollenweider FX, Preller KH. (2021). \textit{Psilocybin Induces Aberrant Prediction Error Processing of Tactile Mismatch Responses-A Simultaneous EEG-FMRI Study.}. Cerebral Cortex. [published; Europe PMC]. \href{https://doi.org/10.1093/cercor/bhab202}{doi:10.1093/cercor/bhab202}.
\item Kozlowska U, Nichols C, Wiatr K, Figiel M. (2021). \textit{From psychiatry to neurology: Psychedelics as prospective therapeutics for neurodegenerative disorders.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1111/jnc.15509}{doi:10.1111/jnc.15509}.
\item Spriggs MJ, Douglass HM, Park RJ, Read T, Danby JL, de Magalhães FJC, Alderton KL, Williams TM, Blemings A, Lafrance A, Nicholls DE, Erritzoe D, Nutt DJ, Carhart-Harris RL. (2021). \textit{Study Protocol for "Psilocybin as a Treatment for Anorexia Nervosa: A Pilot Study".}. Frontiers in Psychiatry. [published; Europe PMC]. \href{https://doi.org/10.3389/fpsyt.2021.735523}{doi:10.3389/fpsyt.2021.735523}.
\item Maryland Oncology Hematology, PA (2021). \textit{The Safety and Efficacy of Psilocybin in Cancer Patients With Major Depressive Disorder}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT04593563}{source link}.
\item Andrian Fajar Kusumadewi (2021). \textit{Case Report: Magic Mushroom (Psilocybe Cubensis) Intoxication}. Archives of The Medicine and Case Reports. [published; OpenAlex]. \href{https://doi.org/10.37275/amcr.v1i2.7}{doi:10.37275/amcr.v1i2.7}.
\item Radakovic C, Radakovic R, Peryer G, Geere J. (2021). \textit{Psychedelics and Mindfulness: A Systematic Review and Meta-Analysis}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/yu7jf}{doi:10.31234/osf.io/yu7jf}.
\item Unknown authors (2021). \textit{Psychedelics and Mindfulness: A Systematic Review and Meta-Analysis}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/yu7jf\_v1}{source link}.
\item Yu CL, Yang FC, Yang SN, Tseng PT, Stubbs B, Yeh TC, Hsu CW, Li DJ, Liang CS. (2021). \textit{Psilocybin for End-of-Life Anxiety Symptoms: A Systematic Review and Meta-Analysis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.30773/pi.2021.0209}{doi:10.30773/pi.2021.0209}.
\item Barnett BS, Parker SE, Weleff J. (2021). \textit{United States National Institutes of Health grant funding for psychedelic-assisted therapy clinical trials from 2006-2020.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.drugpo.2021.103473}{doi:10.1016/j.drugpo.2021.103473}.
\item Murray CH, Tare I, Perry CM, Malina M, Lee R, de Wit H. (2021). \textit{Low doses of LSD reduce broadband oscillatory power and modulate event-related potentials in healthy adults.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s00213-021-05991-9}{doi:10.1007/s00213-021-05991-9}.
\item Vejmola Č, Tylš F, Piorecká V, Koudelka V, Kadeřábek L, Novák T, Páleníček T. (2021). \textit{Psilocin, LSD, mescaline, and DOB all induce broadband desynchronization of EEG and disconnection in rats with robust translational validity.}. Translational Psychiatry. [published; Europe PMC]. \href{https://doi.org/10.1038/s41398-021-01603-4}{doi:10.1038/s41398-021-01603-4}.
\item Fitzgerald PJ (2021). \textit{Many Drugs of Abuse May Be Acutely Transformed to Dopamine, Norepinephrine and Epinephrine In Vivo.}. International journal of molecular sciences. [published; PubMed]. \href{https://doi.org/10.3390/ijms221910706}{doi:10.3390/ijms221910706}.
\item Charles S. Grob (2021). \textit{6.3 CURRENT RESEARCH ON PSILOCYBIN TREATMENT ON END-OF-LIFE ANXIETY AND MDMA TREATMENT OF SOCIAL ANXIETY IN AUTISM SPECTRUM DISORDER}. Journal of the American Academy of Child \& Adolescent Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.jaac.2021.07.053}{doi:10.1016/j.jaac.2021.07.053}.
\item Castro BN, Prata Saraiva R, Afonso João D, Dantas Costa S (2021). \textit{Magic mushroom: all is not as it seems.}. Acta chirurgica Belgica. [published; PubMed]. \href{https://doi.org/10.1080/00015458.2021.1972590}{doi:10.1080/00015458.2021.1972590}.
\item Liu WQ, Shi Y, Xiang P, Yu F, Xie B, Dong M, Ha J, Ma CL, Wen D. (2021). \textit{Analysis of Five Mushroom Toxins in Blood by UPLC-HRMS.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.12116/j.issn.1004-5619.2020.301001}{doi:10.12116/j.issn.1004-5619.2020.301001}.
\item Bogadi M, Kaštelan S. (2021). \textit{A potential effect of psilocybin on anxiety in neurotic personality structures in adolescents.}. Croatian Medical Journal. [published; Europe PMC]. \href{https://doi.org/10.3325/cmj.2021.62.528}{doi:10.3325/cmj.2021.62.528}.
\item Gonda X, Dome P, Neill JC, Tarazi FI. (2021). \textit{Novel antidepressant drugs: Beyond monoamine targets.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1017/s1092852921000791}{doi:10.1017/s1092852921000791}.
\item Castelhano J, Lima G, Teixeira M, Soares C, Pais M, Castelo-Branco M. (2021). \textit{The Effects of Tryptamine Psychedelics in the Brain: A meta-Analysis of Functional and Review of Molecular Imaging Studies.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fphar.2021.739053}{doi:10.3389/fphar.2021.739053}.
\item Rodríguez Arce JM, Winkelman MJ. (2021). \textit{Psychedelics, Sociality, and Human Evolution.}. Frontiers in Psychology. [published; Europe PMC]. \href{https://doi.org/10.3389/fpsyg.2021.729425}{doi:10.3389/fpsyg.2021.729425}.
\item Vincent Verroust, Rayyan Zafar, Meg J. Spriggs (2021). \textit{Psilocybin in the treatment of anorexia nervosa: The English transition of a French 1959 case study}. Annales Médico-psychologiques revue psychiatrique. [published; OpenAlex]. \href{https://doi.org/10.1016/j.amp.2021.08.004}{doi:10.1016/j.amp.2021.08.004}.
\item Zeiss R, Gahr M, Graf H. (2021). \textit{Rediscovering Psilocybin as an Antidepressive Treatment Strategy.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/ph14100985}{doi:10.3390/ph14100985}.
\item Alison Knopf (2021). \textit{Psilocybin: Next to treat depression, OCD and nicotine addiction}. Alcoholism \& Drug Abuse Weekly. [published; OpenAlex]. \href{https://doi.org/10.1002/adaw.33204}{doi:10.1002/adaw.33204}.
\item Aleksandrova LR, Phillips AG. (2021). \textit{Neuroplasticity as a convergent mechanism of ketamine and classical psychedelics.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.tips.2021.08.003}{doi:10.1016/j.tips.2021.08.003}.
\item Pascal Kintz, Jean-Sébastien Raul, Alice Ameline (2021). \textit{Testing human hair after magic mushrooms abuse by LC-MS/MS: Pitfalls and limitations}. Forensic Chemistry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.forc.2021.100364}{doi:10.1016/j.forc.2021.100364}.
\item Li NX, Hu YR, Chen WN, Zhang B. (2021). \textit{Dose effect of psilocybin on primary and secondary depression: a preliminary systematic review and meta-analysis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jad.2021.09.041}{doi:10.1016/j.jad.2021.09.041}.
\item Morita I, Kiguchi Y, Oyama H, Takeuchi A, Tode C, Tanaka R, Ogata J, Kikura-Hanajiri R, Kobayashi N. (2021). \textit{Derivatization-assisted enzyme-linked immunosorbent assay for identifying hallucinogenic mushrooms with enhanced sensitivity.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1039/d1ay01157j}{doi:10.1039/d1ay01157j}.
\item Basedow LA, Riemer TG, Reiche S, Kreutz R, Majić T. (2021). \textit{Neuropsychological Functioning in Users of Serotonergic Psychedelics - A Systematic Review and Meta-Analysis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fphar.2021.739966}{doi:10.3389/fphar.2021.739966}.
\item Leger RF, Unterwald EM. (2021). \textit{Assessing the effects of methodological differences on outcomes in the use of psychedelics in the treatment of anxiety and depressive disorders: A systematic review and meta-analysis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811211044688}{doi:10.1177/02698811211044688}.
\item Kargbo RB. (2021). \textit{Psilocin Derivatives as Serotonergic Psychedelic Agents for the Treatment of CNS Disorders.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/acsmedchemlett.1c00467}{doi:10.1021/acsmedchemlett.1c00467}.
\item de Vos CMH, Mason NL, Kuypers KPC. (2021). \textit{Psychedelics and Neuroplasticity: A Systematic Review Unraveling the Biological Underpinnings of Psychedelics.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fpsyt.2021.724606}{doi:10.3389/fpsyt.2021.724606}.
\item Gonçalo Cotovio, Ana Maia, Ana Velosa, Carolina Seybert, Albino J. Oliveira-Maia (2021). \textit{Treating Major Depression Disorder with Psychedelics: A Potential Therapeutic Application for Psilocybin?}. Revista Portuguesa de Psiquiatria e Saúde Mental. [published; OpenAlex]. \href{https://doi.org/10.51338/rppsm.2021.v7.i3.241}{doi:10.51338/rppsm.2021.v7.i3.241}.
\item Argento E, Christie D, Mackay L, Callon C, Walsh Z. (2021). \textit{Psychedelic-Assisted Psychotherapy After COVID-19: The Therapeutic Uses of Psilocybin and MDMA for Pandemic-Related Mental Health Problems.}. Frontiers in Psychiatry. [published; Europe PMC]. \href{https://doi.org/10.3389/fpsyt.2021.716593}{doi:10.3389/fpsyt.2021.716593}.
\item Lehto RH, Miller M, Sender J. (2021). \textit{The Role of Psilocybin-Assisted Psychotherapy to Support Patients With Cancer: A Critical Scoping Review of the Research.}. Journal of Holistic Nursing. [published; Europe PMC]. \href{https://doi.org/10.1177/08980101211039086}{doi:10.1177/08980101211039086}.
\item Samantha K. Podrebarac, Kelley C. O’Donnell, Sarah E. Mennenga, Lindsey T. Owens, Tara C. Malone, Jessie H. Duane, Michael P. Bogenschutz (2021). \textit{Spiritual experiences in psychedelic-assisted psychotherapy: Case reports of communion with the divine, the departed, and saints in research using psilocybin for the treatment of alcohol dependence.}. Spirituality in Clinical Practice. [published; OpenAlex]. \href{https://doi.org/10.1037/scp0000242}{doi:10.1037/scp0000242}.
\item Kverno KS, Mangano E. (2021). \textit{Treatment-Resistant Depression: Approaches to Treatment.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3928/02793695-20210816-01}{doi:10.3928/02793695-20210816-01}.
\item Hagsäter SM, Pettersson R, Pettersson C, Atanasovski D, Näslund J, Eriksson E. (2021). \textit{A Complex Impact of Systemically Administered 5-HT2A Receptor Ligands on Conditioned Fear.}. The International Journal of Neuropsychopharmacology. [published; Europe PMC]. \href{https://doi.org/10.1093/ijnp/pyab040}{doi:10.1093/ijnp/pyab040}.
\item Muthukumaraswamy SD, Forsyth A, Lumley T. (2021). \textit{Blinding and expectancy confounds in psychedelic randomized controlled trials.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/17512433.2021.1933434}{doi:10.1080/17512433.2021.1933434}.
\item Yaden DB, Johnson MW, Griffiths RR, Doss MK, Garcia-Romeu A, Nayak S, Gukasyan N, Mathur BN, Barrett FS (2021). \textit{Psychedelics and Consciousness: Distinctions, Demarcations, and Opportunities.}. The international journal of neuropsychopharmacology. [published; PubMed]. \href{https://doi.org/10.1093/ijnp/pyab026}{doi:10.1093/ijnp/pyab026}.
\item Frederico Marques Silveira, Amanda Pereira Mendes, Mayara Rodrigues dos Santos, Júlia Ramos Cerchi, IRIS TIYONO TAVARES UMEDA, Breno Basílio de Melo, Luiza Elena Casaburi, Mateus Nóbrega Oliveira, Douglas Reis Abdalla (2021). \textit{Use of alternative therapy with Psilocybin in oncologic patients with depression and/or anxiety disorders - integrative review}. Research Society and Development. [published; OpenAlex]. \href{https://doi.org/10.33448/rsd-v10i10.19297}{doi:10.33448/rsd-v10i10.19297}.
\item Corneille JS, Luke D. (2021). \textit{Spontaneous Spiritual Awakenings: Phenomenology, Altered States, Individual Differences, and Well-Being.}. Frontiers in Psychology. [published; Europe PMC]. \href{https://doi.org/10.3389/fpsyg.2021.720579}{doi:10.3389/fpsyg.2021.720579}.
\item Figueiredo I, Viegas F, Ferreira F, Santos A, Ramos J, Miranda J. (2021). \textit{Therapeutic interventions for PTSD - current evidence on the the role of psychedelics}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC9475922}{source link}.
\item Peixoto C, Santos F, Rego D, Medeiros H. (2021). \textit{Psychedelics and psychiatric disorders: A emerging role}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC9470409}{source link}.
\item Miranda J, Barbosa M, Figueiredo I, Mota P, Tarelho A. (2021). \textit{Treating addiction with psychedelics - are we waking up?}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC9480123}{source link}.
\item Torres S. (2021). \textit{Psychedelics: A new era of treatment?}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC9475866}{source link}.
\item Fraga A, Esteves-Sousa D, Facucho-Oliveira J, Albuquerque M, Costa M, Dos Santos P, Moura N, Moutinho A. (2021). \textit{Effects of psilocybin-assisted therapy on treatment-resistant depression}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC9480034}{source link}.
\item Descalço N, Medeiros A, Santos C, Borges G. (2021). \textit{Psilocybin in the treatment of obsessive-compulsive disorder: What do we know so far?}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC9476072}{source link}.
\item Więckiewicz G, Stokłosa I, Piegza M, Gorczyca P, Pudlo R. (2021). \textit{Lysergic Acid Diethylamide, Psilocybin and Dimethyltryptamine in Depression Treatment: A Systematic Review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/ph14080793}{doi:10.3390/ph14080793}.
\item Mendes Rocha J, Rossi GN, Osório FL, Bouso Saiz JC, Silveira GO, Yonamine M, Crevelin EJ, Queiroz ME, Cecílio Hallak JE, Dos Santos RG. (2021). \textit{Effects of Ayahuasca on Personality: Results of Two Randomized, Placebo-Controlled Trials in Healthy Volunteers.}. Frontiers in Psychiatry. [published; Europe PMC]. \href{https://doi.org/10.3389/fpsyt.2021.688439}{doi:10.3389/fpsyt.2021.688439}.
\item Nkadimeng SM, Steinmann CML, Eloff JN. (2021). \textit{Anti-Inflammatory Effects of Four Psilocybin-Containing Magic Mushroom Water Extracts in vitro on 15-Lipoxygenase Activity and on Lipopolysaccharide-Induced Cyclooxygenase-2 and Inflammatory Cytokines in Human U937 Macrophage Cells.}. DOAJ (DOAJ: Directory of Open Access Journals). [published; Europe PMC]. \href{https://doi.org/10.2147/jir.s317182}{source link}.
\item Lukačovič M, Masaryk R. (2021). \textit{Use of hallucinogens in Slovakia: Does it differ from global trends?}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.drugpo.2021.103385}{doi:10.1016/j.drugpo.2021.103385}.
\item Nayak SM, Gukasyan N, Barrett FS, Erowid E, Erowid F, Griffiths RR. (2021). \textit{Classic Psychedelic Coadministration with Lithium, but Not Lamotrigine, is Associated with Seizures: An Analysis of Online Psychedelic Experience Reports.}. Pharmacopsychiatry. [published; Europe PMC]. \href{https://doi.org/10.1055/a-1524-2794}{doi:10.1055/a-1524-2794}.
\item Sanah Malomile Nkadimeng, Christiaan ML Steinmann, J.N. Eloff (2021). \textit{Anti-Inflammatory Effects of Four Psilocybin-Containing Magic Mushroom Water Extracts in vitro on 15-Lipoxygenase Activity and on Lipopolysaccharide-Induced Cyclooxygenase-2 and Inflammatory Cytokines in Human U937 Macrophage Cells}. Journal of Inflammation Research. [published; OpenAlex]. \href{https://doi.org/10.2147/jir.s317182}{doi:10.2147/jir.s317182}.
\item Markus Weih (2021). \textit{Mit Psilocybin gegen Depression}. InFo Neurologie + Psychiatrie. [published; OpenAlex]. \href{https://doi.org/10.1007/s15005-021-2012-7}{doi:10.1007/s15005-021-2012-7}.
\item van Dongen RM, Alderliefste GJ, Onderwater GLJ, Ferrari MD, Terwindt GM (2021). \textit{Migraine prevalence in visual snow with prior illicit drug use (hallucinogen persisting perception disorder) versus without.}. European journal of neurology. [published; PubMed]. \href{https://doi.org/10.1111/ene.14914}{doi:10.1111/ene.14914}.
\item Waters K. (2021). \textit{Pharmacologic Similarities and Differences Among Hallucinogens.}. The Journal of Clinical Pharmacology. [published; Europe PMC]. \href{https://doi.org/10.1002/jcph.1917}{doi:10.1002/jcph.1917}.
\item DiBerto JF, Roth BL. (2021). \textit{The cranial windows of perception.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neuron.2021.07.017}{doi:10.1016/j.neuron.2021.07.017}.
\item Wiley JF, Bei B. (2021). \textit{Psilocybin for Depression.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1056/nejmc2108082}{doi:10.1056/nejmc2108082}.
\item Psiuk D, Nowak E, Cholewa K, Łopuszańska U, Samardakiewicz M. (2021). \textit{The Potential Role of Serotonergic Hallucinogens in Depression Treatment.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/life11080765}{doi:10.3390/life11080765}.
\item Chong Siew Koon, Tuan Sharipah binti Tuan Hadi, Izatt Syafieq bin Abd Rashad, Ruzila binti Ali (2021). \textit{A Case Series Describing the Tale of ‘The Magic Mushroom’; An Increasing Trend of Psychedelic Misuse Among Substance Abusers in Terengganu}. Unknown journal. [published; OpenAlex]. \href{https://openalex.org/W3186346443}{source link}.
\item Borroto-Escuela DO, Ambrogini P, Narvaez M, Di Liberto V, Beggiato S, Ferraro L, Fores-Pons R, Alvarez-Contino JE, Lopez-Salas A, Mudò G, Díaz-Cabiale Z, Fuxe K. (2021). \textit{Serotonin Heteroreceptor Complexes and Their Integration of Signals in Neurons and Astroglia-Relevance for Mental Diseases.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/cells10081902}{doi:10.3390/cells10081902}.
\item Yaden DB, Berghella AP, Regier PS, Garcia-Romeu A, Johnson MW, Hendricks PS. (2021). \textit{Classic psychedelics in the treatment of substance use disorder: Potential synergies with twelve-step programs.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.drugpo.2021.103380}{doi:10.1016/j.drugpo.2021.103380}.
\item Horton DM, Morrison B, Schmidt J. (2021). \textit{Systematized Review of Psychotherapeutic Components of Psilocybin-Assisted Psychotherapy.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1176/appi.psychotherapy.20200055}{doi:10.1176/appi.psychotherapy.20200055}.
\item King's College London (2021). \textit{A Randomised, Placebo Controlled Trial of Psilocybin in Treatment Resistant Depression: A Feasibility Study}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT04959253}{source link}.
\item Siegel V, Emmert-Aronson B. (2021). \textit{Both partners practicing orgasmic meditation report having a mystical-type experience: results using the Mystical Experience Questionnaire}. F1000Res. [preprint; Europe PMC]. \href{https://doi.org/10.12688/f1000research.53496.1}{doi:10.12688/f1000research.53496.1}.
\item Cox DJ, Johnson MW. (2021). \textit{Verbal behavior related to drug reinforcement in polysubstance cannabis users: Comparison across drugs.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1037/pha0000404}{doi:10.1037/pha0000404}.
\item Mayer CE, LeBaron VT, Acquaviva KD. (2021). \textit{Exploring the Use of Psilocybin Therapy for Existential Distress: A Qualitative Study of Palliative Care Provider Perceptions.}. Journal of Psychoactive Drugs. [published; Europe PMC]. \href{https://doi.org/10.1080/02791072.2021.1916659}{doi:10.1080/02791072.2021.1916659}.
\item Letheby C. (2021). \textit{Naturalistic Entheogenics: Précis of Philosophy of Psychedelics}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/ztewb}{doi:10.31234/osf.io/ztewb}.
\item Unknown authors (2021). \textit{Naturalistic Entheogenics: Précis of Philosophy of Psychedelics}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/ztewb\_v1}{source link}.
\item Madsen MK, Stenbæk DS, Arvidsson A, Armand S, Marstrand-Joergensen MR, Johansen SS, Linnet K, Ozenne B, Knudsen GM, Fisher PM. (2021). \textit{Psilocybin-induced changes in brain network integrity and segregation correlate with plasma psilocin level and psychedelic experience.}. European Neuropsychopharmacology. [published; Europe PMC]. \href{https://doi.org/10.1016/j.euroneuro.2021.06.001}{doi:10.1016/j.euroneuro.2021.06.001}.
\item Lenz C, Dörner S, Sherwood A, Hoffmeister D. (2021). \textit{Structure Elucidation and Spectroscopic Analysis of Chromophores Produced by Oxidative Psilocin Dimerization.}. Chemistry - A European Journal. [published; Europe PMC]. \href{https://doi.org/10.1002/chem.202101382}{doi:10.1002/chem.202101382}.
\item Unknown authors (2021). \textit{Trial of psilocybin does not show major difference from antidepressant}. The Brown University Psychopharmacology Update. [published; OpenAlex]. \href{https://doi.org/10.1002/pu.30751}{doi:10.1002/pu.30751}.
\item Watts R. (2021). \textit{Psilocybin for Depression: The ACE Model Manual}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/5x2bu}{doi:10.31234/osf.io/5x2bu}.
\item Unknown authors (2021). \textit{Psilocybin for Depression: The ACE Model Manual}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/5x2bu\_v1}{source link}.
\item Shao LX, Liao C, Gregg I, Davoudian PA, Savalia NK, Delagarza K, Kwan AC. (2021). \textit{Psilocybin induces rapid and persistent growth of dendritic spines in frontal cortex in vivo.}. Neuron. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neuron.2021.06.008}{doi:10.1016/j.neuron.2021.06.008}.
\item Kevin McKernan, Liam T. Kane, Yvonne Helbert, Lei Zhang, Nathan Houde, Stephen McLaughlin (2021). \textit{A whole genome atlas of 81 Psilocybe genomes as a resource for psilocybin production.}. Zenodo (CERN European Organization for Nuclear Research). [published; OpenAlex]. \href{https://doi.org/10.5281/zenodo.5062843}{doi:10.5281/zenodo.5062843}.
\item Z C (2021). \textit{Psilocybin Therapy May Work as Well as Common Antidepressant}. Scientific American. [published; OpenAlex]. \href{https://doi.org/10.1038/scientificamericanmind0821-9}{doi:10.1038/scientificamericanmind0821-9}.
\item Bao SH, Jiang H, Zhu LY, Yao G, Han PG, Wan XK, Wang K, Song TY, Liu CJ, Wang S, Zhang ZY, Zhang DY, Meng E. (2021). \textit{A dynamic and multilocus metabolic regulation strategy using quorum-sensing-controlled bacterial small RNA.}. Cell Reports. [published; Europe PMC]. \href{https://doi.org/10.1016/j.celrep.2021.109413}{doi:10.1016/j.celrep.2021.109413}.
\item Zhou Liying, Xiang Ping, Wen Di, Shen Baohua, Wang Xin, Li Le, Deng Hongxiao, Chen Hang, Yan Hui, Shen Min, Shi Yan, Liu Wanhui (2021). \textit{Sensitive quantitative analysis of psilocin and psilocybin in hair samples from suspected users and their distribution in seized hallucinogenic mushrooms}. Forensic Toxicology. [published; Crossref]. \href{https://doi.org/10.1007/s11419-020-00566-3}{doi:10.1007/s11419-020-00566-3}.
\item McCulloch DE, Madsen MK, Stenbæk DS, Kristiansen S, Ozenne B, Jensen PS, Knudsen GM, Fisher PM. (2021). \textit{Lasting effects of a single psilocybin dose on resting-state functional connectivity in healthy individuals.}. Journal of Psychopharmacology. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811211026454}{doi:10.1177/02698811211026454}.
\item Mans K, Kettner H, Erritzoe D, Haijen ECHM, Kaelen M, Carhart-Harris RL. (2021). \textit{Sustained, Multifaceted Improvements in Mental Well-Being Following Psychedelic Experiences in a Prospective Opportunity Sample.}. Frontiers in Psychiatry. [published; Europe PMC]. \href{https://doi.org/10.3389/fpsyt.2021.647909}{doi:10.3389/fpsyt.2021.647909}.
\item Coppola M, Bevione F, Mondola R. (2021). \textit{Psilocybin for Treating Psychiatric Disorders: Is it a Psychonaut Legend or a Promising Therapeutic Perspective?}. Preprints.org. [preprint; Europe PMC]. \href{https://doi.org/10.20944/preprints202106.0682.v1}{doi:10.20944/preprints202106.0682.v1}.
\item McCartney A, McGovern H, De Foe A. (2021). \textit{Psychedelic Assisted Therapy for Major Depressive Disorder: A Review}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/9kuhs}{doi:10.31234/osf.io/9kuhs}.
\item Unknown authors (2021). \textit{Psychedelic Assisted Therapy for Major Depressive Disorder: A Review}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/9kuhs\_v1}{source link}.
\item Sarah-Catherine Rodan, Phillip Aouad, Iain S. McGregor, Sarah Maguire (2021). \textit{Psilocybin as a Novel Pharmacotherapy for Treatment-Refractory Anorexia Nervosa}. OBM Neurobiology. [published; OpenAlex]. \href{https://doi.org/10.21926/obm.neurobiol.2102102}{doi:10.21926/obm.neurobiol.2102102}.
\item Corrigan A, Burchill E, Pelton L, Marrocu A, Mazzoleni A, Shackshaft L. (2021). \textit{Psilocybin: the magic medicine for depression?}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC8770735}{source link}.
\item Révész D, Ona G, Rossi GN, Rocha JM, Dos Santos RG, Hallak JEC, Alcázar-Córcoles MÁ, Bouso JC. (2021). \textit{Cross-Sectional Associations Between Lifetime Use of Psychedelic Drugs and Psychometric Measures During the COVID-19 Confinement: A Transcultural Study.}. Frontiers in Psychiatry. [published; Europe PMC]. \href{https://doi.org/10.3389/fpsyt.2021.687546}{doi:10.3389/fpsyt.2021.687546}.
\item McKernan K, Kane LT, Crawford S, Chin C, Trippe A, McLaughlin S. (2021). \textit{A draft reference assembly of the Psilocybe cubensis genome}. F1000Res. [preprint; Europe PMC]. \href{https://doi.org/10.12688/f1000research.51613.2}{doi:10.12688/f1000research.51613.2}.
\item Corrigan K, Haran M, McCandliss C, McManus R, Cleary S, Trant R, Kelly Y, Ledden K, Rush G, O'Keane V, Kelly JR. (2021). \textit{Psychedelic perceptions: mental health service user attitudes to psilocybin therapy.}. Irish Journal of Medical Science (1971 -). [published; Europe PMC]. \href{https://doi.org/10.1007/s11845-021-02668-2}{doi:10.1007/s11845-021-02668-2}.
\item Prochazkova L, van Elk M, Marschall JC, Rifkin BD, Fejer G, Schoen N, Fiacchino D, Kuchar M, Hommel B. (2021). \textit{Microdosing psychedelics and its effect on creativity: Lessons learned from three double-blind placebo controlled longitudinal trials}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/emcxw}{doi:10.31234/osf.io/emcxw}.
\item Unknown authors (2021). \textit{Microdosing psychedelics and its effect on creativity: Lessons learned from three double-blind placebo controlled longitudinal trials}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/emcxw\_v1}{source link}.
\item Gabrielle Agin-Liebes, Eve Ekman, B. Anderson, Maxx Malloy, Alexandra Haas, Josh Woolley (2021). \textit{Participant Reports of Mindfulness, Posttraumatic Growth, and Social Connectedness in Psilocybin-Assisted Group Therapy: An Interpretive Phenomenological Analysis}. Journal of Humanistic Psychology. [published; OpenAlex]. \href{https://doi.org/10.1177/00221678211022949}{doi:10.1177/00221678211022949}.
\item McCulloch DE, Knudsen GM, Barrett FS, Doss M, Deco G, Carhart-Harris R, Rosas F, Preller K, Ramaekers J, Mason N, Müller F, Fisher PM. (2021). \textit{Psychedelic resting-state neuroimaging: a review and perspective on balancing replication and novel analyses}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/64kyg}{doi:10.31234/osf.io/64kyg}.
\item Bambauer TP, Wagmann L, Weber AA, Meyer MR. (2021). \textit{Further development of a liquid chromatography-high-resolution mass spectrometry/mass spectrometry-based strategy for analyzing eight biomarkers in human urine indicating toxic mushroom or Ricinus communis ingestions.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1002/dta.3106}{doi:10.1002/dta.3106}.
\item Unknown authors (2021). \textit{Psychedelic resting-state neuroimaging: a review and perspective on balancing replication and novel analyses}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/64kyg\_v1}{source link}.
\item Fradkin D. (2021). \textit{Psilocybin: A brief overview for psychiatric mental health nurse practitioners.}. Perspectives In Psychiatric Care. [published; Europe PMC]. \href{https://doi.org/10.1111/ppc.12888}{doi:10.1111/ppc.12888}.
\item Fogg C, Michaels TI, de la Salle S, Jahn ZW, Williams MT. (2021). \textit{Ethnoracial health disparities and the ethnopsychopharmacology of psychedelic-assisted psychotherapies.}. Experimental and Clinical Psychopharmacology. [published; Europe PMC]. \href{https://doi.org/10.1037/pha0000490}{doi:10.1037/pha0000490}.
\item Cox DJ, Garcia-Romeu A, Johnson MW. (2021). \textit{Predicting changes in substance use following psychedelic experiences: natural language processing of psychedelic session narratives.}. The American Journal of Drug and Alcohol Abuse. [published; Europe PMC]. \href{https://doi.org/10.1080/00952990.2021.1910830}{doi:10.1080/00952990.2021.1910830}.
\item Amber Elyse Corrigan, Ella Burchill, Lucy Pelton, Alessia Marrocu, Adele Mazzoleni, Lydia Shackshaft (2021). \textit{Psilocybin: the magic medicine for depression?}. BJPsych Open. [published; OpenAlex]. \href{https://doi.org/10.1192/bjo.2021.456}{doi:10.1192/bjo.2021.456}.
\item Chao YS, Horton J. (2021). \textit{Psychedelic-Assisted Psychotherapy for Post-Traumatic Stress Disorder, Anxiety Disorders, Mood Disorders, or Substance Use Disorders}. Canadian Agency for Drugs and Technologies in Health, Ottawa (ON). [published; Europe PMC]. \href{https://europepmc.org/article/MED/36170470}{source link}.
\item Corneille JS, Luke D. (2021). \textit{Spontaneous Spiritual Awakenings: Phenomenology, Altered States, Individual Differences, and Wellbeing}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/8aeyf}{doi:10.31234/osf.io/8aeyf}.
\item Unknown authors (2021). \textit{Spontaneous Spiritual Awakenings: Phenomenology, Altered States, Individual Differences, and Wellbeing}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/8aeyf\_v1}{source link}.
\item Teixeira PJ, Johnson MW, Timmermann C, Watts R, Erritzoe D, Douglass H, Kettner H, Carhart-Harris RL. (2021). \textit{Psychedelics and health behaviour change.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811211008554}{doi:10.1177/02698811211008554}.
\item Magaraggia I, Kuiperes Z, Schreiber R. (2021). \textit{Improving cognitive functioning in major depressive disorder with psychedelics: A dimensional approach.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.nlm.2021.107467}{doi:10.1016/j.nlm.2021.107467}.
\item Daws R, Timmerman C, Giribaldi B, Sexton J, Wall M, Erritzoe D, Roseman L, Nutt D, Carhart-Harris R. (2021). \textit{Decreased brain modularity after psilocybin therapy for depression.}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-513323/v1}{doi:10.21203/rs.3.rs-513323/v1}.
\item Unknown authors (2021). \textit{Future Directions for Clinical Psilocybin Research: The Relaxed Symptom Network}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.1037/pne0000290}{doi:10.1037/pne0000290}.
\item Lewis-Healey E, Laukkonen RE, van Elk M. (2021). \textit{Future Directions for Clinical Psilocybin Research: The Relaxed Symptom Network}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/q3ymd}{doi:10.31234/osf.io/q3ymd}.
\item Siegel AN, Meshkat S, Benitah K, Lipsitz O, Gill H, Lui LMW, Teopiz KM, McIntyre RS, Rosenblat JD. (2021). \textit{Registered clinical studies investigating psychedelic drugs for psychiatric disorders.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jpsychires.2021.05.019}{doi:10.1016/j.jpsychires.2021.05.019}.
\item Hendin HM, Penn AD. (2021). \textit{An episode of mania following self-reported ingestion of psilocybin mushrooms in a woman previously not diagnosed with bipolar disorder: A case report.}. Bipolar Disorders. [published; Europe PMC]. \href{https://doi.org/10.1111/bdi.13095}{doi:10.1111/bdi.13095}.
\item Singleton SP, Luppi AI, Carhart-Harris RL, Cruzat J, Roseman L, Nutt DJ, Deco G, Kringelbach ML, Stamatakis EA, Kuceyeski A. (2021). \textit{LSD and psilocybin flatten the brain’s energy landscape: insights from receptor-informed network control theory}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2021.05.14.444193}{doi:10.1101/2021.05.14.444193}.
\item Lowe H, Toyang N, Steele B, Valentine H, Grant J, Ali A, Ngwa W, Gordon L. (2021). \textit{The Therapeutic Potential of Psilocybin.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/molecules26102948}{doi:10.3390/molecules26102948}.
\item Gründer G, Jungaberle H. (2021). \textit{The Potential Role of Psychedelic Drugs in Mental Health Care of the Future.}. Pharmacopsychiatry. [published; Europe PMC]. \href{https://doi.org/10.1055/a-1486-7386}{doi:10.1055/a-1486-7386}.
\item Forstmann M, Sagioglou C. (2021). \textit{New insights into the clinical and nonclinical effects of psychedelic substances: an integrative review}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/2489x}{doi:10.31234/osf.io/2489x}.
\item Unknown authors (2021). \textit{New insights into the clinical and nonclinical effects of psychedelic substances: an integrative review}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/2489x\_v1}{source link}.
\item Simonsson O, Hendricks PS, Carhart-Harris R, Kettner H, Osika W (2021). \textit{Association Between Lifetime Classic Psychedelic Use and Hypertension in the Past Year.}. Hypertension (Dallas, Tex.: 1979). [published; PubMed]. \href{https://doi.org/10.1161/hypertensionaha.120.16715}{doi:10.1161/hypertensionaha.120.16715}.
\item Fabiana Venancio Santana Silva, Alexandre Libanio Silva Reis, Amanda Prazeres Costa, Maria Carolaine Souza da Silva, Rafaela da Conceição de Lemos, Elisângela Marcionilo Da Conceição, Joyce Kelly Soares da Silva, Carlos Alberto Tiburcio Valeriano, David Filipe de Santana (2021). \textit{A utilização terapêutica da psilocibina como coadjuvante no tratamento do transtorno depressivo maior: uma revisão narrativa de literatura / The therapeutic use of psilocybin as an adjunct in the treatment of major depressive disorder: a narrative literature review}. Brazilian Journal of Health Review. [published; OpenAlex]. \href{https://doi.org/10.34119/bjhrv4n3-012}{doi:10.34119/bjhrv4n3-012}.
\item Madison Hagood (2021). \textit{Non-Traditional Psychotherapy Techniques: An Assessment of the Value of MDMA, Psilocybin and LSD.}. Unknown journal. [published; OpenAlex]. \href{https://repository.asu.edu/items/63943}{source link}.
\item Despina Stratidakis (2021). \textit{Addressing the Implicit Impacts of Sexual Trauma: An Exploration of Somatic Experiencing as an Adjunct to Psilocybin-Assisted Therapy}. National University System Repository (National University System). [published; OpenAlex]. \href{http://hdl.handle.net/20.500.11803/1295}{source link}.
\item Reynolds CF. (2021). \textit{Psilocybin-Assisted Supportive Psychotherapy in the Treatment of Major Depression-Quo Vadis?}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1001/jamapsychiatry.2020.2901}{doi:10.1001/jamapsychiatry.2020.2901}.
\item Davis AK, Griffiths RR. (2021). \textit{Errors in a Response Rate and in Effect Sizes in Study of Psilocybin-Assisted Therapy for Major Depressive Disorder.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1001/jamapsychiatry.2020.4638}{doi:10.1001/jamapsychiatry.2020.4638}.
\item Romeo B, Hermand M, Pétillion A, Karila L, Benyamina A (2021). \textit{Clinical and biological predictors of psychedelic response in the treatment of psychiatric and addictive disorders: A systematic review.}. Journal of psychiatric research. [published; PubMed]. \href{https://doi.org/10.1016/j.jpsychires.2021.03.002}{doi:10.1016/j.jpsychires.2021.03.002}.
\item Rocha JM, Rossi GN, de Lima Osório F, Bouso JC, de Oliveira Silveira G, Yonamine M, Campos AC, Bertozi G, Cecílio Hallak JE, Dos Santos RG. (2021). \textit{Effects of Ayahuasca on the Recognition of Facial Expressions of Emotions in Naive Healthy Volunteers: A Pilot, Proof-of-Concept, Randomized Controlled Trial.}. Journal of Clinical Psychopharmacology. [published; Europe PMC]. \href{https://doi.org/10.1097/jcp.0000000000001396}{doi:10.1097/jcp.0000000000001396}.
\item Bird CIV, Modlin NL, Rucker JJH. (2021). \textit{Psilocybin and MDMA for the treatment of trauma-related psychopathology.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/09540261.2021.1919062}{doi:10.1080/09540261.2021.1919062}.
\item Senese Nicolas, Nguyen Thu, Cologna Stephanie, Rasenick Mark (2021). \textit{Effects of the putative antidepressant psilocin on the lipid-raft proteome and lipid-raft signaling}. The FASEB Journal. [published; Crossref]. \href{https://doi.org/10.1096/fasebj.2021.35.s1.03168}{doi:10.1096/fasebj.2021.35.s1.03168}.
\item van Elk M, Fejer G, Lempe P, Prochazckova L, Kuchar M, Hajkova K, Marschall J. (2021). \textit{Effects of psilocybin microdosing on awe and aesthetic experiences: a preregistered field and lab-based study.}. Psychopharmacology. [published; Europe PMC]. \href{https://doi.org/10.1007/s00213-021-05857-0}{doi:10.1007/s00213-021-05857-0}.
\item University of Zurich (2021). \textit{Characterization of Altered Waking States of Consciousness in Healthy Humans}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT03853577}{source link}.
\item Katrin H. Preller (2021). \textit{Altered Prediction-Error Processing May Underlie Psilocybin-Induced Changes in Self-Processing}. Biological Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.biopsych.2021.02.036}{doi:10.1016/j.biopsych.2021.02.036}.
\item Julia Benville, Gabrielle Agin-Liebes, Daniel E. Roberts, Sharon L. Lo, Leila Ghazal, Silvia J. Franco-Corso, Stephen Ross (2021). \textit{Effects of Psilocybin on Suicidal Ideation in Patients With Life-Threatening Cancer}. Biological Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.biopsych.2021.02.591}{doi:10.1016/j.biopsych.2021.02.591}.
\item Hisham Alshaikhli, Redhwan Ahmed Al-Naggar, Gwen Erlam (2021). \textit{Effectiveness of Psilocybin on Depression: A Qualitative Study}. Electronic Journal of General Medicine. [published; OpenAlex]. \href{https://doi.org/10.29333/ejgm/10862}{doi:10.29333/ejgm/10862}.
\item University Hospital, Basel, Switzerland (2021). \textit{Direct Comparison of Altered States of Consciousness Induced by LSD and Psilocybin in a Random-order Placebo-controlled Cross-over Study in Healthy Subjects}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT03604744}{source link}.
\item Cumming P, Scheidegger M, Dornbierer D, Palner M, Quednow BB, Martin-Soelch C. (2021). \textit{Molecular and Functional Imaging Studies of Psychedelic Drug Action in Animals and Humans.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/molecules26092451}{doi:10.3390/molecules26092451}.
\item Rucker JJ, Young AH. (2021). \textit{Psilocybin: From Serendipity to Credibility?}. Frontiers in Psychiatry. [published; Europe PMC]. \href{https://doi.org/10.3389/fpsyt.2021.659044}{doi:10.3389/fpsyt.2021.659044}.
\item Berkovitch L, Roméo B, Karila L, Gaillard R, Benyamina A. (2021). \textit{[Efficacy of psychedelics in psychiatry, a systematic review of the literature].}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.encep.2020.12.002}{doi:10.1016/j.encep.2020.12.002}.
\item Giovanni Pereira Pio, Aline Moreira Vitorino, Naira Braga Aidar, Alissa Amoras Magalhães, Eduardo Cammerer Mombelli, Gabriela Marques Ferraz, Rodrigo Pereira Pio (2021). \textit{O papel da Psilocibina no tratamento de depressão resistente / The role of Psilocybin in the treatment of resistant depression}. Brazilian Journal of Health Review. [published; OpenAlex]. \href{https://doi.org/10.34119/bjhrv4n2-395}{doi:10.34119/bjhrv4n2-395}.
\item Anna Lutkajtis (2021). \textit{Four individuals' experiences during and following a psilocybin truffle retreat in the Netherlands}. Journal of Psychedelic Studies. [published; OpenAlex]. \href{https://doi.org/10.1556/2054.2021.00162}{doi:10.1556/2054.2021.00162}.
\item Henrik Børsting Jacobsen, Audun Stubhaug, Bjørn Holmøy, Tor Morten Kvam, Silje Endresen Rème (2021). \textit{Have Norwegians tried psilocybin, and do they accept it as a medicine?}. Journal of Psychedelic Studies. [published; OpenAlex]. \href{https://doi.org/10.1556/2054.2021.00167}{doi:10.1556/2054.2021.00167}.
\item Zhang X, Yu H, Wang Z, Yang Q, Xia R, Qu Y, Tao R, Shi Y, Xiang P, Zhang S, Li C. (2021). \textit{Multi-locus identification of Psilocybe cubensis by high-resolution melting (HRM).}. Forensic Sciences Research. [published; Europe PMC]. \href{https://doi.org/10.1080/20961790.2021.1875580}{doi:10.1080/20961790.2021.1875580}.
\item Mason NL, Kuypers KPC, Reckweg JT, Müller F, Tse DHY, Da Rios B, Toennes SW, Stiers P, Feilding A, Ramaekers JG. (2021). \textit{Spontaneous and deliberate creative cognition during and after psilocybin exposure.}. Translational Psychiatry. [published; Europe PMC]. \href{https://doi.org/10.1038/s41398-021-01335-5}{doi:10.1038/s41398-021-01335-5}.
\item Gard DE, Pleet MM, Bradley ER, Penn A, Gallenstein ML, Riley LS, DellaCrosse M, Garfinkle E, Michalak EE, Woolley JD. (2021). \textit{Evaluating the Risk of Psilocybin for the Treatment of Bipolar Depression: A Review of the Research Literature and Published Case Studies}. medRxiv. [preprint; medRxiv]. \href{https://doi.org/10.1101/2021.04.02.21254838}{doi:10.1101/2021.04.02.21254838}.
\item Sasha Faichuk (2021). \textit{‘Is There Magic in These Mushrooms?’ Discussing Current Psychiatric Treatment Options, and the Potential of Psilocybin Mushrooms in the Future of Such Treatments}. Unknown journal. [published; OpenAlex]. \href{https://jps.library.utoronto.ca/index.php/forensic/article/download/36300/27603}{source link}.
\item Dworatzyk K, Jansen T, Schmidt TT. (2021). \textit{Phenomenological assessment of psychedelic induced experiences: Translation and validation of the German Challenging Experience Questionnaire (CEQ) and Ego-Dissolution Inventory (EDI)}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/kxmgq}{doi:10.31234/osf.io/kxmgq}.
\item Unknown authors (2021). \textit{Phenomenological assessment of psychedelic induced experiences: Translation and validation of the German Challenging Experience Questionnaire (CEQ) and Ego-Dissolution Inventory (EDI)}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/kxmgq\_v1}{source link}.
\item Nelson Descalço, Ana Beatriz Medeiros, Cátia Fernandes Santos, Guilherme Borges (2021). \textit{Psilocybin in the treatment of obsessive-compulsive disorder: What do we know so far?}. European Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1192/j.eurpsy.2021.1114}{doi:10.1192/j.eurpsy.2021.1114}.
\item A. Fraga, Daniel Esteves-Sousa, João Facucho-Oliveira, Margarida Albuquerque, M. Costa, Paulo Santos, Nuno Moura, A. Moutinho (2021). \textit{Effects of psilocybin-assisted therapy on treatment-resistant depression}. European Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1192/j.eurpsy.2021.1836}{doi:10.1192/j.eurpsy.2021.1836}.
\item Simonsson O, Sexton JD, Hendricks PS (2021). \textit{Associations between lifetime classic psychedelic use and markers of physical health.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/0269881121996863}{doi:10.1177/0269881121996863}.
\item Carhart-Harris R, Giribaldi B, Watts R, Baker-Jones M, Murphy-Beiner A, Murphy R, Martell J, Blemings A, Erritzoe D, Nutt DJ. (2021). \textit{Trial of Psilocybin versus Escitalopram for Depression.}. New England Journal of Medicine. [published; Europe PMC]. \href{https://doi.org/10.1056/nejmoa2032994}{doi:10.1056/nejmoa2032994}.
\item Hesselgrave N, Troppoli TA, Wulff AB, Cole AB, Thompson SM. (2021). \textit{Harnessing psilocybin: antidepressant-like behavioral and synaptic actions of psilocybin are independent of 5-HT2R activation in mice.}. Proceedings of the National Academy of Sciences. [published; Europe PMC]. \href{https://doi.org/10.1073/pnas.2022489118}{doi:10.1073/pnas.2022489118}.
\item Earleywine M, Ueno LF, Mian MN, Altman BR. (2021). \textit{Cannabis-induced oceanic boundlessness.}. Journal of Psychopharmacology. [published; Europe PMC]. \href{https://doi.org/10.1177/0269881121997099}{doi:10.1177/0269881121997099}.
\item Teixeira PJ, Johnson M, Timmermann C, Watts R, Erritzoe D, Douglass H, Kettner H, Carhart-Harris R. (2021). \textit{Psychedelics and Health Behavior Change - Journal of Psychopharmacology (in press)}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/8vks6}{doi:10.31234/osf.io/8vks6}.
\item Unknown authors (2021). \textit{Psychedelics and Health Behavior Change - Journal of Psychopharmacology (in press)}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/8vks6\_v1}{source link}.
\item Perkins D, Sarris J, Rossell S, Bonomo Y, Forbes D, Davey C, Hoyer D, Loo C, Murray G, Hood S, Schubert V, Galvão-Coelho NL, O'Donnell M, Carter O, Liknaitzky P, Williams M, Siskind D, Penington D, Berk M, Castle D. (2021). \textit{Medicinal psychedelics for mental health and addiction: Advancing research of an emerging paradigm.}. Australian \& New Zealand Journal of Psychiatry. [published; Europe PMC]. \href{https://doi.org/10.1177/0004867421998785}{doi:10.1177/0004867421998785}.
\item Dos Santos RG, Hallak JE, Baker G, Dursun S. (2021). \textit{Hallucinogenic/psychedelic 5HT2A receptor agonists as rapid antidepressant therapeutics: Evidence and mechanisms of action.}. Journal of Psychopharmacology. [published; Europe PMC]. \href{https://doi.org/10.1177/0269881120986422}{doi:10.1177/0269881120986422}.
\item Cho SE, Jo JW, Kwag YN, Lee H, Chung JW, Oh SH, Kim CS. (2021). \textit{Complete mitochondrial genome sequence of Gymnopilus junonius.}. Mitochondrial DNA Part B. [published; Europe PMC]. \href{https://doi.org/10.1080/23802359.2021.1895692}{doi:10.1080/23802359.2021.1895692}.
\item Ross S, Agin-Liebes G, Lo S, Zeifman RJ, Ghazal L, Benville J, Franco Corso S, Bjerre Real C, Guss J, Bossis A, Mennenga SE. (2021). \textit{Acute and Sustained Reductions in Loss of Meaning and Suicidal Ideation Following Psilocybin-Assisted Psychotherapy for Psychiatric and Existential Distress in Life-Threatening Cancer.}. ACS Pharmacology \& Translational Science. [published; Europe PMC]. \href{https://doi.org/10.1021/acsptsci.1c00020}{doi:10.1021/acsptsci.1c00020}.
\item Khan A, Singh G, Jacob J. (2021). \textit{A Rare Presentation of Anticholinergic Toxicity in a Young Patient Due to Over-The-Counter Cold Medicines.}. Cureus. [published; Europe PMC]. \href{https://doi.org/10.7759/cureus.13919}{doi:10.7759/cureus.13919}.
\item Musikaphongsakul P, Ya K, Subsoontorn P, Lohitnavy M. (2021). \textit{Development of a physiologically based pharmacokinetic (PBPK) model of psilocybin and psilocin from magic mushroom in rats and humans}. F1000Res. [preprint; Europe PMC]. \href{https://doi.org/10.12688/f1000research.28133.1}{doi:10.12688/f1000research.28133.1}.
\item Zeifman RJ, Singhal N, Breslow L, Weissman CR. (2021). \textit{On the Relationship between Classic Psychedelics and Suicidality: A Systematic Review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/acsptsci.1c00024}{doi:10.1021/acsptsci.1c00024}.
\item Muthukumaraswamy S, Forsyth A, Lumley T. (2021). \textit{Blinding and Expectancy Confounds in Psychedelic Randomised Controlled Trials}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/q2hzm}{doi:10.31234/osf.io/q2hzm}.
\item Unknown authors (2021). \textit{Blinding and Expectancy Confounds in Psychedelic Randomised Controlled Trials}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/q2hzm\_v1}{source link}.
\item Kozłowska U, Klimczak A, Wiatr K, Figiel M. (2021). \textit{The DMT and Psilocin Treatment Changes CD11b+ Activated Microglia Immunological Phenotype}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2021.03.07.434103}{doi:10.1101/2021.03.07.434103}.
\item Dos Santos RG, Bouso JC, Rocha JM, Rossi GN, Hallak JE. (2021). \textit{The Use of Classic Hallucinogens/Psychedelics in a Therapeutic Context: Healthcare Policy Opportunities and Challenges.}. DOAJ (DOAJ: Directory of Open Access Journals). [published; Europe PMC]. \href{https://doi.org/10.2147/rmhp.s300656}{source link}.
\item Fricke J, Sherwood AM, Halberstadt AL, Kargbo RB, Hoffmeister D. (2021). \textit{Chemoenzymatic Synthesis of 5-Methylpsilocybin: A Tryptamine with Potential Psychedelic Activity.}. Journal of Natural Products. [published; Europe PMC]. \href{https://doi.org/10.1021/acs.jnatprod.1c00087}{doi:10.1021/acs.jnatprod.1c00087}.
\item Hirschfeld T, Schmidt TT. (2021). \textit{Dose-response relationships of psilocybin-induced subjective experiences in humans.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/0269881121992676}{doi:10.1177/0269881121992676}.
\item Higgins GA, Carroll NK, Brown M, MacMillan C, Silenieks LB, Thevarkunnel S, Izhakova J, Magomedova L, DeLannoy I, Sellers EM. (2021). \textit{Low Doses of Psilocybin and Ketamine Enhance Motivation and Attention in Poor Performing Rats: Evidence for an Antidepressant Property.}. Frontiers in Pharmacology. [published; Europe PMC]. \href{https://doi.org/10.3389/fphar.2021.640241}{doi:10.3389/fphar.2021.640241}.
\item Natasha L. Mason, Kim P. C. Kuypers, Johannes T. Reckweg, Felix Müller, Johannes G. Ramaekers (2021). \textit{P.214 (Sub)acute effects of psilocybin on creative cognition: a double-blind, placebo-controlled experimental study}. European Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/j.euroneuro.2021.01.043}{doi:10.1016/j.euroneuro.2021.01.043}.
\item Nayak S, Gukasyan N, Barrett FS, Erowid E, Erowid F, Griffiths RR. (2021). \textit{Classic psychedelic coadministration with lithium, but not lamotrigine, is associated with seizures: an analysis of online psychedelic experience reports}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/r726d}{doi:10.31234/osf.io/r726d}.
\item Patocka J, Wu R, Nepovimova E, Valis M, Wu W, Kuca K. (2021). \textit{Chemistry and Toxicology of Major Bioactive Substances in Inocybe Mushrooms.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/ijms22042218}{doi:10.3390/ijms22042218}.
\item Winkelman MJ. (2021). \textit{The Evolved Psychology of Psychedelic Set and Setting: Inferences Regarding the Roles of Shamanism and Entheogenic Ecopsychology.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fphar.2021.619890}{doi:10.3389/fphar.2021.619890}.
\item Fedorova EV, Wong CF, Ataiants J, Iverson E, Conn BM, Lankenau SE. (2021). \textit{Cannabidiol (CBD) and other drug use among young adults who use cannabis in Los Angeles.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.drugalcdep.2021.108648}{doi:10.1016/j.drugalcdep.2021.108648}.
\item Garcia-Romeu A, Barrett FS, Carbonaro TM, Johnson MW, Griffiths RR. (2021). \textit{Optimal dosing for psilocybin pharmacotherapy: Considering weight-adjusted and fixed dosing approaches.}. Journal of Psychopharmacology. [published; Europe PMC]. \href{https://doi.org/10.1177/0269881121991822}{doi:10.1177/0269881121991822}.
\item Shao L, Liao C, Gregg I, Davoudian PA, Savalia NK, Delagarza K, Kwan AC. (2021). \textit{Psilocybin induces rapid and persistent growth of dendritic spines in frontal cortex in vivo}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2021.02.17.431629}{doi:10.1101/2021.02.17.431629}.
\item Thomas CW, Blanco-Duque C, Bréant B, Goodwin GM, Sharp T, Bannerman DM, Vyazovskiy VV. (2021). \textit{Psilocin acutely disrupts sleep and affects local but not global sleep homeostasis in laboratory mice}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2021.02.16.431276}{doi:10.1101/2021.02.16.431276}.
\item Madsen MK, Stenbæk DS, Arvidsson A, Armand S, Marstrand-Joergensen MR, Johansen SS, Linnet K, Ozenne B, Knudsen GM, Fisher PM. (2021). \textit{Psilocybin-induced changes in brain network integrity and segregation correlate with plasma psilocin level and psychedelic experience}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2021.02.03.429325}{doi:10.1101/2021.02.03.429325}.
\item R. Andrew Yockey, Keith A. King (2021). \textit{Use of psilocybin (“mushrooms”) among US adults: 2015-2018}. Journal of Psychedelic Studies. [published; OpenAlex]. \href{https://doi.org/10.1556/2054.2020.00159}{doi:10.1556/2054.2020.00159}.
\item Tai SJ, Nielson EM, Lennard-Jones M, Johanna Ajantaival RL, Winzer R, Richards WA, Reinholdt F, Richards BD, Gasser P, Malievskaia E. (2021). \textit{Development and Evaluation of a Therapist Training Program for Psilocybin Therapy for Treatment-Resistant Depression in Clinical Research.}. Frontiers in Psychiatry. [published; Europe PMC]. \href{https://doi.org/10.3389/fpsyt.2021.586682}{doi:10.3389/fpsyt.2021.586682}.
\item Lawrence DW, Sharma B, Griffiths RR, Carhart-Harris R. (2021). \textit{Trends in the Top-Cited Articles on Classic Psychedelics.}. Journal of Psychoactive Drugs. [published; Europe PMC]. \href{https://doi.org/10.1080/02791072.2021.1874573}{doi:10.1080/02791072.2021.1874573}.
\item Zoe Cormier (2021). \textit{Psilocybin Treatment for Mental Health Gets Legal Framework}. Scientific American. [published; OpenAlex]. \href{https://doi.org/10.1038/scientificamerican022021-2ffafdugrrwbrn7c72rys4}{doi:10.1038/scientificamerican022021-2ffafdugrrwbrn7c72rys4}.
\item Elcock C. (2021). \textit{Psychedelic philanthropy: The nonprofit sector and Timothy Leary's 1960s psychedelic movement.}. Journal of the History of the Behavioral Sciences. [published; Europe PMC]. \href{https://doi.org/10.1002/jhbs.22083}{doi:10.1002/jhbs.22083}.
\item McCulloch DE, Madsen MK, Stenbæk DS, Kristiansen S, Ozenne B, Jensen PS, Knudsen GM, Fisher PM. (2021). \textit{Lasting effects of a single psilocybin dose on resting-state functional connectivity in healthy individuals}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2021.01.28.428377}{doi:10.1101/2021.01.28.428377}.
\item Liokaftos D. (2021). \textit{Sociological investigations of human enhancement drugs: The case of microdosing psychedelics.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.drugpo.2020.103099}{doi:10.1016/j.drugpo.2020.103099}.
\item Bates MLS, Trujillo KA. (2021). \textit{Use and abuse of dissociative and psychedelic drugs in adolescence.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.pbb.2021.173129}{doi:10.1016/j.pbb.2021.173129}.
\item Higgins GA, Sellers EM. (2021). \textit{5-HT2A and 5-HT2C receptors as potential targets for the treatment of nicotine use and dependence.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/bs.pbr.2021.01.007}{doi:10.1016/bs.pbr.2021.01.007}.
\item Joost J. Breeksema, Martijn H B Koolen, Metten Somers, Robert A. Schoevers (2021). \textit{Behandeling met psilocybine}. Data Archiving and Networked Services (DANS). [published; OpenAlex]. \href{https://research.rug.nl/en/publications/5e83b45d-b208-402a-a435-f0380fad6429}{source link}.
\item Breeksema JJ, Koolen MHB, Somers M, Schoevers RA. (2021). \textit{[Treatment with psilocybin: applications for patients with psychiatric disorders].}. PubMed. [published; Europe PMC]. \href{https://europepmc.org/article/MED/33560605}{source link}.
\item Barnett BS, Greer GR. (2021). \textit{Psychedelic Psychiatry and the Consult-Liaison Psychiatrist: A Primer.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jaclp.2020.12.011}{doi:10.1016/j.jaclp.2020.12.011}.
\item Mertens LJ, Preller KH. (2021). \textit{Classical Psychedelics as Therapeutics in Psychiatry - Current Clinical Evidence and Potential Therapeutic Mechanisms in Substance Use and Mood Disorders.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1055/a-1341-1907}{doi:10.1055/a-1341-1907}.
\item Raval NR, Johansen A, Donovan LL, Ros NF, Ozenne B, Hansen HD, Knudsen GM. (2021). \textit{A Single Dose of Psilocybin Increases Synaptic Density and Decreases 5-HT2A Receptor Density in the Pig Brain.}. International Journal of Molecular Sciences. [published; Europe PMC]. \href{https://doi.org/10.3390/ijms22020835}{doi:10.3390/ijms22020835}.
\item Anthony P. Bossis (2021). \textit{Psilocybin, Spirituality, and Palliative Care: Research and Implications}. Alternative and Complementary Therapies. [published; OpenAlex]. \href{https://doi.org/10.1089/act.2020.29309.apb}{doi:10.1089/act.2020.29309.apb}.
\item Galvão-Coelho NL, Marx W, Gonzalez M, Sinclair J, de Manincor M, Perkins D, Sarris J. (2021). \textit{Classic serotonergic psychedelics for mood and depressive symptoms: a meta-analysis of mood disorder patients and healthy participants.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s00213-020-05719-1}{doi:10.1007/s00213-020-05719-1}.
\item Healy CJ. (2021). \textit{The acute effects of classic psychedelics on memory in humans.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s00213-020-05756-w}{doi:10.1007/s00213-020-05756-w}.
\item Davis AK, Barrett FS, So S, Gukasyan N, Swift TC, Griffiths RR. (2021). \textit{Development of the Psychological Insight Questionnaire among a sample of people who have consumed psilocybin or LSD.}. Journal of Psychopharmacology. [published; Europe PMC]. \href{https://doi.org/10.1177/0269881120967878}{doi:10.1177/0269881120967878}.
\item Pham DNK, Chadeayne AR, Golen JA, Manke DR. (2021). \textit{Psilacetin derivatives: fumarate salts of the meth-yl-ethyl, meth-yl-allyl and diallyl variants of the psilocin prodrug.}. Acta Crystallographica Section E Crystallographic Communications. [published; Europe PMC]. \href{https://doi.org/10.1107/s2056989021000116}{doi:10.1107/s2056989021000116}.
\item Unknown authors (2021). \textit{Study: Psilocybin enhances therapy in patients with major depression}. The Brown University Psychopharmacology Update. [published; OpenAlex]. \href{https://doi.org/10.1002/pu.30675}{doi:10.1002/pu.30675}.
\item Joshua Woolley (2021). \textit{Psilocybin-assisted Group Therapy for Demoralization in Long-term AIDS Survivors}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT02950467}{source link}.
\item Konkel Z, Scott K, Slot JC. (2021). \textit{Draft Genome Sequence of the Termite-Associated "Cuckoo Fungus," Athelia (Fibularhizoctonia) sp. TMB Strain TB5.}. Microbiology Resource Announcements. [published; Europe PMC]. \href{https://doi.org/10.1128/mra.01230-20}{doi:10.1128/mra.01230-20}.
\item Michael W. Dzierlenga (2020). \textit{Referee report. For: Development of a physiologically based pharmacokinetic (PBPK) model of psilocybin and psilocin from magic mushroom in rats and humans [version 1; peer review: 1 not approved]}. Faculty of 1000 Research Ltd. [published; OpenAlex]. \href{https://doi.org/10.5256/f1000research.31120.r81816}{doi:10.5256/f1000research.31120.r81816}.
\item Quoc Ba Tran (2020). \textit{Referee report. For: Development of a physiologically based pharmacokinetic (PBPK) model of psilocybin and psilocin from magic mushroom in rats and humans [version 1; peer review: 1 approved with reservations, 1 not approved]}. Faculty of 1000 Research Ltd. [published; OpenAlex]. \href{https://doi.org/10.5256/f1000research.31120.r81474}{doi:10.5256/f1000research.31120.r81474}.
\item Bryn T. M. Dentinger, Alexander J. Bradshaw (2020). \textit{Referee report. For: A whole genome atlas of 81 Psilocybe genomes as a resource for psilocybin production. [version 1; peer review: 1 not approved]}. Faculty of 1000 Research Ltd. [published; OpenAlex]. \href{https://doi.org/10.5256/f1000research.58864.r95528}{doi:10.5256/f1000research.58864.r95528}.
\item Victor Lange, Marie, Sidsel (2020). \textit{Exploring moral bio-enhancement through psilocybin facilitated prosocial effects}. Research at the University of Copenhagen (University of Copenhagen). [published; OpenAlex]. \href{https://researchprofiles.ku.dk/da/publications/f4c6737a-15ce-4a92-a7c5-ce5345cc1cff}{source link}.
\item Unknown authors (2020). \textit{Psilocybin therapy appears as effective as escitalopram, small study finds}. Pharmaceutical journal/The pharmaceutical journal. [published; OpenAlex]. \href{https://doi.org/10.1211/pj.2021.1.91592}{doi:10.1211/pj.2021.1.91592}.
\item Ravital LaBua (2020). \textit{The Effect of Psilocybin on Personality}. CUNY Academic Works (City University of New York). [published; OpenAlex]. \href{https://academicworks.cuny.edu/gc\_etds/4460}{source link}.
\item Danielle Nicole Daniel (2020). \textit{"It kind of polishes all your flaws away": long-term experiences with psilocybin mushrooms and the influence of set and setting}. Unknown journal. [published; OpenAlex]. \href{https://digitalcommons.humboldt.edu/cgi/viewcontent.cgi?article=1541\&context=etd}{source link}.
\item Yogesh Kumar Chahar (2020). \textit{Unmet need in depression: Psilocybin, a breakthrough treatment option}. International Journal of Advanced Research in Medicine. [published; OpenAlex]. \href{https://doi.org/10.22271/27069567.2021.v3.i1f.159}{doi:10.22271/27069567.2021.v3.i1f.159}.
\item Robert A. Mikos (2020). \textit{We Need a Cole Memorandum for Magic Mushrooms}. SSRN Electronic Journal. [published; OpenAlex]. \href{https://papers.ssrn.com/sol3/papers.cfm?abstract\_id=3839551}{source link}.
\item Michael Paulzen (2020). \textit{Psilocybin im Dorsch Lexikon der Psychologie}. Unknown journal. [published; OpenAlex]. \href{https://dorsch.hogrefe.com/stichwort/psilocybin}{source link}.
\item Jacob Evans (2020). \textit{Waiting for a Miracle: Medical Psilocybin and Mdma under 'Right to Try'}. SSRN Electronic Journal. [published; OpenAlex]. \href{https://doi.org/10.2139/ssrn.3762134}{doi:10.2139/ssrn.3762134}.
\item Harmony I. Risca (2020). \textit{Preclinical Behavioral Assessment of Chronic, Intermittent Low-Dose Psilocybin in Rodent Models of Depression and Anxiety}. Unknown journal. [published; OpenAlex]. \href{https://scholarworks.wmich.edu/cgi/viewcontent.cgi?article=4777\&context=dissertations}{source link}.
\item Reiff CM, Richman EE, Nemeroff CB, Carpenter LL, Widge AS, Rodriguez CI, Kalin NH, McDonald WM, Work Group on Biomarkers and Novel Treatments, a Division of the American Psychiatric Association Council of Research (2020). \textit{Psychedelics and Psychedelic-Assisted Psychotherapy.}. Focus (American Psychiatric Publishing). [published; PubMed]. \href{https://doi.org/10.1176/appi.focus.19104}{doi:10.1176/appi.focus.19104}.
\item Gashi L, Sandberg S, Pedersen W (2020). \textit{Making "bad trips" good: How users of psychedelics narratively transform challenging trips into valuable experiences.}. The International journal on drug policy. [published; PubMed]. \href{https://doi.org/10.1016/j.drugpo.2020.102997}{doi:10.1016/j.drugpo.2020.102997}.
\item Inserra A, De Gregorio D, Gobbi G. (2020). \textit{Psychedelics in Psychiatry: Neuroplastic, Immunomodulatory, and Neurotransmitter Mechanisms.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1124/pharmrev.120.000056}{doi:10.1124/pharmrev.120.000056}.
\item Tullis P. (2020). \textit{How ecstasy and psilocybin are shaking up psychiatry.}. Nature. [published; Europe PMC]. \href{https://doi.org/10.1038/d41586-021-00187-9}{doi:10.1038/d41586-021-00187-9}.
\item Bouso JC, Ona G, Dos Santos RG, Hallak JEC. (2020). \textit{Psychedelic Medicines in Major Depression: Progress and Future Challenges.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/978-981-33-6044-0\_26}{doi:10.1007/978-981-33-6044-0\_26}.
\item Sheppard B. (2020). \textit{A Trip Through Employment Law: Protecting Therapeutic Psilocybin Users in the Workplace.}. PubMed. [published; Europe PMC]. \href{https://europepmc.org/article/MED/35026878}{source link}.
\item Castro Santos H, Gama Marques J. (2020). \textit{What is the clinical evidence on psilocybin for the treatment of psychiatric disorders? A systematic review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1097/j.pbj.0000000000000128}{doi:10.1097/j.pbj.0000000000000128}.
\item Gorman I, Nielson EM, Molinar A, Cassidy K, Sabbagh J (2020). \textit{Psychedelic Harm Reduction and Integration: A Transtheoretical Model for Clinical Practice.}. Frontiers in psychology. [published; PubMed]. \href{https://doi.org/10.3389/fpsyg.2021.645246}{doi:10.3389/fpsyg.2021.645246}.
\item Gerber K, Flores IG, Ruiz AC, Ali I, Ginsberg NL, Schenberg EE. (2020). \textit{Ethical Concerns about Psilocybin Intellectual Property.}. ACS Pharmacology \& Translational Science. [published; Europe PMC]. \href{https://doi.org/10.1021/acsptsci.0c00171}{doi:10.1021/acsptsci.0c00171}.
\item Giancola NB, Korson CJ, Caplan JP, McKnight CA. (2020). \textit{A "Trip" to the Intensive Care Unit: An Intravenous Injection of Psilocybin.}. Journal of the Academy of Consultation-Liaison Psychiatry. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jaclp.2020.12.012}{doi:10.1016/j.jaclp.2020.12.012}.
\item Kočárová R, Horáček J, Carhart-Harris R (2020). \textit{Does Psychedelic Therapy Have a Transdiagnostic Action and Prophylactic Potential?}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2021.661233}{doi:10.3389/fpsyt.2021.661233}.
\item Eleftheriou ME, Thomas E (2020). \textit{Examining the Potential Synergistic Effects Between Mindfulness Training and Psychedelic-Assisted Therapy.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2021.707057}{doi:10.3389/fpsyt.2021.707057}.
\item Vargas MV, Meyer R, Avanes AA, Rus M, Olson DE (2020). \textit{Psychedelics and Other Psychoplastogens for Treating Mental Illness.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2021.727117}{doi:10.3389/fpsyt.2021.727117}.
\item Williams ML, Korevaar D, Harvey R, Fitzgerald PB, Liknaitzky P, O'Carroll S, Puspanathan P, Ross M, Strauss N, Bennett-Levy J (2020). \textit{Translating Psychedelic Therapies From Clinical Trials to Community Clinics: Building Bridges and Addressing Potential Challenges Ahead.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2021.737738}{doi:10.3389/fpsyt.2021.737738}.
\item Kelly JR, Gillan CM, Prenderville J, Kelly C, Harkin A, Clarke G, O'Keane V (2020). \textit{Psychedelic Therapy's Transdiagnostic Effects: A Research Domain Criteria (RDoC) Perspective.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2021.800072}{doi:10.3389/fpsyt.2021.800072}.
\item Frontiers Production Office (2020). \textit{Erratum: A Spectrum of Selves Reinforced in Multilevel Coherence: A Contextual Behavioural Response to the Challenges of Psychedelic-Assisted Therapy Development.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2021.832766}{doi:10.3389/fpsyt.2021.832766}.
\item Matzopoulos R, Morlock R, Morlock A, Lerer B, Lerer L (2020). \textit{Psychedelic Mushrooms in the USA: Knowledge, Patterns of Use, and Association With Health Outcomes.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2021.780696}{doi:10.3389/fpsyt.2021.780696}.
\item Strickland JC, Garcia-Romeu A, Johnson M. (2020). \textit{Set and Setting: A Randomized Study of Different Musical Genres in Supporting Psychedelic Therapy}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/f5dmt}{doi:10.31234/osf.io/f5dmt}.
\item Anna U. Odland, Jesper L. Kristensen, Jesper T. Andreasen (2020). \textit{Investigating the role of 5-HT2A and 5-HT2C receptor activation in the effects of psilocybin, DOI, and citalopram on marble burying in mice}. Behavioural Brain Research. [published; OpenAlex]. \href{https://doi.org/10.1016/j.bbr.2020.113093}{doi:10.1016/j.bbr.2020.113093}.
\item Savalia NK, Shao LX, Kwan AC. (2020). \textit{A Dendrite-Focused Framework for Understanding the Actions of Ketamine and Psychedelics.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.tins.2020.11.008}{doi:10.1016/j.tins.2020.11.008}.
\item Sanah Malomile Nkadimeng, Christiaan M.L. Steinmann, J.N. Eloff (2020). \textit{Effects and safety of Psilocybe cubensis and Panaeolus cyanescens magic mushroom extracts on endothelin-1-induced hypertrophy and cell injury in cardiomyocytes}. Scientific Reports. [published; OpenAlex]. \href{https://doi.org/10.1038/s41598-020-79328-5}{doi:10.1038/s41598-020-79328-5}.
\item Adam K. Klein, Muhammad Chatha, Lauren J. Laskowski, Emilie I. Anderson, Simon D. Brandt, Stephen J. Chapman, John D. McCorvy, Adam L. Halberstadt (2020). \textit{Investigation of the Structure-Activity Relationships of Psilocybin Analogues}. ACS Pharmacology \& Translational Science. [published; OpenAlex]. \href{https://doi.org/10.1021/acsptsci.0c00176}{doi:10.1021/acsptsci.0c00176}.
\item Christopher S. Stauffer, B. Anderson, Kile Ortigo, Joshua Woolley (2020). \textit{Psilocybin-Assisted Group Therapy and Attachment: Observed Reduction in Attachment Anxiety and Influences of Attachment Insecurity on the Psilocybin Experience}. ACS Pharmacology \& Translational Science. [published; OpenAlex]. \href{https://doi.org/10.1021/acsptsci.0c00169}{doi:10.1021/acsptsci.0c00169}.
\item Karolina E. Kolaczynska, Matthias E. Liechti, Urs Duthaler (2020). \textit{Development and validation of an LC-MS/MS method for the bioanalysis of psilocybin’s main metabolites, psilocin and 4-hydroxyindole-3-acetic acid, in human plasma}. Journal of Chromatography B. [published; OpenAlex]. \href{https://doi.org/10.1016/j.jchromb.2020.122486}{doi:10.1016/j.jchromb.2020.122486}.
\item Lene Lundgaard Donovan, Jens Vilstrup Johansen, Nídia Fernandez Ros, Elham Jaberi, Kristían Línnet, Sys Stybe Johansen, Brice Ozenne, Shohreh Issazadeh-Navikas, Hanne D. Hansen, Gitte M. Knudsen (2020). \textit{Effects of a single dose of psilocybin on behaviour, brain 5-HT2A receptor occupancy and gene expression in the pig}. European Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/j.euroneuro.2020.11.013}{doi:10.1016/j.euroneuro.2020.11.013}.
\item Daniela Dudysová, Karolína Janků, Michal Šmotek, Elizaveta Saifutdinová, Jana Kopřivová, Jitka Bušková, Bryce A. Mander, Martin Brunovský, Peter Zach, Jakub Korčák, Veronika Andrashko, Michaela Viktorinová, Filip Tylš, Anna Bravermanová, Tom Froese, Tomáš Páleníček, Jiřı́ Horáček (2020). \textit{The Effects of Daytime Psilocybin Administration on Sleep: Implications for Antidepressant Action}. Frontiers in Pharmacology. [published; OpenAlex]. \href{https://doi.org/10.3389/fphar.2020.602590}{doi:10.3389/fphar.2020.602590}.
\item Dudysová Daniela, Janku Karolina, Smotek Michal, Saifutdinova Elizaveta, Koprivova Jana, Bušková Jitka, Mander Bryce Anthony, Brunovský Martin, Zach Peter, Korčák Jakub, Andrashko Veronika, Viktorinová Michaela, Tylš Filip, Bravermanová Anna, Froese Tom, Páleníček Tomáš, Horáček Jiří (2020). \textit{The Effects of Daytime Psilocybin Administration on Sleep: Implications for Antidepressant Action}. Institutional Repositories DataBase (IRDB). [published; OpenAlex]. \href{http://id.nii.ac.jp/1394/00001681/}{source link}.
\item University Hospital, Basel, Switzerland (2020). \textit{Effects of Serotonin Transporter Inhibition on the Subjective Response to Psilocybin in Healthy Subjects}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT03912974}{source link}.
\item Weston NM, Gibbs D, Bird CIV, Daniel A, Jelen LA, Knight G, Goldsmith D, Young AH, Rucker JJ (2020). \textit{Historic psychedelic drug trials and the treatment of anxiety disorders.}. Depression and anxiety. [published; PubMed]. \href{https://doi.org/10.1002/da.23065}{doi:10.1002/da.23065}.
\item Holoyda B (2020). \textit{Psychedelic Psychiatry: Preparing for Novel Treatments Involving Altered States of Consciousness.}. Psychiatric services (Washington, D.C.). [published; PubMed]. \href{https://doi.org/10.1176/appi.ps.202000213}{doi:10.1176/appi.ps.202000213}.
\item Andersen KAA, Carhart-Harris R, Nutt DJ, Erritzoe D. (2020). \textit{Therapeutic effects of classic serotonergic psychedelics: A systematic review of modern-era clinical studies.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1111/acps.13249}{doi:10.1111/acps.13249}.
\item Raval NR, Johansen A, Donovan LL, Ros NF, Ozenne B, Hansen HD, Knudsen GM. (2020). \textit{A Single Dose of Psilocybin Increases Synaptic Density and Decreases 5-HT2A Receptor Density in the Pig Brain}. Preprints.org. [preprint; Europe PMC]. \href{https://doi.org/10.20944/preprints202011.0742.v1}{doi:10.20944/preprints202011.0742.v1}.
\item De Gregorio D, Aguilar-Valles A, Preller KH, Heifets BD, Hibicke M, Mitchell J, Gobbi G. (2020). \textit{Hallucinogens in Mental Health: Preclinical and Clinical Studies on LSD, Psilocybin, MDMA, and Ketamine.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1523/jneurosci.1659-20.2020}{doi:10.1523/jneurosci.1659-20.2020}.
\item Askew R, Williams L. (2020). \textit{Rethinking enhancement substance use: A critical discourse studies approach.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.drugpo.2020.102994}{doi:10.1016/j.drugpo.2020.102994}.
\item Lenz C, Sherwood A, Kargbo R, Hoffmeister D. (2020). \textit{Taking Different Roads: l-Tryptophan as the Origin of Psilocybe Natural Products.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1002/cplu.202000581}{doi:10.1002/cplu.202000581}.
\item Agustín Lugo-Radillo, Jorge Luis Cortés-López (2020). \textit{Long-term Amelioration of OCD Symptoms in a Patient with Chronic Consumption of Psilocybin-containing Mushrooms}. Journal of Psychoactive Drugs. [published; OpenAlex]. \href{https://doi.org/10.1080/02791072.2020.1849879}{doi:10.1080/02791072.2020.1849879}.
\item Al-Matrouk A, Al-Hasan M, Naqi HA, Al-Abkal N, Mohammed H, Haider M, Al-Shammeri D, Bojbarah H. (2020). \textit{Snapshot of narcotic drugs and psychoactive substances in Kuwait: a qualitative analysis of illicit drugs and their associated mortality in Kuwait from 2015 to 2018}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-33143/v2}{doi:10.21203/rs.3.rs-33143/v2}.
\item Emmanuelle A. D. Schindler, R. Andrew Sewell, Christopher Gottschalk, Christina Luddy, L. Taylor Flynn, Hayley Lindsey, Brian Pittman, Nicholas V. Cozzi, Deepak Cyril D’Souza (2020). \textit{Exploratory Controlled Study of the Migraine-Suppressing Effects of Psilocybin}. Neurotherapeutics. [published; OpenAlex]. \href{https://doi.org/10.1007/s13311-020-00962-y}{doi:10.1007/s13311-020-00962-y}.
\item Bottemanne H, Claret A, Fossati P. (2020). \textit{[Ketamine, psilocybin, and rapid acting antidepressant: new promise for psychiatry?]}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.encep.2020.08.006}{doi:10.1016/j.encep.2020.08.006}.
\item University of Zurich (2020). \textit{Beyond the Self and Back: Neuropharmacological Mechanisms Underlying the Dissolution of the Self}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT03736980}{source link}.
\item Goldberg SB, Shechet B, Nicholas CR, Ng CW, Deole G, Chen Z, Raison CL. (2020). \textit{Post-acute psychological effects of classical serotonergic psychedelics: a systematic review and meta-analysis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1017/s003329172000389x}{doi:10.1017/s003329172000389x}.
\item Oskar Hougaard Jefsen, Betina Elfving, Gregers Wegener, Heidi Kaastrup Müller (2020). \textit{Transcriptional regulation in the rat prefrontal cortex and hippocampus after a single administration of psilocybin}. Journal of Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1177/0269881120959614}{doi:10.1177/0269881120959614}.
\item Alan K. Davis, Frederick S. Barrett, Darrick G. May, Mary P Cosimano, Nathan D. Sepeda, Matthew W. Johnson, Patrick H. Finan, Roland R. Griffiths (2020). \textit{Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder}. JAMA Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1001/jamapsychiatry.2020.3285}{doi:10.1001/jamapsychiatry.2020.3285}.
\item EPUB Download The Psilocybin Mushroom Bible: The Definitive Guide to Growing and Using Magic Mushrooms TXT,PDF,EPUB (2020). \textit{EPUB Download The Psilocybin Mushroom Bible: The Definitive Guide to Growing and Using Magic Mushrooms TXT,PDF,EPUB}. Zenodo (CERN European Organization for Nuclear Research). [published; OpenAlex]. \href{https://doi.org/10.5281/zenodo.4208978}{doi:10.5281/zenodo.4208978}.
\item Best [PDF] The Psilocybin Mushroom Bible: The Definitive Guide to Growing and Using Magic Mushrooms Full PDF Online (2020). \textit{Best [PDF] The Psilocybin Mushroom Bible: The Definitive Guide to Growing and Using Magic Mushrooms Full PDF Online}. Zenodo (CERN European Organization for Nuclear Research). [published; OpenAlex]. \href{https://doi.org/10.5281/zenodo.4208128}{doi:10.5281/zenodo.4208128}.
\item Nakul Ravi Raval, Annette Johansen, Lene Lundgaard Donovan, Nelson Ros, Brice Ozenne, Hanne D. Hansen, Gitte M. Knudsen (2020). \textit{P.804A single dose of psilocybin increases synaptic density and decreases 5-HT2A receptor density in the pig brain}. European Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/j.euroneuro.2020.09.589}{doi:10.1016/j.euroneuro.2020.09.589}.
\item M. Madsen, Dea Siggaard Stenbæk, Brice Ozenne, Sophia Armand, M.R. Marstrand-Jørgensen, Albin Arvidsson, Sys Stybe Johansen, Kristían Línnet, Gitte M. Knudsen, Patrick M. Fisher (2020). \textit{P.227 Psilocybin induces resting-state functional connectivity changes, which correlate with plasma psilocin levels and psychedelic experience}. European Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/j.euroneuro.2020.09.169}{doi:10.1016/j.euroneuro.2020.09.169}.
\item Klára Gotvaldová, Kateřina Hájková, Jan Borovička, Radek Jurok, Petra Cihlářová, Martin Kuchař (2020). \textit{Stability of psilocybin and its four analogs in the biomass of the psychotropic mushroom Psilocybe cubensis}. Drug Testing and Analysis. [published; OpenAlex]. \href{https://doi.org/10.1002/dta.2950}{doi:10.1002/dta.2950}.
\item Luoma JB, Chwyl C, Bathje G, Davis AK, Lancelotta RL. (2020). \textit{A Meta-Analysis of Placebo-Controlled Trials of Psychedelic-Assisted Therapy}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/nhbjk}{doi:10.31234/osf.io/nhbjk}.
\item Ona GS, Dos Santos RG, Hallak JEC, Bouso JC (2020). \textit{Polypharmacology or "Pharmacological Promiscuity" In Psychedelic Research: What Are We Missing?}. ACS chemical neuroscience. [published; PubMed]. \href{https://doi.org/10.1021/acschemneuro.0c00614}{doi:10.1021/acschemneuro.0c00614}.
\item NYU Langone Health (2020). \textit{Effects of Psilocybin on Anxiety and Psychosocial Distress in Cancer Patients}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT00957359}{source link}.
\item Shi Y, Wang R, Yuan S, Qiang H, Shen M, Shen B, Drummer OH, Yu Z, Zhao Y, Xiang P. (2020). \textit{UHPLC-MS/MS method for simultaneously detecting 16 tryptamines and their metabolites in human hair and applications to real forensics cases.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jchromb.2020.122392}{doi:10.1016/j.jchromb.2020.122392}.
\item Dea Siggaard Stenbæk, M. Madsen, Brice Ozenne, Sara Kristiansen, Daniel Burmester, David Erritzøe, Gitte M. Knudsen, Patrick M. Fisher (2020). \textit{Brain serotonin 2A receptor binding predicts subjective temporal and mystical effects of psilocybin in healthy humans}. Journal of Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1177/0269881120959609}{doi:10.1177/0269881120959609}.
\item Ona G, Bouso JC. (2020). \textit{Potential safety, benefits, and influence of the placebo effect in microdosing psychedelic drugs: A systematic review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neubiorev.2020.09.035}{doi:10.1016/j.neubiorev.2020.09.035}.
\item Unknown authors (2020). \textit{Psilocybin in the news}. Field Mycology. [published; OpenAlex]. \href{https://doi.org/10.1016/j.fldmyc.2020.10.011}{doi:10.1016/j.fldmyc.2020.10.011}.
\item Romeo B, Karila L, Martelli C, Benyamina A (2020). \textit{Efficacy of psychedelic treatments on depressive symptoms: A meta-analysis.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/0269881120919957}{doi:10.1177/0269881120919957}.
\item Peter S. Hendricks (2020). \textit{Psilocybin-assisted group therapy: A new hope for demoralization}. EClinicalMedicine. [published; OpenAlex]. \href{https://doi.org/10.1016/j.eclinm.2020.100557}{doi:10.1016/j.eclinm.2020.100557}.
\item Gill H, Gill B, Chen-Li D, El-Halabi S, Rodrigues NB, Cha DS, Lipsitz O, Lee Y, Rosenblat JD, Majeed A, Mansur RB, Nasri F, Ho R, McIntyre RS. (2020). \textit{The emerging role of psilocybin and MDMA in the treatment of mental illness.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/14737175.2020.1826931}{doi:10.1080/14737175.2020.1826931}.
\item Nicole Harrington Cirino (2020). \textit{Wait for the Science Before Widespread Use of Psilocybin}. Psychiatric News. [published; OpenAlex]. \href{https://doi.org/10.1176/appi.pn.2020.10a32}{doi:10.1176/appi.pn.2020.10a32}.
\item Agata Tadeja (2020). \textit{Drugs in therapy. LSD, MDMA, marijuana, psilocybin, designer drugs and its potential in modern medicine.}. Farmacja Polska. [published; OpenAlex]. \href{https://doi.org/10.32383/farmpol/127922}{doi:10.32383/farmpol/127922}.
\item B. Anderson, Alicia Danforth, Prof Robert Daroff, Christopher S. Stauffer, Eve Ekman, Gabrielle Agin-Liebes, Alexander Trope, Matthew Tyler Boden, James Dilley, Jennifer Mitchell, Joshua Woolley (2020). \textit{Psilocybin-assisted group therapy for demoralized older long-term AIDS survivor men: An open-label safety and feasibility pilot study}. EClinicalMedicine. [published; OpenAlex]. \href{https://doi.org/10.1016/j.eclinm.2020.100538}{doi:10.1016/j.eclinm.2020.100538}.
\item Varker T, Watson L, Gibson K, Forbes D, O'Donnell ML. (2020). \textit{Efficacy of Psychoactive Drugs for the Treatment of Posttraumatic Stress Disorder: A Systematic Review of MDMA, Ketamine, LSD and Psilocybin.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/02791072.2020.1817639}{doi:10.1080/02791072.2020.1817639}.
\item Mollinedo-Gajate I, Song C, Sintes-Rodriguez M, Whelan T, Soula A, Selimbeyoglu A, Hurley S, Knöpfel T. (2020). \textit{Psilocybin rescues sociability deficits in an animal model of autism}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2020.09.09.289348}{doi:10.1101/2020.09.09.289348}.
\item Vitkauskas M, Mathuru AS. (2020). \textit{Total Recall: Lateral Habenula and Psychedelics in the Study of Depression and Comorbid Brain Disorders.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/ijms21186525}{doi:10.3390/ijms21186525}.
\item Vargas AS, Luís Â, Barroso M, Gallardo E, Pereira L. (2020). \textit{Psilocybin as a New Approach to Treat Depression and Anxiety in the Context of Life-Threatening Diseases-A Systematic Review and Meta-Analysis of Clinical Trials.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/biomedicines8090331}{doi:10.3390/biomedicines8090331}.
\item Teresa Kay Jones, Steven Lippmann (2020). \textit{Psilocybin Can Diminish Depression}. The Primary Care Companion For CNS Disorders. [published; OpenAlex]. \href{https://doi.org/10.4088/pcc.19br02580}{doi:10.4088/pcc.19br02580}.
\item Greif A, Šurkala M. (2020). \textit{Compassionate use of psychedelics.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s11019-020-09958-z}{doi:10.1007/s11019-020-09958-z}.
\item Breeksema JJ, Niemeijer AR, Krediet E, Vermetten E, Schoevers RA. (2020). \textit{Psychedelic Treatments for Psychiatric Disorders: A Systematic Review and Thematic Synthesis of Patient Experiences in Qualitative Studies.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s40263-020-00748-y}{doi:10.1007/s40263-020-00748-y}.
\item Sanah Malomile Nkadimeng, Alice Nabatanzi, Christiaan M.L. Steinmann, J.N. Eloff (2020). \textit{Phytochemical, Cytotoxicity, Antioxidant and Anti-Inflammatory Effects of Psilocybe Natalensis Magic Mushroom}. Plants. [published; OpenAlex]. \href{https://doi.org/10.3390/plants9091127}{doi:10.3390/plants9091127}.
\item Kuypers KPC. (2020). \textit{The therapeutic potential of microdosing psychedelics in depression.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/2045125320950567}{doi:10.1177/2045125320950567}.
\item M. Madsen, Gitte M. Knudsen (2020). \textit{Plasma psilocin critically determines behavioral and neurobiological effects of psilocybin}. Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1038/s41386-020-00823-4}{doi:10.1038/s41386-020-00823-4}.
\item Vann Jones SA, O'Kelly A. (2020). \textit{Psychedelics as a Treatment for Alzheimer's Disease Dementia.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fnsyn.2020.00034}{doi:10.3389/fnsyn.2020.00034}.
\item Lukasz Smigielski, Michael Kometer, Milan Scheidegger, Cornelia Stress, Katrin H. Preller, Thomas Koenig, Franz X. Vollenweider (2020). \textit{P300-mediated modulations in self-other processing under psychedelic psilocybin are related to connectedness and changed meaning: A window into the self-other overlap}. Human Brain Mapping. [published; OpenAlex]. \href{https://doi.org/10.1002/hbm.25174}{doi:10.1002/hbm.25174}.
\item Lin Denise S (2020). \textit{Case Report: Resolution of Rheumatoid Arthritis in a Patient Consuming Psilocybin Mushrooms}. Journal of Healthcare. [published; OpenAlex]. \href{https://doi.org/10.36959/569/456}{doi:10.36959/569/456}.
\item James D. Tucker (2020). \textit{Oregon's Pioneering Effort to Enact State Law to Allow Access to Psilocybin}. SSRN Electronic Journal. [published; OpenAlex]. \href{https://papers.ssrn.com/sol3/Delivery.cfm/SSRN\_ID3783484\_code4550530.pdf?abstractid=3783484\&mirid=1}{source link}.
\item Jones NT, Zahid Z, Grady SM, Sultan ZW, Zheng Z, Banks MI, Wenthur CJ. (2020). \textit{Delayed Anxiolytic-Like Effects of Psilocybin in Male Mice Are Supported by Acute Glucocorticoid Release}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2020.08.12.248229}{doi:10.1101/2020.08.12.248229}.
\item Guss J, Krause R, Sloshower J. (2020). \textit{The Yale Manual for Psilocybin-Assisted Therapy of Depression (using Acceptance and Commitment Therapy as a Therapeutic Frame)}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/u6v9y}{doi:10.31234/osf.io/u6v9y}.
\item Unknown authors (2020). \textit{The Yale Manual for Psilocybin-Assisted Therapy of Depression (using Acceptance and Commitment Therapy as a Therapeutic Frame)}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/u6v9y\_v1}{source link}.
\item Callie Munson, Elyse Sunshine (2020). \textit{Psilocybin as an Effective Treatment for Patients with Life-Threatening Cancer and Psychological Distress: A Critically Appraised Topic}. Unknown journal. [published; OpenAlex]. \href{https://commons.pacificu.edu/work/sc/b2be0580-b85b-405c-af50-8414cb3b2419}{source link}.
\item Mitina O, Mirsaidov M, Molchanova N, Tutrin A. (2020). \textit{Confirmatory factor analysis of Mystical Experience in Freediving as a recreative way to higher efficiency in sport performance and planet saving and money making}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/b7mnz}{doi:10.31234/osf.io/b7mnz}.
\item Unknown authors (2020). \textit{Confirmatory factor analysis of Mystical Experience in Freediving as a recreative way to higher efficiency in sport performance and planet saving and money making}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/b7mnz\_v1}{source link}.
\item Reinert JP, Colunga K, Etuk A, Richardson V, Dunn RL. (2020). \textit{Management of overdoses of salvia, kratom, and psilocybin mushrooms: a literature review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/17512433.2020.1794811}{doi:10.1080/17512433.2020.1794811}.
\item Izumi Morita, Hiroyuki Oyama, Yuki Kiguchi, Akari Oguri, Natsumi Fujimoto, Atsuko Takeuchi, Rie Tanaka, Jun Ogata, Ruri Kikura-Hanajiri, Norihiro Kobayashi (2020). \textit{Immunochemical monitoring of psilocybin and psilocin to identify hallucinogenic mushrooms}. Journal of Pharmaceutical and Biomedical Analysis. [published; OpenAlex]. \href{https://doi.org/10.1016/j.jpba.2020.113485}{doi:10.1016/j.jpba.2020.113485}.
\item Anthony L. Back (2020). \textit{What Psilocybin Taught Me, One Year Later}. Journal of Palliative Medicine. [published; OpenAlex]. \href{https://doi.org/10.1089/jpm.2020.0018}{doi:10.1089/jpm.2020.0018}.
\item O'Callaghan C, Hubik DJ, Dwyer J, Williams M, Ross M. (2020). \textit{Experience of Music Used With Psychedelic Therapy: A Rapid Review and Implications.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1093/jmt/thaa006}{doi:10.1093/jmt/thaa006}.
\item Robert B. Kargbo, Alexander M. Sherwood, Andrew J. Walker, Nicholas V. Cozzi, Raymond E. Dagger, Jessica Sable, Kelsey O’Hern, Kristi W. Kaylo, Tura Patterson, Gary Tarpley, Poncho Meisenheimer (2020). \textit{Direct Phosphorylation of Psilocin Enables Optimized cGMP Kilogram-Scale Manufacture of Psilocybin}. ACS Omega. [published; OpenAlex]. \href{https://doi.org/10.1021/acsomega.0c02387}{doi:10.1021/acsomega.0c02387}.
\item James E, Robertshaw TL, Hoskins M, Sessa B. (2020). \textit{Psilocybin occasioned mystical-type experiences.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1002/hup.2742}{doi:10.1002/hup.2742}.
\item Luoma JB. (2020). \textit{A Meta-Analysis of Placebo-Controlled Trials of Psychedelic-Assisted Therapy}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/sgujx}{doi:10.31234/osf.io/sgujx}.
\item Hirschfeld T, Schmidt TT. (2020). \textit{How does it feel to be on psilocybin? Dose-response relationships of subjective experiences in humans}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2020.06.09.142802}{doi:10.1101/2020.06.09.142802}.
\item Theresa M. Carbonaro, Matthew W. Johnson, Roland R. Griffiths (2020). \textit{Subjective features of the psilocybin experience that may account for its self-administration by humans: a double-blind comparison of psilocybin and dextromethorphan}. Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1007/s00213-020-05533-9}{doi:10.1007/s00213-020-05533-9}.
\item Edward Jacobs (2020). \textit{A potential role for psilocybin in the treatment of obsessive-compulsive disorder}. Journal of Psychedelic Studies. [published; OpenAlex]. \href{https://doi.org/10.1556/2054.2020.00128}{doi:10.1556/2054.2020.00128}.
\item Greenway KT, Garel N, Jerome L, Feduccia AA (2020). \textit{Integrating psychotherapy and psychopharmacology: psychedelic-assisted psychotherapy and other combined treatments.}. Expert review of clinical pharmacology. [published; PubMed]. \href{https://doi.org/10.1080/17512433.2020.1772054}{doi:10.1080/17512433.2020.1772054}.
\item Krediet E, Bostoen T, Breeksema J, van Schagen A, Passie T, Vermetten E. (2020). \textit{Reviewing the Potential of Psychedelics for the Treatment of PTSD.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1093/ijnp/pyaa018}{doi:10.1093/ijnp/pyaa018}.
\item William Smith, Dominic Sisti (2020). \textit{Ethics and ego dissolution: the case of psilocybin}. Journal of Medical Ethics. [published; OpenAlex]. \href{https://doi.org/10.1136/medethics-2020-106070}{doi:10.1136/medethics-2020-106070}.
\item Frederick S. Barrett, Samuel R. Krimmel, Roland R. Griffiths, David A. Seminowicz, Brian N. Mathur (2020). \textit{Psilocybin acutely alters the functional connectivity of the claustrum with brain networks that support perception, memory, and attention}. NeuroImage. [published; OpenAlex]. \href{https://doi.org/10.1016/j.neuroimage.2020.116980}{doi:10.1016/j.neuroimage.2020.116980}.
\item Natasha L. Mason, Kim P. C. Kuypers, Felix Müller, Johannes T. Reckweg, Desmond H. Y. Tse, Stefan W. Toennes, Nadia R. P. W. Hutten, Jacobus F.A. Jansen, Peter Stiers, Amanda Feilding, Johannes G. Ramaekers (2020). \textit{Me, myself, bye: regional alterations in glutamate and the experience of ego dissolution with psilocybin}. Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1038/s41386-020-0718-8}{doi:10.1038/s41386-020-0718-8}.
\item Ron Shore, Nigel Barnim, Katrina Dobson, Sandra McKeown, Éric C. Dumont, Craig Goldie (2020). \textit{Scoping Review Protocol: Mapping Psilocybin Animal Research}. Unknown journal. [published; OpenAlex]. \href{https://qspace.library.queensu.ca/handle/1974/27834}{source link}.
\item Ron Shore, Paul Ioudovski, Sandra McKeown, Éric C. Dumont, Craig Goldie (2020). \textit{Scoping Review Protocol: Mapping Psilocybin Therapy Research}. Unknown journal. [published; OpenAlex]. \href{https://qspace.library.queensu.ca/jspui/handle/1974/27833}{source link}.
\item Nichols DE. (2020). \textit{Psilocybin: from ancient magic to modern medicine.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41429-020-0311-8}{doi:10.1038/s41429-020-0311-8}.
\item Butler M, Seynaeve M, Nicholson TR, Pick S, Kanaan RA, Lees A, Young AH, Rucker J. (2020). \textit{Psychedelic treatment of functional neurological disorder: a systematic review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/2045125320912125}{doi:10.1177/2045125320912125}.
\item Tehila Mishraki-Berkowitz, Esti Kochelski, Pierce V. Kavanagh, John E. O’Brien, Clodagh Dunne, Brian Talbot, Patricia Ennis, Udi Wolf (2020). \textit{The Psilocin (4-hydroxy-N,N-dimethyltryptamine) and Bufotenine (5-hydroxy-N,N-dimethyltryptamine) Case: Ensuring the Correct Isomer has Been Identified}. Journal of Forensic Sciences. [published; OpenAlex]. \href{https://doi.org/10.1111/1556-4029.14368}{doi:10.1111/1556-4029.14368}.
\item Katie R. Barnes, Stephanie N. Lewis (2020). \textit{Binding Interactions of Psilocin and Serotonin in the 5-HT2A Receptor}. VTechWorks (Virginia Tech). [published; OpenAlex]. \href{http://hdl.handle.net/10919/99299}{source link}.
\item Marcus W. Meinhardt, Cansu Güngör, Ivan Skorodumov, Lea J. Mertens, Rainer Spanagel (2020). \textit{Psilocybin and LSD have no long-lasting effects in an animal model of alcohol relapse}. Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1038/s41386-020-0694-z}{doi:10.1038/s41386-020-0694-z}.
\item Girn M, Roseman L, Bernhardt B, Smallwood J, Carhart-Harris R, Spreng RN. (2020). \textit{Serotonergic psychedelic drugs LSD and psilocybin reduce the hierarchical differentiation of unimodal and transmodal cortex}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2020.05.01.072314}{doi:10.1101/2020.05.01.072314}.
\item Halberstadt AL, Chatha M, Klein AK, Wallach J, Brandt SD (2020). \textit{Correlation between the potency of hallucinogens in the mouse head-twitch response assay and their behavioral and subjective effects in other species.}. Neuropharmacology. [published; PubMed]. \href{https://doi.org/10.1016/j.neuropharm.2019.107933}{doi:10.1016/j.neuropharm.2019.107933}.
\item Lea T, Amada N, Jungaberle H, Schecke H, Scherbaum N, Klein M (2020). \textit{Perceived outcomes of psychedelic microdosing as self-managed therapies for mental and substance use disorders.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-020-05477-0}{doi:10.1007/s00213-020-05477-0}.
\item Morten Hesse (2020). \textit{Klassiske psykedeliske stoffer - inkl. psilocybin og LSD}. Unknown journal. [published; OpenAlex]. \href{https://pure.au.dk/portal/en/publications/45be7e79-66e2-4f51-af03-6c20860526cd}{source link}.
\item University of Wisconsin, Madison (2020). \textit{Pharmacokinetics of Psilocybin in Normal Adult Volunteers}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT02163707}{source link}.
\item Petranker R, Anderson T, Maier L, Barratt MJ, Ferris J, Winstock A. (2020). \textit{Global Drug Survey}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/xb8ve}{doi:10.31234/osf.io/xb8ve}.
\item Unknown authors (2020). \textit{Global Drug Survey}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/xb8ve\_v1}{source link}.
\item Elyes Dahmane, Paul R. Hutson, Jogarao Gobburu (2020). \textit{Exposure-Response Analysis to Assess the Concentration-QTc Relationship of Psilocybin/Psilocin}. Clinical Pharmacology in Drug Development. [published; OpenAlex]. \href{https://doi.org/10.1002/cpdd.796}{doi:10.1002/cpdd.796}.
\item Meghan Hibicke, Charles D. Nichols (2020). \textit{One Dose of Psilocybin in Late Adolescence Mitigates Deleterious Effects of Developmental Stress on Cognition and Behavioral Despair in Adult Female Rats}. The FASEB Journal. [published; OpenAlex]. \href{https://doi.org/10.1096/fasebj.2020.34.s1.02912}{doi:10.1096/fasebj.2020.34.s1.02912}.
\item Heuschkel K, Kuypers KPC. (2020). \textit{Depression, Mindfulness, and Psilocybin: Possible Complementary Effects of Mindfulness Meditation and Psilocybin in the Treatment of Depression. A Review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fpsyt.2020.00224}{doi:10.3389/fpsyt.2020.00224}.
\item Anna Poliwoda, Katarzyna Zielińska, Piotr Wieczorek (2020). \textit{Direct Analysis of Psilocin and Muscimol in Urine Samples Using Single Drop Microextraction Technique In-Line with Capillary Electrophoresis}. Molecules. [published; OpenAlex]. \href{https://doi.org/10.3390/molecules25071566}{doi:10.3390/molecules25071566}.
\item Richard Simoneaux (2020). \textit{Long-Term Analysis of Psilocybin in Cancer Patients With Distress}. Oncology Times. [published; OpenAlex]. \href{https://doi.org/10.1097/01.cot.0000660232.19098.7f}{doi:10.1097/01.cot.0000660232.19098.7f}.
\item N. Milne, Philip Tinggaard Thomsen, Niels Aage Tvis Knudsen, P. Rubaszka, Mette Kristensen, Irina Borodina (2020). \textit{Metabolic engineering of Saccharomyces cerevisiae for the de novo production of psilocybin and related tryptamine derivatives}. Metabolic Engineering. [published; OpenAlex]. \href{https://doi.org/10.1016/j.ymben.2019.12.007}{doi:10.1016/j.ymben.2019.12.007}.
\item Aday JS, Mitzkovitz CM, Bloesch EK, Davoli CC, Davis AK. (2020). \textit{Long-term effects of psychedelic drugs: A systematic review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neubiorev.2020.03.017}{doi:10.1016/j.neubiorev.2020.03.017}.
\item Olson JA, Suissa-Rocheleau L, Lifshitz M, Raz A, Veissière SPL. (2020). \textit{Tripping on nothing: placebo psychedelics and contextual factors.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s00213-020-05464-5}{doi:10.1007/s00213-020-05464-5}.
\item Benko J, Vranková S. (2020). \textit{Natural Psychoplastogens As Antidepressant Agents.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/molecules25051172}{doi:10.3390/molecules25051172}.
\item M. Madsen, Patrick M. Fisher, Dea Siggaard Stenbæk, Sara Kristiansen, Daniel Burmester, Szabolcs Lehel, Tomáš Páleníček, Martin Kuchař, Claus Svarer, Brice Ozenne, Gitte M. Knudsen (2020). \textit{A single psilocybin dose is associated with long-term increased mindfulness, preceded by a proportional change in neocortical 5-HT2A receptor binding}. European Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/j.euroneuro.2020.02.001}{doi:10.1016/j.euroneuro.2020.02.001}.
\item Robert B. Kargbo (2020). \textit{Psilocybin Therapeutic Research: The Present and Future Paradigm}. ACS Medicinal Chemistry Letters. [published; OpenAlex]. \href{https://doi.org/10.1021/acsmedchemlett.0c00048}{doi:10.1021/acsmedchemlett.0c00048}.
\item Janis Fricke, Robert B. Kargbo, Lars Regestein, Claudius Lenz, Gundela Peschel, Miriam A. Rosenbaum, Alexander M. Sherwood, Dirk Hoffmeister (2020). \textit{Scalable Hybrid Synthetic/Biocatalytic Route to Psilocybin}. Chemistry - A European Journal. [published; OpenAlex]. \href{https://doi.org/10.1002/chem.202000134}{doi:10.1002/chem.202000134}.
\item Reiff CM, Richman EE, Nemeroff CB, Carpenter LL, Widge AS, Rodriguez CI, Kalin NH, McDonald WM, the Work Group on Biomarkers and Novel Treatments, a Division of the American Psychiatric Association Council of Research. (2020). \textit{Psychedelics and Psychedelic-Assisted Psychotherapy.}. Diseño interior. [published; Europe PMC]. \href{https://doi.org/10.1176/appi.ajp.2019.19010035}{doi:10.1176/appi.ajp.2019.19010035}.
\item Case Medical Research (2020). \textit{Prophylactic Effects of Psilocybin on Chronic Cluster Headache}. Case Medical Research. [published; OpenAlex]. \href{https://doi.org/10.31525/ct1-nct04280055}{doi:10.31525/ct1-nct04280055}.
\item Bheatrix Bienemann, Nina Stamato Ruschel, Maria Luiza Pesse Campos, Marco Aurélio Negreiros, Daniel C. Mograbi (2020). \textit{Self-reported negative outcomes of psilocybin users: A quantitative textual analysis}. PLoS ONE. [published; OpenAlex]. \href{https://doi.org/10.1371/journal.pone.0229067}{doi:10.1371/journal.pone.0229067}.
\item Candace R. Lewis, Katrin H. Preller, B. Blair Braden, Cory Riecken, Franz X. Vollenweider (2020). \textit{Rostral Anterior Cingulate Thickness Predicts the Emotional Psilocybin Experience}. Biomedicines. [published; OpenAlex]. \href{https://doi.org/10.3390/biomedicines8020034}{doi:10.3390/biomedicines8020034}.
\item Bambauer TP, Wagmann L, Maurer HH, Weber AA, Meyer MR. (2020). \textit{Development and application of a strategy for analyzing eight biomarkers in human urine to verify toxic mushroom or ricinus communis ingestions by means of hydrophilic interaction LC coupled to HRMS/MS.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.talanta.2020.120847}{doi:10.1016/j.talanta.2020.120847}.
\item Frederick S. Barrett, Manoj K. Doss, Nathan D. Sepeda, James J. Pekar, Roland R. Griffiths (2020). \textit{Emotions and brain function are altered up to one month after a single high dose of psilocybin}. Scientific Reports. [published; OpenAlex]. \href{https://doi.org/10.1038/s41598-020-59282-y}{doi:10.1038/s41598-020-59282-y}.
\item Foldi CJ, Liknaitzky P, Williams M, Oldfield BJ. (2020). \textit{Rethinking Therapeutic Strategies for Anorexia Nervosa: Insights From Psychedelic Medicine and Animal Models.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fnins.2020.00043}{doi:10.3389/fnins.2020.00043}.
\item Maho Hirasawa (2020). \textit{Effects of psilocin on the striatal monoamine contents in mice and rats}. The Pharmaceutical Society of Japan. [published; OpenAlex]. \href{https://confit.atlas.jp/guide/event/pharm140/subject/4P156-201-13/detail}{source link}.
\item Unknown authors (2020). \textit{LSD und Psilocybin als Selbstmedikation}. Suchttherapie. [published; OpenAlex]. \href{https://doi.org/10.1055/a-1085-0309}{doi:10.1055/a-1085-0309}.
\item Chi T, Gold JA. (2020). \textit{A review of emerging therapeutic potential of psychedelic drugs in the treatment of psychiatric illnesses.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jns.2020.116715}{doi:10.1016/j.jns.2020.116715}.
\item Natasha L. Mason, Kim P. C. Kuypers, Johannes T. Reckweg, Desmond H. Y. Tse, Felix Müller, Stefan W. Toennes, Amanda Feilding, Johannes G. Ramaekers (2020). \textit{P.324 Acute effects of psilocybin on glutamate concentration levels, functional connectivity and subjective state}. European Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/j.euroneuro.2019.12.087}{doi:10.1016/j.euroneuro.2019.12.087}.
\item Lea J. Mertens, Matthew B. Wall, Leor Roseman, Lysia Demetriou, David Nutt, Robin Carhart-Harris (2020). \textit{Therapeutic mechanisms of psilocybin: Changes in amygdala and prefrontal functional connectivity during emotional processing after psilocybin for treatment-resistant depression}. Journal of Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1177/0269881119895520}{doi:10.1177/0269881119895520}.
\item Case Medical Research (2020). \textit{Comparative Acute Effects of LSD, Psilocybin and Mescaline}. Case Medical Research. [published; OpenAlex]. \href{https://doi.org/10.31525/ct1-nct04227756}{doi:10.31525/ct1-nct04227756}.
\item Katrin H. Preller, Patricia Duerler, Joshua B. Burt, Jie Lisa Ji, Brendan Adkinson, Philipp Stämpfli, Erich Seifritz, Grega Repovš, John H. Krystal, John D. Murray, Alan Anticevic, Franz X. Vollenweider (2020). \textit{Psilocybin Induces Time-Dependent Changes in Global Functional Connectivity}. Biological Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.biopsych.2019.12.027}{doi:10.1016/j.biopsych.2019.12.027}.
\item Gabrielle Agin-Liebes, Tara C. Malone, Matthew M. Yalch, Sarah E. Mennenga, Katherine Ponte, Jeffrey Guss, Anthony P. Bossis, Jim Grigsby, Stacy M. Fischer, Stephen Ross (2020). \textit{Long-term follow-up of psilocybin-assisted psychotherapy for psychiatric and existential distress in patients with life-threatening cancer}. Journal of Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1177/0269881119897615}{doi:10.1177/0269881119897615}.
\item Robert B. Kargbo, Alexander M. Sherwood, Poncho Meisenheimer, Gary Tarpley (2020). \textit{An Improved, Practical, and Scalable Five-Step Synthesis of Psilocybin}. Synthesis. [published; OpenAlex]. \href{https://doi.org/10.1055/s-0039-1691565}{doi:10.1055/s-0039-1691565}.
\item Case Medical Research (2020). \textit{Repeat Dosing of Psilocybin in Migraine Headache}. Case Medical Research. [published; OpenAlex]. \href{https://doi.org/10.31525/ct1-nct04218539}{doi:10.31525/ct1-nct04218539}.
\item Goldberg SB, Pace BT, Nicholas CR, Raison CL, Hutson PR. (2020). \textit{The experimental effects of psilocybin on symptoms of anxiety and depression: A meta-analysis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.psychres.2020.112749}{doi:10.1016/j.psychres.2020.112749}.
\item Brooke Reichenbach (2019). \textit{Is Psilocybin an Effective Treatment to Reduce Depression and Anxiety in Cancer Patients with a Diagnosis of an Anxiety Disorder, Mood Disorder, And/Or Stress Disorder?}. Digital Commons - PCOM (Philadelphia College of Osteopathic Medicine). [published; OpenAlex]. \href{https://digitalcommons.pcom.edu/pa\_systematic\_reviews/531}{source link}.
\item Dax Oliver (2019). \textit{Analysis of Newspaper Coverage of Psilocybin from January 1, 1989 to December 31, 2019}. CUNY Academic Works (City University of New York). [published; OpenAlex]. \href{https://academicworks.cuny.edu/gc\_etds/4074}{source link}.
\item Marcus Allgulin (2019). \textit{Psilocybin and LSD in the Treatment of Depression and Anxiety}. Diva portal (Dalarna University Library). [published; OpenAlex]. \href{http://urn.kb.se/resolve?urn=urn:nbn:se:his:diva-18843}{source link}.
\item Kiomary Rivera Quintana (2019). \textit{Psychedelics: A Window To Mental Illness; Psilocybin And Depression}. Unknown journal. [published; OpenAlex]. \href{https://nsuworks.nova.edu/cgi/viewcontent.cgi?article=1000\&context=hpd\_corx\_stuarticles}{source link}.
\item Sofia Gyllvik (2019). \textit{The Therapeutic Potential of Psilocybin and 3,4-Methylenedioxymethamphetamine in the Treatment of Depression and Post-Traumatic Stress Disorder}. Diva portal (Dalarna University Library). [published; OpenAlex]. \href{http://urn.kb.se/resolve?urn=urn:nbn:se:his:diva-18729}{source link}.
\item Courtney Ledford (2019). \textit{Predicting the Efficacy of Psilocybin in Treating Mental Health and Addiction}. PDXScholar (Portland State University). [published; OpenAlex]. \href{https://pdxscholar.library.pdx.edu/altreu\_projects/5}{source link}.
\item Katariina Sarajärvi (2019). \textit{Psilocybin's effects on the brain and implications for depression treatment}. Epubl LTU. [published; OpenAlex]. \href{http://urn.kb.se/resolve?urn=urn:nbn:se:ltu:diva-79481}{source link}.
\item Ammar Jawad (2019). \textit{Drugs and the Music Industry: How the Neurological and Visual Effects of LSD and Psilocybin Impact Creativity and Songwriting Abilities}. VCU Scholars Compass (Virginia Commonwealth University). [published; OpenAlex]. \href{https://scholarscompass.vcu.edu/uresposters/356}{source link}.
\item Krista Worden (2019). \textit{The Efficacy of Psilocybin Compared to Selective Serotonin Reuptake Inhibitors in the Treatment of Adults with Major Depressive Disorder}. Unknown journal. [published; OpenAlex]. \href{https://scholarworks.arcadia.edu/showcase/2020/pa/60/}{source link}.
\item Laura Sanders (2019). \textit{Psilocybin may help cancer patients with depression and anxiety for years}. Access Science. [published; OpenAlex]. \href{https://www.accessscience.com/content/psilocybin-may-help-cancer-patients-with-depression-and-anxiety-for-years/SN2002031}{source link}.
\item Reham Shaba (2019). \textit{Development of an improved psilocybin synthesis}. Uppsala University Publications (Uppsala University). [published; OpenAlex]. \href{http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-420295}{source link}.
\item James Rucker, Jessie Schnall, Daniel D’Hotman, David King, Timmy Davis, Joanna C. Neill (2019). \textit{Medicinal use of psilocybin: Reducing restrictions on research and treatment.}. Unknown journal. [published; OpenAlex]. \href{https://www.drugsandalcohol.ie/32599/}{source link}.
\item Moreton SG, Szalla L, Menzies RE, Arena AF (2019). \textit{Embedding existential psychology within psychedelic science: reduced death anxiety as a mediator of the therapeutic effects of psychedelics.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-019-05391-0}{doi:10.1007/s00213-019-05391-0}.
\item Ho JT, Preller KH, Lenggenhager B (2019). \textit{Neuropharmacological modulation of the aberrant bodily self through psychedelics.}. Neuroscience and biobehavioral reviews. [published; PubMed]. \href{https://doi.org/10.1016/j.neubiorev.2019.12.006}{doi:10.1016/j.neubiorev.2019.12.006}.
\item Wolff M, Evens R, Mertens LJ, Koslowski M, Betzler F, Gründer G, Jungaberle H (2019). \textit{Learning to Let Go: A Cognitive-Behavioral Model of How Psychedelic Therapy Promotes Acceptance.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2020.00005}{doi:10.3389/fpsyt.2020.00005}.
\item Lea T, Amada N, Jungaberle H (2019). \textit{Psychedelic Microdosing: A Subreddit Analysis.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2019.1683260}{doi:10.1080/02791072.2019.1683260}.
\item Müller F, Johnson MW, Borgwardt S (2019). \textit{Editorial: Hallucinogens and Entactogens: Establishing a New Class of Drugs?}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2020.00497}{doi:10.3389/fpsyt.2020.00497}.
\item Petranker R, Anderson T, Farb N (2019). \textit{Psychedelic Research and the Need for Transparency: Polishing Alice's Looking Glass.}. Frontiers in psychology. [published; PubMed]. \href{https://doi.org/10.3389/fpsyg.2020.01681}{doi:10.3389/fpsyg.2020.01681}.
\item Kangaslampi S, Hausen A, Rauteenmaa T (2019). \textit{Mystical Experiences in Retrospective Reports of First Times Using a Psychedelic in Finland.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2020.1767321}{doi:10.1080/02791072.2020.1767321}.
\item Nobile B, Olié E, Courtet P (2019). \textit{Commentary: Psychedelic Psychiatry's Brave New World.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2020.594077}{doi:10.3389/fpsyt.2020.594077}.
\item Grassi G, Cecchelli C, Vignozzi L, Pacini S. (2019). \textit{Investigational and Experimental Drugs to Treat Obsessive-Compulsive Disorder.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.2147/jep.s255375}{doi:10.2147/jep.s255375}.
\item Krishna Kumar Varshney (2019). \textit{Structure Based Drug Design towards Exploring Potential Anti-Psychotic and Anti-Depressant Activity of Possible Stiff Base of Psilocybin}. SSRN Electronic Journal. [published; OpenAlex]. \href{https://papers.ssrn.com/sol3/papers.cfm?abstract\_id=3528349}{source link}.
\item Johns Hopkins University (2019). \textit{Effects of Psilocybin on Behavior, Psychology and Brain Function in Long-term Meditators}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT02145091}{source link}.
\item Mathai DS, Meyer MJ, Storch EA, Kosten TR. (2019). \textit{The relationship between subjective effects induced by a single dose of ketamine and treatment response in patients with major depressive disorder: A systematic review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jad.2019.12.023}{doi:10.1016/j.jad.2019.12.023}.
\item Shore R, Ioudovski P, Goldie C, McKeown S, Dumont E, Queen’s University, Kingston On. (2019). \textit{Mapping Psilocybin-Assisted Therapies: A Scoping Review}. medRxiv. [preprint; medRxiv]. \href{https://doi.org/10.1101/2019.12.04.19013896}{doi:10.1101/2019.12.04.19013896}.
\item Corne R, Mongeau R. (2019). \textit{[Neurotrophic mechanisms of psychedelic therapy].}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1051/jbio/2019015}{doi:10.1051/jbio/2019015}.
\item Richard Demmler, Janis Fricke, Sebastian Dörner, Markus Gressler, Dirk Hoffmeister (2019). \textit{S-Adenosyl-l-Methionine Salvage Impacts Psilocybin Formation in “Magic” Mushrooms}. ChemBioChem. [published; OpenAlex]. \href{https://doi.org/10.1002/cbic.201900649}{doi:10.1002/cbic.201900649}.
\item Dos Santos RG, Hallak JEC. (2019). \textit{Therapeutic use of serotoninergic hallucinogens: A review of the evidence and of the biological and psychological mechanisms.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neubiorev.2019.12.001}{doi:10.1016/j.neubiorev.2019.12.001}.
\item K. Kiilerich, Nikolaj Speth, J. Lorenz, Agata Casado-Sainz, Vladimir Shalgunov, Denise Lange, Mengfei Xiong, Matthias M. Herth, Agnete Overgaard, Hanne D. Hansen, Mikael Palner (2019). \textit{P.228 The polypharmacological profile of psilocybin and potential behavioural effects of very low doses}. European Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/j.euroneuro.2019.09.271}{doi:10.1016/j.euroneuro.2019.09.271}.
\item Mie Madsen, P.M. Fisher, D.S. Stenbæk, S. Kristiansen, D. Burmester, S. Lehel, Tomáš Páleníček, Claus Svarer, B. Ozenne, Gitte M. Knudsen (2019). \textit{P.188 Long-term effects of psilocybin on cerebral serotonin 2A receptor levels and personality}. European Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/j.euroneuro.2019.09.232}{doi:10.1016/j.euroneuro.2019.09.232}.
\item Laura Mertens, M.B. Wall, L. Roseman, L. Demetriou, D.J. Nutt, R.L. Carhart-Harris (2019). \textit{P.609 Therapeutic mechanisms of psychedelic drugs: Changes in amygdala and prefrontal functional connectivity during emotional processing after psilocybin for treatment-resistant depression}. European Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/j.euroneuro.2019.09.593}{doi:10.1016/j.euroneuro.2019.09.593}.
\item Dea Siggaard Stenbæk, M.K. Madsen, Brice Ozenne, Søren Kristiansen, Daniel Burmester, David Erritzøe, Gitte M. Knudsen, Patrick M. Fisher (2019). \textit{P.839 Modelling the acute temporal dynamics of psilocybin psychoactive effects; relation to brain serotonin 2a receptor levels}. European Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/j.euroneuro.2019.09.702}{doi:10.1016/j.euroneuro.2019.09.702}.
\item Sally Meikle, Paul Liknaitzky, Susan L. Rossell, Margaret Ross, Nigel Strauss, Neil Thomas, Greg Murray, M.L. Williams, David Castle (2019). \textit{Psilocybin-assisted therapy for depression: How do we advance the field?}. Australian \& New Zealand Journal of Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1177/0004867419888575}{doi:10.1177/0004867419888575}.
\item Claudius Lenz, Jonas Wick, Daniel Braga, María García-Altares, Gerald Lackner, Christian Hertweck, Markus Gressler, Dirk Hoffmeister (2019). \textit{Injury-Triggered Blueing Reactions of Psilocybe “Magic” Mushrooms}. Angewandte Chemie. [published; OpenAlex]. \href{https://doi.org/10.1002/ange.201910175}{doi:10.1002/ange.201910175}.
\item Felix Blei, Sebastian Dörner, Janis Fricke, Florian Baldeweg, Felix Trottmann, Anna J. Komor, Florian Meyer, Christian Hertweck, Dirk Hoffmeister (2019). \textit{Simultaneous Production of Psilocybin and a Cocktail of β-Carboline Monoamine Oxidase Inhibitors in “Magic” Mushrooms}. Chemistry - A European Journal. [published; OpenAlex]. \href{https://doi.org/10.1002/chem.201904363}{doi:10.1002/chem.201904363}.
\item Case Medical Research (2019). \textit{Psilocybin-assisted Psychotherapy for Opioid Use Disorder}. Case Medical Research. [published; OpenAlex]. \href{https://doi.org/10.31525/ct1-nct04161066}{doi:10.31525/ct1-nct04161066}.
\item Poulie CBM, Jensen AA, Halberstadt AL, Kristensen JL. (2019). \textit{DARK Classics in Chemical Neuroscience: NBOMes.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/acschemneuro.9b00528}{doi:10.1021/acschemneuro.9b00528}.
\item Jordan Sloshower, Jeffrey Guss, Robert Krause, Ryan Wallace, Monnica T. Williams, Sara Reed, Matthew D. Skinta (2019). \textit{Psilocybin-assisted therapy of major depressive disorder using Acceptance and Commitment Therapy as a therapeutic frame}. Journal of Contextual Behavioral Science. [published; OpenAlex]. \href{https://doi.org/10.1016/j.jcbs.2019.11.002}{doi:10.1016/j.jcbs.2019.11.002}.
\item Case Medical Research (2019). \textit{Clinical and Mechanistic Effects of Psilocybin in Alcohol Addicted Patients}. Case Medical Research. [published; OpenAlex]. \href{https://doi.org/10.31525/ct1-nct04141501}{doi:10.31525/ct1-nct04141501}.
\item Dos Santos RG, Bouso JC, Hallak JEC. (2019). \textit{Serotonergic hallucinogens/psychedelics could be promising treatments for depressive and anxiety disorders in end-stage cancer.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1186/s12888-019-2288-z}{doi:10.1186/s12888-019-2288-z}.
\item Lukasz Smigielski, Michael Kometer, Milan Scheidegger, Rainer Krähenmann, Theo Huber, Franz X. Vollenweider (2019). \textit{Characterization and prediction of acute and sustained response to psychedelic psilocybin in a mindfulness group retreat}. Scientific Reports. [published; OpenAlex]. \href{https://doi.org/10.1038/s41598-019-50612-3}{doi:10.1038/s41598-019-50612-3}.
\item Kernel Networks Inc. (2019). \textit{Psilocybin for Depression in People With Mild Cognitive Impairment or Early Alzheimer's Disease}. Case Medical Research. [published; OpenAlex]. \href{https://doi.org/10.31525/ct1-nct04123314}{doi:10.31525/ct1-nct04123314}.
\item Megha Satyanarayana (2019). \textit{Modified E. coli pump out psilocybin}. C\&EN Global Enterprise. [published; OpenAlex]. \href{https://doi.org/10.1021/cen-09739-scicon9}{doi:10.1021/cen-09739-scicon9}.
\item Christopher B. Germann (2019). \textit{The Psilocybin-Telomere Hypothesis: An empirically falsifiable prediction concerning the beneficial neuropsychopharmacological effects of psilocybin on genetic aging}. Medical Hypotheses. [published; OpenAlex]. \href{https://doi.org/10.1016/j.mehy.2019.109406}{doi:10.1016/j.mehy.2019.109406}.
\item Kelly JR, Baker A, Babiker M, Burke L, Brennan C, O'Keane V. (2019). \textit{The psychedelic renaissance: the next trip for psychiatry?}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1017/ipm.2019.39}{doi:10.1017/ipm.2019.39}.
\item Alexandra M. Adams, Nicholas A. Kaplan, Zhangyue Wei, John D. Brinton, Chantal Monnier, Alexis L. Enacopol, Theresa A. Ramelot, J. Andrew Jones (2019). \textit{In vivo production of psilocybin in E. coli}. Metabolic Engineering. [published; OpenAlex]. \href{https://doi.org/10.1016/j.ymben.2019.09.009}{doi:10.1016/j.ymben.2019.09.009}.
\item Johns Hopkins University (2019). \textit{Measurement of Persisting Changes in Emotional Brain Functioning Produced by Psilocybin}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT02971605}{source link}.
\item Kelley C. O’Donnell, Sarah E. Mennenga, Michael P. Bogenschutz (2019). \textit{Psilocybin for depression: Considerations for clinical trial design}. Journal of Psychedelic Studies. [published; OpenAlex]. \href{https://doi.org/10.1556/2054.2019.026}{doi:10.1556/2054.2019.026}.
\item Grandjean J, Buehlmann D, Buerge M, Sigrist H, Seifritz E, Vollenweider FX, Pryce CR, Rudin M. (2019). \textit{Psilocybin exerts distinct effects on resting state networks associated with serotonin and dopamine in mice}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/751255}{doi:10.1101/751255}.
\item Begola MJ, Schillerstrom JE. (2019). \textit{Hallucinogens and Their Therapeutic Use: A Literature Review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1097/pra.0000000000000409}{doi:10.1097/pra.0000000000000409}.
\item A.R. Chadeayne, Duyen N. K. Pham, James A. Golen, David R. Manke (2019). \textit{The fumarate salts of the N-isopropyl-N-methyl derivatives of DMT and psilocin}. Acta Crystallographica Section E Crystallographic Communications. [published; OpenAlex]. \href{https://doi.org/10.1107/s2056989019011253}{doi:10.1107/s2056989019011253}.
\item King's College London (2019). \textit{A Randomised, Balanced, Double-blind Two-way Crossover Design Study to Evaluate the Effects of SRC Kinase Inhibitor, Saracatinib, on Brain Activity Associated With Visual Processing in Patients With Parkinson's Disease Psychosis.}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT03661125}{source link}.
\item Muttoni S, Ardissino M, John C. (2019). \textit{Classical psychedelics for the treatment of depression and anxiety: A systematic review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jad.2019.07.076}{doi:10.1016/j.jad.2019.07.076}.
\item Barnett L, Muthukumaraswamy SD, Carhart-Harris RL, Seth AK. (2019). \textit{Decreased Directed Functional Connectivity in the Psychedelic State}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/703660}{doi:10.1101/703660}.
\item Kuypers KP, Ng L, Erritzoe D, Knudsen GM, Nichols CD, Nichols DE, Pani L, Soula A, Nutt D. (2019). \textit{Microdosing psychedelics: More questions than answers? An overview and suggestions for future research.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/0269881119857204}{doi:10.1177/0269881119857204}.
\item Carhart-Harris RL, Friston KJ. (2019). \textit{REBUS and the Anarchic Brain: Toward a Unified Model of the Brain Action of Psychedelics.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1124/pr.118.017160}{doi:10.1124/pr.118.017160}.
\item Richard Simoneaux (2019). \textit{The Potential of Psilocybin Administration in Terminal Cancer Patients}. Oncology Times. [published; OpenAlex]. \href{https://doi.org/10.1097/01.cot.0000574916.46844.cf}{doi:10.1097/01.cot.0000574916.46844.cf}.
\item Suzanne L. Russ, Robin Carhart-Harris, Geoffrey Maruyama, Melody S. Elliott (2019). \textit{Replication and extension of a model predicting response to psilocybin}. Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1007/s00213-019-05279-z}{doi:10.1007/s00213-019-05279-z}.
\item Madsen MK, Fisher PM, Burmester D, Dyssegaard A, Stenbæk DS, Kristiansen S, Johansen SS, Lehel S, Linnet K, Svarer C, Erritzoe D, Ozenne B, Knudsen GM. (2019). \textit{Correction: Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41386-019-0360-5}{doi:10.1038/s41386-019-0360-5}.
\item Janis Fricke, Alexander M. Sherwood, Robert B. Kargbo, Andrew Orry, Felix Blei, Andreas Naschberger, Bernhard Rupp, Dirk Hoffmeister (2019). \textit{Enzymatic Route toward 6-Methylated Baeocystin and Psilocybin}. ChemBioChem. [published; OpenAlex]. \href{https://doi.org/10.1002/cbic.201900358}{doi:10.1002/cbic.201900358}.
\item A.R. Chadeayne, James A. Golen, David R. Manke (2019). \textit{Bis(4-acetoxy-N,N-dimethyltryptammonium) fumarate: a new crystalline form of psilacetin, an alternative to psilocybin as a psilocin prodrug}. Acta Crystallographica Section E Crystallographic Communications. [published; OpenAlex]. \href{https://doi.org/10.1107/s2056989019007370}{doi:10.1107/s2056989019007370}.
\item Louis-David Lord, Paul Expert, Selen Atasoy, Leor Roseman, Kristina M. Rapuano, Renaud Lambiotte, David Nutt, Gustavo Deco, Robin Carhart-Harris, Morten L. Kringelbach, Joana Cabral (2019). \textit{Dynamical exploration of the repertoire of brain networks at rest is modulated by psilocybin}. NeuroImage. [published; OpenAlex]. \href{https://doi.org/10.1016/j.neuroimage.2019.05.060}{doi:10.1016/j.neuroimage.2019.05.060}.
\item Oskar Hougaard Jefsen, Kristoffer Højgaard, Sofie Laage Christiansen, Betina Elfving, David Nutt, Gregers Wegener, Heidi Kaastrup Müller (2019). \textit{Psilocybin lacks antidepressant-like effect in the Flinders Sensitive Line rat}. Acta Neuropsychiatrica. [published; OpenAlex]. \href{https://doi.org/10.1017/neu.2019.15}{doi:10.1017/neu.2019.15}.
\item Izumi Morita, Hiroyuki Oyama, Rie Tanaka, Ruri Kikura-Hanajiri, Norihiro Kobayashi (2019). \textit{Generation of monoclonal antibodies for on-site analysis of psilocin and psilocybin in hallucinogenic mushrooms}. Clinica Chimica Acta. [published; OpenAlex]. \href{https://doi.org/10.1016/j.cca.2019.03.139}{doi:10.1016/j.cca.2019.03.139}.
\item Garcia-Romeu A, Davis AK, Erowid F, Erowid E, Griffiths RR, Johnson MW. (2019). \textit{Cessation and reduction in alcohol consumption and misuse after psychedelic use.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/0269881119845793}{doi:10.1177/0269881119845793}.
\item B. Anderson, Alicia Danforth, Robert B. Daroff, Christopher S. Stauffer, James Dilley, Jennifer Mitchell, Joshua Woolley (2019). \textit{T137. Psilocybin-Assisted Group Therapy for Demoralization in Long-Term AIDS Survivors}. Biological Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.biopsych.2019.03.460}{doi:10.1016/j.biopsych.2019.03.460}.
\item Paul Webster (2019). \textit{Denver votes to decriminalise psilocybin mushrooms}. The Lancet. [published; OpenAlex]. \href{https://doi.org/10.1016/s0140-6736(19)31082-7}{doi:10.1016/s0140-6736(19)31082-7}.
\item Rocha JM, Osório FL, Crippa JAS, Bouso JC, Rossi GN, Hallak JEC, Dos Santos RG. (2019). \textit{Serotonergic hallucinogens and recognition of facial emotion expressions: a systematic review of the literature.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/2045125319845774}{doi:10.1177/2045125319845774}.
\item Witkin JM, Martin AE, Golani LK, Xu NZ, Smith JL. (2019). \textit{Rapid-acting antidepressants.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/bs.apha.2019.03.002}{doi:10.1016/bs.apha.2019.03.002}.
\item Roland R. Griffiths, Ethan Hurwitz, Alan K. Davis, Matthew W. Johnson, Robert L. Jesse (2019). \textit{Survey of subjective "God encounter experiences": Comparisons among naturally occurring experiences and those occasioned by the classic psychedelics psilocybin, LSD, ayahuasca, or DMT}. PLoS ONE. [published; OpenAlex]. \href{https://doi.org/10.1371/journal.pone.0214377}{doi:10.1371/journal.pone.0214377}.
\item Kernel Networks Inc. (2019). \textit{Effects of SERT Inhibition on the Subjective Response to Psilocybin in Healthy Subjects}. Case Medical Research. [published; OpenAlex]. \href{https://doi.org/10.31525/ct1-nct03912974}{doi:10.31525/ct1-nct03912974}.
\item Lukasz Smigielski, Milan Scheidegger, Michael Kometer, Franz X. Vollenweider (2019). \textit{Psilocybin-assisted mindfulness training modulates self-consciousness and brain default mode network connectivity with lasting effects}. NeuroImage. [published; OpenAlex]. \href{https://doi.org/10.1016/j.neuroimage.2019.04.009}{doi:10.1016/j.neuroimage.2019.04.009}.
\item Trope A, Anderson BT, Hooker AR, Glick G, Stauffer C, Woolley JD. (2019). \textit{Psychedelic-Assisted Group Therapy: A Systematic Review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/02791072.2019.1593559}{doi:10.1080/02791072.2019.1593559}.
\item de Coo IF, Naber WC, Wilbrink LA, Haan J, Ferrari MD, Fronczek R (2019). \textit{Increased use of illicit drugs in a Dutch cluster headache population.}. Cephalalgia: an international journal of headache. [published; PubMed]. \href{https://doi.org/10.1177/0333102418804160}{doi:10.1177/0333102418804160}.
\item Kuypers KPC (2019). \textit{Psychedelic medicine: The biology underlying the persisting psychedelic effects.}. Medical hypotheses. [published; PubMed]. \href{https://doi.org/10.1016/j.mehy.2019.02.029}{doi:10.1016/j.mehy.2019.02.029}.
\item Yuri Rahayu, Andi Riyanto, Agung Wibowo (2019). \textit{Relationship Of Magic Mushroom Literation As A Drug With Abuse It's Use As A Hallucination}. International Journal on Advanced Science Education and Religion. [published; OpenAlex]. \href{https://doi.org/10.33648/ijoaser.v2i1.25}{doi:10.33648/ijoaser.v2i1.25}.
\item Kernel Networks Inc. (2019). \textit{A Study of Psilocybin for Major Depressive Disorder (MDD)}. Case Medical Research. [published; OpenAlex]. \href{https://doi.org/10.31525/ct1-nct03866174}{doi:10.31525/ct1-nct03866174}.
\item Rácz N, Nagy J, Jiang W, Veress T. (2019). \textit{Modeling Retention Behavior on Analysis of Hallucinogenic Mushrooms Using Hydrophilic Interaction Liquid Chromatography.}. Journal of Chromatographic Science. [published; Europe PMC]. \href{https://doi.org/10.1093/chromsci/bmy104}{doi:10.1093/chromsci/bmy104}.
\item Natasha L. Mason, Elisabeth Mischler, Malin V. Uthaug, Kim P. C. Kuypers (2019). \textit{Sub-Acute Effects of Psilocybin on Empathy, Creative Thinking, and Subjective Well-Being}. Journal of Psychoactive Drugs. [published; OpenAlex]. \href{https://doi.org/10.1080/02791072.2019.1580804}{doi:10.1080/02791072.2019.1580804}.
\item James E, Robertshaw TL, Westwell AD (2019). \textit{Emerging from the dark side: new therapeutic applications of scheduled psychoactive substances.}. Future medicinal chemistry. [published; PubMed]. \href{https://doi.org/10.4155/fmc-2018-0447}{doi:10.4155/fmc-2018-0447}.
\item Michiel van Elk, George Fejer, Josephine Marschall, Pascal Lempe (2019). \textit{The effects of psilocybin microdosing on perception: a double-blind controlled study}. OSF Preprints (OSF Preprints). [published; OpenAlex]. \href{https://osf.io/cn8z4}{source link}.
\item M. Madsen, Patrick M. Fisher, Daniel Burmester, Agnete Dyssegaard, Dea Siggaard Stenbæk, Sara Kristiansen, Sys Stybe Johansen, Sczabolz Lehel, Kristían Línnet, Claus Svarer, David Erritzøe, Brice Ozenne, Gitte M. Knudsen (2019). \textit{Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels}. Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1038/s41386-019-0324-9}{doi:10.1038/s41386-019-0324-9}.
\item Varley T, Carhart-Harris R, Roseman L, Menon DK, Stamatakis E. (2019). \textit{Serotonergic Psychedelics LSD \& Psilocybin Increase the Fractal Dimension of Cortical Brain Activity in Spatial and Temporal Domains}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/517847}{doi:10.1101/517847}.
\item Cao B, Zhu J, Zuckerman H, Rosenblat JD, Brietzke E, Pan Z, Subramanieapillai M, Park C, Lee Y, McIntyre RS. (2019). \textit{Pharmacological interventions targeting anhedonia in patients with major depressive disorder: A systematic review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.pnpbp.2019.01.002}{doi:10.1016/j.pnpbp.2019.01.002}.
\item Anderson T, Petranker R, Rosenbaum D, Weissman CR, Dinh-Williams LA, Hui K, Hapke E, Farb NAS. (2019). \textit{Microdosing psychedelics: personality, mental health, and creativity differences in microdosers.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s00213-018-5106-2}{doi:10.1007/s00213-018-5106-2}.
\item Katherine Gruppo (2018). \textit{Psilocybin-Assisted Therapy: A Double-Blind Randomized Controlled Trial}. Unknown journal. [published; OpenAlex]. \href{https://elischolar.library.yale.edu/cgi/viewcontent.cgi?article=1050\&context=ysmpa\_theses}{source link}.
\item Isabella Stendahl (2018). \textit{THE POTENTIAL THERAPEUTIC VALUE OF PSILOCYBIN: In Relation to Depression}. Diva portal (Dalarna University Library). [published; OpenAlex]. \href{http://urn.kb.se/resolve?urn=urn:nbn:se:his:diva-17749}{source link}.
\item Tina Hesman Saey (2018). \textit{These fungi drug cicadas with psilocybin or amphetamine to make them mate nonstop}. Access Science. [published; OpenAlex]. \href{https://www.accessscience.com/content/these-fungi-drug-cicadas-with-psilocybin-or-amphetamine-to-make-them-mate-nonstop/SN1907011}{source link}.
\item Camden Grant-Howard, Joel S. Steele (2018). \textit{Use of MDMA \& Psilocybin in the Treatment of PTSD}. PDXScholar (Portland State University). [published; OpenAlex]. \href{https://pdxscholar.library.pdx.edu/studentsymposium/2019/Posters/14}{source link}.
\item P. Dürler (2018). \textit{Psilocybin induces aberrant prediction error processing for tactile mismatch responses}. European Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/j.euroneuro.2018.11.477}{doi:10.1016/j.euroneuro.2018.11.477}.
\item Felix Scholkmann, Lisa Holper, Katrin H. Preller, Franz X. Vollenweider (2018). \textit{Effects of psilocybin on functional connectivity measured with fNIRS: Insights from a single-subject pilot study}. Zurich Open Repository and Archive (University of Zurich). [published; OpenAlex]. \href{https://doi.org/10.5167/uzh-181782}{doi:10.5167/uzh-181782}.
\item Kelly M. Brinsko, Dean Golemis, Meggan B. King, Gary J. Laughlin, Sebastian B. Sparenga (2018). \textit{Microcrystal Tests for the Identification of Illicit Drugs: Phencyclidine, Pseudoephedrine, and Psilocin}. The Microscope. [published; OpenAlex]. \href{https://doi.org/10.59082/tnwk8166}{doi:10.59082/tnwk8166}.
\item Dinis-Oliveira RJ, Pereira CL, da Silva DD. (2018). \textit{Pharmacokinetic and Pharmacodynamic Aspects of Peyote and Mescaline: Clinical and Forensic Repercussions.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.2174/1874467211666181010154139}{doi:10.2174/1874467211666181010154139}.
\item Fadiman J, Korb S (2018). \textit{Might Microdosing Psychedelics Be Safe and Beneficial? An Initial Exploration.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2019.1593561}{doi:10.1080/02791072.2019.1593561}.
\item Hutten NRPW, Mason NL, Dolder PC, Kuypers KPC (2018). \textit{Self-Rated Effectiveness of Microdosing With Psychedelics for Mental and Physical Health Problems Among Microdosers.}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2019.00672}{doi:10.3389/fpsyt.2019.00672}.
\item Vorster A, Gerber AM, van der Merwe LJ, van Zyl S (2018). \textit{Second and third year medical students' self-reported alcohol and substance use, smoking habits and academic performance at a South African medical school.}. Health SA = SA Gesondheid. [published; PubMed]. \href{https://doi.org/10.4102/hsag.v24i0.1041}{doi:10.4102/hsag.v24i0.1041}.
\item Peterson A, Tagliazucchi E, Weijer C (2018). \textit{The ethics of psychedelic research in disorders of consciousness.}. Neuroscience of consciousness. [published; PubMed]. \href{https://doi.org/10.1093/nc/niz013}{doi:10.1093/nc/niz013}.
\item M. Madsen, Daniel Burmester, Dea Siggaard Stenbæk, Søren Kristiansen, Agnete Dyssegaard, Szabolcs Lehel, Kristían Línnet, Sys Stybe Johansen, Claus Svarer, Brice Ozenne, David Erritzøe, Patrick M. Fisher, Gitte M. Knudsen (2018). \textit{Psilocybin occupancy of brain serotonin 2A receptors correlates with psilocin levels and subjective experience: a [11C]Cimbi-36 PET study in humans}. European Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/j.euroneuro.2018.11.474}{doi:10.1016/j.euroneuro.2018.11.474}.
\item Austin E, Myron HS, Summerbell RK, Mackenzie C. (2018). \textit{Acute renal injury cause by confirmed Psilocybe cubensis mushroom ingestion.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.mmcr.2018.12.007}{doi:10.1016/j.mmcr.2018.12.007}.
\item Honyiglo E, Franchi A, Cartiser N, Bottinelli C, Advenier AS, Bévalot F, Fanton L. (2018). \textit{Unpredictable Behavior Under the Influence of "Magic Mushrooms": A Case Report and Review of the Literature.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1111/1556-4029.13982}{doi:10.1111/1556-4029.13982}.
\item Torrens-Spence MP, Liu CT, Pluskal T, Chung YK, Weng JK. (2018). \textit{Monoamine Biosynthesis via a Noncanonical Calcium-Activatable Aromatic Amino Acid Decarboxylase in Psilocybin Mushroom.}. ACS Chemical Biology. [published; Europe PMC]. \href{https://doi.org/10.1021/acschembio.8b00821}{doi:10.1021/acschembio.8b00821}.
\item Barsuglia J, Davis AK, Palmer R, Lancelotta R, Windham-Herman AM, Peterson K, Polanco M, Grant R, Griffiths RR. (2018). \textit{Intensity of Mystical Experiences Occasioned by 5-MeO-DMT and Comparison With a Prior Psilocybin Study.}. Frontiers in Psychology. [published; Europe PMC]. \href{https://doi.org/10.3389/fpsyg.2018.02459}{doi:10.3389/fpsyg.2018.02459}.
\item Johnson MW, Hendricks PS, Barrett FS, Griffiths RR. (2018). \textit{Classic psychedelics: An integrative review of epidemiology, therapeutics, mystical experience, and brain network function.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.pharmthera.2018.11.010}{doi:10.1016/j.pharmthera.2018.11.010}.
\item Fricke J, Lenz C, Wick J, Blei F, Hoffmeister D. (2018). \textit{Production Options for Psilocybin: Making of the Magic.}. Chemistry - A European Journal. [published; Europe PMC]. \href{https://doi.org/10.1002/chem.201802758}{doi:10.1002/chem.201802758}.
\item Kvam TM, Stewart LH, Andreassen OA. (2018). \textit{Psychedelic drugs in the treatment of anxiety, depression and addiction.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.4045/tidsskr.17.1110}{doi:10.4045/tidsskr.17.1110}.
\item Back AL. (2018). \textit{What Psilocybin Taught Me About Dying.}. Journal of Palliative Medicine. [published; Europe PMC]. \href{https://doi.org/10.1089/jpm.2018.0561}{doi:10.1089/jpm.2018.0561}.
\item Anderson T, Petranker R, Rosenbaum D, Weissman C, Dinh-Williams L, Hui K, Hapke E, Farb NAS. (2018). \textit{Microdosing Psychedelics: Personality, mental health, and creativity differences in microdosers}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/gk4jd}{doi:10.31234/osf.io/gk4jd}.
\item Unknown authors (2018). \textit{Microdosing Psychedelics: Personality, mental health, and creativity differences in microdosers}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/gk4jd\_v1}{source link}.
\item Atasoy S, Vohryzek J, Deco G, Carhart-Harris RL, Kringelbach ML. (2018). \textit{Common neural signatures of psychedelics: Frequency-specific energy changes and repertoire expansion revealed using connectome-harmonic decomposition.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/bs.pbr.2018.08.009}{doi:10.1016/bs.pbr.2018.08.009}.
\item Lyons T, Carhart-Harris RL. (2018). \textit{More Realistic Forecasting of Future Life Events After Psilocybin for Treatment-Resistant Depression.}. Frontiers in Psychology. [published; Europe PMC]. \href{https://doi.org/10.3389/fpsyg.2018.01721}{doi:10.3389/fpsyg.2018.01721}.
\item Wasko MJ, Witt-Enderby PA, Surratt CK. (2018). \textit{DARK Classics in Chemical Neuroscience: Ibogaine.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/acschemneuro.8b00294}{doi:10.1021/acschemneuro.8b00294}.
\item Jalal B. (2018). \textit{The neuropharmacology of sleep paralysis hallucinations: serotonin 2A activation and a novel therapeutic drug.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s00213-018-5042-1}{doi:10.1007/s00213-018-5042-1}.
\item Blei F, Fricke J, Wick J, Slot JC, Hoffmeister D. (2018). \textit{Iterative l-Tryptophan Methylation in Psilocybe Evolved by Subdomain Duplication.}. ChemBioChem. [published; Europe PMC]. \href{https://doi.org/10.1002/cbic.201800336}{doi:10.1002/cbic.201800336}.
\item Müller F, Liechti ME, Lang UE, Borgwardt S. (2018). \textit{Advances and challenges in neuroimaging studies on the effects of serotonergic hallucinogens: Contributions of the resting brain.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/bs.pbr.2018.08.004}{doi:10.1016/bs.pbr.2018.08.004}.
\item Bayne T, Carter O. (2018). \textit{Dimensions of consciousness and the psychedelic state.}. Neuroscience of Consciousness. [published; Europe PMC]. \href{https://doi.org/10.1093/nc/niy008}{doi:10.1093/nc/niy008}.
\item Leonard JB, Anderson B, Klein-Schwartz W. (2018). \textit{Does getting high hurt? Characterization of cases of LSD and psilocybin-containing mushroom exposures to national poison centers between 2000 and 2016.}. Journal of Psychopharmacology. [published; Europe PMC]. \href{https://doi.org/10.1177/0269881118793086}{doi:10.1177/0269881118793086}.
\item Millière R, Carhart-Harris RL, Roseman L, Trautwein FM, Berkovich-Ohana A. (2018). \textit{Psychedelics, Meditation, and Self-Consciousness.}. Frontiers in Psychology. [published; Europe PMC]. \href{https://doi.org/10.3389/fpsyg.2018.01475}{doi:10.3389/fpsyg.2018.01475}.
\item Cowan AF, Elkins KM (2018). \textit{Detection and Identification of Psilocybe cubensis DNA Using a Real-Time Polymerase Chain Reaction High Resolution Melt Assay.}. Journal of forensic sciences. [published; PubMed]. \href{https://doi.org/10.1111/1556-4029.13714}{doi:10.1111/1556-4029.13714}.
\item Horsley RR, Páleníček T, Kolin J, Valeš K. (2018). \textit{Psilocin and ketamine microdosing: effects of subchronic intermittent microdoses in the elevated plus-maze in male Wistar rats.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1097/fbp.0000000000000394}{doi:10.1097/fbp.0000000000000394}.
\item De Gregorio D, Enns JP, Nuñez NA, Posa L, Gobbi G. (2018). \textit{d-Lysergic acid diethylamide, psilocybin, and other classic hallucinogens: Mechanism of action and potential therapeutic applications in mood disorders.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/bs.pbr.2018.07.008}{doi:10.1016/bs.pbr.2018.07.008}.
\item Dos Santos RG, Bouso JC, Alcázar-Córcoles MÁ, Hallak JEC. (2018). \textit{Efficacy, tolerability, and safety of serotonergic psychedelics for the management of mood, anxiety, and substance-use disorders: a systematic review of systematic reviews.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/17512433.2018.1511424}{doi:10.1080/17512433.2018.1511424}.
\item Solano J, Anabalón L, Figueroa S, Lizama C, Reyes LC, Gangitano D. (2018). \textit{Psychedelic fungus (Psilocybe sp.) authentication in a case of illegal drug traffic: sporological, molecular analysis and identification of the psychoactive substance.}. Science \& Justice. [published; Europe PMC]. \href{https://doi.org/10.1016/j.scijus.2018.08.005}{doi:10.1016/j.scijus.2018.08.005}.
\item Flanagan TW, Nichols CD. (2018). \textit{Psychedelics as anti-inflammatory agents.}. International Review of Psychiatry. [published; Europe PMC]. \href{https://doi.org/10.1080/09540261.2018.1481827}{doi:10.1080/09540261.2018.1481827}.
\item Ross S. (2018). \textit{Therapeutic use of classic psychedelics to treat cancer-related psychiatric distress.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/09540261.2018.1482261}{doi:10.1080/09540261.2018.1482261}.
\item Sophie-Charlotte Alice Adler (2018). \textit{Entheogene Pilze: Welches Potential bietet die psychoaktive Substanz Psilocybin für die moderne Psychotherapie in Forschung und Praxis? / Sophie-Charlotte Alice Adler}. Unknown journal. [published; OpenAlex]. \href{https://diglib.uibk.ac.at/ulbtirolhs/content/titleinfo/2793753}{source link}.
\item Chu Hsien Lim, Brian D. Kangas, Jack Bergman (2018). \textit{The Utility of Psilocybin in Managing Anxiety and Depression in Cancer Patients}. Biochemistry and Molecular Biology Education. [published; OpenAlex]. \href{https://www.jyi.org/2018-august/2018/7/6/the-utility-of-psilocybin-in-managing-anxiety-and-depression-in-cancer-patients}{source link}.
\item Barrett FS, Preller KH, Kaelen M (2018). \textit{Psychedelics and music: neuroscience and therapeutic implications.}. International review of psychiatry (Abingdon, England). [published; PubMed]. \href{https://doi.org/10.1080/09540261.2018.1484342}{doi:10.1080/09540261.2018.1484342}.
\item Hendricks PS (2018). \textit{Awe: a putative mechanism underlying the effects of classic psychedelic-assisted psychotherapy.}. International review of psychiatry (Abingdon, England). [published; PubMed]. \href{https://doi.org/10.1080/09540261.2018.1474185}{doi:10.1080/09540261.2018.1474185}.
\item Garcia-Romeu A, Richards WA (2018). \textit{Current perspectives on psychedelic therapy: use of serotonergic hallucinogens in clinical interventions.}. International review of psychiatry (Abingdon, England). [published; PubMed]. \href{https://doi.org/10.1080/09540261.2018.1486289}{doi:10.1080/09540261.2018.1486289}.
\item Puschner B, Wegenast C. (2018). \textit{Mushroom Poisoning Cases in Dogs and Cats: Diagnosis and Treatment of Hepatotoxic, Neurotoxic, Gastroenterotoxic, Nephrotoxic, and Muscarinic Mushrooms.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.cvsm.2018.06.008}{doi:10.1016/j.cvsm.2018.06.008}.
\item Barrett FS, Carbonaro TM, Hurwitz E, Johnson MW, Griffiths RR. (2018). \textit{Double-blind comparison of the two hallucinogens psilocybin and dextromethorphan: effects on cognition.}. Psychopharmacology. [published; Europe PMC]. \href{https://doi.org/10.1007/s00213-018-4981-x}{doi:10.1007/s00213-018-4981-x}.
\item Lord L, Expert P, Atasoy S, Roseman L, Rapuano K, Lambiotte R, Nutt DJ, Deco G, Carhart-Harris RL, Kringelbach ML, Cabral J. (2018). \textit{Altered trajectories in the dynamical repertoire of functional network states under psilocybin}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/376491}{doi:10.1101/376491}.
\item Awan AR, Winter JM, Turner D, Shaw WM, Suz LM, Bradshaw AJ, Ellis T, Dentinger BT. (2018). \textit{Convergent evolution of psilocybin biosynthesis by psychedelic mushrooms}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/374199}{doi:10.1101/374199}.
\item Boyce GR, Gluck-Thaler E, Slot JC, Stajich JE, Davis WJ, James TY, Cooley JR, Panaccione DG, Eilenberg J, Licht HHDF, Macias AM, Berger MC, Wickert KL, Stauder CM, Spahr EJ, Maust MD, Metheny AM, Simon C, Kritsky G, Hodge KT, Humber RA, Gullion T, Short DPG, Kijimoto T, Mozgai D, Arguedas N, Kasson MT. (2018). \textit{Psychoactive plant- and mushroom-associated alkaloids from two behavior modifying cicada pathogens}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/375105}{doi:10.1101/375105}.
\item Cameron LP, Olson DE. (2018). \textit{Dark Classics in Chemical Neuroscience: N, N-Dimethyltryptamine (DMT).}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/acschemneuro.8b00101}{doi:10.1021/acschemneuro.8b00101}.
\item Johns Hopkins University (2018). \textit{Psychopharmacology of Psilocybin in Cancer Patients}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT00465595}{source link}.
\item Geiger HA, Wurst MG, Daniels RN. (2018). \textit{DARK Classics in Chemical Neuroscience: Psilocybin.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/acschemneuro.8b00186}{doi:10.1021/acschemneuro.8b00186}.
\item Schenberg EE. (2018). \textit{Psychedelic-Assisted Psychotherapy: A Paradigm Shift in Psychiatric Research and Development.}. Frontiers in Pharmacology. [published; Europe PMC]. \href{https://doi.org/10.3389/fphar.2018.00733}{doi:10.3389/fphar.2018.00733}.
\item Barnby JM, Mehta MA. (2018). \textit{Psilocybin and Mental Health-Don't Lose Control.}. Frontiers in Psychiatry. [published; Europe PMC]. \href{https://doi.org/10.3389/fpsyt.2018.00293}{doi:10.3389/fpsyt.2018.00293}.
\item Skryabin VY, Vinnikova M, Nenastieva A, Alekseyuk V. (2018). \textit{Hallucinogen persisting perception disorder: A literature review and three case reports.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/10550887.2019.1673655}{doi:10.1080/10550887.2019.1673655}.
\item Nicholas CR, Henriquez KM, Gassman MC, Cooper KM, Muller D, Hetzel S, Brown RT, Cozzi NV, Thomas C, Hutson PR. (2018). \textit{High dose psilocybin is associated with positive subjective effects in healthy volunteers.}. Journal of Psychopharmacology. [published; Europe PMC]. \href{https://doi.org/10.1177/0269881118780713}{doi:10.1177/0269881118780713}.
\item Noorani T, Garcia-Romeu A, Swift TC, Griffiths RR, Johnson MW. (2018). \textit{Psychedelic therapy for smoking cessation: Qualitative analysis of participant accounts.}. Journal of Psychopharmacology. [published; Europe PMC]. \href{https://doi.org/10.1177/0269881118780612}{doi:10.1177/0269881118780612}.
\item Blei F, Baldeweg F, Fricke J, Hoffmeister D. (2018). \textit{Biocatalytic Production of Psilocybin and Derivatives in Tryptophan Synthase-Enhanced Reactions.}. Chemistry - A European Journal. [published; Europe PMC]. \href{https://doi.org/10.1002/chem.201801047}{doi:10.1002/chem.201801047}.
\item Erritzoe D, Roseman L, Nour MM, MacLean K, Kaelen M, Nutt DJ, Carhart-Harris RL. (2018). \textit{Effects of psilocybin therapy on personality structure.}. Acta Psychiatrica Scandinavica. [published; Europe PMC]. \href{https://doi.org/10.1111/acps.12904}{doi:10.1111/acps.12904}.
\item Johnson MW, Griffiths RR, Hendricks PS, Henningfield JE. (2018). \textit{The abuse potential of medical psilocybin according to the 8 factors of the Controlled Substances Act.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neuropharm.2018.05.012}{doi:10.1016/j.neuropharm.2018.05.012}.
\item Aixalà M, Dos Santos RG, Hallak JEC, Bouso JC. (2018). \textit{Psychedelics and Personality.}. ACS Chemical Neuroscience. [published; Europe PMC]. \href{https://doi.org/10.1021/acschemneuro.8b00237}{doi:10.1021/acschemneuro.8b00237}.
\item Vigerelli H, Sciani JM, Eula MAC, Sato LA, Antoniazzi MM, Jared C, Pimenta DC. (2018). \textit{Biological Effects and Biodistribution of Bufotenine on Mice.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1155/2018/1032638}{doi:10.1155/2018/1032638}.
\item Gabay AS, Carhart-Harris RL, Mazibuko N, Kempton MJ, Morrison PD, Nutt DJ, Mehta MA. (2018). \textit{Psilocybin and MDMA reduce costly punishment in the Ultimatum Game.}. Scientific Reports. [published; Europe PMC]. \href{https://doi.org/10.1038/s41598-018-26656-2}{doi:10.1038/s41598-018-26656-2}.
\item Thiessen MS, Walsh Z, Bird BM, Lafrance A. (2018). \textit{Psychedelic use and intimate partner violence: The role of emotion regulation.}. Journal of Psychopharmacology. [published; Europe PMC]. \href{https://doi.org/10.1177/0269881118771782}{doi:10.1177/0269881118771782}.
\item Hoefgen S, Lin J, Fricke J, Stroe MC, Mattern DJ, Kufs JE, Hortschansky P, Brakhage AA, Hoffmeister D, Valiante V. (2018). \textit{Facile assembly and fluorescence-based screening method for heterologous expression of biosynthetic pathways in fungi.}. Metabolic Engineering. [published; Europe PMC]. \href{https://doi.org/10.1016/j.ymben.2018.05.014}{doi:10.1016/j.ymben.2018.05.014}.
\item Whelan A, Johnson MI. (2018). \textit{Lysergic acid diethylamide and psilocybin for the management of patients with persistent pain: a potential role?}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.2217/pmt-2017-0068}{doi:10.2217/pmt-2017-0068}.
\item Grimm O, Kraehenmann R, Preller KH, Seifritz E, Vollenweider FX. (2018). \textit{Psilocybin modulates functional connectivity of the amygdala during emotional face discrimination.}. European Neuropsychopharmacology. [published; Europe PMC]. \href{https://doi.org/10.1016/j.euroneuro.2018.03.016}{doi:10.1016/j.euroneuro.2018.03.016}.
\item Michael C. McKenna, John R. Fedota, Albert Garcia-Romeu, Matthew R. Johnson, Roland R. Griffiths, Elliot A. Stein (2018). \textit{T263. Psilocybin Improves Cognitive Control and Downregulates Parietal Cortex in Treatment-Seeking Smokers}. Biological Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.biopsych.2018.02.600}{doi:10.1016/j.biopsych.2018.02.600}.
\item Malone TC, Mennenga SE, Guss J, Podrebarac SK, Owens LT, Bossis AP, Belser AB, Agin-Liebes G, Bogenschutz MP, Ross S. (2018). \textit{Individual Experiences in Four Cancer Patients Following Psilocybin-Assisted Psychotherapy.}. Frontiers in Pharmacology. [published; Europe PMC]. \href{https://doi.org/10.3389/fphar.2018.00256}{doi:10.3389/fphar.2018.00256}.
\item Carrillo F, Sigman M, Fernández Slezak D, Ashton P, Fitzgerald L, Stroud J, Nutt DJ, Carhart-Harris RL. (2018). \textit{Natural speech algorithm applied to baseline interview data can predict which patients will respond to psilocybin for treatment-resistant depression.}. Journal of Affective Disorders. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jad.2018.01.006}{doi:10.1016/j.jad.2018.01.006}.
\item Ramachandran V, Chunharas C, Marcus Z, Furnish T, Lin A. (2018). \textit{Relief from intractable phantom pain by combining psilocybin and mirror visual-feedback (MVF).}. Neurocase. [published; Europe PMC]. \href{https://doi.org/10.1080/13554794.2018.1468469}{doi:10.1080/13554794.2018.1468469}.
\item Dorsen C, Palamar J, Shedlin MG. (2018). \textit{Ceremonial "plant medicine" use and its relationship to recreational drug use: an exploratory study.}. Addiction Research \& Theory. [published; Europe PMC]. \href{https://doi.org/10.1080/16066359.2018.1455187}{doi:10.1080/16066359.2018.1455187}.
\item Kuypers KPC. (2018). \textit{Out of the box: A psychedelic model to study the creative mind.}. Medical Hypotheses. [published; Europe PMC]. \href{https://doi.org/10.1016/j.mehy.2018.03.010}{doi:10.1016/j.mehy.2018.03.010}.
\item Elaheh Mahmoudi, Mehrdad Faizi, Reza Hajiaghaee, Ali Razmi (2018). \textit{Alteration of Depressive-like Behaviors by Psilocybe cubensis Alkaloid Extract in Mice: the Role of Glutamate Pathway}. DOAJ (DOAJ: Directory of Open Access Journals). [published; OpenAlex]. \href{https://doi.org/10.22127/rjp.2018.58486}{doi:10.22127/rjp.2018.58486}.
\item Barrett FS, Schlienz NJ, Lembeck N, Waqas M, Vandrey R. (2018). \textit{"Hallucinations" Following Acute Cannabis Dosing: A Case Report and Comparison to Other Hallucinogenic Drugs.}. Cannabis and Cannabinoid Research. [published; Europe PMC]. \href{https://doi.org/10.1089/can.2017.0052}{doi:10.1089/can.2017.0052}.
\item Nichols DE. (2018). \textit{Dark Classics in Chemical Neuroscience: Lysergic Acid Diethylamide (LSD).}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/acschemneuro.8b00043}{doi:10.1021/acschemneuro.8b00043}.
\item Reynolds HT, Vijayakumar V, Gluck-Thaler E, Korotkin HB, Matheny PB, Slot JC. (2018). \textit{Horizontal gene cluster transfer increased hallucinogenic mushroom diversity.}. Evolution Letters. [published; Europe PMC]. \href{https://doi.org/10.1002/evl3.42}{doi:10.1002/evl3.42}.
\item Nielson EM, May DG, Forcehimes AA, Bogenschutz MP. (2018). \textit{The Psychedelic Debriefing in Alcohol Dependence Treatment: Illustrating Key Change Phenomena through Qualitative Content Analysis of Clinical Sessions.}. Frontiers in Pharmacology. [published; Europe PMC]. \href{https://doi.org/10.3389/fphar.2018.00132}{doi:10.3389/fphar.2018.00132}.
\item Bogenschutz MP, Podrebarac SK, Duane JH, Amegadzie SS, Malone TC, Owens LT, Ross S, Mennenga SE. (2018). \textit{Clinical Interpretations of Patient Experience in a Trial of Psilocybin-Assisted Psychotherapy for Alcohol Use Disorder.}. Frontiers in Pharmacology. [published; Europe PMC]. \href{https://doi.org/10.3389/fphar.2018.00100}{doi:10.3389/fphar.2018.00100}.
\item Kaelen M, Giribaldi B, Raine J, Evans L, Timmerman C, Rodriguez N, Roseman L, Feilding A, Nutt D, Carhart-Harris R. (2018). \textit{The hidden therapist: evidence for a central role of music in psychedelic therapy.}. Psychopharmacology. [published; Europe PMC]. \href{https://doi.org/10.1007/s00213-017-4820-5}{doi:10.1007/s00213-017-4820-5}.
\item N. M. Uaniti, O. O. Ratnayani, S. A. Sari (2018). \textit{ANALISIS SENYAWA HALUSINOGEN DALAM MINUMAN MAGIC MUSHROOM (Psilocybin baeocystis) YANG BEREDAR DI KAWASAN KUTA-BALI}. Jurnal Kimia. [published; OpenAlex]. \href{https://doi.org/10.24843/jchem.2018.v12.i01.p17}{doi:10.24843/jchem.2018.v12.i01.p17}.
\item Byock I. (2018). \textit{Taking Psychedelics Seriously.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1089/jpm.2017.0684}{doi:10.1089/jpm.2017.0684}.
\item Roseman L, Nutt DJ, Carhart-Harris RL. (2018). \textit{Quality of Acute Psychedelic Experience Predicts Therapeutic Efficacy of Psilocybin for Treatment-Resistant Depression.}. Frontiers in Pharmacology. [published; Europe PMC]. \href{https://doi.org/10.3389/fphar.2017.00974}{doi:10.3389/fphar.2017.00974}.
\item Lyons T, Carhart-Harris RL. (2018). \textit{Increased nature relatedness and decreased authoritarian political views after psilocybin for treatment-resistant depression.}. Journal of Psychopharmacology. [published; Europe PMC]. \href{https://doi.org/10.1177/0269881117748902}{doi:10.1177/0269881117748902}.
\item Bravermanová A, Viktorinová M, Tylš F, Novák T, Androvičová R, Korčák J, Horáček J, Balíková M, Griškova-Bulanova I, Danielová D, Vlček P, Mohr P, Brunovský M, Koudelka V, Páleníček T. (2018). \textit{Psilocybin disrupts sensory and higher order cognitive processing but not pre-attentive cognitive processing-study on P300 and mismatch negativity in healthy volunteers.}. Psychopharmacology. [published; Europe PMC]. \href{https://doi.org/10.1007/s00213-017-4807-2}{doi:10.1007/s00213-017-4807-2}.
\item Belton Cadmael (2017). \textit{The The hallucinogenic species of the Psilocybe genus on Cancer}. Unknown journal. [published; OpenAlex]. \href{https://demo.openjournaltheme.com/novelty/article/view/69}{source link}.
\item Anisha Lela Larsson (2017). \textit{Mikrodosering av lysergsyradietylamid och psilocybin och dess effekter på psykisk hälsa}. KTH Publication Database DiVA (KTH Royal Institute of Technology). [published; OpenAlex]. \href{http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-358476}{source link}.
\item Thomas Cody Swift (2017). \textit{Cancer at the Dinner Table: Experiences of Psilocybin-Assisted Psychotherapy for the Treatment of Cancer-Related Psychological Distress}. Western CEDAR (Western Washington University). [published; OpenAlex]. \href{https://cedar.wwu.edu/pci/lectures\_events/holistic\_pain\_management/3}{source link}.
\item Lord L. (2017). \textit{Integration and segregation in whole-brain networks: implications for altered states of consciousness}. University of Oxford. [published; Europe PMC]. \href{https://europepmc.org/article/ETH/770691}{source link}.
\item Kometer M, Vollenweider FX. (2017). \textit{Serotonergic Hallucinogen-Induced Visual Perceptual Alterations.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/7854\_2016\_461}{doi:10.1007/7854\_2016\_461}.
\item Preller KH, Vollenweider FX (2017). \textit{Phenomenology, Structure, and Dynamic of Psychedelic States.}. Current topics in behavioral neurosciences. [published; PubMed]. \href{https://doi.org/10.1007/7854\_2016\_459}{doi:10.1007/7854\_2016\_459}.
\item Halberstadt AL, Geyer MA (2017). \textit{Effect of Hallucinogens on Unconditioned Behavior.}. Current topics in behavioral neurosciences. [published; PubMed]. \href{https://doi.org/10.1007/7854\_2016\_466}{doi:10.1007/7854\_2016\_466}.
\item Barrett FS, Griffiths RR. (2017). \textit{Classic Hallucinogens and Mystical Experiences: Phenomenology and Neural Correlates.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/7854\_2017\_474}{doi:10.1007/7854\_2017\_474}.
\item Bogenschutz MP, Ross S. (2017). \textit{Therapeutic Applications of Classic Hallucinogens.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/7854\_2016\_464}{doi:10.1007/7854\_2016\_464}.
\item Martin DA, Nichols CD. (2017). \textit{The Effects of Hallucinogens on Gene Expression.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/7854\_2017\_479}{doi:10.1007/7854\_2017\_479}.
\item López-Giménez JF, González-Maeso J. (2017). \textit{Hallucinogens and Serotonin 5-HT2A Receptor-Mediated Signaling Pathways.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/7854\_2017\_478}{doi:10.1007/7854\_2017\_478}.
\item Sherwood AM, Prisinzano TE (2017). \textit{Novel psychotherapeutics - a cautiously optimistic focus on Hallucinogens.}. Expert review of clinical pharmacology. [published; PubMed]. \href{https://doi.org/10.1080/17512433.2018.1415755}{doi:10.1080/17512433.2018.1415755}.
\item Canal CE. (2017). \textit{Serotonergic Psychedelics: Experimental Approaches for Assessing Mechanisms of Action.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/164\_2018\_107}{doi:10.1007/164\_2018\_107}.
\item Swanson LR (2017). \textit{Unifying Theories of Psychedelic Drug Effects.}. Frontiers in pharmacology. [published; PubMed]. \href{https://doi.org/10.3389/fphar.2018.00172}{doi:10.3389/fphar.2018.00172}.
\item Brandenburg WE, Ward KJ (2017). \textit{Mushroom poisoning epidemiology in the United States.}. Mycologia. [published; PubMed]. \href{https://doi.org/10.1080/00275514.2018.1479561}{doi:10.1080/00275514.2018.1479561}.
\item Witkin JM, Knutson DE, Rodriguez GJ, Shi S. (2017). \textit{Rapid-Acting Antidepressants.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.2174/1381612824666180730104707}{doi:10.2174/1381612824666180730104707}.
\item Roseman L, Demetriou L, Wall MB, Nutt DJ, Carhart-Harris RL. (2017). \textit{Increased amygdala responses to emotional faces after psilocybin for treatment-resistant depression.}. Neuropharmacology. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neuropharm.2017.12.041}{doi:10.1016/j.neuropharm.2017.12.041}.
\item Rucker JJH, Iliff J, Nutt DJ. (2017). \textit{Psychiatry \& the psychedelic drugs. Past, present \& future.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neuropharm.2017.12.040}{doi:10.1016/j.neuropharm.2017.12.040}.
\item University of Helsinki (2017). \textit{Psilocybin and Depression - Assessing the Long-term Effects of a Single Administration of Psilocybin on the Psychiatric Symptoms and Brain Activity of Patients With Severe Depression}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT03380442}{source link}.
\item Brown RT, Nicholas CR, Cozzi NV, Gassman MC, Cooper KM, Muller D, Thomas CD, Hetzel SJ, Henriquez KM, Ribaudo AS, Hutson PR. (2017). \textit{Pharmacokinetics of Escalating Doses of Oral Psilocybin in Healthy Adults.}. Clinical Pharmacokinetics. [published; Europe PMC]. \href{https://doi.org/10.1007/s40262-017-0540-6}{doi:10.1007/s40262-017-0540-6}.
\item Rocchi R, Simeoni MC, Montesano C, Vannutelli G, Curini R, Sergi M, Compagnone D. (2017). \textit{Analysis of new psychoactive substances in oral fluids by means of microextraction by packed sorbent followed by ultra-high-performance liquid chromatography-tandem mass spectrometry.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1002/dta.2330}{doi:10.1002/dta.2330}.
\item Orsolini L, Papanti GD, De Berardis D, Guirguis A, Corkery JM, Schifano F. (2017). \textit{The "Endless Trip" among the NPS Users: Psychopathology and Psychopharmacology in the Hallucinogen-Persisting Perception Disorder. A Systematic Review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fpsyt.2017.00240}{doi:10.3389/fpsyt.2017.00240}.
\item Kraehenmann R, Pokorny D, Aicher H, Preller KH, Pokorny T, Bosch OG, Seifritz E, Vollenweider FX. (2017). \textit{LSD Increases Primary Process Thinking via Serotonin 2A Receptor Activation.}. Frontiers in Pharmacology. [published; Europe PMC]. \href{https://doi.org/10.3389/fphar.2017.00814}{doi:10.3389/fphar.2017.00814}.
\item Carhart-Harris RL, Bolstridge M, Day CMJ, Rucker J, Watts R, Erritzoe DE, Kaelen M, Giribaldi B, Bloomfield M, Pilling S, Rickard JA, Forbes B, Feilding A, Taylor D, Curran HV, Nutt DJ. (2017). \textit{Psilocybin with psychological support for treatment-resistant depression: six-month follow-up.}. Psychopharmacology. [published; Europe PMC]. \href{https://doi.org/10.1007/s00213-017-4771-x}{doi:10.1007/s00213-017-4771-x}.
\item Carbonaro TM, Johnson MW, Hurwitz E, Griffiths RR. (2017). \textit{Double-blind comparison of the two hallucinogens psilocybin and dextromethorphan: similarities and differences in subjective experiences.}. Psychopharmacology. [published; Europe PMC]. \href{https://doi.org/10.1007/s00213-017-4769-4}{doi:10.1007/s00213-017-4769-4}.
\item Barbara Geller (2017). \textit{Can Psilocybin Treat Severe Depression}. Journal watch. [published; OpenAlex]. \href{https://doi.org/10.1056/nejm-jw.na45292}{doi:10.1056/nejm-jw.na45292}.
\item Stroud JB, Freeman TP, Leech R, Hindocha C, Lawn W, Nutt DJ, Curran HV, Carhart-Harris RL. (2017). \textit{Psilocybin with psychological support improves emotional face recognition in treatment-resistant depression.}. Psychopharmacology. [published; Europe PMC]. \href{https://doi.org/10.1007/s00213-017-4754-y}{doi:10.1007/s00213-017-4754-y}.
\item Hendricks PS, Crawford MS, Cropsey KL, Copes H, Sweat NW, Walsh Z, Pavela G. (2017). \textit{The relationships of classic psychedelic use with criminal behavior in the United States adult population.}. Journal of Psychopharmacology. [published; Europe PMC]. \href{https://doi.org/10.1177/0269881117735685}{doi:10.1177/0269881117735685}.
\item Carhart-Harris RL, Roseman L, Bolstridge M, Demetriou L, Pannekoek JN, Wall MB, Tanner M, Kaelen M, McGonigle J, Murphy K, Leech R, Curran HV, Nutt DJ. (2017). \textit{Psilocybin for treatment-resistant depression: fMRI-measured brain mechanisms.}. Scientific Reports. [published; Europe PMC]. \href{https://doi.org/10.1038/s41598-017-13282-7}{doi:10.1038/s41598-017-13282-7}.
\item Griffiths RR, Johnson MW, Richards WA, Richards BD, Jesse R, MacLean KA, Barrett FS, Cosimano MP, Klinedinst MA. (2017). \textit{Psilocybin-occasioned mystical-type experience in combination with meditation and other spiritual practices produces enduring positive changes in psychological functioning and in trait measures of prosocial attitudes and behaviors.}. Journal of Psychopharmacology. [published; Europe PMC]. \href{https://doi.org/10.1177/0269881117731279}{doi:10.1177/0269881117731279}.
\item Di Giovanni G, De Deurwaerdère P. (2017). \textit{TCB-2 [(7R)-3-bromo-2, 5-dimethoxy-bicyclo[4.2.0]octa-1,3,5-trien-7-yl]methanamine]: A hallucinogenic drug, a selective 5-HT2A receptor pharmacological tool, or none of the above?}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neuropharm.2017.10.004}{doi:10.1016/j.neuropharm.2017.10.004}.
\item Dolder PC, Schmid Y, Steuer AE, Kraemer T, Rentsch KM, Hammann F, Liechti ME (2017). \textit{Pharmacokinetics and Pharmacodynamics of Lysergic Acid Diethylamide in Healthy Subjects.}. Clinical pharmacokinetics. [published; PubMed]. \href{https://doi.org/10.1007/s40262-017-0513-9}{doi:10.1007/s40262-017-0513-9}.
\item Kyzar EJ, Nichols CD, Gainetdinov RR, Nichols DE, Kalueff AV. (2017). \textit{Psychedelic Drugs in Biomedicine.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.tips.2017.08.003}{doi:10.1016/j.tips.2017.08.003}.
\item Reiche S, Hermle L, Gutwinski S, Jungaberle H, Gasser P, Majić T. (2017). \textit{Serotonergic hallucinogens in the treatment of anxiety and depression in patients suffering from a life-threatening disease: A systematic review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.pnpbp.2017.09.012}{doi:10.1016/j.pnpbp.2017.09.012}.
\item Andersson M, Persson M, Kjellgren A. (2017). \textit{Psychoactive substances as a last resort-a qualitative study of self-treatment of migraine and cluster headaches.}. Harm Reduction Journal. [published; Europe PMC]. \href{https://doi.org/10.1186/s12954-017-0186-6}{doi:10.1186/s12954-017-0186-6}.
\item Pokorny T, Preller KH, Kometer M, Dziobek I, Vollenweider FX. (2017). \textit{Effect of Psilocybin on Empathy and Moral Decision-Making.}. The International Journal of Neuropsychopharmacology. [published; Europe PMC]. \href{https://doi.org/10.1093/ijnp/pyx047}{doi:10.1093/ijnp/pyx047}.
\item Fricke J, Blei F, Hoffmeister D. (2017). \textit{Enzymatic Synthesis of Psilocybin.}. Angewandte Chemie International Edition. [published; Europe PMC]. \href{https://doi.org/10.1002/anie.201705489}{doi:10.1002/anie.201705489}.
\item Sellers EM, Leiderman DB. (2017). \textit{Psychedelic Drugs as Therapeutics: No Illusions About the Challenges.}. Clinical Pharmacology \& Therapeutics. [published; Europe PMC]. \href{https://doi.org/10.1002/cpt.776}{doi:10.1002/cpt.776}.
\item Sessa B. (2017). \textit{The 21st century psychedelic renaissance: heroic steps forward on the back of an elephant.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s00213-017-4713-7}{doi:10.1007/s00213-017-4713-7}.
\item STEVE RITTER (2017). \textit{‘Magic mushroom’ enzyme mystery solved}. C\&EN Global Enterprise. [published; OpenAlex]. \href{https://doi.org/10.1021/cen-09533-notw1}{doi:10.1021/cen-09533-notw1}.
\item Al-Imam A. (2017). \textit{Could Hallucinogens Induce Permanent Pupillary Changes in (Ab)users? A Case Report from New Zealand.}. Case Reports in Neurological Medicine. [published; Europe PMC]. \href{https://doi.org/10.1155/2017/2503762}{doi:10.1155/2017/2503762}.
\item Reynolds HT, Vijayakumar V, Gluck-Thaler E, Korotkin HB, Matheny PB, Slot JC. (2017). \textit{Horizontal gene cluster transfer increased hallucinogenic mushroom diversity}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/176347}{doi:10.1101/176347}.
\item Janis Fricke, Felix Blei, Dirk Hoffmeister (2017). \textit{Enzymatische Synthese von Psilocybin}. Angewandte Chemie. [published; OpenAlex]. \href{https://doi.org/10.1002/ange.201705489}{doi:10.1002/ange.201705489}.
\item Paul May (2017). \textit{Psilocybin and Mescaline - Molecule of the Month October 1999 [Archived version]}. Bristol Research (University of Bristol). [published; OpenAlex]. \href{https://doi.org/10.6084/m9.figshare.5245549}{doi:10.6084/m9.figshare.5245549}.
\item Barrett FS, Robbins H, Smooke D, Brown JL, Griffiths RR. (2017). \textit{Qualitative and Quantitative Features of Music Reported to Support Peak Mystical Experiences during Psychedelic Therapy Sessions.}. Frontiers in Psychology. [published; Europe PMC]. \href{https://doi.org/10.3389/fpsyg.2017.01238}{doi:10.3389/fpsyg.2017.01238}.
\item Lewis CR, Preller KH, Kraehenmann R, Michels L, Staempfli P, Vollenweider FX. (2017). \textit{Two dose investigation of the 5-HT-agonist psilocybin on relative and global cerebral blood flow.}. NeuroImage. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neuroimage.2017.07.020}{doi:10.1016/j.neuroimage.2017.07.020}.
\item Larsen JK. (2017). \textit{LSD treatment in Scandinavia: emphasizing indications and short-term treatment outcomes of 151 patients in Denmark.}. Nordic Journal of Psychiatry. [published; Europe PMC]. \href{https://doi.org/10.1080/08039488.2017.1336251}{doi:10.1080/08039488.2017.1336251}.
\item Johnson MW, Griffiths RR. (2017). \textit{Potential Therapeutic Effects of Psilocybin.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s13311-017-0542-y}{doi:10.1007/s13311-017-0542-y}.
\item Majić T, Jungaberle H, Jungaberle H, Schmidt TT, Zeuch A, Hermle L, Gallinat J. (2017). \textit{[Psychotherapy with Adjuvant use of Serotonergic Psychoactive Substances: Possibilities and Challenges].}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1055/s-0043-103085}{doi:10.1055/s-0043-103085}.
\item Feng LY, Battulga A, Han E, Chung H, Li JH (2017). \textit{New psychoactive substances of natural origin: A brief review.}. Journal of food and drug analysis. [published; PubMed]. \href{https://doi.org/10.1016/j.jfda.2017.04.001}{doi:10.1016/j.jfda.2017.04.001}.
\item Forstmann M, Sagioglou C. (2017). \textit{Lifetime experience with (classic) psychedelics predicts pro-environmental behavior through an increase in nature relatedness.}. Journal of Psychopharmacology. [published; Europe PMC]. \href{https://doi.org/10.1177/0269881117714049}{doi:10.1177/0269881117714049}.
\item Rosalind Watts, Camilla Day, Jacob Krzanowski, David Nutt, Robin Carhart-Harris (2017). \textit{Patients’ Accounts of Increased “Connectedness” and “Acceptance” After Psilocybin for Treatment-Resistant Depression}. Journal of Humanistic Psychology. [published; OpenAlex]. \href{https://doi.org/10.1177/0022167817709585}{doi:10.1177/0022167817709585}.
\item Thomas Cody Swift, Alexander Belser, Gabrielle Agin-Liebes, Neşe Devenot, Sara Terrana, Harris L. Friedman, Jeffrey Guss, Anthony P. Bossis, Stephen Ross (2017). \textit{Cancer at the Dinner Table: Experiences of Psilocybin-Assisted Psychotherapy for the Treatment of Cancer-Related Distress}. Journal of Humanistic Psychology. [published; OpenAlex]. \href{https://doi.org/10.1177/0022167817715966}{doi:10.1177/0022167817715966}.
\item Barrett FS, Johnson MW, Griffiths RR. (2017). \textit{Neuroticism is associated with challenging experiences with psilocybin mushrooms.}. Personality and Individual Differences. [published; Europe PMC]. \href{https://doi.org/10.1016/j.paid.2017.06.004}{doi:10.1016/j.paid.2017.06.004}.
\item Fabregat-Safont D, Barneo-Muñoz M, Martinez-Garcia F, Sancho JV, Hernández F, Ibáñez M. (2017). \textit{Proposal of 5-methoxy-N-methyl-N-isopropyltryptamine consumption biomarkers through identification of in vivo metabolites from mice.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.chroma.2017.06.010}{doi:10.1016/j.chroma.2017.06.010}.
\item Strauss N. (2017). \textit{Psilocybin-assisted therapy for anxiety and depression: implications for euthanasia.}. The Medical Journal of Australia. [published; Europe PMC]. \href{https://doi.org/10.5694/mja17.00081}{doi:10.5694/mja17.00081}.
\item Sellers EM. (2017). \textit{Psilocybin: Good Trip or Bad Trip.}. Clinical Pharmacology \& Therapeutics. [published; Europe PMC]. \href{https://doi.org/10.1002/cpt.697}{doi:10.1002/cpt.697}.
\item Anne Walley (2017). \textit{The Effects of LSD and Psilocin on Anxiety-Related Behaviours in Zebrafish}. Student Research Proceedings. [published; OpenAlex]. \href{https://journals.macewan.ca/studentresearch/article/view/1171}{source link}.
\item Thomas K, Malcolm B, Lastra D. (2017). \textit{Psilocybin-Assisted Therapy: A Review of a Novel Treatment for Psychiatric Disorders.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/02791072.2017.1320734}{doi:10.1080/02791072.2017.1320734}.
\item Alexander Belser, Gabrielle Agin-Liebes, Thomas Cody Swift, Sara Terrana, Neşe Devenot, Harris L. Friedman, Jeffrey Guss, Anthony P. Bossis, Stephen Ross (2017). \textit{Patient Experiences of Psilocybin-Assisted Psychotherapy: An Interpretative Phenomenological Analysis}. Journal of Humanistic Psychology. [published; OpenAlex]. \href{https://doi.org/10.1177/0022167817706884}{doi:10.1177/0022167817706884}.
\item Carhart-Harris RL, Goodwin GM. (2017). \textit{The Therapeutic Potential of Psychedelic Drugs: Past, Present, and Future.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/npp.2017.84}{doi:10.1038/npp.2017.84}.
\item Schartner MM, Carhart-Harris RL, Barrett AB, Seth AK, Muthukumaraswamy SD. (2017). \textit{Increased spontaneous MEG signal diversity for psychoactive doses of ketamine, LSD and psilocybin.}. Scientific Reports. [published; Europe PMC]. \href{https://doi.org/10.1038/srep46421}{doi:10.1038/srep46421}.
\item Schenk-Jaeger KM, Hofer-Lentner KE, Plenert B, Eckart D, Haberl B, Schulze G, Borchert-Avalone J, Stedtler U, Pfab R (2017). \textit{No clinically relevant effects in children after accidental ingestion of Panaeolina foenisecii (lawn mower's mushroom).}. Clinical toxicology (Philadelphia, Pa.). [published; PubMed]. \href{https://doi.org/10.1080/15563650.2016.1271129}{doi:10.1080/15563650.2016.1271129}.
\item Dos Santos RG, Bouso JC, Hallak JEC. (2017). \textit{Ayahuasca, dimethyltryptamine, and psychosis: a systematic review of human studies.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/2045125316689030}{doi:10.1177/2045125316689030}.
\item Huestis MA, Tyndale RF. (2017). \textit{Designer Drugs 2.0.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1002/cpt.575}{doi:10.1002/cpt.575}.
\item Dinis-Oliveira RJ. (2017). \textit{Metabolism of psilocybin and psilocin: clinical and forensic toxicological relevance.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/03602532.2016.1278228}{doi:10.1080/03602532.2016.1278228}.
\item Idell RD, Florova G, Komissarov AA, Shetty S, Girard RB, Idell S. (2017). \textit{The fibrinolytic system: A new target for treatment of depression with psychedelics.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.mehy.2017.01.013}{doi:10.1016/j.mehy.2017.01.013}.
\item Theresa M. Carbonaro, Matthew W. Johnson, Roland R. Griffiths (2017). \textit{Comparison of anomalous experiences after ingesting psilocybin mushrooms in research and non-research settings}. Drug and Alcohol Dependence. [published; OpenAlex]. \href{https://doi.org/10.1016/j.drugalcdep.2016.08.107}{doi:10.1016/j.drugalcdep.2016.08.107}.
\item Frederick S. Barrett, Matthew W. Johnson, Roland R. Griffiths (2017). \textit{Psilocybin in long-term meditators: Effects on default mode network functional connectivity and retrospective ratings of qualitative experience}. Drug and Alcohol Dependence. [published; OpenAlex]. \href{https://doi.org/10.1016/j.drugalcdep.2016.08.058}{doi:10.1016/j.drugalcdep.2016.08.058}.
\item Johnson MW, Garcia-Romeu A, Johnson PS, Griffiths RR. (2017). \textit{An online survey of tobacco smoking cessation associated with naturalistic psychedelic use.}. Journal of Psychopharmacology. [published; Europe PMC]. \href{https://doi.org/10.1177/0269881116684335}{doi:10.1177/0269881116684335}.
\item Unknown authors (2016). \textit{Magic mushrooms as a treatment for depression}. Clinical pharmacist. [published; OpenAlex]. \href{https://doi.org/10.1211/cp.2017.20204046}{doi:10.1211/cp.2017.20204046}.
\item Paul May (2016). \textit{Psilocybin and Mescaline - Molecule of the Month October 1999 [Archived version]}. Open MIND. [published; OpenAlex]. \href{https://doi.org/10.6084/m9.figshare.5245549.v1}{doi:10.6084/m9.figshare.5245549.v1}.
\item Krishna Lavanya, T.R. Baggi (2016). \textit{A New Spectrophotometric Method for the Determination of Psilocin and Psilocybin}. International Journal of Analytical and Applied Chemistry. [published; OpenAlex]. \href{http://chemical.journalspub.info/index.php?journal=JAAC\&page=article\&op=view\&path\%5B\%5D=263}{source link}.
\item Natalie Engström (2016). \textit{Lysergsyradietylamid (LSD) och psilocybin vid depression och ångestsjukdom: En litteraturstudie om effekter och biverkningar av LSD- och psilocybin-assisterad psykoterapi}. KTH Publication Database DiVA (KTH Royal Institute of Technology). [published; OpenAlex]. \href{http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-136681}{source link}.
\item Thomas L. Walden (2016). \textit{"Flipping the Switch": Connective Effect of Psilocybin Mushrooms Help Hospice Patients Enjoy End of Life}. Unknown journal. [published; OpenAlex]. \href{https://doi.org/10.13140/rg.2.2.16083.99361}{doi:10.13140/rg.2.2.16083.99361}.
\item Carlyn Delavan (2016). \textit{Narrative therapy-assisted psilocybin use for treatment of depression}. Unknown journal. [published; OpenAlex]. \href{https://digitalcommons.spu.edu/spfc\_research\_conference/spfc\_conf\_2017/spfc\_conf\_2017\_events/43/}{source link}.
\item Piret Saar-Reismaa, Merike Vaher, Mihkel Kaljurand, Maria Kulp, Jekaterina Mazina-Šinkar (2016). \textit{Simultaneous determination of γ-hydroxybutyric acid, ibotenic acid and psilocybin in saliva samples by capillary electrophoresis coupled with a contactless conductivity detector}. Analytical Methods. [published; OpenAlex]. \href{https://doi.org/10.1039/c7ay00742f}{doi:10.1039/c7ay00742f}.
\item Golden C. (2016). \textit{Neuronal dynamics of the anterior cingulate cortex during working memory and serotonergic manipulation}. Imperial College London. [published; Europe PMC]. \href{https://doi.org/10.25560/45527}{doi:10.25560/45527}.
\item Kraehenmann R. (2016). \textit{Dreams and Psychedelics: Neurophenomenological Comparison and Therapeutic Implications.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.2174/1573413713666170619092629}{doi:10.2174/1573413713666170619092629}.
\item Letheby C, Gerrans P (2016). \textit{Self unbound: ego dissolution in psychedelic experience.}. Neuroscience of consciousness. [published; PubMed]. \href{https://doi.org/10.1093/nc/nix016}{doi:10.1093/nc/nix016}.
\item Daniel J, Haberman M. (2016). \textit{Clinical potential of psilocybin as a treatment for mental health conditions.}. Mental Health Clinician. [published; Europe PMC]. \href{https://doi.org/10.9740/mhc.2017.01.024}{doi:10.9740/mhc.2017.01.024}.
\item Nichols DE, Johnson MW, Nichols CD. (2016). \textit{Psychedelics as Medicines: An Emerging New Paradigm.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1002/cpt.557}{doi:10.1002/cpt.557}.
\item Bobby Lazzara (2016). \textit{Psilocybin to Manage Cancer-Related Depression}. Unknown journal. [published; OpenAlex]. \href{https://www.endocrinologynetwork.com/hormone-related-cancers/psilocybin-manage-cancer-related-depression}{source link}.
\item Nutt D. (2016). \textit{Psilocybin for anxiety and depression in cancer care? Lessons from the past and prospects for the future.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/0269881116675754}{doi:10.1177/0269881116675754}.
\item Ross S, Bossis A, Guss J, Agin-Liebes G, Malone T, Cohen B, Mennenga SE, Belser A, Kalliontzi K, Babb J, Su Z, Corby P, Schmidt BL. (2016). \textit{Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial.}. Journal of Psychopharmacology. [published; Europe PMC]. \href{https://doi.org/10.1177/0269881116675512}{doi:10.1177/0269881116675512}.
\item Griffiths RR, Johnson MW, Carducci MA, Umbricht A, Richards WA, Richards BD, Cosimano MP, Klinedinst MA. (2016). \textit{Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial.}. Journal of Psychopharmacology. [published; Europe PMC]. \href{https://doi.org/10.1177/0269881116675513}{doi:10.1177/0269881116675513}.
\item Goodwin GM. (2016). \textit{Psilocybin: Psychotherapy or drug?}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/0269881116675757}{doi:10.1177/0269881116675757}.
\item Summergrad P. (2016). \textit{Psilocybin in end of life care: Implications for further research.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/0269881116675758}{doi:10.1177/0269881116675758}.
\item Shelton RC, Hendricks PS. (2016). \textit{Psilocybin and palliative end-of-life care.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/0269881116675764}{doi:10.1177/0269881116675764}.
\item McCorvy JD, Olsen RH, Roth BL. (2016). \textit{Psilocybin for depression and anxiety associated with life-threatening illnesses.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/0269881116675771}{doi:10.1177/0269881116675771}.
\item Kelmendi B, Corlett P, Ranganathan M, D'Souza C, Krystal JH. (2016). \textit{The role of psychedelics in palliative care reconsidered: A case for psilocybin.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/0269881116675781}{doi:10.1177/0269881116675781}.
\item Spiegel D. (2016). \textit{Psilocybin-assisted psychotherapy for dying cancer patients - aiding the final trip.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/0269881116675783}{doi:10.1177/0269881116675783}.
\item Breckenridge A, Grobbee DE. (2016). \textit{Psilocybin: promising results in double-blind trials require confirmation by real-world evidence.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/0269881116675784}{doi:10.1177/0269881116675784}.
\item Bodnar Willard MA, McGuffin VL, Smith RW. (2016). \textit{Statistical comparison of mass spectra for identification of amphetamine-type stimulants.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.forsciint.2016.11.013}{doi:10.1016/j.forsciint.2016.11.013}.
\item Barrett FS, Bradstreet MP, Leoutsakos JS, Johnson MW, Griffiths RR. (2016). \textit{The Challenging Experience Questionnaire: Characterization of challenging experiences with psilocybin mushrooms.}. Journal of Psychopharmacology. [published; Europe PMC]. \href{https://doi.org/10.1177/0269881116678781}{doi:10.1177/0269881116678781}.
\item Rucker JJ, Jelen LA, Flynn S, Frowde KD, Young AH. (2016). \textit{Psychedelics in the treatment of unipolar mood disorders: a systematic review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/0269881116679368}{doi:10.1177/0269881116679368}.
\item Dos Santos RG, Osório FL, Crippa JAS, Hallak JEC. (2016). \textit{Classical hallucinogens and neuroimaging: A systematic review of human studies: Hallucinogens and neuroimaging.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neubiorev.2016.10.026}{doi:10.1016/j.neubiorev.2016.10.026}.
\item Mahapatra A, Gupta R. (2016). \textit{Role of psilocybin in the treatment of depression.}. Therapeutic Advances in Psychopharmacology. [published; Europe PMC]. \href{https://doi.org/10.1177/2045125316676092}{doi:10.1177/2045125316676092}.
\item Michael P. Bogenschutz, Alyssa A. Forcehimes (2016). \textit{Development of a Psychotherapeutic Model for Psilocybin-Assisted Treatment of Alcoholism}. Journal of Humanistic Psychology. [published; OpenAlex]. \href{https://doi.org/10.1177/0022167816673493}{doi:10.1177/0022167816673493}.
\item Liechti ME, Dolder PC, Schmid Y. (2016). \textit{Alterations of consciousness and mystical-type experiences after acute LSD in humans.}. Psychopharmacology. [published; Europe PMC]. \href{https://doi.org/10.1007/s00213-016-4453-0}{doi:10.1007/s00213-016-4453-0}.
\item Jeanne G, Purper-Ouakil D, Rigole H, Franc N. (2016). \textit{[New patterns of substance use and abuse among French adolescents, a knowledge synthesis].}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.encep.2016.05.012}{doi:10.1016/j.encep.2016.05.012}.
\item Filip Tylš, Čestmír Vejmola, Michaela Viktorinová, L. Kadeřábek, Tomáš Páleníček (2016). \textit{Psilocybin-induced psychosis in humans and in rats − translational quantitative EEG study}. European Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/s0924-977x(16)31133-6}{doi:10.1016/s0924-977x(16)31133-6}.
\item O. Grimm, Rainer Krähenmann, Katrin H. Preller, Erich Seifritz, F.X. Vollenweider (2016). \textit{Psilocybin-induced decrease in amygdala-putamen coupling during an event-related face discrimination task}. European Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/s0924-977x(16)31070-7}{doi:10.1016/s0924-977x(16)31070-7}.
\item Karolina Dydak, Mariola Śliwińska-Mossoń, Halina Milnerowicz (2016). \textit{Psilocybin as an alternative medicine for patients suffering from depression}. Psychiatria i Psychologia Kliniczna. [published; OpenAlex]. \href{https://doi.org/10.15557/pipk.2016.0023}{doi:10.15557/pipk.2016.0023}.
\item Unknown authors (2016). \textit{Psilocybin zur Behandlung der therapieresistenten Depression}. PSYCH up2date. [published; OpenAlex]. \href{https://doi.org/10.1055/s-0042-110896}{doi:10.1055/s-0042-110896}.
\item Hendrie C, Pickles A. (2016). \textit{Psilocybin: panacea or placebo?}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/s2215-0366(16)30103-1}{doi:10.1016/s2215-0366(16)30103-1}.
\item Dijkstra FM, Jacobs GE, Cohen AF. (2016). \textit{Question-based Drug Development for psilocybin.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/s2215-0366(16)30214-0}{doi:10.1016/s2215-0366(16)30214-0}.
\item Carhart-Harris RL, Nutt DJ. (2016). \textit{Question-based Drug Development for psilocybin - Authors' reply.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/s2215-0366(16)30217-6}{doi:10.1016/s2215-0366(16)30217-6}.
\item Dasgupta A. (2016). \textit{Challenges in Laboratory Detection of Unusual Substance Abuse: Issues with Magic Mushroom, Peyote Cactus, Khat, and Solvent Abuse.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/bs.acc.2016.07.004}{doi:10.1016/bs.acc.2016.07.004}.
\item Carbonaro TM, Bradstreet MP, Barrett FS, MacLean KA, Jesse R, Johnson MW, Griffiths RR. (2016). \textit{Survey study of challenging experiences after ingesting psilocybin mushrooms: Acute and enduring positive and negative consequences.}. Journal of Psychopharmacology. [published; Europe PMC]. \href{https://doi.org/10.1177/0269881116662634}{doi:10.1177/0269881116662634}.
\item Bogenschutz MP. (2016). \textit{It's time to take psilocybin seriously as a possible treatment for substance use disorders.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/00952990.2016.1200060}{doi:10.1080/00952990.2016.1200060}.
\item Patra S. (2016). \textit{Return of the psychedelics: Psilocybin for treatment resistant depression.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.ajp.2016.08.010}{doi:10.1016/j.ajp.2016.08.010}.
\item de Veen BT, Schellekens AF, Verheij MM, Homberg JR. (2016). \textit{Psilocybin for treating substance use disorders?}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/14737175.2016.1220834}{doi:10.1080/14737175.2016.1220834}.
\item Tófoli LF, de Araujo DB. (2016). \textit{Treating Addiction: Perspectives from EEG and Imaging Studies on Psychedelics.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/bs.irn.2016.06.005}{doi:10.1016/bs.irn.2016.06.005}.
\item Johnson MW, Garcia-Romeu A, Griffiths RR. (2016). \textit{Long-term follow-up of psilocybin-facilitated smoking cessation.}. The American Journal of Drug and Alcohol Abuse. [published; Europe PMC]. \href{https://doi.org/10.3109/00952990.2016.1170135}{doi:10.3109/00952990.2016.1170135}.
\item Maqueda AE, Valle M, Addy PH, Antonijoan RM, Puntes M, Coimbra J, Ballester MR, Garrido M, González M, Claramunt J, Barker S, Lomnicka I, Waguespack M, Johnson MW, Griffiths RR, Riba J. (2016). \textit{Naltrexone but Not Ketanserin Antagonizes the Subjective, Cardiovascular, and Neuroendocrine Effects of Salvinorin-A in Humans.}. The International Journal of Neuropsychopharmacology. [published; Europe PMC]. \href{https://doi.org/10.1093/ijnp/pyw016}{doi:10.1093/ijnp/pyw016}.
\item Hardaway R, Schweitzer J, Suzuki J (2016). \textit{Hallucinogen Use Disorders.}. Child and adolescent psychiatric clinics of North America. [published; PubMed]. \href{https://doi.org/10.1016/j.chc.2016.03.006}{doi:10.1016/j.chc.2016.03.006}.
\item Howland RH. (2016). \textit{Antidepressant, Antipsychotic, and Hallucinogen Drugs for the Treatment of Psychiatric Disorders: A Convergence at the Serotonin-2A Receptor.}. Journal of Psychosocial Nursing and Mental Health Services. [published; Europe PMC]. \href{https://doi.org/10.3928/02793695-20160616-09}{doi:10.3928/02793695-20160616-09}.
\item Bartolucci Silvia, Mari Michele, Di Gregorio Giovanni, Piersanti Giovanni (2016). \textit{ChemInform Abstract: Observations Concerning the Synthesis of Tryptamine Homologues and Branched Tryptamine Derivatives via the Borrowing Hydrogen Process: Synthesis of Psilocin, Bufotenin, and Serotonin.}. ChemInform. [published; Crossref]. \href{https://doi.org/10.1002/chin.201633131}{doi:10.1002/chin.201633131}.
\item Pietsch J, Scheffel K, Acquarone D, Koch I, Deters M, Hermanns-Clausen M. (2016). \textit{[Trends in Abuse of Biogenic Drugs in Parts of Germany 2007-2013].}. Das Gesundheitswesen. [published; Europe PMC]. \href{https://doi.org/10.1055/s-0042-108644}{doi:10.1055/s-0042-108644}.
\item Unknown authors (2016). \textit{Magic mushroom compound is a potential treatment for patients with major depression.}. Nursing standard (Royal College of Nursing (Great Britain): 1987). [published; PubMed]. \href{https://doi.org/10.7748/ns.30.41.15.s18}{doi:10.7748/ns.30.41.15.s18}.
\item Tylš F, Páleníček T, Kadeřábek L, Lipski M, Kubešová A, Horáček J. (2016). \textit{Sex differences and serotonergic mechanisms in the behavioural effects of psilocin.}. Behavioural Pharmacology. [published; Europe PMC]. \href{https://doi.org/10.1097/fbp.0000000000000198}{doi:10.1097/fbp.0000000000000198}.
\item Tomáš Páleníček, Filip Tylš, Michaela Viktorinová, Dominika Prokopcova, Jakub Korčák, Renata Androvičová, Martin Brunovský, Jiřı́ Horáček (2016). \textit{PM502. Effect of psilocybin on EEG brain connectivity in healthy volunteers - preliminary report}. The International Journal of Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1093/ijnp/pyw041.502}{doi:10.1093/ijnp/pyw041.502}.
\item Filip Tylš, Michaela Viktorinová, Dominika Prokopcova, Jakub Korčák, Renata Androvičová, Martin Brunovský, Jiřı́ Horáček (2016). \textit{PM506. Psilocybin Clinical Trial: Acute Effects and its relationship to the brain activity as measured by quantitative EEG}. The International Journal of Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1093/ijnp/pyw041.506}{doi:10.1093/ijnp/pyw041.506}.
\item Tyls F, Michaela Viktorinova T, Prokopcova D, Korcak J, Androvicova R, Brunovsky M, Horacek J. (2016). \textit{PM506. Psilocybin Clinical Trial: Acute Effects and its relationship to the brain activity as measured by quantitative EEG}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC5616440}{source link}.
\item Palenicek T, Tyls F, Viktorinova M, Prokopcova D, Korcak J, Androvicova R, Brunovsky M, Horacek J. (2016). \textit{PM502. Effect of psilocybin on EEG brain connectivity in healthy volunteers - preliminary report}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC5616436}{source link}.
\item Joseph A. Zamaria (2016). \textit{A Phenomenological Examination of Psilocybin and its Positive and Persisting Aftereffects}. NeuroQuantology. [published; OpenAlex]. \href{https://doi.org/10.14704/nq.2016.14.2.943}{doi:10.14704/nq.2016.14.2.943}.
\item Rickli A, Moning OD, Hoener MC, Liechti ME. (2016). \textit{Receptor interaction profiles of novel psychoactive tryptamines compared with classic hallucinogens.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.euroneuro.2016.05.001}{doi:10.1016/j.euroneuro.2016.05.001}.
\item Shebloski KL, Broadway JM. (2016). \textit{Commentary: Effects of psilocybin on time perception and temporal control of behavior in humans.}. Frontiers in Psychology. [published; Europe PMC]. \href{https://doi.org/10.3389/fpsyg.2016.00736}{doi:10.3389/fpsyg.2016.00736}.
\item Hawkes N. (2016). \textit{Sixty seconds on... psilocybin.}. BMJ. [published; Europe PMC]. \href{https://doi.org/10.1136/bmj.i2775}{doi:10.1136/bmj.i2775}.
\item Carhart-Harris RL, Bolstridge M, Rucker J, Day CM, Erritzoe D, Kaelen M, Bloomfield M, Rickard JA, Forbes B, Feilding A, Taylor D, Pilling S, Curran VH, Nutt DJ. (2016). \textit{Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study.}. The Lancet Psychiatry. [published; Europe PMC]. \href{https://doi.org/10.1016/s2215-0366(16)30065-7}{doi:10.1016/s2215-0366(16)30065-7}.
\item Cowen P. (2016). \textit{Altered states: psilocybin for treatment-resistant depression.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/s2215-0366(16)30087-6}{doi:10.1016/s2215-0366(16)30087-6}.
\item Tom Froese, Gastón Guzmán, Laura Guzmán-Dávalos (2016). \textit{On the Origin of the Genus Psilocybe and Its Potential Ritual Use in Ancient Africa and Europe1}. Economic Botany. [published; OpenAlex]. \href{https://doi.org/10.1007/s12231-016-9342-2}{doi:10.1007/s12231-016-9342-2}.
\item Bartolucci Silvia, Mari Michele, Di Gregorio Giovanni, Piersanti Giovanni (2016). \textit{Observations concerning the synthesis of tryptamine homologues and branched tryptamine derivatives via the borrowing hydrogen process: synthesis of psilocin, bufotenin, and serotonin}. Tetrahedron. [published; Crossref]. \href{https://doi.org/10.1016/j.tet.2016.03.007}{doi:10.1016/j.tet.2016.03.007}.
\item Preller KH, Pokorny T, Hock A, Kraehenmann R, Stämpfli P, Seifritz E, Scheidegger M, Vollenweider FX. (2016). \textit{Effects of serotonin 2A/1A receptor stimulation on social exclusion processing.}. Proceedings of the National Academy of Sciences. [published; Europe PMC]. \href{https://doi.org/10.1073/pnas.1524187113}{doi:10.1073/pnas.1524187113}.
\item Mithoefer MC, Grob CS, Brewerton TD. (2016). \textit{Novel psychopharmacological therapies for psychiatric disorders: psilocybin and MDMA.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/s2215-0366(15)00576-3}{doi:10.1016/s2215-0366(15)00576-3}.
\item Nichols DE. (2016). \textit{Psychedelics.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1124/pr.115.011478}{doi:10.1124/pr.115.011478}.
\item Gambaro V, Roda G, Visconti GL, Arnoldi S, Casagni E, Dell'Acqua L, Farè F, Paladino E, Rusconi C, Arioli S, Mora D. (2016). \textit{DNA-based taxonomic identification of basidiospores in hallucinogenic mushrooms cultivated in "grow-kits" seized by the police: LC-UV quali-quantitative determination of psilocybin and psilocin.}. Journal of Pharmaceutical and Biomedical Analysis. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jpba.2016.03.043}{doi:10.1016/j.jpba.2016.03.043}.
\item Kyzar EJ, Kalueff AV. (2016). \textit{Exploring Hallucinogen Pharmacology and Psychedelic Medicine with Zebrafish Models.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1089/zeb.2016.1251}{doi:10.1089/zeb.2016.1251}.
\item Dos Santos RG, Osório FL, Crippa JA, Riba J, Zuardi AW, Hallak JE. (2016). \textit{Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 years.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/2045125316638008}{doi:10.1177/2045125316638008}.
\item Suzuki K. (2016). \textit{[Three cases of acute serotonin syndrome due to psilocybin mushroom poisoning].}. PubMed. [published; Europe PMC]. \href{https://europepmc.org/article/MED/27255023}{source link}.
\item Johns Hopkins University (2016). \textit{Effects of Psilocybin and Spiritual Practice on Persisting Changes in Attitudes and Behavior}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT00802282}{source link}.
\item Davenport WJ. (2016). \textit{Psychedelic and nonpsychedelic LSD and psilocybin for cluster headache.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1503/cmaj.1150082}{doi:10.1503/cmaj.1150082}.
\item Pokorny T, Preller KH, Kraehenmann R, Vollenweider FX. (2016). \textit{Modulatory effect of the 5-HT1A agonist buspirone and the mixed non-hallucinogenic 5-HT1A/2A agonist ergotamine on psilocybin-induced psychedelic experience.}. European Neuropsychopharmacology. [published; Europe PMC]. \href{https://doi.org/10.1016/j.euroneuro.2016.01.005}{doi:10.1016/j.euroneuro.2016.01.005}.
\item Unknown authors (2015). \textit{Psilocybin shows potential as treatment for depression}. Pharmaceutical journal/The pharmaceutical journal. [published; OpenAlex]. \href{https://doi.org/10.1211/pj.2016.20201222}{doi:10.1211/pj.2016.20201222}.
\item Unknown authors (2015). \textit{Psilocybin shows potential as treatment for depression}. Clinical pharmacist. [published; OpenAlex]. \href{https://doi.org/10.1211/cp.2016.20201222}{doi:10.1211/cp.2016.20201222}.
\item Susanna Prepeliczay (2015). \textit{Motivationen und Morphologie des Freizeitgebrauchs von Psychedelika (LSD, Psilocybin-Pilze): eine qualitative Interviewstudie}. Unknown journal. [published; OpenAlex]. \href{http://elib.suub.uni-bremen.de/peid=D00105749}{source link}.
\item C. Meribha Christy (2015). \textit{MAGIC MUSHROOM AND ITS EFFECTIVENESS}. International Journal of Pharma and Bio Sciences. [published; OpenAlex]. \href{https://ijpbs.net/abstract.php?article=NTMzNw==}{source link}.
\item Joseph Havens (2015). \textit{MEMO ON THE RELIGIOUS IMPLICATIONS OF THE CONSCIOUSNESS-CHANGING DRUGS (LSD, Mescalin, Psilocybin)}. Unknown journal. [published; OpenAlex]. \href{https://www.jstor.org/stable/1384511}{source link}.
\item Dimitria Electra Gatzia, Berit Brogaard (2015). \textit{Psilocybin, LSD, Mescaline and drug-induced synesthesia}. PhilPapers (PhilPapers Foundation). [published; OpenAlex]. \href{https://philarchive.org/rec/BROPLM}{source link}.
\item Letheby C (2015). \textit{The epistemic innocence of psychedelic states.}. Consciousness and cognition. [published; PubMed]. \href{https://doi.org/10.1016/j.concog.2015.11.012}{doi:10.1016/j.concog.2015.11.012}.
\item Sweat NW, Bates LW, Hendricks PS (2015). \textit{The Associations of Naturalistic Classic Psychedelic Use, Mystical Experience, and Creative Problem Solving.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2016.1234090}{doi:10.1080/02791072.2016.1234090}.
\item Nagy Julia, Veress Tibor (2015). \textit{HPLC Analysis of Hallucinogenic Mushroom Alkaloids (Psilocin and Psilocybin) Applying Hydrophilic Interaction Chromatography (HILIC)}. Journal of Forensic Research. [published; Crossref]. \href{https://doi.org/10.4172/2157-7145.1000356}{doi:10.4172/2157-7145.1000356}.
\item Schindler EA, Gottschalk CH, Weil MJ, Shapiro RE, Wright DA, Sewell RA. (2015). \textit{Indoleamine Hallucinogens in Cluster Headache: Results of the Clusterbusters Medication Use Survey.}. Journal of Psychoactive Drugs. [published; Europe PMC]. \href{https://doi.org/10.1080/02791072.2015.1107664}{doi:10.1080/02791072.2015.1107664}.
\item Albert Garcia-Romeu, Tehseen Noorani, Roland R. Griffiths, Matthew W. Johnson (2015). \textit{Long-term follow-up of psilocybin-facilitated smoking cessation: Abstinence outcomes and qualitative analysis of participant accounts}. Drug and Alcohol Dependence. [published; OpenAlex]. \href{https://doi.org/10.1016/j.drugalcdep.2015.07.1130}{doi:10.1016/j.drugalcdep.2015.07.1130}.
\item Frederick S. Barrett, Matthew W. Johnson, Roland R. Griffiths (2015). \textit{Validation of the revised mystical experiences questionnaire in experimental sessions with psilocybin}. Drug and Alcohol Dependence. [published; OpenAlex]. \href{https://doi.org/10.1016/j.drugalcdep.2015.07.961}{doi:10.1016/j.drugalcdep.2015.07.961}.
\item Theresa M. Carbonaro, Margaret A. Klinedinst, Matthew W. Johnson, Roland R. Griffiths (2015). \textit{Comparative phenomenology of psilocybin experiences in research and non-research settings}. Drug and Alcohol Dependence. [published; OpenAlex]. \href{https://doi.org/10.1016/j.drugalcdep.2015.07.1017}{doi:10.1016/j.drugalcdep.2015.07.1017}.
\item Barrett FS, Johnson MW, Griffiths RR. (2015). \textit{Validation of the revised Mystical Experience Questionnaire in experimental sessions with psilocybin.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/0269881115609019}{doi:10.1177/0269881115609019}.
\item Lowe LM, Peterson BL, Couper FJ. (2015). \textit{A Case Review of the First Analytically Confirmed 25I-NBOMe-Related Death in Washington State.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1093/jat/bkv092}{doi:10.1093/jat/bkv092}.
\item Geyer MA. (2015). \textit{Lysergic Acid Diethylamide and Psilocybin Revisited.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.biopsych.2015.08.003}{doi:10.1016/j.biopsych.2015.08.003}.
\item Dydak K, Śliwińska-Mossoń M, Milnerowicz H. (2015). \textit{[Psilocybin - public available psychodysleptic].}. PubMed. [published; Europe PMC]. \href{https://doi.org/10.5604/01.3001.0009.6569}{doi:10.5604/01.3001.0009.6569}.
\item Katrin H. Preller, Thomas Pokorny, Rainer Krähenmann, Milan Scheidegger, I. Dziobek, Philipp Stämpfli, F.X. Vollenweider (2015). \textit{P.1.i.005 The 5-HT2A/1A agonist psilocybin reduces social pain and enhances empathy in healthy volunteers}. European Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/s0924-977x(15)30364-3}{doi:10.1016/s0924-977x(15)30364-3}.
\item Hendricks PS, Johnson MW, Griffiths RR. (2015). \textit{Psilocybin, psychological distress, and suicidality.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/0269881115598338}{doi:10.1177/0269881115598338}.
\item Kraehenmann R, Schmidt A, Friston K, Preller KH, Seifritz E, Vollenweider FX. (2015). \textit{The mixed serotonin receptor agonist psilocybin reduces threat-induced modulation of amygdala connectivity.}. NeuroImage Clinical. [published; Europe PMC]. \href{https://doi.org/10.1016/j.nicl.2015.08.009}{doi:10.1016/j.nicl.2015.08.009}.
\item Kometer M, Pokorny T, Seifritz E, Volleinweider FX. (2015). \textit{Psilocybin-induced spiritual experiences and insightfulness are associated with synchronization of neuronal oscillations.}. Psychopharmacology. [published; Europe PMC]. \href{https://doi.org/10.1007/s00213-015-4026-7}{doi:10.1007/s00213-015-4026-7}.
\item Spain A, Howarth C, Khrapitchev AA, Sharp T, Sibson NR, Martin C. (2015). \textit{Neurovascular and neuroimaging effects of the hallucinogenic serotonin receptor agonist psilocin in the rat brain.}. Neuropharmacology. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neuropharm.2015.07.018}{doi:10.1016/j.neuropharm.2015.07.018}.
\item Gallimore AR. (2015). \textit{Restructuring consciousness -the psychedelic state in light of integrated information theory.}. Frontiers in Human Neuroscience. [published; Europe PMC]. \href{https://doi.org/10.3389/fnhum.2015.00346}{doi:10.3389/fnhum.2015.00346}.
\item Wiltshire PE, Hawksworth DL, Edwards KJ. (2015). \textit{Light microscopy can reveal the consumption of a mixture of psychotropic plant and fungal material in suspicious death.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jflm.2015.05.010}{doi:10.1016/j.jflm.2015.05.010}.
\item Lebedev AV, Lövdén M, Rosenthal G, Feilding A, Nutt DJ, Carhart-Harris RL. (2015). \textit{Finding the self by losing the self: Neural correlates of ego-dissolution under psilocybin.}. Human Brain Mapping. [published; Europe PMC]. \href{https://doi.org/10.1002/hbm.22833}{doi:10.1002/hbm.22833}.
\item Patricia A. Helvenston (2015). \textit{Psilocybin-containing mushrooms, upper palaeolithic rock art and the neuropsychological model}. Rock Art Research. [published; OpenAlex]. \href{https://search.informit.com.au/documentSummary;dn=997302336792843;res=IELIND}{source link}.
\item Di Lorenzo C, Coppola G, Di Lorenzo G, Bracaglia M, Rossi P, Pierelli F. (2015). \textit{The use of illicit drugs as self-medication in the treatment of cluster headache: Results from an Italian online survey.}. Cephalalgia. [published; Europe PMC]. \href{https://doi.org/10.1177/0333102415583145}{doi:10.1177/0333102415583145}.
\item Araújo AM, Carvalho F, Bastos Mde L, Guedes de Pinho P, Carvalho M. (2015). \textit{The hallucinogenic world of tryptamines: an updated review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s00204-015-1513-x}{doi:10.1007/s00204-015-1513-x}.
\item Baumeister D, Tojo LM, Tracy DK. (2015). \textit{Legal highs: staying on top of the flood of novel psychoactive substances.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/2045125314559539}{doi:10.1177/2045125314559539}.
\item Jochen Gartz, Georg Wiedemann (2015). \textit{Discovery of a new caerulescent Psilocybe mushroom in Germany: Psilocybe germanica sp.nov.}. Drug Testing and Analysis. [published; OpenAlex]. \href{https://doi.org/10.1002/dta.1795}{doi:10.1002/dta.1795}.
\item Zhuk O, Jasicka-Misiak I, Poliwoda A, Kazakova A, Godovan VV, Halama M, Wieczorek PP. (2015). \textit{Research on acute toxicity and the behavioral effects of methanolic extract from psilocybin mushrooms and psilocin in mice.}. Toxins. [published; Europe PMC]. \href{https://doi.org/10.3390/toxins7041018}{doi:10.3390/toxins7041018}.
\item Bogenschutz MP, Johnson MW. (2015). \textit{Classic hallucinogens in the treatment of addictions.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.pnpbp.2015.03.002}{doi:10.1016/j.pnpbp.2015.03.002}.
\item Johansen PØ, Krebs TS. (2015). \textit{Psychedelics not linked to mental health problems or suicidal behavior: a population study.}. Journal of Psychopharmacology. [published; Europe PMC]. \href{https://doi.org/10.1177/0269881114568039}{doi:10.1177/0269881114568039}.
\item Hendricks PS, Thorne CB, Clark CB, Coombs DW, Johnson MW (2015). \textit{Classic psychedelic use is associated with reduced psychological distress and suicidality in the United States adult population.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/0269881114565653}{doi:10.1177/0269881114565653}.
\item Majić T, Schmidt TT, Gallinat J (2015). \textit{Peak experiences and the afterglow phenomenon: when and how do therapeutic effects of hallucinogens depend on psychedelic experiences?}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/0269881114568040}{doi:10.1177/0269881114568040}.
\item Cirriez JP. (2015). \textit{[Ilicit drugs frequently used by drug addicts].}. PubMed. [published; Europe PMC]. \href{https://europepmc.org/article/MED/26571792}{source link}.
\item Palhano-Fontes F, Andrade KC, Tofoli LF, Santos AC, Crippa JA, Hallak JE, Ribeiro S, de Araujo DB. (2015). \textit{The psychedelic state induced by ayahuasca modulates the activity and connectivity of the default mode network.}. PLoS ONE. [published; Europe PMC]. \href{https://doi.org/10.1371/journal.pone.0118143}{doi:10.1371/journal.pone.0118143}.
\item Steeds H, Carhart-Harris RL, Stone JM (2015). \textit{Drug models of schizophrenia.}. Therapeutic advances in psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1177/2045125314557797}{doi:10.1177/2045125314557797}.
\item Bogenschutz MP, Forcehimes AA, Pommy JA, Wilcox CE, Barbosa PC, Strassman RJ. (2015). \textit{Psilocybin-assisted treatment for alcohol dependence: a proof-of-concept study.}. Journal of Psychopharmacology. [published; Europe PMC]. \href{https://doi.org/10.1177/0269881114565144}{doi:10.1177/0269881114565144}.
\item Filip Tylš (2014). \textit{Neurobiology of psilocybin in the context of its potential therapeutic use}. Unknown journal. [published; OpenAlex]. \href{https://dissem.in/p/24022444/neurobiology-of-psilocybin-in-the-context-of-its-potential-therapeutic-use}{source link}.
\item Kenny Farisan Badri, Sigit Kirana Lintang Bhima, Tuntas Dhanardhono (2014). \textit{PENGARUH PEMBERIAN EKSTRAK JAMUR PSILOCYBE CUBENSIS DOSIS BERTINGKAT TERHADAP RASA INGIN TAHU MENCIT SWISS WEBSTER YANG DIUKUR DENGAN MANUAL HOLE BOARD}. Neliti. [published; OpenAlex]. \href{https://www.neliti.com/publications/107936/pengaruh-pemberian-ekstrak-jamur-psilocybe-cubensis-dosis-bertingkat-terhadap-ra}{source link}.
\item Sessa B, Johnson MW. (2014). \textit{Can psychedelic compounds play a part in drug dependence therapy?}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1192/bjp.bp.114.148031}{doi:10.1192/bjp.bp.114.148031}.
\item Tittarelli R, Mannocchi G, Pantano F, Romolo FS. (2014). \textit{Recreational use, analysis and toxicity of tryptamines.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.2174/1570159x13666141210222409}{doi:10.2174/1570159x13666141210222409}.
\item Unknown authors (2014). \textit{Taxonomic Identification of Hallucinogenic Mushrooms Seized on the Illegal Market Using a DNA-Based Approach and LC/MS-MS Determination of Psilocybin and Psilocin}. Journal of Analytical \& Bioanalytical Techniques. [published; Crossref]. \href{https://doi.org/10.4172/2155-9872.1000277}{doi:10.4172/2155-9872.1000277}.
\item Martin R, Schürenkamp J, Gasse A, Pfeiffer H, Köhler H. (2014). \textit{Analysis of psilocin, bufotenine and LSD in hair.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1093/jat/bku141}{doi:10.1093/jat/bku141}.
\item Theresa M. Carbonaro, Frederick S. Barrett, Matthew P. Bradstreet, Matthew W. Johnson, Katherine A. MacLean, Robert L. Jesse, Roland R. Griffiths (2014). \textit{Survey study of challenging experiences after ingesting psilocybin mushrooms: Demographics and phenomenology}. Drug and Alcohol Dependence. [published; OpenAlex]. \href{https://doi.org/10.1016/j.drugalcdep.2014.09.118}{doi:10.1016/j.drugalcdep.2014.09.118}.
\item Frederick S. Barrett, Matthew P. Bradstreet, Jeannie-Marie Leoutsakos, Matthew W. Johnson, Katherine A. MacLean, Robert L. Jesse, Roland R. Griffiths (2014). \textit{The challenging experience questionnaire: Characterization of acute adverse reactions to psilocybin}. Drug and Alcohol Dependence. [published; OpenAlex]. \href{https://doi.org/10.1016/j.drugalcdep.2014.09.060}{doi:10.1016/j.drugalcdep.2014.09.060}.
\item Petri G, Expert P, Turkheimer F, Carhart-Harris R, Nutt D, Hellyer PJ, Vaccarino F. (2014). \textit{Homological scaffolds of brain functional networks.}. Journal of The Royal Society Interface. [published; Europe PMC]. \href{https://doi.org/10.1098/rsif.2014.0873}{doi:10.1098/rsif.2014.0873}.
\item Wilcox JA. (2014). \textit{Psilocybin and Obsessive Compulsive Disorder.}. Journal of Psychoactive Drugs. [published; Europe PMC]. \href{https://doi.org/10.1080/02791072.2014.963754}{doi:10.1080/02791072.2014.963754}.
\item Sakashita Y, Abe K, Katagiri N, Kambe T, Saitoh T, Utsunomiya I, Horiguchi Y, Taguchi K. (2014). \textit{Effect of psilocin on extracellular dopamine and serotonin levels in the mesoaccumbens and mesocortical pathway in awake rats.}. Biological and Pharmaceutical Bulletin. [published; Europe PMC]. \href{https://doi.org/10.1248/bpb.b14-00315}{doi:10.1248/bpb.b14-00315}.
\item Borovička J, Oborník M, Stříbrný J, Noordeloos ME, Parra Sánchez LA, Gryndler M. (2014). \textit{Phylogenetic and chemical studies in the potential psychotropic species complex of Psilocybe atrobrunnea with taxonomic and nomenclatural notes.}. Persoonia - Molecular Phylogeny and Evolution of Fungi. [published; Europe PMC]. \href{https://doi.org/10.3767/003158515x685283}{doi:10.3767/003158515x685283}.
\item Rainer Kraehenmann, Katrin H. Preller, Erich Seifritz, F.X. Vollenweider (2014). \textit{P.1.g.005 Serotonergic modulation of emotion processing by the mixed 5-HT1A/2A receptor agonist psilocybin reduces amygdala activation to negative stimuli - a pharmacological fMRI study}. European Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/s0924-977x(14)70316-5}{doi:10.1016/s0924-977x(14)70316-5}.
\item Johnson MW, Garcia-Romeu A, Cosimano MP, Griffiths RR. (2014). \textit{Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction.}. Journal of Psychopharmacology. [published; Europe PMC]. \href{https://doi.org/10.1177/0269881114548296}{doi:10.1177/0269881114548296}.
\item Pichini S, Marchei E, García-Algar O, Gomez A, Di Giovannandrea R, Pacifici R. (2014). \textit{Ultra-high-pressure liquid chromatography tandem mass spectrometry determination of hallucinogenic drugs in hair of psychedelic plants and mushrooms consumers.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jpba.2014.08.006}{doi:10.1016/j.jpba.2014.08.006}.
\item Baumeister D, Barnes G, Giaroli G, Tracy D (2014). \textit{Classical hallucinogens as antidepressants? A review of pharmacodynamics and putative clinical roles.}. Therapeutic advances in psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1177/2045125314527985}{doi:10.1177/2045125314527985}.
\item Law Francis, Poon Grace, Chui Y. C., He Shao-Xiong (2014). \textit{14C-Psilocin tissue distribution in pregnant rats after intravenous administration}. Functional Foods in Health and Disease. [published; Crossref]. \href{https://doi.org/10.31989/ffhd.v4i6.9}{doi:10.31989/ffhd.v4i6.9}.
\item Halberstadt AL. (2014). \textit{Recent advances in the neuropsychopharmacology of serotonergic hallucinogens.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.bbr.2014.07.016}{doi:10.1016/j.bbr.2014.07.016}.
\item Tagliazucchi E, Carhart-Harris R, Leech R, Nutt D, Chialvo DR. (2014). \textit{Enhanced repertoire of brain dynamical states during the psychedelic experience.}. Human Brain Mapping. [published; Europe PMC]. \href{https://doi.org/10.1002/hbm.22562}{doi:10.1002/hbm.22562}.
\item Matthew P. Bradstreet, Matthew W. Johnson, Katherine A. MacLean, Roland R. Griffiths (2014). \textit{Characterization of challenging experiences (i.e., bad trips) after ingesting psilocybin}. Drug and Alcohol Dependence. [published; OpenAlex]. \href{https://doi.org/10.1016/j.drugalcdep.2014.02.072}{doi:10.1016/j.drugalcdep.2014.02.072}.
\item Albert Garcia-Romeu, Matthew W. Johnson, Roland R. Griffiths (2014). \textit{Examining the psychological mechanisms of psilocybin-assisted smoking cessation treatment: A pilot study}. Drug and Alcohol Dependence. [published; OpenAlex]. \href{https://doi.org/10.1016/j.drugalcdep.2014.02.200}{doi:10.1016/j.drugalcdep.2014.02.200}.
\item Roseman L, Leech R, Feilding A, Nutt DJ, Carhart-Harris RL. (2014). \textit{The effects of psilocybin and MDMA on between-network resting state functional connectivity in healthy volunteers.}. Frontiers in Human Neuroscience. [published; Europe PMC]. \href{https://doi.org/10.3389/fnhum.2014.00204}{doi:10.3389/fnhum.2014.00204}.
\item Johns Hopkins University (2014). \textit{Pilot Study: Effects of Psilocybin on Behavior, Psychology and Brain Function in Long-term Meditators}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT01988311}{source link}.
\item Rambousek L, Palenicek T, Vales K, Stuchlik A. (2014). \textit{The effect of psilocin on memory acquisition, retrieval, and consolidation in the rat.}. Frontiers in Behavioral Neuroscience. [published; Europe PMC]. \href{https://doi.org/10.3389/fnbeh.2014.00180}{doi:10.3389/fnbeh.2014.00180}.
\item Appendino G, Minassi A, Taglialatela-Scafati O. (2014). \textit{Recreational drug discovery: natural products as lead structures for the synthesis of smart drugs.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1039/c4np00010b}{doi:10.1039/c4np00010b}.
\item Kraehenmann R, Preller KH, Scheidegger M, Pokorny T, Bosch OG, Seifritz E, Vollenweider FX. (2014). \textit{Psilocybin-Induced Decrease in Amygdala Reactivity Correlates with Enhanced Positive Mood in Healthy Volunteers.}. Biological Psychiatry. [published; Europe PMC]. \href{https://doi.org/10.1016/j.biopsych.2014.04.010}{doi:10.1016/j.biopsych.2014.04.010}.
\item Karaki S, Becamel C, Murat S, Mannoury la Cour C, Millan MJ, Prézeau L, Bockaert J, Marin P, Vandermoere F. (2014). \textit{Quantitative phosphoproteomics unravels biased phosphorylation of serotonin 2A receptor at Ser280 by hallucinogenic versus nonhallucinogenic agonists.}. Molecular \& Cellular Proteomics. [published; Europe PMC]. \href{https://doi.org/10.1074/mcp.m113.036558}{doi:10.1074/mcp.m113.036558}.
\item Damianus Diaz Ferianto (2014). \textit{TINJAUAN PELAKSANAAN KETENTUAN PIDANA UNDANGUNDANG NOMOR 35 TAHUN 2009 TERHADAP PENYALAHGUNAAN MAGIC MUSHROOM}. UAJY Repository (University of Southampton). [published; OpenAlex]. \href{https://openalex.org/W1489109450}{source link}.
\item Tyls F., Palenicek T., Novakova P., Kaderabek L., Fujakova M., Kubesova A., Horacek J. (2014). \textit{P.4.022 The impact of serotonin system modulation on behavior and quantitative EEG in an animal model of psychosis induced by psilocin}. European Neuropsychopharmacology. [published; Crossref]. \href{https://doi.org/10.1016/s0924-977x(14)70111-7}{doi:10.1016/s0924-977x(14)70111-7}.
\item Carhart-Harris RL, Leech R, Hellyer PJ, Shanahan M, Feilding A, Tagliazucchi E, Chialvo DR, Nutt D. (2014). \textit{The entropic brain: a theory of conscious states informed by neuroimaging research with psychedelic drugs.}. Frontiers in Human Neuroscience. [published; Europe PMC]. \href{https://doi.org/10.3389/fnhum.2014.00020}{doi:10.3389/fnhum.2014.00020}.
\item dos Santos RG. (2014). \textit{Potential therapeutic effects of psilocybin/psilocin are minimized while possible adverse reactions are overrated.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1097/ftd.0000000000000028}{doi:10.1097/ftd.0000000000000028}.
\item Martin R, Schürenkamp J, Pfeiffer H, Lehr M, Köhler H. (2014). \textit{Synthesis, hydrolysis and stability of psilocin glucuronide.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.forsciint.2014.01.006}{doi:10.1016/j.forsciint.2014.01.006}.
\item Mary P Cosimano (2013). \textit{My Experience as a Guide in the Johns Hopkins Psilocybin Research Project}. Unknown journal. [published; OpenAlex]. \href{http://www.maps.org/news-letters/v24n3/v24n3\_p39-41.pdf}{source link}.
\item Robert L. Jesse, Roland R. Griffi (2013). \textit{PSILOCYBIN RESEARCH AT JOHNS HOPKINS: A2014 REPORT}. Unknown journal. [published; OpenAlex]. \href{http://csp.org/HopkinsPsilocybin2014.pdf}{source link}.
\item Faruk Aşıcıoğlu, Mustafa Okudan, Nilay Derman, Mahmut Koca (2013). \textit{Magic Mushroom Growing Kits: A new method for infringement of the narcotic laws.}. Turkish Journal of Forensic Medicine. [published; OpenAlex]. \href{https://doi.org/10.5505/adlitip.2014.60566}{doi:10.5505/adlitip.2014.60566}.
\item Hendricks PS, Clark CB, Johnson MW, Fontaine KR, Cropsey KL (2013). \textit{Hallucinogen use predicts reduced recidivism among substance-involved offenders under community corrections supervision.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/0269881113513851}{doi:10.1177/0269881113513851}.
\item Nichols DE. (2013). \textit{The Heffter Research Institute: past and hopeful future.}. Journal of Psychoactive Drugs. [published; Europe PMC]. \href{https://doi.org/10.1080/02791072.2014.873688}{doi:10.1080/02791072.2014.873688}.
\item Garcia-Romeu A, Griffiths RR, Johnson MW. (2013). \textit{Psilocybin-occasioned mystical experiences in the treatment of tobacco addiction.}. Current Drug Abuse Reviews. [published; Europe PMC]. \href{https://doi.org/10.2174/1874473708666150107121331}{doi:10.2174/1874473708666150107121331}.
\item Turton S, Nutt DJ, Carhart-Harris RL. (2013). \textit{A qualitative report on the subjective experience of intravenous psilocybin administered in an FMRI environment.}. Current Drug Abuse Reviews. [published; Europe PMC]. \href{https://doi.org/10.2174/1874473708666150107120930}{doi:10.2174/1874473708666150107120930}.
\item Tylš F, Páleníček T, Horáček J. (2013). \textit{Psilocybin--summary of knowledge and new perspectives.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.euroneuro.2013.12.006}{doi:10.1016/j.euroneuro.2013.12.006}.
\item Icaza EE, Mashour GA. (2013). \textit{Altered states: psychedelics and anesthetics.}. Anesthesiology. [published; Europe PMC]. \href{https://doi.org/10.1097/01.anes.0000435635.42332.ee}{doi:10.1097/01.anes.0000435635.42332.ee}.
\item Winstock AR, Kaar S, Borschmann R. (2013). \textit{Dimethyltryptamine (DMT): prevalence, user characteristics and abuse liability in a large global sample.}. Journal of Psychopharmacology. [published; Europe PMC]. \href{https://doi.org/10.1177/0269881113513852}{doi:10.1177/0269881113513852}.
\item Jastrzebski M, Bala A. (2013). \textit{[The impact of psilocybin on visual perception and spatial orientation--neuropsychological approach].}. PubMed. [published; Europe PMC]. \href{https://europepmc.org/article/MED/25007546}{source link}.
\item Brogaard B. (2013). \textit{Serotonergic hyperactivity as a potential factor in developmental, acquired and drug-induced synesthesia.}. Frontiers in Human Neuroscience. [published; Europe PMC]. \href{https://doi.org/10.3389/fnhum.2013.00657}{doi:10.3389/fnhum.2013.00657}.
\item Burdick BV, Adinoff B. (2013). \textit{A proposal to evaluate mechanistic efficacy of hallucinogens in addiction treatment.}. The American Journal of Drug and Alcohol Abuse. [published; Europe PMC]. \href{https://doi.org/10.3109/00952990.2013.811513}{doi:10.3109/00952990.2013.811513}.
\item Carhart-Harris RL, Nutt DJ. (2013). \textit{Experienced drug users assess the relative harms and benefits of drugs: a web-based survey.}. Journal of Psychoactive Drugs. [published; Europe PMC]. \href{https://doi.org/10.1080/02791072.2013.825034}{doi:10.1080/02791072.2013.825034}.
\item Muthukumaraswamy SD, Carhart-Harris RL, Moran RJ, Brookes MJ, Williams TM, Errtizoe D, Sessa B, Papadopoulos A, Bolstridge M, Singh KD, Feilding A, Friston KJ, Nutt DJ. (2013). \textit{Broadband cortical desynchronization underlies the human psychedelic state.}. Journal of Neuroscience. [published; Europe PMC]. \href{https://doi.org/10.1523/jneurosci.2063-13.2013}{doi:10.1523/jneurosci.2063-13.2013}.
\item Krebs TS, Johansen PØ. (2013). \textit{Psychedelics and mental health: a population study.}. PLoS ONE. [published; Europe PMC]. \href{https://doi.org/10.1371/journal.pone.0063972}{doi:10.1371/journal.pone.0063972}.
\item Halberstadt AL, Geyer MA. (2013). \textit{Serotonergic hallucinogens as translational models relevant to schizophrenia.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1017/s1461145713000722}{doi:10.1017/s1461145713000722}.
\item Stebelska K. (2013). \textit{Fungal hallucinogens psilocin, ibotenic acid, and muscimol: analytical methods and biologic activities.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1097/ftd.0b013e31828741a5}{doi:10.1097/ftd.0b013e31828741a5}.
\item Bernasconi F, Schmidt A, Pokorny T, Kometer M, Seifritz E, Vollenweider FX. (2013). \textit{Spatiotemporal brain dynamics of emotional face processing modulations induced by the serotonin 1A/2A receptor agonist psilocybin.}. Cerebral Cortex. [published; Europe PMC]. \href{https://doi.org/10.1093/cercor/bht178}{doi:10.1093/cercor/bht178}.
\item Kjellgren A, Jonsson K. (2013). \textit{Methoxetamine (MXE)--a phenomenological study of experiences induced by a "legal high" from the internet.}. Journal of Psychoactive Drugs. [published; Europe PMC]. \href{https://doi.org/10.1080/02791072.2013.803647}{doi:10.1080/02791072.2013.803647}.
\item Carhart-Harris RL, Brugger S, Nutt DJ, Stone JM. (2013). \textit{Psychiatry's next top model: cause for a re-think on drug models of psychosis and other psychiatric disorders.}. Journal of Psychopharmacology. [published; Europe PMC]. \href{https://doi.org/10.1177/0269881113494107}{doi:10.1177/0269881113494107}.
\item Catlow BJ, Song S, Paredes DA, Kirstein CL, Sanchez-Ramos J. (2013). \textit{Effects of psilocybin on hippocampal neurogenesis and extinction of trace fear conditioning.}. Experimental Brain Research. [published; Europe PMC]. \href{https://doi.org/10.1007/s00221-013-3579-0}{doi:10.1007/s00221-013-3579-0}.
\item Kometer M, Schmidt A, Jäncke L, Vollenweider FX. (2013). \textit{Activation of serotonin 2A receptors underlies the psilocybin-induced effects on α oscillations, N170 visual-evoked potentials, and visual hallucinations.}. Journal of Neuroscience. [published; Europe PMC]. \href{https://doi.org/10.1523/jneurosci.3007-12.2013}{doi:10.1523/jneurosci.3007-12.2013}.
\item Kosentka P, Sprague SL, Ryberg M, Gartz J, May AL, Campagna SR, Matheny PB. (2013). \textit{Evolution of the toxins muscarine and psilocybin in a family of mushroom-forming fungi.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1371/journal.pone.0064646}{doi:10.1371/journal.pone.0064646}.
\item Helander A, Beck O, Hägerkvist R, Hultén P. (2013). \textit{Identification of novel psychoactive drug use in Sweden based on laboratory analysis--initial experiences from the STRIDA project.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3109/00365513.2013.793817}{doi:10.3109/00365513.2013.793817}.
\item Müller K, Püschel K, Iwersen-Bergmann S. (2013). \textit{[Suicide under the influence of "magic mushrooms"].}. PubMed. [published; Europe PMC]. \href{https://europepmc.org/article/MED/23878898}{source link}.
\item Cummins C, Lyke J. (2013). \textit{Peak experiences of psilocybin users and non-users.}. Journal of Psychoactive Drugs. [published; Europe PMC]. \href{https://doi.org/10.1080/02791072.2013.785855}{doi:10.1080/02791072.2013.785855}.
\item Krebs TS, Johansen PØ. (2013). \textit{Over 30 million psychedelic users in the United States.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.12688/f1000research.2-98.v1}{doi:10.12688/f1000research.2-98.v1}.
\item Nenad Manevski (2013). \textit{Activity and Enzyme Kinetics of Human UDP-Glucuronosyltransferases: Studies of Psilocin Glucuronidation and the Effects of Albumin on the Enzyme Kinetic Mechanism}. Työväentutkimus Vuosikirja. [published; OpenAlex]. \href{http://hdl.handle.net/10138/38186}{source link}.
\item Young SN. (2013). \textit{Single treatments that have lasting effects: some thoughts on the antidepressant effects of ketamine and botulinum toxin and the anxiolytic effect of psilocybin.}. Фундаментальные исследования (Fundamental Research). [published; Europe PMC]. \href{https://doi.org/10.1503/jpn.120128}{doi:10.1503/jpn.120128}.
\item Bogenschutz MP. (2013). \textit{Studying the effects of classic hallucinogens in the treatment of alcoholism: rationale, methodology, and current research with psilocybin.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.2174/15733998113099990002}{doi:10.2174/15733998113099990002}.
\item Moreno JL, Holloway T, Rayannavar V, Sealfon SC, González-Maeso J. (2013). \textit{Chronic treatment with LY341495 decreases 5-HT(2A) receptor binding and hallucinogenic effects of LSD in mice.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neulet.2012.12.053}{doi:10.1016/j.neulet.2012.12.053}.
\item Weissbart Hugo (2012). \textit{Effects of psilocybin on the human brain functional network}. Figshare. [published; OpenAlex]. \href{https://doi.org/10.6084/m9.figshare.798836.v1}{doi:10.6084/m9.figshare.798836.v1}.
\item Mochamad Muntaha, Sigit Kirana Lintang Bhima, Tuntas Dhanardhono (2012). \textit{DETEKSI PSILOCIN URIN PADA MENCIT SWISS WEBSTER TERHADAP PEMBERIAN JAMUR PSILOCYBE CUBENSIS DOSIS BERTINGKAT.}. Jurnal Kedokteran Diponegoro (Diponegoro Medical Journal). [published; OpenAlex]. \href{http://ejournal-s1.undip.ac.id/index.php/medico/article/download/4951/4777}{source link}.
\item Kometer, Michael, Schmidt, André, Jäncke, Lutz, Vollenweider, Franz X (2012). \textit{Activation of Serotonin 2A Receptors Underlies the Psilocybin-Induced Effects on α Oscillations, N170 Visual-Evoked Potentials, and Visual Hallucinations}. Open MIND. [published; OpenAlex]. \href{https://openalex.org/W6929930661}{source link}.
\item Hallock RM, Dean A, Knecht ZA, Spencer J, Taverna EC. (2012). \textit{A survey of hallucinogenic mushroom use, factors related to usage, and perceptions of use among college students.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.drugalcdep.2012.11.010}{doi:10.1016/j.drugalcdep.2012.11.010}.
\item Maclean KA, Leoutsakos JM, Johnson MW, Griffiths RR. (2012). \textit{Factor Analysis of the Mystical Experience Questionnaire: A Study of Experiences Occasioned by the Hallucinogen Psilocybin.}. Journal for the Scientific Study of Religion. [published; Europe PMC]. \href{https://doi.org/10.1111/j.1468-5906.2012.01685.x}{doi:10.1111/j.1468-5906.2012.01685.x}.
\item Martin R, Schürenkamp J, Gasse A, Pfeiffer H, Köhler H. (2012). \textit{Determination of psilocin, bufotenine, LSD and its metabolites in serum, plasma and urine by SPE-LC-MS/MS.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s00414-012-0796-1}{doi:10.1007/s00414-012-0796-1}.
\item Lim TH, Wasywich CA, Ruygrok PN (2012). \textit{A fatal case of 'magic mushroom' ingestion in a heart transplant recipient.}. Internal medicine journal. [published; PubMed]. \href{https://doi.org/10.1111/j.1445-5994.2012.02955.x}{doi:10.1111/j.1445-5994.2012.02955.x}.
\item Lyvers M, Meester M. (2012). \textit{Illicit use of LSD or psilocybin, but not MDMA or nonpsychedelic drugs, is associated with mystical experiences in a dose-dependent manner.}. Journal of Psychoactive Drugs. [published; Europe PMC]. \href{https://doi.org/10.1080/02791072.2012.736842}{doi:10.1080/02791072.2012.736842}.
\item Carhart-Harris RL, Leech R, Erritzoe D, Williams TM, Stone JM, Evans J, Sharp DJ, Feilding A, Wise RG, Nutt DJ. (2012). \textit{Functional connectivity measures after psilocybin inform a novel hypothesis of early psychosis.}. Schizophrenia Bulletin. [published; Europe PMC]. \href{https://doi.org/10.1093/schbul/sbs117}{doi:10.1093/schbul/sbs117}.
\item Hanks JB, González-Maeso J. (2012). \textit{Animal models of serotonergic psychedelics.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/cn300138m}{doi:10.1021/cn300138m}.
\item Pellegrini M, Rotolo MC, Marchei E, Pacifici R, Saggio F, Pichini S. (2012). \textit{Magic truffles or Philosopher's stones: a legal way to sell psilocybin?}. Drug Testing and Analysis. [published; Europe PMC]. \href{https://doi.org/10.1002/dta.1400}{doi:10.1002/dta.1400}.
\item Tennison MN. (2012). \textit{Moral transhumanism: the next step.}. The Journal of Medicine and Philosophy A Forum for Bioethics and Philosophy of Medicine. [published; Europe PMC]. \href{https://doi.org/10.1093/jmp/jhs024}{doi:10.1093/jmp/jhs024}.
\item Schmidt A, Kometer M, Bachmann R, Seifritz E, Vollenweider F. (2012). \textit{The NMDA antagonist ketamine and the 5-HT agonist psilocybin produce dissociable effects on structural encoding of emotional face expressions.}. Psychopharmacology. [published; Europe PMC]. \href{https://doi.org/10.1007/s00213-012-2811-0}{doi:10.1007/s00213-012-2811-0}.
\item Licht CL, Christoffersen M, Okholm M, Damgaard L, Fink-Jensen A, Knudsen GM, Erritzoe D. (2012). \textit{Simultaneous polysubstance use among Danish 3,4-methylenedioxymethamphetamine and hallucinogen users: combination patterns and proposed biological bases.}. Human Psychopharmacology Clinical and Experimental. [published; Europe PMC]. \href{https://doi.org/10.1002/hup.2234}{doi:10.1002/hup.2234}.
\item Jacomien Aleman, Mirjam Crul, Peter H. J. van der Voort, Eric J. F. Franssen (2012). \textit{Anticholinergic toxicity after the ingestion of serotonergic 'magic mushrooms'}. Pure Amsterdam UMC. [published; OpenAlex]. \href{https://pure.amsterdamumc.nl/en/publications/9641390d-ba9e-4cf0-a1d5-445ec0f4717b}{source link}.
\item Olthuis JV, Darredeau C, Barrett SP. (2012). \textit{Substance use initiation: the role of simultaneous polysubstance use.}. Drug and Alcohol Review. [published; Europe PMC]. \href{https://doi.org/10.1111/j.1465-3362.2012.00470.x}{doi:10.1111/j.1465-3362.2012.00470.x}.
\item Kometer M, Schmidt A, Bachmann R, Studerus E, Seifritz E, Vollenweider FX. (2012). \textit{Psilocybin biases facial recognition, goal-directed behavior, and mood state toward positive relative to negative emotions through different serotonergic subreceptors.}. Biological Psychiatry. [published; Europe PMC]. \href{https://doi.org/10.1016/j.biopsych.2012.04.005}{doi:10.1016/j.biopsych.2012.04.005}.
\item Reissig CJ, Carter LP, Johnson MW, Mintzer MZ, Klinedinst MA, Griffiths RR. (2012). \textit{High doses of dextromethorphan, an NMDA antagonist, produce effects similar to classic hallucinogens.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s00213-012-2680-6}{doi:10.1007/s00213-012-2680-6}.
\item Evan J. Kyzar, Christopher Collins, Jeremy Green, Siddharth Gaikwad, Andrew Roth, Louis Monnig, Mohamed El-Ounsi, Nicholas Capezio, Andrew J. Freeman, Ari Davis, Allan V. Kalueff (2012). \textit{Effects of the hallucinogenic drugs mescaline, phencyclidine and psilocybin on zebrafish behavior and physiology}. The FASEB Journal. [published; OpenAlex]. \href{https://doi.org/10.1096/fasebj.26.1\_supplement.1043.3}{doi:10.1096/fasebj.26.1\_supplement.1043.3}.
\item Roiser JP, Rees G. (2012). \textit{Neuroimaging: a scanner, colourfully.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.cub.2012.02.033}{doi:10.1016/j.cub.2012.02.033}.
\item Studerus E, Gamma A, Kometer M, Vollenweider FX. (2012). \textit{Prediction of psilocybin response in healthy volunteers.}. PLoS ONE. [published; Europe PMC]. \href{https://doi.org/10.1371/journal.pone.0030800}{doi:10.1371/journal.pone.0030800}.
\item Carhart-Harris RL, Leech R, Williams TM, Erritzoe D, Abbasi N, Bargiotas T, Hobden P, Sharp DJ, Evans J, Feilding A, Wise RG, Nutt DJ. (2012). \textit{Implications for psychedelic-assisted psychotherapy: functional magnetic resonance imaging study with psilocybin.}. The British Journal of Psychiatry. [published; Europe PMC]. \href{https://doi.org/10.1192/bjp.bp.111.103309}{doi:10.1192/bjp.bp.111.103309}.
\item Carhart-Harris RL, Erritzoe D, Williams T, Stone JM, Reed LJ, Colasanti A, Tyacke RJ, Leech R, Malizia AL, Murphy K, Hobden P, Evans J, Feilding A, Wise RG, Nutt DJ. (2012). \textit{Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin.}. Proceedings of the National Academy of Sciences. [published; Europe PMC]. \href{https://doi.org/10.1073/pnas.1119598109}{doi:10.1073/pnas.1119598109}.
\item Natasha Amalda Ediwan (2011). \textit{GAMBARAN KARAKTERISTIK SOSIODEMOGRAFIK, TINGKAT PENGETAHUAN DAN POLA PENGGUNAAN JAMUR Psilocybin PADA MAHASISWA S1 UNIVERSITAS PADJAJARAN PERIODE AJAR2010-2011}. Unknown journal. [published; OpenAlex]. \href{https://repository.unpad.ac.id/frontdoor/index/index/year/2019/docId/118252}{source link}.
\item LI Yu-bai (2011). \textit{Flavone Glycoside Antagonizes Psilocybin-Induced Toxicity by Reducing Oxidative Stress in Rats Model}. Zhongguo Yike Daxue xuebao. [published; OpenAlex]. \href{https://en.cnki.com.cn/Article\_en/CJFDTOTAL-ZGYK201201019.htm}{source link}.
\item Martin R, Schürenkamp J, Pfeiffer H, Köhler H. (2011). \textit{A validated method for quantitation of psilocin in plasma by LC-MS/MS and study of stability.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s00414-011-0652-8}{doi:10.1007/s00414-011-0652-8}.
\item Johnson MW, Sewell RA, Griffiths RR. (2011). \textit{Psilocybin dose-dependently causes delayed, transient headaches in healthy volunteers.}. Drug and Alcohol Dependence. [published; Europe PMC]. \href{https://doi.org/10.1016/j.drugalcdep.2011.10.029}{doi:10.1016/j.drugalcdep.2011.10.029}.
\item Schmidt A, Bachmann R, Kometer M, Csomor PA, Stephan KE, Seifritz E, Vollenweider FX. (2011). \textit{Mismatch negativity encoding of prediction errors predicts S-ketamine-induced cognitive impairments.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/npp.2011.261}{doi:10.1038/npp.2011.261}.
\item MacLean KA, Johnson MW, Griffiths RR. (2011). \textit{Mystical experiences occasioned by the hallucinogen psilocybin lead to increases in the personality domain of openness.}. Journal of Psychopharmacology. [published; Europe PMC]. \href{https://doi.org/10.1177/0269881111420188}{doi:10.1177/0269881111420188}.
\item Quednow BB, Kometer M, Geyer MA, Vollenweider FX. (2011). \textit{Psilocybin-induced deficits in automatic and controlled inhibition are attenuated by ketanserin in healthy human volunteers.}. Neuropsychopharmacology. [published; Europe PMC]. \href{https://doi.org/10.1038/npp.2011.228}{doi:10.1038/npp.2011.228}.
\item Carod-Artal FJ. (2011). \textit{Hallucinogenic drugs in pre-Columbian Mesoamerican cultures.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.nrl.2011.07.003}{doi:10.1016/j.nrl.2011.07.003}.
\item Pettigrew J. (2011). \textit{Iconography in Bradshaw rock art: breaking the circularity.}. Clinical and Experimental Optometry. [published; Europe PMC]. \href{https://doi.org/10.1111/j.1444-0938.2011.00648.x}{doi:10.1111/j.1444-0938.2011.00648.x}.
\item Robin Carhart-Harris, David Erritzøe, James Stone, Rjs Wise, David Nutt (2011). \textit{P.1.e.017 The functional brain correlates of the psychedelic state: an arterial spin labelling study with psilocybin}. European Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/s0924-977x(11)70495-3}{doi:10.1016/s0924-977x(11)70495-3}.
\item Chen J, Li M, Yan X, Wu E, Zhu H, Lee KJ, Chu VM, Zhan L, Lee W, Kang JS. (2011). \textit{Determining the pharmacokinetics of psilocin in rat plasma using ultra-performance liquid chromatography coupled with a photodiode array detector after orally administering an extract of Gymnopilus spectabilis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jchromb.2011.07.003}{doi:10.1016/j.jchromb.2011.07.003}.
\item Móró L, Simon K, Bárd I, Rácz J. (2011). \textit{Voice of the psychonauts: coping, life purpose, and spirituality in psychedelic drug users.}. Journal of Psychoactive Drugs. [published; Europe PMC]. \href{https://doi.org/10.1080/02791072.2011.605661}{doi:10.1080/02791072.2011.605661}.
\item Kjellgren A, Soussan C. (2011). \textit{Heaven and hell--a phenomenological study of recreational use of 4-HO-MET in Sweden.}. Journal of Psychoactive Drugs. [published; Europe PMC]. \href{https://doi.org/10.1080/02791072.2011.605699}{doi:10.1080/02791072.2011.605699}.
\item Griffiths RR, Johnson MW, Richards WA, Richards BD, McCann U, Jesse R. (2011). \textit{Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects.}. Psychopharmacology. [published; Europe PMC]. \href{https://doi.org/10.1007/s00213-011-2358-5}{doi:10.1007/s00213-011-2358-5}.
\item van Amsterdam J, Opperhuizen A, van den Brink W (2011). \textit{Harm potential of magic mushroom use: a review.}. Regulatory toxicology and pharmacology: RTP. [published; PubMed]. \href{https://doi.org/10.1016/j.yrtph.2011.01.006}{doi:10.1016/j.yrtph.2011.01.006}.
\item Sun-Edelstein C, Mauskop A. (2011). \textit{Alternative headache treatments: nutraceuticals, behavioral and physical treatments.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1111/j.1526-4610.2011.01846.x}{doi:10.1111/j.1526-4610.2011.01846.x}.
\item Shoda T, Fukuhara K, Goda Y, Okuda H. (2011). \textit{Enzyme-assisted synthesis of the glucuronide conjugate of psilocin, an hallucinogenic component of magic mushrooms.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1002/dta.244}{doi:10.1002/dta.244}.
\item Meyer MR, Maurer HH. (2011). \textit{Absorption, distribution, metabolism and excretion pharmacogenomics of drugs of abuse.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.2217/pgs.10.171}{doi:10.2217/pgs.10.171}.
\item Moreno JL, Kurita M, Holloway T, López J, Cadagan R, Martínez-Sobrido L, García-Sastre A, González-Maeso J. (2011). \textit{Maternal influenza viral infection causes schizophrenia-like alterations of 5-HT₂A and mGlu₂ receptors in the adult offspring.}. Journal of Neuroscience. [published; Europe PMC]. \href{https://doi.org/10.1523/jneurosci.4230-10.2011}{doi:10.1523/jneurosci.4230-10.2011}.
\item Moreno JL, Holloway T, Albizu L, Sealfon SC, González-Maeso J. (2011). \textit{Metabotropic glutamate mGlu2 receptor is necessary for the pharmacological and behavioral effects induced by hallucinogenic 5-HT2A receptor agonists.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neulet.2011.01.046}{doi:10.1016/j.neulet.2011.01.046}.
\item Halberstadt AL, Geyer MA. (2011). \textit{Multiple receptors contribute to the behavioral effects of indoleamine hallucinogens.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neuropharm.2011.01.017}{doi:10.1016/j.neuropharm.2011.01.017}.
\item Halberstadt AL, Koedood L, Powell SB, Geyer MA. (2010). \textit{Differential contributions of serotonin receptors to the behavioral effects of indoleamine hallucinogens in mice.}. Journal of Psychopharmacology. [published; Europe PMC]. \href{https://doi.org/10.1177/0269881110388326}{doi:10.1177/0269881110388326}.
\item Kometer M, Cahn BR, Andel D, Carter OL, Vollenweider FX. (2010). \textit{The 5-HT2A/1A agonist psilocybin disrupts modal object completion associated with visual hallucinations.}. Biological Psychiatry. [published; Europe PMC]. \href{https://doi.org/10.1016/j.biopsych.2010.10.002}{doi:10.1016/j.biopsych.2010.10.002}.
\item Riley S, Thompson J, Griffin C. (2010). \textit{Turn on, tune in, but don't drop out: The impact of neo-liberalism on magic mushroom users' (in)ability to imagine collectivist social worlds.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.drugpo.2010.07.001}{doi:10.1016/j.drugpo.2010.07.001}.
\item Sumnall HR, Measham F, Brandt SD, Cole JC. (2010). \textit{Salvia divinorum use and phenomenology: results from an online survey.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/0269881110385596}{doi:10.1177/0269881110385596}.
\item Studerus E, Kometer M, Hasler F, Vollenweider FX. (2010). \textit{Acute, subacute and long-term subjective effects of psilocybin in healthy humans: a pooled analysis of experimental studies.}. Journal of Psychopharmacology. [published; Europe PMC]. \href{https://doi.org/10.1177/0269881110382466}{doi:10.1177/0269881110382466}.
\item Grob CS, Danforth AL, Chopra GS, Hagerty M, McKay CR, Halberstadt AL, Greer GR. (2010). \textit{Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer.}. Archives of General Psychiatry. [published; Europe PMC]. \href{https://doi.org/10.1001/archgenpsychiatry.2010.116}{doi:10.1001/archgenpsychiatry.2010.116}.
\item Studerus E, Gamma A, Vollenweider FX. (2010). \textit{Psychometric evaluation of the altered states of consciousness rating scale (OAV).}. PLoS ONE. [published; Europe PMC]. \href{https://doi.org/10.1371/journal.pone.0012412}{doi:10.1371/journal.pone.0012412}.
\item Vollenweider FX, Kometer M. (2010). \textit{The neurobiology of psychedelic drugs: implications for the treatment of mood disorders.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/nrn2884}{doi:10.1038/nrn2884}.
\item Thiago Berti Kirsten, Maria Martha Bernardi (2010). \textit{Acute toxicity of Psilocybe cubensis (Ear.) Sing., Strophariaceae, aqueous extract in mice}. Revista Brasileira de Farmacognosia. [published; OpenAlex]. \href{https://doi.org/10.1590/s0102-695x2010000300017}{doi:10.1590/s0102-695x2010000300017}.
\item Jan RK, Lin JC, Lee H, Sheridan JL, Kydd RR, Kirk IJ, Russell BR. (2010). \textit{Determining the subjective effects of TFMPP in human males.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s00213-010-1911-y}{doi:10.1007/s00213-010-1911-y}.
\item Guy A. Rutter (2010). \textit{Psilocybin Mushrooms of the World: an identification guide. Paul Stamets.}. Edinburgh Journal of Botany. [published; OpenAlex]. \href{https://doi.org/10.1017/s0960428600001426}{doi:10.1017/s0960428600001426}.
\item Carhart-Harris RL, Williams TM, Sessa B, Tyacke RJ, Rich AS, Feilding A, Nutt DJ. (2010). \textit{The administration of psilocybin to healthy, hallucinogen-experienced volunteers in a mock-functional magnetic resonance imaging environment: a preliminary investigation of tolerability.}. Journal of Psychopharmacology. [published; Europe PMC]. \href{https://doi.org/10.1177/0269881110367445}{doi:10.1177/0269881110367445}.
\item O. Carter, John D. Pettigrew, Felix Hasler, Guy Wallis, Franz X. Vollenweider (2010). \textit{Psilocybin slows binocular rivalry switching through serotonin modulation}. Journal of Vision. [published; OpenAlex]. \href{https://doi.org/10.1167/6.6.43}{doi:10.1167/6.6.43}.
\item Olivia Carter, David C. Burr, John D. Pettigrew, Franz X. Vollenweider (2010). \textit{Using psilocybin to investigate the relationship between attention, working memory and the serotonin 5-HT1A and 5-HT2A receptors}. Journal of Vision. [published; OpenAlex]. \href{https://doi.org/10.1167/5.8.683}{doi:10.1167/5.8.683}.
\item Hu Chunmei, Qin Hua, Cui Yuxin, Jia Yanxing (2010). \textit{ChemInform Abstract: Palladium-Catalyzed Synthesis of Tryptamines and Tryptamine Homologues: Synthesis of Psilocin.}. ChemInform. [published; Crossref]. \href{https://doi.org/10.1002/chin.201009186}{doi:10.1002/chin.201009186}.
\item Butelman ER, Rus S, Prisinzano TE, Kreek MJ. (2010). \textit{The discriminative effects of the kappa-opioid hallucinogen salvinorin A in nonhuman primates: dissociation from classic hallucinogen effects.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s00213-009-1771-5}{doi:10.1007/s00213-009-1771-5}.
\item Laussmann T, Meier-Giebing S. (2010). \textit{Forensic analysis of hallucinogenic mushrooms and khat (Catha edulis Forsk) using cation-exchange liquid chromatography.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.forsciint.2009.12.013}{doi:10.1016/j.forsciint.2009.12.013}.
\item Weiwei Wang (2009). \textit{Aspects of secondary metabolism in basidiomycetes: I. biological and biochemical studies on Psilocybe cubensis II. a survey of phenol-o-methyltransferase in species of Lentinus and Lentinellus}. cIRcle (University of British Columbia). [published; OpenAlex]. \href{https://doi.org/10.14288/1.0094541}{doi:10.14288/1.0094541}.
\item Rose Jade (2009). \textit{Current Research on the Human Experience of Spirituality Following the Ingestion of ‘Magic’ Psilocybin Mushrooms: An Annotated Bibliography for Social Workers and Other Health Care Professionals}. SSRN Electronic Journal. [published; OpenAlex]. \href{https://doi.org/10.2139/ssrn.1714051}{doi:10.2139/ssrn.1714051}.
\item Manevski N, Kurkela M, Höglund C, Mauriala T, Court MH, Yli-Kauhaluoma J, Finel M. (2009). \textit{Glucuronidation of psilocin and 4-hydroxyindole by the human UDP-glucuronosyltransferases.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1124/dmd.109.031138}{doi:10.1124/dmd.109.031138}.
\item Koçak A, De Cotiis LM, Hoffman DB. (2009). \textit{Comparative study of ATR and transflection IR spectroscopic techniques for the analysis of hallucinogenic mushrooms.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.forsciint.2009.11.002}{doi:10.1016/j.forsciint.2009.11.002}.
\item Brandon Huskins, Christopher R. Dockery (2009). \textit{Detection of Psilocybin Mushroom Analogs in Chocolate}. The Chemical Educator. [published; OpenAlex]. \href{https://doi.org/10.1333/s00897092230a}{doi:10.1333/s00897092230a}.
\item Morvan Y, Rouvier J, Olié JP, Lôo H, Krebs MO. (2009). \textit{[Student's use of illicit drugs: a survey in a preventive health service].}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/s0013-7006(09)73471-2}{doi:10.1016/s0013-7006(09)73471-2}.
\item Hu Chunmei, Qin Hua, Cui Yuxin, Jia Yanxing (2009). \textit{Palladium-catalyzed synthesis of tryptamines and tryptamine homologues: synthesis of psilocin}. Tetrahedron. [published; Crossref]. \href{https://doi.org/10.1016/j.tet.2009.09.050}{doi:10.1016/j.tet.2009.09.050}.
\item Wark C, Galliher JF. (2009). \textit{Timothy Leary, Richard Alpert (Ram Dass) and the changing definition of psilocybin.}. International Journal of Drug Policy. [published; Europe PMC]. \href{https://doi.org/10.1016/j.drugpo.2009.08.004}{doi:10.1016/j.drugpo.2009.08.004}.
\item Lott JP, Marlowe DB, Forman RF. (2009). \textit{Availability of websites offering to sell psilocybin spores and psilocybin.}. Journal of Psychoactive Drugs. [published; Europe PMC]. \href{https://doi.org/10.1080/02791072.2009.10400541}{doi:10.1080/02791072.2009.10400541}.
\item Kovacic P, Somanathan R. (2009). \textit{Novel, unifying mechanism for mescaline in the central nervous system: electrochemistry, catechol redox metabolite, receptor, cell signaling and structure activity relationships.}. Oxidative Medicine and Cellular Longevity. [published; Europe PMC]. \href{https://doi.org/10.4161/oxim.2.4.9380}{doi:10.4161/oxim.2.4.9380}.
\item Matsushima Y, Shirota O, Kikura-Hanajiri R, Goda Y, Eguchi F. (2009). \textit{Effects of Psilocybe argentipes on marble-burying behavior in mice.}. Bioscience Biotechnology and Biochemistry. [published; Europe PMC]. \href{https://doi.org/10.1271/bbb.90095}{doi:10.1271/bbb.90095}.
\item Kovacic P. (2009). \textit{Unifying electron transfer mechanism for psilocybin and psilocin.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.mehy.2009.06.022}{doi:10.1016/j.mehy.2009.06.022}.
\item Björnstad K, Hultén P, Beck O, Helander A. (2009). \textit{Bioanalytical and clinical evaluation of 103 suspected cases of intoxications with psychoactive plant materials.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/15563650903037181}{doi:10.1080/15563650903037181}.
\item Barbee G, Berry-Cabán C, Barry J, Borys D, Ward J, Salyer S. (2009). \textit{Analysis of mushroom exposures in Texas requiring hospitalization, 2005-2006.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/bf03161087}{doi:10.1007/bf03161087}.
\item Kawamura M, Kikura-Hanajiri R, Goda Y. (2009). \textit{[Simple and rapid screening for psychotropic natural products using Direct Analysis in Real Time (DART)-TOFMS].}. YAKUGAKU ZASSHI. [published; Europe PMC]. \href{https://doi.org/10.1248/yakushi.129.719}{doi:10.1248/yakushi.129.719}.
\item Flammer R, Schenk-Jäger KM. (2009). \textit{[Mushroom poisoning--the dark side of mycetism].}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1024/0040-5930.66.5.357}{doi:10.1024/0040-5930.66.5.357}.
\item Björnstad K, Beck O, Helander A. (2009). \textit{A multi-component LC-MS/MS method for detection of ten plant-derived psychoactive substances in urine.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jchromb.2009.03.004}{doi:10.1016/j.jchromb.2009.03.004}.
\item Gonmori K, Yokoyama K (2009). \textit{[Acute encephalopathy caused by cyanogenic fungi in 2004, and magic mushroom regulation in Japan].}. Chudoku kenkyu: Chudoku Kenkyukai jun kikanshi = The Japanese journal of toxicology. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/19344063/}{source link}.
\item Hasan Rafati, Hossein Riahi, Ali Mohammadi (2008). \textit{Enhancement of Indole Alkaloids Produced by Psilocybe cubensis (Earle) Singer (Agaricomycetideae) in Controlled Harvesting Light Conditions}. International journal of medicinal mushrooms. [published; OpenAlex]. \href{https://doi.org/10.1615/intjmedmushr.v11.i4.80}{doi:10.1615/intjmedmushr.v11.i4.80}.
\item David Serrano Hurtado (2008). \textit{Psilocybin: Historical and pharmacological perspective and current authorized research}. Repositorio Universidad de Caldas. [published; OpenAlex]. \href{https://revistasojs.ucaldas.edu.co/index.php/culturaydroga/article/view/5437}{source link}.
\item Kevin Sean Bunch, Bunch Kevin (2008). \textit{PSILOCYBIN AND SPIRITUAL EXPERIENCE}. Unknown journal. [published; OpenAlex]. \href{http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.670.5522}{source link}.
\item Brandon Huskins, Christopher R. Dockery (2008). \textit{Detection of Psilocybin Mushroom Analogs in Chocolate: Incorporating Current Events into the Undergraduate Teaching Laboratory}. DigitalCommons - Kennesaw State University (Kennesaw State University). [published; OpenAlex]. \href{https://digitalcommons.kennesaw.edu/facpubs/997}{source link}.
\item González-Maeso J, Sealfon SC. (2008). \textit{Agonist-trafficking and hallucinogens.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.2174/092986709787581851}{doi:10.2174/092986709787581851}.
\item Adams JD. (2008). \textit{Chemical interactions with pyramidal neurons in layer 5 of the cerebral cortex: control of pain and anxiety.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.2174/092986709789057626}{doi:10.2174/092986709789057626}.
\item Hasler F, Kuznetsova OF, Krasikova RN, Cservenyak T, Quednow BB, Vollenweider FX, Ametamey SM, Westera G. (2008). \textit{GMP-compliant radiosynthesis of [18F]altanserin and human plasma metabolite studies.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.apradiso.2008.12.007}{doi:10.1016/j.apradiso.2008.12.007}.
\item McClintock RL, Watts DJ, Melanson S (2008). \textit{Unrecognized magic mushroom abuse in a 28-year-old man.}. The American journal of emergency medicine. [published; PubMed]. \href{https://doi.org/10.1016/j.ajem.2008.01.058}{doi:10.1016/j.ajem.2008.01.058}.
\item Geyer MA, Vollenweider FX. (2008). \textit{Serotonin research: contributions to understanding psychoses.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.tips.2008.06.006}{doi:10.1016/j.tips.2008.06.006}.
\item F.X. Vollenweider, Daniel Hell, Michael Kometer (2008). \textit{Effects of the hallucinogenic 5-HT2A agonist psilocybin on object completion in humans}. International Journal of Psychophysiology. [published; OpenAlex]. \href{https://doi.org/10.1016/j.ijpsycho.2008.05.397}{doi:10.1016/j.ijpsycho.2008.05.397}.
\item Arran Frood (2008). \textit{Benefits of 'magic mushroom' therapy long lasting}. Nature. [published; OpenAlex]. \href{https://doi.org/10.1038/news.2008.934}{doi:10.1038/news.2008.934}.
\item Griffiths R, Richards W, Johnson M, McCann U, Jesse R. (2008). \textit{Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later.}. Journal of Psychopharmacology. [published; Europe PMC]. \href{https://doi.org/10.1177/0269881108094300}{doi:10.1177/0269881108094300}.
\item Hermle L, Kovar KA, Hewer W, Ruchsow M. (2008). \textit{[Hallucinogen-induced psychological disorders].}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1055/s-2008-1038191}{doi:10.1055/s-2008-1038191}.
\item H. Holfeld (2008). \textit{Psychophysische Korrelationen unter der Einwirkung von Psycholytika (LSD, Psilocybin und ähnl.)}. Medicina Experimentalis. [published; OpenAlex]. \href{https://doi.org/10.1159/000135082}{doi:10.1159/000135082}.
\item Heekeren K, Daumann J, Daumann J, Neukirch A, Stock C, Kawohl W, Norra C, Waberski TD, Gouzoulis-Mayfrank E. (2008). \textit{Mismatch negativity generation in the human 5HT2A agonist and NMDA antagonist model of psychosis.}. Psychopharmacology. [published; Europe PMC]. \href{https://doi.org/10.1007/s00213-008-1129-4}{doi:10.1007/s00213-008-1129-4}.
\item H. Heimann (2008). \textit{Ausdrucksphänomenologie der Modellpsychosen (Psilocybin); pp. 85-100}. Psychiatria et Neurologia. [published; OpenAlex]. \href{https://doi.org/10.1159/000131192}{doi:10.1159/000131192}.
\item M. Sercl, J Kovarik, O. Jaros (2008). \textit{Klinische Erfahrungen mit Psilocybin (CY39 Sandoz)}. Psychiatria et Neurologia. [published; OpenAlex]. \href{https://doi.org/10.1159/000131157}{doi:10.1159/000131157}.
\item H Heimann (2008). \textit{Ausdrucksphänomenologie der Modellpsychosen (Psilocybin); pp. 69-84}. Psychiatria et Neurologia. [published; OpenAlex]. \href{https://doi.org/10.1159/000131191}{doi:10.1159/000131191}.
\item Nef HM, Möllmann H, Hilpert P, Krause N, Troidl C, Weber M, Rolf A, Dill T, Hamm C, Elsässer A. (2008). \textit{Apical regional wall motion abnormalities reminiscent to Tako-Tsubo cardiomyopathy following consumption of psychoactive fungi.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.ijcard.2007.12.064}{doi:10.1016/j.ijcard.2007.12.064}.
\item Lee IK, Cho SM, Seok SJ, Yun BS. (2008). \textit{Chemical Constituents of Gymnopilus spectabilis and Their Antioxidant Activity.}. Mycobiology. [published; Europe PMC]. \href{https://doi.org/10.4489/myco.2008.36.1.055}{doi:10.4489/myco.2008.36.1.055}.
\item Bray JK, Goddard WA. (2008). \textit{The structure of human serotonin 2c G-protein-coupled receptor bound to agonists and antagonists.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jmgm.2008.02.006}{doi:10.1016/j.jmgm.2008.02.006}.
\item González-Maeso J, Ang RL, Yuen T, Chan P, Weisstaub NV, López-Giménez JF, Zhou M, Okawa Y, Callado LF, Callado LF, Milligan G, Gingrich JA, Filizola M, Meana JJ, Sealfon SC. (2008). \textit{Identification of a serotonin/glutamate receptor complex implicated in psychosis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/nature06612}{doi:10.1038/nature06612}.
\item Wackermann J, Wittmann M, Hasler F, Vollenweider FX. (2008). \textit{Effects of varied doses of psilocybin on time interval reproduction in human subjects.}. Neuroscience Letters. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neulet.2008.02.006}{doi:10.1016/j.neulet.2008.02.006}.
\item J.C. Ballenger (2007). \textit{Safety, Tolerability, and Efficacy of Psilocybin in 9 Patients With Obsessive-Compulsive Disorder}. Yearbook of Psychiatry and Applied Mental Health. [published; OpenAlex]. \href{https://doi.org/10.1016/s0084-3970(08)70820-x}{doi:10.1016/s0084-3970(08)70820-x}.
\item William A. Richards (2007). \textit{The Phenomenology and Potential Religious Import of States of Consciousness Facilitated by Psilocybin}. Archive for the Psychology of Religion. [published; OpenAlex]. \href{https://doi.org/10.1163/157361208x317196}{doi:10.1163/157361208x317196}.
\item Riley SC, Blackman G (2007). \textit{Between prohibitions: patterns and meanings of magic mushroom use in the UK.}. Substance use \& misuse. [published; PubMed]. \href{https://doi.org/10.1080/10826080701772363}{doi:10.1080/10826080701772363}.
\item Louis Garraway, Rean Maharaj (2007). \textit{The Screening of Mushrooms Found in Trinidad to Determine the Presence of the Psychoactive Substances Psilocin and Psilocybin}. Living World, Journal of the Trinidad and Tobago Field Naturalists' Club. [published; OpenAlex]. \href{https://www.ttfnc.org/livingworld/index.php/lwj/article/view/garraway2007}{source link}.
\item Attema-de Jonge ME, Portier CB, Franssen EJ. (2007). \textit{[Automutilation after consumption of hallucinogenic mushrooms].}. PubMed. [published; Europe PMC]. \href{https://europepmc.org/article/MED/18257429}{source link}.
\item del Mar Ramirez Fernandez M, Laloup M, Wood M, De Boeck G, Lopez-Rivadulla M, Wallemacq P, Samyn N. (2007). \textit{Liquid chromatography-tandem mass spectrometry method for the simultaneous analysis of multiple hallucinogens, chlorpheniramine, ketamine, ritalinic acid, and metabolites, in urine.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1093/jat/31.8.497}{doi:10.1093/jat/31.8.497}.
\item Carter OL, Hasler F, Pettigrew JD, Wallis GM, Liu GB, Vollenweider FX. (2007). \textit{Psilocybin links binocular rivalry switch rate to attention and subjective arousal levels in humans.}. Psychopharmacology. [published; Europe PMC]. \href{https://doi.org/10.1007/s00213-007-0930-9}{doi:10.1007/s00213-007-0930-9}.
\item Fantegrossi WE, Reissig CJ, Katz EB, Yarosh HL, Rice KC, Winter JC. (2007). \textit{Hallucinogen-like effects of N,N-dipropyltryptamine (DPT): possible mediation by serotonin 5-HT1A and 5-HT2A receptors in rodents.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.pbb.2007.09.007}{doi:10.1016/j.pbb.2007.09.007}.
\item Winter JC. (2007). \textit{Antagonism of phencyclidine-induced stimulus control in the rat by other psychoactive drugs.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.pbb.2007.07.007}{doi:10.1016/j.pbb.2007.07.007}.
\item TIMOTHY F. KIRN (2007). \textit{Psilocybin Results Inspire Researchers}. Clinical Psychiatry News. [published; OpenAlex]. \href{https://doi.org/10.1016/s0270-6644(07)70405-8}{doi:10.1016/s0270-6644(07)70405-8}.
\item Adamczyk A, Sadakierska-Chudy A, Janoszka J, Rymkiewicz A, Dobosz T. (2007). \textit{[Hallucinogenic fungi (psilocybe). Part II. Identification of Psilocybe semilanceata by PCR].}. PubMed. [published; Europe PMC]. \href{https://europepmc.org/article/MED/17907620}{source link}.
\item Winter JC, Rice KC, Amorosi DJ, Rabin RA. (2007). \textit{Psilocybin-induced stimulus control in the rat.}. Pharmacology Biochemistry and Behavior. [published; Europe PMC]. \href{https://doi.org/10.1016/j.pbb.2007.06.003}{doi:10.1016/j.pbb.2007.06.003}.
\item Marona-Lewicka D, Nichols DE. (2007). \textit{Further evidence that the delayed temporal dopaminergic effects of LSD are mediated by a mechanism different than the first temporal phase of action.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.pbb.2007.06.001}{doi:10.1016/j.pbb.2007.06.001}.
\item Heekeren K, Neukirch A, Daumann J, Stoll M, Obradovic M, Kovar KA, Geyer MA, Gouzoulis-Mayfrank E. (2007). \textit{Prepulse inhibition of the startle reflex and its attentional modulation in the human S-ketamine and N,N-dimethyltryptamine (DMT) models of psychosis.}. Journal of Psychopharmacology. [published; Europe PMC]. \href{https://doi.org/10.1177/0269881107077734}{doi:10.1177/0269881107077734}.
\item Vollenweider FX, Csomor PA, Knappe B, Geyer MA, Quednow BB. (2007). \textit{The effects of the preferential 5-HT2A agonist psilocybin on prepulse inhibition of startle in healthy human volunteers depend on interstimulus interval.}. Neuropsychopharmacology. [published; Europe PMC]. \href{https://doi.org/10.1038/sj.npp.1301324}{doi:10.1038/sj.npp.1301324}.
\item González-Maeso J, Weisstaub NV, Zhou M, Chan P, Ivic L, Ang R, Lira A, Bradley-Moore M, Ge Y, Zhou Q, Sealfon SC, Gingrich JA. (2007). \textit{Hallucinogens recruit specific cortical 5-HT(2A) receptor-mediated signaling pathways to affect behavior.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neuron.2007.01.008}{doi:10.1016/j.neuron.2007.01.008}.
\item Veniero Gambaro, Lucia Dell’Acqua, P.F. Croci, CM Pecoraro (2006). \textit{HPLC/DAD analysis of psilocin and psilocybin in psilocybe cubensis}. Unknown journal. [published; OpenAlex]. \href{https://air.unimi.it/handle/2434/146135}{source link}.
\item McCambridge J, Winstock A, Hunt N, Mitcheson L. (2006). \textit{5-Year trends in use of hallucinogens and other adjunct drugs among UK dance drug users.}. European Addiction Research. [published; Europe PMC]. \href{https://doi.org/10.1159/000095816}{doi:10.1159/000095816}.
\item Majdanik S, Borowiak K, Brzezńska M, Machoy-Mokrzyńska A. (2006). \textit{[Concentration of selected microelements in blood serum of rats exposed to the action of psilocin and phenylethylamine].}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/20143700}{source link}.
\item Ondra P, Zedníková K, Válka I. (2006). \textit{Detection and determination of abused hallucinogens in biological material.}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/17159796}{source link}.
\item Frecska E, Luna LE. (2006). \textit{The adverse effects of hallucinogens from intramural perspective.}. PubMed. [published; Europe PMC]. \href{https://europepmc.org/article/MED/17211054}{source link}.
\item Sempere AP, Berenguer-Ruiz L, Almazán F. (2006). \textit{[Chronic cluster headache: Response to psilocybin].}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.33588/rn.4309.2006432}{doi:10.33588/rn.4309.2006432}.
\item Moreno FA, Wiegand CB, Taitano EK, Delgado PL. (2006). \textit{Safety, tolerability, and efficacy of psilocybin in 9 patients with obsessive-compulsive disorder.}. The Journal of Clinical Psychiatry. [published; Europe PMC]. \href{https://doi.org/10.4088/jcp.v67n1110}{doi:10.4088/jcp.v67n1110}.
\item Ivan Amato (2006). \textit{PSILOCYBIN STUDIES TURN A NEW LEAF}. Chemical \& Engineering News. [published; OpenAlex]. \href{https://doi.org/10.1021/cen-v084n029.p010a}{doi:10.1021/cen-v084n029.p010a}.
\item Griffiths RR, Richards WA, McCann U, Jesse R. (2006). \textit{Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance.}. Psychopharmacology. [published; Europe PMC]. \href{https://doi.org/10.1007/s00213-006-0457-5}{doi:10.1007/s00213-006-0457-5}.
\item Herbert D. Kleber (2006). \textit{Commentary on: Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance by Griffiths et al.}. Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1007/s00213-006-0461-9}{doi:10.1007/s00213-006-0461-9}.
\item Charles R. Schuster (2006). \textit{Commentary on: Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance by Griffiths et al.}. Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1007/s00213-006-0460-x}{doi:10.1007/s00213-006-0460-x}.
\item David E. Nichols (2006). \textit{Commentary on: Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance by Griffiths et al.}. Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1007/s00213-006-0458-4}{doi:10.1007/s00213-006-0458-4}.
\item Solomon H. Snyder (2006). \textit{Commentary on: Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance by Griffiths et al.}. Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1007/s00213-006-0459-3}{doi:10.1007/s00213-006-0459-3}.
\item Kamata Tooru, Nishikawa Mayumi, Katagi Munehiro, Tsuchihashi Hitoshi (2006). \textit{Direct detection of serum psilocin glucuronide by LC/MS and LC/MS/MS: time-courses of total and free (unconjugated) psilocin concentrations in serum specimens of a “magic mushroom” user}. Forensic Toxicology. [published; Crossref]. \href{https://doi.org/10.1007/s11419-006-0006-2}{doi:10.1007/s11419-006-0006-2}.
\item Barrett SP, Darredeau C, Pihl RO. (2006). \textit{Patterns of simultaneous polysubstance use in drug using university students.}. Human Psychopharmacology Clinical and Experimental. [published; Europe PMC]. \href{https://doi.org/10.1002/hup.766}{doi:10.1002/hup.766}.
\item Lerner M, Lyvers M. (2006). \textit{Values and beliefs of psychedelic drug users: a cross-cultural study.}. Journal of Psychoactive Drugs. [published; Europe PMC]. \href{https://doi.org/10.1080/02791072.2006.10399838}{doi:10.1080/02791072.2006.10399838}.
\item Sewell RA, Halpern JH, Pope HG. (2006). \textit{Response of cluster headache to psilocybin and LSD.}. Neurology. [published; Europe PMC]. \href{https://doi.org/10.1212/01.wnl.0000219761.05466.43}{doi:10.1212/01.wnl.0000219761.05466.43}.
\item Tiscione NB, Miller MI. (2006). \textit{Psilocin identified in a DUID investigation.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1093/jat/30.5.342}{doi:10.1093/jat/30.5.342}.
\item Wittmann M, Carter O, Hasler F, Cahn BR, Grimberg U, Spring P, Hell D, Flohr H, Vollenweider FX. (2006). \textit{Effects of psilocybin on time perception and temporal control of behaviour in humans.}. Queensland's institutional digital repository (The University of Queensland). [published; Europe PMC]. \href{https://doi.org/10.1177/0269881106065859}{source link}.
\item Jensen N, Gartz J, Laatsch H. (2006). \textit{Aeruginascin, a trimethylammonium analogue of psilocybin from the hallucinogenic mushroom Inocybe aeruginascens.}. Planta Medica. [published; Europe PMC]. \href{https://doi.org/10.1055/s-2006-931576}{doi:10.1055/s-2006-931576}.
\item L. G Nicholas Kerry Ogame (2006). \textit{Psilocybin Mushroom Handbook by L. G Nicholas \& Kerry Ogame Social Science}. Unknown journal. [published; OpenAlex]. \href{https://www.cpcaga.org/book/download-psilocybin-mushroom-handbook-by-l-g-nicholas-384677410}{source link}.
\item Anastos N, Barnett NW, Pfeffer FM, Lewis SW. (2006). \textit{Investigation into the temporal stability of aqueous standard solutions of psilocin and psilocybin using high performance liquid chromatography.}. Science \& Justice. [published; Europe PMC]. \href{https://doi.org/10.1016/s1355-0306(06)71579-9}{doi:10.1016/s1355-0306(06)71579-9}.
\item Stamets P. (2006). \textit{Can mushrooms help save the world? Interview by Bonnie J. Horrigan.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.explore.2005.12.011}{doi:10.1016/j.explore.2005.12.011}.
\item Krzysztof Borowiak, Anna Machoy-Mokrzyńska, Sławomir Majdanik, Piotr Waloszczyk, Małgorzata Piasecka, Tomasz Janus, E. Jasionowicz-Piatek, Mirosław Parafiniuk (2005). \textit{Psilocin multiple intake resulted and in cardiotoxic effects}. Acta Toxicologica. [published; OpenAlex]. \href{http://yadda.icm.edu.pl/yadda/element/bwmeta1.element.agro-article-f39ab4e7-0a77-47a4-b535-5656f3d5df88}{source link}.
\item Anastos N, Lewis SW, Barnett NW, Sims DN. (2005). \textit{The determination of psilocin and psilocybin in hallucinogenic mushrooms by HPLC utilizing a dual reagent acidic potassium permanganate and tris(2,2'-bipyridyl)ruthenium(II) chemiluminescence detection system.}. Journal of Forensic Sciences. [published; Europe PMC]. \href{https://doi.org/10.1111/j.1556-4029.2005.00033.x}{doi:10.1111/j.1556-4029.2005.00033.x}.
\item Maruyama T, Kawahara N, Yokoyama K, Makino Y, Fukiharu T, Goda Y. (2005). \textit{Phylogenetic relationship of psychoactive fungi based on rRNA gene for a large subunit and their identification using the TaqMan assay (II).}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.forsciint.2004.10.028}{doi:10.1016/j.forsciint.2004.10.028}.
\item Howard Sard, Govindaraj Kumaran, Cynthia Morency, Bryan L. Roth, Beth Ann Toth, Ping He, Louis Shuster (2005). \textit{SAR of Psilocybin Analogues: Discovery of a Selective 5-HT2C Agonist.}. ChemInform. [published; OpenAlex]. \href{https://doi.org/10.1002/chin.200602219}{doi:10.1002/chin.200602219}.
\item Bickel M, Ditting T, Watz H, Roesler A, Weidauer S, Jacobi V, Gueller S, Betz C, Fichtlscherer S, Stein J (2005). \textit{Severe rhabdomyolysis, acute renal failure and posterior encephalopathy after 'magic mushroom' abuse.}. European journal of emergency medicine: official journal of the European Society for Emergency Medicine. [published; PubMed]. \href{https://doi.org/10.1097/00063110-200512000-00011}{doi:10.1097/00063110-200512000-00011}.
\item Gouzoulis-Mayfrank E, Heekeren K, Neukirch A, Stoll M, Stock C, Obradovic M, Kovar KA. (2005). \textit{Psychological effects of (S)-ketamine and N,N-dimethyltryptamine (DMT): a double-blind, cross-over study in healthy volunteers.}. Pharmacopsychiatry. [published; Europe PMC]. \href{https://doi.org/10.1055/s-2005-916185}{doi:10.1055/s-2005-916185}.
\item Carter OL, Burr DC, Pettigrew JD, Wallis GM, Hasler F, Vollenweider FX. (2005). \textit{Using psilocybin to investigate the relationship between attention, working memory, and the serotonin 1A and 2A receptors.}. Journal of Cognitive Neuroscience. [published; Europe PMC]. \href{https://doi.org/10.1162/089892905774597191}{doi:10.1162/089892905774597191}.
\item Sard H, Kumaran G, Morency C, Roth BL, Toth BA, He P, Shuster L. (2005). \textit{SAR of psilocybin analogs: discovery of a selective 5-HT2C agonist.}. Bioorganic \& Medicinal Chemistry Letters. [published; Europe PMC]. \href{https://doi.org/10.1016/j.bmcl.2005.06.104}{doi:10.1016/j.bmcl.2005.06.104}.
\item Palenicek T., Bubenikova V., Votava M. (2005). \textit{B31 3,4-METHYLENEDIOXYMETHAPMHETAMINE (MDMA) AND4-OH-DIMETHYLTRYPTAMINE (PSILOCIN) INTERACTION IN RATS: BEHAVIORAL STUDY ON PREPULSE INHIBITION OF ACOUSTIC STARTLE REACTION AND ON LOCOMOTION}. Behavioural Pharmacology. [published; Crossref]. \href{https://doi.org/10.1097/00008877-200509001-00236}{doi:10.1097/00008877-200509001-00236}.
\item Espiard ML, Lecardeur L, Abadie P, Halbecq I, Dollfus S. (2005). \textit{Hallucinogen persisting perception disorder after psilocybin consumption: a case study.}. European Psychiatry. [published; Europe PMC]. \href{https://doi.org/10.1016/j.eurpsy.2005.04.008}{doi:10.1016/j.eurpsy.2005.04.008}.
\item Anastos N, Barnett NW, Lewis SW, Gathergood N, Scammells PJ, Sims DN. (2005). \textit{Determination of psilocin and psilocybin using flow injection analysis with acidic potassium permanganate and tris(2,2'-bipyridyl)ruthenium(II) chemiluminescence detection respectively.}. Talanta. [published; Europe PMC]. \href{https://doi.org/10.1016/j.talanta.2004.11.038}{doi:10.1016/j.talanta.2004.11.038}.
\item Carter OL, Pettigrew JD, Hasler F, Wallis GM, Liu GB, Hell D, Vollenweider FX. (2005). \textit{Modulating the rate and rhythmicity of perceptual rivalry alternations with the mixed 5-HT2A and 5-HT1A agonist psilocybin.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/sj.npp.1300621}{doi:10.1038/sj.npp.1300621}.
\item Soyka M, Koch W, Möller HJ, Rüther T, Tatsch K. (2005). \textit{Hypermetabolic pattern in frontal cortex and other brain regions in unmedicated schizophrenia patients. Results from a FDG-PET study.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s00406-005-0563-0}{doi:10.1007/s00406-005-0563-0}.
\item Maruyama T, Kawahara N, Fukiharu T, Yokoyama K, Makino Y, Goda Y. (2005). \textit{[DNA and chemical analyses of commercial fly agaric-related products].}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3358/shokueishi.46.49}{doi:10.3358/shokueishi.46.49}.
\item Kamata T, Nishikawa M, Katagi M, Tsuchihashi H. (2005). \textit{Liquid chromatography-mass spectrometric and liquid chromatography-tandem mass spectrometric determination of hallucinogenic indoles psilocin and psilocybin in "magic mushroom" samples.}. Journal of Forensic Sciences. [published; Europe PMC]. \href{https://doi.org/10.1520/jfs2004276}{doi:10.1520/jfs2004276}.
\item Kamata T, Nishikawa M, Katagi M, Tsuchihashi H (2005). \textit{Liquid chromatography-mass spectrometric and liquid chromatography-tandem mass spectrometric determination of hallucinogenic indoles psilocin and psilocybin in "magic mushroom" samples.}. Journal of forensic sciences. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/15813544/}{source link}.
\item Percy A, McAlister S, Higgins K, McCrystal P, Thornton M (2005). \textit{Response consistency in young adolescents' drug use self-reports: a recanting rate analysis.}. Addiction (Abingdon, England). [published; PubMed]. \href{https://doi.org/10.1111/j.1360-0443.2004.00943.x}{doi:10.1111/j.1360-0443.2004.00943.x}.
\item Rimsza ME, Moses KS. (2005). \textit{Substance abuse on the college campus.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.pcl.2004.10.008}{doi:10.1016/j.pcl.2004.10.008}.
\item Saito K, Toyo'oka T, Kato M, Fukushima T, Shirota O, Goda Y. (2005). \textit{Determination of psilocybin in hallucinogenic mushrooms by reversed-phase liquid chromatography with fluorescence detection.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.talanta.2004.11.031}{doi:10.1016/j.talanta.2004.11.031}.
\item He Xinsheng. (2004). \textit{Study on the biological characteristics and cultivation of panaeolus bisporus}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/CBA/602890}{source link}.
\item Saito Kimie, Toyo’oka Toshimasa, Fukushima Takeshi, Kato Masaru, Shirota Osamu, Goda Yukihiro (2004). \textit{Determination of psilocin in magic mushrooms and rat plasma by liquid chromatography with fluorimetry and electrospray ionization mass spectrometry}. Analytica Chimica Acta. [published; Crossref]. \href{https://doi.org/10.1016/j.aca.2004.08.071}{doi:10.1016/j.aca.2004.08.071}.
\item Albers C, Köhler H, Lehr M, Brinkmann B, Beike J. (2004). \textit{Development of a psilocin immunoassay for serum and blood samples.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s00414-004-0469-9}{doi:10.1007/s00414-004-0469-9}.
\item Carter OL, Pettigrew JD, Burr DC, Alais D, Hasler F, Vollenweider FX. (2004). \textit{Psilocybin impairs high-level but not low-level motion perception.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1097/00001756-200408260-00023}{doi:10.1097/00001756-200408260-00023}.
\item Beuhler M, Lee DC, Gerkin R. (2004). \textit{The Meixner test in the detection of alpha-amanitin and false-positive reactions caused by psilocin and 5-substituted tryptamines.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.annemergmed.2004.03.017}{doi:10.1016/j.annemergmed.2004.03.017}.
\item Scholey AB, Parrott AC, Buchanan T, Heffernan TM, Ling J, Rodgers J. (2004). \textit{Increased intensity of Ecstasy and polydrug usage in the more experienced recreational Ecstasy/MDMA users: a WWW study.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.addbeh.2004.02.022}{doi:10.1016/j.addbeh.2004.02.022}.
\item Halpern JH. (2004). \textit{Hallucinogens and dissociative agents naturally growing in the United States.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.pharmthera.2004.03.003}{doi:10.1016/j.pharmthera.2004.03.003}.
\item Fantegrossi WE, Woods JH, Winger G. (2004). \textit{Transient reinforcing effects of phenylisopropylamine and indolealkylamine hallucinogens in rhesus monkeys.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1097/00008877-200403000-00007}{doi:10.1097/00008877-200403000-00007}.
\item Nugent KG, Saville BJ. (2004). \textit{Forensic analysis of hallucinogenic fungi: a DNA-based approach.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.forsciint.2003.11.022}{doi:10.1016/j.forsciint.2003.11.022}.
\item O. Carter, David Alais, David C. Burr, Felix Hasler, G. Liu, Guy Wallis, Franz X. Vollenweider, John D. Pettigrew (2003). \textit{The Effects of he Hallucinogenic Serotonin 1A/2A Agonist, Psilocybin, on Binocular Rivalry and Visual Contrast Detection Thresholds}. Queensland's institutional digital repository (The University of Queensland). [published; OpenAlex]. \href{https://openalex.org/W111026355}{source link}.
\item Nielen RJ, van der Heijden FM, Tuinier S, Verhoeven WM. (2003). \textit{Khat and mushrooms associated with psychosis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/15622970410029908}{doi:10.1080/15622970410029908}.
\item Yamaguchi Mitsune, Saito Toshiaki, Horiguchi Yoshie, Ogawa Keita, Tsuchiya Yukihiro, Hishinuma Kayoko, Chikuma Toshiyuki, Makino Yukiko, Hojo Hiroshi (2003). \textit{Preparation of Monoclonal Antibodies Reactive to a Hallucinogenic Drug, Psilocin}. Journal of Health Science. [published; Crossref]. \href{https://doi.org/10.1248/jhs.50.600}{doi:10.1248/jhs.50.600}.
\item Tsujikawa K, Kanamori T, Iwata Y, Ohmae Y, Sugita R, Inoue H, Kishi T. (2003). \textit{Morphological and chemical analysis of magic mushrooms in Japan.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.forsciint.2003.08.009}{doi:10.1016/j.forsciint.2003.08.009}.
\item Hasler F, Grimberg U, Benz MA, Huber T, Vollenweider FX. (2003). \textit{Acute psychological and physiological effects of psilocybin in healthy humans: a double-blind, placebo-controlled dose-effect study.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s00213-003-1640-6}{doi:10.1007/s00213-003-1640-6}.
\item Kamata T, Nishikawa M, Katagi M, Tsuchihashi H. (2003). \textit{Optimized glucuronide hydrolysis for the detection of psilocin in human urine samples.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jchromb.2003.08.030}{doi:10.1016/j.jchromb.2003.08.030}.
\item Felix Hasler, Ulrike Grimberg, Martin Benz, F.X. Vollenweider (2003). \textit{P.6.057 Effects of 2A receptor challenge by psilocybin on cognitive performance and neuroendocrine measures in healthy humans: A serotonin model of psychosis}. European Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/s0924-977x(03)92355-8}{doi:10.1016/s0924-977x(03)92355-8}.
\item Saviuc P, Flesch F. (2003). \textit{[Acute higher funghi mushroom poisoning and its treatment].}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/14534493}{source link}.
\item Ventegodt S, Merrick J. (2003). \textit{Psychoactive drugs and quality of life.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1100/tsw.2003.57}{doi:10.1100/tsw.2003.57}.
\item NANBA YASUHARU, MOCHIZUKI TAKESHI, OZAKI KEIKO, HOJO HIROSHI, YAMAGUCHI MITSUMINE. (2003). \textit{METHOD FOR DETECTING IMMUNOCHROMATOGRAPHY OF PSILOCIN BY COMPETITION METHOD, AND TEST KIT}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/PAT/JP2005031029}{source link}.
\item Stríbrný J, Borovicka J, Sokol M. (2003). \textit{[Levels of psilocybin and psilocin in various types of mushrooms].}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/14631713}{source link}.
\item Vollenweider FX, Vollenweider-Scherpenhuyzen MF. (2003). \textit{[Hallucinogens, amphetamines and entactogens].}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1024/0040-5930.60.6.323}{doi:10.1024/0040-5930.60.6.323}.
\item Shirota O, Hakamata W, Goda Y. (2003). \textit{Concise large-scale synthesis of psilocin and psilocybin, principal hallucinogenic constituents of "magic mushroom".}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/np030059u}{doi:10.1021/np030059u}.
\item Carod Artal FJ. (2003). \textit{[Neurological syndromes associated with the ingestion of plants and fungi with a toxic component (II). Hallucinogenic fungi and plants, mycotoxins and medicinal herbs].}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.33588/rn.3610.2003019}{doi:10.33588/rn.3610.2003019}.
\item Gonmori K, Yoshioka N (2003). \textit{The examination of mushroom poisonings at Akita University.}. Legal medicine (Tokyo, Japan). [published; PubMed]. \href{https://doi.org/10.1016/s1344-6223(02)00127-x}{doi:10.1016/s1344-6223(02)00127-x}.
\item Gathergood N, Scammells PJ. (2003). \textit{Preparation of the 4-hydroxytryptamine scaffold via palladium-catalyzed cyclization: a practical and versatile synthesis of psilocin.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/ol0341039}{doi:10.1021/ol0341039}.
\item Maruyama T, Shirota O, Kawahara N, Yokoyama K, Makino Y, Goda Y. (2003). \textit{[Discrimination of psychoactive fungi (commonly called "magic mushrooms") based on the DNA sequence of the internal transcribed spacer region].}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3358/shokueishi.44.44}{doi:10.3358/shokueishi.44.44}.
\item Anna Machoy-Mokrzyńska, Krzysztof Safranow, Krzysztof Borowiak, Sławomir Majdanik, Violetta Dziedziejko, Monika Białecka, Dariusz Chlubek (2002). \textit{The influence of psilocin and phenylethylamine on the energy metabolism in the rat heart}. Acta Toxicologica. [published; OpenAlex]. \href{http://yadda.icm.edu.pl/yadda/element/bwmeta1.element.agro-article-8e3dbd92-615e-497e-af12-c98c681b8b63}{source link}.
\item Krzysztof Borowiak, Anna Machoy-Mokrzyńska, Leszek Domański, Sławomir Majdanik, Edward Dutkiewicz, K Safranow, Tomasz Janus, V Mikolajek (2002). \textit{Electrocardiographic examination of heart function in rats exposed to hallucinogens from Psilocybe mushrooms}. Acta Toxicologica. [published; OpenAlex]. \href{http://yadda.icm.edu.pl/yadda/element/bwmeta1.element.agro-article-d607ea49-70b5-4739-b280-7088af5d6e30}{source link}.
\item O. Carter, Shaun P. Collin, Felix Hasler, George Liu, Franz X. Vollenweider, John D. Pettigrew (2002). \textit{A double-blind, placebo controlled study of the effect of the hallucinogenic 5-HT1A\&2A agonist psilocybin on binocular rivalry rate and rhythmicity}. Social Neuroscience. [published; OpenAlex]. \href{https://espace.library.uq.edu.au/view/UQ:161618}{source link}.
\item Umbricht D, Vollenweider FX, Schmid L, Grübel C, Skrabo A, Huber T, Koller R. (2002). \textit{Effects of the 5-HT2A agonist psilocybin on mismatch negativity generation and AX-continuous performance task: implications for the neuropharmacology of cognitive deficits in schizophrenia.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/sj.npp.1300005}{doi:10.1038/sj.npp.1300005}.
\item Gross ST. (2002). \textit{Psychotropic drugs in developmental mushrooms: a case study review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1520/jfs15564j}{doi:10.1520/jfs15564j}.
\item Riba J, Rodríguez-Fornells A, Barbanoj MJ. (2002). \textit{Effects of ayahuasca on sensory and sensorimotor gating in humans as measured by P50 suppression and prepulse inhibition of the startle reflex, respectively.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s00213-002-1237-5}{doi:10.1007/s00213-002-1237-5}.
\item Passie T, Seifert J, Schneider U, Emrich HM. (2002). \textit{The pharmacology of psilocybin.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/1355621021000005937}{doi:10.1080/1355621021000005937}.
\item Hasler F, Bourquin D, Brenneisen R, Vollenweider FX. (2002). \textit{Renal excretion profiles of psilocin following oral administration of psilocybin: a controlled study in man.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/s0731-7085(02)00278-9}{doi:10.1016/s0731-7085(02)00278-9}.
\item Albers C, Lehr M, Beike J, Köhler H, Brinkmann B. (2002). \textit{Synthesis of a psilocin hapten and a protein-hapten conjugate.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1211/002235702320402116}{doi:10.1211/002235702320402116}.
\item Gross SR, Barrett SP, Shestowsky JS, Pihl RO. (2002). \textit{Ecstasy and drug consumption patterns: a Canadian rave population study.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/070674370204700606}{doi:10.1177/070674370204700606}.
\item Yamada Fumio, Tamura Mayumi, Hasegawa Atsuko, Somei Masanori (2002). \textit{ChemInform Abstract: The Chemistry of Indoles. Part 109. Synthetic Studies of Psilocin Analogues Having Either a Formyl Group or Bromine Atom at the 5- or 7-Position.}. ChemInform. [published; Crossref]. \href{https://doi.org/10.1002/chin.200229147}{doi:10.1002/chin.200229147}.
\item ten Berge J. (2002). \textit{Jekyll and Hyde revisited: paradoxes in the appreciation of drug experiences and their effects on creativity.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/02791072.2002.10399961}{doi:10.1080/02791072.2002.10399961}.
\item Rabin RA, Regina M, Doat M, Winter JC. (2002). \textit{5-HT2A receptor-stimulated phosphoinositide hydrolysis in the stimulus effects of hallucinogens.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/s0091-3057(01)00720-1}{doi:10.1016/s0091-3057(01)00720-1}.
\item Moeller MR, Kraemer T. (2002). \textit{Drugs of abuse monitoring in blood for control of driving under the influence of drugs.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1097/00007691-200204000-00003}{doi:10.1097/00007691-200204000-00003}.
\item Bressloff PC, Cowan JD, Golubitsky M, Thomas PJ, Wiener MC. (2002). \textit{What geometric visual hallucinations tell us about the visual cortex.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1162/089976602317250861}{doi:10.1162/089976602317250861}.
\item Umbricht D, Koller R, Vollenweider FX, Schmid L. (2002). \textit{Mismatch negativity predicts psychotic experiences induced by NMDA receptor antagonist in healthy volunteers.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/s0006-3223(01)01242-2}{doi:10.1016/s0006-3223(01)01242-2}.
\item Fukuda K. (2002). \textit{Possible mechanisms of panic attack and schizophrenia via APUD system.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1054/mehy.2001.1473}{doi:10.1054/mehy.2001.1473}.
\item Adrian Linacre, Michael D. Cole, Lee Jc (2001). \textit{Identifying the presence of ‘magic mushrooms’ by DNA profiling}. Science \& Justice. [published; OpenAlex]. \href{https://doi.org/10.1016/s1355-0306(02)71797-8}{doi:10.1016/s1355-0306(02)71797-8}.
\item Gouzoulis-Mayfrank E, Thelen B, Maier S, Heekeren K, Kovar KA, Sass H, Spitzer M. (2001). \textit{Effects of the hallucinogen psilocybin on covert orienting of visual attention in humans.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1159/000063672}{doi:10.1159/000063672}.
\item Yamada F, Tamura M, Hasegawa A, Somei M. (2001). \textit{Synthetic studies of psilocin analogs having either a formyl group or bromine atom at the 5- or 7-position.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1248/cpb.50.92}{doi:10.1248/cpb.50.92}.
\item Vollenweider FX. (2001). \textit{Brain mechanisms of hallucinogens and entactogens.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.31887/dcns.2001.3.4/fxvollenweider}{doi:10.31887/dcns.2001.3.4/fxvollenweider}.
\item Vollenweider FX, Geyer MA. (2001). \textit{A systems model of altered consciousness: integrating natural and drug-induced psychoses.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/s0361-9230(01)00646-3}{doi:10.1016/s0361-9230(01)00646-3}.
\item Riley SC, James C, Gregory D, Dingle H, Cadger M. (2001). \textit{Patterns of recreational drug use at dance events in Edinburgh, Scotland.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1046/j.1360-0443.2001.967103513.x}{doi:10.1046/j.1360-0443.2001.967103513.x}.
\item Grieshaber AF, Moore KA, Levine B. (2001). \textit{The detection of psilocin in human urine.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1520/jfs15014j}{doi:10.1520/jfs15014j}.
\item Vetulani J. (2001). \textit{Drug addiction. Part I. Psychoactive substances in the past and presence.}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/11785921}{source link}.
\item Grieshaber AF, Moore KA, Levine B (2001). \textit{The detection of psilocin in human urine.}. Journal of forensic sciences. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/11373000/}{source link}.
\item Lee JC. (2000). \textit{Towards a molecular approach for the identification of fungal taxa that contain psilocybin}. University of Strathclyde. [published; Europe PMC]. \href{https://doi.org/10.48730/zty1-g223}{doi:10.48730/zty1-g223}.
\item Moldavan MG, Grodzinskaya AA, Solomko EF, Lomberh ML, Wasser SP, Storozhuk VM. (2000). \textit{The effect of Psilocybe cubensis extract on hippocampal neurons in vitro.}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/11962085}{source link}.
\item Ho E, Karimi-Tabesh L, Koren G (2000). \textit{Characteristics of pregnant women who use ecstasy (3, 4-methylenedioxymethamphetamine).}. Neurotoxicology and teratology. [published; PubMed]. \href{https://doi.org/10.1016/s0892-0362(01)00178-7}{doi:10.1016/s0892-0362(01)00178-7}.
\item Salomé F, Boyer P, Fayol M. (2000). \textit{The effects of psychoactive drugs and neuroleptics on language in normal subjects and schizophrenic patients: a review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/s0924-9338(00)00520-4}{doi:10.1016/s0924-9338(00)00520-4}.
\item Blair JB, Kurrasch-Orbaugh D, Marona-Lewicka D, Cumbay MG, Watts VJ, Barker EL, Nichols DE. (2000). \textit{Effect of ring fluorination on the pharmacology of hallucinogenic tryptamines.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/jm000339w}{doi:10.1021/jm000339w}.
\item Bogusz MJ. (2000). \textit{Liquid chromatography-mass spectrometry as a routine method in forensic sciences: a proof of maturity.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/s0378-4347(00)00461-8}{doi:10.1016/s0378-4347(00)00461-8}.
\item Pierrot M, Josse P, Raspiller MF, Goulmy M, Rambourg MO, Manel J, Lambert H. (2000). \textit{[Intoxications by hallucinogenic mushrooms].}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/11104939}{source link}.
\item Barrett SP, Archambault J, Engelberg MJ, Pihl RO. (2000). \textit{Hallucinogenic drugs attenuate the subjective response to alcohol in humans.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1002/1099-1077(200010)15:7<559::aid-hup230>3.0.co;2-j}{doi:10.1002/1099-1077(200010)15:7<559::aid-hup230>3.0.co;2-j}.
\item Musshoff F, Madea B, Beike J. (2000). \textit{Hallucinogenic mushrooms on the German market - simple instructions for examination and identification.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/s0379-0738(00)00211-5}{doi:10.1016/s0379-0738(00)00211-5}.
\item Sticht G, Käferstein H. (2000). \textit{Detection of psilocin in body fluids.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/s0379-0738(00)00213-9}{doi:10.1016/s0379-0738(00)00213-9}.
\item McBride MC. (2000). \textit{Bufotenine: toward an understanding of possible psychoactive mechanisms.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/02791072.2000.10400456}{doi:10.1080/02791072.2000.10400456}.
\item Adlaf EM, Paglia A, Ivis FJ, Ialomiteanu A. (2000). \textit{Nonmedical drug use among adolescent students: highlights from the 1999 Ontario Student Drug Use Survey.}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/10870495}{source link}.
\item Gross ST. (2000). \textit{Detecting psychoactive drugs in the developmental stages of mushrooms.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1520/jfs14725j}{doi:10.1520/jfs14725j}.
\item Yamada F. (2000). \textit{[Development of synthetic methods for 4-substituted indoles and their applications for the syntheses of natural products].}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1248/yakushi1947.120.4\_363}{doi:10.1248/yakushi1947.120.4\_363}.
\item Spengos K, Schwartz A, Hennerici M (2000). \textit{Multifocal cerebral demyelination after magic mushroom abuse.}. Journal of neurology. [published; PubMed]. \href{https://doi.org/10.1007/s004150050570}{doi:10.1007/s004150050570}.
\item M. G. Moldavan, Elvira F. Solomko, Anna A. Grodzínskaya, V. М. Storozhuk, Margarita Lomberg (1999). \textit{Neurotropic Effect of Extracts from the Hallucinogenic Mushroom Psilocybe cubensis (Earle) Sing. (Agaricomycetideae). In Vitro Studies}. International journal of medicinal mushrooms. [published; OpenAlex]. \href{https://doi.org/10.1615/intjmedmushr.v2.i4.130}{doi:10.1615/intjmedmushr.v2.i4.130}.
\item Gilbert Asselborn, Robert Wennig, Michel Yegles (1999). \textit{TRAGIC FLYING ATTEMPT UNDER THE INFLUENCE OF "MAGIC MUSHROOMS"}. Unknown journal. [published; OpenAlex]. \href{http://www.forensicscience.pl/pfs/42\_asselborn.pdf}{source link}.
\item Schäfer AT. (1999). \textit{[Microscopic study of powders of hallucinogenic mushrooms--Psilocybe sp].}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/10726173}{source link}.
\item Senn-Irlet Beatrice, Nyffenegger Adolf, Brenneisen Rudolf (1999). \textit{Panaeolus bisporus - an adventitious fungus in central Europe, rich in psilocin}. Mycologist. [published; Crossref]. \href{https://doi.org/10.1016/s0269-915x(99)80107-4}{doi:10.1016/s0269-915x(99)80107-4}.
\item Paul May (1999). \textit{Molecule of the Month: Psilocybin and Mescaline}. Unknown journal. [published; OpenAlex]. \href{http://research-information.bristol.ac.uk/en/publications/molecule-of-the-month-psilocybin-and-mescaline(71cfb946-4451-433a-af87-aa1426e8f418).html}{source link}.
\item Gerasimov M, Marona-Lewicka D, Kurrasch-Orbaugh DM, Qandil AM, Nichols DE. (1999). \textit{Further studies on oxygenated tryptamines with LSD-like activity incorporating a chiral pyrrolidine moiety into the side chain.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/jm990325u}{doi:10.1021/jm990325u}.
\item Drummer OH. (1999). \textit{Chromatographic screening techniques in systematic toxicological analysis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/s0378-4347(99)00265-0}{doi:10.1016/s0378-4347(99)00265-0}.
\item Keller T, Schneider A, Regenscheit P, Dirnhofer R, Rucker T, Jaspers J, Kisser W (1999). \textit{Analysis of psilocybin and psilocin in psilocybe subcubensis Guzman by ion mobility spectrometry and gas chromatography-mass spectrometry}. Journal of Clinical Forensic Medicine. [published; Crossref]. \href{https://doi.org/10.1016/s1353-1131(99)90073-1}{doi:10.1016/s1353-1131(99)90073-1}.
\item Nichols David E., Frescas Steward (1999). \textit{ChemInform Abstract: Improvements to the Synthesis of Psilocybin and a Facile Method for Preparing the O-Acetyl Prodrug of Psilocin.}. ChemInform. [published; Crossref]. \href{https://doi.org/10.1002/chin.199933137}{doi:10.1002/chin.199933137}.
\item Sakagami Hideki, Ogasawara Kunio (1999). \textit{ChemInform Abstract: A New Synthesis of Psilocin}. ChemInform. [published; Crossref]. \href{https://doi.org/10.1002/chin.199932235}{doi:10.1002/chin.199932235}.
\item Krämer E, Kovar KA. (1999). \textit{On-line coupling of automated solid-phase extraction with high-performance liquid chromatography and electrochemical detection. Quantitation of oxidizable drugs of abuse and their metabolites in plasma and urine.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/s0378-4347(99)00212-1}{doi:10.1016/s0378-4347(99)00212-1}.
\item Löhrer F, Albers M. (1999). \textit{[Biological addictive drugs--is there a change in drug taking behavior of young drug addicts?].}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/10457973}{source link}.
\item Yamada Fumio, Tamura Mayumi, Somei Masanori (1999). \textit{ChemInform Abstract: Chemistry of Indoles. Part 88. A Five-Step Synthesis of Psilocin from Indole-3-carbaldehyde.}. ChemInform. [published; Crossref]. \href{https://doi.org/10.1002/chin.199923257}{doi:10.1002/chin.199923257}.
\item Gouzoulis-Mayfrank E, Schreckenberger M, Sabri O, Arning C, Thelen B, Spitzer M, Kovar KA, Hermle L, Büll U, Sass H. (1999). \textit{Neurometabolic effects of psilocybin, 3,4-methylenedioxyethylamphetamine (MDE) and d-methamphetamine in healthy volunteers. A double-blind, placebo-controlled PET study with [18F]FDG.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/s0893-133x(98)00089-x}{doi:10.1016/s0893-133x(98)00089-x}.
\item Nichols David E. (1999). \textit{Improvements to the Synthesis of Psilocybin and a Facile Method for Preparing the O-Acetyl Prodrug of Psilocin}. Synthesis. [published; Crossref]. \href{https://doi.org/10.1055/s-1999-3490}{doi:10.1055/s-1999-3490}.
\item Vollenweider FX, Vontobel P, Hell D, Leenders KL. (1999). \textit{5-HT modulation of dopamine release in basal ganglia in psilocybin-induced psychosis in man--a PET study with [11C]raclopride.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/s0893-133x(98)00108-0}{doi:10.1016/s0893-133x(98)00108-0}.
\item Babakhanian RV, Ivanova GV, Kostyrko TA, Safraĭ AE, Iagmurov OD. (1999). \textit{[The morphofunctional changes in the internal organs in the modelling of poisonings by psilocybine-containing mushrooms].}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/10396957}{source link}.
\item Gouzoulis-Mayfrank E, Thelen B, Habermeyer E, Kunert HJ, Kovar KA, Lindenblatt H, Hermle L, Spitzer M, Sass H. (1999). \textit{Psychopathological, neuroendocrine and autonomic effects of 3,4-methylenedioxyethylamphetamine (MDE), psilocybin and d-methamphetamine in healthy volunteers. Results of an experimental double-blind placebo-controlled study.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s002130050860}{doi:10.1007/s002130050860}.
\item Franco Tagliaro (1998). \textit{Recommended Methods for the Detection and Assay of Lysergide (LSD), Phencyclidine (PCP), Psilocybin and Methaqualone in biological Specimens (multiauthored manual)}. Unknown journal. [published; OpenAlex]. \href{https://iris.univr.it/handle/11562/302309}{source link}.
\item D A Reid, A. Eicker (1998). \textit{South African fungi 9: Psilocybe natalensis - a blueing hallucinogenic species from South Africa}. Mycotaxon. [published; OpenAlex]. \href{https://doi.org/10.5962/p.415161}{doi:10.5962/p.415161}.
\item Shirahama Haruhisa, Sogawa Kazuyo, Hashimoto Kimiko (1998). \textit{H-D Exchange of Psilocin and Its Analogs}. HETEROCYCLES. [published; Crossref]. \href{https://doi.org/10.3987/com-98-s(h)87}{doi:10.3987/com-98-s(h)87}.
\item Keller T, Schneider A, Regenscheit P, Dirnhofer R, Rücker T, Jaspers J, Kisser W. (1998). \textit{Analysis of psilocybin and psilocin in Psilocybe subcubensis Guzmán by ion mobility spectrometry and gas chromatography-mass spectrometry.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/s0379-0738(98)00168-6}{doi:10.1016/s0379-0738(98)00168-6}.
\item Ogasawara Kunio, Sakagami Hideki (1998). \textit{A New Synthesis of Psilocin}. HETEROCYCLES. [published; Crossref]. \href{https://doi.org/10.3987/com-99-8492}{doi:10.3987/com-99-8492}.
\item Stig Pedersen-Bjergaard, Knut Einar Rasmussen (1998). \textit{Capillary electrophoresis of psilocybin in hallucinogenic mushrooms}. Research at the University of Copenhagen (University of Copenhagen). [published; OpenAlex]. \href{https://researchprofiles.ku.dk/da/publications/55ac5ed7-ff92-4676-a56e-cd075fdb7b65}{source link}.
\item Vollenweider FX, Vollenweider-Scherpenhuyzen MF, Bäbler A, Vogel H, Hell D. (1998). \textit{Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1097/00001756-199812010-00024}{doi:10.1097/00001756-199812010-00024}.
\item Gouzoulis-Mayfrank E, Heekeren K, Thelen B, Lindenblatt H, Kovar KA, Sass H, Geyer MA. (1998). \textit{Effects of the hallucinogen psilocybin on habituation and prepulse inhibition of the startle reflex in humans.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1097/00008877-199811000-00011}{doi:10.1097/00008877-199811000-00011}.
\item Babakhanian RV, Bushuev ES, Zenkevich IG, Kazankov SP, Kostyrko TA, Kuz'minykh KS. (1998). \textit{[The forensic chemical study of psilocybine-containing fungi].}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/9989170}{source link}.
\item Doblin R. (1998). \textit{Dr. Leary's Concord Prison Experiment: a 34-year follow-up study.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/02791072.1998.10399715}{doi:10.1080/02791072.1998.10399715}.
\item Euphrosyne Gouzoulis-Mayfrank, Karsten Heekeren, B. Thelen, Hiltrud Lindenblatt, K.-A. Kovar, H. Sass, M.A. Geyer (1998). \textit{529 The hallucinogen psilocybin increases prepulse inhibition of the startle reflex in healthy humans}. International Journal of Psychophysiology. [published; OpenAlex]. \href{https://doi.org/10.1016/s0167-8760(98)90528-1}{doi:10.1016/s0167-8760(98)90528-1}.
\item Adlaf EM, Ivis FJ. (1998). \textit{Recent findings from the Ontario Student Drug Use Survey.}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/9757168}{source link}.
\item Vollenweider FX. (1998). \textit{Advances and pathophysiological models of hallucinogenic drug actions in humans: a preamble to schizophrenia research.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1055/s-2007-979353}{doi:10.1055/s-2007-979353}.
\item Gouzoulis-Mayfrank E, Schneider F, Friedrich J, Spitzer M, Thelen B, Sass H. (1998). \textit{Methodological issues of human experimental research with hallucinogens.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1055/s-2007-979356}{doi:10.1055/s-2007-979356}.
\item Ametamey S., Vollenweider F. X., Patt J., Bourquin D., Hasler F., Beer H.-F., Schubiger P. A. (1998). \textit{11C-radiolabeling of hallucinogenic psilocin, a potential radioligand for studying the role of serotonin receptors in psychotic symptom formation}. Journal of Labelled Compounds and Radiopharmaceuticals. [published; Crossref]. \href{https://doi.org/10.1002/(sici)1099-1344(199807)41:7<585::aid-jlcr115>3.0.co;2-u}{doi:10.1002/(sici)1099-1344(199807)41:7<585::aid-jlcr115>3.0.co;2-u}.
\item Lindenblatt H, Krämer E, Holzmann-Erens P, Gouzoulis-Mayfrank E, Kovar KA. (1998). \textit{Quantitation of psilocin in human plasma by high-performance liquid chromatography and electrochemical detection: comparison of liquid-liquid extraction with automated on-line solid-phase extraction.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/s0378-4347(98)00067-x}{doi:10.1016/s0378-4347(98)00067-x}.
\item Mansi Kala, Wojciech Lechowicz, Roman Stanaszek (1997). \textit{Analysis of psilocin in Polish hallucinogenic mushrooms}. Acta Poloniae Toxicologica. [published; OpenAlex]. \href{http://yadda.icm.edu.pl/yadda/element/bwmeta1.element.agro-article-64d5aaec-f7ca-4434-ad46-5e05030850c8}{source link}.
\item Beck O, Helander A, Karlson-Stiber C, Stephansson N. (1997). \textit{Presence of phenylethylamine in hallucinogenic Psilocybe mushroom: possible role in adverse reactions.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1093/jat/22.1.45}{doi:10.1093/jat/22.1.45}.
\item Pedersen-Bjergaard S, Rasmussen KE, Sannes E. (1997). \textit{Strategies for the capillary electrophoretic separation of indole alkaloids in Psilocybe semilanceata.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1002/elps.1150190107}{doi:10.1002/elps.1150190107}.
\item Borowiak KS, Ciechanowski K, Waloszczyk P. (1997). \textit{Psilocybin mushroom (Psilocybe semilanceata) intoxication with myocardial infarction.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3109/15563659809162584}{doi:10.3109/15563659809162584}.
\item Somei Masanori, Yamada Fumio, Tamura Mayumi (1997). \textit{A Five-Step Synthesis of Psilocin from Indole-3-carbaldehyde}. HETEROCYCLES. [published; Crossref]. \href{https://doi.org/10.3987/com-98-s18}{source link}.
\item Pedersen-Bjergaard S, Sannes E, Rasmussen KE, Tønnesen F. (1997). \textit{Determination of psilocybin in Psilocybe semilanceata by capillary zone electrophoresis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/s0378-4347(97)00127-8}{doi:10.1016/s0378-4347(97)00127-8}.
\item Hasler F, Bourquin D, Brenneisen R, Bär T, Vollenweider FX. (1997). \textit{Determination of psilocin and 4-hydroxyindole-3-acetic acid in plasma by HPLC-ECD and pharmacokinetic profiles of oral and intravenous psilocybin in man.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/s0031-6865(97)00014-9}{doi:10.1016/s0031-6865(97)00014-9}.
\item Vollenweider FX, Leenders KL, Scharfetter C, Maguire P, Stadelmann O, Angst J. (1997). \textit{Positron emission tomography and fluorodeoxyglucose studies of metabolic hyperfrontality and psychopathology in the psilocybin model of psychosis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/s0893-133x(96)00246-1}{doi:10.1016/s0893-133x(96)00246-1}.
\item Unknown authors (1997). \textit{Psilocybin mushrooms of the world: an identification guide}. Choice Reviews Online. [published; OpenAlex]. \href{https://doi.org/10.5860/choice.34-4479}{doi:10.5860/choice.34-4479}.
\item Almaula N, Ebersole BJ, Ballesteros JA, Weinstein H, Sealfon SC. (1996). \textit{Contribution of a helix 5 locus to selectivity of hallucinogenic and nonhallucinogenic ligands for the human 5-hydroxytryptamine2A and 5-hydroxytryptamine2C receptors: direct and indirect effects on ligand affinity mediated by the same locus.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/s0026-895x(25)09149-7}{doi:10.1016/s0026-895x(25)09149-7}.
\item Spitzer M, Thimm M, Hermle L, Holzmann P, Kovar KA, Heimann H, Gouzoulis-Mayfrank E, Kischka U, Schneider F. (1996). \textit{Increased activation of indirect semantic associations under psilocybin.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/0006-3223(95)00418-1}{doi:10.1016/0006-3223(95)00418-1}.
\item Hanes KR. (1996). \textit{Serotonin, psilocybin, and body dysmorphic disorder: a case report.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1097/00004714-199604000-00011}{doi:10.1097/00004714-199604000-00011}.
\item Horace J. Beach (1995). \textit{Listening for the logos: a study of reports of audible voices at high doses of psilocybin}. Medical Entomology and Zoology. [published; OpenAlex]. \href{http://ci.nii.ac.jp/ncid/BB19813140}{source link}.
\item Hughes JR. (1995). \textit{A review of the usefulness of the standard EEG in psychiatry.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/155005949602700106}{doi:10.1177/155005949602700106}.
\item Bergman B, Karlsson AC. (1995). \textit{[A caution for psilocybine in wild mushrooms. A young addict acquired acute delirium].}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/7564628}{source link}.
\item Gartz J, Allen JW, Merlin MD. (1994). \textit{Ethnomycology, biochemistry, and cultivation of Psilocybe samuiensis Guzmán, Bandala and Allen, a new psychoactive fungus from Koh Samui, Thailand.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/0378-8741(94)90006-x}{doi:10.1016/0378-8741(94)90006-x}.
\item Marcano V, Morales Méndez A, Castellano F, Salazar FJ, Martinez L. (1994). \textit{Occurrence of psilocybin and psilocin in Psilocybe pseudobullacea (Petch) Pegler from the Venezuelan Andes.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/0378-8741(94)90013-2}{doi:10.1016/0378-8741(94)90013-2}.
\item Chamakura RP. (1994). \textit{Bufotenine - A Hallucinogen in Ancient Snuff Powders of South America and a Drug of Abuse on the Streets of New York City.}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/26270149}{source link}.
\item Cuomo MJ, Dyment PG, Gammino VM. (1994). \textit{Increasing use of "Ecstasy" (MDMA) and other hallucinogens on a college campus.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/07448481.1994.9936359}{doi:10.1080/07448481.1994.9936359}.
\item Gouzoulis E, Hermle L, Sass H. (1994). \textit{[Psychedelic experiences at the onset of productive episodes of endogenous psychoses].}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/8177361}{source link}.
\item Gartz J. (1993). \textit{Extraction and analysis of indole derivatives from fungal biomass.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1002/jobm.3620340104}{doi:10.1002/jobm.3620340104}.
\item Köppel C. (1993). \textit{Clinical symptomatology and management of mushroom poisoning.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/0041-0101(93)90337-i}{doi:10.1016/0041-0101(93)90337-i}.
\item Hery F, Hamon M. (1993). \textit{[Neuroleptics and serotonin].}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/7905821}{source link}.
\item Merlin MD, Allen JW. (1993). \textit{Species identification and chemical analysis of psychoactive fungi in the Hawaiian islands.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/0378-8741(93)90086-k}{doi:10.1016/0378-8741(93)90086-k}.
\item Robert S. Gable (1993). \textit{Skinner, Maslow, and Psilocybin}. Journal of Humanistic Psychology. [published; OpenAlex]. \href{https://doi.org/10.1177/00221678930333005}{doi:10.1177/00221678930333005}.
\item Riedlinger TJ. (1993). \textit{Wasson's alternative candidates for soma.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/02791072.1993.10472245}{doi:10.1080/02791072.1993.10472245}.
\item Gable RS. (1992). \textit{Toward a comparative overview of dependence potential and acute toxicity of psychoactive substances used nonmedically.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3109/00952999309001618}{doi:10.3109/00952999309001618}.
\item Strassman RJ. (1992). \textit{Human hallucinogen interactions with drugs affecting serotonergic neurotransmission.}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/1388647}{source link}.
\item Lassen JF, Lassen NF, Skov J. (1992). \textit{[Consumption of psilocybin-containing hallucinogenic mushrooms by young people].}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/1413197}{source link}.
\item Smith C, Nutbeam D. (1992). \textit{Adolescent drug use in Wales.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1111/j.1360-0443.1992.tb02696.x}{doi:10.1111/j.1360-0443.1992.tb02696.x}.
\item T. Stijve (1991). \textit{Psilocin, psilocybin, serotonin and urea in Panaeolus cyanescens from various origin}. The Digital Academic Repository of Naturalis Biodiversity Center (Naturalis Biodiversity Center). [published; OpenAlex]. \href{http://www.repository.naturalis.nl/record/532101}{source link}.
\item Allen JW, Merlin MD. (1991). \textit{Psychoactive mushroom use in Koh Samui and Koh Pha-Ngan, Thailand.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/0378-8741(92)90020-r}{doi:10.1016/0378-8741(92)90020-r}.
\item Jones J (1990). \textit{'Magic mushroom' poisoning in a colt.}. The Veterinary record. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/2075691/}{source link}.
\item Kysilka R. (1990). \textit{Determination of psilocin in rat urine by high-performance liquid chromatography with electrochemical detection.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/s0378-4347(00)82176-3}{doi:10.1016/s0378-4347(00)82176-3}.
\item Kysilka R, Wurst M. (1990). \textit{A novel extraction procedure for psilocybin and psilocin determination in mushroom samples.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1055/s-2006-960970}{doi:10.1055/s-2006-960970}.
\item Buckholtz NS, Zhou DF, Freedman DX, Potter WZ. (1990). \textit{Lysergic acid diethylamide (LSD) administration selectively downregulates serotonin2 receptors in rat brain.}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/1969270}{source link}.
\item Kirwan AP (1990). \textit{'Magic mushroom' poisoning in a dog.}. The Veterinary record. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/2316139/}{source link}.
\item L. S. Gurevich, E. L. Nezdoĭminogo (1989). \textit{Possible uses of psilocybin and muscarin alkaloids in the chemotaxonomy of Inocybe (Fr.)Fr.}. Unknown journal. [published; OpenAlex]. \href{https://www.cabdirect.org/abstracts/19921250159.html}{source link}.
\item Lassen JF, Ravn HB, Lassen SF. (1989). \textit{[Hallucinogenic psilocybine containing mushrooms. Toxins contained in Danish wild mushrooms].}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/2301080}{source link}.
\item Leikin JB, Krantz AJ, Zell-Kanter M, Barkin RL, Hryhorczuk DO. (1989). \textit{Clinical features and management of intoxication due to hallucinogenic drugs.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/bf03259916}{doi:10.1007/bf03259916}.
\item Gartz J. (1989). \textit{Biotransformation of Tryptamine in Fruiting Mycelia of Psilocybe cubensis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1055/s-2006-961995}{doi:10.1055/s-2006-961995}.
\item Jochen Gartz (1988). \textit{Occurrence of psilocybin, psilocin and baeocystin in Gymnopilus purpuratus}. The Digital Academic Repository of Naturalis Biodiversity Center (Naturalis Biodiversity Center). [published; OpenAlex]. \href{http://www.repository.naturalis.nl/record/532047}{source link}.
\item Jochen Gartz, Gregory Möller (1988). \textit{Analysis and Cultivation of Fruit Bodies and Mycelia of Psilocybe bohemica}. Biochemie und Physiologie der Pflanzen. [published; OpenAlex]. \href{https://doi.org/10.1016/s0015-3796(89)80023-x}{doi:10.1016/s0015-3796(89)80023-x}.
\item Eivindvik K, Rasmussen KE, Sund RB. (1988). \textit{Handling of psilocybin and psilocin by everted sacs of rat jejunum and colon.}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/2610906}{source link}.
\item Gartz J. (1988). \textit{Biotransformation of tryptamine derivatives in mycelial cultures of Psilocybe.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1002/jobm.3620290608}{doi:10.1002/jobm.3620290608}.
\item Appel JB, Callahan PM. (1988). \textit{Involvement of 5-HT receptor subtypes in the discriminative stimulus properties of mescaline.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/0014-2999(89)90041-1}{doi:10.1016/0014-2999(89)90041-1}.
\item Callahan PM, Appel JB. (1988). \textit{Differences in the stimulus properties of 3,4-methylenedioxyamphetamine and 3,4- methylenedioxymethamphetamine in animals trained to discriminate hallucinogens from saline.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/s0022-3565(25)22199-1}{doi:10.1016/s0022-3565(25)22199-1}.
\item Rudolf Brenneisen, Stefan Borner (1988). \textit{The Occurrence of Tryptamine Derivatives in Psilocybe semilanceata}. Zeitschrift für Naturforschung C. [published; OpenAlex]. \href{https://doi.org/10.1515/znc-1988-7-806}{doi:10.1515/znc-1988-7-806}.
\item Schwartz RH, Smith DE. (1988). \textit{Hallucinogenic mushrooms.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/000992288802700202}{doi:10.1177/000992288802700202}.
\item Rudolf Brenneisen, Stefan Borner, Nelly Peter-Oesch, U. P. Schlunegger (1987). \textit{Synthesis of Baeocystin, a natural Psilocybin Analogue}. Archiv der Pharmazie. [published; OpenAlex]. \href{https://doi.org/10.1002/ardp.19883210812}{doi:10.1002/ardp.19883210812}.
\item T. Stijve, Th.W. Kuyper (1987). \textit{Absence of psilocybin in species of fungi previously reported to contain psilocybin and related tryptamine derivatives}. The Digital Academic Repository of Naturalis Biodiversity Center (Naturalis Biodiversity Center). [published; OpenAlex]. \href{http://www.repository.naturalis.nl/record/531853}{source link}.
\item Musha M, Kusano G, Tanaka F, Gotoh Y, Ishii A. (1987). \textit{[Poisoning by the hallucinogenic mushroom hikageshibiretake (Psilocybe argentipes)--with special reference to subjective experiences during psilocybin poisoning].}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/3413259}{source link}.
\item Gartz J. (1987). \textit{Variation of the Amount of Alkaloids in Fruit Bodies of Inocybe aeruginascens.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1055/s-2006-962805}{doi:10.1055/s-2006-962805}.
\item Leonard HL, Rapoport JL. (1987). \textit{Relief of obsessive-compulsive symptoms by LSD and psilocin.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1176/ajp.144.9.1239b}{doi:10.1176/ajp.144.9.1239b}.
\item Ohenoja E, Jokiranta J, Mäkinen T, Kaikkonen A, Airaksinen MM. (1987). \textit{The occurrence of psilocybin and psilocin in Finnish fungi.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/np50052a030}{doi:10.1021/np50052a030}.
\item Gartz J. (1987). \textit{Occurrence of Psilocybin and Baeocystin in Fruit Bodies of Pluteus salicinus.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1055/s-2006-962710}{doi:10.1055/s-2006-962710}.
\item Zilker T. (1987). \textit{[Diagnosis and therapy of mushroom poisoning (1)].}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/3586830}{source link}.
\item Marta Semerdžieva, M. Wurst, T. Koza, Jochen Gartz (1986). \textit{Psilocybin in Fruchtkörpern vonInocybe aeruginascens}. Planta Medica. [published; OpenAlex]. \href{https://doi.org/10.1055/s-2007-969085}{doi:10.1055/s-2007-969085}.
\item Martin WR, Sloan JW. (1986). \textit{Relationship of CNS tryptaminergic processes and the action of LSD-like hallucinogens.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/0091-3057(86)90369-2}{doi:10.1016/0091-3057(86)90369-2}.
\item Nichols DE. (1986). \textit{Studies of the relationship between molecular structure and hallucinogenic activity.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/0091-3057(86)90362-x}{doi:10.1016/0091-3057(86)90362-x}.
\item Poon Grace, Chui Yun-Cheung, Law Francis C. P. (1986). \textit{Synthesis of psilocin labelled with 14C and 3H}. Journal of Labelled Compounds and Radiopharmaceuticals. [published; Crossref]. \href{https://doi.org/10.1002/jlcr.2580230207}{doi:10.1002/jlcr.2580230207}.
\item Jochen Gartz (1985). \textit{Psilocybin in Mycelkulturen von Inocybe aeruginascens}. Biochemie und Physiologie der Pflanzen. [published; OpenAlex]. \href{https://doi.org/10.1016/s0015-3796(86)80042-7}{doi:10.1016/s0015-3796(86)80042-7}.
\item Jochen Gartz (1985). \textit{Quantitative Bestimmung der Indolderivate von Psilocybe semilanceata (Fr.) Kumm.}. Biochemie und Physiologie der Pflanzen. [published; OpenAlex]. \href{https://doi.org/10.1016/s0015-3796(86)80079-8}{doi:10.1016/s0015-3796(86)80079-8}.
\item Musha M, Ishii A, Tanaka F, Kusano G. (1985). \textit{Poisoning by hallucinogenic mushroom hikageshibiretake (Psilocybe argentipes K. Yokoyama) indigenous to Japan.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1620/tjem.148.73}{doi:10.1620/tjem.148.73}.
\item Stijve T, Kuyper TW. (1985). \textit{Occurrence of psilocybin in various higher fungi from several European countries.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1055/s-2007-969526}{doi:10.1055/s-2007-969526}.
\item Lee RE. (1985). \textit{A technique for the rapid isolation and identification of psilocin from psilocin/psilocybin-containing mushrooms.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1520/jfs11028j}{doi:10.1520/jfs11028j}.
\item Lee RE (1985). \textit{A technique for the rapid isolation and identification of psilocin from psilocin/psilocybin-containing mushrooms.}. Journal of forensic sciences. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/4040953/}{source link}.
\item Siegel RK. (1985). \textit{New trends in drug use among youth in California.}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/3878176}{source link}.
\item T. Stijve, Jaroslav Klán, Th.W. Kuyper (1984). \textit{Occurrence of Psilocybin and Baeocystin in the genus Inocybe (Fr.) Fr}. The Digital Academic Repository of Naturalis Biodiversity Center (Naturalis Biodiversity Center). [published; OpenAlex]. \href{http://www.repository.naturalis.nl/record/532375}{source link}.
\item Casale JF. (1984). \textit{An aqueous-organic extraction method for the isolation and identification of psilocin from hallucinogenic mushrooms.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1520/jfs10989j}{doi:10.1520/jfs10989j}.
\item Casale JF (1984). \textit{An aqueous-organic extraction method for the isolation and identification of psilocin from hallucinogenic mushrooms.}. Journal of forensic sciences. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/4038992/}{source link}.
\item Christiansen AL, Rasmussen KE, Høiland K. (1984). \textit{Detection of psilocybin and psilocin in norwegian species of pluteus and conocybe.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1055/s-2007-969726}{doi:10.1055/s-2007-969726}.
\item Gonzalez-Lima F, Stiehl WL, Medina R. (1984). \textit{Long-lasting behavioral effects of bromocriptine in cats.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/0014-2999(84)90259-0}{doi:10.1016/0014-2999(84)90259-0}.
\item Jokiranta J, Mustola S, Ohenoja E, Airaksinen MM. (1984). \textit{Psilocybin in Finnish Psilocybe semilanceata.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1055/s-2007-969703}{doi:10.1055/s-2007-969703}.
\item Richard Evans Schultes (1984). \textit{The genus psilocybe}. Journal of Ethnopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/0378-8741(84)90031-x}{doi:10.1016/0378-8741(84)90031-x}.
\item Badham ER. (1984). \textit{Ethnobotany of psilocybin mushrooms, especially Psilocybe cubensis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/0378-8741(84)90007-2}{doi:10.1016/0378-8741(84)90007-2}.
\item Trulson ME, Preussler DW, Trulson VM. (1983). \textit{Differential effects of hallucinogenic drugs on the activity of serotonin-containing neurons in the nucleus centralis superior and nucleus raphe pallidus in freely moving cats.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/s0022-3565(25)21616-0}{doi:10.1016/s0022-3565(25)21616-0}.
\item Mack RB. (1983). \textit{Phenomenally phunny phungi--psilocybin toxicity.}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/6580536}{source link}.
\item Sottolano SM, Lurie IS. (1983). \textit{The quantitation of psilocybin in hallucinogenic mushrooms using high performance liquid chromatography.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1520/jfs11601j}{doi:10.1520/jfs11601j}.
\item Valdés LJ, Díaz JL, Paul AG. (1983). \textit{Ethnopharmacology of ska María Pastora (Salvia divinorum, Epling and Játiva-M.).}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/0378-8741(83)90004-1}{doi:10.1016/0378-8741(83)90004-1}.
\item J. Francis, Virginia Murray (1983). \textit{Review of Enquiries made to the NPIS Concerning Psilocybe Mushroom Ingestion, 1978-1981}. Human Toxicology. [published; OpenAlex]. \href{https://doi.org/10.1177/096032718300200229}{doi:10.1177/096032718300200229}.
\item Peden NR, Pringle SD, Crooks J. (1982). \textit{The problem of psilocybin mushroom abuse.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/096032718200100408}{doi:10.1177/096032718200100408}.
\item Unknown authors (1982). \textit{Confusion over psilocybin toxicity}. Reactions. [published; OpenAlex]. \href{https://doi.org/10.1007/bf03266040}{doi:10.1007/bf03266040}.
\item A.L. Christiansen, Knut Rasmussen (1982). \textit{Analysis of indole alkaloids in Norwegian Psilocybe semilanceata using high-performance liquid chromatography and mass spectrometry}. Journal of Chromatography A. [published; OpenAlex]. \href{https://doi.org/10.1016/s0021-9673(00)85700-3}{doi:10.1016/s0021-9673(00)85700-3}.
\item Repke David B., Ferguson Wilfred J. (1982). \textit{Psilocin analogs. III. Synthesis of 5-methoxy- and 5-hydroxy-1,2,3,4-tetrahydro-9H-pyrido[3,4-b]indoles}. Journal of Heterocyclic Chemistry. [published; Crossref]. \href{https://doi.org/10.1002/jhet.5570190428}{doi:10.1002/jhet.5570190428}.
\item Beug MW, Bigwood J. (1982). \textit{Psilocybin and psilocin levels in twenty species from seven genera of wild mushrooms in the Pacific Northwest, U.S.A.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/0378-8741(82)90013-7}{doi:10.1016/0378-8741(82)90013-7}.
\item Bigwood J, Beug MW. (1982). \textit{Variation of psilocybin and psilocin levels with repeated flushes (harvests) of mature sporocarps of Psilocybe cubensis (Earle) Singer.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/0378-8741(82)90014-9}{doi:10.1016/0378-8741(82)90014-9}.
\item van Poorten JF, Stienstra R, Dworacek B, Moleman P, Rupreht J. (1982). \textit{Physostigmine reversal of psilocybin intoxication.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1097/00000542-198204000-00017}{doi:10.1097/00000542-198204000-00017}.
\item Koerner J, Appel JB. (1981). \textit{Psilocybin as a discriminative stimulus: lack of specificity in an animal behavior model for 'hallucinogens'.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/bf00435266}{doi:10.1007/bf00435266}.
\item McCall RB. (1981). \textit{Neurophysiological effects of hallucinogens on serotonergic neuronal systems.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/0149-7634(82)90033-1}{doi:10.1016/0149-7634(82)90033-1}.
\item Mohan D, Mohandas E, Rajat R. (1981). \textit{Chloroquine psychosis: a chemical psychosis?}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/7310924}{source link}.
\item Peden NR, Bissett AF, Macaulay KE, Crooks J, Pelosi AJ (1981). \textit{Clinical toxicology of "magic mushroom" ingestion.}. Postgraduate medical journal. [published; PubMed]. \href{https://doi.org/10.1136/pgmj.57.671.543}{doi:10.1136/pgmj.57.671.543}.
\item Harries AD, Evans V (1981). \textit{Sequelae of a 'magic mushroom banquet'.}. Postgraduate medical journal. [published; PubMed]. \href{https://doi.org/10.1136/pgmj.57.671.571}{doi:10.1136/pgmj.57.671.571}.
\item REPKE D. B., FERGUSON W. J., BATES D. K. (1981). \textit{ChemInform Abstract: PSILOCIN ANALOGS. PART2. SYNTHESIS OF3-(2-(DIALKYLAMINO)ETHYL)-, 3-(2-(N-METHYL-N-ALKYLAMINO)ETHYL)-, AND3-(2-(CYCLOALKYLAMINO)ETHYL)INDOL-4-OLS}. Chemischer Informationsdienst. [published; Crossref]. \href{https://doi.org/10.1002/chin.198131198}{doi:10.1002/chin.198131198}.
\item MIGLIACCIO G. P., SHIEH T.-L. N., BYRN S. R., HATHAWAY A., NICHOLS D. E. (1981). \textit{ChemInform Abstract: COMPARISON OF SOLUTION CONFORMATIONAL PREFERENCES FOR THE HALLUCINOGENS BUFOTENIN AND PSILOCIN USING 360-MHZ PROTON NMR SPECTROSCOPY}. Chemischer Informationsdienst. [published; Crossref]. \href{https://doi.org/10.1002/chin.198128356}{doi:10.1002/chin.198128356}.
\item Stephen G. Saupe (1981). \textit{Occurrence of Psilocybin/Psilocin in Pluteus salicinus (Pluteaceae)}. Mycologia. [published; OpenAlex]. \href{https://doi.org/10.2307/3759505}{doi:10.2307/3759505}.
\item Christiansen AL, Rasmussen KE, Høiland K. (1981). \textit{The content of Psilocybin in Norwegian Psilocybe semilanceata.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1055/s-2007-971632}{doi:10.1055/s-2007-971632}.
\item Saupe Stephen G. (1981). \textit{Occurrence of Psilocybin/Psilocin in Pluteus Salicinus (Pluteaceae)}. Mycologia. [published; Crossref]. \href{https://doi.org/10.1080/00275514.1981.12021406}{doi:10.1080/00275514.1981.12021406}.
\item Trulson ME, Heym J, Jacobs BL. (1981). \textit{Dissociations between the effects of hallucinogenic drugs on behavior and raphe unit activity in freely moving cats.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/0006-8993(81)90507-2}{doi:10.1016/0006-8993(81)90507-2}.
\item A.L. Christiansen, Knut Rasmussen, Finn Tønnesen (1981). \textit{Determination of psilocybin in Psilocybe semilanceata using high-performance liquid chromatography on a silica column}. Journal of Chromatography A. [published; OpenAlex]. \href{https://doi.org/10.1016/s0021-9673(00)91195-6}{doi:10.1016/s0021-9673(00)91195-6}.
\item Yutaka Koike, Kohko Wada, Genjiro Kusano, Shigeo Nozoe, Kazumasa Yokoyama (1981). \textit{Isolation of Psilocybin From Psilocybe argentipes and Its Determination in Specimens of Some Mushrooms}. Journal of Natural Products. [published; OpenAlex]. \href{https://doi.org/10.1021/np50015a023}{doi:10.1021/np50015a023}.
\item Beug MW, Bigwood J. (1981). \textit{Quantitative analysis of psilocybin and psilocin in psilocybe baeocystis (Singer and Smith) by high-performance liquid chromatography and by thin-layer chromatography.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/s0021-9673(00)88741-5}{doi:10.1016/s0021-9673(00)88741-5}.
\item Laubscher A, Pletscher A, Noll H. (1981). \textit{Interaction of D-LSD with blood platelets of rabbits: shape change and specific binding.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/s0022-3565(25)32431-6}{doi:10.1016/s0022-3565(25)32431-6}.
\item Migliaccio GP, Shieh TL, Byrn SR, Hathaway BA, Nichols DE. (1981). \textit{Comparison of solution conformational preferences for the hallucinogens bufotenin and psilocin using 360-MHz proton NMR spectroscopy.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/jm00134a016}{doi:10.1021/jm00134a016}.
\item Gelpke R. (1980). \textit{On travels in the universe of the soul: reports on self-experiments with delysid (LSD) and psilocybin (CY).}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/02791072.1981.10471454}{doi:10.1080/02791072.1981.10471454}.
\item Repke David B., Ferguson Wilfred J., Bates Dallas K. (1980). \textit{Psilocin analogs II. Synthesis of 3-[2-(dialkylamino)ethyl]-, 3-[2-(N-methyl-N-alkylamino)ethyl]-, and 3-[2-(cycloalkylamino)ethyl]indol-4-ols}. Journal of Heterocyclic Chemistry. [published; Crossref]. \href{https://doi.org/10.1002/jhet.5570180131}{doi:10.1002/jhet.5570180131}.
\item McDonald A. (1980). \textit{Mushrooms and madness. Hallucinogenic mushrooms and some psychopharmacological implications.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/070674378002500709}{doi:10.1177/070674378002500709}.
\item Thomson BM (1980). \textit{Analysis of Psilocybin and Psilocin in Mushroom Extracts by Reversed-Phase High Performance Liquid Chromatography}. Journal of Forensic Sciences. [published; Crossref]. \href{https://doi.org/10.1520/jfs11292j}{doi:10.1520/jfs11292j}.
\item Järbe TU. (1980). \textit{LDS-25 as a discriminative stimulus for response selection by pigeons.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/0091-3057(80)90279-8}{doi:10.1016/0091-3057(80)90279-8}.
\item Thomson BM. (1980). \textit{Analysis of psilocybin and psilocin in mushroom extracts by reversed-phase high performance liquid chromatography.}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/7191888}{source link}.
\item Dewhurst K. (1980). \textit{Psilocybin intoxication.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1192/bjp.137.3.303a}{doi:10.1192/bjp.137.3.303a}.
\item Kaul B, Davidow B. (1980). \textit{Application of a radioimmunoassay screening test for detection and management of phencyclidine intoxication.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1002/j.1552-4604.1980.tb02542.x}{doi:10.1002/j.1552-4604.1980.tb02542.x}.
\item Fairchild MD, Jenden DJ, Mickey MR, Yale C. (1979). \textit{EEG effects of hallucinogens and cannabinoids using sleep-waking behavior as baseline.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/0091-3057(80)90422-0}{doi:10.1016/0091-3057(80)90422-0}.
\item Shulgin AT. (1979). \textit{Profiles of psychedelic drugs. Psilocybin.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/02791072.1980.10471557}{doi:10.1080/02791072.1980.10471557}.
\item Mills PR, Lesinskas D, Watkinson G. (1979). \textit{The danger of hallucinogenic mushrooms.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/003693307902400413}{doi:10.1177/003693307902400413}.
\item Geyer MA, Light RK, Rose GJ, Petersen LR, Horwitt DD, Adams LM, Hawkins RL. (1979). \textit{A characteristic effect of hallucinogens on investigatory responding in rats.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/bf00491975}{doi:10.1007/bf00491975}.
\item Vaupel DB, Nozaki M, Martin WR, Bright LD, Morton EC. (1979). \textit{The inhibition of food intake in the dog by LDS, mescaline, psilocin, d-amphetamine and phenylisopropylamine derivatives.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/0024-3205(79)90451-x}{doi:10.1016/0024-3205(79)90451-x}.
\item Benjamin C. (1979). \textit{Persistent psychiatric symptoms after eating psilocybin mushrooms.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1136/bmj.1.6174.1319}{doi:10.1136/bmj.1.6174.1319}.
\item S. E. Unger, R. Graham Cooks (1978). \textit{Application of Mass Spectrometry/Mass Spectrometry (MS/MS) to the Identification of Natural Products in Psilocybe Cyanescens}. Analytical Letters. [published; OpenAlex]. \href{https://doi.org/10.1080/00032717908067906}{doi:10.1080/00032717908067906}.
\item Sbordone RJ, Wingard JA, Gorelick DA, Elliott ML. (1978). \textit{Severe aggression in rats induced by mescaline but not other hallucinogens.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/bf00428319}{doi:10.1007/bf00428319}.
\item Chilton WS, Bigwood J, Jensen RE. (1978). \textit{Psilocin, bufotenine and serotonin: historical and biosynthetic observations.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/02791072.1979.10472093}{doi:10.1080/02791072.1979.10472093}.
\item Geyer MA, Petersen LR, Rose GJ, Horwitt DD, Light RK, Adams LM, Zook JA, Hawkins RL, Mandell AJ. (1978). \textit{The effects of lysergic acid diethylamide and mescaline-derived hallucinogens on sensory-integrative function: tactile startle.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/s0022-3565(25)31486-2}{doi:10.1016/s0022-3565(25)31486-2}.
\item Castellano C. (1978). \textit{Effects of mescaline and psilocin on acquisition, consolidation, and performance of light-dark discrimination in two inbred strains of mice.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/bf00427746}{doi:10.1007/bf00427746}.
\item Whitaker PM, Seeman P. (1978). \textit{High-affinity 3H-serotonin binding to caudate: inhibition by hallucinogens and serotoninergic drugs.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/bf00428022}{doi:10.1007/bf00428022}.
\item Hyde C, Glancy G, Omerod P, Hall D, Taylor GS. (1978). \textit{Abuse of indigenous psilocybin mushrooms: a new fashion and some psychiatric complications.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1192/bjp.132.6.602}{doi:10.1192/bjp.132.6.602}.
\item Meltzer HY, Fessler RG, Simonovic M, Fang VS. (1978). \textit{Stimulation of rat prolactin secretion by indolealkylamine hallucinogens.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/bf00432847}{doi:10.1007/bf00432847}.
\item Martin WR, Vaupel DB, Nozaki M, Bright LD. (1978). \textit{The identification of LSD-like hallucinogens using the chronic spinal dog.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/0376-8716(78)90024-8}{doi:10.1016/0376-8716(78)90024-8}.
\item Hatfield GM, Valdes LJ. (1978). \textit{The occurrence of psilocybin in Gymnopilus species.}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/565861}{source link}.
\item Van Went GF. (1978). \textit{Mutagenicity testing of 3 hallucinogens: LSD, psilocybin and delta 9-THC, using the micronucleus test.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/bf01923013}{doi:10.1007/bf01923013}.
\item Green JP, Weinstein H, Maayani S. (1977). \textit{Defining the histamine H2-receptor in brain: the interaction with LSD.}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/30911}{source link}.
\item Repke DB, Leslie DT, Guzmán G. (1977). \textit{Baeocystin in psilocybe, conocybe and panaeolus.}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/600026}{source link}.
\item Jacobs BL, Trulson ME, Stern WC. (1977). \textit{Behavioral effects of LSD in the cat: proposal of an animal behavior model for studying the actions of hallucinogenic drugs.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/0006-8993(77)90423-1}{doi:10.1016/0006-8993(77)90423-1}.
\item REPKE D. B., FERGUSON W. J., BATES D. K. (1977). \textit{ChemInform Abstract: PSILOCIN ANALOGS. 1. SYNTHESIS OF3-(2-(DIALKYLAMINO)ETHYL)- AND3-(2-(CYCLOALKYLAMINO)ETHYL)INDOL-4-OLS}. Chemischer Informationsdienst. [published; Crossref]. \href{https://doi.org/10.1002/chin.197728193}{doi:10.1002/chin.197728193}.
\item Trulson ME, Stark AD, Jacobs BL. (1977). \textit{Comparative effects of hallucinogenic drugs on rotational behavior in rats with unilateral 6-hydroxydopamine lesions.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/0014-2999(77)90097-8}{doi:10.1016/0014-2999(77)90097-8}.
\item Repke DB, Leslie DT, Mandell DM, Kish NG. (1977). \textit{GLC-mass spectral analysis of psilocin and psilocybin.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1002/jps.2600660539}{doi:10.1002/jps.2600660539}.
\item Davis M, Walters JK. (1977). \textit{Psilocybin: biphasic dose-response effects on the acoustic startle reflex in the rat.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/0091-3057(77)90180-0}{doi:10.1016/0091-3057(77)90180-0}.
\item Repke David B., Ferguson Wilfred J., Bates Dallas K. (1977). \textit{Psilocin analogs. 1. Synthesis of 3-[2-(dialkylamino)ethyl] -and 3-[2-(cycloalkylamino)ethyl] indol-4-ols}. Journal of Heterocyclic Chemistry. [published; Crossref]. \href{https://doi.org/10.1002/jhet.5570140113}{doi:10.1002/jhet.5570140113}.
\item James Edward Guest (1976). \textit{Electroencephalographic and behavioral effects of 4-phosphoryloxy N, N-dimethyltryptamine (psilocybin) on the New Zealand albino rabbit}. UA Campus Repository (The University of Arizona). [published; OpenAlex]. \href{http://hdl.handle.net/10150/348103}{source link}.
\item Repke DB, Leslie DT. (1976). \textit{Baeocystin in Psilocybe semilanceata.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1002/jps.2600660130}{doi:10.1002/jps.2600660130}.
\item Martindale C, Fischer R. (1976). \textit{The effects of psilocybin on primary process content in language.}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/608346}{source link}.
\item Holt-Hansen K. (1976). \textit{Extraordinary experiences during cross-modal perception.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.2466/pms.1976.43.3f.1023}{doi:10.2466/pms.1976.43.3f.1023}.
\item Kuhnert-Brandstätter M, Heindl W. (1976). \textit{[Polymorphe forms of psilocine and psilocybine].}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1002/ardp.19763090804}{doi:10.1002/ardp.19763090804}.
\item Ott J, Guzmán G. (1976). \textit{Detection of psilocybin in species of Psilocybe, Panaeolus and Psathyrella.}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/957919}{source link}.
\item Parashos AJ. (1976). \textit{The psilocybin-induced "state of drunkenness" in normal volunteers and schizophrenics.}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/1052267}{source link}.
\item A. Gottlieb (1976). \textit{The psilocybin producer's guide}. Unknown journal. [published; OpenAlex]. \href{https://eurekamag.com/pdf/038/038903782.pdf}{source link}.
\item Cameron OG, Appel JB. (1976). \textit{Drug-induced conditioned suppression: specificity due to drug employed as UCS.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/0091-3057(76)90020-4}{doi:10.1016/0091-3057(76)90020-4}.
\item Sybil H. Bullock (1975). \textit{Hallucinogenic Mushrooms Including Chemical Hallucinogens: Bufotenin and Psilocybin; a Select Bibliography.}. Defense Technical Information Center (DTIC). [published; OpenAlex]. \href{http://oai.dtic.mil/oai/oai?\&amp;verb=getRecord\&amp;metadataPrefix=html\&amp;identifier=ADA028792}{source link}.
\item Greenberg I, Kuhn D, Appel JB. (1975). \textit{Comparison of the discriminative stimulus properties of delta9-THC and psilocybin in rats.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/0091-3057(75)90131-8}{doi:10.1016/0091-3057(75)90131-8}.
\item Hungen KV, Roberts S, Hill DF. (1975). \textit{Interactions between lysergic acid diethylamide and dopamine-sensitive adenylate cyclase systems in rat brain.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/0006-8993(75)90876-8}{doi:10.1016/0006-8993(75)90876-8}.
\item Fischer R, Goldman H. (1975). \textit{Therapeutic usefulness of hallucinogenic drugs as a function of their chemical structure.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1055/s-0028-1094457}{doi:10.1055/s-0028-1094457}.
\item Steven H. Pollock (1974). \textit{The Psilocybin Mushroom Pandemic}. Journal of Psychedelic Drugs. [published; OpenAlex]. \href{https://doi.org/10.1080/02791072.1975.10472640}{doi:10.1080/02791072.1975.10472640}.
\item Aghajanian GK, Hailgler HJ. (1974). \textit{Hallucinogenic indoleamines: Preferential action upon presynaptic serotonin receptors.}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/1063421}{source link}.
\item Rech RH, Tilson HA, Marquis WJ. (1974). \textit{Adaptive changes in behavior after repeated administration of various psychoactive drugs.}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/1163377}{source link}.
\item GERMAIN CLAUDE, BOURDAIS JACQUES (1974). \textit{ChemInform Abstract: NEUER ZUGANG ZU PSILOCIN-DERIVATEN}. Chemischer Informationsdienst. [published; Crossref]. \href{https://doi.org/10.1002/chin.197449273}{doi:10.1002/chin.197449273}.
\item Fanciullacci M, Franchi G, Sicuteri F. (1974). \textit{Hypersensitivity to lysergic acid diethylamide (LSD-25) and psilocybin in essential headache.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/bf01919685}{doi:10.1007/bf01919685}.
\item 昌子 大野 (1974). \textit{幻覚剤に関する研究-5-Psilocybinの合成(ノ-ト)}. 衛生試験所報告. [published; OpenAlex]. \href{http://ci.nii.ac.jp/naid/40000202990}{source link}.
\item Hans Peter Weber, Trevor J. Petcher (1974). \textit{ChemInform Abstract: CRYSTAL STRUCTURES OF THE TEONANACATL HALLUCINOGENS PART1, PSILOCYBIN C12H17N2O4O}. Chemischer Informationsdienst. [published; OpenAlex]. \href{https://doi.org/10.1002/chin.197435062}{doi:10.1002/chin.197435062}.
\item PETCHER TREVOR J., WEBER HANS PETER (1974). \textit{ChemInform Abstract: CRYSTAL STRUCTURES OF THE TEONANACATL HALLUCINOGENS PART2, PSILOCIN C12H15N2O}. Chemischer Informationsdienst. [published; Crossref]. \href{https://doi.org/10.1002/chin.197435063}{doi:10.1002/chin.197435063}.
\item CAMPAIGNE E., ROGERS R. B. (1974). \textit{ChemInform Abstract: BENZO(B)THIOPHENE DERIVATIVES PART21, ON THE PROOF OF STRUCTURE OF THE SULFUR ISOSTERE OF PSILOCIN}. Chemischer Informationsdienst. [published; Crossref]. \href{https://doi.org/10.1002/chin.197428268}{doi:10.1002/chin.197428268}.
\item Jan Kolařı́k (1974). \textit{Underlying mechanism of psilocybin induced psychosis}. Acta Universitatis Palackianae Olomucensis Facultatis Medicae. [published; OpenAlex]. \href{https://eurekamag.com/research/027/815/027815362.php}{source link}.
\item Aboul-Enein HY. (1974). \textit{Psilocybin: a pharmacological profile.}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/4853936}{source link}.
\item Ladefoged O. (1974). \textit{The effect of LSD, psilocybin, harmaline and amphetamine on the body temperature of para-chlorophenylalanine pretreated rabbits.}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/4277695}{source link}.
\item Horibe M. (1974). \textit{The effects of psilocybin on EEG and behaviour in monkeys.}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/4454934}{source link}.
\item Hopf A, Eckert H. (1974). \textit{Distribution patterns of 14-C-psilocin in the brains of various animals.}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/4454947}{source link}.
\item Hans Peter Weber, Trevor J. Petcher (1973). \textit{Crystal structures of the Teonanácatl hallucinogens. Part I. Psilocybin C12 H17 N2 O4 P}. Journal of the Chemical Society Perkin Transactions 2. [published; OpenAlex]. \href{https://doi.org/10.1039/p29740000942}{doi:10.1039/p29740000942}.
\item Petcher Trevor J., Weber Hans Peter (1973). \textit{Crystal structures of the Teonanácatl hallucinogens. Part II. Psilocin, C12 H15 N2 O}. J. Chem. Soc., Perkin Trans. 2. [published; Crossref]. \href{https://doi.org/10.1039/p29740000946}{doi:10.1039/p29740000946}.
\item Ono M, Shimamine M, Takahashi K, Inoue T. (1973). \textit{[Studies on hallucinogens. V. Synthesis of psilocybin].}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/4477493}{source link}.
\item Campaigne E., Rogers R. B. (1973). \textit{Benzo[b]thiophene derivatives. XXI. On the proof of structure of the sulfur isostere of psilocin}. Journal of Heterocyclic Chemistry. [published; Crossref]. \href{https://doi.org/10.1002/jhet.5570100614}{doi:10.1002/jhet.5570100614}.
\item CAMPAIGNE E., ROGERS R. B. (1973). \textit{ChemInform Abstract: BENZO(B)THIOPHENE DERIVATIVES PART19, THE SULFUR ISOSTERES OF PSILOCIN AND RELATED ISOMERS}. Chemischer Informationsdienst. [published; Crossref]. \href{https://doi.org/10.1002/chin.197345337}{doi:10.1002/chin.197345337}.
\item Fabrick DM, Winefordner JD. (1973). \textit{Quantitative measurement of mixtures of hallucinogens by fluorometry and phosphorimetry.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/0039-9140(73)80087-6}{doi:10.1016/0039-9140(73)80087-6}.
\item Kang S, Johnson CL, Green JP. (1973). \textit{Theoretical studies on the conformations of psilocin and mescaline.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/s0026-895x(25)13989-8}{doi:10.1016/s0026-895x(25)13989-8}.
\item Hill RM, Fischer R. (1973). \textit{Induction and extinction of psilocybin induced transformations of visual space.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1055/s-0028-1094389}{doi:10.1055/s-0028-1094389}.
\item Kang S, Johnson CL, Green JP (1973). \textit{Theoretical studies on the conformations of psilocin and mescaline.}. Molecular pharmacology. [published; PubMed]. \href{https://pubmed.ncbi.nlm.nih.gov/4788158/}{source link}.
\item Ladefoged O. (1973). \textit{The effects of LSD, psilocybin, harmaline and amphetamine on the body temperature of para-chlorophenylalanine pretreated rats.}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/4270656}{source link}.
\item Shaffer JH, Hill RM. (1973). \textit{Psychophysics of psilocybin and 9 -tetrahydrocannabinol.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/bf02023852}{doi:10.1007/bf02023852}.
\item Panton Y, Fischer R. (1973). \textit{Hallucinogenic drug-induced behavior under sensory attenuation. Prediction of response to psilocybin.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1001/archpsyc.1973.01750330106017}{doi:10.1001/archpsyc.1973.01750330106017}.
\item CHAPMAN N. B., SCROWSTON R. M., SUTTON T. M. (1973). \textit{ChemInform Abstract: SYNTH. DES SCHWEFELANALOGEN VON PSILOCIN UND EINIGEN VERWANDTEN VERBINDUNGEN}. Chemischer Informationsdienst. [published; Crossref]. \href{https://doi.org/10.1002/chin.197308246}{doi:10.1002/chin.197308246}.
\item Baker RW, Chothia C, Pauling P, Weber HP. (1972). \textit{Molecular structures of hallucinogenic substances: lysergic acid diethylamide, psilocybin, and 2,4,5-trimethoxyamphetamine.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/s0026-895x(25)13703-6}{doi:10.1016/s0026-895x(25)13703-6}.
\item Ono M, Shimamine M, Takahashi K. (1972). \textit{[Studies on hallucinogens. 3. Synthesis of psilocin (author's transl)].}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/4800137}{source link}.
\item 襄 三隅 (1972). \textit{精神分裂病者の病像とPsilocybin,LSD-25反応に関する精神病理学的研究}. Medical Entomology and Zoology. [published; OpenAlex]. \href{http://ci.nii.ac.jp/naid/40018016189}{source link}.
\item Mulkey D. (1972). \textit{Psilocybin.}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/5039020}{source link}.
\item Robert Walker, G.N. Woodruff (1972). \textit{The effect of bufotenine, melatonin, psilocybin, and related compounds on the 5-hydroxytryptamine excitatory receptors of Helix aspersa neurons}. Comparative and General Pharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/0010-4035(72)90039-0}{doi:10.1016/0010-4035(72)90039-0}.
\item Chapman N. B., Scrowston R. M., Sutton T. M. (1971). \textit{Synthesis of the sulphur analogue of psilocin and some related compounds}. Journal of the Chemical Society, Perkin Transactions 1. [published; Crossref]. \href{https://doi.org/10.1039/p19720003011}{doi:10.1039/p19720003011}.
\item Meldrum BS, Naquet R. (1971). \textit{Effects of psilocybin, dimethyltryptamine, mescaline and various lysergic acid derivatives on the EEG and on photically induced epilepsy in the baboon (Papio papio).}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/0013-4694(71)90072-1}{doi:10.1016/0013-4694(71)90072-1}.
\item Thatcher K, Wiederholt WC, Fischer R. (1971). \textit{An electroencephalographic analysis of personality-dependent performance under psilocybin.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/bf01965376}{doi:10.1007/bf01965376}.
\item Marc Julià, JOEL DE ROSNAY (1971). \textit{ChemInform Abstract: CHLORIERTE 2-HYDROXY- UND2-METHOXY-PHENOXYAETHYLAMINE, ANALOGA VON PSILOCYBIN}. Chemischer Informationsdienst Organische Chemie. [published; OpenAlex]. \href{https://doi.org/10.1002/chin.197110243}{doi:10.1002/chin.197110243}.
\item Kolarík J. (1970). \textit{Different reaction of focal and diffuse epileptic EEG activity to psilocybin.}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/5000337}{source link}.
\item Kolarĩk J. (1970). \textit{EEG changes after psilocybin in organic brain lesions.}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/5122145}{source link}.
\item JULIA MARC, PASCAL YVES ROBERT (1970). \textit{ChemInform Abstract: INDOLE 22. MITT. INDOLSYNTH., ANWENDUNG AUF PSILOCIN}. Chemischer Informationsdienst. Organische Chemie. [published; Crossref]. \href{https://doi.org/10.1002/chin.197051318}{doi:10.1002/chin.197051318}.
\item Meldrum BS, Naquet R. (1970). \textit{Effects of psilocybin, dimethyltryptamine and various lysergic acid derivatives on photically-induced epilepsy in the baboon (Papio papio).}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/4992165}{source link}.
\item 五郎 中村 (1970). \textit{PsilocybinおよびLSDの精神身体症状におよぼす影響-1-LSDに就て}. 新潟医学会雑誌. [published; OpenAlex]. \href{http://ci.nii.ac.jp/naid/40018192360}{source link}.
\item Fischer R, Hill R, Thatcher K, Scheib J. (1970). \textit{Psilocybin-induced contraction of nearby visual space.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/bf01965761}{doi:10.1007/bf01965761}.
\item J. PICKER, R. W. RICKARDS (1970). \textit{ChemInform Abstract: AUFTRETEN DES PSYCHOTOMIMETISCHEN AGENS PSILOCYBIN IN DEM AUSTRALISCHEN BLAETTERPILZ PSILOCYBE SUBAERUGINOSA}. Chemischer Informationsdienst Organische Chemie. [published; OpenAlex]. \href{https://doi.org/10.1002/chin.197029316}{doi:10.1002/chin.197029316}.
\item Richard Hill, Roland A. Fischer (1970). \textit{Psilocybin-Induced Transformations of Visual Space}. Pharmacopsychiatry. [published; OpenAlex]. \href{https://doi.org/10.1055/s-0028-1094281}{doi:10.1055/s-0028-1094281}.
\item J. PICKER, R. W. RICKARDS (1970). \textit{The occurrence of the psychotomimetic agent psilocybin in an Australian agaric, Psilocybe subaeruginosa}. Australian Journal of Chemistry. [published; OpenAlex]. \href{https://doi.org/10.1071/ch9700853}{doi:10.1071/ch9700853}.
\item Thatcher K, Kappeler T, Wisecup P, Fischer R. (1970). \textit{Personality trait dependent performance under psilocybin. II.}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/4392526}{source link}.
\item Fischer R, Kappeler T, Wisecup P, Thatcher K. (1970). \textit{Personality trait dependent performance under psilocybin.}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/5438334}{source link}.
\item Eberle P, Leuner H. (1969). \textit{[Chromosome defects in patients treated with Psilocybine].}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/bf00286993}{doi:10.1007/bf00286993}.
\item Landon M, Fischer R. (1969). \textit{On similar linguistic structures in creative performance and psilocybin-induced experience.}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/5478353}{source link}.
\item Peter Gwynne, Roland Fischer, Richard Hill (1969). \textit{Hypnotic Induction of the Interference of Psilocybin with Optically Induced Spatial Distortion}. Pharmacopsychiatry. [published; OpenAlex]. \href{https://doi.org/10.1055/s-0028-1094250}{doi:10.1055/s-0028-1094250}.
\item Peter G. Mantle, E. S. Waight (1969). \textit{Occurrence of psilocybin in the sporophores of Psilocybe semilanceata}. Transactions of the British Mycological Society. [published; OpenAlex]. \href{https://doi.org/10.1016/s0007-1536(69)80066-5}{doi:10.1016/s0007-1536(69)80066-5}.
\item Robbers JE, Tyler VE, Ola'h GM. (1969). \textit{Additional evidence supporting the occurrence of psilocybin in Panaeolus foenisecii.}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/5390043}{source link}.
\item Bermond F, Bert J. (1969). \textit{[Electrophysiological effects of psilocybin in a cercopithecinae, Papio papio].}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/0013-4694(69)90108-4}{doi:10.1016/0013-4694(69)90108-4}.
\item Fischer R, Kappeler T, Wisecup P, Thatcher K. (1969). \textit{Measurement of handwriting area to pressure ratios during psilocybin-induced hallucinations.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/bf01990020}{doi:10.1007/bf01990020}.
\item Leung AY, Paul AG. (1969). \textit{The relationship of carbon and nitrogen nutrition of Psilocybe baeocystis to the production of psilocybin and its analogs.}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/5788770}{source link}.
\item Sugrue MF. (1969). \textit{A study of the role of noradrenaline in behavioral changes produced in the rat by psychotomimetic drugs.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1111/j.1476-5381.1969.tb07983.x}{doi:10.1111/j.1476-5381.1969.tb07983.x}.
\item Fischer R, Hill RM, Warshay D. (1969). \textit{Effects of psychodysleptic drug psilocybin on visual perception. Changes in brightness preference.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/bf01899102}{doi:10.1007/bf01899102}.
\item Francesca Bermond, Julien Bert (1968). \textit{Action de la psilocybine sur le comportement d'un cercopithecinae papio-papio}. Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1007/bf00407043}{doi:10.1007/bf00407043}.
\item Hopf A, Eckert H. (1968). \textit{Autoradiographic studies on the distribution of psychoactive drugs in the rat brain. 3. 14C-psilocin.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/bf02456045}{doi:10.1007/bf02456045}.
\item R Fischer, Diana Warshay (1968). \textit{Psilocybin-induced Autonomic, Perceptual, and Behavioral Change}. Pharmacopsychiatry. [published; OpenAlex]. \href{https://doi.org/10.1055/s-0028-1094227}{doi:10.1055/s-0028-1094227}.
\item Leung AY, Paul AG. (1968). \textit{Baeocystin and norbaeocystin: new analogs of psilocybin from Psilocybe baeocystis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1002/jps.2600571007}{doi:10.1002/jps.2600571007}.
\item Duke RB, Keeler MH. (1968). \textit{The effects of psilocybin, dextro-amphetamine and placebo on performance of the trail making test.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1002/1097-4679(196807)24:3<316::aid-jclp2270240310>3.0.co;2-g}{doi:10.1002/1097-4679(196807)24:3<316::aid-jclp2270240310>3.0.co;2-g}.
\item Tosi O, Rockey MA, Fischer R. (1968). \textit{Quantitative measurement of time contraction induced by psilocybin.}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/5755879}{source link}.
\item Robert R. Rynearson, M. Robert Wilson, Reginald G. Bickford (1968). \textit{PSILOCYBIN-INDUCED CHANGES IN PSYCHOLOGIC FUNCTION, ELECTROENCEPHALOGRAM, AND LIGHT-EVOKED POTENTIALS IN HUMAN SUBJECTS}. Mayo Clinic Proceedings. [published; OpenAlex]. \href{https://doi.org/10.1016/s0025-6196(26)01583-1}{doi:10.1016/s0025-6196(26)01583-1}.
\item Rynearson RR, Wilson MR, Bickford RG. (1968). \textit{Psilocybin-induced changes in psychologic function, electroencephalogram, and light-evoked potentials in human subjects.}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/4384806}{source link}.
\item Horibe M. (1968). \textit{[Pharmacological studies of hallucinogens. Report 3. I. Bibliographical considerations of psilocybin, with special reference to its actions on the central nervous system].}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/4881757}{source link}.
\item Horibe M. (1968). \textit{[Pharmacological studies of hallucinogens. Report 3. II. Pharmacological studies of influence of psilocybin on the central nervous system].}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/4972692}{source link}.
\item Gessner PK, Godse DD, Krull AH, McMullan JM. (1968). \textit{Structure-activity relationships among 5-methoxy-n:n-dimethyltryptamine, 4-hydroxy-n:n-dimethyltryptamine (psilocin) and other substituted tryptamines.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/0024-3205(68)90200-2}{doi:10.1016/0024-3205(68)90200-2}.
\item Agurell S, Nilsson JL. (1968). \textit{A biosynthetic sequence from tryptophan to psilocybin.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/s0040-4039(01)98891-4}{doi:10.1016/s0040-4039(01)98891-4}.
\item 真広 堀部 (1967). \textit{催幻覚薬に関する薬理学的研究(第3報):第1篇 Psilocybinの文献的考察ことに中枢作用について}. 日本薬理学雑誌. [published; OpenAlex]. \href{http://ci.nii.ac.jp/naid/130000757038}{source link}.
\item Agurell S, Nilsson JL. (1967). \textit{Biosynthesis of psilocybin. II. Incorporation of labelled tryptamine derivatives.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3891/acta.chem.scand.22-1210}{doi:10.3891/acta.chem.scand.22-1210}.
\item 望 諏訪, 晃資 山崎, 裕二 斉藤, 博明 加藤, 勇夫 小野寺, 歩 坂下, 雅之 遠藤, 隆嗣 諸治, 耗三 伊藤 (1967). \textit{34)Psilocybin投与による情動の変化と血中17-CHCSの動態(精神生理)(第8回日本精神身体医学会総会)}. 精神身体医学. [published; OpenAlex]. \href{https://ci.nii.ac.jp/naid/110001112648}{source link}.
\item Dubanský B, Vyhmánková M. (1967). \textit{[Psilocybine in brain injured subjects and its different effects in relation to the localization of the lesion].}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/5612963}{source link}.
\item Dubanský B, Vyhnánková M, Setlík L. (1967). \textit{[The association of proprioceptive sensations and neurologic symptoms after psilocybine].}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/5612947}{source link}.
\item Dubanský B, Vyhnánsková M, Setlík L. (1967). \textit{[Psilocybine induced changes in extraoptical perception].}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/5612948}{source link}.
\item Snyder SH, Faillace L, Hollister L. (1967). \textit{2,5-dimethoxy-4-methyl-amphetamine (STP): a new hallucinogenic drug.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1126/science.158.3801.669}{doi:10.1126/science.158.3801.669}.
\item Levine WG. (1967). \textit{Formation of blue oxidation product from psilocybin.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/2151292a0}{doi:10.1038/2151292a0}.
\item Uyeno ET. (1967). \textit{Effects of mescaline and psilocybin on dominance behavior of the rat.}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/6034329}{source link}.
\item C. Rolsten (1966). \textit{Effects of chlorpromazine and psilocin on pregnancy of c57bl/10 mice and their offspring at birth. Abstr.}. The Mouseion at the JAXlibrary (Jackson Laboratory). [published; OpenAlex]. \href{https://mouseion.jax.org/ssbb1967/193}{source link}.
\item Albert Leung (1966). \textit{Investigations On Psilocybin And Its Analogs In Certain Fungi.}. Deep Blue (University of Michigan). [published; OpenAlex]. \href{https://doi.org/10.7302/15497}{doi:10.7302/15497}.
\item Weber K. (1966). \textit{[Alteration of music perception in experimental psychosis (psilocybin)].}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/5585740}{source link}.
\item Leung AY, Paul AG. (1966). \textit{Baeocystin, a mono-methyl analog of psilocybin from Psilocybe baeocystis saprophytic culture.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1002/jps.2600560132}{doi:10.1002/jps.2600560132}.
\item Gilmour LP, O'Brien RD. (1966). \textit{Psilocybin: reaction with a fraction of rat brain.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1126/science.155.3759.207}{doi:10.1126/science.155.3759.207}.
\item Unknown authors (1966). \textit{Review of Drugs and Phantasy: The Effects of LSD, Psilocybin, and Sernyl on College Students.}. Contemporary Psychology. [published; OpenAlex]. \href{https://doi.org/10.1037/008835}{doi:10.1037/008835}.
\item Richard R. Heim, K. Genest, Donald W. Hughes, G. Belec (1966). \textit{Botanical and Chemical Characterisation of a Forensic Mushroom Specimen of the Genus Psilocybe}. Journal of the Forensic Science Society. [published; OpenAlex]. \href{https://doi.org/10.1016/s0015-7368(66)70336-3}{doi:10.1016/s0015-7368(66)70336-3}.
\item Agurell S, Blomkvist S, Catalfomo P. (1966). \textit{Biosynthesis of psilocybin in submerged culture of Psilocybe cubensis. 1. Incorporation of labelled tryptophan and tryptamine.}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/5948634}{source link}.
\item Fischer R, England SM, Archer RC, Dean RK. (1966). \textit{Psilocybin reactivity and time contraction as measured by psychomotor performance.}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/6014013}{source link}.
\item Collins RL, Ordy JM, Samorajski T. (1966). \textit{Psilocin: effects on behaviour and brain serotonin in mice.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/209785a0}{doi:10.1038/209785a0}.
\item Hebbard FW, Fischer R. (1965). \textit{Effect of Psilocybin, LSD, and mescaline on small, involuntary eye movements.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/bf00404719}{doi:10.1007/bf00404719}.
\item Fischer R, Mead EL. (1965). \textit{Time contraction and psychomotor performance produced by "Psilocybin".}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/209433a0}{doi:10.1038/209433a0}.
\item Keeler MH. (1965). \textit{Similarity of schizophrenia and the psilocybin syndrome as determined by objective methods.}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/4380179}{source link}.
\item Albert Leung, Alexander H. Smith, A.G. Paul (1965). \textit{Production of Psilocybin in Psilocybe baeocystis Saprophytic Culture}. Journal of Pharmaceutical Sciences. [published; OpenAlex]. \href{https://doi.org/10.1002/jps.2600541104}{doi:10.1002/jps.2600541104}.
\item Abramson HA, Rolo A. (1965). \textit{Lysergic acid diethylamide (LSD-25). 38. Comparison with action of methysergide and psilocybin on test subjects.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3109/02770906509106904}{doi:10.3109/02770906509106904}.
\item Dubanský B, Vyhnánková M. (1965). \textit{Pathologic laughter as manifestation of the psychotomimetic action of psilocybin.}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/5882137}{source link}.
\item KEELER MH, DOEHNE EF. (1965). \textit{CONSISTENCY OF PSILOCYBIN INDUCED CHANGES IN THE MINNESOTA MULTIPHASIC PERSONALITY INVENTORY.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1002/1097-4679(196507)21:3<284::aid-jclp2270210319>3.0.co;2-c}{doi:10.1002/1097-4679(196507)21:3<284::aid-jclp2270210319>3.0.co;2-c}.
\item Keeler MH. (1965). \textit{The effects of psilocybin on a test of after-image perception.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/bf00404173}{doi:10.1007/bf00404173}.
\item Timothy Leary, Ralph Metzner, Presnell Madison, Gunther Weil, Schwitzgebel Ralph, Kinne Sara (1964). \textit{A new behavior change program using psilocybin.}. Psychotherapy. [published; OpenAlex]. \href{https://doi.org/10.1037/h0088612}{doi:10.1037/h0088612}.
\item John C. Pollard, Leonard Uhr, Elizabeth Stein (1964). \textit{Drugs and phantasy: the effects of LSD, psilocybin, and sernyl on college students}. Medical Entomology and Zoology. [published; OpenAlex]. \href{http://ci.nii.ac.jp/ncid/BA15610290}{source link}.
\item FERNANDEZ-CERDENO A, LEUNER H. (1964). \textit{[THE EXPERIENCE OF ORAL REGRESSION DUE TO THE EFFECT OF HALLUCINOGENS (LSD-25 AND PSILOCYBIN)].}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/14301325}{source link}.
\item MIYOSHI A. (1964). \textit{[A PSYCHOPATHOLOGICAL STUDY OF THE PSILOCYBIN PSYCHOSIS; COMPARISON WITH THE LSD-25 PSYCHOSIS].}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/14286595}{source link}.
\item HOLLISTER LE, SJOBERG BM. (1964). \textit{CLINICAL SYNDROMES AND BIOCHEMICAL ALTERATIONS FOLLOWING MESCALINE, LYSERGIC ACID DIETHYLAMIDE, PSILOCYBIN AND A COMBINATION OF THE THREE PSYCHOTOMIMETIC DRUGS.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/s0010-440x(64)80030-4}{doi:10.1016/s0010-440x(64)80030-4}.
\item DUBANSKY B. (1964). \textit{[USE OF PSILOCYBIN AS A DIAGNOSTIC TEST IN NEUROLOGY].}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/14178690}{source link}.
\item REDA GC, VELLA G, CANCRINI L, D AGOSTINO E. (1964). \textit{[CLINICAL AND PSYCHOPATHOLOGICAL STUDY OF PSILOCYBIN].}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/14144273}{source link}.
\item Joseph Havens (1963). \textit{A Working Paper: Memo on the Religious Implications of the Consciousness-Changing Drugs (LSD, Mescalin, Psilocybin)}. Journal for the Scientific Study of Religion. [published; OpenAlex]. \href{https://doi.org/10.2307/1384511}{doi:10.2307/1384511}.
\item P. Catalfomo, Varro E. Tyler (1963). \textit{The production of psilocybin in submerged culture by Psilocybe cubensis.}. Unknown journal. [published; OpenAlex]. \href{https://www.cabdirect.org/cabdirect/abstract/19661300859}{source link}.
\item GODET R, DUPE M, BERT J. (1963). \textit{[ACTION OF CHLORPROMAZINE AND PSILOCYBIN ON THE TELENCEPHALIC AROUSAL REACTION OF A DIPNOAN].}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/14210583}{source link}.
\item Alnaes R. (1963). \textit{THERAPEUTIC APPLICATION OF THE CHANGE IN CONSCIOUSNESS PRODUCED BY PSYCHOLYTICA (LSD, PSILOCYBIN, ETC.). THE PSYCHEDELIC EXPERIENCE IN THE TREATEMENT OF NEUROSIS.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1111/j.1600-0447.1964.tb04952.x}{doi:10.1111/j.1600-0447.1964.tb04952.x}.
\item LEARY T, LITWIN GH, METZNER R. (1963). \textit{REACTIONS TO PSILOCYBIN ADMINISTERED IN A SUPPORTIVE ENVIRONMENT.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1097/00005053-196312000-00007}{doi:10.1097/00005053-196312000-00007}.
\item ABRAMSON HA, GETTNER HH, ROLO A, DEAN G. (1963). \textit{LYSERGIC ACID DIETHYLAMIDE (LSD-25). 34. COMPARISON WITH EFFECT OF PSILOCYBIN ON THE SIAMESE FIGHTING FISH.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/00223980.1963.9916652}{doi:10.1080/00223980.1963.9916652}.
\item STEINER JE, SULMAN FG. (1963). \textit{SIMULTANEOUS STUDIES OF BLOOD SUGAR, BEHAVIOURAL CHANGES AND EEG ON THE WAKE RABBIT AFTER ADMINISTRATION OF PSILOCYBIN.}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/14067558}{source link}.
\item McKay J. B., Parkhurst R. M., Silverstein R. M., Skinner W. A. (1963). \textit{ANALOGUES OF PSILOCIN AND LYSERGIC ACID DIETHYLAMIDE I. CHLORO, NITRO, AND AMINO DERIVATIVES OF3-SUBSTITUTED INDOLES}. Canadian Journal of Chemistry. [published; Crossref]. \href{https://doi.org/10.1139/v63-378}{doi:10.1139/v63-378}.
\item SOGLIANI G, RABASSINI A, BUOSO GM. (1963). \textit{[PSYCHOMIMETIC SUBSTANCES. (CONTRIBUTION TO THE CLINICAL PSYCHOPATHOLOGICAL STUDY OF PSILOCYBIN)].}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/14093369}{source link}.
\item HARTMAN AM, HOLLISTER LE. (1963). \textit{EFFECT OF MESCALINE, LYSERGIC ACID DIETHYLAMIDE AND PSILOCYBIN ON COLOR PERCEPTION.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/bf00403349}{doi:10.1007/bf00403349}.
\item UNGER SM. (1963). \textit{Mescaline, LSD, psilocybin, and personality change.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/00332747.1963.11023344}{doi:10.1080/00332747.1963.11023344}.
\item KANDIC B, DORDEVIC D. (1963). \textit{[COMPARISON OF PSYCHOPHARMACA LSD-25, BOL-148 AND PSILOCYBIN IN CLINICAL PRACTICE].}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/14067329}{source link}.
\item DUBANSKY B, KOLARIK R, SEVCIK M, VYHNANKOVA M. (1963). \textit{[EFFECT OF PSILOCYBIN ON THE CLINICAL AND ELECTROENCEPHALOGRAPHIC PICTURE IN ORGANIC CNS LESIONS].}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/14070660}{source link}.
\item ZSIGMOND EK, FOLDES VM, FOLDES FF. (1963). \textit{THE IN VITRO INHIBITORY EFFECT OF PSILOCYBIN AND RELATED COMPOUNDS OF HUMAN CHOLINESTERASES.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/bf02584093}{doi:10.1007/bf02584093}.
\item HORITA A. (1963). \textit{Some biochemical studies on psilocybin and psilogin.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.21236/ad0291057}{doi:10.21236/ad0291057}.
\item BRODEY JF, STEINER WG, HIMWICH HE. (1963). \textit{An electrographic study of psilocin and 4-methyl-alpha-methyl tryptamine (MP-809).}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/14015664}{source link}.
\item Brodey James F., Steiner William G., Himwich Harold E. (1963). \textit{AN ELECTROGRAPHIC STUDY OF PSILOCIN AND4-METHYL-α-METHYL TRYPTAMINE (MP-809)}. The Journal of Pharmacology and Experimental Therapeutics. [published; Crossref]. \href{https://doi.org/10.1016/s0022-3565(25)26511-9}{doi:10.1016/s0022-3565(25)26511-9}.
\item TOSCANO AGUILAR M. (1963). \textit{[Psilocybin: prospects of its use in clinical psychiatry].}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/13993760}{source link}.
\item ALDAHEFF BW. (1962). \textit{[The psychomimetic effects of LSD and psilocybin in the clinical exploration of the personality].}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/14011802}{source link}.
\item CALANCA A. (1962). \textit{[Auto-experimentation with LSD-25 and psilocybin].}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/14017795}{source link}.
\item KRISTENSEN KK. (1962). \textit{[CLINICAL EXPERIENCES WITH PSILOCYBIN].}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3109/08039486309132763}{doi:10.3109/08039486309132763}.
\item WIART C. (1962). \textit{[AUTO-OBSERVATION OF2 EXPERIMENTAL INTOXICATIONS WITH PSILOCYBIN].}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/14070405}{source link}.
\item DORDEVIC D. (1962). \textit{[OUR CLINICAL EXPERIENCE WITH A NEW PHARMACOLOGICAL PREPARATION PSILOCYBIN].}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/14181869}{source link}.
\item KEELER MH. (1962). \textit{Inter-relations of the effects of psilocybin on subjective sensation, photopic critical frequency of fusion, and circulating non-esterified fatty acids.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/bf02135348}{doi:10.1007/bf02135348}.
\item GREGORETTI L, SINISI C. (1962). \textit{[Pharmacopsychiatric observations with psilocybin].}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/13950258}{source link}.
\item HORITA A, WEBER LJ. (1962). \textit{Dephosphorylation of psilocybin in the intact mouse.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/0041-008x(62)90102-3}{doi:10.1016/0041-008x(62)90102-3}.
\item R. Gordon Wasson (1962). \textit{The Hallucinogenic Mushrooms of Mexico and Psilocybin: a Bibliography}. Botanical Museum leaflets Harvard University. [published; OpenAlex]. \href{https://doi.org/10.5962/p.168536}{doi:10.5962/p.168536}.
\item ADEY WR, BELL FR, DENNIS BJ. (1962). \textit{Effects of LSD-25, psiolocybin, and psilocin on temporal lobe EEG patterns and learned behavior in the cat.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1212/wnl.12.9.591}{doi:10.1212/wnl.12.9.591}.
\item HOLLISTER LE, HARTMAN AM. (1962). \textit{Mescaline, lysergic acid diethylamide and psilocybin comparison of clinical syndromes, effects on color perception and biochemical measures.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/s0010-440x(62)80024-8}{doi:10.1016/s0010-440x(62)80024-8}.
\item REDA GC, VELLA G, CASINI-NENCINI MG, D'AGOSTINO N, CANCRINI L. (1962). \textit{[Initial results of the action of psilocybin in a group of psychiatric patients].}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/13973488}{source link}.
\item WOOLLEY DW, CAMPBELL NK. (1962). \textit{Serotonin-like and antiserotonin properties of psilocybin and psilocin.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1126/science.136.3518.777}{doi:10.1126/science.136.3518.777}.
\item MAXWELL GM, KNEEBONE GM, ELLIOTT RB. (1962). \textit{The effect of psilocybin upon the systemic, pulmonary, and coronary circulation of the intact dog.}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/14471633}{source link}.
\item BENEDICT RG, BRADY LR, TYLER VE. (1962). \textit{Occurrence of psilocin in Psilocybe baeocystis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1002/jps.2600510428}{doi:10.1002/jps.2600510428}.
\item CHRISTIANSEN A, BAUM R, WITT PN. (1962). \textit{Changes in spider webs brought about by mescaline, psilocybin and an increase in body weight.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/s0022-3565(25)26256-5}{doi:10.1016/s0022-3565(25)26256-5}.
\item KALBERER F, KREIS W, RUTSCHMANN J. (1962). \textit{The fate of psilocin in the rat.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/0006-2952(62)90050-3}{doi:10.1016/0006-2952(62)90050-3}.
\item R. G. Benedict, L.R. Brady, Alexander H. Smith, Varro E. Tyler (1961). \textit{Occurrence of psilocybin and psilocin in certain Gonocybe and Psilocybe species.}. Unknown journal. [published; OpenAlex]. \href{https://www.cabdirect.org/abstracts/19631301636.html}{source link}.
\item HEIMANN H. (1961). \textit{[On the treatment of therapy-resistant neuroses with model psychoses (psilocybin)].}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/13906023}{source link}.
\item WOLBACH AB, MINER EJ, ISBELL H. (1961). \textit{Comparison of psilocin with psilocybin, mescaline and LSD-25.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/bf00412109}{doi:10.1007/bf00412109}.
\item DUCHE DJ. (1961). \textit{[The effects of psilocybin in a case of hysteria].}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/13888139}{source link}.
\item HORITA A, WEBER LJ. (1961). \textit{The enzymic dephosphorylation and oxidation of psilocybin and psilocin by mammalian tissue homogenates.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/0006-2952(61)90124-1}{doi:10.1016/0006-2952(61)90124-1}.
\item VITEK V, VOJTECHOVSKY M, GROF S. (1961). \textit{[Serotonin metabolism in experimental psilocybin psychosis].}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/13926289}{source link}.
\item Elemér K. Zsigmond, F. F. Foldes, V. M. Foldes (1961). \textit{The inhibitory effect of psilocybin and related compounds on human cholinesterases}. Unknown journal. [published; OpenAlex]. \href{https://eurekamag.com/research/025/833/025833520.php}{source link}.
\item HOLLISTER LE. (1961). \textit{Clinical, biochemical and psychologic effects of psilocybin.}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/13715376}{source link}.
\item Richard R. Heim (1960). \textit{Psilocybin in psychiatry, and beyond.}. Unknown journal. [published; OpenAlex]. \href{https://www.cabdirect.org/abstracts/19631301013.html}{source link}.
\item Jacoby, John Eric (1960). \textit{The effects of psilocybin and lycergic acid on the extinction of avoidance behavior in rats.}. The Mouseion at the JAXlibrary (Jackson Laboratory). [published; OpenAlex]. \href{https://mouseion.jax.org/strp/1105}{source link}.
\item HEIMANN H. (1960). \textit{[Expressive phenomenology of model psychoses (psilocybin). Comparison with self-description and psychic deficiency of performance].}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/13712866}{source link}.
\item HORITA A, WEBER LJ. (1960). \textit{Dephosphorylation of psilocybin to psilocin by alkaline phosphatase.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3181/00379727-106-26228}{doi:10.3181/00379727-106-26228}.
\item ISBELL H, WOLBACH AB, WIKLER A, MINER EJ. (1960). \textit{Cross tolerance between LSD and psilocybin.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/bf00407974}{doi:10.1007/bf00407974}.
\item HOLFELD H. (1960). \textit{[Psychopsychic correlations under the effect of psycholytics (LSD, psilocybin and similar drugs)].}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/13908338}{source link}.
\item SERCL M, KOVARIK J, JAROS O. (1960). \textit{[Clinical experiences with psilocybin (CY39 Sandoz)].}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/13910754}{source link}.
\item SERCL M, KOVARIK J, JAROS O. (1960). \textit{[Clinical experiences with psilocybin Sandoz (CY39 Sandoz)].}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/13910755}{source link}.
\item CHAUCHARD P, MAZOUE H. (1960). \textit{[Action of psilocybin on the excitability of the nerve centers].}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/24545494}{source link}.
\item F. Silva, R.G. Heath, Thomas Rafferty, Robert A. Johnson, William R. Robinson (1960). \textit{Comparative effects of the administration of taraxein, d-LSD, mescaline, and psilocybin to human volunteers}. Comprehensive Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/s0010-440x(60)80060-0}{doi:10.1016/s0010-440x(60)80060-0}.
\item POLLARD JC, BAKKER C, UHR L, FEUERFILE DF. (1960). \textit{Controlled sensory input: a note on the technic of drug evaluation with a preliminary report on a comparative study of sernyl, psilocybin, and LSD-25.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/s0010-440x(60)80061-2}{doi:10.1016/s0010-440x(60)80061-2}.
\item HOLLISTER LE, PRUSMACK JJ, PAULSEN A, ROSENQUIST N. (1960). \textit{Comparison of three psychotropic drugs (psilocybin, JB-329, and IT-290) in volunteer subjects.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1097/00005053-196011000-00007}{doi:10.1097/00005053-196011000-00007}.
\item GESSNER PK, KHAIRALLAH PA, McISAAC WM, PAGE IH. (1960). \textit{The relationship between the metabolic fate and pharmacological actions of serotonin, bufotenine and psilocybin.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/s0022-3565(25)25873-6}{doi:10.1016/s0022-3565(25)25873-6}.
\item Unknown authors (1960). \textit{Psilocybin, Its History and Pharmacology.}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/20326260}{source link}.
\item Unknown authors (1960). \textit{[PSILOCYBIN].}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/13858316}{source link}.
\item S MALITZ, H ESECOVER, B WILKENS, P HOCH (1960). \textit{Some observations on psilocybin, a new hallucinogen, in volunteer subjects}. Corrosion Science. [published; OpenAlex]. \href{https://doi.org/10.1016/s0010-938x(60)80004-2}{doi:10.1016/s0010-938x(60)80004-2}.
\item MALITZ S, ESECOVER H, WILKENS B, HOCH PH. (1960). \textit{Some observations on psilocybin, a new hallucinogen, in volunteer subjects.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/s0010-440x(60)80045-4}{doi:10.1016/s0010-440x(60)80045-4}.
\item ROUBICEK J, DRVOTA S. (1960). \textit{[Psilocybin, a new hallucinogen].}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/14439519}{source link}.
\item K. S�llner (1959). \textit{Zur Identifizierung von Psilocin, einem psychotropen Inhaltstoff mexikanischer Rauschpilze der Gattungen Psilocybe und Stropharia}. Analytical and Bioanalytical Chemistry. [published; OpenAlex]. \href{https://doi.org/10.1007/bf00449214}{doi:10.1007/bf00449214}.
\item Henri Michaux (1959). \textit{Psilocybin (experiments and subjective criticism).}. Unknown journal. [published; OpenAlex]. \href{https://www.cabdirect.org/cabdirect/abstract/19631300232}{source link}.
\item Harold A. Abramson, Anabela P. Rolo, B. Sklarofsky, J. Stache (1959). \textit{Production of Cross-Tolerance to Psychosis-Producing Doses of Lysergic Acid Diethylamide and Psilocybin}. The Journal of Psychology. [published; OpenAlex]. \href{https://doi.org/10.1080/00223980.1960.9916396}{doi:10.1080/00223980.1960.9916396}.
\item WEIDMANN H, CERLETTI A. (1959). \textit{Studies on psilocybin and related compounds. I. Communication. Structure/activity relationship of oxyindole-derivatives with regard to their effect on the knee jerk of spinal cats.}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/13843476}{source link}.
\item CERLETTI A. (1959). \textit{[Teonanacatl and psilocybin].}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1055/s-0028-1114618}{doi:10.1055/s-0028-1114618}.
\item DELAY J, PICHOT P, LEMPERIERE T, QUETIN AM. (1959). \textit{[Therapeutic effect of psilocybin on convulsive neurosis].}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/13815609}{source link}.
\item MONNIER M. (1959). \textit{[The action of psilocybin on the rabbit brain].}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/bf02158550}{doi:10.1007/bf02158550}.
\item W. de Borr (1959). \textit{Psilocybin - eine neue psychotrope Substanz}. DMW - Deutsche Medizinische Wochenschrift. [published; OpenAlex]. \href{https://doi.org/10.1055/s-0028-1114457}{doi:10.1055/s-0028-1114457}.
\item Unknown authors (1959). \textit{[PSILOCYBIN, a new psychotropic substance].}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/13857060}{source link}.
\item HOFMANN A, TROXLER F. (1959). \textit{[Identification of psilocin].}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/bf02166696}{doi:10.1007/bf02166696}.
\item F. Troxler, Frauke Seemann, A. Hofmann (1958). \textit{Abwandlungsprodukte von Psilocybin und Psilocin. 2. Mitteilung über synthetische Indolverbindungen}. Helvetica Chimica Acta. [published; OpenAlex]. \href{https://doi.org/10.1002/hlca.19590420638}{doi:10.1002/hlca.19590420638}.
\item A. Hofmann, Richard R. Heim, A. Brack, H. Kobel, A. Frey, H. Ott, Th. Petrzilka, F. Troxler (1958). \textit{Psilocybin und Psilocin, zwei psychotrope Wirkstoffe aus mexikanischen Rauschpilzen}. Helvetica Chimica Acta. [published; OpenAlex]. \href{https://doi.org/10.1002/hlca.19590420518}{doi:10.1002/hlca.19590420518}.
\item DELAY J, THUILLIER J, NAKAJIMA H, DURANDIN MC. (1958). \textit{[Effect of psilocybin on the behavior of normal mice \& waltzing mice; comparison with lysergic acid monoethylamide \& diethylamide].}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/13663414}{source link}.
\item GNIRSS F. (1958). \textit{[Studies on psilocybin, a hallucinogenic drug from the Mexican mushroom Psilocybe mexicana].}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/13850311}{source link}.
\item ISBELL H. (1958). \textit{Comparison of the reactions induced by psilocybin and LSD-25 in man.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/bf00408109}{doi:10.1007/bf00408109}.
\item RUEMMELE W. (1958). \textit{[The place of psilocybin among other psychotropic substances].}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/14440055}{source link}.
\item HOFMANN A, FREY A, OTT H, PETR ZILKA T, TROXLER F. (1958). \textit{[Elucidation of the structure and the synthesis of psilocybin].}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/bf02160424}{doi:10.1007/bf02160424}.
\item WEIDMANN H, TAESCHLER M, KONZETT H. (1958). \textit{[The pharmacology of psilocybin, an ac' principle from Psilocybe mexicana Heim].}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/bf02159166}{doi:10.1007/bf02159166}.
\item HOFMANN A, HEIM R, BRACK A, KOBEL H. (1958). \textit{[Psilocybin, a psychotropic substance from the Mexican mushroom Psilicybe mexicana Heim].}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/bf02159243}{doi:10.1007/bf02159243}.
\item A. Hofmann, Richard R. Heim, A. Brack, H. Kobel (1957). \textit{Psilocybin, an active psychotropic material from the Mexican hallucinogenic fungus.}. Unknown journal. [published; OpenAlex]. \href{https://www.cabdirect.org/abstracts/19601300599.html}{source link}.
\item Richard R. Heim, A. Brack, H. Kobel, A. Hofmann, R Cailleux (1957). \textit{The determination of the formation of the carpophores and sclerotia in culture of Psilocybe mexicana Heim, a Mexican, hallucinogenic agaric, and the demonstration of the presence of psilocybin and psilocin.}. Unknown journal. [published; OpenAlex]. \href{https://www.cabdirect.org/abstracts/19601300598.html}{source link}.
\end{enumerate}
\end{document}
